PTID 4,Gender,Age,Vaccine name,Visit/Time point,Days since 2nd dose,Days since 3rd dose,Comments,COVID+ during study,Days since 1st infection,Days since 2nd infection,Analysis date,COV2G,COV2R,COV2E,COV2NG,COV2NR,PTID_Visit,COV2NW,COV2ND,COV2NO,Disease,Diagnosis,Immunosuppressive therapy,Type of medication,Currently treated,Group,Simplified,Other relevant diagnosis,Other relevant treatment,DX,T1,T2,T3,T4,RTXBF,ptgroup,EMA_meds,codelist_meds,atc_codelist,ema_codelist
CTL001,M,65.1,Pfizer,V3,31,NA,NA,NA,NA,NA,15/mar/2021,Positif,106.8,NA,NA,NA,CTL001V3b,332.9,190.5,44.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL001,M,65.1,Pfizer,V4,89,NA,NA,NA,NA,NA,12/mai/2021,Positif,93.3,NA,NA,NA,CTL001V4b,196,118,25,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL001,M,65.1,Pfizer,V5,187,NA,NA,NA,NA,NA,18/aoû/2021,Positif,31.8,NA,Positif,9.2,CTL001V5b,58.9,51.6,11,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL001,M,65.1,Pfizer,3M3,368,81,NA,NA,NA,NA,15/fév/2022,Positif,99.8,2575,Positif,6.3,CTL001 3M3,956.9,539.7,192,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL001,M,65.1,Pfizer,3M6,466,179,NA,NA,NA,NA,24/mai/2022,Positif,159.8,6574,Positif,7.8,CTL001 3M6,636.9,361.4,156.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL002,M,41.2,Moderna,V3,36,NA,NA,V5+-3M3,NA,NA,06/avr/2021,Positif,130.3,NA,NA,NA,CTL002V3b,386,129.6,18.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL002,M,41.2,Moderna,V4,92,NA,NA,V5+-3M3,NA,NA,01/jun/2021,Positif,91.8,NA,NA,NA,CTL002V4b,411,208,86,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL002,M,41.2,Moderna,V5,179,NA,NA,V5+-3M3,NA,NA,27/aoû/2021,Positif,85.8,NA,Négatif,0.7,CTL002V5b,276.2,160,92.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL002,M,41.2,Moderna,V5+,316,34,NA,V5+-3M3,NA,NA,11/jan/2022,Positif,150.2,5810,Négatif,0.3,CTL002V5+,1390.6,378.8,170.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL002,M,41.2,Moderna,3M3,361,79,NA,V5+-3M3,29,NA,25/fév/2022,Positif,100.6,2616,Positif,24.3,CTL002 3M3,2430,1327.5,798.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL003,F,25.2,Moderna/Pfizer,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Positif,112,NA,NA,NA,CTL003V3b,561.2,188,19.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL003,F,25.2,Moderna/Pfizer,V4,91,NA,NA,NA,NA,NA,24/jun/2021,Positif,85.2,NA,Négatif,1.6,CTL003V4b,11,45,10,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL003,F,25.2,Moderna/Pfizer,V5,186,NA,NA,NA,NA,NA,27/sep/2021,Positif,60.5,NA,Négatif,1.1,CTL003V5b,88.1,40.6,13.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL003,F,25.2,Moderna/Pfizer,V5+,301,42,NA,NA,NA,NA,20/jan/2022,Positif,99.7,2570,Négatif,0.3,CTL003V5+,1083.9,477.6,214.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL003,F,25.2,Moderna/Pfizer,3M3,350,91,NA,NA,NA,NA,10/mar/2022,Positif,80.8,1693,Négatif,0,CTL003 3M3,562.4,199.7,152.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL004,M,85.1,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,23/mar/2021,Positif,72,NA,NA,NA,CTL004V3b,67.3,33.6,16,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL004,M,85.1,Pfizer,V4,94,NA,NA,V5-V6,NA,NA,27/mai/2021,Positif,38.5,NA,NA,NA,CTL004V4b,34.7,18.3,8.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL004,M,85.1,Pfizer,V5,176,NA,NA,V5-V6,NA,NA,17/aoû/2021,Positif,15.1,NA,Négatif,0.3,CTL004V5b,24.7,16,7.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL004,M,85.1,Pfizer,V6,368,176,NA,V5-V6,17,NA,25/fév/2022,Positif,100.8,2626,Indéterminé,4.9,CTL004V6,361,194.7,153,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,V3,28,NA,NA,NA,NA,NA,29/mar/2021,Positif,90.3,NA,NA,NA,CTL005V3b,439.2,193.1,18.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,V4,92,NA,NA,NA,NA,NA,01/jun/2021,Positif,93.8,NA,NA,NA,CTL005V4b,303,131,47,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,V5,185,NA,NA,NA,NA,NA,02/sep/2021,Positif,67.2,NA,Négatif,0.3,CTL005V5b,162,93.8,51.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,V5+,318,36,NA,NA,NA,NA,13/jan/2022,Positif,97.1,2438,Négatif,0.2,CTL005V5+,948.8,338.3,147.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,3M3,367,85,NA,NA,NA,NA,03/mar/2022,Positif,98.7,2519,Négatif,0.2,CTL005 3M3,433.8,175.6,86.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL005,F,60.2,Moderna,3M6,458,176,NA,NA,NA,NA,02/jun/2022,Positif,177.7,8126,Négatif,0,CTL005 3M6,492.8536224741252,156.25,71.27583749109051,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL006,F,61.2,Moderna,V3,32,NA,NA,V5+-3M3,NA,NA,20/avr/2021,Positif,133.1,NA,NA,NA,CTL006V3b,343.9,108.2,52.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL006,F,61.2,Moderna,V4,94,NA,NA,V5+-3M3,NA,NA,21/jun/2021,Positif,76.5,NA,Négatif,0.7,CTL006V4b,189,61,23.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL006,F,61.2,Moderna,V5,186,NA,NA,V5+-3M3,NA,NA,21/sep/2021,Positif,48.8,NA,Négatif,0.7,CTL006V5b,143,57.1,26.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL006,F,61.2,Moderna,V5+,304,29,NA,V5+-3M3,NA,NA,17/jan/2022,Positif,129.9,4350,Négatif,0.5,CTL006V5+,931.1,208.5,148.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL006,F,61.2,Moderna,3M3,368,93,NA,V5+-3M3,18,NA,22/mar/2022,Positif,95.7,2369,Positif,13.5,CTL006 3M3,2233.1,772.8,1044.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL007,F,37.2,Moderna,V3,31,NA,NA,NA,NA,NA,01/avr/2021,Positif,146.8,NA,NA,NA,CTL007V3b,534.2,280.3,97.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL007,F,37.2,Moderna,V4,92,NA,NA,NA,NA,NA,01/jun/2021,Positif,68.5,NA,NA,NA,CTL007V4b,190.5,94.1,31.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL007,F,37.2,Moderna,V5,189,NA,NA,NA,NA,NA,06/sep/2021,Positif,43.9,NA,Négatif,0.3,CTL007V5b,127.5,69.1,25.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL007,F,37.2,Moderna,3M3,351,78,NA,NA,NA,NA,15/fév/2022,Positif,102.3,2704,Négatif,0.2,CTL007 3M3,795.5,336.9,181.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL007,F,37.2,Moderna,3M6,449,176,NA,NA,NA,NA,24/mai/2022,Positif,163.6,6890,Négatif,0.2,CTL007 3M6,366.7,227.6,108.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL008,M,63.2,Moderna,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Positif,98.5,NA,NA,NA,CTL008V3b,438.8,138.9,15.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL008,M,63.2,Moderna,V4,91,NA,NA,NA,NA,NA,24/jun/2021,Positif,84.9,NA,Négatif,0.6,CTL008V4b,381,161,50,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL008,M,63.2,Moderna,V5,186,NA,NA,NA,NA,NA,27/sep/2021,Positif,83.2,NA,Négatif,0.4,CTL008V5b,235.5,141.6,61.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL008,M,63.2,Moderna,3M3,361,88,NA,NA,NA,NA,21/mar/2022,Positif,93.8,2276,Négatif,0,CTL008 3M3,921.7,349.4,103.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL009,F,26.2,Moderna/Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,28/avr/2021,Positif,103.3,NA,NA,NA,CTL009V3b,433.1,138.2,34.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL009,F,26.2,Moderna/Pfizer,V4,94,NA,NA,V5-3M3,NA,NA,28/jun/2021,Positif,82.4,NA,Négatif,3,CTL009V4b,196,99,46,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL009,F,26.2,Moderna/Pfizer,V5,185,NA,NA,V5-3M3,NA,NA,27/sep/2021,Positif,58.3,NA,Négatif,1.7,CTL009V5b,188.3,102.5,47,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL009,F,26.2,Moderna/Pfizer,3M3,374,109,NA,V5-3M3,75,NA,04/avr/2022,Positif,98.4,2503,Négatif,2.5,CTL009 3M3,1092.2,469.3,321.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL011,M,33.2,Pfizer,V3,31,NA,NA,NA,NA,NA,19/avr/2021,Positif,118,NA,NA,NA,CTL011V3b,681.2,214,108,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL011,M,33.2,Pfizer,V4,94,NA,NA,NA,NA,NA,21/jun/2021,Positif,87,NA,Négatif,2.9,CTL011V4b,221.2,85.4,46.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL011,M,33.2,Pfizer,V5,186,NA,NA,NA,NA,NA,21/sep/2021,Positif,50.3,NA,Négatif,3.1,CTL011V5b,136.9,75.2,43.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL011,M,33.2,Pfizer,V5+,307,37,NA,NA,NA,NA,20/jan/2022,Positif,80.9,1697,Négatif,1.8,CTL011V5+,1150,496,221.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL011,M,33.2,Pfizer,3M3,368,98,NA,NA,NA,NA,22/mar/2022,Positif,96.7,2418,Négatif,0.1,CTL011 3M3,594.5,271.8,203.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,V3,32,NA,NA,3M3-3M6,NA,NA,19/avr/2021,Positif,134.8,NA,NA,NA,CTL012V3b,134.7,58.5,13.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,V4,90,NA,NA,3M3-3M6,NA,NA,16/jun/2021,Positif,61.1,NA,Négatif,1,CTL012V4b,89.8,49.3,19.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,V5,187,NA,NA,3M3-3M6,NA,NA,21/sep/2021,Positif,23.8,NA,Négatif,1,CTL012V5b,36.5,29.7,11.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,V5+,298,33,NA,3M3-3M6,NA,NA,10/jan/2022,Positif,122.7,3883,Négatif,0.2,CTL012V5+,473.5,221.6,147,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,3M3,365,100,NA,3M3-3M6,NA,NA,18/mar/2022,Positif,98.8,2524,Négatif,0.2,CTL012 3M3,262.8,186.1,91.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,3M3+,400,135,NA,3M3-3M6,18,NA,22/avr/2022,Positif,77.4,1555,Positif,19.2,CTL012 3M3+,2430,2062.3,1107.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL012,F,43.2,Pfizer,3M6,439,174,NA,3M3-3M6,57,NA,31/mai/2022,Positif,116.4,3496,Positif,7.3,CTL012 3M6,24330,1804.7,1108.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL013,F,30.2,Pfizer,V3,33,NA,NA,NA,NA,NA,19/avr/2021,Positif,122.4,NA,NA,NA,CTL013V3b,647.2,322.8,178.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL013,F,30.2,Pfizer,V4,92,NA,NA,NA,NA,NA,17/jun/2021,Positif,98.6,NA,Négatif,0.3,CTL013V4b,264.4,140.8,73.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL013,F,30.2,Pfizer,V5,183,NA,NA,NA,NA,NA,16/sep/2021,Positif,77.4,NA,Négatif,0.2,CTL013V5b,302.1,153.1,93.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL013,F,30.2,Pfizer,3M3,379,122,NA,NA,NA,NA,31/mar/2022,Positif,99.3,2549,Positif,9.8,CTL013 3M3,272.6,178.9,130.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL013,F,30.2,Pfizer,3M6,432,175,NA,NA,NA,NA,23/mai/2022,Positif,145.9,5483,Positif,7.5,CTL013 3M6,288.8,149.4,148.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL014,F,60.2,Moderna,V3,31,NA,NA,NA,NA,NA,29/avr/2021,Positif,102.4,NA,NA,NA,CTL014V3b,156,33.1,8.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL014,F,60.2,Moderna,V4,99,NA,NA,NA,NA,NA,06/jui/2021,Positif,77.9,NA,Négatif,0.4,CTL014V4b,147,65,35,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL014,F,60.2,Moderna,V5,184,NA,NA,NA,NA,NA,29/sep/2021,Positif,37.8,NA,Négatif,0.4,CTL014V5b,83.8,49.5,28.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL014,F,60.2,Moderna,3M3,379,95,NA,NA,NA,NA,12/avr/2022,Positif,94,2286,Négatif,0.2,CTL014 3M3,388.5,157.1,81.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL015,F,55.2,Pfizer,V3,33,NA,NA,V5-V5+,NA,NA,20/avr/2021,Positif,123.2,NA,NA,NA,CTL015V3b,101.7,36.9,10.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL015,F,55.2,Pfizer,V4,98,NA,NA,V5-V5+,NA,NA,24/jun/2021,Positif,57,NA,Négatif,1.7,CTL015V4b,76,43,20,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL015,F,55.2,Pfizer,V5,189,NA,NA,V5-V5+,NA,NA,23/sep/2021,Positif,44.7,NA,Négatif,0.7,CTL015V5b,79.3,75.6,37.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL015,F,55.2,Pfizer,V5+,307,49,NA,V5-V5+,14,NA,19/jan/2022,Positif,105,2848,Positif,9.1,CTL015V5+,1450.7,484.7,410,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL015,F,55.2,Pfizer,3M3,348,90,NA,V5-V5+,55,NA,01/mar/2022,Positif,98.7,2519,Positif,17.3,CTL015 3M3,2069.1,813.7,688.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL016,F,46.2,Moderna,V3,34,NA,NA,V5-3M3,NA,NA,27/avr/2021,Positif,141,NA,NA,NA,CTL016V3b,628.9,276.2,26.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL016,F,46.2,Moderna,V4,90,NA,NA,V5-3M3,NA,NA,22/jun/2021,Positif,60.8,NA,Négatif,2,CTL016V4b,259,135,34,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL016,F,46.2,Moderna,V5,181,NA,NA,V5-3M3,NA,NA,21/sep/2021,Positif,64.2,NA,Négatif,1.3,CTL016V5b,168.4,119.8,46.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL016,F,46.2,Moderna,3M3,356,94,NA,V5-3M3,77,NA,15/mar/2022,Positif,94.8,2325,Indéterminé,5.8,CTL016 3M3,2098.6,854,427.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL017,F,38.2,Moderna,V3,31,NA,NA,V5+-3M3,NA,NA,29/avr/2021,Positif,99.4,NA,NA,NA,CTL017V3b,250.6,84.7,40.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL017,F,38.2,Moderna,V4,92,NA,NA,V5+-3M3,NA,NA,29/jun/2021,Positif,58.9,NA,Négatif,0.7,CTL017V4b,58,16,7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL017,F,38.2,Moderna,V5,185,NA,NA,V5+-3M3,NA,NA,30/sep/2021,Positif,32.6,NA,Négatif,0.7,CTL017V5b,39.8,19.9,11.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL017,F,38.2,Moderna,V5+,290,35,NA,V5+-3M3,NA,NA,13/jan/2022,Positif,96.8,2423,Négatif,1.1,CTL017V5+,724.6,264.6,153.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL017,F,38.2,Moderna,3M3,333,78,NA,V5+-3M3,29,NA,25/fév/2022,Positif,98.9,2529,Indéterminé,4.5,CTL017 3M3,709.2,323.8,415.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,V3,30,NA,NA,NA,NA,NA,20/mai/2021,Positif,89.6,NA,NA,NA,CTL018V3b,508.1,210.5,73.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,V4,91,NA,NA,NA,NA,NA,20/jui/2021,Positif,68.2,NA,Négatif,2.1,CTL018V4b,335.9,158.1,42.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,V5,189,NA,NA,NA,NA,NA,26/oct/2021,Positif,66.1,NA,Négatif,2.1,CTL018V5b,237.8,109.4,37.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,V5+,266,40,NA,NA,NA,NA,11/jan/2022,Positif,154.8,6170,Négatif,1.5,CTL018V5+,740.7,256.9,82.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,3M3,324,98,NA,NA,NA,NA,10/mar/2022,Positif,82,1743,Négatif,0.9,CTL018 3M3,249,106.5,39.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL018,F,41.3,Moderna,3M6,406,180,NA,NA,NA,NA,31/mai/2022,Positif,89.8,2088,Négatif,1,CTL018 3M6,152.4,72.8,26.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL019,F,50.2,Moderna,V3,30,NA,NA,NA,NA,NA,21/avr/2021,Positif,103.1,NA,NA,NA,CTL019V3b,516.3,208.2,47,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL019,F,50.2,Moderna,V4,92,NA,NA,NA,NA,NA,22/jun/2021,Positif,59.3,NA,Négatif,1.3,CTL019V4b,413,200,82,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL019,F,50.2,Moderna,V5,185,NA,NA,NA,NA,NA,23/sep/2021,Positif,80.6,NA,Négatif,0.6,CTL019V5b,258.3,155.4,70.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL019,F,50.2,Moderna,V5+,302,35,NA,NA,NA,NA,18/jan/2022,Positif,110.6,3158,Négatif,1,CTL019V5+,1631.6,577.4,236.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL019,F,50.2,Moderna,3M3,365,98,NA,NA,NA,NA,22/mar/2022,Positif,100.4,2605,Négatif,0.6,CTL019 3M3,712.8,272.2,156.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL021,F,33.2,Pfizer,V3,36,NA,NA,NA,NA,NA,04/mai/2021,Positif,84.8,NA,NA,NA,CTL021V3b,114.7,41.3,4.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL021,F,33.2,Pfizer,V4,101,NA,NA,NA,NA,NA,08/jui/2021,Positif,62.7,NA,Négatif,0.1,CTL021V4b,59.5,37.4,15.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL021,F,33.2,Pfizer,V5,178,NA,NA,NA,NA,NA,23/sep/2021,Positif,34.2,NA,Négatif,0.1,CTL021V5b,56.7,41.8,20.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL021,F,33.2,Pfizer,3M3,374,122,NA,NA,NA,NA,07/avr/2022,Positif,104.3,2811,Négatif,0,CTL021 3M3,158,92.4,34.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL021,F,33.2,Pfizer,3M6,428,176,NA,NA,NA,NA,31/mai/2022,Positif,88.9,2046,Négatif,0.3,CTL021 3M6,96.8,68.9,27.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,110.4,NA,NA,NA,CTL022V3b,614.6,204.2,125.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,V4,90,NA,NA,NA,NA,NA,28/jun/2021,Positif,82.4,NA,Négatif,1.4,CTL022V4b,152.4,56.8,16.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,V5,184,NA,NA,NA,NA,NA,30/sep/2021,Positif,48.5,NA,Négatif,1.6,CTL022V5b,117.5,73.8,55.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,V5+,287,36,NA,NA,NA,NA,11/jan/2022,Positif,148.9,5710,Négatif,0.3,CTL022V5+,765.1,247.5,177.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,3M3,356,105,NA,NA,NA,NA,21/mar/2022,Positif,88.7,2037,Négatif,0,CTL022 3M3,293,120.8,114.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL022,F,54.2,Pfizer,3M6,419,168,NA,NA,NA,NA,23/mai/2022,Positif,119.5,3684,Négatif,0.2,CTL022 3M6,121.5,64.9,62.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL023,F,24.3,Moderna,V3,32,NA,NA,V5-3M3,NA,NA,17/mai/2021,Positif,107.7,NA,NA,NA,CTL023V3b,484.3,144.1,73.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL023,F,24.3,Moderna,V4,97,NA,NA,V5-3M3,NA,NA,21/jui/2021,Positif,70,NA,Négatif,0.2,CTL023V4b,283,86.1,27.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL023,F,24.3,Moderna,V5,182,NA,NA,V5-3M3,NA,NA,14/oct/2021,Positif,52.9,NA,Négatif,0.3,CTL023V5b,186.6,83.3,48.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL023,F,24.3,Moderna,3M3,361,81,NA,V5-3M3,76,NA,11/avr/2022,Positif,99.9,2580,Négatif,2.7,CTL023 3M3,1527.7,655.3,408,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL024,F,43.2,Moderna/Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,29/avr/2021,Positif,105.1,NA,NA,NA,CTL024V3b,969.9,366.3,169.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL024,F,43.2,Moderna/Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,29/jun/2021,Positif,85.1,NA,Négatif,0.8,CTL024V4b,279.6,89.1,29.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL024,F,43.2,Moderna/Pfizer,V5,185,NA,NA,V5-3M3,NA,NA,30/sep/2021,Positif,57.1,NA,Négatif,0.6,CTL024V5b,273.9,71.6,40.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL024,F,43.2,Moderna/Pfizer,3M3,372,99,NA,V5-3M3,60,NA,05/avr/2022,Positif,121.6,3814,Positif,13.6,CTL024 3M3,1648.8,894.5,1035.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL025,F,37.3,Moderna,V3,28,NA,NA,V5-V5+,NA,NA,18/mai/2021,Positif,94.1,NA,NA,NA,CTL025V3b,644.3,247.2,97.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL025,F,37.3,Moderna,V4,98,NA,NA,V5-V5+,NA,NA,27/jui/2021,Positif,78.8,NA,Négatif,1,CTL025V4b,406,178.8,81,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL025,F,37.3,Moderna,V5,184,NA,NA,V5-V5+,NA,NA,21/oct/2021,Positif,63.8,NA,Négatif,0.7,CTL025V5b,164.8,77.9,45,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL025,F,37.3,Moderna,V5+,272,31,NA,V5-V5+,16,NA,17/jan/2022,Positif,132.2,4505,Négatif,0.7,CTL025V5+,431.2,184.1,100.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL025,F,37.3,Moderna,3M3,356,115,NA,V5-V5+,100,NA,11/avr/2022,Positif,98.9,2529,Négatif,0.4,CTL025 3M3,291.7,142.3,64.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL026,F,60.2,Pfizer,V3,33,NA,NA,NA,NA,NA,28/avr/2021,Positif,96.5,NA,NA,NA,CTL026V3b,515.7,132.2,41.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL026,F,60.2,Pfizer,V4,96,NA,NA,NA,NA,NA,30/jun/2021,Positif,77.5,NA,Négatif,0.5,CTL026V4b,354,115,63,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL026,F,60.2,Pfizer,V5,180,NA,NA,NA,NA,NA,22/sep/2021,Positif,81.4,NA,Négatif,0.2,CTL026V5b,239.3,106.2,74.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL026,F,60.2,Pfizer,V5+,297,14,NA,NA,NA,NA,17/jan/2022,Positif,119.3,3672,Positif,16.3,CTL026V5+,2430,2227.2,925.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL026,F,60.2,Pfizer,3M3,360,77,NA,NA,NA,NA,21/mar/2022,Positif,82.4,1760,Positif,8.6,CTL026 3M3,6105,1426.5,656.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL027,M,72.1,Pfizer,V3,36,NA,NA,NA,NA,NA,17/mar/2021,Positif,140.1,NA,NA,NA,CTL027V3b,55.5,18,2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL027,M,72.1,Pfizer,V4,90,NA,NA,NA,NA,NA,10/mai/2021,Positif,76.2,NA,NA,NA,CTL027V4b,109,41,24,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL027,M,72.1,Pfizer,V5,181,NA,NA,NA,NA,NA,09/aoû/2021,Positif,31.2,NA,Négatif,0.1,CTL027V5b,39.2,23,9.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL027,M,72.1,Pfizer,3M3,363,89,NA,NA,NA,NA,07/fév/2022,Positif,102.1,2694,Négatif,0.1,CTL027 3M3,191.8,66.7,46.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL027,M,72.1,Pfizer,3M6,447,173,NA,NA,NA,NA,02/mai/2022,Positif,113.5,3325,Négatif,0,CTL027 3M6,104.14496979795877,43.196544276457885,38.12428516965307,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL028,F,49.3,Pfizer,V3,31,NA,NA,NA,NA,NA,03/jun/2021,Positif,104.6,NA,NA,NA,CTL028V3b,540.8,112.2,44.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL028,F,49.3,Pfizer,V4,99,NA,NA,NA,NA,NA,10/aoû/2021,Positif,62.4,NA,Négatif,1.1,CTL028V4b,164,61,29,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL028,F,49.3,Pfizer,V5,183,NA,NA,NA,NA,NA,02/nov/2021,Positif,48,NA,Négatif,0.9,CTL028V5b,116.4,56.6,31.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL028,F,49.3,Pfizer,V5+,255,34,NA,NA,NA,NA,13/jan/2022,Positif,88.4,2023,Négatif,0.8,CTL028V5+,1453.9,592.8,303.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL028,F,49.3,Pfizer,3M3,317,96,NA,NA,NA,NA,16/mar/2022,Positif,91.7,2176,Négatif,0.1,CTL028 3M3,591.4,249.8,182,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL029,F,49.5,Pfizer,V3,34,NA,NA,NA,NA,NA,10/aoû/2021,Positif,67.4,NA,Négatif,0.2,CTL029V3b,195.2,128.4,55.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL029,F,49.5,Pfizer,V4,97,NA,NA,NA,NA,NA,12/oct/2021,Positif,39,NA,Négatif,0.1,CTL029V4b,72.2,38.9,15,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL029,F,49.5,Pfizer,V5,183,NA,NA,NA,NA,NA,06/jan/2022,Positif,29.4,232,Négatif,0.1,CTL029V5b,35.2,28.8,10.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL029,F,49.5,Pfizer,3M3,266,82,NA,NA,NA,NA,30/mar/2022,Positif,88.2,2014,Négatif,0,CTL029 3M3,239.4,138.4,72,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Positif,96.1,NA,NA,NA,CTL031V3b,241.4,45.9,6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,V4,95,NA,NA,NA,NA,NA,28/jun/2021,Positif,81.1,NA,Négatif,0,CTL031V4b,169,66,29,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,V5,181,NA,NA,NA,NA,NA,22/sep/2021,Positif,60,NA,Négatif,0,CTL031V5b,76.9,35.6,15.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,V5+,292,33,NA,NA,NA,NA,11/jan/2022,Positif,157.7,6403,Positif,6.4,CTL031V5+,1557.9,470.6,329.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,3M3,372,113,NA,NA,NA,NA,01/avr/2022,Positif,91.7,2176,Négatif,2.4,CTL031 3M3,1161.3,374,223.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL031,F,42.2,Moderna,3M6,434,175,NA,NA,NA,NA,02/jun/2022,Positif,218.3,12256,Négatif,1.5,CTL031 3M6,725.6894049346879,270.7825616030328,237.81212841854932,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL032,M,40.2,Moderna,V3,35,NA,NA,NA,NA,NA,29/avr/2021,Positif,115.2,NA,NA,NA,CTL032V3b,1067.2,508.1,165.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL032,M,40.2,Moderna,V4,89,NA,NA,NA,NA,NA,22/jun/2021,Positif,58.3,NA,Négatif,0.5,CTL032V4b,396,193.5,74.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL032,M,40.2,Moderna,V5,187,NA,NA,NA,NA,NA,28/sep/2021,Positif,81.5,NA,Négatif,0.3,CTL032V5b,446.8,210.3,107.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL032,M,40.2,Moderna,V5+,302,31,NA,NA,NA,NA,21/jan/2022,Positif,129.5,4323,Positif,37.6,CTL032V5+,719.4,392.6,214,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL032,M,40.2,Moderna,3M3,362,91,NA,NA,NA,NA,22/mar/2022,Positif,96.9,2428,Positif,14.8,CTL032 3M3,566.9,289.4,221.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL033,M,80.1,Pfizer,V3,40,NA,NA,NA,NA,NA,31/mar/2021,Positif,133.4,NA,NA,NA,CTL033V3b,328.8,122.3,68.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL033,M,80.1,Pfizer,V4,89,NA,NA,NA,NA,NA,19/mai/2021,Positif,77.1,NA,NA,NA,CTL033V4b,161.3,56.2,22.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL033,M,80.1,Pfizer,V5,181,NA,NA,NA,NA,NA,19/aoû/2021,Positif,43.5,NA,Négatif,0.9,CTL033V5b,70.1,39.2,19.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL033,M,80.1,Pfizer,3M3,363,94,NA,NA,NA,NA,17/fév/2022,Positif,122.2,3852,Négatif,0.8,CTL033 3M3,832.6,285.9,210,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL033,M,80.1,Pfizer,3M6,451,182,NA,NA,NA,NA,16/mai/2022,Positif,134.3,4649,Positif,17.3,CTL033 3M6,2430,2300.4,2023.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL034,F,43.2,Moderna,V3,35,NA,NA,NA,NA,NA,03/mai/2021,Positif,125.3,NA,NA,NA,CTL034V3b,398.1,103.9,16.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL034,F,43.2,Moderna,V4,94,NA,NA,NA,NA,NA,01/jui/2021,Positif,78.2,NA,Négatif,0.1,CTL034V4b,147,57,16,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL034,F,43.2,Moderna,V5,185,NA,NA,NA,NA,NA,30/sep/2021,Positif,37.6,NA,Négatif,0.1,CTL034V5b,89,53,22.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL034,F,43.2,Moderna,V5+,290,35,NA,NA,NA,NA,13/jan/2022,Positif,88.6,2033,Négatif,0.1,CTL034V5+,1002.9,384.6,210.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL034,F,43.2,Moderna,3M3,358,103,NA,NA,NA,NA,22/mar/2022,Positif,97.4,2453,Positif,15.6,CTL034 3M3,1463.9,1124.2,994,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,110.1,NA,NA,NA,CTL035V3b,343.6,166.4,67.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,V4,92,NA,NA,NA,NA,NA,30/jun/2021,Positif,58,NA,Négatif,0.7,CTL035V4b,127.5,66.5,27.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,V5,184,NA,NA,NA,NA,NA,30/sep/2021,Positif,34.7,NA,Négatif,0.7,CTL035V5b,89.6,50.9,17.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,V5+,293,39,NA,NA,NA,NA,17/jan/2022,Positif,103.1,2747,Négatif,0.4,CTL035V5+,150.7,68.2,58,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,3M3,343,89,NA,NA,NA,NA,08/mar/2022,Positif,75.1,1464,Négatif,0.3,CTL035 3M3,146.9,74.5,46.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL035,F,49.2,Moderna,3M6,414,160,NA,NA,NA,NA,18/mai/2022,Positif,67.2,1175,Négatif,0.3,CTL035 3M6,80.1,45.9,28.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL036,M,74.2,Pfizer,V3,31,NA,NA,NA,NA,NA,29/mar/2021,Positif,57.5,NA,NA,NA,CTL036V3b,136.7,62.5,19.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL036,M,74.2,Pfizer,V4,89,NA,NA,NA,NA,NA,26/mai/2021,Positif,29,NA,NA,NA,CTL036V4b,43,14,6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL036,M,74.2,Pfizer,V5,186,NA,NA,NA,NA,NA,31/aoû/2021,Positif,19.8,NA,Négatif,0.3,CTL036V5b,1,1,1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL036,M,74.2,Pfizer,3M3,361,97,NA,NA,NA,NA,22/fév/2022,Positif,83.7,1816,Négatif,0.2,CTL036 3M3,224.4,66,53.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL036,M,74.2,Pfizer,3M6,445,181,NA,NA,NA,NA,17/mai/2022,Positif,86.5,1938,Négatif,0,CTL036 3M6,65.7,20.6,24.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL038,M,40.3,Moderna,V3,33,NA,NA,NA,NA,NA,31/mai/2021,Positif,101,NA,NA,NA,CTL038V3b,531.9,184.6,72.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL038,M,40.3,Moderna,V4,83,NA,NA,NA,NA,NA,20/jui/2021,Positif,67.8,NA,Négatif,0.1,CTL038V4b,242.5,93.7,42.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL038,M,40.3,Moderna,V5,188,NA,NA,NA,NA,NA,02/nov/2021,Positif,64.7,NA,Négatif,0.2,CTL038V5b,167.5,78.4,49.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL038,M,40.3,Moderna,V5+,275,52,NA,NA,NA,NA,28/jan/2022,Positif,104.7,2832,Négatif,0.2,CTL038V5+,1131.6,324.7,205.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL038,M,40.3,Moderna,3M3,307,84,NA,NA,NA,NA,01/mar/2022,Positif,101.1,2642,Négatif,0.2,CTL038 3M3,679.3,234.7,185.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL039,F,62.4,Pfizer,V3,35,NA,NA,NA,NA,NA,02/jui/2021,Positif,59.6,NA,Négatif,2.7,CTL039V3b,2430,2430,758.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL039,F,62.4,Pfizer,V4,95,NA,NA,NA,NA,NA,31/aoû/2021,Positif,82.1,NA,Négatif,2.9,CTL039V4b,2430,2233.6,554.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL039,F,62.4,Pfizer,V5,182,NA,NA,NA,NA,NA,26/nov/2021,Positif,108.9,3062,Négatif,2.6,CTL039V5b,2430,1555.2,347.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL039,F,62.4,Pfizer,V5+,265,20,NA,NA,NA,NA,17/fév/2022,Positif,98.7,2519,Négatif,1.7,CTL039V5+,1919,885,474.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL039,F,62.4,Pfizer,3M3,335,90,NA,NA,NA,NA,28/avr/2022,Positif,102.5,2715,Négatif,1.1,CTL039 3M3,2024.3,939.8,373.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL040,F,32.4,Pfizer,V3,31,NA,NA,NA,NA,NA,01/jui/2021,Positif,69.6,NA,Négatif,1.4,CTL040V3b,1100.4,336.2,101.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL040,F,32.4,Pfizer,V4,88,NA,NA,NA,NA,NA,27/aoû/2021,Positif,88.8,NA,Négatif,1.7,CTL040V4b,456.8,155.3,77.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL040,F,32.4,Pfizer,V5,189,NA,NA,NA,NA,NA,06/déc/2021,Positif,75.6,1484,Négatif,0.4,CTL040V5b,81.8,10.9,3.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL040,F,32.4,Pfizer,V5+,233,28,NA,NA,NA,NA,19/jan/2022,Positif,95,2334,Négatif,0.8,CTL040V5+,892.1,370.6,184.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL040,F,32.4,Pfizer,3M3,291,86,NA,NA,NA,NA,18/mar/2022,Positif,100.7,2621,Négatif,0.1,CTL040 3M3,815,332.8,139.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL041,F,29.4,Pfizer,V3,29,NA,NA,NA,NA,NA,15/jun/2021,Positif,104.9,NA,Négatif,1.3,CTL041V3b,413.4,165.4,56.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL041,F,29.4,Pfizer,V4,92,NA,NA,NA,NA,NA,17/aoû/2021,Positif,66.9,NA,Négatif,1,CTL041V4b,280,137.1,53.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL041,F,29.4,Pfizer,V5,178,NA,NA,NA,NA,NA,11/nov/2021,Positif,71.5,NA,Négatif,1.1,CTL041V5b,193.6,98.6,60.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL041,F,29.4,Pfizer,V5+,247,29,NA,NA,NA,NA,19/jan/2022,Positif,101.4,2657,Négatif,0.7,CTL041V5+,721.5,284.5,188.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL041,F,29.4,Pfizer,3M3,309,91,NA,NA,NA,NA,22/mar/2022,Positif,98.1,2488,Négatif,0.1,CTL041 3M3,325.1,159.6,144.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL042,F,31.4,Pfizer,V3,32,NA,NA,NA,NA,NA,02/jui/2021,Positif,88.4,NA,Positif,9.4,CTL042V3b,316.9,133.5,62.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL042,F,31.4,Pfizer,V4,92,NA,NA,NA,NA,NA,31/aoû/2021,Positif,63.3,NA,Positif,11.3,CTL042V4b,159.3,63.5,29.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL042,F,31.4,Pfizer,V5,183,NA,NA,NA,NA,NA,30/nov/2021,Positif,39.6,415,Positif,19.7,CTL042V5b,119,55.5,23.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL042,F,31.4,Pfizer,V5+,227,34,NA,NA,NA,NA,13/jan/2022,Positif,97.3,2448,Positif,8.4,CTL042V5+,630.1,206.9,98,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL042,F,31.4,Pfizer,3M3,281,88,NA,NA,NA,NA,08/mar/2022,Positif,92.7,2224,Positif,8.3,CTL042 3M3,289.2,99.8,51.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL043,F,48.4,Pfizer,V3,33,NA,NA,NA,NA,NA,21/jun/2021,Positif,90.3,NA,Négatif,0.1,CTL043V3b,313.1,132.4,50.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL043,F,48.4,Pfizer,V4,99,NA,NA,NA,NA,NA,26/aoû/2021,Positif,76.7,NA,Négatif,0.2,CTL043V4b,144.9,71.9,34.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL043,F,48.4,Pfizer,V5,187,NA,NA,NA,NA,NA,22/nov/2021,Positif,47.2,NA,Négatif,0.1,CTL043V5b,86.6,55.7,27.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL043,F,48.4,Pfizer,V5+,247,44,NA,NA,NA,NA,21/jan/2022,Positif,123.9,3959,Négatif,0.1,CTL043V5+,1140.3,434.4,241.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL043,F,48.4,Pfizer,3M3,288,85,NA,NA,NA,NA,03/mar/2022,Positif,92.7,2224,Négatif,0.1,CTL043 3M3,514.1,202.1,196.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,V3,43,NA,NA,NA,NA,NA,29/jun/2021,Positif,82.7,NA,Négatif,1,CTL044V3b,267.6,94.8,46,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,V4,92,NA,NA,NA,NA,NA,17/aoû/2021,Positif,53.8,NA,Négatif,0.2,CTL044V4b,134.6,89.9,47.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,V5,185,NA,NA,NA,NA,NA,18/nov/2021,Positif,52.9,NA,Négatif,0.2,CTL044V5b,94.9,63.6,37.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,V5+,234,34,NA,NA,NA,NA,06/jan/2022,Positif,108.5,3040,Négatif,0.2,CTL044V5+,1286.3,409.5,283.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,3M3,290,90,NA,NA,NA,NA,03/mar/2022,Positif,96.3,2398,Négatif,0.2,CTL044 3M3,503.3,182.8,158.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL044,M,35.4,Pfizer,3M6,372,172,NA,NA,NA,NA,24/mai/2022,Positif,158.7,6484,Négatif,0.1,CTL044 3M6,353.1,140.6,113.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL045,M,63.4,Pfizer,V3,32,NA,NA,NA,NA,NA,18/jun/2021,Positif,95.8,NA,Négatif,0.3,CTL045V3b,173.8,73.3,35.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL045,M,63.4,Pfizer,V4,99,NA,NA,NA,NA,NA,24/aoû/2021,Positif,62.4,NA,Négatif,0.2,CTL045V4b,146,85.3,42.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL045,M,63.4,Pfizer,V5,190,NA,NA,NA,NA,NA,23/nov/2021,Positif,52.5,NA,Négatif,0.1,CTL045V5b,149.1,77.1,43.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL045,M,63.4,Pfizer,V5+,245,31,NA,NA,NA,NA,17/jan/2022,Positif,131.6,4464,Négatif,0,CTL045V5+,790.5,216.8,145.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL045,M,63.4,Pfizer,3M3,302,88,NA,NA,NA,NA,15/mar/2022,Positif,94.2,2296,Négatif,0,CTL045 3M3,422.7,158.8,132.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL046,F,47.4,Pfizer,V3,31,NA,NA,NA,NA,NA,25/jun/2021,Positif,102,NA,Négatif,1.2,CTL046V3b,220.7,92.3,39.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL046,F,47.4,Pfizer,V4,92,NA,NA,NA,NA,NA,25/aoû/2021,Positif,44.7,NA,Négatif,1.4,CTL046V4b,158,50,22,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL046,F,47.4,Pfizer,V5,189,NA,NA,NA,NA,NA,30/nov/2021,Positif,45.7,550,Négatif,2.4,CTL046V5b,117.6,49.1,33,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL046,F,47.4,Pfizer,V5+,237,35,NA,NA,NA,NA,17/jan/2022,Positif,126.8,4146,Négatif,1.2,CTL046V5+,272.6,108.7,80,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL046,F,47.4,Pfizer,3M3,297,95,NA,NA,NA,NA,18/mar/2022,Positif,85.3,1885,Négatif,0.9,CTL046 3M3,150.7,55.7,39.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,V3,32,NA,NA,3M3-3M6,NA,NA,18/jun/2021,Positif,112,NA,Négatif,0.5,CTL047V3b,558.3,148.2,47.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,V4,92,NA,NA,3M3-3M6,NA,NA,17/aoû/2021,Positif,59.6,NA,Négatif,0.5,CTL047V4b,260,97,49,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,V5,184,NA,NA,3M3-3M6,NA,NA,17/nov/2021,Positif,58.9,NA,Négatif,0.3,CTL047V5b,120,56.8,23.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,V5+,242,37,NA,3M3-3M6,NA,NA,14/jan/2022,Positif,75.2,1468,Négatif,0.5,CTL047V5+,742.4,239.4,180.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,3M3,296,91,NA,3M3-3M6,NA,NA,09/mar/2022,Positif,99.6,2564,Négatif,0.1,CTL047 3M3,318.7,146,102.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL047,F,36.4,Pfizer,3M3+,331,126,NA,3M3-3M6,15,NA,13/avr/2022,Positif,95.7,2369,Positif,10.5,CTL047 3M3+,1355.4,626.2,497,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL048,M,37.4,Pfizer,V3,29,NA,NA,NA,NA,NA,16/jun/2021,Positif,121.6,NA,Négatif,1.2,CTL048V3b,581.4,215.1,70.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL048,M,37.4,Pfizer,V4,86,NA,NA,NA,NA,NA,12/aoû/2021,Positif,61.9,NA,Négatif,1.1,CTL048V4b,225.5,100.1,31.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL048,M,37.4,Pfizer,V5,182,NA,NA,NA,NA,NA,16/nov/2021,Positif,66.6,NA,Négatif,0.8,CTL048V5b,186.6,102.4,46.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL048,M,37.4,Pfizer,V5+,240,35,NA,NA,NA,NA,13/jan/2022,Positif,97.2,2443,Négatif,0.8,CTL048V5+,1152.3,466.2,145.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL048,M,37.4,Pfizer,3M3,289,84,NA,NA,NA,NA,03/mar/2022,Positif,93.3,2252,Négatif,0.7,CTL048 3M3,594.9,259.3,92,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL049,F,45.4,Pfizer,V3,34,NA,NA,V4-V5 /V5+-3M3,NA,NA,22/jun/2021,Positif,57.6,NA,Négatif,0.1,CTL049V3b,604.2,263.2,78.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL049,F,45.4,Pfizer,V4,93,NA,NA,V4-V5 /V5+-3M3,NA,NA,20/aoû/2021,Positif,73.8,NA,Négatif,0.1,CTL049V4b,287.9,137.9,43.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL049,F,45.4,Pfizer,V5,180,NA,NA,V4-V5 /V5+-3M3,68,NA,15/nov/2021,Positif,58.4,NA,Négatif,0.1,CTL049V5b,143.3,83.9,31.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL049,F,45.4,Pfizer,V5+,253,17,NA,V4-V5 /V5+-3M3,141,NA,27/jan/2022,Positif,108.7,3051,Négatif,0.2,CTL049V5+,1402.5,482.2,196.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL049,F,45.4,Pfizer,3M3,355,119,NA,V4-V5 /V5+-3M3,243,23,09/mai/2022,Positif,171.9,7605,Positif,28.2,CTL049 3M3,5221.9321148825065,2127.6595744680853,1043.8413361169103,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL050,F,25.3,Moderna/Pfizer,V3,28,NA,NA,NA,NA,NA,17/mai/2021,Positif,111.8,NA,NA,NA,CTL050V3b,560.5,222.6,100.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL050,F,25.3,Moderna/Pfizer,V4,94,NA,NA,NA,NA,NA,22/jui/2021,Positif,74.6,NA,Négatif,0.7,CTL050V4b,296.7,118.7,36,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL050,F,25.3,Moderna/Pfizer,V5,175,NA,NA,NA,NA,NA,11/oct/2021,Positif,44.9,NA,Négatif,0.4,CTL050V5b,148.8,87.3,45.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL050,F,25.3,Moderna/Pfizer,V5+,275,29,NA,NA,NA,NA,19/jan/2022,Positif,111.2,3192,Négatif,0.3,CTL050V5+,1123.3,429.4,147.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL050,F,25.3,Moderna/Pfizer,3M3,366,120,NA,NA,NA,NA,20/avr/2022,Positif,107.3,2974,Négatif,0.2,CTL050 3M3,357.4,146.1,57.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL051,F,55.4,Moderna,V3,32,NA,NA,NA,NA,NA,11/jun/2021,Positif,96.5,NA,Négatif,0.2,CTL051V3b,1006.4,459.6,123.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL051,F,55.4,Moderna,V4,92,NA,NA,NA,NA,NA,10/aoû/2021,Positif,71.4,NA,Négatif,0.1,CTL051V4b,470.4,247.1,69.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL051,F,55.4,Moderna,V5,182,NA,NA,NA,NA,NA,08/nov/2021,Positif,66.6,NA,Négatif,0.1,CTL051V5b,263.9,165,76.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL051,F,55.4,Moderna,V5+,252,32,NA,NA,NA,NA,17/jan/2022,Positif,130,4357,Négatif,0.1,CTL051V5+,1237.6,502.5,224.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL051,F,55.4,Moderna,3M3,308,88,NA,NA,NA,NA,14/mar/2022,Positif,140.5,5086,Négatif,0,CTL051 3M3,613.5,268.7,156.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL052,F,42.4,Pfizer,V3,30,NA,NA,V4-V5,NA,NA,24/jun/2021,Positif,83.5,NA,Négatif,0.1,CTL052V3b,499.8,180.6,54.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL052,F,42.4,Pfizer,V4,93,NA,NA,V4-V5,NA,NA,26/aoû/2021,Positif,64.8,NA,Négatif,0.1,CTL052V4b,161.7,69.1,21.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL052,F,42.4,Pfizer,V5,184,NA,NA,V4-V5,25,NA,25/nov/2021,Positif,100.1,NA,Négatif,3.8,CTL052V5b,3429.4,892.9,369,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL052,F,42.4,Pfizer,V6,363,NA,NA,V4-V5,204,NA,23/mai/2022,Positif,146.8,5551,Négatif,1.2,CTL052V6,532.8,186.3,85.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL054,F,38.4,Pfizer,V3,33,NA,NA,V5-V6,NA,NA,29/jun/2021,Positif,83.8,NA,Négatif,1.1,CTL054V3b,375,154.8,70.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL054,F,38.4,Pfizer,V4,90,NA,NA,V5-V6,NA,NA,25/aoû/2021,Positif,63.5,NA,Négatif,0.9,CTL054V4b,158.9,75.8,30.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL054,F,38.4,Pfizer,V5,194,NA,NA,V5-V6,NA,NA,07/déc/2021,Positif,42.2,470,Négatif,1,CTL054V5b,85.3,53.7,22.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL054,F,38.4,Pfizer,V6,363,153,NA,V5-V6,139,NA,25/mai/2022,Positif,155.5,6226,Indéterminé,5.4,CTL054V6,757,458.5,410.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL055,F,36.4,Pfizer,3M3,302,84,NA,NA,NA,NA,29/mar/2022,Positif,89.4,2069,Négatif,1.4,CTL055 3M3,114,69.6,40.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL056,F,53.4,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,21/jun/2021,Positif,90.7,NA,Négatif,0.6,CTL056V3b,439.6,167,61.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL056,F,53.4,Pfizer,V4,104,NA,NA,V5-3M3,NA,NA,30/aoû/2021,Positif,72.8,NA,Négatif,0.8,CTL056V4b,138.3,72.6,31,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL056,F,53.4,Pfizer,V5,188,NA,NA,V5-3M3,NA,NA,22/nov/2021,Positif,54.6,NA,Négatif,0.9,CTL056V5b,80.1,57.1,17.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL056,F,53.4,Pfizer,3M3,379,86,NA,V5-3M3,55,NA,01/jun/2022,Positif,112.9,3290,Positif,6.5,CTL056 3M3,2206.531332744925,1103.6309458117207,716.3323782234957,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL057,F,36.4,Pfizer,V3,31,NA,NA,V4-V5,NA,NA,17/jun/2021,Positif,100.1,NA,Négatif,2.5,CTL057V3b,659.2,223.4,92.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL057,F,36.4,Pfizer,V4,94,NA,NA,V4-V5,NA,NA,19/aoû/2021,Positif,86.9,NA,Négatif,2.1,CTL057V4b,243.8,105.5,37,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL057,F,36.4,Pfizer,V5,190,NA,NA,V4-V5,27,NA,23/nov/2021,Positif,91.4,NA,Positif,10.6,CTL057V5b,2430,1958.5,884.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL057,F,36.4,Pfizer,V6,368,NA,NA,V4-V5,205,NA,20/mai/2022,Positif,140.7,5100,Négatif,3.4,CTL057V6,2042.5,827.1,455.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL058,F,38.4,Pfizer,V4,101,NA,NA,NA,NA,NA,26/aoû/2021,Positif,71.6,NA,Négatif,0.5,CTL058V4b,129.6,64.4,31,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL058,F,38.4,Pfizer,V5,185,NA,NA,NA,NA,NA,18/nov/2021,Positif,56.3,NA,Négatif,0.5,CTL058V5b,82.2,43.3,16.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL058,F,38.4,Pfizer,V6,367,160,NA,NA,NA,NA,19/mai/2022,Positif,84.4,1846,Négatif,0.2,CTL058V6,120.2,45.3,23.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL059,F,31.4,Pfizer,V3,35,NA,NA,NA,NA,NA,21/jun/2021,Positif,91.1,NA,Négatif,0.1,CTL059V3b,442.9,176,66.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL060,F,60.4,Pfizer,V3,32,NA,NA,NA,NA,NA,18/jun/2021,Positif,102.8,NA,Négatif,3,CTL060V3b,2153.8,866.6,338.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL060,F,60.4,Pfizer,V4,93,NA,NA,NA,NA,NA,18/aoû/2021,Positif,77.9,NA,Négatif,2.4,CTL060V4b,873.4,556.5,157.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL060,F,60.4,Pfizer,V5,190,NA,NA,NA,NA,NA,23/nov/2021,Positif,94.3,NA,Négatif,1.7,CTL060V5b,816.3,460.6,179.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL060,F,60.4,Pfizer,3M3,294,96,NA,NA,NA,NA,07/mar/2022,Positif,97.2,2443,Négatif,1.7,CTL060 3M3,873.4,513.9,424.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL060,F,60.4,Pfizer,3M6,366,168,NA,NA,NA,NA,18/mai/2022,Positif,93.1,2243,Négatif,1.9,CTL060 3M6,728.9,519.8,331,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL061,M,45.4,Pfizer,V3,31,NA,NA,NA,NA,NA,18/jun/2021,Positif,112.8,NA,Négatif,0.9,CTL061V3b,451.5,169.8,66.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL061,M,45.4,Pfizer,V4,86,NA,NA,NA,NA,NA,12/aoû/2021,Positif,63.5,NA,Négatif,0.4,CTL061V4b,190.2,95.6,37.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL061,M,45.4,Pfizer,V5,184,NA,NA,NA,NA,NA,18/nov/2021,Positif,77.8,NA,Négatif,0.4,CTL061V5b,119.7,66,30.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL061,M,45.4,Pfizer,V6,366,NA,NA,NA,45,NA,19/mai/2022,Positif,130.5,4390,Positif,13.1,CTL061V6,1396.6,664,451.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL062,F,53.4,Pfizer,V3,31,NA,NA,NA,NA,NA,17/jun/2021,Positif,87.9,NA,Négatif,0.7,CTL062V3b,469.3,152.4,87.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL062,F,53.4,Pfizer,V4,93,NA,NA,NA,NA,NA,18/aoû/2021,Positif,78.4,NA,Négatif,0.2,CTL062V4b,277.5,106.8,65.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL062,F,53.4,Pfizer,V5,175,NA,NA,NA,NA,NA,08/nov/2021,Positif,62.2,NA,Négatif,0.3,CTL062V5b,146,69.3,56.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL062,F,53.4,Pfizer,3M3,273,75,NA,NA,NA,NA,14/fév/2022,Positif,102.2,2699,Négatif,0.3,CTL062 3M3,399.5,203.7,143.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL062,F,53.4,Pfizer,3M6,378,180,NA,NA,NA,NA,30/mai/2022,Positif,139.4,5007,Négatif,0.2,CTL062 3M6,193.9,83.2,70.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL063,F,27.4,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,30/jun/2021,Positif,78.2,NA,Négatif,0.6,CTL063V3b,441.3,182.3,62.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL063,F,27.4,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,02/sep/2021,Positif,64.8,NA,Négatif,0.6,CTL063V4b,141.7,63.9,34.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL063,F,27.4,Pfizer,V5,173,NA,NA,V5-3M3,NA,NA,17/nov/2021,Positif,58.1,NA,Négatif,3,CTL063V5b,94.1,54.7,21.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL063,F,27.4,Pfizer,3M3,269,84,NA,V5-3M3,22,NA,21/fév/2022,Positif,85,1872,Positif,7.1,CTL063 3M3,937.2,443.7,500.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL063,F,27.4,Pfizer,3M6,360,175,NA,V5-3M3,113,NA,23/mai/2022,Positif,155.5,6226,Indéterminé,4.2,CTL063 3M6,1020.7,470.8,456.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL064,M,49.4,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,18/jun/2021,Positif,112.2,NA,Négatif,3.3,CTL064V3b,554.3,249.5,96.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL064,M,49.4,Pfizer,V4,92,NA,NA,V5-V6,NA,NA,18/aoû/2021,Positif,59,NA,Indéterminé,5,CTL064V4b,208.3,104.7,55.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL064,M,49.4,Pfizer,V5,184,NA,NA,V5-V6,NA,NA,18/nov/2021,Positif,44.1,NA,Négatif,1.5,CTL064V5b,71.4,47,26.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL064,M,49.4,Pfizer,V6,352,NA,NA,V5-V6,152,NA,05/mai/2022,Positif,140.3,5072,Indéterminé,5.3,CTL064 V6,628.1407035175879,292.74004683840747,208.42017507294705,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL065,F,57.4,Pfizer,V3,34,NA,NA,NA,NA,NA,22/jun/2021,Positif,38.1,NA,Positif,7.2,CTL065V3b,2378.7,757.6,442.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL065,F,57.4,Pfizer,V4,91,NA,NA,NA,NA,NA,18/aoû/2021,Positif,79.9,NA,Négatif,3.7,CTL065V4b,2057.6,848.9,407.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL065,F,57.4,Pfizer,V5,184,NA,NA,NA,NA,NA,19/nov/2021,Positif,89,NA,Positif,7.4,CTL065V5b,2343.6,806.5,385.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL065,F,57.4,Pfizer,3M3,287,62,NA,NA,NA,NA,02/mar/2022,Positif,83.4,1803,Indéterminé,5.9,CTL065 3M3,1810.6,755.9,552.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL066,F,47.4,Pfizer,V3,34,NA,NA,NA,NA,NA,21/jun/2021,Positif,90.7,NA,Négatif,1.7,CTL066V3b,435.7,160.1,65.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL066,F,47.4,Pfizer,V4,93,NA,NA,NA,NA,NA,19/aoû/2021,Positif,87.2,NA,Négatif,1,CTL066V4b,184.7,80,50.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL066,F,47.4,Pfizer,V5,188,NA,NA,NA,NA,NA,22/nov/2021,Positif,65.7,NA,Négatif,0.8,CTL066V5b,142.8,65.2,52.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL066,F,47.4,Pfizer,V5+,244,35,NA,NA,NA,NA,17/jan/2022,Positif,130,4357,Négatif,0.7,CTL066V5+,648.1,302.8,178.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL066,F,47.4,Pfizer,3M3,294,85,NA,NA,NA,NA,08/mar/2022,Positif,84.7,1859,Positif,12,CTL066 3M3,2430,2430,1655.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL067,M,30.4,Pfizer,V3,32,NA,NA,NA,NA,NA,09/jui/2021,Positif,100.1,NA,Négatif,2.6,CTL067V3b,453.7,215.4,95.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL067,M,30.4,Pfizer,V4,94,NA,NA,NA,NA,NA,09/sep/2021,Positif,69.3,NA,Négatif,2.5,CTL067V4b,232,109.2,46.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL067,M,30.4,Pfizer,V5,189,NA,NA,NA,NA,NA,13/déc/2021,Positif,60.5,955,Négatif,3.1,CTL067V5b,94.6,60.6,22.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL067,M,30.4,Pfizer,3M3,290,84,NA,NA,NA,NA,24/mar/2022,Positif,112.7,3279,Négatif,0.2,CTL067 3M3,392,187.3,112.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL068,F,32.4,Pfizer,3M3,294,91,NA,NA,NA,NA,15/mar/2022,Positif,92.5,2214,Négatif,0.5,CTL068 3M3,466.9,215,137.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL069,F,54.4,Pfizer,V3,30,NA,NA,NA,NA,NA,24/jun/2021,Positif,58.9,NA,Négatif,0.4,CTL069V3b,78.9,38.8,14.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL069,F,54.4,Pfizer,V4,91,NA,NA,NA,NA,NA,24/aoû/2021,Positif,34.3,NA,Négatif,0.3,CTL069V4b,95.3,61.5,22.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL069,F,54.4,Pfizer,V5,182,NA,NA,NA,NA,NA,23/nov/2021,Positif,24.5,NA,Négatif,0.2,CTL069V5b,52.4,28.1,15.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL069,F,54.4,Pfizer,V5+,237,34,NA,NA,NA,NA,17/jan/2022,Positif,129.1,4297,Négatif,0.1,CTL069V5+,480.3,147.2,100.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL069,F,54.4,Pfizer,3M3,287,84,NA,NA,NA,NA,08/mar/2022,Positif,86.2,1925,Négatif,0.1,CTL069 3M3,498.3,181.5,118.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL070,M,45.4,Pfizer,V3,33,NA,NA,NA,NA,NA,16/jun/2021,Positif,115.3,NA,Négatif,0.9,CTL070V3b,865.1,237.9,138.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL070,M,45.4,Pfizer,V4,94,NA,NA,NA,NA,NA,16/aoû/2021,Positif,67.6,NA,Négatif,0.7,CTL070V4b,317.9,103.1,79.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL070,M,45.4,Pfizer,V5,185,NA,NA,NA,NA,NA,15/nov/2021,Positif,74.5,NA,Négatif,1.6,CTL070V5b,317.7,132.2,111.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL070,M,45.4,Pfizer,V5+,251,22,NA,NA,NA,NA,20/jan/2022,Positif,86.4,1934,Négatif,1.8,CTL070V5+,1859.4,641.8,448.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL070,M,45.4,Pfizer,3M3,314,85,NA,NA,NA,NA,24/mar/2022,Positif,110.2,3136,Négatif,1.4,CTL070 3M3,926.8,334.7,229.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL071,F,45.4,Pfizer,V3,35,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.5,NA,Négatif,2.7,CTL071V3b,453.1,215.1,107.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL071,F,45.4,Pfizer,V4,90,NA,NA,NA,NA,NA,23/aoû/2021,Positif,73.8,NA,Négatif,2.1,CTL071V4b,250.4,109.2,60.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL071,F,45.4,Pfizer,V5,192,NA,NA,NA,NA,NA,03/déc/2021,Positif,48.3,613,Négatif,1.7,CTL071V5b,34.6,10,2.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL071,F,45.4,Pfizer,V5+,248,42,NA,NA,NA,NA,28/jan/2022,Positif,101.1,2642,Négatif,2.3,CTL071V5+,1692.3,865.8,508.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL072,F,46.4,Pfizer,V3,34,NA,NA,NA,NA,NA,21/jun/2021,Positif,88.7,NA,Indéterminé,5.5,CTL072V3b,261,97.9,26.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL072,F,46.4,Pfizer,V4,92,NA,NA,NA,NA,NA,18/aoû/2021,Positif,49.9,NA,Indéterminé,5.5,CTL072V4b,181,82,21,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL072,F,46.4,Pfizer,V5,182,NA,NA,NA,NA,NA,16/nov/2021,Positif,52.1,NA,Positif,8.2,CTL072V5b,103.3,56.9,20.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL072,F,46.4,Pfizer,3M3,295,90,NA,NA,NA,NA,09/mar/2022,Positif,99.2,2544,Négatif,0.2,CTL072 3M3,357.5,145.7,87.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL072,F,46.4,Pfizer,3M6,379,174,NA,NA,NA,NA,01/jun/2022,Positif,93.1,2243,Négatif,0.6,CTL072 3M6,2430,1804.7283883775492,1108.8933244621867,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL073,F,52.4,Pfizer,V3,37,NA,NA,V5-3M3,NA,NA,23/jun/2021,Positif,98.7,NA,Négatif,3.8,CTL073V3b,367,112.7,57.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL073,F,52.4,Pfizer,V4,87,NA,NA,V5-3M3,NA,NA,12/aoû/2021,Positif,63.7,NA,Négatif,3.2,CTL073V4b,93,26,9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL073,F,52.4,Pfizer,V5,177,NA,NA,V5-3M3,NA,NA,10/nov/2021,Positif,46.1,NA,Négatif,2.7,CTL073V5b,130.1,92,59.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL073,F,52.4,Pfizer,3M3,294,88,NA,V5-3M3,61,NA,07/mar/2022,Positif,95.7,2369,Positif,15.5,CTL073 3M3,2430,1382.4,1028.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL073,F,52.4,Pfizer,3M6,381,175,NA,V5-3M3,148,NA,02/jun/2022,Positif,197.7,10054,Positif,8.2,CTL073 3M6,2039.983680130559,991.0802775024778,712.7583749109052,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL074,F,56.4,Pfizer,3M3,318,93,NA,NA,NA,NA,28/mar/2022,Positif,49.6,646,Négatif,0,CTL074 3M3,9784.7,5115.1,2287.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL075,F,32.4,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,21/jun/2021,Positif,91.2,NA,Négatif,0.4,CTL075V3b,535.9,246.4,83.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL075,F,32.4,Pfizer,V6,367,NA,NA,V5-V6,42,NA,23/mai/2022,Positif,162.2,6773,Positif,15.3,CTL075V6,1254.7,645.2,311,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL076,F,40.4,Pfizer,V5+,254,21,NA,NA,NA,NA,26/jan/2022,Positif,74.2,1430,Négatif,1.2,CTL076V5+,812.3,352.6,183.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL076,F,40.4,Pfizer,3M3,318,85,NA,NA,NA,NA,31/mar/2022,Positif,104.8,2837,Négatif,0.2,CTL076 3M3,308.1,221.4,93.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL077,F,41.4,Pfizer,V3,31,NA,NA,3M3-3M6,NA,NA,17/jun/2021,Positif,96.5,NA,Négatif,0.4,CTL077V3b,702.2,192.6,88.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL077,F,41.4,Pfizer,V4,92,NA,NA,3M3-3M6,NA,NA,17/aoû/2021,Positif,65,NA,Négatif,0.1,CTL077V4b,240.6,101.2,51.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL077,F,41.4,Pfizer,V5,185,NA,NA,3M3-3M6,NA,NA,18/nov/2021,Positif,64.4,NA,Négatif,0.2,CTL077V5b,107.8,59.7,38.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL077,F,41.4,Pfizer,3M3,276,79,NA,3M3-3M6,NA,NA,17/fév/2022,Positif,119.4,3678,Négatif,0.1,CTL077 3M3,691.1,301.3,151.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL077,F,41.4,Pfizer,3M6,380,183,NA,3M3-3M6,101,NA,01/jun/2022,Positif,115.9,3467,Indéterminé,4.5,CTL077 3M6,2430,2354.0489642184557,1903.311762466692,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL078,F,36.4,Pfizer,V3,41,NA,NA,NA,NA,NA,05/jui/2021,Positif,95.9,NA,Négatif,1.5,CTL078V3b,530.5,308.9,108.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL078,F,36.4,Pfizer,V4,90,NA,NA,NA,NA,NA,23/aoû/2021,Positif,75.3,NA,Négatif,1.4,CTL078V4b,307.5,150.3,64.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL078,F,36.4,Pfizer,V5,184,NA,NA,NA,NA,NA,25/nov/2021,Positif,88.9,NA,Négatif,1.3,CTL078V5b,218.3,120.9,63.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL078,F,36.4,Pfizer,V5+,237,14,NA,NA,NA,NA,17/jan/2022,Positif,127.3,4178,Négatif,0.8,CTL078V5+,967.1,492.6,215.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL078,F,36.4,Pfizer,3M3,307,84,NA,NA,NA,NA,28/mar/2022,Positif,89.4,2069,Négatif,0,CTL078 3M3,849.6,418.4,158.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL079,M,62.4,Pfizer,V3,33,NA,NA,NA,NA,NA,28/jun/2021,Positif,82.9,NA,Négatif,2.6,CTL079V3b,384.9,166.3,62.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL079,M,62.4,Pfizer,V4,92,NA,NA,NA,NA,NA,26/aoû/2021,Positif,85.5,NA,Indéterminé,4.7,CTL079V4b,110.5,49.4,22.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL079,M,62.4,Pfizer,V5,182,NA,NA,NA,NA,NA,24/nov/2021,Positif,34.9,NA,Négatif,3.1,CTL079V5b,67.7,40.4,12.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL080,F,55.4,Pfizer,V3,29,NA,NA,NA,NA,NA,01/jui/2021,Positif,83.9,NA,Négatif,1.5,CTL080V3b,370.6,112.4,51.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL080,F,55.4,Pfizer,V4,106,NA,NA,NA,NA,NA,16/sep/2021,Positif,51.2,NA,Négatif,0.7,CTL080V4b,120.9,58.8,33.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL080,F,55.4,Pfizer,V5,183,NA,NA,NA,NA,NA,02/déc/2021,Positif,39.4,411,Négatif,0.8,CTL080V5b,52.8,44,21.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL080,F,55.4,Pfizer,V5+,232,36,NA,NA,NA,NA,20/jan/2022,Positif,98.1,2488,Négatif,0.6,CTL080V5+,1328.6,441.5,208.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL080,F,55.4,Pfizer,3M3,281,85,NA,NA,NA,NA,10/mar/2022,Positif,80.7,1689,Négatif,0.3,CTL080 3M3,738.6,299,202.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL081,F,57.4,Pfizer,V3,30,NA,NA,V5-V5+,NA,NA,24/jun/2021,Positif,59.8,NA,Négatif,1.6,CTL081V3b,2430,776.4,199.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL081,F,57.4,Pfizer,V4,93,NA,NA,V5-V5+,NA,NA,26/aoû/2021,Positif,84.6,NA,Négatif,3.1,CTL081V4b,1549.4,500.5,184.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL081,F,57.4,Pfizer,V5,191,NA,NA,V5-V5+,NA,NA,02/déc/2021,Positif,89.6,2078,Positif,6,CTL081V5b,335.1,103,23.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL081,F,57.4,Pfizer,V5+,239,NA,NA,V5-V5+,7,NA,19/jan/2022,Positif,94.3,2300,Positif,16.4,CTL081V5+,1294.2,549.8,431.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL081,F,57.4,Pfizer,V6,359,NA,NA,V5-V5+,127,NA,19/mai/2022,Positif,103.3,2757,Positif,19.2,CTL081V6,831.9,401,496.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL082,F,63.4,Pfizer,V3,31,NA,NA,NA,NA,NA,14/jun/2021,Positif,119.3,NA,Négatif,0.3,CTL082V3b,508.6,199.5,60.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL082,F,63.4,Pfizer,V4,94,NA,NA,NA,NA,NA,16/aoû/2021,Positif,41.6,NA,Négatif,0.3,CTL082V4b,83.8,38.4,15.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL082,F,63.4,Pfizer,V5,199,NA,NA,NA,NA,NA,29/nov/2021,Positif,39.4,411,Négatif,0.5,CTL082V5b,65.7,42.5,14.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL083,F,53.4,Pfizer,V3,30,NA,NA,NA,NA,NA,30/jun/2021,Positif,78,NA,Négatif,0.2,CTL083V3b,334.7,131.8,49.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL083,F,53.4,Pfizer,V4,94,NA,NA,NA,NA,NA,02/sep/2021,Positif,63.7,NA,Négatif,0.2,CTL083V4b,141.2,95.4,36,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL083,F,53.4,Pfizer,V5,185,NA,NA,NA,NA,NA,02/déc/2021,Positif,53.2,741,Négatif,0.2,CTL083V5b,93.3,59.1,23.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL083,F,53.4,Pfizer,V5+,234,36,NA,NA,NA,NA,20/jan/2022,Positif,106,2902,Négatif,0.2,CTL083V5+,519.2,265,117,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL083,F,53.4,Pfizer,3M3,290,92,NA,NA,NA,NA,17/mar/2022,Positif,103.3,2757,Négatif,0.1,CTL083 3M3,280.6,140.9,83.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL084,M,50.4,Pfizer,V3,32,NA,NA,NA,NA,NA,28/jun/2021,Positif,81.2,NA,Négatif,0.9,CTL084V3b,464,198.4,59.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL084,M,50.4,Pfizer,V4,96,NA,NA,NA,NA,NA,31/aoû/2021,Positif,46.5,NA,Négatif,0.9,CTL084V4b,74.7,39.4,15.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL084,M,50.4,Pfizer,V5,186,NA,NA,NA,NA,NA,29/nov/2021,Positif,30.2,245,Négatif,0.6,CTL084V5b,51.6,37.7,16.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL084,M,50.4,Pfizer,3M3,287,101,NA,NA,NA,NA,10/mar/2022,Positif,80.3,1672,Positif,18.3,CTL084 3M3,2430,1905.1,1410.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL084,M,50.4,Pfizer,3M6,371,185,NA,NA,NA,NA,02/jun/2022,Positif,208.1,11138,Positif,12,CTL084 3M6,2809.778027535825,1228.0486307257768,1022.1813349688234,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL085,F,59.4,Pfizer,V3,33,NA,NA,NA,NA,NA,29/jun/2021,Positif,70.4,NA,Négatif,0.1,CTL085V3b,190.3,82.1,33.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL085,F,59.4,Pfizer,V4,91,NA,NA,NA,NA,NA,26/aoû/2021,Positif,37,NA,Négatif,0.1,CTL085V4b,107.4,60.8,22.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL085,F,59.4,Pfizer,V5,182,NA,NA,NA,NA,NA,25/nov/2021,Positif,29.4,NA,Négatif,0.1,CTL085V5b,33.8,17.8,7.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL085,F,59.4,Pfizer,V5+,245,42,NA,NA,NA,NA,27/jan/2022,Positif,109,3068,Négatif,0.1,CTL085V5+,329.1,132.9,85.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL085,F,59.4,Pfizer,3M3,291,88,NA,NA,NA,NA,14/mar/2022,Positif,121,3777,Négatif,0,CTL085 3M3,131.2,75.8,49.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL086,M,51.4,Pfizer,V3,34,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.2,NA,Négatif,0.9,CTL086V3b,383,176.3,50.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL086,M,51.4,Pfizer,V4,96,NA,NA,NA,NA,NA,30/aoû/2021,Positif,78.1,NA,Négatif,0.9,CTL086V4b,125.8,64.2,30.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL086,M,51.4,Pfizer,V5,188,NA,NA,NA,NA,NA,30/nov/2021,Positif,47.9,603,Négatif,0.5,CTL086V5b,135.9,85,39.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL086,M,51.4,Pfizer,V5+,245,42,NA,NA,NA,NA,26/jan/2022,Positif,88.6,2033,Négatif,0.6,CTL086V5+,1162,591.7,256.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL086,M,51.4,Pfizer,3M3,302,99,NA,NA,NA,NA,24/mar/2022,Positif,111.9,3233,Négatif,0.1,CTL086 3M3,386.7,242,146.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL087,F,62.4,Pfizer,V3,33,NA,NA,NA,NA,NA,29/jun/2021,Positif,71.7,NA,Négatif,0.3,CTL087V3b,803.2,395.7,122.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL087,F,62.4,Pfizer,V4,96,NA,NA,NA,NA,NA,31/aoû/2021,Positif,80.9,NA,Négatif,0.2,CTL087V4b,289.5,119.8,56.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL087,F,62.4,Pfizer,V5,182,NA,NA,NA,NA,NA,25/nov/2021,Positif,83,NA,Négatif,0.2,CTL087V5b,161.8,87,43.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL087,F,62.4,Pfizer,V5+,236,28,NA,NA,NA,NA,18/jan/2022,Positif,78.3,1591,Négatif,0.5,CTL087V5+,1964.3,751.3,453.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL087,F,62.4,Pfizer,3M3,288,80,NA,NA,NA,NA,11/mar/2022,Positif,103.3,2757,Négatif,0.1,CTL087 3M3,1050.1,500.8,290.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL088,M,54.4,Pfizer,V3,30,NA,NA,NA,NA,NA,07/jui/2021,Positif,107.6,NA,Négatif,0.1,CTL088V3b,718.9,257.1,100.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL088,M,54.4,Pfizer,V4,92,NA,NA,NA,NA,NA,07/sep/2021,Positif,96.4,NA,Négatif,0.3,CTL088V4b,542.6,193.1,92.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL088,M,54.4,Pfizer,V5,183,4,NA,NA,NA,NA,07/déc/2021,Positif,92.6,2219,Négatif,0.2,CTL088V5b,124.7,43.6,13.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL088,M,54.4,Pfizer,3M3,273,94,NA,NA,NA,NA,07/mar/2022,Positif,110.6,3158,Négatif,0.1,CTL088 3M3,629.7,229.8,193.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL089,F,44.3,Pfizer,3M3,301,88,NA,NA,NA,NA,01/mar/2022,Positif,93.2,2247,Négatif,1,CTL089 3M3,854.7,502.5,358.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL090,F,26.4,Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,16/jun/2021,Positif,109.1,NA,Négatif,0.6,CTL090V3b,1293.7,335.6,122.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL090,F,26.4,Pfizer,V4,93,NA,NA,V5-3M3,NA,NA,18/aoû/2021,Positif,75.8,NA,Négatif,0.5,CTL090V4b,275.4,114.7,41.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL090,F,26.4,Pfizer,V5,182,NA,NA,V5-3M3,NA,NA,15/nov/2021,Positif,61.5,NA,Négatif,0.4,CTL090V5b,187.8,92.4,49.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL090,F,26.4,Pfizer,3M3,303,90,NA,V5-3M3,42,NA,16/mar/2022,Positif,88.4,2023,Positif,6.6,CTL090 3M3,1480.4,966.2,942.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL091,F,53.4,Pfizer,V3,28,NA,NA,NA,NA,NA,07/jui/2021,Positif,107,NA,Négatif,0.6,CTL091V3b,287.2,150.4,74,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL091,F,53.4,Pfizer,V4,92,NA,NA,NA,NA,NA,09/sep/2021,Positif,73.8,NA,Négatif,0.5,CTL091V4b,159.9,62,39.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL091,F,53.4,Pfizer,V5,183,NA,NA,NA,NA,NA,09/déc/2021,Positif,76.1,1503,Négatif,0.3,CTL091V5b,124.7,71,31.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,V3,33,NA,NA,V5+ - 3M3,NA,NA,30/jun/2021,Positif,78.1,NA,Négatif,0.3,CTL092V3b,811.7,250.6,83.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,V4,101,NA,NA,V5+ - 3M3,NA,NA,06/sep/2021,Positif,76.6,NA,Négatif,0.2,CTL092V4b,184.7,87.6,32.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,V5,186,NA,NA,V5+ - 3M3,NA,NA,30/nov/2021,Positif,47.2,586,Négatif,0,CTL092V5b,115.6,70,27.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,V5+,235,35,NA,V5+ - 3M3,NA,NA,18/jan/2022,Positif,112.3,3256,Négatif,0.1,CTL092V5+,775.8,287.5,178,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,3M3,290,90,NA,V5+ - 3M3,19,NA,14/mar/2022,Positif,128.3,4244,Positif,22.9,CTL092 3M3,2430,2120.4,2076.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL092,M,62.4,Pfizer,3M6,369,169,NA,V5+ - 3M3,98,NA,01/jun/2022,Positif,112.6,3273,Indéterminé,4.3,CTL092 3M6,193.87359441644048,83.19467554076539,70.52186177715092,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL093,F,61.4,Pfizer,V3,42,NA,NA,V5-V6,NA,NA,20/jui/2021,Positif,66.6,NA,Négatif,0,CTL093V3b,514.9,337.4,102.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL093,F,61.4,Pfizer,V4,98,NA,NA,V5-V6,NA,NA,14/sep/2021,Positif,90.5,NA,Négatif,0.1,CTL093V4b,398.4,202.7,75.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL093,F,61.4,Pfizer,V5,182,NA,NA,V5-V6,NA,NA,07/déc/2021,Positif,79.6,1643,Négatif,0.1,CTL093V5b,58.3,33.2,6.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL093,F,61.4,Pfizer,V5+,295,NA,NA,V5-V6,44,NA,30/mar/2022,Positif,90.8,2134,Positif,9.9,CTL093V5+,2430,2399.2,1134.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL093,F,61.4,Pfizer,V6,358,NA,NA,V5-V6,107,NA,01/jun/2022,Positif,111.3,3198,Négatif,3,CTL093 V6,180.37518037518038,88.261253309797,44.18912947414936,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL094,M,62.4,Moderna,V3,32,NA,NA,NA,NA,NA,05/jui/2021,Positif,95.7,NA,Négatif,0.6,CTL094V3b,1228.2,488.8,139.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL094,M,62.4,Moderna,V4,96,NA,NA,NA,NA,NA,07/sep/2021,Positif,94.8,NA,Négatif,0.4,CTL094V4b,595.2,278.9,100.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL094,M,62.4,Moderna,V5,187,NA,NA,NA,NA,NA,07/déc/2021,Positif,94.2,2296,Négatif,1.5,CTL094V5b,447.2,217.8,83.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL094,M,62.4,Moderna,V5+,228,41,NA,NA,NA,NA,17/jan/2022,Positif,129.8,4343,Négatif,0.6,CTL094V5+,1213.9,561.8,201.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL094,M,62.4,Moderna,3M3,280,93,NA,NA,NA,NA,10/mar/2022,Positif,81.1,1705,Négatif,0.4,CTL094 3M3,936.3,415.5,190.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL095,F,52.4,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,28/jun/2021,Positif,74,NA,Négatif,0.1,CTL095V3b,742.9,157.7,66.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL095,F,52.4,Pfizer,V4,96,NA,NA,V5-3M3,NA,NA,30/aoû/2021,Positif,87.1,NA,Négatif,0.1,CTL095V4b,425.4,78.7,38.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL095,F,52.4,Pfizer,V5,190,NA,NA,V5-3M3,NA,NA,02/déc/2021,Positif,88.6,2033,Négatif,0.3,CTL095V5b,463.2,100.4,51.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL095,F,52.4,Pfizer,V5+,232,34,NA,V5-3M3,NA,NA,13/jan/2022,Positif,91.1,2148,Négatif,0.1,CTL095V5+,1079.6,293,182.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL095,F,52.4,Pfizer,3M3,281,83,NA,V5-3M3,NA,NA,03/mar/2022,Positif,89.6,2078,Négatif,0.8,CTL095 3M3,758.7,223,214.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL096,F,46.4,Pfizer,V3,34,NA,NA,NA,NA,NA,21/jun/2021,Positif,90.3,NA,Négatif,1.2,CTL096V3b,335.9,148.9,48.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL096,F,46.4,Pfizer,V4,90,NA,NA,NA,NA,NA,16/aoû/2021,Positif,44.5,NA,Négatif,1.1,CTL096V4b,127,77,16,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL096,F,46.4,Pfizer,V5,182,NA,NA,NA,NA,NA,16/nov/2021,Positif,29.9,NA,Négatif,1.1,CTL096V5b,47.8,31.5,10.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL096,F,46.4,Pfizer,V5+,244,35,NA,NA,NA,NA,17/jan/2022,Positif,131.9,4485,Négatif,0.7,CTL096V5+,711.2,276.3,176.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL096,F,46.4,Pfizer,3M3,286,77,NA,NA,NA,NA,28/fév/2022,Positif,102.6,2720,Négatif,1.2,CTL096 3M3,269.5,149.8,92.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL097,F,59.4,Pfizer,V3,32,NA,NA,NA,NA,NA,01/jui/2021,Positif,63,NA,Négatif,0.1,CTL097V3b,1578.5,575.7,160.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL097,F,59.4,Pfizer,V4,99,NA,NA,NA,NA,NA,06/sep/2021,Positif,86.4,NA,Négatif,0.1,CTL097V4b,654.9,312.5,123.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL097,F,59.4,Pfizer,V5,186,NA,NA,NA,NA,NA,02/déc/2021,Positif,89.9,2092,Négatif,0.1,CTL097V5b,208.4,115.1,23,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL097,F,59.4,Pfizer,3M3,303,76,NA,NA,NA,NA,29/mar/2022,Positif,107.3,2974,Négatif,0,CTL097 3M3,2209.9,1355.2,448,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL098,F,61.4,Moderna,V3,29,NA,NA,NA,NA,NA,16/jun/2021,Positif,113.3,NA,Négatif,0.3,CTL098V3b,760.5,365,105.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL098,F,61.4,Moderna,V4,91,NA,NA,NA,NA,NA,17/aoû/2021,Positif,69.4,NA,Négatif,0.1,CTL098V4b,262.8,161.5,59.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL098,F,61.4,Moderna,V5,182,NA,NA,NA,NA,NA,16/nov/2021,Positif,82.8,NA,Négatif,0.2,CTL098V5b,339.2,200.6,92.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL098,F,61.4,Moderna,V5+,247,38,NA,NA,NA,NA,20/jan/2022,Positif,88.4,2023,Négatif,0,CTL098V5+,2430,903.3,497.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL099,F,38.4,Pfizer,V3,53,NA,NA,V2-V3,14,NA,19/jui/2021,Positif,72.6,NA,Indéterminé,5.2,CTL099V3b,214.8,109.5,65.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL099,F,38.4,Pfizer,V4,95,NA,NA,V2-V3,56,NA,30/aoû/2021,Positif,69.8,NA,Négatif,2.3,CTL099V4b,181.3,86.9,59.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL099,F,38.4,Pfizer,V5,187,NA,NA,V2-V3,148,NA,30/nov/2021,Positif,41.2,448,Négatif,0.7,CTL099V5b,115,54.1,37.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL100,F,44.4,Pfizer,V3,34,NA,NA,NA,NA,NA,28/jun/2021,Positif,77.2,NA,Négatif,1.7,CTL100V3b,560.2,262.7,109,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL100,F,44.4,Pfizer,V4,92,NA,NA,NA,NA,NA,25/aoû/2021,Positif,73.8,NA,Négatif,1.3,CTL100V4b,260.6,105.7,54.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL100,F,44.4,Pfizer,V5,184,NA,NA,NA,NA,NA,25/nov/2021,Positif,65,NA,Négatif,1.6,CTL100V5b,116.4,72.7,52,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL101,F,51.4,Moderna,V3,33,NA,NA,NA,NA,NA,14/jun/2021,Positif,119.1,NA,Négatif,0.2,CTL101V3b,501.5,173.1,70.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL101,F,51.4,Moderna,V4,92,NA,NA,NA,NA,NA,12/aoû/2021,Positif,64.5,NA,Négatif,0.2,CTL101V4b,106.1,32.9,3.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL101,F,51.4,Moderna,V5,187,NA,NA,NA,NA,NA,15/nov/2021,Positif,60.6,NA,Négatif,0.2,CTL101V5b,137.7,96.3,47.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL101,F,51.4,Moderna,3M3,293,83,NA,NA,NA,NA,01/mar/2022,Positif,98.3,2498,Négatif,0.2,CTL101 3M3,618,281.7,186.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL101,F,51.4,Moderna,3M6,377,167,NA,NA,NA,NA,24/mai/2022,Positif,160.8,6657,Négatif,0.1,CTL101 3M6,690.6,351.2,173.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL103,F,57.4,Moderna,V3,30,NA,NA,NA,NA,NA,30/jun/2021,Positif,73.4,NA,Négatif,3,CTL103V3b,1301.1,525.5,187.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL103,F,57.4,Moderna,V4,93,NA,NA,NA,NA,NA,01/sep/2021,Positif,69.3,NA,Négatif,1.7,CTL103V4b,719.4,374,161.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL103,F,57.4,Moderna,V5,197,NA,NA,NA,NA,NA,14/déc/2021,Positif,82,1743,Négatif,0.9,CTL103V5b,466.4,276.2,157.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL103,F,57.4,Moderna,V5+,231,28,NA,NA,NA,NA,17/jan/2022,Positif,123.9,3959,Négatif,1.3,CTL103V5+,2173,882.6,597.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL103,F,57.4,Moderna,3M3,296,93,NA,NA,NA,NA,23/mar/2022,Positif,83.6,1811,Négatif,0.7,CTL103 3M3,1377.2,687.3,531.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL105,F,56.4,Pfizer,V3,36,NA,NA,NA,NA,NA,01/jui/2021,Positif,78.7,NA,Négatif,2.5,CTL105V3b,791.1,312.9,101.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL105,F,56.4,Pfizer,V4,97,NA,NA,NA,NA,NA,31/aoû/2021,Positif,83.1,NA,Négatif,1.9,CTL105V4b,471.9,169,94.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL105,F,56.4,Pfizer,V5,188,NA,NA,NA,NA,NA,30/nov/2021,Positif,70.4,1289,Négatif,1.6,CTL105V5b,241.1,109.7,66.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL105,F,56.4,Pfizer,3M3,275,84,NA,NA,NA,NA,25/fév/2022,Positif,89.1,2055,Négatif,1.7,CTL105 3M3,654.9,269.1,255.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL105,F,56.4,Pfizer,3M6,364,173,NA,NA,NA,NA,25/mai/2022,Positif,152.8,6012,Négatif,0.3,CTL105 3M6,495,213.6,188.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL107,F,46.4,Pfizer,V3,29,NA,NA,V5-V5+,NA,NA,23/jun/2021,Positif,101.4,NA,Négatif,1.1,CTL107V3b,561.2,237.6,92.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL107,F,46.4,Pfizer,V4,91,NA,NA,V5-V5+,NA,NA,24/aoû/2021,Positif,77.6,NA,Négatif,1,CTL107V4b,160.6,96.6,34.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL107,F,46.4,Pfizer,V5,189,NA,NA,V5-V5+,NA,NA,30/nov/2021,Positif,41.5,455,Négatif,0.3,CTL107V5b,93,68.1,16.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL107,F,46.4,Pfizer,V5+,241,NA,NA,V5-V5+,29,NA,21/jan/2022,Positif,129.5,4323,Positif,14.3,CTL107V5+,2151.5,687.3,103.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL107,F,46.4,Pfizer,V6,365,NA,NA,V5-V5+,153,NA,25/mai/2022,Positif,150.9,5864,Indéterminé,4.7,CTL107V6,1749.5,634.9,92.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,V3,34,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.5,NA,Négatif,0.4,CTL108V3b,541.1,197.2,90.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,V4,98,NA,NA,NA,NA,NA,01/sep/2021,Positif,69.3,NA,Négatif,0.3,CTL108V4b,365.8,106,65.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,V5,189,NA,NA,NA,NA,NA,01/déc/2021,Positif,79.4,1635,Négatif,0.4,CTL108V5b,213.2,84.8,53,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,V5+,229,35,NA,NA,NA,NA,10/jan/2022,Positif,124.2,3978,Négatif,0.2,CTL108V5+,1156.3,411.5,290.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,3M3,280,86,NA,NA,NA,NA,02/mar/2022,Positif,94.3,2300,Négatif,0.2,CTL108 3M3,391.4,221.6,184.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL108,F,59.4,Pfizer,3M6,371,177,NA,NA,NA,NA,01/jun/2022,Positif,109.4,3090,Négatif,0.3,CTL108 3M6,235.73785950023574,100.13016921998599,44.52359750667854,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL109,M,56.4,Pfizer,V3,29,NA,NA,NA,NA,NA,01/jui/2021,Positif,82.5,NA,Négatif,0.2,CTL109V3b,684,228.6,151.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL109,M,56.4,Pfizer,V4,93,NA,NA,NA,NA,NA,03/sep/2021,Positif,88.5,NA,Négatif,0.2,CTL109V4b,262.4,108.2,78.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL109,M,56.4,Pfizer,V5,191,NA,NA,NA,NA,NA,10/déc/2021,Positif,63.3,1044,Négatif,0,CTL109V5b,68.1,15.9,9.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL109,M,56.4,Pfizer,3M3,330,112,NA,NA,NA,NA,28/avr/2022,Positif,128.4,4251,Négatif,0.1,CTL109 3M3,1002.6,304.1,186.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL110,F,61.4,Pfizer,V3,34,NA,NA,NA,NA,NA,05/jui/2021,Positif,95.9,NA,Négatif,3.8,CTL110V3b,275.9,130.3,63,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL110,F,61.4,Pfizer,V4,104,NA,NA,NA,NA,NA,13/sep/2021,Positif,59.8,NA,Négatif,2.7,CTL110V4b,101.1,51.3,23.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL110,F,61.4,Pfizer,V5,183,NA,NA,NA,NA,NA,01/déc/2021,Positif,53,736,Négatif,3.1,CTL110V5b,76.8,44.5,21.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL110,F,61.4,Pfizer,V5+,231,28,NA,NA,NA,NA,18/jan/2022,Positif,114,3354,Négatif,3.3,CTL110V5+,438.8,133.8,82.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL110,F,61.4,Pfizer,3M3,297,94,NA,NA,NA,NA,25/mar/2022,Positif,89.7,2083,Négatif,2.3,CTL110 3M3,219.3,89.4,63.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL111,F,38.4,Pfizer,V3,31,NA,NA,NA,NA,NA,17/jun/2021,Positif,97.6,NA,Négatif,1.2,CTL111V3b,462.1,138.1,51.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL111,F,38.4,Pfizer,V4,99,NA,NA,NA,NA,NA,24/aoû/2021,Positif,84,NA,Négatif,1.4,CTL111V4b,128.5,53.4,30.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL111,F,38.4,Pfizer,V5,183,NA,NA,NA,NA,NA,16/nov/2021,Positif,91.4,NA,Négatif,1.6,CTL111V5b,212.2,108.1,61.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL111,F,38.4,Pfizer,3M3,288,90,NA,NA,NA,NA,01/mar/2022,Positif,94.7,2320,Négatif,0.9,CTL111 3M3,215.2,111.1,89.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL111,F,38.4,Pfizer,3M6,381,183,NA,NA,NA,NA,02/jun/2022,Positif,120.4,3740,Négatif,0.4,CTL111 3M6,263.6435539151068,133.36889837289942,119.99040076793857,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL112,F,53.4,Pfizer,V3,31,NA,NA,NA,NA,NA,25/jun/2021,Positif,109.4,NA,Positif,8.7,CTL112V3b,557.7,139.3,53.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL112,F,53.4,Pfizer,V4,99,NA,NA,NA,NA,NA,01/sep/2021,Positif,72.5,NA,Indéterminé,5,CTL112V4b,469.9,129,56,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL112,F,53.4,Pfizer,V5,188,NA,NA,NA,NA,NA,29/nov/2021,Positif,86.4,1934,Indéterminé,5.5,CTL112V5b,315.6,96.8,43,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL112,F,53.4,Pfizer,V5+,241,39,NA,NA,NA,NA,21/jan/2022,Positif,126.3,4113,Négatif,3.2,CTL112V5+,1231.7,340.9,149.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL112,F,53.4,Pfizer,3M3,293,91,NA,NA,NA,NA,14/mar/2022,Positif,135.8,4753,Négatif,3.4,CTL112 3M3,849.6,255.7,191.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL113,F,56.4,Pfizer,V3,29,NA,NA,NA,NA,NA,24/jun/2021,Positif,66.5,NA,Positif,24.4,CTL113V3b,1837.2,687.3,312.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL113,F,56.4,Pfizer,V4,92,NA,NA,NA,NA,NA,26/aoû/2021,Positif,92.7,NA,Positif,28.7,CTL113V4b,835.4,388.3,171,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL113,F,56.4,Pfizer,V5,183,NA,NA,NA,NA,NA,25/nov/2021,Positif,100.5,NA,Positif,24,CTL113V5b,900.9,409.3,178.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL113,F,56.4,Pfizer,V5+,265,18,NA,NA,NA,NA,15/fév/2022,Positif,97,2433,Positif,17.6,CTL113V5+,835.4,421.1,271.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL113,F,56.4,Pfizer,3M3,337,90,NA,NA,NA,NA,28/avr/2022,Positif,124,3965,Positif,14,CTL113 3M3,683.1,379.7,217.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL114,F,41.4,Pfizer,V3,31,NA,NA,V5+-3M3,NA,NA,28/jun/2021,Positif,84.4,NA,Négatif,0.7,CTL114V3b,143.6,49.7,4.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL114,F,41.4,Pfizer,V4,84,NA,NA,V5+-3M3,NA,NA,20/aoû/2021,Positif,58.7,NA,Négatif,0.4,CTL114V4b,156,78,25,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL114,F,41.4,Pfizer,V5,181,NA,NA,V5+-3M3,NA,NA,25/nov/2021,Positif,55.9,NA,Négatif,0.5,CTL114V5b,103.4,57.5,24.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL114,F,41.4,Pfizer,V5+,234,11,NA,V5+-3M3,NA,NA,17/jan/2022,Positif,130.2,4370,Négatif,0.4,CTL114V5+,1045.3,379.9,202.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL114,F,41.4,Pfizer,3M3,293,70,NA,V5+-3M3,56,NA,17/mar/2022,Positif,106.5,2930,Positif,6.3,CTL114 3M3,1470.8,1046.8,929.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL115,F,60.4,Pfizer,V3,32,NA,NA,NA,NA,NA,13/jui/2021,Positif,79.8,NA,Négatif,1.1,CTL115V3b,631.3,156.7,75,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL115,F,60.4,Pfizer,V4,94,NA,NA,NA,NA,NA,13/sep/2021,Positif,82.3,NA,Négatif,1,CTL115V4b,261,92.6,44.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL115,F,60.4,Pfizer,V5,185,NA,NA,NA,NA,NA,13/déc/2021,Positif,94.6,2315,Négatif,1.8,CTL115V5b,196,81.8,39.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL115,F,60.4,Pfizer,3M3,277,92,NA,NA,NA,NA,15/mar/2022,Positif,86,1916,Négatif,0.1,CTL115 3M3,431.2,192.9,138.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL115,F,60.4,Pfizer,3M6,356,171,NA,NA,NA,NA,02/jun/2022,Positif,203.1,10610,Négatif,0.6,CTL115 3M6,521.9206680584551,195.80967299784606,125.80198767140521,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL117,F,36.4,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,28/jun/2021,Positif,81.2,NA,Négatif,1,CTL117V3b,441.9,101.1,69.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL117,F,36.4,Pfizer,V4,84,NA,NA,V5-3M3,NA,NA,23/aoû/2021,Positif,72,NA,Négatif,0.9,CTL117V4b,156.7,53.9,34.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL117,F,36.4,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,06/déc/2021,Positif,60.5,955,Négatif,0.6,CTL117V5b,54.4,21,13.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL117,F,36.4,Pfizer,3M3,282,82,NA,V5-3M3,57,NA,09/mar/2022,Positif,98.5,2508,Positif,9.4,CTL117 3M3,687.3,460,509.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL118,M,33.4,Pfizer,V3,33,NA,NA,NA,NA,NA,28/jun/2021,Positif,84.9,NA,Négatif,0.1,CTL118V3b,390.9,153.1,81.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL118,M,33.4,Pfizer,V4,91,NA,NA,NA,NA,NA,25/aoû/2021,Positif,68,NA,Négatif,0.1,CTL118V4b,164.1,91.3,43,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL118,M,33.4,Pfizer,V5,189,NA,NA,NA,NA,NA,01/déc/2021,Positif,57.6,867,Négatif,0.1,CTL118V5b,99.4,64,36,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL118,M,33.4,Pfizer,V6,372,129,NA,NA,NA,NA,02/jun/2022,Positif,204.6,10767,Négatif,1.1,CTL118 V6,837.5209380234506,405.35062829347385,318.1673560292714,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL119,M,46.4,Pfizer,V3,39,NA,NA,NA,NA,NA,05/jui/2021,Positif,72.1,NA,Négatif,0.3,CTL119V3b,216.5,56,17.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL119,M,46.4,Pfizer,V4,99,NA,NA,NA,NA,NA,03/sep/2021,Positif,59.9,NA,Négatif,0.6,CTL119V4b,199.3,102.8,43.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL119,M,46.4,Pfizer,V5,200,NA,NA,NA,NA,NA,13/déc/2021,Positif,49.9,653,Négatif,0.2,CTL119V5b,112.8,65.7,39.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL119,M,46.4,Pfizer,3M3,291,90,NA,NA,NA,NA,14/mar/2022,Positif,139.4,5007,Négatif,0.3,CTL119 3M3,356.1,151.9,91.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL120,F,61.5,Pfizer,V3,33,NA,NA,NA,NA,NA,20/jui/2021,Positif,67.5,NA,Indéterminé,5.9,CTL120V3b,715.8,413.6,181.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL120,F,61.5,Pfizer,V4,91,NA,NA,NA,NA,NA,16/sep/2021,Positif,81.7,NA,Négatif,3.6,CTL120V4b,280.3,131,66.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL120,F,61.5,Pfizer,V5,186,NA,NA,NA,NA,NA,20/déc/2021,Positif,105.9,2897,Négatif,1.8,CTL120V5b,218.3,87.7,44.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL120,F,61.5,Pfizer,3M3,291,89,NA,NA,NA,NA,04/avr/2022,Positif,90.2,2106,Négatif,1.1,CTL120 3M3,2430,2430,1603.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL121,M,40.4,Pfizer,V3,30,NA,NA,NA,NA,NA,24/jun/2021,Positif,85.1,NA,Négatif,2.8,CTL121V3b,478.7,222.4,211.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL121,M,40.4,Pfizer,V4,98,NA,NA,NA,NA,NA,31/aoû/2021,Positif,69.7,NA,Indéterminé,4.1,CTL121V4b,123.9,54.6,47.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL121,M,40.4,Pfizer,V5,195,NA,NA,NA,NA,NA,06/déc/2021,Positif,43.1,490,Négatif,2.6,CTL121V5b,86.7,56.3,29.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL121,M,40.4,Pfizer,3M3,316,98,NA,NA,NA,NA,06/avr/2022,Positif,107.7,2996,Négatif,0,CTL121 3M3,995,432.2,135.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL123,M,41.4,Pfizer,V3,35,NA,NA,V5-3M3,NA,NA,22/jun/2021,Positif,57.6,NA,Négatif,0.4,CTL123V3b,464,71.9,46.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL123,M,41.4,Pfizer,V4,93,NA,NA,V5-3M3,NA,NA,19/aoû/2021,Positif,93.6,NA,Négatif,0.4,CTL123V4b,239.2,52.5,33.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL123,M,41.4,Pfizer,V5,184,NA,NA,V5-3M3,NA,NA,18/nov/2021,Positif,92.1,NA,Négatif,1,CTL123V5b,210.6,46.4,31,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL123,M,41.4,Pfizer,3M3,303,91,NA,V5-3M3,79,NA,17/mar/2022,Positif,105.3,2864,Positif,6.4,CTL123 3M3,1710.6,449.2,532.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL124,F,49.4,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,21/jun/2021,Positif,68.2,NA,Négatif,0.3,CTL124V3b,151.6,59.4,16.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL124,F,49.4,Pfizer,V4,90,NA,NA,V5-3M3,NA,NA,16/aoû/2021,Positif,27.2,NA,Négatif,0.4,CTL124V4b,69.3,39.3,8.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL124,F,49.4,Pfizer,V5,184,NA,NA,V5-3M3,NA,NA,18/nov/2021,Positif,81.5,NA,Négatif,0.5,CTL124V5b,239.8,28,52.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL124,F,49.4,Pfizer,3M3,288,83,NA,V5-3M3,42,NA,02/mar/2022,Positif,93.3,2252,Positif,12.6,CTL124 3M3,2430,1990.4,1221.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL124,F,49.4,Pfizer,3M6,380,175,NA,V5-3M3,134,NA,02/jun/2022,Positif,207.7,11095,Négatif,2.5,CTL124 3M6,2509.4102885821835,1551.1090429657204,979.4319294809011,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL125,F,28.4,Pfizer,V3,34,NA,NA,NA,NA,NA,30/jun/2021,Positif,78.2,NA,Négatif,0.7,CTL125V3b,406.7,170.4,90.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL125,F,28.4,Pfizer,V4,95,NA,NA,NA,NA,NA,30/aoû/2021,Positif,71.4,NA,Négatif,0.8,CTL125V4b,116.7,55,28.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL125,F,28.4,Pfizer,V5,187,NA,NA,NA,NA,NA,30/nov/2021,Positif,36.2,348,Négatif,0.5,CTL125V5b,113.1,79.2,34.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL126,F,44.4,Pfizer,V3,29,NA,NA,V3-V4,NA,NA,24/jun/2021,Positif,83.7,NA,Positif,8.2,CTL126V3b,507.9,146.8,48.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL126,F,44.4,Pfizer,V4,97,NA,NA,V3-V4,36,NA,31/aoû/2021,Positif,84.1,NA,Positif,19.7,CTL126V4b,1506,615,206,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL126,F,44.4,Pfizer,V5,197,NA,NA,V3-V4,136,NA,09/déc/2021,Positif,107.9,3007,Positif,11.3,CTL126V5b,293.7,148,76.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL126,F,44.4,Pfizer,V6,369,NA,NA,V3-V4,308,NA,30/mai/2022,Positif,114.9,3407,Indéterminé,4.7,CTL126V6,180.4,88.3,44.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL127,F,41.4,Pfizer,V3,35,NA,NA,NA,NA,NA,22/jun/2021,Positif,56.2,NA,Négatif,0.6,CTL127V3b,447.8,245.8,56.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL127,F,41.4,Pfizer,V4,100,NA,NA,NA,NA,NA,26/aoû/2021,Positif,100.2,NA,Négatif,0.7,CTL127V4b,274.9,146.3,53.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL127,F,41.4,Pfizer,V5,185,NA,NA,NA,NA,NA,19/nov/2021,Positif,87.7,NA,Négatif,0.6,CTL127V5b,216.5,125,47.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL127,F,41.4,Pfizer,3M3,322,85,NA,NA,NA,NA,05/avr/2022,Positif,123.7,3946,Négatif,0.3,CTL127 3M3,693.5,329.1,157.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,V3,32,NA,NA,3M3-3M6,NA,NA,28/jun/2021,Positif,82.2,NA,Négatif,2,CTL128V3b,260.8,74.6,37.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,V4,91,NA,NA,3M3-3M6,NA,NA,26/aoû/2021,Positif,102.7,NA,Négatif,3.1,CTL128V4b,145.9,57,28.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,V5,186,NA,NA,3M3-3M6,NA,NA,29/nov/2021,Positif,73.5,1403,Négatif,1.6,CTL128V5b,91.4,30,18.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,V5+,243,35,NA,3M3-3M6,NA,NA,25/jan/2022,Positif,89,2051,Négatif,1.7,CTL128V5+,302,115.2,81.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,3M3,284,76,NA,3M3-3M6,NA,NA,07/mar/2022,Positif,108.5,3040,Négatif,1.6,CTL128 3M3,167,65.6,52.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL128,F,39.4,Pfizer,3M3+,312,104,NA,3M3-3M6,21,NA,04/avr/2022,Positif,97,2433,Positif,9.1,CTL128 3M3+,1742.2,869.6,466.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL129,F,42.4,Pfizer,V3,31,NA,NA,NA,NA,NA,25/jun/2021,Positif,106.4,NA,Négatif,0.6,CTL129V3b,894.5,318.1,82.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL129,F,42.4,Pfizer,V4,91,NA,NA,NA,NA,NA,24/aoû/2021,Positif,81.3,NA,Négatif,0.6,CTL129V4b,293,136.6,39.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL129,F,42.4,Pfizer,V5,189,NA,NA,NA,NA,NA,30/nov/2021,Positif,43.4,497,Négatif,0.4,CTL129V5b,75.7,45,19.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL129,F,42.4,Pfizer,3M3,294,91,NA,NA,NA,NA,15/mar/2022,Positif,93.1,2243,Positif,6.6,CTL129 3M3,1361.1,520.6,532.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL130,F,44.4,Moderna,V3,32,NA,NA,NA,NA,NA,05/jui/2021,Positif,95.5,NA,Négatif,1.1,CTL130V3b,585.8,232.3,109.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL130,F,44.4,Moderna,V4,95,NA,NA,NA,NA,NA,06/sep/2021,Positif,86.4,NA,Négatif,0.8,CTL130V4b,337.6,124.9,69.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL130,F,44.4,Moderna,V5,186,NA,NA,NA,NA,NA,06/déc/2021,Positif,67.6,1189,Négatif,0.8,CTL130V5b,185.6,87.3,59.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL131,F,55.5,Pfizer,V3,31,NA,NA,NA,NA,NA,15/jui/2021,Positif,62.1,NA,Négatif,0.1,CTL131V3b,518.9,208.3,62.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL131,F,55.5,Pfizer,V4,93,NA,NA,NA,NA,NA,15/sep/2021,Positif,103.8,NA,Négatif,0.1,CTL131V4b,273,105.7,41,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL131,F,55.5,Pfizer,V5,185,NA,NA,NA,NA,NA,16/déc/2021,Positif,83.5,1807,Négatif,0,CTL131V5b,130.6,60,27.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL131,F,55.5,Pfizer,V5+,220,35,NA,NA,NA,NA,20/jan/2022,Positif,103.7,2778,Négatif,0.1,CTL131V5+,977.5,311.8,138.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL131,F,55.5,Pfizer,3M3,277,92,NA,NA,NA,NA,18/mar/2022,Positif,101.6,2668,Négatif,0,CTL131 3M3,543.2,210.5,104.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL132,M,32.4,Pfizer,V3,29,NA,NA,NA,NA,NA,23/jun/2021,Positif,89.9,NA,Négatif,1.6,CTL132V3b,887.3,313.3,116.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL132,M,32.4,Pfizer,V4,90,NA,NA,NA,NA,NA,23/aoû/2021,Positif,75.2,NA,Négatif,0.9,CTL132V4b,357.5,153.7,60.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL132,M,32.4,Pfizer,V5,190,NA,NA,NA,NA,NA,01/déc/2021,Positif,96.4,2403,Négatif,0.4,CTL132V5b,212.3,110.8,50.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL132,M,32.4,Pfizer,3M3,286,84,NA,NA,NA,NA,07/mar/2022,Positif,109.3,3085,Négatif,0.3,CTL132 3M3,351.4,177.9,132.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL133,F,62.4,Pfizer,V3,30,NA,NA,V4-V5-V5+,NA,NA,08/jui/2021,Positif,102,NA,Négatif,1.1,CTL133V3b,732.1,276.1,92.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL133,F,62.4,Pfizer,V4,86,NA,NA,V4-V5-V5+,NA,NA,02/sep/2021,Positif,85.2,NA,Négatif,1.1,CTL133V4b,496.8,213.8,79.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL133,F,62.4,Pfizer,V5,189,NA,NA,V4-V5-V5+,12,NA,14/déc/2021,Positif,61.2,977,Positif,8.8,CTL133V5b,832.6,351.6,168.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL133,F,62.4,Pfizer,V5+,225,NA,NA,V4-V5-V5+,48,33,19/jan/2022,Positif,76.4,1515,Positif,25,CTL133V5+,2430,2430,2379.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL134,M,61.4,Pfizer,V3,33,NA,NA,NA,NA,NA,12/jui/2021,Positif,82.1,NA,Négatif,0.4,CTL134V3b,552.8,203.5,69.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL134,M,61.4,Pfizer,V4,96,NA,NA,NA,NA,NA,13/sep/2021,Positif,74,NA,Négatif,0.3,CTL134V4b,252.4,83.3,32.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL134,M,61.4,Pfizer,V5,183,NA,NA,NA,NA,NA,09/déc/2021,Positif,75.7,1488,Négatif,0.3,CTL134V5b,168.6,70.5,30.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL134,M,61.4,Pfizer,V5+,216,32,NA,NA,NA,NA,11/jan/2022,Positif,158.1,6435,Négatif,0.2,CTL134V5+,894.5,394.5,176.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL134,M,61.4,Pfizer,3M3,274,90,NA,NA,NA,NA,10/mar/2022,Positif,80.7,1689,Négatif,0.1,CTL134 3M3,594.9,273.1,105.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL135,F,61.5,Pfizer,V3,31,NA,NA,NA,NA,NA,15/jui/2021,Positif,64.6,NA,Négatif,0.2,CTL135V3b,256,101.9,46.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL135,F,61.5,Pfizer,V4,92,NA,NA,NA,NA,NA,14/sep/2021,Positif,70.4,NA,Négatif,1.2,CTL135V4b,227.8,84.1,41.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL135,F,61.5,Pfizer,V5,190,NA,NA,NA,NA,NA,21/déc/2021,Positif,65.6,1121,Négatif,0.1,CTL135V5b,86.8,49.7,28.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL135,F,61.5,Pfizer,V5+,221,30,NA,NA,NA,NA,21/jan/2022,Positif,125.6,4068,Négatif,0.1,CTL135V5+,1144.6,336.2,177.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL135,F,61.5,Pfizer,3M3,281,90,NA,NA,NA,NA,22/mar/2022,Positif,98.2,2493,Négatif,0,CTL135 3M3,560.9,180.5,161.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL136,F,60.4,Pfizer,V3,28,NA,NA,NA,NA,NA,08/jui/2021,Positif,108.1,NA,Négatif,3.9,CTL136V3b,561.5,220.1,81.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL136,F,60.4,Pfizer,V4,89,NA,NA,NA,NA,NA,07/sep/2021,Positif,95.2,NA,Indéterminé,4.7,CTL136V4b,402.4,161.3,82.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL136,F,60.4,Pfizer,V5,183,NA,NA,NA,NA,NA,10/déc/2021,Positif,83.2,1794,Négatif,2.3,CTL136V5b,98.7,40.6,9.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL137,M,31.4,Pfizer,V3,32,NA,NA,NA,NA,NA,29/jun/2021,Positif,82.7,NA,Négatif,1.7,CTL137V3b,520.8,169.2,61.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL137,M,31.4,Pfizer,V4,94,NA,NA,NA,NA,NA,30/aoû/2021,Positif,66,NA,Négatif,1.7,CTL137V4b,128.6,64.4,33.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL137,M,31.4,Pfizer,V5,208,6,NA,NA,NA,NA,22/déc/2021,Positif,137.2,4851,Négatif,1.1,CTL137V5b,435.5,202,127.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,V3,31,NA,NA,NA,NA,NA,25/jun/2021,Positif,106.4,NA,Négatif,3.9,CTL138V3b,643.5,285.2,88.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,V4,91,NA,NA,NA,NA,NA,24/aoû/2021,Positif,85.4,NA,Indéterminé,4.3,CTL138V4b,285.7,177.3,64.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,V5,184,NA,NA,NA,NA,NA,25/nov/2021,Positif,95.8,NA,Négatif,0.5,CTL138V5b,186.7,88,46.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,V5+,233,36,NA,NA,NA,NA,13/jan/2022,Positif,83.5,1807,Négatif,2.9,CTL138V5+,2430,1030.2,423.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,3M3,294,97,NA,NA,NA,NA,15/mar/2022,Positif,95.4,2354,Négatif,2.6,CTL138 3M3,1472.8,591,319.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL138,F,32.4,Pfizer,3M6,359,162,NA,NA,NA,NA,19/mai/2022,Positif,121,3777,Positif,15.9,CTL138 3M6,2430,2430,2414.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,V3,30,NA,NA,NA,NA,NA,25/jun/2021,Positif,107.6,NA,Négatif,0.9,CTL140V3b,509.2,177.3,48.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,V4,93,NA,NA,NA,NA,NA,27/aoû/2021,Positif,83.4,NA,Négatif,1.1,CTL140V4b,204.2,100.8,32.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,V5,191,NA,NA,NA,NA,NA,03/déc/2021,Positif,51,682,Négatif,1.3,CTL140V5b,83.1,48.2,20.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,V5+,236,40,NA,NA,NA,NA,17/jan/2022,Positif,129.9,4350,Positif,12.2,CTL140V5+,1336.4,526.6,351,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,3M3,278,82,NA,NA,NA,NA,28/fév/2022,Positif,102,2689,Positif,8.2,CTL140 3M3,2430,2430,1945.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL140,M,58.4,Pfizer,3M6,369,173,NA,NA,NA,NA,30/mai/2022,Positif,214.8,11866,Indéterminé,4.6,CTL140 3M6,2430,2354,1903.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL141,F,50.4,Pfizer,V3,34,NA,NA,NA,NA,NA,28/jun/2021,Positif,75.9,NA,Négatif,0.2,CTL141V3b,461.5,191.1,77.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL141,F,50.4,Pfizer,V4,92,NA,NA,NA,NA,NA,25/aoû/2021,Positif,70.5,NA,Négatif,0.2,CTL141V4b,165,86.1,35.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL141,F,50.4,Pfizer,V5,188,NA,NA,NA,NA,NA,29/nov/2021,Positif,56.2,826,Négatif,0.2,CTL141V5b,137.6,85.9,46.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL142,M,55.4,Pfizer,V3,31,NA,NA,V5+-3M3,NA,NA,12/jui/2021,Positif,58.4,NA,Négatif,0,CTL142V3b,198.2,92.9,33.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL142,M,55.4,Pfizer,V4,96,NA,NA,V5+-3M3,NA,NA,15/sep/2021,Positif,51.9,NA,Négatif,0.1,CTL142V4b,129.6,55.9,18.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL142,M,55.4,Pfizer,V5,193,NA,NA,V5+-3M3,NA,NA,21/déc/2021,Positif,37.6,375,Négatif,0.1,CTL142V5b,84,35.6,16.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL142,M,55.4,Pfizer,V5+,222,28,NA,V5+-3M3,NA,NA,19/jan/2022,Positif,106.8,2946,Négatif,0.1,CTL142V5+,766.3,167.6,75.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL142,M,55.4,Pfizer,3M3,286,92,NA,V5+-3M3,14,NA,24/mar/2022,Positif,110.7,3164,Positif,6.4,CTL142 3M3,686.3,225.5,149.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL144,F,43.4,Pfizer,V3,29,NA,NA,NA,NA,NA,23/jun/2021,Positif,101,NA,Négatif,2.9,CTL144V3b,512,165.9,67.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL144,F,43.4,Pfizer,V4,99,NA,NA,NA,NA,NA,01/sep/2021,Positif,72.5,NA,Négatif,2.1,CTL144V4b,113.6,51.5,26.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL144,F,43.4,Pfizer,V5,197,NA,NA,NA,NA,NA,08/déc/2021,Positif,95.7,2369,Négatif,2.6,CTL144V5b,121.5,73,38.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL144,F,43.4,Pfizer,V5+,233,35,NA,NA,NA,NA,13/jan/2022,Positif,95.3,2349,Négatif,1.7,CTL144V5+,759.3,367.9,183.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL144,F,43.4,Pfizer,3M3,287,89,NA,NA,NA,NA,08/mar/2022,Positif,86.8,1951,Négatif,1.8,CTL144 3M3,613.1,354.1,176.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL145,M,54.4,Pfizer,V3,33,NA,NA,NA,NA,NA,28/jun/2021,Positif,81.4,NA,Négatif,0.4,CTL145V3b,246.1,100.8,49,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL145,M,54.4,Pfizer,V4,96,NA,NA,NA,NA,NA,30/aoû/2021,Positif,56.4,NA,Négatif,0.4,CTL145V4b,105.6,63.3,30.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL145,M,54.4,Pfizer,V5,188,NA,NA,NA,NA,NA,30/nov/2021,Positif,28.1,213,Négatif,0.3,CTL145V5b,43.3,27.8,15.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL145,M,54.4,Pfizer,3M3,301,78,NA,NA,NA,NA,23/mar/2022,Positif,86,1916,Négatif,0.2,CTL145 3M3,634.9,246.1,185.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL146,M,32.4,Pfizer,V3,35,NA,NA,V5+-3M3,NA,NA,22/jun/2021,Positif,59.5,NA,Négatif,0.4,CTL146V3b,381.8,108.4,44.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL146,M,32.4,Pfizer,V4,92,NA,NA,V5+-3M3,NA,NA,18/aoû/2021,Positif,51.8,NA,Négatif,0.3,CTL146V4b,107,51,24,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL146,M,32.4,Pfizer,V5,189,NA,NA,V5+-3M3,NA,NA,23/nov/2021,Positif,50,NA,Négatif,0.5,CTL146V5b,67.5,33.2,18.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL146,M,32.4,Pfizer,V5+,251,25,NA,V5+-3M3,NA,NA,24/jan/2022,Positif,105,2848,Négatif,0.4,CTL146V5+,996,363.1,163.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL146,M,32.4,Pfizer,3M3,325,99,NA,V5+-3M3,29,NA,08/avr/2022,Positif,115.9,3467,Positif,7.5,CTL146 3M3,2430,2430,1250.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL147,F,45.4,Pfizer,V3,31,NA,NA,V5+-3M3,NA,NA,21/jun/2021,Positif,86.6,NA,Négatif,0.3,CTL147V3b,266.3,103.8,71.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL147,F,45.4,Pfizer,V4,95,NA,NA,V5+-3M3,NA,NA,24/aoû/2021,Positif,50.1,NA,Négatif,0.3,CTL147V4b,122.5,61.2,25.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL147,F,45.4,Pfizer,V5,185,NA,NA,V5+-3M3,NA,NA,22/nov/2021,Positif,47.5,NA,Négatif,0.2,CTL147V5b,62.4,40.1,16.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL147,F,45.4,Pfizer,V5+,241,28,NA,V5+-3M3,NA,NA,17/jan/2022,Positif,131.7,4471,Négatif,0.2,CTL147V5+,635.3,233.8,84,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL147,F,45.4,Pfizer,3M3,297,84,NA,V5+-3M3,35,NA,14/mar/2022,Positif,142.5,5231,Négatif,3.5,CTL147 3M3,2271.7,871.1,633.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL148,F,37.4,Pfizer,V3,31,NA,NA,NA,NA,NA,25/jun/2021,Positif,105.3,NA,Négatif,1.3,CTL148V3b,431.8,139.9,63.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL148,F,37.4,Pfizer,V4,91,NA,NA,NA,NA,NA,24/aoû/2021,Positif,71.7,NA,Négatif,1.5,CTL148V4b,172.8,62.5,40.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL148,F,37.4,Pfizer,V5,184,NA,NA,NA,NA,NA,25/nov/2021,Positif,56.3,NA,Négatif,1.5,CTL148V5b,140,58.8,33.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL148,F,37.4,Pfizer,V6,349,104,NA,NA,NA,NA,09/mai/2022,Positif,125.9,4087,Négatif,0.9,CTL148 V6,176.3668430335097,71.83908045977012,56.14823133071308,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL149,F,52.4,Pfizer,V3,27,NA,NA,NA,NA,NA,05/jui/2021,Positif,95.6,NA,Négatif,0.3,CTL149V3b,443.5,164.7,63.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL149,F,52.4,Pfizer,V4,93,NA,NA,NA,NA,NA,09/sep/2021,Positif,60.4,NA,Négatif,0.5,CTL149V4b,117.7,55,21.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL149,F,52.4,Pfizer,V5,184,NA,NA,NA,NA,NA,09/déc/2021,Positif,48.4,615,Négatif,0.3,CTL149V5b,71.3,48.2,17.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL149,F,52.4,Pfizer,V5+,224,36,NA,NA,NA,NA,18/jan/2022,Positif,111.5,3210,Négatif,0.2,CTL149V5+,910.7,265.3,167.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL149,F,52.4,Pfizer,3M3,279,91,NA,NA,NA,NA,14/mar/2022,Positif,138.5,4943,Négatif,0.1,CTL149 3M3,272.8,121.1,80.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL151,F,54.4,Moderna,V3,34,NA,NA,NA,NA,NA,21/jun/2021,Positif,89.6,NA,Négatif,0.7,CTL151V3b,751.9,303.8,96.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL151,F,54.4,Moderna,V4,93,NA,NA,NA,NA,NA,19/aoû/2021,Positif,99.2,NA,Négatif,0.8,CTL151V4b,453.5,210,70.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL151,F,54.4,Moderna,V5,195,NA,NA,NA,NA,NA,29/nov/2021,Positif,83.7,1816,Négatif,0.8,CTL151V5b,225.3,124.1,55.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL151,F,54.4,Moderna,V5+,244,35,NA,NA,NA,NA,17/jan/2022,Positif,127.5,4191,Négatif,0.7,CTL151V5+,1313,416.8,219.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL151,F,54.4,Moderna,3M3,286,77,NA,NA,NA,NA,28/fév/2022,Positif,101.5,2663,Positif,10,CTL151 3M3,2430,1500.4,1107.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL152,F,51.4,Pfizer,V3,31,NA,NA,NA,NA,NA,30/jun/2021,Positif,76.7,NA,Négatif,0.1,CTL152V3b,521.6,271.2,102.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL152,F,51.4,Pfizer,V4,99,NA,NA,NA,NA,NA,06/sep/2021,Positif,79,NA,Négatif,0.1,CTL152V4b,219.3,110.7,60.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL152,F,51.4,Pfizer,V5,185,NA,NA,NA,NA,NA,01/déc/2021,Positif,47.5,593,Négatif,0.1,CTL152V5b,75.5,45,32.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL152,F,51.4,Pfizer,V5+,232,28,NA,NA,NA,NA,17/jan/2022,Positif,126.6,4133,Négatif,0,CTL152V5+,2430,993,494.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL152,F,51.4,Pfizer,3M3,292,88,NA,NA,NA,NA,18/mar/2022,Positif,97.3,2448,Négatif,0,CTL152 3M3,1001.8,471,280.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL153,F,63.5,Pfizer,V3,29,NA,NA,NA,NA,NA,23/jui/2021,Positif,71.4,NA,Négatif,0.1,CTL153V3b,640.2,309.9,183.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL153,F,63.5,Pfizer,V4,92,NA,NA,NA,NA,NA,24/sep/2021,Positif,92.4,NA,Négatif,0.1,CTL153V4b,212.3,93.6,35.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL153,F,63.5,Pfizer,V5,180,NA,NA,NA,NA,NA,21/déc/2021,Positif,93.7,2271,Négatif,0.1,CTL153V5b,242.4,148.5,66.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,V3,30,NA,NA,V5+-3M3,NA,NA,01/jui/2021,Positif,84.3,NA,Négatif,0.4,CTL154V3b,233.6,111,15.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,V4,93,NA,NA,V5+-3M3,NA,NA,02/sep/2021,Positif,87.9,NA,Négatif,0.2,CTL154V4b,476.9,198.4,103.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,V5,183,NA,NA,V5+-3M3,NA,NA,01/déc/2021,Positif,93,2238,Négatif,0.1,CTL154V5b,157.3,79.2,43.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,V5+,223,35,NA,V5+-3M3,NA,NA,10/jan/2022,Positif,128.2,4237,Négatif,0,CTL154V5+,472.8,191.5,88.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,3M3,279,91,NA,V5+-3M3,16,NA,07/mar/2022,Positif,98.2,2493,Positif,12.6,CTL154 3M3,2430,1433.9,1190.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL154,M,43.4,Moderna,3M6,365,177,NA,V5+-3M3,102,NA,01/jun/2022,Positif,112.4,3261,Négatif,2.9,CTL154 3M6,2430,2096.4360587002097,1170.4119850187267,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL155,M,62.4,Pfizer,V3,30,NA,NA,NA,NA,NA,07/jui/2021,Positif,108.1,NA,Négatif,1.7,CTL155V3b,473,208.1,78.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL155,M,62.4,Pfizer,V4,102,NA,NA,NA,NA,NA,17/sep/2021,Positif,71.4,NA,Négatif,1.7,CTL155V4b,207.1,104.4,49.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL155,M,62.4,Pfizer,V5,183,NA,NA,NA,NA,NA,07/déc/2021,Positif,58.6,897,Négatif,3.8,CTL155V5b,182.4,119,44.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL155,M,62.4,Pfizer,V5+,220,36,NA,NA,NA,NA,13/jan/2022,Positif,94.4,2305,Négatif,1.1,CTL155V5+,640.6,263.6,186.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL155,M,62.4,Pfizer,3M3,276,92,NA,NA,NA,NA,10/mar/2022,Positif,80.5,1680,Négatif,1.7,CTL155 3M3,419.1,186.4,140.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL156,F,46.4,Moderna,V3,29,NA,NA,NA,NA,NA,08/jui/2021,Positif,99.8,NA,Négatif,2.9,CTL156V3b,1150.2,379.1,141.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL156,F,46.4,Moderna,V4,92,NA,NA,NA,NA,NA,09/sep/2021,Positif,77.3,NA,Négatif,1.4,CTL156V4b,417.4,166.3,71.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL156,F,46.4,Moderna,V5,183,NA,NA,NA,NA,NA,09/déc/2021,Positif,94.9,2330,Négatif,2.7,CTL156V5b,160.1,45.2,14.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL156,F,46.4,Moderna,V5+,218,35,NA,NA,NA,NA,13/jan/2022,Positif,69.9,1270,Négatif,1.8,CTL156V5+,2430,956.9,472.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL156,F,46.4,Moderna,3M3,288,105,NA,NA,NA,NA,24/mar/2022,Positif,91.1,2148,Positif,6.3,CTL156 3M3,7610.4,5592.8,4235.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL157,M,34.5,Moderna,V3,30,NA,NA,V5-3M3,NA,NA,15/jui/2021,Positif,65.9,NA,Négatif,2.3,CTL157V3b,438.8,179.6,91.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL157,M,34.5,Moderna,V4,93,NA,NA,V5-3M3,NA,NA,16/sep/2021,Positif,82.3,NA,Négatif,2.3,CTL157V4b,244.3,88,55.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL157,M,34.5,Moderna,V5,184,NA,NA,V5-3M3,NA,NA,16/déc/2021,Positif,81,1701,Négatif,2.2,CTL157V5b,97.8,40.9,31.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL157,M,34.5,Moderna,3M3,303,91,NA,V5-3M3,3,NA,14/avr/2022,Positif,96.9,2428,Négatif,1.1,CTL157 3M3,364.6,159.8,76.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL158,F,28.4,Moderna/Pfizer,V3,30,NA,NA,NA,NA,NA,06/jui/2021,Positif,92.7,NA,Négatif,0.2,CTL158V3b,552.2,219.2,102.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL158,F,28.4,Moderna/Pfizer,V4,92,NA,NA,NA,NA,NA,06/sep/2021,Positif,87.1,NA,Négatif,0.2,CTL158V4b,439.9,188.5,135.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL158,F,28.4,Moderna/Pfizer,V5,186,NA,NA,NA,NA,NA,09/déc/2021,Positif,76.7,1527,Négatif,0.1,CTL158V5b,121.6,79.4,54.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL158,F,28.4,Moderna/Pfizer,V5+,226,22,NA,NA,NA,NA,18/jan/2022,Positif,90.8,2134,Négatif,0.1,CTL158V5+,1272.8,670.2,448.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL158,F,28.4,Moderna/Pfizer,3M3,291,87,NA,NA,NA,NA,24/mar/2022,Positif,109.3,3085,Négatif,0,CTL158 3M3,738.6,342,304.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL160,F,41.4,Moderna,V3,30,NA,NA,NA,NA,NA,13/jui/2021,Positif,87.3,NA,Négatif,0.1,CTL160V3b,621.5,168.5,32.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL160,F,41.4,Moderna,V4,92,NA,NA,NA,NA,NA,13/sep/2021,Positif,83.8,NA,Négatif,0.1,CTL160V4b,512,175.5,55.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL160,F,41.4,Moderna,V5,186,NA,NA,NA,NA,NA,16/déc/2021,Positif,91.7,2176,Négatif,0,CTL160V5b,195,76.9,36.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL160,F,41.4,Moderna,V5+,218,31,NA,NA,NA,NA,17/jan/2022,Positif,129,4290,Négatif,0,CTL160V5+,2430,503,185.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL160,F,41.4,Moderna,3M3,277,90,NA,NA,NA,NA,17/mar/2022,Positif,105.2,2859,Négatif,0,CTL160 3M3,2551.7,474.8,203.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL161,F,35.4,Moderna,V3,30,NA,NA,NA,NA,NA,08/jui/2021,Positif,97.1,NA,Négatif,0.3,CTL161V3b,2430,1025.1,208.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL161,F,35.4,Moderna,V4,91,NA,NA,NA,NA,NA,07/sep/2021,Positif,93.9,NA,Négatif,0.3,CTL161V4b,902.5,399.7,91.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL161,F,35.4,Moderna,V5,184,NA,NA,NA,NA,NA,09/déc/2021,Positif,108.6,3046,Négatif,0.3,CTL161V5b,319.9,189.8,52,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL161,F,35.4,Moderna,V5+,223,34,NA,NA,NA,NA,17/jan/2022,Positif,131.8,4478,Négatif,0.1,CTL161V5+,2430,2430,547,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL161,F,35.4,Moderna,3M3,282,93,NA,NA,NA,NA,17/mar/2022,Positif,107,2957,Négatif,0,CTL161 3M3,4945.6,1327.5,333.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL162,F,48.4,Moderna,V3,32,NA,NA,V5+ -3M3,NA,NA,12/jui/2021,Positif,78.9,NA,Négatif,0,CTL162V3b,337,140.8,54.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL162,F,48.4,Moderna,V4,91,NA,NA,V5+ -3M3,NA,NA,09/sep/2021,Positif,69.6,NA,Négatif,0.1,CTL162V4b,156.1,85.5,34.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL162,F,48.4,Moderna,V5,186,NA,NA,V5+ -3M3,NA,NA,13/déc/2021,Positif,78.4,1595,Négatif,0.1,CTL162V5b,119.6,76.4,29.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL162,F,48.4,Moderna,V5+,224,31,NA,V5+ -3M3,NA,NA,20/jan/2022,Positif,100.2,2595,Négatif,0,CTL162V5+,595.6,267.5,146.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL162,F,48.4,Moderna,3M3,292,99,NA,V5+ -3M3,68,NA,29/mar/2022,Positif,123.8,3953,Négatif,0.8,CTL162 3M3,873.4,547.3,361.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL163,M,38.4,Moderna,V3,29,NA,NA,NA,NA,NA,07/jui/2021,Positif,109.9,NA,Négatif,0.1,CTL163V3b,915.8,301.4,117.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL163,M,38.4,Moderna,V4,91,NA,NA,NA,NA,NA,07/sep/2021,Positif,95.5,NA,Négatif,0.4,CTL163V4b,628.1,196.1,99.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL163,M,38.4,Moderna,V5,189,NA,NA,NA,NA,NA,14/déc/2021,Positif,83,1786,Négatif,0.1,CTL163V5b,301.1,69.3,20.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL163,M,38.4,Moderna,V5+,225,35,NA,NA,NA,NA,19/jan/2022,Positif,103.7,2778,Négatif,0.2,CTL163V5+,2430,1027.9,467.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL163,M,38.4,Moderna,3M3,280,90,NA,NA,NA,NA,15/mar/2022,Positif,91.7,2176,Négatif,0.1,CTL163 3M3,1430.2,653.2,384.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL164,F,44.5,Pfizer,V3,41,NA,NA,V5-V6,NA,NA,03/aoû/2021,Positif,75.9,NA,Négatif,0.5,CTL164V3b,377.6,115.2,67.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL164,F,44.5,Pfizer,V4,92,NA,NA,V5-V6,NA,NA,23/sep/2021,Positif,79.6,NA,Négatif,1,CTL164V4b,144.6,75.2,46.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL164,F,44.5,Pfizer,V5,176,NA,NA,V5-V6,NA,NA,16/déc/2021,Positif,53.8,758,Négatif,0.3,CTL164V5b,68,33.7,23.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL165,F,43.5,Moderna,V3,30,NA,NA,V5-3M3,NA,NA,15/jui/2021,Positif,60.3,NA,Négatif,0.6,CTL165V3b,639.4,237.3,111.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL165,F,43.5,Moderna,V4,100,NA,NA,V5-3M3,NA,NA,23/sep/2021,Positif,88.4,NA,Négatif,0.7,CTL165V4b,381.8,232,103,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL165,F,43.5,Moderna,V5,188,4,NA,V5-3M3,NA,NA,20/déc/2021,Positif,108.5,3040,Négatif,0.6,CTL165V5b,148.2,47.6,12.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL165,F,43.5,Moderna,3M3,279,95,NA,V5-3M3,14,NA,21/mar/2022,Positif,90.5,2120,Positif,7,CTL165 3M3,631.7,209.7,141.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL166,M,31.4,Pfizer,V3,35,NA,NA,V5-V6,NA,NA,29/jun/2021,Positif,82.9,NA,Négatif,0.8,CTL166V3b,457.7,197.4,66.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL166,M,31.4,Pfizer,V4,91,NA,NA,V5-V6,NA,NA,24/aoû/2021,Positif,68.7,NA,Négatif,0.4,CTL166V4b,157.2,81.7,31.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL166,M,31.4,Pfizer,V5,182,NA,NA,V5-V6,NA,NA,23/nov/2021,Positif,64.8,NA,Négatif,0.4,CTL166V5b,167.6,93.5,34.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL166,M,31.4,Pfizer,V6,364,NA,NA,V5-V6,105,NA,24/mai/2022,Positif,161,6673,Positif,10,CTL166V6,2430,1776.2,758.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL167,M,60.4,Moderna,V3,31,NA,NA,V5+-3M3,NA,NA,28/jun/2021,Positif,83.7,NA,Négatif,1.1,CTL167V3b,337,114.1,39.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL167,M,60.4,Moderna,V4,94,NA,NA,V5+-3M3,NA,NA,30/aoû/2021,Positif,74.5,NA,Négatif,1.3,CTL167V4b,239.1,91,35.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL167,M,60.4,Moderna,V5,188,NA,NA,V5+-3M3,NA,NA,02/déc/2021,Positif,53.2,741,Négatif,0.9,CTL167V5b,140,54.2,23.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL167,M,60.4,Moderna,V5+,230,36,NA,V5+-3M3,NA,NA,13/jan/2022,Positif,99.5,2559,Négatif,0.8,CTL167V5+,1476.9,332.2,191.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL167,M,60.4,Moderna,3M3,294,100,NA,V5+-3M3,46,NA,18/mar/2022,Positif,102.3,2704,Positif,9.7,CTL167 3M3,9784.7,4608.3,3769.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL168,M,34.5,Moderna,V3,27,NA,NA,V5-3M3,NA,NA,13/jui/2021,Positif,86.6,NA,Négatif,0.1,CTL168V3b,648.1,224.5,73.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL168,M,34.5,Moderna,V4,89,NA,NA,V5-3M3,NA,NA,13/sep/2021,Positif,81.7,NA,Négatif,0.3,CTL168V4b,194.9,113.8,38,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL168,M,34.5,Moderna,V5,187,NA,NA,V5-3M3,NA,NA,20/déc/2021,Positif,90.1,2101,Négatif,0.2,CTL168V5b,130.5,89.5,32.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL168,M,34.5,Moderna,3M3,285,98,NA,V5-3M3,55,NA,28/mar/2022,Positif,91.1,2148,Négatif,1.8,CTL168 3M3,1206.3,586.5,383.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL169,F,47.5,Moderna,V3,35,NA,NA,NA,NA,NA,20/jui/2021,Positif,67.8,NA,Négatif,0.1,CTL169V3b,484.7,260.2,82.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL169,F,47.5,Moderna,V4,92,NA,NA,NA,NA,NA,15/sep/2021,Positif,102.1,NA,Négatif,0.1,CTL169V4b,240,116.8,53,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL169,F,47.5,Moderna,V5,188,NA,NA,NA,NA,NA,20/déc/2021,Positif,89.3,2065,Négatif,0.2,CTL169V5b,77.4,26.7,12.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL169,F,47.5,Moderna,V5+,219,31,NA,NA,NA,NA,20/jan/2022,Positif,106.7,2941,Négatif,0.1,CTL169V5+,777,289.8,108.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL169,F,47.5,Moderna,3M3,279,91,NA,NA,NA,NA,21/mar/2022,Positif,88.5,2028,Négatif,0.1,CTL169 3M3,216.1,96.8,54.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL170,F,43.5,Pfizer,V3,49,NA,NA,NA,NA,NA,16/aoû/2021,Positif,68.1,NA,Indéterminé,4,CTL170V3b,759.9,299,74.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL170,F,43.5,Pfizer,V4,92,NA,NA,NA,NA,NA,28/sep/2021,Positif,80.8,NA,Négatif,1.8,CTL170V4b,415.8,172.3,57.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL170,F,43.5,Pfizer,V5,175,NA,NA,NA,NA,NA,20/déc/2021,Positif,99.8,2575,Indéterminé,4,CTL170V5b,148.3,59.6,29.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL170,F,43.5,Pfizer,V5+,203,18,NA,NA,NA,NA,17/jan/2022,Positif,128.9,4284,Négatif,1.4,CTL170V5+,605,284.9,151.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL170,F,43.5,Pfizer,3M3,273,88,NA,NA,NA,NA,28/mar/2022,Positif,88.1,2010,Négatif,0.1,CTL170 3M3,415.3,207,89.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,V3,30,NA,NA,NA,NA,NA,30/jun/2021,Positif,67,NA,Négatif,0.8,CTL171V3b,1134.2,383.3,147,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,V4,91,NA,NA,NA,NA,NA,30/aoû/2021,Positif,89.2,NA,Négatif,0.9,CTL171V4b,494.3,178,87.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,V5,184,NA,NA,NA,NA,NA,01/déc/2021,Positif,97,2433,Négatif,1.2,CTL171V5b,204.8,63.1,24.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,V5+,227,34,NA,NA,NA,NA,13/jan/2022,Positif,96.5,2408,Négatif,0.6,CTL171V5+,735.8,249,148.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,3M3,276,83,NA,NA,NA,NA,03/mar/2022,Positif,96,2384,Négatif,0.7,CTL171 3M3,399,147.2,103.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL171,F,44.4,Moderna,3M6,364,171,NA,NA,NA,NA,30/mai/2022,Positif,127.3,4178,Négatif,0.2,CTL171 3M6,201.9,80.2,49.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL173,F,58.5,Pfizer,V3,28,NA,NA,NA,NA,NA,12/jui/2021,Positif,74.4,NA,Négatif,0.1,CTL173V3b,662.3,281.6,102.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL173,F,58.5,Pfizer,V4,93,NA,NA,NA,NA,NA,15/sep/2021,Positif,99,NA,Négatif,0.5,CTL173V4b,172.5,80,38.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL173,F,58.5,Pfizer,V5,185,7,NA,NA,NA,NA,16/déc/2021,Positif,95.6,2364,Négatif,0.1,CTL173V5b,962.5,423.7,306.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL173,F,58.5,Pfizer,V5+,213,35,NA,NA,NA,NA,13/jan/2022,Positif,94,2286,Négatif,0.1,CTL173V5+,645.6,296.8,190.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL173,F,58.5,Pfizer,3M3,268,90,NA,NA,NA,NA,09/mar/2022,Positif,99.3,2549,Négatif,0,CTL173 3M3,353.5,163.3,125,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL174,F,43.4,Moderna,V3,32,NA,NA,V4-V5,NA,NA,01/jui/2021,Positif,84.7,NA,Négatif,3,CTL174V3b,684.9,239.3,86.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL174,F,43.4,Moderna,V4,93,NA,NA,V4-V5,NA,NA,31/aoû/2021,Positif,72.5,NA,Négatif,2.5,CTL174V4b,122.8,52.8,24.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL174,F,43.4,Moderna,V5,186,NA,NA,V4-V5,77,NA,02/déc/2021,Positif,90.8,2134,Positif,11.8,CTL174V5b,601.3,394.8,127.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL174,F,43.4,Moderna,3M3,317,85,NA,V4-V5,208,NA,12/avr/2022,Positif,94.1,2291,Positif,13.8,CTL174 3M3,1153.1,481.7,158.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL175,M,47.5,Moderna,V3,30,NA,NA,NA,NA,NA,15/jui/2021,Positif,60.5,NA,Négatif,1.7,CTL175V3b,1667.8,565,152.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL175,M,47.5,Moderna,V4,98,NA,NA,NA,NA,NA,21/sep/2021,Positif,75.4,NA,Négatif,0.9,CTL175V4b,1298.4,464,191.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL175,M,47.5,Moderna,V5,184,NA,NA,NA,NA,NA,16/déc/2021,Positif,101.8,2678,Négatif,0.9,CTL175V5b,763,252.3,118.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL175,M,47.5,Moderna,3M3,288,91,NA,NA,NA,NA,30/mar/2022,Positif,92.3,2205,Négatif,0.1,CTL175 3M3,859.8,291.9,156.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL176,M,41.4,Moderna,V3,30,NA,NA,V4-V5,NA,NA,08/jui/2021,Positif,107.6,NA,Négatif,0.2,CTL176V3b,585.8,205,56.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL176,M,41.4,Moderna,V4,90,NA,NA,V4-V5,NA,NA,06/sep/2021,Positif,87.6,NA,Négatif,0.3,CTL176V4b,317.2,133.9,46.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL176,M,41.4,Moderna,V5,210,21,NA,V4-V5,22,NA,04/jan/2022,Positif,122.6,3877,Indéterminé,5.1,CTL176V5b,1931.2,935.5,325.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL177,F,44.4,Moderna,V3,30,NA,NA,V5-3M3,NA,NA,08/jui/2021,Positif,108.2,NA,Négatif,2.1,CTL177V3b,458.3,156.5,25.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL177,F,44.4,Moderna,V4,100,NA,NA,V5-3M3,NA,NA,16/sep/2021,Positif,82.7,NA,Négatif,1.2,CTL177V4b,477.6,221.7,65.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL177,F,44.4,Moderna,V5,188,NA,NA,V5-3M3,NA,NA,13/déc/2021,Positif,26.3,187,Négatif,0.2,CTL177V5b,117.2,44.3,18.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL177,F,44.4,Moderna,V5+,227,39,NA,V5-3M3,NA,NA,21/jan/2022,Positif,126.1,4100,Négatif,0.9,CTL177V5+,1188.8,459.6,145.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL177,F,44.4,Moderna,3M3,279,91,NA,V5-3M3,27,NA,14/mar/2022,Positif,139.3,5000,Positif,10.2,CTL177 3M3,1220.4,506.1,288.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL179,M,33.4,Moderna,V3,30,NA,NA,NA,NA,NA,09/jui/2021,Positif,98.8,NA,Négatif,0.5,CTL179V3b,440.3,167.3,73.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL179,M,33.4,Moderna,V4,92,NA,NA,NA,NA,NA,09/sep/2021,Positif,78.7,NA,Négatif,0.5,CTL179V4b,224.5,85,36,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL179,M,33.4,Moderna,V5,188,NA,NA,NA,NA,NA,14/déc/2021,Positif,79.5,1639,Négatif,0.6,CTL179V5b,130,66.5,30.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL179,M,33.4,Moderna,V5+,224,33,NA,NA,NA,NA,19/jan/2022,Positif,105.8,2891,Négatif,0.5,CTL179V5+,692,273.3,176.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL179,M,33.4,Moderna,3M3,286,95,NA,NA,NA,NA,22/mar/2022,Positif,97.6,2463,Négatif,0.1,CTL179 3M3,491.4,138,100.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL180,F,37.5,Moderna,V3,36,NA,NA,V5-3M3,NA,NA,20/jui/2021,Positif,68.8,NA,Négatif,1.6,CTL180V3b,510.5,173.3,27.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL180,F,37.5,Moderna,V4,92,NA,NA,V5-3M3,NA,NA,14/sep/2021,Positif,91.8,NA,Négatif,1,CTL180V4b,456.6,166.1,26.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL180,F,37.5,Moderna,V5,183,NA,NA,V5-3M3,NA,NA,14/déc/2021,Positif,68.4,1217,Négatif,1.3,CTL180V5b,156.6,63.3,22.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL180,F,37.5,Moderna,3M3,273,89,NA,V5-3M3,63,NA,14/mar/2022,Positif,142.7,5246,Négatif,1.7,CTL180 3M3,1787.6,573.4,276,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL181,M,49.5,Pfizer,V3,36,NA,NA,V5-V5+,NA,NA,29/jui/2021,Positif,78.2,NA,Négatif,0.5,CTL181V3b,460.6,202.9,76.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL181,M,49.5,Pfizer,V4,92,NA,NA,V5-V5+,NA,NA,23/sep/2021,Positif,77.5,NA,Négatif,0.5,CTL181V4b,284.1,113.1,43,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL181,M,49.5,Pfizer,V5,173,NA,NA,V5-V5+,NA,NA,13/déc/2021,Positif,50.6,671,Négatif,0.3,CTL181V5b,140.5,61.3,23.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL181,M,49.5,Pfizer,V5+,212,NA,NA,V5-V5+,24,NA,21/jan/2022,Positif,125.5,4062,Positif,14.3,CTL181V5+,972.8,665.8,488.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL182,F,35.5,Moderna,V3,31,NA,NA,NA,NA,NA,26/jui/2021,Positif,84.8,NA,Négatif,0.4,CTL182V3b,441.3,143,61.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL182,F,35.5,Moderna,V4,94,NA,NA,NA,NA,NA,27/sep/2021,Positif,64.9,NA,Négatif,0.3,CTL182V4b,185.8,87.6,34.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL182,F,35.5,Moderna,V5,174,NA,NA,NA,NA,NA,16/déc/2021,Positif,54.5,777,Négatif,0.4,CTL182V5b,106.9,57,19,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL182,F,35.5,Moderna,3M3,277,81,NA,NA,NA,NA,29/mar/2022,Positif,124.2,3978,Négatif,0.2,CTL182 3M3,552.2,155.7,49.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL183,F,47.5,Moderna,V3,31,NA,NA,V5+-3M3,NA,NA,15/jui/2021,Positif,63.6,NA,Négatif,0.1,CTL183V3b,373,142.4,66.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL183,F,47.5,Moderna,V4,92,NA,NA,V5+-3M3,NA,NA,14/sep/2021,Positif,86.5,NA,Négatif,0.1,CTL183V4b,345.3,118.8,70.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL183,F,47.5,Moderna,V5,190,NA,NA,V5+-3M3,NA,NA,21/déc/2021,Positif,84.9,1868,Négatif,0.1,CTL183V5b,49.3,17.7,6.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL183,F,47.5,Moderna,V5+,219,29,NA,V5+-3M3,NA,NA,19/jan/2022,Positif,101.8,2678,Négatif,0.1,CTL183V5+,1367.2,530.8,172.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL183,F,47.5,Moderna,3M3,282,92,NA,V5+-3M3,15,NA,23/mar/2022,Positif,81.8,1735,Positif,16.3,CTL183 3M3,2696.1,791.8,698.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,V3,28,NA,NA,3M3-3M6,NA,NA,07/jui/2021,Positif,108.2,NA,Négatif,0.1,CTL184V3b,511.5,159.1,46.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,V4,89,NA,NA,3M3-3M6,NA,NA,06/sep/2021,Positif,86.3,NA,Négatif,0.2,CTL184V4b,244.4,123.1,37.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,V5,182,NA,NA,3M3-3M6,NA,NA,08/déc/2021,Positif,76.5,1519,Négatif,0.2,CTL184V5b,139.8,72,30.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,V5+,224,42,NA,3M3-3M6,NA,NA,19/jan/2022,Positif,108,3012,Négatif,0.1,CTL184V5+,568.8,145.7,60.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,3M3,273,91,NA,3M3-3M6,NA,NA,09/mar/2022,Positif,97.2,2443,Négatif,0.1,CTL184 3M3,285.8,90.8,42.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL184,M,37.4,Moderna,3M3+,308,126,NA,3M3-3M6,14,NA,13/avr/2022,Positif,101.5,2663,Indéterminé,5.5,CTL184 3M3+,1453.5,600.2,361.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL185,M,36.4,Moderna,V3,35,NA,NA,NA,NA,NA,15/jui/2021,Positif,63.1,NA,Indéterminé,4.2,CTL185V3b,1058.9,466.2,149.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL185,M,36.4,Moderna,V4,95,NA,NA,NA,NA,NA,13/sep/2021,Positif,83.1,NA,Négatif,3,CTL185V4b,497.3,203.8,56.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL185,M,36.4,Moderna,V5,214,NA,NA,NA,NA,NA,10/jan/2022,Positif,123.4,3927,Négatif,3.6,CTL185V5,457.7,206.9,73.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL186,F,49.5,Pfizer,V3,42,NA,NA,NA,NA,NA,19/aoû/2021,Positif,96.1,NA,Négatif,0.2,CTL186V3b,310.7,143,75.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL186,F,49.5,Pfizer,V4,91,NA,NA,NA,NA,NA,07/oct/2021,Positif,62.4,NA,Négatif,0.2,CTL186V4b,153.2,95.6,36.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL186,F,49.5,Pfizer,V5,182,NA,NA,NA,NA,NA,06/jan/2022,Positif,55.7,811,Négatif,0.1,CTL186V5,86,45.1,20.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL186,F,49.5,Pfizer,V5+,196,13,NA,NA,NA,NA,20/jan/2022,Positif,102.2,2699,Négatif,0.1,CTL186V5+,561.5,260,140.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL186,F,49.5,Pfizer,3M3,273,90,NA,NA,NA,NA,07/avr/2022,Positif,105.9,2897,Négatif,0,CTL186 3M3,287.4,169,121.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL187,F,45.5,Pfizer,V3,30,NA,NA,NA,NA,NA,23/jui/2021,Positif,73,NA,Négatif,0.1,CTL187V3b,2087.2,542.3,203.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL187,F,45.5,Pfizer,V4,86,NA,NA,NA,NA,NA,17/sep/2021,Positif,79.7,NA,Négatif,0.3,CTL187V4b,999,308.2,111.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL187,F,45.5,Pfizer,V5,182,NA,NA,NA,NA,NA,22/déc/2021,Positif,126.4,4120,Négatif,0.1,CTL187V5b,732.1,267.2,76.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL187,F,45.5,Pfizer,3M3,322,84,NA,NA,NA,NA,11/mai/2022,Positif,140.8,5108,Négatif,0.1,CTL187 3M3,499.001996007984,235.2941176470588,117.71630370806355,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL188,M,33.4,Moderna,V3,30,NA,NA,NA,NA,NA,12/jui/2021,Positif,84.4,NA,Négatif,2.4,CTL188V3b,714.3,268.9,68.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL188,M,33.4,Moderna,V4,93,NA,NA,NA,NA,NA,13/sep/2021,Positif,83.7,NA,Négatif,1.7,CTL188V4b,435.5,186.4,67.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL188,M,33.4,Moderna,V5,185,NA,NA,NA,NA,NA,14/déc/2021,Positif,82.3,1756,Négatif,1.8,CTL188V5b,118.8,54.5,15.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL188,M,33.4,Moderna,V5+,219,34,NA,NA,NA,NA,17/jan/2022,Positif,129.7,4337,Négatif,1.5,CTL188V5+,760.5,332.6,146.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL188,M,33.4,Moderna,3M3,277,92,NA,NA,NA,NA,16/mar/2022,Positif,94.2,2296,Négatif,1.1,CTL188 3M3,420.7,240.7,90.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL189,F,34.5,Pfizer,V3,24,NA,NA,V5-V5+,NA,NA,15/jui/2021,Positif,64.7,NA,Négatif,0.5,CTL189V3b,415.3,199.6,70.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL189,F,34.5,Pfizer,V4,85,NA,NA,V5-V5+,NA,NA,14/sep/2021,Positif,86.6,NA,Négatif,0.5,CTL189V4b,231.4,109.5,51.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL189,F,34.5,Pfizer,V5,184,NA,NA,V5-V5+,NA,NA,22/déc/2021,Positif,73.6,1407,Négatif,0.3,CTL189V5b,35.5,12.9,1.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL189,F,34.5,Pfizer,V5+,281,NA,NA,V5-V5+,93,NA,29/mar/2022,Positif,121,3777,Négatif,3.6,CTL189V5+,870.3,490.7,238.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL190,F,48.5,Moderna,V3,30,NA,NA,NA,NA,NA,21/jui/2021,Positif,69.7,NA,Négatif,0.5,CTL190V3b,785.5,280.3,107,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL190,F,48.5,Moderna,V4,92,NA,NA,NA,NA,NA,21/sep/2021,Positif,74.8,NA,Négatif,0.8,CTL190V4b,351.7,150.1,63.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL190,F,48.5,Moderna,V5,183,NA,NA,NA,NA,NA,21/déc/2021,Positif,103.4,2763,Négatif,0.3,CTL190V5b,187.2,59.2,23.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL190,F,48.5,Moderna,V5+,212,23,NA,NA,NA,NA,19/jan/2022,Positif,89.9,2092,Négatif,0.3,CTL190V5+,2430,1371.9,586.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL191,M,60.5,Pfizer,V3,31,NA,NA,NA,NA,NA,15/jui/2021,Positif,58.8,NA,Négatif,0.6,CTL191V3b,172.7,81,28.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL191,M,60.5,Pfizer,V4,87,NA,NA,NA,NA,NA,09/sep/2021,Positif,43.5,NA,Négatif,0.6,CTL191V4b,100.3,60.2,22.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL191,M,60.5,Pfizer,V5,185,NA,NA,NA,NA,NA,16/déc/2021,Positif,26.4,188,Négatif,0.4,CTL191V5b,33.8,20.5,9.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL191,M,60.5,Pfizer,V5+,218,28,NA,NA,NA,NA,18/jan/2022,Positif,107,2957,Négatif,0.7,CTL191V5+,165.5,82.9,43.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL191,M,60.5,Pfizer,3M3,282,92,NA,NA,NA,NA,23/mar/2022,Positif,67,1168,Négatif,0.4,CTL191 3M3,142.6,82.6,43.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL192,F,33.5,Moderna,V3,36,NA,NA,V5-3M3,NA,NA,22/jui/2021,Positif,74.9,NA,Négatif,0.1,CTL192V3b,478.9,187.9,73.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL192,F,33.5,Moderna,V4,98,NA,NA,V5-3M3,NA,NA,22/sep/2021,Positif,98.1,NA,Négatif,0.1,CTL192V4b,309.6,193.8,58.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL192,F,33.5,Moderna,V5,188,NA,NA,V5-3M3,NA,NA,21/déc/2021,Positif,81.3,1714,Négatif,0.1,CTL192V5b,83.8,26.4,7.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL192,F,33.5,Moderna,3M3,294,91,NA,V5-3M3,23,NA,06/avr/2022,Positif,109.7,3107,Positif,20.3,CTL192 3M3,635.7,279.8,165.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL193,M,28.4,Moderna/Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,02/jui/2021,Positif,85.8,NA,Négatif,1.2,CTL193V3b,489.5,243,83.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL193,M,28.4,Moderna/Pfizer,V4,83,NA,NA,V5-3M3,NA,NA,24/aoû/2021,Positif,84.8,NA,Négatif,0.9,CTL193V4b,513.3,186.7,60.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL193,M,28.4,Moderna/Pfizer,V5,187,NA,NA,V5-3M3,NA,NA,06/déc/2021,Positif,74.2,1430,Négatif,0.7,CTL193V5b,127.7,53.4,8.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL193,M,28.4,Moderna/Pfizer,3M3,307,76,NA,V5-3M3,74,NA,05/avr/2022,Positif,120.2,3727,Positif,18.2,CTL193 3M3,1178.3,543.2,495.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL194,M,39.4,Pfizer,V3,33,NA,NA,NA,NA,NA,13/jui/2021,Positif,81,NA,Négatif,0.5,CTL194V3b,182.5,54.7,11.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL194,M,39.4,Pfizer,V4,96,NA,NA,NA,NA,NA,14/sep/2021,Positif,62.6,NA,Négatif,0.4,CTL194V4b,225.2,116.9,42.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL194,M,39.4,Pfizer,V5,187,NA,NA,NA,NA,NA,14/déc/2021,Positif,42.5,477,Négatif,0.5,CTL194V5b,90.3,60.4,33.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL194,M,39.4,Pfizer,V5+,222,33,NA,NA,NA,NA,18/jan/2022,Positif,112.2,3250,Négatif,0.5,CTL194V5+,641.4,240.1,154.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL194,M,39.4,Pfizer,3M3,271,82,NA,NA,NA,NA,08/mar/2022,Positif,86,1916,Négatif,0.6,CTL194 3M3,374.1,153.4,99.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL195,M,61.5,Pfizer,V5+,215,32,NA,NA,NA,NA,18/jan/2022,Positif,108.8,3057,Négatif,1.2,CTL195V5+,1011.6,413.7,286.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL196,M,32.5,Pfizer,V3,32,NA,NA,NA,NA,NA,20/aoû/2021,Positif,76.7,NA,Négatif,0.7,CTL196V3b,1063,347.2,162.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL196,M,32.5,Pfizer,V4,91,NA,NA,NA,NA,NA,18/oct/2021,Positif,73.3,NA,Négatif,0.8,CTL196V4b,763.9,288.3,157.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL196,M,32.5,Pfizer,V5,189,NA,NA,NA,NA,NA,24/jan/2022,Positif,86.9,1956,Négatif,1.1,CTL196V5,174.2,83.9,48.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL197,F,34.5,Pfizer,V3,30,NA,NA,NA,NA,NA,23/jui/2021,Positif,73,NA,Négatif,0.3,CTL197V3b,359.7,122.9,44.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL197,F,34.5,Pfizer,V4,92,NA,NA,NA,NA,NA,23/sep/2021,Positif,42.6,NA,Négatif,0.3,CTL197V4b,86.9,53,22.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL197,F,34.5,Pfizer,V5,180,NA,NA,NA,NA,NA,20/déc/2021,Positif,29.5,234,Négatif,0.3,CTL197V5b,52.6,26.9,12.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL197,F,34.5,Pfizer,V5+,211,28,NA,NA,NA,NA,20/jan/2022,Positif,105.7,2886,Négatif,0.4,CTL197V5+,345.2,137.4,75,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL197,F,34.5,Pfizer,3M3,273,90,NA,NA,NA,NA,23/mar/2022,Positif,76.9,1535,Négatif,0.1,CTL197 3M3,200.9,83.4,53.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL198,F,44.5,Pfizer,V3,34,NA,NA,V4-V5,NA,NA,26/jui/2021,Positif,72.1,NA,Négatif,0.8,CTL198V3b,147.8,62.8,35.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL198,F,44.5,Pfizer,V4,91,NA,NA,V4-V5,NA,NA,21/sep/2021,Positif,39.9,NA,Négatif,1.6,CTL198V4b,79.4,46.1,21.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL198,F,44.5,Pfizer,V5,181,NA,NA,V4-V5,48,NA,20/déc/2021,Positif,119.2,3666,Positif,10.9,CTL198V5b,601.3,461.7,189,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL199,F,62.6,NA,V5,182,NA,NA,NA,NA,NA,10/fév/2022,Positif,35.6,337,Négatif,0.8,CTL199V5,38.2,14.9,7.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL200,M,49.5,Moderna,V3,30,NA,NA,NA,NA,NA,28/jui/2021,Positif,77.8,NA,Négatif,0.3,CTL200V3b,836.8,341.2,85.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL200,M,49.5,Moderna,V4,92,NA,NA,NA,NA,NA,28/sep/2021,Positif,81.3,NA,Négatif,0.4,CTL200V4b,366.2,186.8,61.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL200,M,49.5,Moderna,V5,176,NA,NA,NA,NA,NA,21/déc/2021,Positif,110.4,3147,Négatif,0.2,CTL200V5b,100.7,41.9,9.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL200,M,49.5,Moderna,V5+,211,35,NA,NA,NA,NA,25/jan/2022,Positif,89,2051,Négatif,0.4,CTL200V5+,1106.4,360.1,139.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL200,M,49.5,Moderna,3M3,267,91,NA,NA,NA,NA,22/mar/2022,Positif,97.9,2478,Négatif,0.1,CTL200 3M3,369.7,166.9,99.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL201,F,24.4,Moderna/Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,08/jui/2021,Positif,105.3,NA,Négatif,1.3,CTL201V3b,312.5,117.5,33.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL201,F,24.4,Moderna/Pfizer,V4,93,NA,NA,V5-3M3,NA,NA,09/sep/2021,Positif,75.5,NA,Négatif,0.8,CTL201V4b,337,138.9,66.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL201,F,24.4,Moderna/Pfizer,V5,184,NA,NA,V5-3M3,NA,NA,09/déc/2021,Positif,73,1384,Négatif,1.2,CTL201V5b,118.8,64,38.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL201,F,24.4,Moderna/Pfizer,3M3,266,77,NA,V5-3M3,48,NA,01/mar/2022,Positif,95.3,2349,Positif,8.7,CTL201 3M3,1862.9,947.9,943.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL202,F,32.4,Moderna,V3,29,NA,NA,V5-3M3,NA,NA,01/jui/2021,Positif,78.7,NA,Positif,17.6,CTL202V3b,694.9,232.4,94.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL202,F,32.4,Moderna,V4,92,NA,NA,V5-3M3,NA,NA,02/sep/2021,Positif,86.1,NA,Positif,18,CTL202V4b,376.6,149.2,77.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL202,F,32.4,Moderna,V5,190,NA,NA,V5-3M3,NA,NA,09/déc/2021,Positif,92.4,2209,Positif,16.5,CTL202V5b,89.5,29.5,4.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL202,F,32.4,Moderna,3M3,309,77,NA,V5-3M3,47,NA,07/avr/2022,Positif,104.3,2811,Positif,12,CTL202 3M3,1324.2,685.9,518.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL203,F,33.5,Pfizer,V3,36,NA,NA,NA,NA,NA,18/aoû/2021,Positif,77.7,NA,Négatif,0.3,CTL203V3b,472.4,167.1,89.4,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL203,F,33.5,Pfizer,V4,91,NA,NA,NA,NA,NA,12/oct/2021,Positif,45.1,NA,Négatif,0.6,CTL203V4b,136.1,79.6,34.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL203,F,33.5,Pfizer,V5,182,NA,NA,NA,NA,NA,11/jan/2022,Positif,28.2,214,Négatif,0.1,CTL203V5,65.2,34.4,22.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL203,F,33.5,Pfizer,3M3,274,86,NA,NA,NA,NA,13/avr/2022,Positif,98.1,2488,Négatif,0,CTL203 3M3,537.6,218.8,124.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL204,F,48.6,Moderna,V3,34,NA,NA,NA,NA,NA,31/aoû/2021,Positif,84.4,NA,Négatif,3.8,CTL204V3b,969,401.9,162.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL204,F,48.6,Moderna,V4,97,NA,NA,NA,NA,NA,02/nov/2021,Positif,79.9,NA,Négatif,2.6,CTL204V4b,345.9,149.4,56.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL204,F,48.6,Moderna,V5,184,NA,NA,NA,NA,NA,28/jan/2022,Positif,86.6,1942,Négatif,2,CTL204V5,130,84.2,41.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL205,F,37.5,Pfizer,V3,31,NA,NA,NA,NA,NA,12/aoû/2021,Positif,64.4,NA,Négatif,0.3,CTL205V3b,398.9,188.7,74.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL205,F,37.5,Pfizer,V4,92,NA,NA,NA,NA,NA,12/oct/2021,Positif,58.9,NA,Négatif,0.2,CTL205V4b,107.4,53.6,23,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL205,F,37.5,Pfizer,V5,183,NA,NA,NA,NA,NA,11/jan/2022,Positif,83.9,1824,Négatif,0.1,CTL205V5,112.1,55.4,36.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL206,M,31.7,Pfizer,V5+,183,36,NA,V5+-3M3,NA,NA,01/mar/2022,Positif,97.2,2443,Négatif,0.6,CTL206 V5+,855.4319931565441,647.6683937823834,258.46471956577926,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL206,M,31.7,Pfizer,3M3,234,87,NA,V5+-3M3,17,NA,21/avr/2022,Positif,106,2902,Négatif,3.8,CTL206 3M3,855.4,647.7,258.5,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL207,F,40.6,Moderna,V3,32,NA,NA,V4-V5,NA,NA,24/sep/2021,Positif,95,NA,Négatif,0.1,CTL207V3b,780.6,299.7,93.8,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL207,F,40.6,Moderna,V4,98,NA,NA,V4-V5,NA,NA,29/nov/2021,Positif,89.6,2078,Négatif,0.2,CTL207V4b,490.9,159.1,71.3,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL207,F,40.6,Moderna,V5,189,NA,NA,V4-V5,38,NA,28/fév/2022,Positif,101.4,2657,Négatif,2.1,CTL207V5,550.1,177.6,91.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL209,F,25.5,Pfizer,V5+,197,28,NA,NA,NA,NA,26/jan/2022,Positif,53.1,738,Négatif,0.4,CTL209V5+,1746.7,812.3,399.7,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL209,F,25.5,Pfizer,3M3,259,90,NA,NA,NA,NA,29/mar/2022,Positif,116.5,3502,Négatif,0.1,CTL209 3M3,879.5,574.4,303.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL210,F,65.7,Pfizer,V3,31,NA,NA,avantV1/V4-V5+,555,NA,30/sep/2021,Positif,36.7,NA,Positif,15.2,CTL210V3b,2430,2430,1945.9,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL210,F,65.7,Pfizer,V4,85,NA,NA,avantV1/V4-V5+,609,NA,23/nov/2021,Positif,69.3,NA,Positif,16.5,CTL210V4b,2430,2430,1309.1,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL210,F,65.7,Pfizer,V5+,154,21,NA,avantV1/V4-V5+,678,10,31/jan/2022,Positif,77.5,1559,Positif,24.3,CTL210V5+,2430,2430,1495.2,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTL210,F,65.7,Pfizer,3M3,203,70,NA,avantV1/V4-V5+,727,59,21/mar/2022,Positif,64.2,1074,Positif,19.6,CTL210 3M3,11339.2,5797.1,4009.6,NA,NA,NA,NA,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CTL,"NA","NA","NA","NA"
CTO001,F,59.1,Pfizer,3M3,332,97,NA,NA,NA,NA,17/jan/2022,Négatif,0.6,1,Négatif,0,CTO001 3M3,1,1,1,Kidney,2ème greffe rénale 1997,"Prednisone 5 Mg 1-0-0 + Rapamune 1,5 Mg 1-0-0",mTOR inhibitor,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Rapamune,Prednisone|Rapamune,H02AB07|L04AA10,L04AA10
CTO001,F,59.1,Pfizer,3M6,416,181,NA,NA,NA,NA,11/avr/2022,Négatif,0.3,0,Négatif,0,CTO001 3M6,1,1,1,Kidney,2ème greffe rénale 1997,"Prednisone 5 Mg 1-0-0 + Rapamune 1,5 Mg 1-0-0",mTOR inhibitor,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Rapamune,Prednisone|Rapamune,H02AB07|L04AA10,L04AA10
CTO002,M,81.1,Pfizer,3M3,332,112,NA,NA,NA,NA,20/jan/2022,Positif,97.6,2463,Négatif,0.1,CTO002 3M3,1117.9,551,219.4,Liver,greffe hépatique 2002,Cellcept 500 Mg-0-250 Mg + Prograf 1 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept,L04AA06,L04AA06
CTO002,M,81.1,Pfizer,3M6,401,181,NA,NA,NA,NA,30/mar/2022,Positif,91.9,2186,Négatif,0.1,CTO002 3M6,547.3,351.1,171.6,Liver,greffe hépatique 2002,Cellcept 500 Mg-0-250 Mg + Prograf 1 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept,L04AA06,L04AA06
CTO003,M,60.2,Pfizer,V6,364,148,NA,NA,NA,NA,15/mar/2022,Positif,13.3,51,Négatif,0.2,CTO003V6,8.6,14.1,6.6,Liver,greffe hépatique 2018,Advagraf 5.5 Mg 1-0-0 Cellcept 250 Mg 1-0-0 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO004,M,74.2,Pfizer,V6,366,149,NA,NA,NA,NA,16/mar/2022,Positif,84.1,1833,Négatif,0.2,CTO004V6,154.1,79,40.7,Kidney,greffe rénale 2004,Sandimmun 100 Mg - 0 - 75 Mg Cellcept 500 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Sandimmun|Cellcept,L04AD01|L04AA06,L04AA06
CTO006,M,65.2,Moderna,V6,374,202,NA,NA,NA,NA,07/avr/2022,Positif,98.8,2524,Négatif,1,CTO006V6,243.2,219.1,23.9,Kidney,greffe rénale 2020,Advagraf 10 Mg 1-0-0 Cellcept 750 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO007,M,71.2,Moderna,3M3,360,88,NA,3M3-3M6,NA,NA,14/mar/2022,Positif,129.9,4350,Négatif,0.8,CTO007 3M3,2365.2,711.2,555.9,Kidney,greffe rénale 2004,Myfortic 360 Mg 1-0-1 Prograf 1 Mg 1.5-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic,L04AA06,"NA"
CTO007,M,71.2,Moderna,3M3+,410,138,NA,3M3-3M6,21,NA,03/mai/2022,Positif,177.8,8135,Positif,18.8,CTO007 3M3+,2430,1124.4799280332845,730.9941520467836,Kidney,greffe rénale 2004,Myfortic 360 Mg 1-0-1 Prograf 1 Mg 1.5-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic,L04AA06,"NA"
CTO008,M,78.2,Pfizer,3M6,361,165,NA,NA,NA,NA,15/mar/2022,Positif,8.8,24,Négatif,0.1,CTO008 3M6,4.3,4.5,2,Kidney,greffe rénale 2019,"Myfortic 180 Mg 1-0-1 Advagraf 4,5 Mg 0-1-0 Prednisone 5 Mg 1-0-0",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Myfortic|Advagraf|Prednisone,L04AA06|L04AD02|H02AB07,L04AD02
CTO009,F,62.1,Pfizer,V3,28,NA,NA,V5-3M3;3M3-3M6,NA,NA,10/mar/2021,Négatif,1.8,NA,NA,NA,CTO009V3b,2.5,6.9,2.7,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO009,F,62.1,Pfizer,V4,89,NA,NA,V5-3M3;3M3-3M6,NA,NA,10/mai/2021,Négatif,3.9,NA,NA,NA,CTO009V4b,3,5.5,2,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO009,F,62.1,Pfizer,V5,181,NA,NA,V5-3M3;3M3-3M6,NA,NA,10/aoû/2021,Indéterminé,4.5,NA,Négatif,1.7,CTO009V5b,8,8.1,3.3,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO009,F,62.1,Pfizer,3M3,315,132,NA,V5-3M3;3M3-3M6,60,NA,22/déc/2021,Positif,137.2,4851,Négatif,2.2,CTO009 3M3,2430,2430,8.4,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO009,F,62.1,Pfizer,3M6,363,180,NA,V5-3M3;3M3-3M6,108,26,08/fév/2022,Positif,100.1,2590,Positif,18.4,CTO009 3M6,1289.3,938.1,135.1,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO009,F,62.1,Pfizer,3M9,453,270,NA,V5-3M3;3M3-3M6,198,116,09/mai/2022,Positif,171.3,7552,Positif,24.7,CTO009 3M9,91.07468123861567,64.47453255963894,14.755791648221928,Lung,greffe bipulmonaire 2020,"Prednisone 12,5 Mg 1-0-0 + Myfortic 540 Mg 1-0-1 + Prograf 1,5 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Prednisone|Myfortic,H02AB07|L04AA06,"NA"
CTO010,F,81.2,Pfizer,V6,379,105,NA,NA,NA,NA,01/avr/2022,Positif,65.8,1127,Négatif,1.7,CTO010V6,137.3,46.5,31.4,Kidney,greffe rénale 2012,Advagraf 5 Mg 1-0-0 Imurek 50 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Advagraf|Imurek,L04AD02|L04AX01,L04AD02
CTO011,M,76.2,Moderna,3M3,346,100,NA,NA,NA,NA,03/mar/2022,Positif,99.1,2539,Négatif,1.3,CTO011 3M3,329.7,118.2,104.9,Kidney,greffe rénale 2001,Cellcept 500 Mg 1-0-1 Advagraf 1 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept|Advagraf,Cellcept|Advagraf,L04AA06|L04AD02,L04AA06|L04AD02
CTO011,M,76.2,Moderna,3M6,420,174,NA,NA,NA,NA,16/mai/2022,Positif,151.3,5895,Négatif,0.9,CTO011 3M6,266.3,91.7,77.1,Kidney,greffe rénale 2001,Cellcept 500 Mg 1-0-1 Advagraf 1 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept|Advagraf,Cellcept|Advagraf,L04AA06|L04AD02,L04AA06|L04AD02
CTO012,F,40.2,Moderna,3M3,334,85,NA,NA,NA,NA,23/fév/2022,Positif,98.2,2493,Négatif,0.3,CTO012 3M3,333.4,63.6,38.2,Kidney,greffe rénale 2005,Cellcept 500 Mg 1-0-1 Prograf 4 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept,L04AA06,L04AA06
CTO012,F,40.2,Moderna,3M6,418,169,NA,NA,NA,NA,18/mai/2022,Positif,112.5,3267,Négatif,0.1,CTO012 3M6,182.8,53.5,33.2,Kidney,greffe rénale 2005,Cellcept 500 Mg 1-0-1 Prograf 4 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept,L04AA06,L04AA06
CTO014,F,69.2,Moderna,V6,366,217,NA,NA,NA,NA,31/mar/2022,Positif,7.2,17,Négatif,0,CTO014V6,8.2,9.8,6.1,Kidney,greffe rénale 2020,Prograf 1 Mg 3-0-2 Myfortic 180 Mg 1-0-0 Prednsione 5 Mg 2-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic|Pred,L04AA06|H02AB07,"NA"
CTO015,M,66.2,Moderna,3M3,351,91,NA,NA,NA,NA,16/mar/2022,Positif,93.9,2281,Négatif,0.9,CTO015 3M3,3056.2,1067.9,644.3,NA,pré-greffe,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,CTO,"NA","NA","NA","NA"
CTO016,F,71.2,Moderna,3M3,299,63,NA,NA,NA,NA,24/jan/2022,Positif,99.6,2564,Négatif,0.1,CTO016 3M3,2115.1,1065.2,278.2,Kidney,greffe rénale 2018,Prednisone 5 Mg 1-0-0 Advagraf 3 Mg 0-1-0 Imurek 75 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Prednisone|Advagraf|Imurek,H02AB07|L04AD02|L04AX01,L04AD02
CTO016,F,71.2,Moderna,3M6,415,179,NA,NA,NA,NA,20/mai/2022,Positif,143.2,5283,Négatif,0.1,CTO016 3M6,1297.2,505.1,197.7,Kidney,greffe rénale 2018,Prednisone 5 Mg 1-0-0 Advagraf 3 Mg 0-1-0 Imurek 75 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Prednisone|Advagraf|Imurek,H02AB07|L04AD02|L04AX01,L04AD02
CTO017,F,51.2,Pfizer,3M3,329,105,"4th dose: 24.05.2022, switch to Moderna",NA,NA,NA,18/fév/2022,Positif,38.2,387,Négatif,0.2,CTO017 3M3,46.7,33.1,21.9,Kidney,greffe rénale 2006,"Rapamune 2,5 Mg 1-0-0 Imurek 75 Mg 1-0-0",mTOR inhibitor,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Rapamune,Rapamune|Imurek,L04AA10|L04AX01,L04AA10
CTO017,F,51.2,Pfizer,3M6,413,189,"4th dose: 24.05.2022, switch to Moderna",NA,NA,NA,13/mai/2022,Positif,38.9,401,Négatif,0.2,CTO017 3M6,36.8,23.8,18.9,Kidney,greffe rénale 2006,"Rapamune 2,5 Mg 1-0-0 Imurek 75 Mg 1-0-0",mTOR inhibitor,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Rapamune,Rapamune|Imurek,L04AA10|L04AX01,L04AA10
CTO018,M,42.2,Pfizer,3M3,288,82,NA,3M3-3M6,NA,NA,11/jan/2022,Positif,146.7,5543,Négatif,0.4,CTO018 3M3,252.2,44.3,34,Kidney,greffe rénale 2017,Advagraf 3 Mg 1-0-0 Imurek 125 Mg 1-0-0 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Advagraf|Imurek|Prednisone,L04AD02|L04AX01|H02AB07,L04AD02
CTO018,M,42.2,Pfizer,3M6,378,172,NA,3M3-3M6,80,NA,11/avr/2022,Positif,101.6,2668,Négatif,2.3,CTO018 3M6,752.4,380.8,233.9,Kidney,greffe rénale 2017,Advagraf 3 Mg 1-0-0 Imurek 125 Mg 1-0-0 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Advagraf|Imurek|Prednisone,L04AD02|L04AX01|H02AB07,L04AD02
CTO019,M,47.3,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,14/mai/2021,Positif,121.1,NA,NA,NA,CTO019V3b,367.6,110,65.4,Kidney,greffe rénale 2012,Advagraf 2.5 Mg 1-0-0 Cellcept 500 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO019,M,47.3,Pfizer,V4,95,NA,NA,V5-3M3,NA,NA,16/jui/2021,Positif,84.6,NA,Négatif,0.4,CTO019V4b,364.7,117.7,69.7,Kidney,greffe rénale 2012,Advagraf 2.5 Mg 1-0-0 Cellcept 500 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO019,M,47.3,Pfizer,V5,193,NA,NA,V5-3M3,NA,NA,22/oct/2021,Positif,65.2,NA,Négatif,0.5,CTO019V5b,232.6,92.4,60.2,Kidney,greffe rénale 2012,Advagraf 2.5 Mg 1-0-0 Cellcept 500 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO019,M,47.3,Pfizer,V5+,330,97,NA,V5-3M3,15,NA,08/mar/2022,Positif,86.1,1920,Positif,18.5,CTO019V5+,646.4,377.4,278.4,Kidney,greffe rénale 2012,Advagraf 2.5 Mg 1-0-0 Cellcept 500 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO019,M,47.3,Pfizer,3M3,351,118,NA,V5-3M3,36,NA,29/mar/2022,Positif,124.2,3978,Positif,9.2,CTO019 3M3,838.2,456.2,378.2,Kidney,greffe rénale 2012,Advagraf 2.5 Mg 1-0-0 Cellcept 500 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO020,M,76.2,Moderna,V6,370,NA,NA,V5-V6,Novembre 21 pas de date exacte,NA,06/avr/2022,Positif,108.4,3035,Négatif,0.1,CTO020V6,1615.2,1764,12.9,Kidney,greffe rénale 2017,"Sandimmun 100 Mg 1-0-1 Prednisone 7,5 Mg 1-0-0",CNI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Sandimmun|Prednisone,L04AD01|H02AB07,"NA"
CTO021,M,32.3,Pfizer,V6,372,205,NA,NA,NA,NA,14/avr/2022,Positif,93.7,2271,Négatif,0.3,CTO021V6,213.6,100.4,47.1,Liver,greffe hépatique 2020,Prograf 2 Mg 1-0-1 Cellcept 500 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept,L04AA06,L04AA06
CTO022,M,48.3,Moderna,3M3,347,96,NA,NA,NA,NA,21/mar/2022,Positif,88.8,2042,Négatif,2.1,CTO022 3M3,841,258.3,226.6,Kidney,greffe rénale 2020,Advagraf 4 Mg 1-0-0 Cellcept 250 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO023,M,59.3,Pfizer,V6,378,146,NA,NA,NA,NA,21/avr/2022,Positif,8.6,23,Négatif,0.1,CTO023V6,11.3,13,8.2,Kidney,greffe rénale 2020,Advagraf 5 Mg 1-0-0 Cellcept 750 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept|Prednisone,L04AD02|L04AA06|H02AB07,L04AD02|L04AA06
CTO024,F,63.3,Pfizer,V6,379,189,NA,V5-V6,38,NA,22/avr/2022,Positif,85.6,1898,Négatif,0.7,CTO024V6,155.7,144.5,52.2,Kidney,greffe rénale 2020,Prograf 3 Mg 1-0-1 Myfortic 360 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI,NA,IS,IS,Lupus érythémateux disséminé,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic|Prednisone,L04AA06|H02AB07,"NA"
CTO025,F,64.3,Pfizer,V6,376,242,NA,NA,NA,NA,19/avr/2022,Négatif,0.1,0,Négatif,0,CTO025 V6,1,1,1,Kidney,3ème greffe rénale 2008,"Prograf 1,5 Mg 1-0-1 Cellcept 250 Mg 1-0-1 Prednisone 5 Mg 1-0-0",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Cellcept|Prednisone,L04AA06|H02AB07,L04AA06
CTO026,M,69.3,Pfizer,V6,365,198,NA,V5-V6,119,NA,08/avr/2022,Positif,115.5,3443,Négatif,0.8,CTO026V6,2033.8,1677.3,72.3,Multiorgan,greffe rénale 2007 greffe pancreas 2010,Prograf 1 Mg 1-0-1 Myfortic 360 Mg 1-0-1 Prednisone 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic|Prednisone,L04AA06|H02AB07,"NA"
CTO027,F,43.3,Pfizer,V6,370,113,NA,V5-V6,107,NA,14/avr/2022,Positif,97.5,2458,Négatif,1.6,CTO027V6,379.2,172,94.2,Kidney,2ème greffe rénale 2007,Advagra 9 Mg 1-0-0 MMF 500 Mg 1-0-1 Pred 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,MMF|Pred,L04AA06|H02AB07,"NA"
CTO028,M,60.1,Pfizer,3M3,328,119,NA,NA,NA,NA,10/jan/2022,Positif,118.9,3647,Négatif,0.2,CTO028 3M3,220.9,85.2,51.4,Kidney,3ème greffe rénale 2012,Prograf 2 Mg 1-0-1 MMF 250 Mg 1-0-1 Pred 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,MMF|Pred,L04AA06|H02AB07,"NA"
CTO028,M,60.1,Pfizer,3M6,381,172,NA,NA,NA,NA,04/mar/2022,Positif,102,2689,Indéterminé,4.3,CTO028 3M6,776.4,367.2,355.7,Kidney,3ème greffe rénale 2012,Prograf 2 Mg 1-0-1 MMF 250 Mg 1-0-1 Pred 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,MMF|Pred,L04AA06|H02AB07,"NA"
CTO029,M,56.3,Pfizer,V6,381,108,NA,NA,NA,NA,29/avr/2022,Positif,165.8,7076,Négatif,0,CTO029 V6,813.6696501220504,320.9242618741977,168.01075268817206,Kidney,greffe rénale 1996,"Rapamune 1,5 Mg 1-0-0",mTOR inhibitor,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Rapamune,Rapamune,L04AA10,L04AA10
CTO030,M,67.1,Pfizer,3M3,329,97,NA,3M3-3M6,NA,NA,17/jan/2022,Positif,127.1,4165,Négatif,0.1,CTO030 3M3,236.2,125.4,46.2,Multiorgan,double greffe cœur-rein 2018,Azathioprine 75 Mg 1-0-0 + Prograf 1 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Azathioprine,Azathioprine,L04AX01,L04AX01
CTO030,M,67.1,Pfizer,3M6,421,189,NA,3M3-3M6,21,NA,19/avr/2022,Positif,96,2384,Négatif,2.9,CTO030 3M6,2430,1675.9,1896.8,Multiorgan,double greffe cœur-rein 2018,Azathioprine 75 Mg 1-0-0 + Prograf 1 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Azathioprine,Azathioprine,L04AX01,L04AX01
CTO031,M,60.3,Pfizer,V6,371,231,NA,NA,NA,NA,20/avr/2022,Positif,18,90,Négatif,0.5,CTO031V6,28.5,24.7,10.9,Liver,greffe hépatique 2019,Advagraf 2 Mg 1-0-0 Cellcept 250 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf|Cellcept,Advagraf|Cellcept,L04AD02|L04AA06,L04AD02|L04AA06
CTO032,M,63.3,Pfizer,V6,385,219,4th dose: 28.02.2022,NA,NA,NA,19/mai/2022,Positif,109.3,3085,Négatif,0.3,CTO032V6,1401.5,505.3,318.6,Kidney,greffe rénale 1997,Sandimmun 75 Mg 1-0-1 MMF 500 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Sandimmun|MMF,L04AD01|L04AA06,"NA"
CTO033,F,69.3,Pfizer,3M3,317,92,NA,NA,NA,NA,03/mar/2022,Positif,89.3,2065,Négatif,0.2,CTO033 3M3,234.2,67.8,62.1,Kidney,greffe rénale 2015,"Advagraf 3,5 Mg 1-0-0 MMF 750 Mg 1-0-1",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Advagraf|MMF,L04AD02|L04AA06,L04AD02
CTO034,F,50.3,Pfizer,V6,387,103,NA,V5-V6,NA,NA,19/mai/2022,Positif,129.2,4304,Négatif,2.1,CTO034V6,1056.2,577.4,266.3,Multiorgan,2ème greffe rénale+pancréas 2016,Advagraf 5 Mg 1-0-0 Myfortic 360 Mg 1-0-1 Pred 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Advagraf,Advagraf|Myfortic|Pred,L04AD02|L04AA06|H02AB07,L04AD02
CTO035,M,64.4,Pfizer,V6,368,148,NA,NA,NA,NA,13/mai/2022,Positif,149.5,5756,Indéterminé,5.9,CTO035V6,896.9,512.6,254.4,Kidney,greffe rénale 2020,Sandimmun 100 Mg 1-0-1 Cellcept 500 Mg 1-0-1 Pred 5 Mg 1-0-0,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,Cellcept,Sandimmun|Cellcept|Pred,L04AD01|L04AA06|H02AB07,L04AA06
CTO036,M,48.4,Pfizer,3M3,300,80,NA,NA,NA,NA,07/mar/2022,Positif,105.8,2891,Positif,7.9,CTO036 3M3,2073.4,786.2,574.1,Kidney,greffe rénale 2010,Prograf 1 Mg 1-0-1 Myfortic 360 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,Myfortic,L04AA06,"NA"
CTO039,M,65.4,Pfizer,3M3,276,85,NA,NA,NA,NA,11/mar/2022,Positif,100.4,2605,Négatif,1,CTO039 3M3,2273.2,974.7,370.8,Kidney,greffe rénale 2005,Prograf 1 Mg 1-0-1 MMF 500 Mg 1-0-1,CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,CTO,,MMF,L04AA06,"NA"
HEM001,F,61.1,Pfizer,V3,29,NA,NA,NA,NA,NA,23/mar/2021,Positif,132.5,NA,NA,NA,HEM001V3b,415.3,137.5,26.8,Multiple myeloma,Multiple myeloma (2014),"2017: Velcade-Revlimid-Dexamethasone X 3, 2018: Melphalan And HSC Reinfusion, >2018 Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Hypothyroidism substituted,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone|Melphalan,Velcade|Revlimid|Dexamethasone|Melphalan,L01XG01|L04AX04|H02AB02|L01AA03,L01XG01|L04AX04|S01BA01|L01AA03
HEM001,F,61.1,Pfizer,V4,94,NA,NA,NA,NA,NA,27/mai/2021,Positif,108.4,NA,NA,NA,HEM001V4b,262.7,143.1,65.4,Multiple myeloma,Multiple myeloma (2014),"2017: Velcade-Revlimid-Dexamethasone X 3, 2018: Melphalan And HSC Reinfusion, >2018 Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Hypothyroidism substituted,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone|Melphalan,Velcade|Revlimid|Dexamethasone|Melphalan,L01XG01|L04AX04|H02AB02|L01AA03,L01XG01|L04AX04|S01BA01|L01AA03
HEM001,F,61.1,Pfizer,V5,178,NA,NA,NA,NA,NA,19/aoû/2021,Positif,41.2,NA,Négatif,0,HEM001V5b,130,79,26,Multiple myeloma,Multiple myeloma (2014),"2017: Velcade-Revlimid-Dexamethasone X 3, 2018: Melphalan And HSC Reinfusion, >2018 Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Hypothyroidism substituted,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone|Melphalan,Velcade|Revlimid|Dexamethasone|Melphalan,L01XG01|L04AX04|H02AB02|L01AA03,L01XG01|L04AX04|S01BA01|L01AA03
HEM002,F,74.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,133,NA,NA,NA,HEM002V3b,830.6,166.9,129.7,Multiple myeloma,Multiple myeloma and AL amyloidosis (2017),"2017-2020: Velcade-Dexamethasone 2017-2020, 2020: Revlimid, Actually No Treatment",NA,No,Not treated,Not treated,Breast cancer 2008 (surgery Rxttt Hormonottt9,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Dexamethasone|Revlimid,Velcade|Dexamethasone|Revlimid,L01XG01|H02AB02|L04AX04,L01XG01|S01BA01|L04AX04
HEM002,F,74.1,Pfizer,V4,93,NA,NA,NA,NA,NA,27/mai/2021,Positif,107.3,NA,NA,NA,HEM002V4b,168.1,57.4,42.8,Multiple myeloma,Multiple myeloma and AL amyloidosis (2017),"2017-2020: Velcade-Dexamethasone 2017-2020, 2020: Revlimid, Actually No Treatment",NA,No,Not treated,Not treated,Breast cancer 2008 (surgery Rxttt Hormonottt9,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Dexamethasone|Revlimid,Velcade|Dexamethasone|Revlimid,L01XG01|H02AB02|L04AX04,L01XG01|S01BA01|L04AX04
HEM002,F,74.1,Pfizer,V5,188,NA,NA,NA,NA,NA,30/aoû/2021,Positif,40.7,NA,Négatif,0.1,HEM002V5b,86.2,39,26,Multiple myeloma,Multiple myeloma and AL amyloidosis (2017),"2017-2020: Velcade-Dexamethasone 2017-2020, 2020: Revlimid, Actually No Treatment",NA,No,Not treated,Not treated,Breast cancer 2008 (surgery Rxttt Hormonottt9,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Dexamethasone|Revlimid,Velcade|Dexamethasone|Revlimid,L01XG01|H02AB02|L04AX04,L01XG01|S01BA01|L04AX04
HEM002,F,74.1,Pfizer,3M3,363,104,NA,NA,NA,NA,21/fév/2022,Positif,56.7,840,Négatif,3.9,HEM002 3M3,3148.6,1851.5,1323.6,Multiple myeloma,Multiple myeloma and AL amyloidosis (2017),"2017-2020: Velcade-Dexamethasone 2017-2020, 2020: Revlimid, Actually No Treatment",NA,No,Not treated,Not treated,Breast cancer 2008 (surgery Rxttt Hormonottt9,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Dexamethasone|Revlimid,Velcade|Dexamethasone|Revlimid,L01XG01|H02AB02|L04AX04,L01XG01|S01BA01|L04AX04
HEM002,F,74.1,Pfizer,3M6,440,181,NA,NA,NA,NA,09/mai/2022,Positif,165.9,7084,Négatif,3.2,HEM002 3M6,1374.0038472107722,722.543352601156,606.4281382656155,Multiple myeloma,Multiple myeloma and AL amyloidosis (2017),"2017-2020: Velcade-Dexamethasone 2017-2020, 2020: Revlimid, Actually No Treatment",NA,No,Not treated,Not treated,Breast cancer 2008 (surgery Rxttt Hormonottt9,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Dexamethasone|Revlimid,Velcade|Dexamethasone|Revlimid,L01XG01|H02AB02|L04AX04,L01XG01|S01BA01|L04AX04
HEM003,M,71.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,23/mar/2021,Positif,107.9,NA,NA,NA,HEM003V3b,155.6,64.9,21.9,Other leukemia,Hairy cell leukemia (2006),2006: 2- Chlorodeoxyadenosine,NA,No,Not treated,Not treated,2006: MGUS,NA,NA,NA,NA,NA,NA,NA,HEM,,Chlorodeoxyadenosine,L01BB04,"NA"
HEM003,M,71.1,Pfizer,V4,92,NA,NA,3M3-3M6,NA,NA,26/mai/2021,Positif,32.7,NA,NA,NA,HEM003V4b,65.6,36.2,11.7,Other leukemia,Hairy cell leukemia (2006),2006: 2- Chlorodeoxyadenosine,NA,No,Not treated,Not treated,2006: MGUS,NA,NA,NA,NA,NA,NA,NA,HEM,,Chlorodeoxyadenosine,L01BB04,"NA"
HEM003,M,71.1,Pfizer,V5,182,NA,NA,3M3-3M6,NA,NA,24/aoû/2021,Positif,24.9,NA,Négatif,0.3,HEM003V5b,32,21,7,Other leukemia,Hairy cell leukemia (2006),2006: 2- Chlorodeoxyadenosine,NA,No,Not treated,Not treated,2006: MGUS,NA,NA,NA,NA,NA,NA,NA,HEM,,Chlorodeoxyadenosine,L01BB04,"NA"
HEM003,M,71.1,Pfizer,3M3,365,104,NA,3M3-3M6,NA,NA,23/fév/2022,Positif,75.8,1492,Négatif,0.2,HEM003 3M3,190.4,99.9,77.4,Other leukemia,Hairy cell leukemia (2006),2006: 2- Chlorodeoxyadenosine,NA,No,Not treated,Not treated,2006: MGUS,NA,NA,NA,NA,NA,NA,NA,HEM,,Chlorodeoxyadenosine,L01BB04,"NA"
HEM003,M,71.1,Pfizer,3M6,443,182,NA,3M3-3M6,62,NA,12/mai/2022,Positif,131,4424,Positif,14.6,HEM003 3M6,2430,2320.2,1809.6,Other leukemia,Hairy cell leukemia (2006),2006: 2- Chlorodeoxyadenosine,NA,No,Not treated,Not treated,2006: MGUS,NA,NA,NA,NA,NA,NA,NA,HEM,,Chlorodeoxyadenosine,L01BB04,"NA"
HEM004,M,78.2,Pfizer,V3,30,NA,NA,NA,NA,NA,30/avr/2021,Positif,59,NA,NA,NA,HEM004V3b,122.7,43.7,30.7,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM004,M,78.2,Pfizer,V4,98,NA,NA,NA,NA,NA,07/jui/2021,Positif,40.6,NA,Négatif,0.1,HEM004V4b,46.9,18.7,17.9,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM004,M,78.2,Pfizer,V5,196,NA,NA,NA,NA,NA,13/oct/2021,Positif,18.6,NA,Négatif,0.1,HEM004V5b,1,1,1,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM004,M,78.2,Pfizer,3M3,287,61,NA,NA,NA,NA,12/jan/2022,Positif,109.5,3096,Négatif,0.1,HEM004 3M3,467.9,213.4,110.1,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM004,M,78.2,Pfizer,3M6,405,179,NA,NA,NA,NA,10/mai/2022,Positif,112.6,3273,Négatif,0.1,HEM004 3M6,257.0694087403599,100.83694665725521,65.40222367560497,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM005,F,72.2,Pfizer,V3,30,NA,NA,NA,NA,NA,14/avr/2021,Positif,106.4,NA,NA,NA,HEM005V3b,245.5,116.4,50.9,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,osteoporosis,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM005,F,72.2,Pfizer,V4,92,NA,NA,NA,NA,NA,15/jun/2021,Positif,59.8,NA,Négatif,0.2,HEM005V4b,89.6,56.6,22.4,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,osteoporosis,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM005,F,72.2,Pfizer,V5,186,NA,NA,NA,NA,NA,17/sep/2021,Positif,31.2,NA,Négatif,0.4,HEM005V5b,91.7,50.8,21.7,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,osteoporosis,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM005,F,72.2,Pfizer,3M3,365,118,NA,NA,NA,NA,15/mar/2022,Positif,93.9,2281,Négatif,0.3,HEM005 3M3,341.4,162.4,75.4,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,osteoporosis,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM005,F,72.2,Pfizer,3M6,428,181,NA,NA,NA,NA,17/mai/2022,Positif,143,5268,Négatif,0.3,HEM005 3M6,233.6,111.9,45.4,CML,CML,Glivec,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,osteoporosis,NA,NA,NA,NA,NA,NA,NA,HEM,Glivec,,"NA",L01EA01
HEM006,M,49.5,Pfizer,V5,180,NA,NA,V5-3M3,NA,NA,04/jan/2022,Positif,12.7,47,Négatif,0,HEM006V5,18.8,21.6,14.2,Multiple myeloma,Multiple myeloma,Revlimid 10 1x/J (Mars 2018),Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM006,M,49.5,Pfizer,3M3,288,107,NA,V5-3M3,24,NA,22/avr/2022,Positif,87.1,1965,Négatif,1,HEM006 3M3,1803.8,736.9,567.9,Multiple myeloma,Multiple myeloma,Revlimid 10 1x/J (Mars 2018),Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM007,M,59.2,Moderna,V3,31,NA,NA,V5-V6,NA,NA,22/avr/2021,Positif,160.6,NA,NA,NA,HEM007V3b,355,108.9,52.5,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2017,"6 R-CHOP 2017, Ritux Every 2 Months Until Jan 2020",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Polymyalgia rheumatica,NA,NA,NA,NA,NA,NA,NA,HEM,,Ritux,L01FA01,"NA"
HEM007,M,59.2,Moderna,V4,95,NA,NA,V5-V6,NA,NA,25/jun/2021,Positif,100.4,NA,Négatif,1.3,HEM007V4b,182.7,115.9,52.2,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2017,"6 R-CHOP 2017, Ritux Every 2 Months Until Jan 2020",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Polymyalgia rheumatica,NA,NA,NA,NA,NA,NA,NA,HEM,,Ritux,L01FA01,"NA"
HEM007,M,59.2,Moderna,V5,198,NA,NA,V5-V6,NA,NA,06/oct/2021,Positif,59.5,NA,Négatif,0.6,HEM007V5b,143,65.7,44.6,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2017,"6 R-CHOP 2017, Ritux Every 2 Months Until Jan 2020",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Polymyalgia rheumatica,NA,NA,NA,NA,NA,NA,NA,HEM,,Ritux,L01FA01,"NA"
HEM007,M,59.2,Moderna,3M3,380,115,NA,V5-V6,26,NA,06/avr/2022,Positif,106.9,2952,Indéterminé,5.7,HEM007 3M3,501.3,280,202.9,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2017,"6 R-CHOP 2017, Ritux Every 2 Months Until Jan 2020",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Polymyalgia rheumatica,NA,NA,NA,NA,NA,NA,NA,HEM,,Ritux,L01FA01,"NA"
HEM008,M,59.2,Moderna,V3,30,NA,NA,NA,NA,NA,21/avr/2021,Positif,110.7,NA,NA,NA,HEM008V3b,851.1,236.4,148.1,Multiple myeloma,Multiple myeloma 2014,4 VRD Jan-Apr 2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM008,M,59.2,Moderna,V4,91,NA,NA,NA,NA,NA,21/jun/2021,Positif,82.8,NA,Négatif,0,HEM008V4b,84.2,26.1,15,Multiple myeloma,Multiple myeloma 2014,4 VRD Jan-Apr 2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM008,M,59.2,Moderna,V5,183,NA,NA,NA,NA,NA,21/sep/2021,Positif,19.3,NA,Négatif,0,HEM008V5b,52.5,36.2,15.8,Multiple myeloma,Multiple myeloma 2014,4 VRD Jan-Apr 2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM008,M,59.2,Moderna,3M3,364,103,NA,NA,NA,NA,21/mar/2022,Positif,84.5,1850,Négatif,0,HEM008 3M3,1779.7,547.3,214.3,Multiple myeloma,Multiple myeloma 2014,4 VRD Jan-Apr 2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM010,M,79.1,Pfizer,V3,29,NA,NA,NA,NA,NA,09/mar/2021,Positif,57.3,NA,NA,NA,HEM010V3b,23.4,5.8,1,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 1988),"1988: Prednimustine 1993, 2-Chlorodeoxyadenosine (X4) 1998, Cyclophosphamide – Vincristine – Prednisone (X4) 2001, 2-Chlorodeoxyadenosine (X4) 2002-2003, Rituximab (X6) 2002-2003, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Exsudative enteropathy (Albumin 60 g weekly).,Ig substitution > 2011,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Prednimustine|2-Chlorodeoxyadenosine|Cyclophosphamide|Prednisone|Rituximab,L01AA08|L01BB04|L01AA01|H02AB07|L01FA01,L01FA01
HEM010,M,79.1,Pfizer,V4,91,NA,NA,NA,NA,NA,10/mai/2021,Positif,29,NA,NA,NA,HEM010V4b,30.7,21.2,14.8,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 1988),"1988: Prednimustine 1993, 2-Chlorodeoxyadenosine (X4) 1998, Cyclophosphamide – Vincristine – Prednisone (X4) 2001, 2-Chlorodeoxyadenosine (X4) 2002-2003, Rituximab (X6) 2002-2003, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Exsudative enteropathy (Albumin 60 g weekly).,Ig substitution > 2011,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Prednimustine|2-Chlorodeoxyadenosine|Cyclophosphamide|Prednisone|Rituximab,L01AA08|L01BB04|L01AA01|H02AB07|L01FA01,L01FA01
HEM010,M,79.1,Pfizer,V5,182,NA,NA,NA,NA,NA,09/aoû/2021,Positif,12,NA,Négatif,2.9,HEM010V5b,1,1,1,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 1988),"1988: Prednimustine 1993, 2-Chlorodeoxyadenosine (X4) 1998, Cyclophosphamide – Vincristine – Prednisone (X4) 2001, 2-Chlorodeoxyadenosine (X4) 2002-2003, Rituximab (X6) 2002-2003, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Exsudative enteropathy (Albumin 60 g weekly).,Ig substitution > 2011,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Prednimustine|2-Chlorodeoxyadenosine|Cyclophosphamide|Prednisone|Rituximab,L01AA08|L01BB04|L01AA01|H02AB07|L01FA01,L01FA01
HEM010,M,79.1,Pfizer,3M3,364,91,NA,NA,NA,NA,07/fév/2022,Positif,21.7,129,Négatif,2.4,HEM010 3M3,26,19.9,11.8,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 1988),"1988: Prednimustine 1993, 2-Chlorodeoxyadenosine (X4) 1998, Cyclophosphamide – Vincristine – Prednisone (X4) 2001, 2-Chlorodeoxyadenosine (X4) 2002-2003, Rituximab (X6) 2002-2003, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Exsudative enteropathy (Albumin 60 g weekly).,Ig substitution > 2011,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Prednimustine|2-Chlorodeoxyadenosine|Cyclophosphamide|Prednisone|Rituximab,L01AA08|L01BB04|L01AA01|H02AB07|L01FA01,L01FA01
HEM010,M,79.1,Pfizer,3M6,451,178,NA,NA,NA,NA,05/mai/2022,Positif,80.6,1685,Négatif,1.8,HEM010 3M6,143.45144168698897,66.711140760507,60.024009603841534,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 1988),"1988: Prednimustine 1993, 2-Chlorodeoxyadenosine (X4) 1998, Cyclophosphamide – Vincristine – Prednisone (X4) 2001, 2-Chlorodeoxyadenosine (X4) 2002-2003, Rituximab (X6) 2002-2003, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,Exsudative enteropathy (Albumin 60 g weekly).,Ig substitution > 2011,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Prednimustine|2-Chlorodeoxyadenosine|Cyclophosphamide|Prednisone|Rituximab,L01AA08|L01BB04|L01AA01|H02AB07|L01FA01,L01FA01
HEM011,M,72.3,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,12/mai/2021,Indéterminé,5.9,NA,NA,NA,HEM011V3b,1,1,1,Multiple myeloma,Multiple myeloma 2020,VCD 2020 Than Daratumumab + CS,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab,Daratumumab,L01FC01,L01FC01
HEM011,M,72.3,Pfizer,V4,87,NA,NA,V5-V6,NA,NA,07/jui/2021,Négatif,2.5,NA,Négatif,0,HEM011V4b,1,1,1,Multiple myeloma,Multiple myeloma 2020,VCD 2020 Than Daratumumab + CS,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab,Daratumumab,L01FC01,L01FC01
HEM011,M,72.3,Pfizer,V5,171,18,NA,V5-V6,NA,NA,29/sep/2021,Positif,10.4,NA,Négatif,0,HEM011V5b,1,1,1,Multiple myeloma,Multiple myeloma 2020,VCD 2020 Than Daratumumab + CS,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab,Daratumumab,L01FC01,L01FC01
HEM011,M,72.3,Pfizer,V6,376,223,NA,V5-V6,17,NA,22/avr/2022,Positif,86.3,1929,Négatif,0.2,HEM011V6,204.6,178.3,57.4,Multiple myeloma,Multiple myeloma 2020,VCD 2020 Than Daratumumab + CS,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab,Daratumumab,L01FC01,L01FC01
HEM012,M,51.2,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,23/avr/2021,Positif,87.8,NA,NA,NA,HEM012V3b,150.3,51.4,8.7,Multiple myeloma,Multiple myeloma 2018,4 VRD + HD Mephalan 2018. Revlimid From 2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,IRC cast nephropathy,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Mephalan|Revlimid,L01AA03|L04AX04,L04AX04
HEM012,M,51.2,Pfizer,V4,94,NA,NA,V5-V6,NA,NA,25/jun/2021,Positif,49.3,NA,Négatif,0.1,HEM012V4b,40.8,22.1,15.4,Multiple myeloma,Multiple myeloma 2018,4 VRD + HD Mephalan 2018. Revlimid From 2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,IRC cast nephropathy,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Mephalan|Revlimid,L01AA03|L04AX04,L04AX04
HEM012,M,51.2,Pfizer,V5,189,NA,NA,V5-V6,NA,NA,28/sep/2021,Positif,29.2,NA,Négatif,0,HEM012V5b,1,1,1,Multiple myeloma,Multiple myeloma 2018,4 VRD + HD Mephalan 2018. Revlimid From 2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,IRC cast nephropathy,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Mephalan|Revlimid,L01AA03|L04AX04,L04AX04
HEM012,M,51.2,Pfizer,V5+,359,NA,NA,V5-V6,126,NA,17/mar/2022,Positif,106.7,2941,Indéterminé,4.2,HEM012V5+,679.3,444.2,198.3,Multiple myeloma,Multiple myeloma 2018,4 VRD + HD Mephalan 2018. Revlimid From 2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,IRC cast nephropathy,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Mephalan|Revlimid,L01AA03|L04AX04,L04AX04
HEM012,M,51.2,Pfizer,V6,380,NA,NA,V5-V6,147,NA,07/avr/2022,Positif,107,2957,Indéterminé,4.1,HEM012V6,992.1,701.3,201.4,Multiple myeloma,Multiple myeloma 2018,4 VRD + HD Mephalan 2018. Revlimid From 2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,IRC cast nephropathy,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Mephalan|Revlimid,L01AA03|L04AX04,L04AX04
HEM013,M,90.2,Pfizer,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,103.6,NA,NA,NA,HEM013V3b,259.2,68,39.4,Multiple myeloma,Multiple Myeloma 2019,RD 4.2019-9.2019. Pomalidomide Dex From 9.2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Prostatic adenoca 2005 surgery and rath,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide,L04AX06,L04AX06
HEM013,M,90.2,Pfizer,V4,99,NA,NA,NA,NA,NA,02/jui/2021,Positif,29,NA,Négatif,0,HEM013V4b,49.5,28,23.9,Multiple myeloma,Multiple Myeloma 2019,RD 4.2019-9.2019. Pomalidomide Dex From 9.2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Prostatic adenoca 2005 surgery and rath,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide,L04AX06,L04AX06
HEM013,M,90.2,Pfizer,V5,174,NA,NA,NA,NA,NA,15/sep/2021,Positif,11.8,NA,Négatif,0,HEM013V5b,14,14,7,Multiple myeloma,Multiple Myeloma 2019,RD 4.2019-9.2019. Pomalidomide Dex From 9.2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Prostatic adenoca 2005 surgery and rath,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide,L04AX06,L04AX06
HEM013,M,90.2,Pfizer,3M3,365,107,NA,NA,NA,NA,25/mar/2022,Positif,34.5,317,Négatif,0,HEM013 3M3,36.9,29.4,18.6,Multiple myeloma,Multiple Myeloma 2019,RD 4.2019-9.2019. Pomalidomide Dex From 9.2019,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,Prostatic adenoca 2005 surgery and rath,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide,L04AX06,L04AX06
HEM014,M,33.3,Moderna,V3,31,NA,NA,NA,NA,NA,10/mai/2021,Positif,93.8,NA,NA,NA,HEM014V3b,538.2,157.6,93.5,Hodgkin lymphoma,Hodgkin lymphoma 2020,AVBD,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM014,M,33.3,Moderna,V4,91,NA,NA,NA,NA,NA,09/jui/2021,Positif,96.4,NA,Négatif,1.5,HEM014V4b,160.1,105.3,70.3,Hodgkin lymphoma,Hodgkin lymphoma 2020,AVBD,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM014,M,33.3,Moderna,V5,195,NA,NA,NA,NA,NA,21/oct/2021,Positif,53.9,NA,Négatif,0.9,HEM014V5b,114,63.8,72.5,Hodgkin lymphoma,Hodgkin lymphoma 2020,AVBD,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM014,M,33.3,Moderna,V6,385,109,NA,NA,NA,NA,29/avr/2022,Positif,166.9,7170,Négatif,0.3,HEM014 V6,684.9315068493152,310.07751937984494,218.38829438742084,Hodgkin lymphoma,Hodgkin lymphoma 2020,AVBD,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM015,M,57.2,Pfizer,V3,30,NA,NA,NA,NA,NA,30/avr/2021,Positif,128.4,NA,NA,NA,HEM015V3b,135.6,43.3,2.4,Hodgkin lymphoma,NLPHL stage I 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM015,M,57.2,Pfizer,V4,93,NA,NA,NA,NA,NA,02/jui/2021,Positif,75.9,NA,Négatif,0.2,HEM015V4b,66,21.4,1.3,Hodgkin lymphoma,NLPHL stage I 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM015,M,57.2,Pfizer,V5,189,NA,NA,NA,NA,NA,06/oct/2021,Positif,50.1,NA,Négatif,0.1,HEM015V5b,133,69,27,Hodgkin lymphoma,NLPHL stage I 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM015,M,57.2,Pfizer,3M3,370,96,NA,NA,NA,NA,05/avr/2022,Positif,123.7,3946,Négatif,0.1,HEM015 3M3,491.2,235,159.2,Hodgkin lymphoma,NLPHL stage I 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM016,M,81.2,Pfizer,V3,33,NA,NA,NA,NA,NA,30/avr/2021,Positif,18.8,NA,NA,NA,HEM016V3b,19.8,12.1,10.7,Multiple myeloma,Multiple myeloma 2020,VRD 11.2020 Until 02.2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,Diabete 2,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM016,M,81.2,Pfizer,V4,96,NA,NA,NA,NA,NA,02/jui/2021,Positif,6.7,NA,Négatif,0.2,HEM016V4b,1,1,1,Multiple myeloma,Multiple myeloma 2020,VRD 11.2020 Until 02.2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,Diabete 2,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM016,M,81.2,Pfizer,V5,200,NA,NA,NA,NA,NA,14/oct/2021,Négatif,1.5,NA,Négatif,0.2,HEM016V5b,1,1,1,Multiple myeloma,Multiple myeloma 2020,VRD 11.2020 Until 02.2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,Diabete 2,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM016,M,81.2,Pfizer,3M3,333,99,NA,NA,NA,NA,24/fév/2022,Positif,108.8,3057,Positif,11.3,HEM016 3M3,706.2,240.2,353.5,Multiple myeloma,Multiple myeloma 2020,VRD 11.2020 Until 02.2021,PIs + IMIDs,NA,Cancer treatment,Cancer treatment,Diabete 2,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM017,M,70.3,Pfizer,V3,34,NA,NA,NA,NA,NA,10/mai/2021,Positif,109.8,NA,NA,NA,HEM017V3b,404.5,136.6,60,Multiple myeloma,Multiple myeloma 2017,Ixazomib,Protease inhibitor PIs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib,Ixazomib,L01XG03,L01XG03
HEM017,M,70.3,Pfizer,V4,101,NA,NA,NA,NA,NA,16/jui/2021,Positif,74,NA,Négatif,0,HEM017V4b,188.7,121.4,31.8,Multiple myeloma,Multiple myeloma 2017,Ixazomib,Protease inhibitor PIs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib,Ixazomib,L01XG03,L01XG03
HEM017,M,70.3,Pfizer,V5,174,NA,NA,NA,NA,NA,27/sep/2021,Positif,51.6,NA,Négatif,0,HEM017V5b,142.7,86.7,32.6,Multiple myeloma,Multiple myeloma 2017,Ixazomib,Protease inhibitor PIs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib,Ixazomib,L01XG03,L01XG03
HEM017,M,70.3,Pfizer,V6,370,122,NA,NA,NA,NA,11/avr/2022,Positif,96.2,2393,Négatif,0,HEM017V6,193.4,100.9,67.7,Multiple myeloma,Multiple myeloma 2017,Ixazomib,Protease inhibitor PIs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib,Ixazomib,L01XG03,L01XG03
HEM018,M,73.2,Pfizer,V3,37,NA,NA,NA,NA,NA,06/mai/2021,Positif,139.6,NA,NA,NA,HEM018V3b,424.3,133.1,57.9,Multiple myeloma,multiple myeloma 2008,7VCD And RD 2014. RD 2014-2016 Then Revlimid Alone,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,"AVC 2018, obesity, SAOS, EP 2017",NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM018,M,73.2,Pfizer,V4,99,NA,NA,NA,NA,NA,07/jui/2021,Positif,85.5,NA,Indéterminé,4.4,HEM018V4b,96.4,43.8,23.1,Multiple myeloma,multiple myeloma 2008,7VCD And RD 2014. RD 2014-2016 Then Revlimid Alone,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,"AVC 2018, obesity, SAOS, EP 2017",NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM018,M,73.2,Pfizer,V5,198,NA,NA,NA,NA,NA,14/oct/2021,Positif,48.9,NA,Indéterminé,4.1,HEM018V5b,131,43.1,19.2,Multiple myeloma,multiple myeloma 2008,7VCD And RD 2014. RD 2014-2016 Then Revlimid Alone,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,"AVC 2018, obesity, SAOS, EP 2017",NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM018,M,73.2,Pfizer,V6,380,163,NA,NA,NA,NA,14/avr/2022,Positif,96,2384,Négatif,3.8,HEM018V6,1315.4,725.7,304.2,Multiple myeloma,multiple myeloma 2008,7VCD And RD 2014. RD 2014-2016 Then Revlimid Alone,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,"AVC 2018, obesity, SAOS, EP 2017",NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM019,M,62.1,Pfizer,V3,30,NA,NA,NA,NA,NA,24/mar/2021,Positif,53.9,NA,NA,NA,HEM019V3b,23,1,1.1,Multiple myeloma,Multiple myeloma (2020),"2020-2021: Velcade Revlimid Dexamethasone X4, 2020: Rxttt (Femur)",PIs + IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone,Velcade|Revlimid|Dexamethasone,L01XG01|L04AX04|H02AB02,L01XG01|L04AX04|S01BA01
HEM019,M,62.1,Pfizer,V4,94,NA,NA,NA,NA,NA,27/mai/2021,Positif,16.9,NA,NA,NA,HEM019V4b,1,0,1,Multiple myeloma,Multiple myeloma (2020),"2020-2021: Velcade Revlimid Dexamethasone X4, 2020: Rxttt (Femur)",PIs + IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone,Velcade|Revlimid|Dexamethasone,L01XG01|L04AX04|H02AB02,L01XG01|L04AX04|S01BA01
HEM019,M,62.1,Pfizer,V5,177,NA,NA,NA,NA,NA,18/aoû/2021,Négatif,3.7,NA,Négatif,0.2,HEM019V5b,1,1,1,Multiple myeloma,Multiple myeloma (2020),"2020-2021: Velcade Revlimid Dexamethasone X4, 2020: Rxttt (Femur)",PIs + IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone,Velcade|Revlimid|Dexamethasone,L01XG01|L04AX04|H02AB02,L01XG01|L04AX04|S01BA01
HEM019,M,62.1,Pfizer,3M3,295,99,NA,NA,NA,NA,14/déc/2021,Positif,56.3,829,Négatif,0.4,HEM019 3M3b,7.9,0.1,1.8,Multiple myeloma,Multiple myeloma (2020),"2020-2021: Velcade Revlimid Dexamethasone X4, 2020: Rxttt (Femur)",PIs + IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone,Velcade|Revlimid|Dexamethasone,L01XG01|L04AX04|H02AB02,L01XG01|L04AX04|S01BA01
HEM019,M,62.1,Pfizer,3M6,392,196,NA,NA,NA,NA,21/mar/2022,Positif,51.1,685,Positif,15.1,HEM019 3M6,44.6,15.2,17,Multiple myeloma,Multiple myeloma (2020),"2020-2021: Velcade Revlimid Dexamethasone X4, 2020: Rxttt (Femur)",PIs + IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Dexamethasone,Velcade|Revlimid|Dexamethasone,L01XG01|L04AX04|H02AB02,L01XG01|L04AX04|S01BA01
HEM020,F,76.2,Pfizer,V3,33,NA,NA,NA,NA,NA,04/mai/2021,Positif,96.4,NA,NA,NA,HEM020V3b,775.8,189.4,68.8,AML,AML 2013,Inductio 1 +2 Allotransplantation 2014,NA,No,Not treated,Not treated,breast carcinoma 1995,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM020,F,76.2,Pfizer,V4,96,NA,NA,NA,NA,NA,06/jui/2021,Positif,98.2,NA,Négatif,0.6,HEM020V4b,276.5,143.6,50.5,AML,AML 2013,Inductio 1 +2 Allotransplantation 2014,NA,No,Not treated,Not treated,breast carcinoma 1995,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM020,F,76.2,Pfizer,V5,194,NA,NA,NA,NA,NA,12/oct/2021,Positif,58.4,NA,Négatif,0.4,HEM020V5b,189.8,95.1,42.7,AML,AML 2013,Inductio 1 +2 Allotransplantation 2014,NA,No,Not treated,Not treated,breast carcinoma 1995,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM020,F,76.2,Pfizer,3M3,365,120,NA,NA,NA,NA,01/avr/2022,Positif,92.6,2219,Négatif,0.2,HEM020 3M3,509.7,170.6,89.5,AML,AML 2013,Inductio 1 +2 Allotransplantation 2014,NA,No,Not treated,Not treated,breast carcinoma 1995,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM020,F,76.2,Pfizer,3M6,414,169,NA,NA,NA,NA,20/mai/2022,Positif,135.9,4760,Négatif,0.2,HEM020 3M6,155.9,56.1,35.5,AML,AML 2013,Inductio 1 +2 Allotransplantation 2014,NA,No,Not treated,Not treated,breast carcinoma 1995,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM021,M,50.2,Pfizer,V3,35,NA,NA,V5-3M3,NA,NA,04/mai/2021,Positif,92.5,NA,NA,NA,HEM021V3b,187.9,60.9,31.7,Multiple myeloma,Multiple myeloma 2018,4 VRD And HD MEL 2019. Revlimid Until Now,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,oligodendroglioma garde II 2018,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM021,M,50.2,Pfizer,V4,99,NA,NA,V5-3M3,NA,NA,07/jui/2021,Positif,50.9,NA,Négatif,0,HEM021V4b,76.1,50.1,29.8,Multiple myeloma,Multiple myeloma 2018,4 VRD And HD MEL 2019. Revlimid Until Now,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,oligodendroglioma garde II 2018,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM021,M,50.2,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,05/oct/2021,Positif,20.1,NA,Négatif,0,HEM021V5b,41,29,10,Multiple myeloma,Multiple myeloma 2018,4 VRD And HD MEL 2019. Revlimid Until Now,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,oligodendroglioma garde II 2018,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM021,M,50.2,Pfizer,3M3,370,111,NA,V5-3M3,13,NA,04/avr/2022,Positif,87.2,1969,Indéterminé,5.7,HEM021 3M3,2430,2360.2,2095.1,Multiple myeloma,Multiple myeloma 2018,4 VRD And HD MEL 2019. Revlimid Until Now,Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,oligodendroglioma garde II 2018,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM022,M,67.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,134.3,NA,NA,NA,HEM022V3b,223.3,71.8,19.3,Other leukemia,ALCL ALK - 2015,"6 CHOP 2015-2016, Brentuximab 2.16-5.16. ASCT 6.2016",NA,No,Not treated,Not treated,paraneoplastic meningoencephalitis,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM022,M,67.2,Pfizer,V4,95,NA,NA,NA,NA,NA,02/jui/2021,Positif,73.5,NA,Négatif,0.8,HEM022V4b,120.8,57.6,29.9,Other leukemia,ALCL ALK - 2015,"6 CHOP 2015-2016, Brentuximab 2.16-5.16. ASCT 6.2016",NA,No,Not treated,Not treated,paraneoplastic meningoencephalitis,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM022,M,67.2,Pfizer,V5,190,NA,NA,NA,NA,NA,05/oct/2021,Positif,30.9,NA,Négatif,0.6,HEM022V5b,68,31,14,Other leukemia,ALCL ALK - 2015,"6 CHOP 2015-2016, Brentuximab 2.16-5.16. ASCT 6.2016",NA,No,Not treated,Not treated,paraneoplastic meningoencephalitis,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM022,M,67.2,Pfizer,3M3,372,110,NA,NA,NA,NA,05/avr/2022,Positif,126.3,4113,Négatif,0.4,HEM022 3M3,589.6,193.8,111.1,Other leukemia,ALCL ALK - 2015,"6 CHOP 2015-2016, Brentuximab 2.16-5.16. ASCT 6.2016",NA,No,Not treated,Not treated,paraneoplastic meningoencephalitis,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM024,M,75.2,Pfizer,V3,34,NA,4th dose: 27.04.2022,NA,NA,NA,05/mai/2021,Positif,7.7,NA,NA,NA,HEM024V3b,2.6,2.6,4,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM024,M,75.2,Pfizer,V4,97,NA,4th dose: 27.04.2022,NA,NA,NA,07/jui/2021,Indéterminé,5.3,NA,Négatif,0.5,HEM024V4b,1,1,1,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM024,M,75.2,Pfizer,V5,195,57,4th dose: 27.04.2022,NA,NA,NA,13/oct/2021,Positif,54.4,NA,Négatif,0.9,HEM024V5b,1,1,1,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM024,M,75.2,Pfizer,3M3,259,121,4th dose: 27.04.2022,NA,NA,NA,16/déc/2021,Positif,50.6,671,Négatif,0.5,HEM024 3M3,37.1,9.5,4.2,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM024,M,75.2,Pfizer,3M6,323,185,4th dose: 27.04.2022,NA,NA,NA,18/fév/2022,Positif,51.6,698,Négatif,0.6,HEM024 3M6,50.1,34,19.3,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM024,M,75.2,Pfizer,3M9,399,261,4th dose: 27.04.2022,NA,NA,NA,05/mai/2022,Positif,74.1,1426,Négatif,0.5,HEM024 3M9,85.76329331046313,28.066236317709794,30.60912151821243,MDS or aplastic anemia,SMD EB-2,Vidaza + Venetoclax,BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza|Venetoclax,Vidaza|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM025,F,83.1,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,23/mar/2021,Négatif,1.7,NA,NA,NA,HEM025V3b,1,1,1,CLL,Chronic lymphocytic leukemia (2013),"2013: Bendamustine–Rituximab (X6) , 2013-2014, Ibrutinib 2017-2018, Ibrutinib 2019, Venetoclax 2019->Today",BCL-2 inhibitor and IVIG,NA,Cancer treatment + other treatment,Cancer treatment,NA,Ig substitution > 06.2018,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib|Venetoclax,Bendamustine|Rituximab|Ibrutinib|Venetoclax,L01AA09|L01FA01|L01EL01|L01XX52,L01FA01|L01EL01|L01XX52
HEM025,F,83.1,Pfizer,V4,94,NA,NA,V5-V6,NA,NA,27/mai/2021,Négatif,3.5,NA,NA,NA,HEM025V4b,1,1,1,CLL,Chronic lymphocytic leukemia (2013),"2013: Bendamustine–Rituximab (X6) , 2013-2014, Ibrutinib 2017-2018, Ibrutinib 2019, Venetoclax 2019->Today",BCL-2 inhibitor and IVIG,NA,Cancer treatment + other treatment,Cancer treatment,NA,Ig substitution > 06.2018,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib|Venetoclax,Bendamustine|Rituximab|Ibrutinib|Venetoclax,L01AA09|L01FA01|L01EL01|L01XX52,L01FA01|L01EL01|L01XX52
HEM025,F,83.1,Pfizer,V5,176,33,NA,V5-V6,NA,NA,17/aoû/2021,Indéterminé,5.8,NA,Négatif,2.6,HEM025V5b,1,1,1,CLL,Chronic lymphocytic leukemia (2013),"2013: Bendamustine–Rituximab (X6) , 2013-2014, Ibrutinib 2017-2018, Ibrutinib 2019, Venetoclax 2019->Today",BCL-2 inhibitor and IVIG,NA,Cancer treatment + other treatment,Cancer treatment,NA,Ig substitution > 06.2018,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib|Venetoclax,Bendamustine|Rituximab|Ibrutinib|Venetoclax,L01AA09|L01FA01|L01EL01|L01XX52,L01FA01|L01EL01|L01XX52
HEM025,F,83.1,Pfizer,V6,368,225,NA,V5-V6,49,NA,25/fév/2022,Positif,97.6,2463,Négatif,3.8,HEM025V6,308.1,206.8,132.1,CLL,Chronic lymphocytic leukemia (2013),"2013: Bendamustine–Rituximab (X6) , 2013-2014, Ibrutinib 2017-2018, Ibrutinib 2019, Venetoclax 2019->Today",BCL-2 inhibitor and IVIG,NA,Cancer treatment + other treatment,Cancer treatment,NA,Ig substitution > 06.2018,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib|Venetoclax,Bendamustine|Rituximab|Ibrutinib|Venetoclax,L01AA09|L01FA01|L01EL01|L01XX52,L01FA01|L01EL01|L01XX52
HEM027,F,71.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,70.3,NA,NA,NA,HEM027V3b,88,40.1,32.7,Other disorders,lung cancer,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM027,F,71.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,39.6,NA,Négatif,0,HEM027V4b,40.2,17.2,16.3,Other disorders,lung cancer,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM027,F,71.2,Pfizer,V5,191,NA,NA,NA,NA,NA,07/oct/2021,Positif,23.4,NA,Négatif,0,HEM027V5b,1,1,1,Other disorders,lung cancer,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM027,F,71.2,Pfizer,V6,370,179,NA,NA,NA,NA,04/avr/2022,Positif,37.4,371,Négatif,0,HEM027V6,57.8,41.8,36.6,Other disorders,lung cancer,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM028,M,80.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,84.9,NA,NA,NA,HEM028V3b,157.2,55.4,25.1,Multiple myeloma,Multiple myelome IgA 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM028,M,80.2,Pfizer,V4,91,NA,NA,NA,NA,NA,29/jun/2021,Positif,48.2,NA,Négatif,0.2,HEM028V4b,66.9,41.1,15,Multiple myeloma,Multiple myelome IgA 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM028,M,80.2,Pfizer,V5,197,NA,NA,NA,NA,NA,13/oct/2021,Positif,23.9,NA,Négatif,0.1,HEM028V5b,44,31,14,Multiple myeloma,Multiple myelome IgA 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM028,M,80.2,Pfizer,3M3,328,104,NA,NA,NA,NA,21/fév/2022,Positif,80.8,1693,Négatif,0,HEM028 3M3,164.9,81.6,72,Multiple myeloma,Multiple myelome IgA 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM028,M,80.2,Pfizer,3M6,408,184,NA,NA,NA,NA,12/mai/2022,Positif,80.5,1680,Négatif,0,HEM028 3M6,129,66.8,57.3,Multiple myeloma,Multiple myelome IgA 2020,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM029,M,56.2,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,29/avr/2021,Positif,8.9,NA,NA,NA,HEM029V3b,4.9,7.1,8.4,Multiple myeloma,Multiple myelome IgE,Daratumumab Et Pomalidomide,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab|Pomalidomide,Daratumumab|Pomalidomide,L01FC01|L04AX06,L01FC01|L04AX06
HEM029,M,56.2,Pfizer,V4,84,NA,NA,V5-V6,NA,NA,23/jun/2021,Négatif,2.3,NA,Négatif,0,HEM029V4b,1,1,1,Multiple myeloma,Multiple myelome IgE,Daratumumab Et Pomalidomide,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab|Pomalidomide,Daratumumab|Pomalidomide,L01FC01|L04AX06,L01FC01|L04AX06
HEM029,M,56.2,Pfizer,V5,176,22,NA,V5-V6,NA,NA,23/sep/2021,Négatif,3.6,NA,Négatif,0,HEM029V5b,1,1,1,Multiple myeloma,Multiple myelome IgE,Daratumumab Et Pomalidomide,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab|Pomalidomide,Daratumumab|Pomalidomide,L01FC01|L04AX06,L01FC01|L04AX06
HEM029,M,56.2,Pfizer,V6,365,211,NA,V5-V6,23,NA,31/mar/2022,Positif,102.2,2699,Négatif,2.7,HEM029V6,108.9,91,58.2,Multiple myeloma,Multiple myelome IgE,Daratumumab Et Pomalidomide,Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Daratumumab|Pomalidomide,Daratumumab|Pomalidomide,L01FC01|L04AX06,L01FC01|L04AX06
HEM030,M,64.3,Pfizer,V3,30,NA,NA,NA,NA,NA,07/mai/2021,Positif,9.9,NA,NA,NA,HEM030V3b,29.8,14.5,13.6,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2020,R-CHOP + RTX,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM030,M,64.3,Pfizer,V4,93,NA,NA,NA,NA,NA,09/jui/2021,Positif,11.2,NA,Négatif,0.2,HEM030V4b,7.6,3.8,2.9,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2020,R-CHOP + RTX,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM030,M,64.3,Pfizer,V5,195,NA,NA,NA,NA,NA,19/oct/2021,Indéterminé,5.7,NA,Négatif,0.1,HEM030V5b,1,1,1,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2020,R-CHOP + RTX,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM030,M,64.3,Pfizer,V6,378,128,NA,NA,NA,NA,20/avr/2022,Positif,37.9,381,Négatif,0,HEM030V6,58.4,30.8,15.7,Diffuse large B cell lymphoma,Diffuse large Bcell lymphoma 2020,R-CHOP + RTX,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM031,M,60.3,Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,07/mai/2021,Positif,63.6,NA,NA,NA,HEM031V3b,498.3,121.6,128.1,Multiple myeloma,Myélome multiple à IgG kappa 2015 avec myasthénie puis GVHD avril 2021,Jakavi 10 Mg 2x/J Et Ciclosporine 140 Mg 2x/J StoppÉ Le 16.02 And Previous RTX,Janus kinase inhibitors + anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy>365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi|Ciclosporin,Jakavi|Ciclosporine|RTX,L01EJ01|L04AD01|L01FA01,L01EJ01|S01XA18
HEM031,M,60.3,Pfizer,V4,84,NA,NA,V5-3M3,NA,NA,30/jun/2021,Positif,68.5,NA,Négatif,0.1,HEM031V4b,234.4,75.6,67.5,Multiple myeloma,Myélome multiple à IgG kappa 2015 avec myasthénie puis GVHD avril 2021,Jakavi 10 Mg 2x/J Et Ciclosporine 140 Mg 2x/J StoppÉ Le 16.02 And Previous RTX,Janus kinase inhibitors + anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy>365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi|Ciclosporin,Jakavi|Ciclosporine|RTX,L01EJ01|L04AD01|L01FA01,L01EJ01|S01XA18
HEM031,M,60.3,Pfizer,V5,183,NA,NA,V5-3M3,NA,NA,07/oct/2021,Positif,69.4,NA,Négatif,0.1,HEM031V5b,236.2,63.1,80.3,Multiple myeloma,Myélome multiple à IgG kappa 2015 avec myasthénie puis GVHD avril 2021,Jakavi 10 Mg 2x/J Et Ciclosporine 140 Mg 2x/J StoppÉ Le 16.02 And Previous RTX,Janus kinase inhibitors + anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy>365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi|Ciclosporin,Jakavi|Ciclosporine|RTX,L01EJ01|L04AD01|L01FA01,L01EJ01|S01XA18
HEM031,M,60.3,Pfizer,V5+,352,95,NA,V5-3M3,14,NA,25/mar/2022,Positif,90.2,2106,Négatif,3.9,HEM031V5+,767.5,420.9,273.4,Multiple myeloma,Myélome multiple à IgG kappa 2015 avec myasthénie puis GVHD avril 2021,Jakavi 10 Mg 2x/J Et Ciclosporine 140 Mg 2x/J StoppÉ Le 16.02 And Previous RTX,Janus kinase inhibitors + anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy>365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi|Ciclosporin,Jakavi|Ciclosporine|RTX,L01EJ01|L04AD01|L01FA01,L01EJ01|S01XA18
HEM031,M,60.3,Pfizer,3M3,366,109,NA,V5-3M3,28,NA,08/avr/2022,Positif,109,3068,Indéterminé,4.2,HEM031 3M3,940.7,583.1,354.7,Multiple myeloma,Myélome multiple à IgG kappa 2015 avec myasthénie puis GVHD avril 2021,Jakavi 10 Mg 2x/J Et Ciclosporine 140 Mg 2x/J StoppÉ Le 16.02 And Previous RTX,Janus kinase inhibitors + anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy>365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi|Ciclosporin,Jakavi|Ciclosporine|RTX,L01EJ01|L04AD01|L01FA01,L01EJ01|S01XA18
HEM033,M,61.3,Pfizer,V3,29,NA,NA,NA,NA,NA,07/mai/2021,Positif,86.6,NA,NA,NA,HEM033V3b,190.2,51.7,52.4,Multiple myeloma,Multiple myeloma 2011 and kidney SOT,Duratumumab +Ixazomib+ Tacrolimus + CS,Anti-CD38 antibody therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib|Tacrolimus,Duratumumab|Ixazomib,L01FC01|L01XG03,L01XG03|L04AD02
HEM033,M,61.3,Pfizer,V4,99,NA,NA,NA,NA,NA,16/jui/2021,Positif,63.1,NA,Négatif,0.1,HEM033V4b,68.8,36,27.6,Multiple myeloma,Multiple myeloma 2011 and kidney SOT,Duratumumab +Ixazomib+ Tacrolimus + CS,Anti-CD38 antibody therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib|Tacrolimus,Duratumumab|Ixazomib,L01FC01|L01XG03,L01XG03|L04AD02
HEM033,M,61.3,Pfizer,V5,187,NA,NA,NA,NA,NA,12/oct/2021,Positif,29.2,NA,Négatif,0.1,HEM033V5b,41.5,25.5,19.4,Multiple myeloma,Multiple myeloma 2011 and kidney SOT,Duratumumab +Ixazomib+ Tacrolimus + CS,Anti-CD38 antibody therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib|Tacrolimus,Duratumumab|Ixazomib,L01FC01|L01XG03,L01XG03|L04AD02
HEM033,M,61.3,Pfizer,3M3,379,108,NA,NA,NA,NA,22/avr/2022,Positif,75.7,1488,Négatif,0,HEM033 3M3,1587.3,592.8,328.4,Multiple myeloma,Multiple myeloma 2011 and kidney SOT,Duratumumab +Ixazomib+ Tacrolimus + CS,Anti-CD38 antibody therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ixazomib|Tacrolimus,Duratumumab|Ixazomib,L01FC01|L01XG03,L01XG03|L04AD02
HEM034,F,55.1,Moderna,V3,28,NA,NA,NA,NA,NA,24/mar/2021,Positif,125.8,NA,NA,NA,HEM034V3b,417.5,82.9,17.8,Diffuse large B cell lymphoma,Diffuse large B cell lymphoma (2014),"2014: R-ACVBP (X4) And Methotrexate High Dose (X2) 2014-2015, BEAM Conditioning Chemotherapy And Autologous HSC Reinfusion 2015",IVIG,NA,Other treatment,Other treatment,NA,Ig substitution > 2015,NA,NA,NA,NA,NA,NA,HEM,Methotrexate,Methotrexate,L04AX03,L04AX03
HEM034,F,55.1,Moderna,V4,90,NA,NA,NA,NA,NA,25/mai/2021,Positif,107.3,NA,NA,NA,HEM034V4b,405,170.3,64.4,Diffuse large B cell lymphoma,Diffuse large B cell lymphoma (2014),"2014: R-ACVBP (X4) And Methotrexate High Dose (X2) 2014-2015, BEAM Conditioning Chemotherapy And Autologous HSC Reinfusion 2015",IVIG,NA,Other treatment,Other treatment,NA,Ig substitution > 2015,NA,NA,NA,NA,NA,NA,HEM,Methotrexate,Methotrexate,L04AX03,L04AX03
HEM034,F,55.1,Moderna,V5,177,NA,NA,NA,NA,NA,20/aoû/2021,Positif,78.4,NA,Négatif,0.4,HEM034V5b,606,277,131,Diffuse large B cell lymphoma,Diffuse large B cell lymphoma (2014),"2014: R-ACVBP (X4) And Methotrexate High Dose (X2) 2014-2015, BEAM Conditioning Chemotherapy And Autologous HSC Reinfusion 2015",IVIG,NA,Other treatment,Other treatment,NA,Ig substitution > 2015,NA,NA,NA,NA,NA,NA,HEM,Methotrexate,Methotrexate,L04AX03,L04AX03
HEM034,F,55.1,Moderna,V6,366,87,NA,NA,NA,NA,25/fév/2022,Positif,98,2483,Positif,23.2,HEM034V6,242,82.4,239.2,Diffuse large B cell lymphoma,Diffuse large B cell lymphoma (2014),"2014: R-ACVBP (X4) And Methotrexate High Dose (X2) 2014-2015, BEAM Conditioning Chemotherapy And Autologous HSC Reinfusion 2015",IVIG,NA,Other treatment,Other treatment,NA,Ig substitution > 2015,NA,NA,NA,NA,NA,NA,HEM,Methotrexate,Methotrexate,L04AX03,L04AX03
HEM035,F,27.2,Pfizer,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,101.2,NA,NA,NA,HEM035V3b,455,222.5,25.8,Hodgkin lymphoma,Hodgkin lymphoma satge III 2020,6 ABVD 2020. C6 17.09.2020,NA,No,Not treated,Not treated,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM035,F,27.2,Pfizer,V4,92,NA,NA,NA,NA,NA,01/jui/2021,Positif,83,NA,Négatif,0.1,HEM035V4b,390,201.1,56.5,Hodgkin lymphoma,Hodgkin lymphoma satge III 2020,6 ABVD 2020. C6 17.09.2020,NA,No,Not treated,Not treated,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM035,F,27.2,Pfizer,V5,183,NA,NA,NA,NA,NA,30/sep/2021,Positif,60.1,NA,Négatif,0.1,HEM035V5b,258,169,61,Hodgkin lymphoma,Hodgkin lymphoma satge III 2020,6 ABVD 2020. C6 17.09.2020,NA,No,Not treated,Not treated,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM035,F,27.2,Pfizer,3M3,365,83,NA,NA,NA,NA,31/mar/2022,Positif,105.3,2864,Négatif,0,HEM035 3M3,1519.8,831.9,264.8,Hodgkin lymphoma,Hodgkin lymphoma satge III 2020,6 ABVD 2020. C6 17.09.2020,NA,No,Not treated,Not treated,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM036,M,43.2,Pfizer,V3,37,NA,NA,NA,NA,NA,07/mai/2021,Positif,89,NA,NA,NA,HEM036V3b,215,63,27.1,Other leukemia,Hairy cell leukemia (2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM036,M,43.2,Pfizer,V4,92,NA,NA,NA,NA,NA,01/jui/2021,Positif,73.4,NA,Négatif,1.7,HEM036V4b,150.5,78.1,41.5,Other leukemia,Hairy cell leukemia (2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM036,M,43.2,Pfizer,V5,187,NA,NA,NA,NA,NA,04/oct/2021,Positif,41.6,NA,Négatif,1.9,HEM036V5b,90,48,22,Other leukemia,Hairy cell leukemia (2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM037,F,58.3,Pfizer,V3,34,NA,NA,NA,NA,NA,10/mai/2021,Positif,106.3,NA,NA,NA,HEM037V3b,625.4,238.3,84.4,MDS or aplastic anemia,SMD EB-2,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM037,F,58.3,Pfizer,V4,97,NA,NA,NA,NA,NA,12/jui/2021,Positif,81.7,NA,Négatif,0.1,HEM037V4b,263.6,141.9,42.4,MDS or aplastic anemia,SMD EB-2,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM037,F,58.3,Pfizer,V5,195,NA,NA,NA,NA,NA,18/oct/2021,Positif,62.4,NA,Négatif,0.1,HEM037V5b,183,106.9,45.8,MDS or aplastic anemia,SMD EB-2,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM037,F,58.3,Pfizer,3M3,346,94,NA,NA,NA,NA,18/mar/2022,Positif,85.2,1881,Négatif,0.2,HEM037 3M3,2944.6,1080.6,705.7,MDS or aplastic anemia,SMD EB-2,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM038,F,62.3,Moderna,V3,29,NA,NA,V5-3M3,Doit rappeler pour la date,NA,07/mai/2021,Positif,68.5,NA,NA,NA,HEM038V3b,1693.8,603.1,115.5,AML,AML  2016,5-Aza DT,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM038,F,62.3,Moderna,V4,92,NA,NA,V5-3M3,Doit rappeler pour la date,NA,09/jui/2021,Positif,92.7,NA,Négatif,0.7,HEM038V4b,1054.6,561.2,97.8,AML,AML  2016,5-Aza DT,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM038,F,62.3,Moderna,V5,182,NA,NA,V5-3M3,Doit rappeler pour la date,NA,07/oct/2021,Positif,73,NA,Négatif,0.5,HEM038V5b,412.4,209.9,91,AML,AML  2016,5-Aza DT,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM038,F,62.3,Moderna,3M3,365,113,NA,V5-3M3,Doit rappeler pour la date,NA,08/avr/2022,Positif,116.4,3496,Négatif,0.3,HEM038 3M3,464.7,295.9,136.2,AML,AML  2016,5-Aza DT,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM039,M,75.3,Pfizer,V3,34,NA,NA,NA,NA,NA,10/mai/2021,Positif,70.1,NA,NA,NA,HEM039V3b,41.1,4.1,2.7,AML,AML 2013 and alloHSC et GVHD,Jakavi 5 Mg 2x/J Et IVIG,Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi,Jakavi|IVIG,L01EJ01|J06BA02,L01EJ01
HEM039,M,75.3,Pfizer,V4,85,NA,NA,NA,NA,NA,30/jun/2021,Positif,36.5,NA,Indéterminé,4,HEM039V4b,57.3,26.8,19.6,AML,AML 2013 and alloHSC et GVHD,Jakavi 5 Mg 2x/J Et IVIG,Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi,Jakavi|IVIG,L01EJ01|J06BA02,L01EJ01
HEM039,M,75.3,Pfizer,V5,178,NA,NA,NA,NA,NA,01/oct/2021,Positif,23.5,NA,Indéterminé,4.8,HEM039V5b,36,19,10,AML,AML 2013 and alloHSC et GVHD,Jakavi 5 Mg 2x/J Et IVIG,Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi,Jakavi|IVIG,L01EJ01|J06BA02,L01EJ01
HEM039,M,75.3,Pfizer,3M3,365,120,NA,NA,NA,NA,06/avr/2022,Positif,107,2957,Négatif,3.8,HEM039 3M3,299.6,122.4,64.9,AML,AML 2013 and alloHSC et GVHD,Jakavi 5 Mg 2x/J Et IVIG,Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Jakavi,Jakavi|IVIG,L01EJ01|J06BA02,L01EJ01
HEM040,F,80.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,71.6,NA,NA,NA,HEM040V3b,183.3,50.4,25.6,Other lymphoma,MALT 2019,Ongoing Rituximab,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM040,F,80.3,Pfizer,V4,98,NA,NA,NA,NA,NA,13/jui/2021,Positif,20.9,NA,Négatif,0.1,HEM040V4b,25.6,6.6,3.3,Other lymphoma,MALT 2019,Ongoing Rituximab,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM040,F,80.3,Pfizer,V5,174,NA,NA,NA,NA,NA,27/sep/2021,Positif,7.6,NA,Négatif,0.2,HEM040V5b,1,1,1,Other lymphoma,MALT 2019,Ongoing Rituximab,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM040,F,80.3,Pfizer,V6,381,178,NA,NA,NA,NA,22/avr/2022,Positif,83.4,1803,Négatif,0,HEM040V6,70.7,11.4,8.4,Other lymphoma,MALT 2019,Ongoing Rituximab,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM041,F,77.3,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,05/mai/2021,Positif,101.1,NA,NA,NA,HEM041V3b,807.8,296.2,92.2,Hodgkin lymphoma,Hodgkin lymphoma satge IA 2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM041,F,77.3,Pfizer,V4,96,NA,NA,3M3-3M6,NA,NA,12/jui/2021,Positif,79.6,NA,Négatif,0.4,HEM041V4b,352.4,151.3,55,Hodgkin lymphoma,Hodgkin lymphoma satge IA 2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM041,F,77.3,Pfizer,V5,194,NA,NA,3M3-3M6,NA,NA,18/oct/2021,Positif,58,NA,Négatif,0.4,HEM041V5b,181.8,98.8,45.3,Hodgkin lymphoma,Hodgkin lymphoma satge IA 2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM041,F,77.3,Pfizer,3M3,321,90,NA,3M3-3M6,NA,NA,22/fév/2022,Positif,87.1,1965,Négatif,0.3,HEM041 3M3,759.9,360.5,262.7,Hodgkin lymphoma,Hodgkin lymphoma satge IA 2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM041,F,77.3,Pfizer,3M6,421,190,NA,3M3-3M6,9,NA,02/jun/2022,Positif,204.5,10757,Négatif,0.6,HEM041 3M6,541.1255411255411,296.7359050445104,255.36261491317669,Hodgkin lymphoma,Hodgkin lymphoma satge IA 2016,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM042,M,64.3,Pfizer,V3,26,NA,NA,V5-3M3,NA,NA,05/mai/2021,Positif,77.3,NA,NA,NA,HEM042V3b,2420.1,455,94.2,Other lymphoma,Peripheral T-Cell Lymphoma (PTCL) 2015 +alloHSC2016,Brentuximab,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM042,M,64.3,Pfizer,V4,95,NA,NA,V5-3M3,NA,NA,13/jui/2021,Positif,85.7,NA,Négatif,0.1,HEM042V4b,846,82.1,11.3,Other lymphoma,Peripheral T-Cell Lymphoma (PTCL) 2015 +alloHSC2016,Brentuximab,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM042,M,64.3,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,15/oct/2021,Positif,93.4,NA,Négatif,0.2,HEM042V5b,536.8,112.3,30.5,Other lymphoma,Peripheral T-Cell Lymphoma (PTCL) 2015 +alloHSC2016,Brentuximab,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM042,M,64.3,Pfizer,3M3,368,106,NA,V5-3M3,56,NA,12/avr/2022,Positif,88.4,2023,Négatif,1.3,HEM042 3M3,2430,2430,2216.3,Other lymphoma,Peripheral T-Cell Lymphoma (PTCL) 2015 +alloHSC2016,Brentuximab,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Brentuximab,L01FX05,"NA"
HEM043,M,66.1,Pfizer,V3,28,NA,NA,NA,NA,NA,16/mar/2021,Positif,11.7,NA,NA,NA,HEM043V3b,9.7,1,1,Follicular lymphoma,Follicular lymphoma grade I Stage IV A (2010),"2010: Rituximab (X4) 2010, R-CHOP (X6) 2010, Rituximab Maintenance, 2010-2012, Radiotherapy (Right Cervical+Thoracic) 2014, Bendamustine 2015, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2) and IVIG,NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,Ig substitution > 2017,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM043,M,66.1,Pfizer,V4,91,NA,NA,NA,NA,NA,18/mai/2021,Positif,10.7,NA,NA,NA,HEM043V4b,13.5,18.9,6.2,Follicular lymphoma,Follicular lymphoma grade I Stage IV A (2010),"2010: Rituximab (X4) 2010, R-CHOP (X6) 2010, Rituximab Maintenance, 2010-2012, Radiotherapy (Right Cervical+Thoracic) 2014, Bendamustine 2015, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2) and IVIG,NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,Ig substitution > 2017,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM043,M,66.1,Pfizer,V5,185,NA,NA,NA,NA,NA,20/aoû/2021,Indéterminé,4.5,NA,Négatif,1.2,HEM043V5b,1,1,1,Follicular lymphoma,Follicular lymphoma grade I Stage IV A (2010),"2010: Rituximab (X4) 2010, R-CHOP (X6) 2010, Rituximab Maintenance, 2010-2012, Radiotherapy (Right Cervical+Thoracic) 2014, Bendamustine 2015, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2) and IVIG,NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,Ig substitution > 2017,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM043,M,66.1,Pfizer,3M3,302,83,NA,NA,NA,NA,15/déc/2021,Positif,14,56,Négatif,0.6,HEM043 3M3b,33.2,19.4,7.4,Follicular lymphoma,Follicular lymphoma grade I Stage IV A (2010),"2010: Rituximab (X4) 2010, R-CHOP (X6) 2010, Rituximab Maintenance, 2010-2012, Radiotherapy (Right Cervical+Thoracic) 2014, Bendamustine 2015, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2) and IVIG,NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,Ig substitution > 2017,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM043,M,66.1,Pfizer,3M6,407,188,NA,NA,NA,NA,30/mar/2022,Positif,70.8,1303,Négatif,2.6,HEM043 3M6,167.3,106,43.5,Follicular lymphoma,Follicular lymphoma grade I Stage IV A (2010),"2010: Rituximab (X4) 2010, R-CHOP (X6) 2010, Rituximab Maintenance, 2010-2012, Radiotherapy (Right Cervical+Thoracic) 2014, Bendamustine 2015, Rituximab Maintenance 2015-2017",anti-CD20 therapy (> 1 year) (375 mg/m2) and IVIG,NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,Ig substitution > 2017,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM044,M,78.1,Pfizer,V3,28,NA,NA,V5-V6,NA,NA,22/mar/2021,Positif,70.2,NA,NA,NA,HEM044V3b,181.5,23.8,16.1,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 2005),"2005 (MGUS IgM : 1980): Fludarabine P.O. 2005, Fludarabine P.O. 2007, Bendamustine + Rituximab (X4) 2010, Rituximab Maintenance , 2010-2012, Ibrutinib 2018 -> Today",BTK inhibitor,NA,Cancer treatment,Cancer treatment,"Parkinson’s disease, Prostate cancer (surgery only)",NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Fludarabine|Bendamustine|Rituximab|Ibrutinib,L01BB05|L01AA09|L01FA01|L01EL01,L01FA01|L01EL01
HEM044,M,78.1,Pfizer,V4,98,NA,NA,V5-V6,NA,NA,31/mai/2021,Positif,69.7,NA,NA,NA,HEM044V4b,46.3,13.1,7.6,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 2005),"2005 (MGUS IgM : 1980): Fludarabine P.O. 2005, Fludarabine P.O. 2007, Bendamustine + Rituximab (X4) 2010, Rituximab Maintenance , 2010-2012, Ibrutinib 2018 -> Today",BTK inhibitor,NA,Cancer treatment,Cancer treatment,"Parkinson’s disease, Prostate cancer (surgery only)",NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Fludarabine|Bendamustine|Rituximab|Ibrutinib,L01BB05|L01AA09|L01FA01|L01EL01,L01FA01|L01EL01
HEM044,M,78.1,Pfizer,V5,186,NA,NA,V5-V6,NA,NA,27/aoû/2021,Positif,33,NA,Négatif,0.5,HEM044V5b,1,1,1,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 2005),"2005 (MGUS IgM : 1980): Fludarabine P.O. 2005, Fludarabine P.O. 2007, Bendamustine + Rituximab (X4) 2010, Rituximab Maintenance , 2010-2012, Ibrutinib 2018 -> Today",BTK inhibitor,NA,Cancer treatment,Cancer treatment,"Parkinson’s disease, Prostate cancer (surgery only)",NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Fludarabine|Bendamustine|Rituximab|Ibrutinib,L01BB05|L01AA09|L01FA01|L01EL01,L01FA01|L01EL01
HEM044,M,78.1,Pfizer,V6,373,135,NA,V5-V6,17,NA,02/mar/2022,Positif,57.5,864,Négatif,0.5,HEM044V6,75.6,36.6,67.9,Waldenstrom macroglobulinemia,Lymphoplasmacytic lymphoma (Waldenström macroglobulinemia - 2005),"2005 (MGUS IgM : 1980): Fludarabine P.O. 2005, Fludarabine P.O. 2007, Bendamustine + Rituximab (X4) 2010, Rituximab Maintenance , 2010-2012, Ibrutinib 2018 -> Today",BTK inhibitor,NA,Cancer treatment,Cancer treatment,"Parkinson’s disease, Prostate cancer (surgery only)",NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Fludarabine|Bendamustine|Rituximab|Ibrutinib,L01BB05|L01AA09|L01FA01|L01EL01,L01FA01|L01EL01
HEM045,M,70.3,Pfizer,V3,28,NA,NA,V2-V3,20,NA,11/mai/2021,Positif,97.7,NA,NA,NA,HEM045V3b,892.9,207.8,77.2,Hodgkin lymphoma,non Hodgkin 2000 et hodgkin lymphoma 2011  ans NET apidermoid carcinoma 2011,"CHOP En 2000, Cisplatine En 2012",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cisplatine,L01XA01,"NA"
HEM045,M,70.3,Pfizer,V4,91,NA,NA,V2-V3,83,NA,13/jui/2021,Positif,82.5,NA,Négatif,0.1,HEM045V4b,189.6,52.6,28,Hodgkin lymphoma,non Hodgkin 2000 et hodgkin lymphoma 2011  ans NET apidermoid carcinoma 2011,"CHOP En 2000, Cisplatine En 2012",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cisplatine,L01XA01,"NA"
HEM045,M,70.3,Pfizer,V5,188,NA,NA,V2-V3,180,NA,18/oct/2021,Positif,59.6,NA,Négatif,0.1,HEM045V5b,121.4,44.6,21.4,Hodgkin lymphoma,non Hodgkin 2000 et hodgkin lymphoma 2011  ans NET apidermoid carcinoma 2011,"CHOP En 2000, Cisplatine En 2012",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cisplatine,L01XA01,"NA"
HEM045,M,70.3,Pfizer,3M3,342,91,NA,V2-V3,334,NA,21/mar/2022,Positif,92.8,2228,Négatif,0,HEM045 3M3,555.9,185.8,111.8,Hodgkin lymphoma,non Hodgkin 2000 et hodgkin lymphoma 2011  ans NET apidermoid carcinoma 2011,"CHOP En 2000, Cisplatine En 2012",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cisplatine,L01XA01,"NA"
HEM046,M,53.3,Pfizer,3M3,302,69,NA,NA,NA,NA,04/fév/2022,Positif,128.6,4264,Négatif,0.1,HEM046 3M3,397.1,139,114.3,Other leukemia,Granulocytic sarcoma 2015 and GVH 2017,Cytarabine Et Idarubicine And AlloHSC In 2015 And No Treatement Since 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cytarabine|Idarubicin,L01BC01|L01DB06,"NA"
HEM046,M,53.3,Pfizer,3M6,407,174,NA,NA,NA,NA,20/mai/2022,Positif,130.8,4410,Négatif,0.1,HEM046 3M6,130.5,60.5,71,Other leukemia,Granulocytic sarcoma 2015 and GVH 2017,Cytarabine Et Idarubicine And AlloHSC In 2015 And No Treatement Since 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Cytarabine|Idarubicin,L01BC01|L01DB06,"NA"
HEM047,F,62.3,Pfizer,V3,33,NA,NA,NA,NA,NA,11/mai/2021,Positif,86.1,NA,NA,NA,HEM047V3b,405.4,160.5,26.1,Other leukemia,Hairy cell leukemia 2007,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM047,F,62.3,Pfizer,V4,91,NA,NA,NA,NA,NA,08/jui/2021,Positif,105.8,NA,Négatif,0.1,HEM047V4b,149.9,43.8,11.3,Other leukemia,Hairy cell leukemia 2007,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM047,F,62.3,Pfizer,V5,189,NA,NA,NA,NA,NA,14/oct/2021,Positif,67.2,NA,Négatif,0.2,HEM047V5b,199,82,43,Other leukemia,Hairy cell leukemia 2007,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM047,F,62.3,Pfizer,3M3,364,87,NA,NA,NA,NA,07/avr/2022,Positif,104.3,2811,Négatif,0,HEM047 3M3,1048.1,490.9,228.4,Other leukemia,Hairy cell leukemia 2007,None,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM048,F,74.3,Pfizer,V3,28,NA,NA,NA,NA,NA,26/mai/2021,Positif,72.3,NA,NA,NA,HEM048V3b,1699.2,560.2,232.6,MDS or aplastic anemia,"PNH, none severe aplastic anemia",Eculizumab,anti-complement therapy,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Eculizumab,Eculizumab,L04AA25,L04AA25
HEM048,F,74.3,Pfizer,V4,89,NA,NA,NA,NA,NA,26/jui/2021,Positif,80.8,NA,Négatif,1.8,HEM048V4b,1266.9,311.1,177.2,MDS or aplastic anemia,"PNH, none severe aplastic anemia",Eculizumab,anti-complement therapy,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Eculizumab,Eculizumab,L04AA25,L04AA25
HEM048,F,74.3,Pfizer,V5,182,NA,NA,NA,NA,NA,27/oct/2021,Positif,63.7,NA,Négatif,2,HEM048V5b,726,210,99,MDS or aplastic anemia,"PNH, none severe aplastic anemia",Eculizumab,anti-complement therapy,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Eculizumab,Eculizumab,L04AA25,L04AA25
HEM048,F,74.3,Pfizer,3M3,329,92,NA,NA,NA,NA,23/mar/2022,Positif,75.5,1480,Négatif,0.7,HEM048 3M3,1078.7,359.3,238.5,MDS or aplastic anemia,"PNH, none severe aplastic anemia",Eculizumab,anti-complement therapy,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Eculizumab,Eculizumab,L04AA25,L04AA25
HEM049,F,67.3,Pfizer,V3,26,NA,NA,NA,NA,NA,05/mai/2021,Positif,93.1,NA,NA,NA,HEM049V3b,354.9,148,37.7,AML,AML 2020,"FLAG 2020, Azacitidine + Venetoclax",BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine|Venetoclax,Azacitidine|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM049,F,67.3,Pfizer,V4,94,NA,NA,NA,NA,NA,12/jui/2021,Positif,60.4,NA,Négatif,0.4,HEM049V4b,150.6,78.8,39.4,AML,AML 2020,"FLAG 2020, Azacitidine + Venetoclax",BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine|Venetoclax,Azacitidine|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM049,F,67.3,Pfizer,V5,193,NA,NA,NA,NA,NA,19/oct/2021,Positif,40.5,NA,Négatif,0.6,HEM049V5b,112,50,21,AML,AML 2020,"FLAG 2020, Azacitidine + Venetoclax",BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine|Venetoclax,Azacitidine|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM049,F,67.3,Pfizer,3M3,384,128,NA,NA,NA,NA,28/avr/2022,Positif,129.9,4350,Négatif,0.3,HEM049 3M3,403.4,135.7,88,AML,AML 2020,"FLAG 2020, Azacitidine + Venetoclax",BCL-2 inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine|Venetoclax,Azacitidine|Venetoclax,L01BC07|L01XX52,L01BC07|L01XX52
HEM050,F,73.3,Pfizer,V3,31,NA,NA,NA,NA,NA,10/mai/2021,Positif,82.3,NA,NA,NA,HEM050V3b,176.6,80.6,29.8,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2019,RTX > 1y,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM050,F,73.3,Pfizer,V4,94,NA,NA,NA,NA,NA,12/jui/2021,Positif,33.4,NA,Négatif,0.2,HEM050V4b,31.4,9.2,1.8,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2019,RTX > 1y,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM050,F,73.3,Pfizer,V5,186,NA,NA,NA,NA,NA,12/oct/2021,Positif,18.4,NA,Négatif,0.3,HEM050V5b,1,1,1,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2019,RTX > 1y,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM050,F,73.3,Pfizer,V6,375,152,NA,NA,NA,NA,19/avr/2022,Positif,65.3,1110,Négatif,0.1,HEM050V6,120.1,82.7,27.5,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2019,RTX > 1y,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM051,M,70.3,Pfizer,V3,27,NA,NA,3M6-3M9,NA,NA,11/mai/2021,Négatif,1.5,NA,NA,NA,HEM051V3b,5.4,11.8,7,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,V4,93,NA,NA,3M6-3M9,NA,NA,16/jui/2021,Négatif,1.6,NA,Négatif,0.6,HEM051V4b,1,1,1,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,V5,194,55,NA,3M6-3M9,NA,NA,25/oct/2021,Négatif,1.3,NA,Négatif,0.9,HEM051V5b,1,1,1,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,3M3,250,111,NA,3M6-3M9,NA,NA,20/déc/2021,Négatif,1.3,1,Négatif,0.6,HEM051 3M3,1.7,7.3,4.1,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,3M6,327,188,NA,3M6-3M9,NA,NA,07/mar/2022,Négatif,1.1,1,Négatif,0.7,HEM051 3M6,1,1,1,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,3M6+,385,246,NA,3M6-3M9,22,NA,04/mai/2022,Positif,136.8,4823,Négatif,0.4,HEM051 3M6+,180.96272167933407,168.54879487611663,95.14747859181732,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM051,M,70.3,Pfizer,3M9,405,266,NA,3M6-3M9,42,NA,24/mai/2022,Positif,162,6756,Négatif,1.3,HEM051 3M9,211.3,192.6,65.4,CML,CML 2014,"FCR 2017, RTX - Benda 2017, Ibrutinib Since 2020",BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,RTX|Ibrutinib,L01FA01|L01EL01,L01EL01
HEM052,F,57.3,Pfizer,V3,25,NA,NA,V5-V6,NA,NA,17/mai/2021,Positif,109.6,NA,NA,NA,HEM052V3b,232,107.7,51.7,Multiple myeloma,MM,"VRD, ASCT, Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM052,F,57.3,Pfizer,V4,90,NA,NA,V5-V6,NA,NA,21/jui/2021,Positif,55.2,NA,Négatif,0.2,HEM052V4b,43.7,16,4.2,Multiple myeloma,MM,"VRD, ASCT, Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM052,F,57.3,Pfizer,V5,175,NA,NA,V5-V6,NA,NA,14/oct/2021,Positif,47.7,NA,Négatif,0.4,HEM052V5b,1,1,1,Multiple myeloma,MM,"VRD, ASCT, Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM052,F,57.3,Pfizer,V6,379,171,NA,V5-V6,77,NA,06/mai/2022,Positif,155,6186,Indéterminé,5.2,HEM052 V6,407.99673602611176,161.21231662098984,161.60310277957336,Multiple myeloma,MM,"VRD, ASCT, Revlimid Maintenance",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM054,M,80.3,Pfizer,V3,34,NA,NA,NA,NA,NA,18/mai/2021,Positif,22,NA,NA,NA,HEM054V3b,11.3,5.9,6.3,Multiple myeloma,"Multiple myeloma 2009,","Previous BMP 2010 And 17, Pomalidomide Et DexamÉThasone Since 2020",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide|DexamÉThasone,L04AX06|H02AB02,L04AX06
HEM054,M,80.3,Pfizer,V4,98,NA,NA,NA,NA,NA,21/jui/2021,Négatif,1.6,NA,Négatif,0,HEM054V4b,1,1,1,Multiple myeloma,"Multiple myeloma 2009,","Previous BMP 2010 And 17, Pomalidomide Et DexamÉThasone Since 2020",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide|DexamÉThasone,L04AX06|H02AB02,L04AX06
HEM054,M,80.3,Pfizer,V5,184,22,NA,NA,NA,NA,15/oct/2021,Positif,28,NA,Négatif,0,HEM054V5b,1,1,1,Multiple myeloma,"Multiple myeloma 2009,","Previous BMP 2010 And 17, Pomalidomide Et DexamÉThasone Since 2020",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide|DexamÉThasone,L04AX06|H02AB02,L04AX06
HEM054,M,80.3,Pfizer,V6,373,211,NA,NA,NA,NA,22/avr/2022,Négatif,0.4,0,Négatif,0,HEM054 V6,1,1,1,Multiple myeloma,"Multiple myeloma 2009,","Previous BMP 2010 And 17, Pomalidomide Et DexamÉThasone Since 2020",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Pomalidomide,Pomalidomide|DexamÉThasone,L04AX06|H02AB02,L04AX06
HEM055,M,44.3,Pfizer,V6,385,147,NA,NA,NA,NA,16/mai/2022,Positif,152.2,5965,Négatif,0,HEM055V6,537.1,278.9,166,CML,LMC,"Imatinb, Nilotinib, Dastinib Ongoing",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Nilotinib,Nilotinib|Dastinib,L01EA03|L01EA02,L01EA03
HEM056,F,33.3,Pfizer,V3,27,NA,NA,V5-V6,NA,NA,12/mai/2021,Positif,144.8,NA,NA,NA,HEM056V3b,834.7,263.1,114.8,Hodgkin lymphoma,Hodgkin lymphma 2020,ABVD 2020 + RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM056,F,33.3,Pfizer,V4,90,NA,NA,V5-V6,NA,NA,14/jui/2021,Positif,72.5,NA,Négatif,0.5,HEM056V4b,433.7,149.2,53.5,Hodgkin lymphoma,Hodgkin lymphma 2020,ABVD 2020 + RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM056,F,33.3,Pfizer,V5,183,NA,NA,V5-V6,NA,NA,15/oct/2021,Positif,90.8,NA,Négatif,1,HEM056V5b,346.1,165.1,64.5,Hodgkin lymphoma,Hodgkin lymphma 2020,ABVD 2020 + RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM056,F,33.3,Pfizer,V6,378,188,NA,V5-V6,95,NA,28/avr/2022,Positif,129.4,4317,Négatif,2.6,HEM056V6,446.8,298.5,240.6,Hodgkin lymphoma,Hodgkin lymphma 2020,ABVD 2020 + RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM057,F,27.3,Pfizer,V6,379,122,NA,NA,NA,NA,28/avr/2022,Positif,130.5,4390,Négatif,0.1,HEM057V6,817.7,363.8,143,Hodgkin lymphoma,Hodgkin lymphoma,ABVD 2020,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM058,M,58.3,Pfizer,V3,30,NA,NA,NA,NA,NA,19/mai/2021,Négatif,3.2,NA,NA,NA,HEM058V3b,1,1,1,MDS or aplastic anemia,MDS 2019 type II  +allo HSC 2020,"IDA Or Dauno+ Cytarabine 2019, Azacitidine Since 2019",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine,Cytarabine|Azacitidine,L01BC01|L01BC07,L01BC07
HEM058,M,58.3,Pfizer,V4,88,NA,NA,NA,NA,NA,16/jui/2021,Négatif,1.8,NA,Négatif,0,HEM058V4b,1,1,1,MDS or aplastic anemia,MDS 2019 type II  +allo HSC 2020,"IDA Or Dauno+ Cytarabine 2019, Azacitidine Since 2019",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine,Cytarabine|Azacitidine,L01BC01|L01BC07,L01BC07
HEM058,M,58.3,Pfizer,V5,190,4,NA,NA,NA,NA,26/oct/2021,Négatif,1.1,NA,Négatif,0,HEM058V5b,1,1,1,MDS or aplastic anemia,MDS 2019 type II  +allo HSC 2020,"IDA Or Dauno+ Cytarabine 2019, Azacitidine Since 2019",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine,Cytarabine|Azacitidine,L01BC01|L01BC07,L01BC07
HEM058,M,58.3,Pfizer,3M3,304,118,NA,NA,NA,NA,17/fév/2022,Positif,102.6,2720,Négatif,0,HEM058 3M3,205.9,50,44.7,MDS or aplastic anemia,MDS 2019 type II  +allo HSC 2020,"IDA Or Dauno+ Cytarabine 2019, Azacitidine Since 2019",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine,Cytarabine|Azacitidine,L01BC01|L01BC07,L01BC07
HEM058,M,58.3,Pfizer,3M6,365,179,NA,NA,NA,NA,19/avr/2022,Positif,56.4,831,Négatif,0,HEM058 3M6,63.4,35.7,22.9,MDS or aplastic anemia,MDS 2019 type II  +allo HSC 2020,"IDA Or Dauno+ Cytarabine 2019, Azacitidine Since 2019",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Azacitidine,Cytarabine|Azacitidine,L01BC01|L01BC07,L01BC07
HEM059,F,78.3,Pfizer,V3,31,NA,NA,NA,NA,NA,21/mai/2021,Négatif,1.5,NA,NA,NA,HEM059V3b,1,1,1,Follicular lymphoma,follicular lymphoma 2005,"Previous RCHOP 2005 Than Rituximab 2008, 2010, 2019 , Obinutuzumab Since 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Obinutuzumab,Rituximab|Obinutuzumab,L01FA01|L01FA03,L01FA01|L01XC15
HEM059,F,78.3,Pfizer,V4,97,NA,NA,NA,NA,NA,26/jui/2021,Indéterminé,4.1,NA,Négatif,0.3,HEM059V4b,1,1,1,Follicular lymphoma,follicular lymphoma 2005,"Previous RCHOP 2005 Than Rituximab 2008, 2010, 2019 , Obinutuzumab Since 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Obinutuzumab,Rituximab|Obinutuzumab,L01FA01|L01FA03,L01FA01|L01XC15
HEM059,F,78.3,Pfizer,V5,185,8,NA,NA,NA,NA,22/oct/2021,Négatif,1.7,NA,Négatif,0.9,HEM059V5b,1,1,1,Follicular lymphoma,follicular lymphoma 2005,"Previous RCHOP 2005 Than Rituximab 2008, 2010, 2019 , Obinutuzumab Since 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Obinutuzumab,Rituximab|Obinutuzumab,L01FA01|L01FA03,L01FA01|L01XC15
HEM059,F,78.3,Pfizer,V6,380,203,NA,NA,NA,NA,05/mai/2022,Négatif,0.4,0,Négatif,0.1,HEM059 V6,1,1,1,Follicular lymphoma,follicular lymphoma 2005,"Previous RCHOP 2005 Than Rituximab 2008, 2010, 2019 , Obinutuzumab Since 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Obinutuzumab,Rituximab|Obinutuzumab,L01FA01|L01FA03,L01FA01|L01XC15
HEM060,M,76.2,Pfizer,V3,31,NA,NA,NA,NA,NA,16/avr/2021,Positif,129.1,NA,NA,NA,HEM060V3b,1141.9,273.5,69.2,Diffuse large B cell lymphoma,DLBCL 2016 stage IV,6 CR-CHOP Plus Revlimid,NA,No,Not treated,Not treated,MGUS. EP 2020. Metabolic synd,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM060,M,76.2,Pfizer,V4,92,NA,NA,NA,NA,NA,16/jun/2021,Positif,124,NA,Négatif,0.3,HEM060V4b,603.1,120.7,31.7,Diffuse large B cell lymphoma,DLBCL 2016 stage IV,6 CR-CHOP Plus Revlimid,NA,No,Not treated,Not treated,MGUS. EP 2020. Metabolic synd,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM060,M,76.2,Pfizer,V5,182,NA,NA,NA,NA,NA,14/sep/2021,Positif,86.4,NA,Négatif,0.2,HEM060V5b,427,109.1,36,Diffuse large B cell lymphoma,DLBCL 2016 stage IV,6 CR-CHOP Plus Revlimid,NA,No,Not treated,Not treated,MGUS. EP 2020. Metabolic synd,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM060,M,76.2,Pfizer,3M3,363,101,NA,NA,NA,NA,14/mar/2022,Positif,140.5,5086,Négatif,0,HEM060 3M3,702.7,194.6,130.2,Diffuse large B cell lymphoma,DLBCL 2016 stage IV,6 CR-CHOP Plus Revlimid,NA,No,Not treated,Not treated,MGUS. EP 2020. Metabolic synd,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM061,F,38.3,Moderna,V3,35,NA,NA,NA,NA,NA,27/mai/2021,Positif,112.5,NA,NA,NA,HEM061V3b,1258.8,544.1,133.4,Other lymphoma,Burkitt LNH,"Rituximab > 1 Year, R-CODOXM, R-IVAC 2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM061,F,38.3,Moderna,V4,96,NA,NA,NA,NA,NA,27/jui/2021,Positif,79.9,NA,Négatif,0.6,HEM061V4b,830.6,367.8,117.9,Other lymphoma,Burkitt LNH,"Rituximab > 1 Year, R-CODOXM, R-IVAC 2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM061,F,38.3,Moderna,V5,193,NA,NA,NA,NA,NA,01/nov/2021,Positif,70.2,NA,Négatif,0.6,HEM061V5b,587.2,284.3,129.3,Other lymphoma,Burkitt LNH,"Rituximab > 1 Year, R-CODOXM, R-IVAC 2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM061,F,38.3,Moderna,3M3,342,100,NA,NA,NA,NA,30/mar/2022,Positif,92.7,2224,Négatif,0.3,HEM061 3M3,1075.7,593.1,241.2,Other lymphoma,Burkitt LNH,"Rituximab > 1 Year, R-CODOXM, R-IVAC 2017",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM062,M,73.2,Pfizer,3M3,344,102,NA,3M3-3M6,NA,NA,22/fév/2022,Positif,79.8,1652,Négatif,0.1,HEM062 3M3,467.9,111.9,150.3,CLL,Chronic lymphocytic leukemia (2017),None,NA,No,Not treated,Not treated,"Lung Adenocarcinoma operated in 2017, in RC",NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM062,M,73.2,Pfizer,3M6,408,166,NA,3M3-3M6,50,NA,27/avr/2022,Positif,123.3,3921,Négatif,0.1,HEM062 3M6,1266.9,325.9,361.3,CLL,Chronic lymphocytic leukemia (2017),None,NA,No,Not treated,Not treated,"Lung Adenocarcinoma operated in 2017, in RC",NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM063,M,69.3,Pfizer,V3,29,NA,NA,NA,NA,NA,18/mai/2021,Positif,100.1,NA,NA,NA,HEM063V3b,226.4,161.1,27.4,Multiple myeloma,MM,"Rev-Dex, Dx ASCT 2007, Revlimid > 2011",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM063,M,69.3,Pfizer,V4,87,NA,NA,NA,NA,NA,15/jui/2021,Positif,46.6,NA,Négatif,0.7,HEM063V4b,155.3,130.4,15.4,Multiple myeloma,MM,"Rev-Dex, Dx ASCT 2007, Revlimid > 2011",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM063,M,69.3,Pfizer,V5,186,NA,NA,NA,NA,NA,22/oct/2021,Positif,37.2,NA,Négatif,1,HEM063V5b,105,105.3,7.1,Multiple myeloma,MM,"Rev-Dex, Dx ASCT 2007, Revlimid > 2011",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM063,M,69.3,Pfizer,V6,394,147,NA,NA,NA,NA,18/mai/2022,Positif,116.9,3526,Négatif,0.1,HEM063V6,775.2,313.7,113.3,Multiple myeloma,MM,"Rev-Dex, Dx ASCT 2007, Revlimid > 2011",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM064,M,57.3,Pfizer,V3,30,NA,NA,NA,NA,NA,19/mai/2021,Positif,101.9,NA,NA,NA,HEM064V3b,304.1,123.4,45.6,Diffuse large B cell lymphoma,DLBCL 2011,"R-ACVBP 2011, AutoHSC 2011,",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM064,M,57.3,Pfizer,V4,95,NA,NA,NA,NA,NA,23/jui/2021,Positif,56.1,NA,Négatif,0,HEM064V4b,130,61.1,28.8,Diffuse large B cell lymphoma,DLBCL 2011,"R-ACVBP 2011, AutoHSC 2011,",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM064,M,57.3,Pfizer,V5,196,NA,NA,NA,NA,NA,01/nov/2021,Positif,28.3,NA,Négatif,0,HEM064V5b,65.3,31.8,13.3,Diffuse large B cell lymphoma,DLBCL 2011,"R-ACVBP 2011, AutoHSC 2011,",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM064,M,57.3,Pfizer,V6,378,130,NA,NA,NA,NA,02/mai/2022,Positif,162.9,6831,Négatif,0,HEM064 V6,487.56704046806436,181.257930034439,138.50415512465375,Diffuse large B cell lymphoma,DLBCL 2011,"R-ACVBP 2011, AutoHSC 2011,",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM065,M,55.3,Pfizer,V3,30,NA,NA,NA,NA,NA,19/mai/2021,Positif,94.9,NA,NA,NA,HEM065V3b,242.2,58.6,42.9,Diffuse large B cell lymphoma,DLBCL,"Rituximab > 1 Year, R-CHOP 2019",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM065,M,55.3,Pfizer,V4,88,NA,NA,NA,NA,NA,16/jui/2021,Positif,65.3,NA,Négatif,1.8,HEM065V4b,92.3,27.1,13.6,Diffuse large B cell lymphoma,DLBCL,"Rituximab > 1 Year, R-CHOP 2019",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM065,M,55.3,Pfizer,V5,190,NA,NA,NA,NA,NA,26/oct/2021,Positif,38.4,NA,Négatif,1.4,HEM065V5b,108.3,54,31.5,Diffuse large B cell lymphoma,DLBCL,"Rituximab > 1 Year, R-CHOP 2019",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM065,M,55.3,Pfizer,V6,372,103,NA,NA,NA,NA,26/avr/2022,Positif,104.1,2800,Positif,10,HEM065V6,2430,1528,1201,Diffuse large B cell lymphoma,DLBCL,"Rituximab > 1 Year, R-CHOP 2019",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM066,F,40.3,Pfizer,V3,30,NA,NA,NA,NA,NA,20/mai/2021,Positif,69.6,NA,NA,NA,HEM066V3b,979.4,348.7,123.5,Other lymphoma,PMBCL 2020,"R-DA-EPOCH 2020, Ongoing CS + HCQ",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,HCQ,P01BA02,"NA"
HEM066,F,40.3,Pfizer,V4,92,NA,NA,NA,NA,NA,21/jui/2021,Positif,69.9,NA,Négatif,1.2,HEM066V4b,233.9,79.9,30.6,Other lymphoma,PMBCL 2020,"R-DA-EPOCH 2020, Ongoing CS + HCQ",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,HCQ,P01BA02,"NA"
HEM066,F,40.3,Pfizer,V5,181,NA,NA,NA,NA,NA,18/oct/2021,Positif,55.6,NA,Négatif,1.1,HEM066V5b,165,59.5,24.1,Other lymphoma,PMBCL 2020,"R-DA-EPOCH 2020, Ongoing CS + HCQ",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,HCQ,P01BA02,"NA"
HEM066,F,40.3,Pfizer,3M3,322,76,NA,NA,NA,NA,08/mar/2022,Positif,78.9,1615,Négatif,1,HEM066 3M3,1716.1,708.2,412.5,Other lymphoma,PMBCL 2020,"R-DA-EPOCH 2020, Ongoing CS + HCQ",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,HCQ,P01BA02,"NA"
HEM067,F,74.3,Pfizer,V3,30,NA,NA,NA,NA,NA,21/mai/2021,Positif,81.4,NA,NA,NA,HEM067V3b,107,42,28,Other lymphoma,Lymphoplasmocytic lymphoma,"Rituximab < 1 Year, R-Bendamustine 2018",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM067,F,74.3,Pfizer,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,60.4,NA,Négatif,0,HEM067V4b,93.7,45.7,22.4,Other lymphoma,Lymphoplasmocytic lymphoma,"Rituximab < 1 Year, R-Bendamustine 2018",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM067,F,74.3,Pfizer,V5,187,NA,NA,NA,NA,NA,25/oct/2021,Positif,56.4,NA,Négatif,0.4,HEM067V5b,78.2,38.3,18.2,Other lymphoma,Lymphoplasmocytic lymphoma,"Rituximab < 1 Year, R-Bendamustine 2018",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM067,F,74.3,Pfizer,V6,369,146,NA,NA,NA,NA,25/avr/2022,Positif,129.3,4310,Négatif,0.3,HEM067V6,348.6,132.7,76.2,Other lymphoma,Lymphoplasmocytic lymphoma,"Rituximab < 1 Year, R-Bendamustine 2018",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Bendamustine,L01FA01|L01AA09,L01FA01
HEM068,F,53.3,Pfizer,V3,28,NA,NA,NA,NA,NA,19/mai/2021,Positif,90.1,NA,NA,NA,HEM068V3b,2430,698.3,287.1,AML,"LMA NPM1+, FLt3-ITD",Allotransplantation 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM068,F,53.3,Pfizer,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,65.4,NA,Négatif,1.3,HEM068V4b,2351.3,812.3,228.3,AML,"LMA NPM1+, FLt3-ITD",Allotransplantation 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM068,F,53.3,Pfizer,V5,189,NA,NA,NA,NA,NA,27/oct/2021,Positif,63.8,NA,Négatif,1,HEM068V5b,1553.8,611.2,155.6,AML,"LMA NPM1+, FLt3-ITD",Allotransplantation 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM068,F,53.3,Pfizer,3M3,371,106,NA,NA,NA,NA,27/avr/2022,Positif,119.8,3703,Négatif,0.4,HEM068 3M3,2430,1218.9,462.3,AML,"LMA NPM1+, FLt3-ITD",Allotransplantation 2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM069,F,73.2,Pfizer,V3,32,NA,NA,NA,NA,NA,19/avr/2021,Positif,35.5,NA,NA,NA,HEM069V3b,39.1,11.9,5.9,Multiple myeloma,MM 2014,"ASCT 2014. ASCT 2017. 2021 Elo-Pom-Dex, Dara Pom Dex",Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM069,F,73.2,Pfizer,V4,97,NA,NA,NA,NA,NA,23/jun/2021,Positif,7.9,NA,Négatif,0,HEM069V4b,1,1,1,Multiple myeloma,MM 2014,"ASCT 2014. ASCT 2017. 2021 Elo-Pom-Dex, Dara Pom Dex",Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM069,F,73.2,Pfizer,V5,189,NA,NA,NA,NA,NA,23/sep/2021,Négatif,3.8,NA,Négatif,0,HEM069V5b,1,1,1,Multiple myeloma,MM 2014,"ASCT 2014. ASCT 2017. 2021 Elo-Pom-Dex, Dara Pom Dex",Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM069,F,73.2,Pfizer,V6,361,143,NA,NA,NA,NA,14/mar/2022,Positif,26.8,194,Négatif,0,HEM069V6,12.9,9.5,4.5,Multiple myeloma,MM 2014,"ASCT 2014. ASCT 2017. 2021 Elo-Pom-Dex, Dara Pom Dex",Anti-CD38 antibody therapy,NA,Cancer treatment,Cancer treatment,none,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM070,M,19.3,Pfizer,V3,30,NA,NA,NA,NA,NA,21/mai/2021,Positif,153,NA,NA,NA,HEM070V3b,682.6,247.5,70.1,Hodgkin lymphoma,Hodgkin,ABVD < 1 Year,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM070,M,19.3,Pfizer,V4,83,NA,NA,NA,NA,NA,13/jui/2021,Positif,79.2,NA,Négatif,0.2,HEM070V4b,173.1,83.5,30.3,Hodgkin lymphoma,Hodgkin,ABVD < 1 Year,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM070,M,19.3,Pfizer,V5,183,NA,NA,NA,NA,NA,21/oct/2021,Positif,80.5,NA,Positif,16,HEM070V5b,3442.3,2182.9,572.4,Hodgkin lymphoma,Hodgkin,ABVD < 1 Year,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM071,F,59.3,Moderna,V3,30,NA,NA,NA,NA,NA,21/mai/2021,Positif,139.2,NA,NA,NA,HEM071V3b,364.8,114.9,7.5,Other lymphoma,NK/T nasal type PTCL,"SMILE, Gem Pegasparaginase",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,asparaginase,,"NA",L01XX02
HEM071,F,59.3,Moderna,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,57.9,NA,Négatif,0.6,HEM071V4b,117,61,10,Other lymphoma,NK/T nasal type PTCL,"SMILE, Gem Pegasparaginase",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,asparaginase,,"NA",L01XX02
HEM071,F,59.3,Moderna,V5,173,NA,NA,NA,NA,NA,11/oct/2021,Positif,35.1,NA,Négatif,1.1,HEM071V5b,57.8,30.3,8.6,Other lymphoma,NK/T nasal type PTCL,"SMILE, Gem Pegasparaginase",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,asparaginase,,"NA",L01XX02
HEM071,F,59.3,Moderna,3M3,371,112,NA,NA,NA,NA,27/avr/2022,Positif,128.7,4270,Négatif,0.2,HEM071 3M3,1858.4,578.7,365.9,Other lymphoma,NK/T nasal type PTCL,"SMILE, Gem Pegasparaginase",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,asparaginase,,"NA",L01XX02
HEM072,M,66.3,Pfizer,V3,31,NA,NA,NA,NA,NA,21/mai/2021,Positif,121.3,NA,NA,NA,HEM072V3b,188.6,89.8,18.6,MGRS,Monoclonal gammopathy of renal significance (MGRS) 2015,"Ips 2015, IMIDs 2015-2017",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM072,M,66.3,Pfizer,V4,92,NA,NA,NA,NA,NA,21/jui/2021,Positif,61.6,NA,Négatif,0,HEM072V4b,143.8,85,24.4,MGRS,Monoclonal gammopathy of renal significance (MGRS) 2015,"Ips 2015, IMIDs 2015-2017",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM072,M,66.3,Pfizer,V5,191,NA,NA,NA,NA,NA,28/oct/2021,Positif,52.6,NA,Négatif,0.1,HEM072V5b,83.1,50,19.2,MGRS,Monoclonal gammopathy of renal significance (MGRS) 2015,"Ips 2015, IMIDs 2015-2017",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM073,F,77.2,Moderna,V3,34,NA,NA,NA,NA,NA,22/avr/2021,Positif,157.2,NA,NA,NA,HEM073V3b,2220.2,683.1,237.1,CML,CML 2004,IMATINIB Since 2005,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,IMATINIB,IMATINIB,L01EA01,L01EA01
HEM073,F,77.2,Moderna,V4,97,NA,NA,NA,NA,NA,24/jun/2021,Positif,85,NA,Positif,12.2,HEM073V4b,765.7,226.5,99.5,CML,CML 2004,IMATINIB Since 2005,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,IMATINIB,IMATINIB,L01EA01,L01EA01
HEM073,F,77.2,Moderna,V5,188,NA,NA,NA,NA,NA,23/sep/2021,Positif,89,NA,Positif,7.8,HEM073V5b,432.5,136.1,76.5,CML,CML 2004,IMATINIB Since 2005,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,IMATINIB,IMATINIB,L01EA01,L01EA01
HEM073,F,77.2,Moderna,3M3,363,121,NA,NA,NA,NA,17/mar/2022,Positif,104.7,2832,Positif,6.4,HEM073 3M3,784.9,273.4,177.3,CML,CML 2004,IMATINIB Since 2005,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,IMATINIB,IMATINIB,L01EA01,L01EA01
HEM073,F,77.2,Moderna,3M6,418,176,NA,NA,NA,NA,11/mai/2022,Positif,139,4978,Positif,6.2,HEM073 3M6,447.42729306487695,146.69209329617132,107.73540185304891,CML,CML 2004,IMATINIB Since 2005,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,IMATINIB,IMATINIB,L01EA01,L01EA01
HEM074,M,38.2,Pfizer,V3,32,NA,NA,NA,NA,NA,20/avr/2021,Positif,108.1,NA,NA,NA,HEM074V3b,1905.1,881.8,257.3,Other lymphoma,Mantle cell lymphoma 2015 and autoHSC 2015,R CHOP And R DHAP 2015,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM074,M,38.2,Pfizer,V4,94,NA,NA,NA,NA,NA,21/jun/2021,Positif,93,NA,Négatif,0.3,HEM074V4b,817,332.9,110.4,Other lymphoma,Mantle cell lymphoma 2015 and autoHSC 2015,R CHOP And R DHAP 2015,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM074,M,38.2,Pfizer,V5,186,NA,NA,NA,NA,NA,21/sep/2021,Positif,76.9,NA,Négatif,0.2,HEM074V5b,559,250.2,132.1,Other lymphoma,Mantle cell lymphoma 2015 and autoHSC 2015,R CHOP And R DHAP 2015,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM074,M,38.2,Pfizer,3M3,427,109,NA,NA,NA,NA,20/mai/2022,Positif,140.8,5108,Négatif,0.2,HEM074 3M3,1656.5,647.7,423.7,Other lymphoma,Mantle cell lymphoma 2015 and autoHSC 2015,R CHOP And R DHAP 2015,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM075,M,58.2,Moderna,V3,31,NA,NA,V5-3M3,NA,NA,23/avr/2021,Positif,88.4,NA,NA,NA,HEM075V3b,856.2,288.4,72.9,Other lymphoma,Angioimmunoblastic T-cell lymphoma (AITL)2019,CHOEP 2019,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM075,M,58.2,Moderna,V4,97,NA,NA,V5-3M3,NA,NA,28/jun/2021,Positif,83.6,NA,Positif,14,HEM075V4b,492.6,255.8,56.4,Other lymphoma,Angioimmunoblastic T-cell lymphoma (AITL)2019,CHOEP 2019,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM075,M,58.2,Moderna,V5,191,NA,NA,V5-3M3,NA,NA,30/sep/2021,Positif,61.1,NA,Positif,9.3,HEM075V5b,313.3,163,60,Other lymphoma,Angioimmunoblastic T-cell lymphoma (AITL)2019,CHOEP 2019,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM075,M,58.2,Moderna,3M3,352,116,NA,V5-3M3,15,NA,10/mar/2022,Positif,82.6,1769,Positif,12.6,HEM075 3M3,2422.5,1559.8,1155.1,Other lymphoma,Angioimmunoblastic T-cell lymphoma (AITL)2019,CHOEP 2019,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM075,M,58.2,Moderna,3M6,422,186,NA,V5-3M3,85,NA,19/mai/2022,Positif,100.5,2611,Positif,13.4,HEM075 3M6,2430,2430,1674.2,Other lymphoma,Angioimmunoblastic T-cell lymphoma (AITL)2019,CHOEP 2019,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM076,F,70.2,Moderna,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,71,NA,NA,NA,HEM076V3b,1540.6,449.6,145.8,CML,CML 2011,Imatinib 2011-2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Imatinib,Imatinib,L01EA01,L01EA01
HEM076,F,70.2,Moderna,V4,91,NA,NA,NA,NA,NA,22/jun/2021,Positif,53,NA,Négatif,1.3,HEM076V4b,682.6,286.2,89.3,CML,CML 2011,Imatinib 2011-2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Imatinib,Imatinib,L01EA01,L01EA01
HEM076,F,70.2,Moderna,V5,184,NA,NA,NA,NA,NA,23/sep/2021,Positif,86.9,NA,Négatif,0.7,HEM076V5b,389.9,162.9,75.5,CML,CML 2011,Imatinib 2011-2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Imatinib,Imatinib,L01EA01,L01EA01
HEM077,M,56.2,Pfizer,V3,33,NA,NA,V5-3M3,73,NA,26/avr/2021,Positif,95.9,NA,NA,NA,HEM077V3b,217.2,63.8,36.6,Other lymphoma,MALT 2009,No Cancer Tttt,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM077,M,56.2,Pfizer,V4,91,NA,NA,V5-3M3,131,NA,23/jun/2021,Positif,72.5,NA,Négatif,0.3,HEM077V4b,29.1,15.7,4.6,Other lymphoma,MALT 2009,No Cancer Tttt,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM077,M,56.2,Pfizer,V5,182,NA,NA,V5-3M3,222,NA,22/sep/2021,Positif,35.4,NA,Négatif,0.1,HEM077V5b,1,1,1,Other lymphoma,MALT 2009,No Cancer Tttt,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM077,M,56.2,Pfizer,3M3,386,127,NA,V5-3M3,426,NA,14/avr/2022,Positif,99,2534,Négatif,3.5,HEM077 3M3,2430,2430,2430,Other lymphoma,MALT 2009,No Cancer Tttt,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM078,M,54.2,Moderna,V3,34,NA,NA,NA,NA,NA,27/avr/2021,Positif,145.9,NA,NA,NA,HEM078V3b,1542.7,359.5,210.9,Diffuse large B cell lymphoma,DLBCL 2014,R-ACVBP 2014,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM078,M,54.2,Moderna,V4,85,NA,NA,NA,NA,NA,17/jun/2021,Positif,100.4,NA,Positif,6.2,HEM078V4b,406,80.2,45.5,Diffuse large B cell lymphoma,DLBCL 2014,R-ACVBP 2014,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM078,M,54.2,Moderna,V5,183,NA,NA,NA,NA,NA,23/sep/2021,Positif,78.6,NA,Indéterminé,4,HEM078V5b,248.8,60.1,29.5,Diffuse large B cell lymphoma,DLBCL 2014,R-ACVBP 2014,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM078,M,54.2,Moderna,V6,377,119,NA,NA,NA,NA,05/avr/2022,Positif,122.1,3845,Négatif,1.9,HEM078V6,2430,781.9,335.1,Diffuse large B cell lymphoma,DLBCL 2014,R-ACVBP 2014,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM079,M,77.2,Moderna,V3,30,NA,NA,NA,NA,NA,21/avr/2021,Positif,102.6,NA,NA,NA,HEM079V3b,460.6,80.3,30.9,CLL,CLL 2005,"RTX-Benda 2005, Ibritunib 2020",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX|Ibritunib,L01FA01|L01EL01,"NA"
HEM079,M,77.2,Moderna,V4,91,NA,NA,NA,NA,NA,21/jun/2021,Positif,61.1,NA,Négatif,0.4,HEM079V4b,146.3,31.6,13.3,CLL,CLL 2005,"RTX-Benda 2005, Ibritunib 2020",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX|Ibritunib,L01FA01|L01EL01,"NA"
HEM079,M,77.2,Moderna,V5,184,NA,NA,NA,NA,NA,22/sep/2021,Positif,31.4,NA,Négatif,0.2,HEM079V5b,55.6,24.2,10.1,CLL,CLL 2005,"RTX-Benda 2005, Ibritunib 2020",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX|Ibritunib,L01FA01|L01EL01,"NA"
HEM079,M,77.2,Moderna,3M3,366,107,NA,NA,NA,NA,23/mar/2022,Positif,82.7,1773,Négatif,0,HEM079 3M3,174.7,95.6,36.3,CLL,CLL 2005,"RTX-Benda 2005, Ibritunib 2020",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX|Ibritunib,L01FA01|L01EL01,"NA"
HEM080,F,67.3,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,27/mai/2021,Positif,114.7,NA,NA,NA,HEM080V3b,292.4,136.6,11.5,Follicular lymphoma,Centrofollicular lymphoma,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM080,F,67.3,Pfizer,V4,86,NA,NA,V5-V6,NA,NA,21/jui/2021,Positif,69.4,NA,Négatif,0.1,HEM080V4b,89.2,37.6,2.6,Follicular lymphoma,Centrofollicular lymphoma,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM080,F,67.3,Pfizer,V5,182,NA,NA,V5-V6,NA,NA,25/oct/2021,Positif,61.2,NA,Négatif,0.3,HEM080V5b,150,103.4,36.2,Follicular lymphoma,Centrofollicular lymphoma,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM080,F,67.3,Pfizer,V5+,232,NA,NA,V5-V6,43,NA,14/déc/2021,Positif,82.1,1747,Négatif,3.9,HEM080V5+b,984.3,593.8,249.7,Follicular lymphoma,Centrofollicular lymphoma,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM080,F,67.3,Pfizer,V6,367,NA,NA,V5-V6,178,NA,28/avr/2022,Positif,118.5,3623,Négatif,1.2,HEM080V6,906.6,425.9,162.8,Follicular lymphoma,Centrofollicular lymphoma,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM081,M,56.3,Pfizer,V3,33,NA,NA,NA,NA,NA,31/mai/2021,Non effectué,Non effectué,NA,NA,NA,HEM081V3b,467.3,119.1,57.9,CLL,CLL,"Rituximab > 1 Year, Fludarabine-Cyclophosphamide-Rituximab",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Fludarabine|Cyclophosphamide,L01FA01|L01BB05|L01AA01,L01FA01
HEM081,M,56.3,Pfizer,V4,86,NA,NA,NA,NA,NA,23/jui/2021,Positif,61.9,NA,Négatif,0.1,HEM081V4b,130.3,57,29.9,CLL,CLL,"Rituximab > 1 Year, Fludarabine-Cyclophosphamide-Rituximab",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Fludarabine|Cyclophosphamide,L01FA01|L01BB05|L01AA01,L01FA01
HEM081,M,56.3,Pfizer,V5,187,NA,NA,NA,NA,NA,01/nov/2021,Positif,33,NA,Négatif,0.1,HEM081V5b,91.2,39.6,24.4,CLL,CLL,"Rituximab > 1 Year, Fludarabine-Cyclophosphamide-Rituximab",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Fludarabine|Cyclophosphamide,L01FA01|L01BB05|L01AA01,L01FA01
HEM081,M,56.3,Pfizer,V6,365,139,NA,NA,NA,NA,28/avr/2022,Positif,103.6,2773,Négatif,0,HEM081V6,1032.5,260.8,143.2,CLL,CLL,"Rituximab > 1 Year, Fludarabine-Cyclophosphamide-Rituximab",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|Fludarabine|Cyclophosphamide,L01FA01|L01BB05|L01AA01,L01FA01
HEM082,F,71.3,Pfizer,V3,33,NA,4th dose: 21.02.2022,NA,NA,NA,01/jun/2021,Négatif,2.7,NA,NA,NA,HEM082V3b,1,1,1,Diffuse large B cell lymphoma,DLBCL,"Rituximab < 1 Year, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM082,F,71.3,Pfizer,V4,91,NA,4th dose: 21.02.2022,NA,NA,NA,29/jui/2021,Négatif,1.4,NA,Négatif,0.1,HEM082V4b,1,1,1,Diffuse large B cell lymphoma,DLBCL,"Rituximab < 1 Year, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM082,F,71.3,Pfizer,V5,182,45,4th dose: 21.02.2022,NA,NA,NA,28/oct/2021,Positif,21.6,NA,Négatif,0.1,HEM082V5b,1,1,1,Diffuse large B cell lymphoma,DLBCL,"Rituximab < 1 Year, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM082,F,71.3,Pfizer,3M3,250,113,4th dose: 21.02.2022,NA,NA,NA,04/jan/2022,Positif,13.4,52,Négatif,0,HEM082 3M3,17.3,11.3,8.8,Diffuse large B cell lymphoma,DLBCL,"Rituximab < 1 Year, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM082,F,71.3,Pfizer,3M6,322,185,4th dose: 21.02.2022,NA,NA,NA,17/mar/2022,Positif,102.7,2725,Négatif,0,HEM082 3M6,920.8,291.5,171.9,Diffuse large B cell lymphoma,DLBCL,"Rituximab < 1 Year, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM083,F,53.3,Pfizer,V3,32,NA,NA,NA,NA,NA,31/mai/2021,Négatif,0.2,NA,NA,NA,HEM083V3b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab > 1 Year, R-CHOP , R Maintenance",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM083,F,53.3,Pfizer,V4,91,NA,NA,NA,NA,NA,29/jui/2021,Négatif,0.2,NA,Négatif,0.1,HEM083V4b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab > 1 Year, R-CHOP , R Maintenance",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM083,F,53.3,Pfizer,V5,186,46,NA,NA,NA,NA,01/nov/2021,Négatif,0.1,NA,Négatif,0,HEM083V5b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab > 1 Year, R-CHOP , R Maintenance",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM083,F,53.3,Pfizer,V6,372,232,NA,NA,NA,NA,06/mai/2022,Négatif,0.1,0,Négatif,0,HEM083 V6,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab > 1 Year, R-CHOP , R Maintenance",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM084,M,67.3,Pfizer,V3,29,NA,NA,NA,NA,NA,27/mai/2021,Positif,6.2,NA,NA,NA,HEM084V3b,11,9.5,6.3,Multiple myeloma,MM,"Prednisone, Velcade, Revlimid, Dexa",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid,Prednisone|Velcade|Revlimid|Dexa,H02AB07|L01XG01|L04AX04|H02AB02,L01XG01|L04AX04
HEM084,M,67.3,Pfizer,V4,89,NA,NA,NA,NA,NA,26/jui/2021,Positif,6.4,NA,Négatif,0.3,HEM084V4b,1,1,1,Multiple myeloma,MM,"Prednisone, Velcade, Revlimid, Dexa",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid,Prednisone|Velcade|Revlimid|Dexa,H02AB07|L01XG01|L04AX04|H02AB02,L01XG01|L04AX04
HEM084,M,67.3,Pfizer,V5,180,NA,NA,NA,NA,NA,25/oct/2021,Indéterminé,5.5,NA,Négatif,0.2,HEM084V5b,1,1,1,Multiple myeloma,MM,"Prednisone, Velcade, Revlimid, Dexa",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid,Prednisone|Velcade|Revlimid|Dexa,H02AB07|L01XG01|L04AX04|H02AB02,L01XG01|L04AX04
HEM086,M,54.4,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,22/jun/2021,Positif,47.1,NA,Négatif,1.8,HEM086V3b,60.2,10.7,5.9,CLL,CLL,"Rituximab < 1 Year, Ibrutinib",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Rituximab|Ibrutinib,L01FA01|L01EL01,L01FA01|L01EL01
HEM086,M,54.4,Pfizer,V4,91,NA,NA,V5-3M3,NA,NA,20/aoû/2021,Positif,40.8,NA,Négatif,0.9,HEM086V4b,54.6,17.9,12.4,CLL,CLL,"Rituximab < 1 Year, Ibrutinib",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Rituximab|Ibrutinib,L01FA01|L01EL01,L01FA01|L01EL01
HEM086,M,54.4,Pfizer,V5,188,NA,NA,V5-3M3,NA,NA,25/nov/2021,Positif,34.3,NA,Négatif,0.2,HEM086V5b,42.9,22.2,7.8,CLL,CLL,"Rituximab < 1 Year, Ibrutinib",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Rituximab|Ibrutinib,L01FA01|L01EL01,L01FA01|L01EL01
HEM086,M,54.4,Pfizer,3M3,311,96,NA,V5-3M3,16,NA,28/mar/2022,Positif,79.8,1652,Négatif,0.1,HEM086 3M3,141.2,44.5,32.1,CLL,CLL,"Rituximab < 1 Year, Ibrutinib",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab|Ibrutinib,Rituximab|Ibrutinib,L01FA01|L01EL01,L01FA01|L01EL01
HEM087,F,57.2,Moderna,V3,34,NA,NA,NA,NA,NA,04/mai/2021,Positif,92.7,NA,NA,NA,HEM087V3b,1143.1,376.2,108.3,AML,LMA NPM1+,"7+3, Clofa-ARAC, Vidaza",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza,Vidaza,L01BC07,L01BC07
HEM087,F,57.2,Moderna,V4,90,NA,NA,NA,NA,NA,29/jun/2021,Positif,82.8,NA,Négatif,0.5,HEM087V4b,431.8,164.4,61.4,AML,LMA NPM1+,"7+3, Clofa-ARAC, Vidaza",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza,Vidaza,L01BC07,L01BC07
HEM087,F,57.2,Moderna,V5,174,NA,NA,NA,NA,NA,21/sep/2021,Positif,73.4,NA,Négatif,0.4,HEM087V5b,235.1,87,56.8,AML,LMA NPM1+,"7+3, Clofa-ARAC, Vidaza",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Vidaza,Vidaza,L01BC07,L01BC07
HEM088,F,81.3,Moderna,V6,365,150,NA,NA,NA,NA,05/mai/2022,Positif,128.5,4257,Négatif,0.1,HEM088 V6,174.33751743375174,109.34937124111536,40.22526146419952,Follicular lymphoma,Transformed  follicular lymphoma,"Rituximab > 1 Year, R-CHOP 2009",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM089,F,59.2,Moderna,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,104.6,NA,NA,NA,HEM089V3b,432.7,173,32.6,Other leukemia,Acute promyelocytic leukemia APL 2011,"ATRA 2011, MTX 2011",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,ATRA|MTX,L01XF01|L04AX03,"NA"
HEM089,F,59.2,Moderna,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,86.3,NA,Négatif,0.3,HEM089V4b,199.8,92.9,38.1,Other leukemia,Acute promyelocytic leukemia APL 2011,"ATRA 2011, MTX 2011",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,ATRA|MTX,L01XF01|L04AX03,"NA"
HEM089,F,59.2,Moderna,V5,168,NA,NA,NA,NA,NA,14/sep/2021,Positif,70.3,NA,Négatif,0.1,HEM089V5b,165.5,90.5,40.6,Other leukemia,Acute promyelocytic leukemia APL 2011,"ATRA 2011, MTX 2011",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,ATRA|MTX,L01XF01|L04AX03,"NA"
HEM089,F,59.2,Moderna,V6,363,111,NA,NA,NA,NA,28/mar/2022,Positif,87.5,1983,Négatif,0.1,HEM089 V6,334.2245989304813,168.71941960519655,82.71298593879239,Other leukemia,Acute promyelocytic leukemia APL 2011,"ATRA 2011, MTX 2011",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,ATRA|MTX,L01XF01|L04AX03,"NA"
HEM090,M,82.2,Pfizer,V3,31,NA,NA,NA,NA,NA,30/avr/2021,Positif,21.2,NA,NA,NA,HEM090V3b,27.2,7.9,8.1,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2017,"R-Benda 2017, RTX 2018-2020 , RTX 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM090,M,82.2,Pfizer,V4,98,NA,NA,NA,NA,NA,06/jui/2021,Positif,8,NA,Négatif,0.6,HEM090V4b,1,1,1,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2017,"R-Benda 2017, RTX 2018-2020 , RTX 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM090,M,82.2,Pfizer,V5,197,NA,NA,NA,NA,NA,13/oct/2021,Négatif,2.1,NA,Négatif,0.2,HEM090V5b,1,1,1,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2017,"R-Benda 2017, RTX 2018-2020 , RTX 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM090,M,82.2,Pfizer,3M3,372,78,NA,NA,NA,NA,06/avr/2022,Négatif,1.4,1,Négatif,0,HEM090 3M3,10.9,25.8,16.1,Waldenstrom macroglobulinemia,Waldenstrom macroglobulinemia 2017,"R-Benda 2017, RTX 2018-2020 , RTX 2020",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM091,F,66.2,Moderna,V3,30,NA,NA,3M3-3M6,NA,NA,29/avr/2021,Positif,105.3,NA,NA,NA,HEM091V3b,1140.9,840.3,172.8,Multiple myeloma,Multiple myeloma 2016 + autoHSC 2017,"VTD 2016, Revlimid 2017-2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM091,F,66.2,Moderna,V4,97,NA,NA,3M3-3M6,NA,NA,05/jui/2021,Positif,95.3,NA,Négatif,0.1,HEM091V4b,327.9,188.4,64.4,Multiple myeloma,Multiple myeloma 2016 + autoHSC 2017,"VTD 2016, Revlimid 2017-2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM091,F,66.2,Moderna,V5,191,NA,NA,3M3-3M6,NA,NA,07/oct/2021,Positif,54.9,NA,Négatif,0,HEM091V5b,115.6,81.2,38.4,Multiple myeloma,Multiple myeloma 2016 + autoHSC 2017,"VTD 2016, Revlimid 2017-2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM091,F,66.2,Moderna,3M3,356,98,NA,3M3-3M6,NA,NA,21/mar/2022,Positif,88.7,2037,Négatif,0,HEM091 3M3,273.1,141,82,Multiple myeloma,Multiple myeloma 2016 + autoHSC 2017,"VTD 2016, Revlimid 2017-2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM091,F,66.2,Moderna,3M3+,413,155,NA,3M3-3M6,15,NA,17/mai/2022,Positif,105.6,2881,Positif,6.5,HEM091 3M3+,1571.1,1093,615.8,Multiple myeloma,Multiple myeloma 2016 + autoHSC 2017,"VTD 2016, Revlimid 2017-2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Revlimid,Revlimid,L04AX04,L04AX04
HEM092,F,45.2,Pfizer,V3,33,NA,NA,V5-V6,NA,NA,28/avr/2021,Négatif,3.7,NA,NA,NA,HEM092V3b,1,1,1,Other lymphoma,grey zone mediastinal lymphoma GZML 2014 + autoHSC 2015,"R-ACVBP + MTX HD 2014, R-Iphos/VP16 + ARA-C 2014, R ICE, BEAM 2015",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,MTX,L04AX03,"NA"
HEM092,F,45.2,Pfizer,V4,94,NA,NA,V5-V6,NA,NA,28/jun/2021,Négatif,1.8,NA,Négatif,0,HEM092V4b,1,1,1,Other lymphoma,grey zone mediastinal lymphoma GZML 2014 + autoHSC 2015,"R-ACVBP + MTX HD 2014, R-Iphos/VP16 + ARA-C 2014, R ICE, BEAM 2015",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,MTX,L04AX03,"NA"
HEM092,F,45.2,Pfizer,V5,186,35,NA,V5-V6,NA,NA,28/sep/2021,Négatif,1.4,NA,Négatif,0,HEM092V5b,1,1,1,Other lymphoma,grey zone mediastinal lymphoma GZML 2014 + autoHSC 2015,"R-ACVBP + MTX HD 2014, R-Iphos/VP16 + ARA-C 2014, R ICE, BEAM 2015",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,MTX,L04AX03,"NA"
HEM092,F,45.2,Pfizer,V6,378,227,NA,V5-V6,141,NA,08/avr/2022,Positif,116.4,3496,Négatif,0,HEM092V6,2430,2430,4.8,Other lymphoma,grey zone mediastinal lymphoma GZML 2014 + autoHSC 2015,"R-ACVBP + MTX HD 2014, R-Iphos/VP16 + ARA-C 2014, R ICE, BEAM 2015",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,MTX,L04AX03,"NA"
HEM093,F,65.3,Pfizer,V3,28,NA,NA,V5-V6,NA,NA,02/jun/2021,Négatif,3.4,NA,NA,NA,HEM093V3b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab Ongoing, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM093,F,65.3,Pfizer,V4,92,NA,NA,V5-V6,NA,NA,05/aoû/2021,Négatif,3.4,NA,Négatif,0.2,HEM093V4b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab Ongoing, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM093,F,65.3,Pfizer,V5,183,10,NA,V5-V6,NA,NA,04/nov/2021,Négatif,3.7,NA,Négatif,0.2,HEM093V5b,1,1,1,Follicular lymphoma,Follicular LNH,"Rituximab Ongoing, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM093,F,65.3,Pfizer,V6,364,191,NA,V5-V6,64,NA,04/mai/2022,Positif,104.6,2827,Négatif,0.1,HEM093 V6,138.33171946327292,116.23852144600721,53.24813631522896,Follicular lymphoma,Follicular LNH,"Rituximab Ongoing, R-CHOP",anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM094,F,78.2,Moderna,V3,33,NA,NA,NA,NA,NA,04/mai/2021,Négatif,0.8,NA,NA,NA,HEM094V3b,1,1,1,Diffuse large B cell lymphoma,DLBCL 2015 EBV+,Ongoing Rituximab Pour Sa PR,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM094,F,78.2,Moderna,V4,97,NA,NA,NA,NA,NA,07/jui/2021,Négatif,0.5,NA,Négatif,0.7,HEM094V4b,1,1,1,Diffuse large B cell lymphoma,DLBCL 2015 EBV+,Ongoing Rituximab Pour Sa PR,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM094,F,78.2,Moderna,V5,188,7,NA,NA,NA,NA,06/oct/2021,Négatif,0.4,NA,Négatif,0.2,HEM094V5b,1,1,1,Diffuse large B cell lymphoma,DLBCL 2015 EBV+,Ongoing Rituximab Pour Sa PR,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM094,F,78.2,Moderna,3M3,299,118,NA,NA,NA,NA,25/jan/2022,Positif,50.3,664,Négatif,0.6,HEM094 3M3,13.6,6.6,6.7,Diffuse large B cell lymphoma,DLBCL 2015 EBV+,Ongoing Rituximab Pour Sa PR,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM094,F,78.2,Moderna,3M6,368,187,NA,NA,NA,NA,04/avr/2022,Positif,36,344,Négatif,0.4,HEM094 3M6,23.2,12.2,10.7,Diffuse large B cell lymphoma,DLBCL 2015 EBV+,Ongoing Rituximab Pour Sa PR,anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM095,M,72.2,Moderna,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,12.8,NA,NA,NA,HEM095V3b,16.4,17,11.4,Other lymphoma,Mantle cell lymphoma 2015,Previous Rituximab,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM095,M,72.2,Moderna,V4,96,NA,NA,NA,NA,NA,05/jui/2021,Positif,9.7,NA,Négatif,0.1,HEM095V4b,1,1,1,Other lymphoma,Mantle cell lymphoma 2015,Previous Rituximab,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM095,M,72.2,Moderna,V5,188,NA,NA,NA,NA,NA,05/oct/2021,Positif,7.8,NA,Négatif,0.1,HEM095V5b,1,1,1,Other lymphoma,Mantle cell lymphoma 2015,Previous Rituximab,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM095,M,72.2,Moderna,3M3,336,84,NA,NA,NA,NA,02/mar/2022,Indéterminé,5.6,11,Négatif,0,HEM095 V6,1,1,1,Other lymphoma,Mantle cell lymphoma 2015,Previous Rituximab,anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab,L01FA01,L01FA01
HEM096,F,51.3,Moderna,V3,33,NA,NA,NA,NA,NA,05/mai/2021,Positif,83.1,NA,NA,NA,HEM096V3b,1895.7,610.5,171.4,CML,CML 2018,"Litalir 2018, Nilotinib 2018, Dasatininb Since 2018",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Nilotinib,Nilotinib,L01EA03,L01EA03
HEM096,F,51.3,Moderna,V4,96,NA,NA,NA,NA,NA,07/jui/2021,Positif,104.7,NA,Négatif,0.1,HEM096V4b,1002.6,455.2,104.4,CML,CML 2018,"Litalir 2018, Nilotinib 2018, Dasatininb Since 2018",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Nilotinib,Nilotinib,L01EA03,L01EA03
HEM096,F,51.3,Moderna,V5,195,NA,NA,NA,NA,NA,14/oct/2021,Positif,80.7,NA,Négatif,0.3,HEM096V5b,1050.1,414.4,126.5,CML,CML 2018,"Litalir 2018, Nilotinib 2018, Dasatininb Since 2018",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Nilotinib,Nilotinib,L01EA03,L01EA03
HEM096,F,51.3,Moderna,3M3,353,84,NA,NA,NA,NA,21/mar/2022,Positif,66.7,1158,Positif,20.3,HEM096 3M3,18968.1,10441.7,9000.9,CML,CML 2018,"Litalir 2018, Nilotinib 2018, Dasatininb Since 2018",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Nilotinib,Nilotinib,L01EA03,L01EA03
HEM097,F,54.4,Pfizer,V3,28,NA,NA,NA,NA,NA,08/jun/2021,Positif,96.2,NA,NA,NA,HEM097V3b,523,206.6,62.7,Follicular lymphoma,follicular lymphoma 2015,"R-CHOP 2015,RTX 2016-2018",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM097,F,54.4,Pfizer,V4,92,NA,NA,NA,NA,NA,11/aoû/2021,Positif,69.2,NA,Négatif,0.1,HEM097V4b,134.8,65.9,25.2,Follicular lymphoma,follicular lymphoma 2015,"R-CHOP 2015,RTX 2016-2018",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM097,F,54.4,Pfizer,V5,181,NA,NA,NA,NA,NA,08/nov/2021,Positif,54.5,NA,Négatif,0.2,HEM097V5b,106.1,73.2,38.3,Follicular lymphoma,follicular lymphoma 2015,"R-CHOP 2015,RTX 2016-2018",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM097,F,54.4,Pfizer,3M3,315,96,NA,NA,NA,NA,22/mar/2022,Positif,93,2238,Négatif,0,HEM097 3M3,170.8,89,62,Follicular lymphoma,follicular lymphoma 2015,"R-CHOP 2015,RTX 2016-2018",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,RTX,L01FA01,"NA"
HEM098,F,63.4,Moderna,3M3,349,115,NA,NA,NA,NA,09/mai/2022,Positif,166.9,7170,Négatif,0,HEM098 3M3,1102.1712774165105,484.73097430925833,319.79533098816756,Other lymphoma,NK/T nasal PTCLNO,"SMILE, ASCT 2017",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,,"NA","NA"
HEM099,F,60.3,Pfizer,V3,28,NA,NA,NA,NA,NA,17/mai/2021,Positif,102.9,NA,NA,NA,HEM099V3b,745.2,361.5,91,AML,AML 2018 + alloHSC 2018,"Ida- Cytara-Midostaurine 2018, ATG, MMF, Tacrolimus, SorafÉNib 2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Midostaurin|Tacrolimus,Midostaurin|MMF|SorafÉNib,L01EX10|L04AA06|L01EX02,L01XE|L04AD02
HEM099,F,60.3,Pfizer,V4,98,NA,NA,NA,NA,NA,26/jui/2021,Positif,85,NA,Négatif,0.3,HEM099V4b,268.1,164,34.6,AML,AML 2018 + alloHSC 2018,"Ida- Cytara-Midostaurine 2018, ATG, MMF, Tacrolimus, SorafÉNib 2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Midostaurin|Tacrolimus,Midostaurin|MMF|SorafÉNib,L01EX10|L04AA06|L01EX02,L01XE|L04AD02
HEM099,F,60.3,Pfizer,V5,189,NA,NA,NA,NA,NA,25/oct/2021,Positif,70.5,NA,Négatif,0.3,HEM099V5b,225.2,135.4,36.4,AML,AML 2018 + alloHSC 2018,"Ida- Cytara-Midostaurine 2018, ATG, MMF, Tacrolimus, SorafÉNib 2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Midostaurin|Tacrolimus,Midostaurin|MMF|SorafÉNib,L01EX10|L04AA06|L01EX02,L01XE|L04AD02
HEM099,F,60.3,Pfizer,3M3,372,109,NA,NA,NA,NA,26/avr/2022,Positif,157.7,6403,Positif,11,HEM099 3M3,2430,2188.2,663.1,AML,AML 2018 + alloHSC 2018,"Ida- Cytara-Midostaurine 2018, ATG, MMF, Tacrolimus, SorafÉNib 2019",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Midostaurin|Tacrolimus,Midostaurin|MMF|SorafÉNib,L01EX10|L04AA06|L01EX02,L01XE|L04AD02
HEM100,F,70.2,Pfizer,3M3,358,107,NA,NA,NA,NA,10/mar/2022,Positif,106.2,2913,Négatif,0,HEM100 3M3,636.9,332.3,122.1,AML,Acute myeloid leukemia,Cladribine-Cytarabine 2017; Hi Dose Cytarabine 2017; Mitoxantrone-Etoposide 2017.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Cladribine,Cladribine|Cytarabine|Mitoxantrone|Etoposide,L01BB04|L01BC01|L01DB07|L01CB01,L04AA40
HEM101,M,43.3,Moderna,V6,390,166,NA,NA,NA,NA,25/mai/2022,Positif,154.6,6154,Positif,6.1,HEM101V6,2430,1733.7,786.8,Multiple myeloma,MM,"Velcade Revlimid Dexa , Pomalidomide-Cyclophosphamide, ASCT 2016",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Velcade|Revlimid|Pomalidomide,Velcade|Revlimid|Dexa|Pomalidomide|Cyclophosphamide,L01XG01|L04AX04|H02AB02|L04AX06|L01AA01,L01XG01|L04AX04|L04AX06
HEM102,M,69.4,Pfizer,V3,30,NA,NA,NA,NA,NA,08/jui/2021,Positif,63.4,NA,Négatif,0.1,HEM102V3b,200.2,40.4,10.3,CLL,CLL,Ibrutinib,BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,Ibrutinib,L01EL01,L01EL01
HEM102,M,69.4,Pfizer,V4,92,NA,NA,NA,NA,NA,08/sep/2021,Positif,30.8,NA,Négatif,0.2,HEM102V4b,106.4,43.7,10.2,CLL,CLL,Ibrutinib,BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,Ibrutinib,L01EL01,L01EL01
HEM102,M,69.4,Pfizer,V5,189,NA,NA,NA,NA,NA,14/déc/2021,Positif,17.4,85,Négatif,0.2,HEM102V5b,79.2,35.2,6.2,CLL,CLL,Ibrutinib,BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,Ibrutinib,L01EL01,L01EL01
HEM102,M,69.4,Pfizer,3M3,315,106,NA,NA,NA,NA,19/avr/2022,Positif,73.6,1407,Négatif,0,HEM102 3M3,258.2,129.1,26.2,CLL,CLL,Ibrutinib,BTK inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Ibrutinib,Ibrutinib,L01EL01,L01EL01
HEM103,F,74.3,Moderna,V3,29,NA,NA,NA,NA,NA,28/mai/2021,Positif,80.2,NA,NA,NA,HEM103V3b,1909.5,725.7,133,Diffuse large B cell lymphoma,DLBCL,"> 1 Year Rituximab, CHOP, High Dose MTX",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|MTX,L01FA01|L04AX03,L01FA01
HEM103,F,74.3,Moderna,V4,91,NA,NA,NA,NA,NA,29/jui/2021,Positif,76.9,NA,Négatif,0,HEM103V4b,854,387.9,68.8,Diffuse large B cell lymphoma,DLBCL,"> 1 Year Rituximab, CHOP, High Dose MTX",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|MTX,L01FA01|L04AX03,L01FA01
HEM103,F,74.3,Moderna,V5,175,NA,NA,NA,NA,NA,21/oct/2021,Positif,83.2,NA,Négatif,0,HEM103V5b,351.2,173.7,54.5,Diffuse large B cell lymphoma,DLBCL,"> 1 Year Rituximab, CHOP, High Dose MTX",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|MTX,L01FA01|L04AX03,L01FA01
HEM103,F,74.3,Moderna,V6,363,NA,NA,NA,NA,NA,27/avr/2022,Positif,106.7,2941,Positif,13.8,HEM103V6,2430,2430,2430,Diffuse large B cell lymphoma,DLBCL,"> 1 Year Rituximab, CHOP, High Dose MTX",anti-CD20 therapy (> 1 year) (375 mg/m2),No,anti-CD20 therapy>365 days,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Rituximab,Rituximab|MTX,L01FA01|L04AX03,L01FA01
HEM104,M,50.5,Pfizer,V3,32,NA,NA,BEFORE V1 + 3M3-3M6,244,NA,16/jui/2021,Positif,74.3,NA,Négatif,1.5,HEM104V3,121.7,31.5,12.9,Multiple myeloma,MM,"Dexamethasone 40mg Per Week, Velcade Stop , Revlimid , Daratumumab",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dexamethasone|Velcade|Revlimid|Daratumumab,Dexamethasone|Velcade|Revlimid|Daratumumab,H02AB02|L01XG01|L04AX04|L01FC01,S01BA01|L01XG01|L04AX04|L01FC01
HEM104,M,50.5,Pfizer,3M3,260,92,NA,BEFORE V1 + 3M3-3M6,472,NA,01/mar/2022,Positif,94.9,2330,Indéterminé,4.7,HEM104 3M3,490,162.8,167.3,Multiple myeloma,MM,"Dexamethasone 40mg Per Week, Velcade Stop , Revlimid , Daratumumab",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dexamethasone|Velcade|Revlimid|Daratumumab,Dexamethasone|Velcade|Revlimid|Daratumumab,H02AB02|L01XG01|L04AX04|L01FC01,S01BA01|L01XG01|L04AX04|L01FC01
HEM104,M,50.5,Pfizer,3M6,351,183,NA,BEFORE V1 + 3M3-3M6,563,53,31/mai/2022,Positif,124.5,3997,Positif,12,HEM104 3M6,941.6,422.7,269.4,Multiple myeloma,MM,"Dexamethasone 40mg Per Week, Velcade Stop , Revlimid , Daratumumab",Immunomodulator drugs IMIDs,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dexamethasone|Velcade|Revlimid|Daratumumab,Dexamethasone|Velcade|Revlimid|Daratumumab,H02AB02|L01XG01|L04AX04|L01FC01,S01BA01|L01XG01|L04AX04|L01FC01
HEM106,F,47.5,Pfizer,V4,98,NA,NA,V5-V6,NA,NA,08/oct/2021,Positif,56.8,NA,Négatif,0.5,HEM106V4b,135.7,70.4,25.5,CML,LMC,"Imetinib, Dasatinib, Nilotinib 2011-Stop 2017",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dasatinib|Nilotinib,Imetinib|Dasatinib|Nilotinib,L01EA01|L01EA02|L01EA03,L01EA02|L01EA03
HEM106,F,47.5,Pfizer,V5,189,NA,NA,V5-V6,NA,NA,07/jan/2022,Positif,30.6,251,Négatif,0.9,HEM106V5,59.4,34.3,18.8,CML,LMC,"Imetinib, Dasatinib, Nilotinib 2011-Stop 2017",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dasatinib|Nilotinib,Imetinib|Dasatinib|Nilotinib,L01EA01|L01EA02|L01EA03,L01EA02|L01EA03
HEM106,F,47.5,Pfizer,V5+,243,NA,NA,V5-V6,28,NA,02/mar/2022,Positif,93.6,2267,Négatif,3.1,HEM106V5+,1582.3,825.1,343.3,CML,LMC,"Imetinib, Dasatinib, Nilotinib 2011-Stop 2017",Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Dasatinib|Nilotinib,Imetinib|Dasatinib|Nilotinib,L01EA01|L01EA02|L01EA03,L01EA02|L01EA03
HEM107,F,75.4,Pfizer,V3,32,NA,NA,NA,NA,NA,09/jui/2021,Positif,12.2,NA,Négatif,0.3,HEM107V3b,9.1,4.2,2.9,Other leukemia,"Leucémie lymphoblastique aiguë B, LLA-B,  NOS, LLA B-2 selon EGIL (common ALL)","ChimiothÉRapie D'Induction Le 19.08.2019 Selon GRAALL 2014, 3 Cures Blinatumomab 2019, Maintenance DÈS Le 12.02.2020 Par Methotrexate 20mg 1x/Semaine, PurinÉThol (Mercaptopurine) 100mg Les Jours Paires En Alternance Avec 50mg Les Jours Impaires, Prednison",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Blinatumomab|Methotrexate|Mercaptopurine,Blinatumomab|Methotrexate|PurinÉThol|Mercaptopurine|Pred,L01FX07|L04AX03|L01BB02|H02AB07,L01FX07|L04AX03|L01BB02
HEM107,F,75.4,Pfizer,V4,93,NA,NA,NA,NA,NA,08/sep/2021,Positif,10.1,NA,Négatif,0.6,HEM107V4b,12.3,7.6,3.4,Other leukemia,"Leucémie lymphoblastique aiguë B, LLA-B,  NOS, LLA B-2 selon EGIL (common ALL)","ChimiothÉRapie D'Induction Le 19.08.2019 Selon GRAALL 2014, 3 Cures Blinatumomab 2019, Maintenance DÈS Le 12.02.2020 Par Methotrexate 20mg 1x/Semaine, PurinÉThol (Mercaptopurine) 100mg Les Jours Paires En Alternance Avec 50mg Les Jours Impaires, Prednison",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Blinatumomab|Methotrexate|Mercaptopurine,Blinatumomab|Methotrexate|PurinÉThol|Mercaptopurine|Pred,L01FX07|L04AX03|L01BB02|H02AB07,L01FX07|L04AX03|L01BB02
HEM107,F,75.4,Pfizer,V5,197,11,NA,NA,NA,NA,21/déc/2021,Positif,110.6,3158,Négatif,0.7,HEM107V5b,1,1,1,Other leukemia,"Leucémie lymphoblastique aiguë B, LLA-B,  NOS, LLA B-2 selon EGIL (common ALL)","ChimiothÉRapie D'Induction Le 19.08.2019 Selon GRAALL 2014, 3 Cures Blinatumomab 2019, Maintenance DÈS Le 12.02.2020 Par Methotrexate 20mg 1x/Semaine, PurinÉThol (Mercaptopurine) 100mg Les Jours Paires En Alternance Avec 50mg Les Jours Impaires, Prednison",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Blinatumomab|Methotrexate|Mercaptopurine,Blinatumomab|Methotrexate|PurinÉThol|Mercaptopurine|Pred,L01FX07|L04AX03|L01BB02|H02AB07,L01FX07|L04AX03|L01BB02
HEM107,F,75.4,Pfizer,3M3,274,88,NA,NA,NA,NA,08/mar/2022,Positif,84.1,1833,Négatif,0.3,HEM107 3M3,1124.4,333.8,233.3,Other leukemia,"Leucémie lymphoblastique aiguë B, LLA-B,  NOS, LLA B-2 selon EGIL (common ALL)","ChimiothÉRapie D'Induction Le 19.08.2019 Selon GRAALL 2014, 3 Cures Blinatumomab 2019, Maintenance DÈS Le 12.02.2020 Par Methotrexate 20mg 1x/Semaine, PurinÉThol (Mercaptopurine) 100mg Les Jours Paires En Alternance Avec 50mg Les Jours Impaires, Prednison",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,HEM,Blinatumomab|Methotrexate|Mercaptopurine,Blinatumomab|Methotrexate|PurinÉThol|Mercaptopurine|Pred,L01FX07|L04AX03|L01BB02|H02AB07,L01FX07|L04AX03|L01BB02
HEM108,M,62.6,Pfizer,V5,180,NA,NA,NA,NA,NA,14/fév/2022,Positif,46.8,576,Négatif,0.4,HEM108V5,40.6,21.3,12.5,AML,Leucémie myéloïde aiguë LMA NPM1 positive,ChimiothÉRapie D’Induction Par Idarubicine Et Cytarabine En 2018 + Consolidation Par Etoposide Et Mitoxantrone En 2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,HEM,,Idarubicin|Cytarabine|Etoposide|Mitoxantrone,L01DB06|L01BC01|L01CB01|L01DB07,"NA"
HEM109,F,32.1,Pfizer,V3,29,NA,NA,NA,NA,NA,11/mar/2022,Positif,53.6,752,Négatif,0.1,HEM109V3,56.7,30.8,14.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HEM,"NA","NA","NA","NA"
HEM109,F,32.1,Pfizer,V4,89,NA,NA,NA,NA,NA,10/mai/2022,Positif,35.6,337,Négatif,0.1,HEM109 V4,35.1493848857645,19.022256039566294,16.608536787908985,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HEM,"NA","NA","NA","NA"
IAL001,M,39.1,Pfizer/Moderna,V3,30,NA,4th dose: 20.01.2022,NA,NA,NA,25/mar/2021,Négatif,2.6,NA,NA,NA,IAL001V3b,1,1,1,Sjoegren's syndrome,Lung transplant (Sjoegren's syndrome),"Prednisone 12.5mg, Advagraf 4mg, Myfortic 720mg X 2",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Advagraf,Prednisone|Advagraf|Myfortic,H02AB07|L04AD02|L04AA06,L04AD02
IAL001,M,39.1,Pfizer/Moderna,V4,91,NA,4th dose: 20.01.2022,NA,NA,NA,25/mai/2021,Indéterminé,5.3,NA,NA,NA,IAL001V4b,1,1,1,Sjoegren's syndrome,Lung transplant (Sjoegren's syndrome),"Prednisone 12.5mg, Advagraf 4mg, Myfortic 720mg X 2",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Advagraf,Prednisone|Advagraf|Myfortic,H02AB07|L04AD02|L04AA06,L04AD02
IAL001,M,39.1,Pfizer/Moderna,V5,183,19,4th dose: 20.01.2022,NA,NA,NA,25/aoû/2021,Positif,8.9,NA,Négatif,2.1,IAL001V5b,1,1,1,Sjoegren's syndrome,Lung transplant (Sjoegren's syndrome),"Prednisone 12.5mg, Advagraf 4mg, Myfortic 720mg X 2",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Advagraf,Prednisone|Advagraf|Myfortic,H02AB07|L04AD02|L04AA06,L04AD02
IAL001,M,39.1,Pfizer/Moderna,3M6,357,193,4th dose: 20.01.2022,NA,NA,NA,15/fév/2022,Positif,33.7,303,Négatif,1,IAL001 3M6b,86.2,35.7,23.5,Sjoegren's syndrome,Lung transplant (Sjoegren's syndrome),"Prednisone 12.5mg, Advagraf 4mg, Myfortic 720mg X 2",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Advagraf,Prednisone|Advagraf|Myfortic,H02AB07|L04AD02|L04AA06,L04AD02
IAL001,M,39.1,Pfizer/Moderna,3M9,442,278,4th dose: 20.01.2022,NA,NA,NA,11/mai/2022,Positif,140.2,5064,Indéterminé,5.6,IAL001 3M9,307.8817733990148,164.14970453053184,84.53085376162299,Sjoegren's syndrome,Lung transplant (Sjoegren's syndrome),"Prednisone 12.5mg, Advagraf 4mg, Myfortic 720mg X 2",CNI+ IMDHIs,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Advagraf,Prednisone|Advagraf|Myfortic,H02AB07|L04AD02|L04AA06,L04AD02
IAL002,F,42.1,Pfizer,V3,28,NA,NA,NA,NA,NA,15/mar/2021,Positif,82.4,NA,NA,NA,IAL002V3b,33.2,5,1.5,Uveitis,Refractory uveitis (Vogt-Harada-Koyanagi),Humira 40mg/2 Semaines,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira,L04AB04,L04AB04
IAL002,F,42.1,Pfizer,V4,91,NA,NA,NA,NA,NA,17/mai/2021,Positif,27.3,NA,NA,NA,IAL002V4b,6.3,13.1,1,Uveitis,Refractory uveitis (Vogt-Harada-Koyanagi),Humira 40mg/2 Semaines,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira,L04AB04,L04AB04
IAL002,F,42.1,Pfizer,V5,189,NA,NA,NA,NA,NA,23/aoû/2021,Positif,12.3,NA,Négatif,0.7,IAL002V5b,1,1,1,Uveitis,Refractory uveitis (Vogt-Harada-Koyanagi),Humira 40mg/2 Semaines,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira,L04AB04,L04AB04
IAL002,F,42.1,Pfizer,3M3,378,87,NA,NA,NA,NA,28/fév/2022,Positif,58.6,897,Négatif,1,IAL002 3M3,80.4,59.9,36.1,Uveitis,Refractory uveitis (Vogt-Harada-Koyanagi),Humira 40mg/2 Semaines,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira,L04AB04,L04AB04
IAL003,F,71.1,Pfizer,V3,31,NA,NA,NA,NA,NA,15/mar/2021,Positif,114.7,NA,NA,NA,IAL003V3b,166.2,73.7,11.3,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL003,F,71.1,Pfizer,V4,89,NA,NA,NA,NA,NA,12/mai/2021,Positif,121.8,NA,NA,NA,IAL003V4b,127.4,11.8,26.4,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL003,F,71.1,Pfizer,V5,180,NA,NA,NA,NA,NA,11/aoû/2021,Positif,45,NA,Négatif,0.2,IAL003V5b,105.1,80.6,22.4,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL003,F,71.1,Pfizer,3M3,383,91,NA,NA,NA,NA,02/mar/2022,Positif,93.2,2247,Négatif,0.1,IAL003 3M3,352,207.1,107.8,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL003,F,71.1,Pfizer,3M6,473,181,NA,NA,NA,NA,31/mai/2022,Positif,95.5,2359,Négatif,0.3,IAL003 3M6,194.6,115.3,68.3,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL005,F,81.1,Pfizer,V3,28,NA,NA,NA,NA,NA,16/mar/2021,Positif,42,NA,NA,NA,IAL005V3b,13.8,1,0.6,Vasculitis,Granulomatosis with polyangeitis; secondary hypogammaglobulinemia after RTX (last dose 05.01.2016),Prednisone 3mg/Jour;,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL005,F,81.1,Pfizer,V4,92,NA,NA,NA,NA,NA,19/mai/2021,Positif,25.1,NA,NA,NA,IAL005V4b,48.6,26.4,18.9,Vasculitis,Granulomatosis with polyangeitis; secondary hypogammaglobulinemia after RTX (last dose 05.01.2016),Prednisone 3mg/Jour;,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL005,F,81.1,Pfizer,V5,181,NA,NA,NA,NA,NA,16/aoû/2021,Positif,9,NA,Négatif,0.1,IAL005V5b,1,1,1,Vasculitis,Granulomatosis with polyangeitis; secondary hypogammaglobulinemia after RTX (last dose 05.01.2016),Prednisone 3mg/Jour;,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL005,F,81.1,Pfizer,V6,366,171,NA,NA,NA,NA,17/fév/2022,Positif,33.5,299,Négatif,0.2,IAL005V6,68.2,32.7,25.8,Vasculitis,Granulomatosis with polyangeitis; secondary hypogammaglobulinemia after RTX (last dose 05.01.2016),Prednisone 3mg/Jour;,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL006,F,43.2,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,19/avr/2021,Positif,119.5,NA,NA,NA,IAL006V3b,380.2,91.4,37.9,SLE,Systemic lupus with cervical myelitis,Azathioprine 125mg; Hydroxychloroquine 300mg,IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine|Hydroxychloroquine,L04AX01|P01BA02,L04AX01
IAL006,F,43.2,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,23/jun/2021,Positif,98.9,NA,Négatif,0.6,IAL006V4b,202.3,86.9,52.5,SLE,Systemic lupus with cervical myelitis,Azathioprine 125mg; Hydroxychloroquine 300mg,IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine|Hydroxychloroquine,L04AX01|P01BA02,L04AX01
IAL006,F,43.2,Pfizer,V5,194,NA,NA,V5-3M3,NA,NA,28/sep/2021,Positif,51.9,NA,Négatif,0.3,IAL006V5b,110.5,66.6,25.4,SLE,Systemic lupus with cervical myelitis,Azathioprine 125mg; Hydroxychloroquine 300mg,IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine|Hydroxychloroquine,L04AX01|P01BA02,L04AX01
IAL006,F,43.2,Pfizer,3M3,382,119,NA,V5-3M3,41,NA,04/avr/2022,Positif,97.1,2438,Négatif,1.7,IAL006 3M3,1446.1,620.7,697.4,SLE,Systemic lupus with cervical myelitis,Azathioprine 125mg; Hydroxychloroquine 300mg,IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine|Hydroxychloroquine,L04AX01|P01BA02,L04AX01
IAL007,M,61.3,Pfizer,V3,30,NA,NA,NA,NA,NA,06/mai/2021,Positif,55,NA,NA,NA,IAL007V3b,63.9,51.3,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy and Crohn's disease,Prednisone 5mg; Methotrexate 15mg; Adalimumab 40mg,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Adalimumab,Prednisone|Methotrexate|Adalimumab,H02AB07|L04AX03|L04AB04,L04AX03|L04AB04
IAL007,M,61.3,Pfizer,V4,91,NA,NA,NA,NA,NA,06/jui/2021,Positif,19.6,NA,Négatif,0.2,IAL007V4b,63.6,67.7,6.4,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy and Crohn's disease,Prednisone 5mg; Methotrexate 15mg; Adalimumab 40mg,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Adalimumab,Prednisone|Methotrexate|Adalimumab,H02AB07|L04AX03|L04AB04,L04AX03|L04AB04
IAL007,M,61.3,Pfizer,V5,182,NA,NA,NA,NA,NA,05/oct/2021,Indéterminé,4.4,NA,Négatif,0.1,IAL007V5b,49.9,65.1,2.9,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy and Crohn's disease,Prednisone 5mg; Methotrexate 15mg; Adalimumab 40mg,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Adalimumab,Prednisone|Methotrexate|Adalimumab,H02AB07|L04AX03|L04AB04,L04AX03|L04AB04
IAL008,F,35.2,Pfizer,V3,33,NA,NA,3M3-3M6,NA,NA,19/avr/2021,Positif,27.6,NA,NA,NA,IAL008V3b,47.3,4.8,1.7,Systemic sclerosis,Systemic sclerosis (dcSSc),Prednisone 5mg; MMF 3000mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|MMF,H02AB07|L04AA06,"NA"
IAL008,F,35.2,Pfizer,V4,96,NA,NA,3M3-3M6,NA,NA,21/jun/2021,Positif,31.2,NA,Négatif,1.9,IAL008V4b,37.5,9.6,5.8,Systemic sclerosis,Systemic sclerosis (dcSSc),Prednisone 5mg; MMF 3000mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|MMF,H02AB07|L04AA06,"NA"
IAL008,F,35.2,Pfizer,V5,183,NA,NA,3M3-3M6,NA,NA,16/sep/2021,Positif,26.6,NA,Négatif,1.3,IAL008V5b,1,1,1,Systemic sclerosis,Systemic sclerosis (dcSSc),Prednisone 5mg; MMF 3000mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|MMF,H02AB07|L04AA06,"NA"
IAL008,F,35.2,Pfizer,3M3,275,85,NA,3M3-3M6,NA,NA,17/déc/2021,Positif,101.7,2673,Négatif,2.1,IAL008 3M3b,138.6,41.7,9.1,Systemic sclerosis,Systemic sclerosis (dcSSc),Prednisone 5mg; MMF 3000mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|MMF,H02AB07|L04AA06,"NA"
IAL008,F,35.2,Pfizer,3M6,373,183,NA,3M3-3M6,17,NA,25/mar/2022,Positif,91.2,2153,Indéterminé,4.5,IAL008 3M6,2352.4,1228.8,730.5,Systemic sclerosis,Systemic sclerosis (dcSSc),Prednisone 5mg; MMF 3000mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|MMF,H02AB07|L04AA06,"NA"
IAL009,F,56.1,Pfizer,V3,27,NA,NA,V5-V6,NA,NA,03/mar/2021,Positif,124.5,NA,NA,NA,IAL009V3b,746.8,245.3,86.9,Sjoegren's syndrome,Sjoegren's syndrome,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL009,F,56.1,Pfizer,V4,89,NA,NA,V5-V6,NA,NA,04/mai/2021,Positif,107.6,NA,NA,NA,IAL009V4b,245.2,135.3,37.8,Sjoegren's syndrome,Sjoegren's syndrome,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL009,F,56.1,Pfizer,V5,195,NA,NA,V5-V6,NA,NA,18/aoû/2021,Positif,45.5,NA,Négatif,1.9,IAL009V5b,124,63.1,29,Sjoegren's syndrome,Sjoegren's syndrome,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL009,F,56.1,Pfizer,V5+,312,NA,NA,V5-V6,28,NA,13/déc/2021,Positif,100.6,2616,Positif,8.1,IAL009V5+,1853.9,983.3,471.7,Sjoegren's syndrome,Sjoegren's syndrome,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL009,F,56.1,Pfizer,V6,361,NA,NA,V5-V6,77,NA,31/jan/2022,Positif,103.7,2778,Positif,6,IAL009V6,1699.5,769.2,295.2,Sjoegren's syndrome,Sjoegren's syndrome,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL010,M,27.2,Moderna,V3,31,NA,NA,V5-V6,NA,NA,29/avr/2021,Positif,104.3,NA,NA,NA,IAL010V3b,859.1,305.8,107.4,Sarcoidosis,Neurosarcoidosis,Prednisone 15mg; Methotrexate 15mg; Infliximab 5mg/Kg 26.02. And 12.03.2021,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL010,M,27.2,Moderna,V4,92,NA,NA,V5-V6,NA,NA,29/jun/2021,Positif,82.5,NA,Négatif,0.5,IAL010V4b,143.2,66.4,23.6,Sarcoidosis,Neurosarcoidosis,Prednisone 15mg; Methotrexate 15mg; Infliximab 5mg/Kg 26.02. And 12.03.2021,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL010,M,27.2,Moderna,V5,184,NA,NA,V5-V6,NA,NA,29/sep/2021,Positif,59.7,NA,Négatif,0.5,IAL010V5b,171.9,90.9,43,Sarcoidosis,Neurosarcoidosis,Prednisone 15mg; Methotrexate 15mg; Infliximab 5mg/Kg 26.02. And 12.03.2021,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL010,M,27.2,Moderna,V6,358,NA,NA,V5-V6,91,NA,22/mar/2022,Positif,93.9,2281,Négatif,1.4,IAL010V6,1429.2,1006.3,332.1,Sarcoidosis,Neurosarcoidosis,Prednisone 15mg; Methotrexate 15mg; Infliximab 5mg/Kg 26.02. And 12.03.2021,bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL011,M,71.2,Moderna,V3,28,NA,NA,3M3-3M6,NA,NA,28/avr/2021,Positif,106.9,NA,NA,NA,IAL011V3b,592.4,260.7,46.1,CVID,CVID (IgG subclass deficiency),"Privigen 17.12.2020; 21.01, 04.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL011,M,71.2,Moderna,V4,91,NA,NA,3M3-3M6,NA,NA,30/jun/2021,Positif,77.3,NA,Négatif,0.3,IAL011V4b,168.1,95.8,25.5,CVID,CVID (IgG subclass deficiency),"Privigen 17.12.2020; 21.01, 04.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL011,M,71.2,Moderna,V5,183,NA,NA,3M3-3M6,NA,NA,30/sep/2021,Positif,48.6,NA,Négatif,0.7,IAL011V5b,128.6,95,31,CVID,CVID (IgG subclass deficiency),"Privigen 17.12.2020; 21.01, 04.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL011,M,71.2,Moderna,3M3,309,85,NA,3M3-3M6,NA,NA,03/fév/2022,Positif,108.6,3046,Négatif,0.6,IAL011 3M3,615.8,240.1,103.5,CVID,CVID (IgG subclass deficiency),"Privigen 17.12.2020; 21.01, 04.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL011,M,71.2,Moderna,3M6,393,169,NA,3M3-3M6,68,NA,28/avr/2022,Positif,131.3,4444,Positif,7.6,IAL011 3M6,2430,1579.5,1182.2,CVID,CVID (IgG subclass deficiency),"Privigen 17.12.2020; 21.01, 04.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,V3,28,NA,NA,NA,NA,NA,16/mar/2021,Indéterminé,5,NA,NA,NA,IAL012V3b,1,1,1,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,V4,90,NA,NA,NA,NA,NA,17/mai/2021,Positif,13.3,NA,NA,NA,IAL012V4b,1.7,2.4,0.2,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,V5,181,NA,NA,NA,NA,NA,16/aoû/2021,Indéterminé,5.2,NA,Négatif,1.8,IAL012V5b,1,1,1,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,3M3,300,112,NA,NA,NA,NA,13/déc/2021,Positif,21.9,131,Indéterminé,4.2,IAL012 3M3b,6.5,1,1,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,3M6,357,169,NA,NA,NA,NA,08/fév/2022,Positif,12.8,48,Négatif,1.9,IAL012 3M6,21,14.1,5.1,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL012,M,53.1,Pfizer,3M9,469,281,NA,NA,NA,NA,31/mai/2022,Positif,72.5,1366,Négatif,1.7,IAL012 3M9,115.7,53.9,26,Secondary immunodeficiency,"Secondary immunodeficiency (HIV, post-chimio for Burkitt's lymphoma, CVID not excluded)","Privigen 14.12.2020; 11.01, 09.02, 09.03, 06.04.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL013,M,52.2,Pfizer,V3,33,NA,NA,NA,NA,NA,20/avr/2021,Positif,115.6,NA,NA,NA,IAL013V3b,265.3,84.9,19.5,Vasculitis,"Eosinophilic granulomatosis with polyangiitis (prior treatement with CYC, rituximab - last dose VII/2017)",Mepolizumab 100mg S/C Monthly,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Mepolizumab,Mepolizumab,R03DX09,R03DX09
IAL013,M,52.2,Pfizer,V4,91,NA,NA,NA,NA,NA,17/jun/2021,Positif,97.3,NA,Négatif,0.2,IAL013V4b,178.4,41.1,44.6,Vasculitis,"Eosinophilic granulomatosis with polyangiitis (prior treatement with CYC, rituximab - last dose VII/2017)",Mepolizumab 100mg S/C Monthly,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Mepolizumab,Mepolizumab,R03DX09,R03DX09
IAL013,M,52.2,Pfizer,V5,182,NA,NA,NA,NA,NA,16/sep/2021,Positif,64.5,NA,Négatif,0.1,IAL013V5b,145.3,71.8,37.3,Vasculitis,"Eosinophilic granulomatosis with polyangiitis (prior treatement with CYC, rituximab - last dose VII/2017)",Mepolizumab 100mg S/C Monthly,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Mepolizumab,Mepolizumab,R03DX09,R03DX09
IAL013,M,52.2,Pfizer,3M3,351,108,NA,NA,NA,NA,04/mar/2022,Positif,101.8,2678,Négatif,0.7,IAL013 3M3,276.1,128.7,106,Vasculitis,"Eosinophilic granulomatosis with polyangiitis (prior treatement with CYC, rituximab - last dose VII/2017)",Mepolizumab 100mg S/C Monthly,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Mepolizumab,Mepolizumab,R03DX09,R03DX09
IAL013,M,52.2,Pfizer,3M6,411,168,NA,NA,NA,NA,03/mai/2022,Positif,152.1,5958,Négatif,0.3,IAL013 3M6,293.42723004694835,104.12328196584757,77.27975270479135,Vasculitis,"Eosinophilic granulomatosis with polyangiitis (prior treatement with CYC, rituximab - last dose VII/2017)",Mepolizumab 100mg S/C Monthly,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Mepolizumab,Mepolizumab,R03DX09,R03DX09
IAL014,M,32.3,Moderna,3M3,308,91,NA,NA,NA,NA,22/fév/2022,Positif,87.6,1987,Négatif,1.6,IAL014 3M3,1408.5,343.9,264.8,Other,Primary biliary cholangitis with extrahepatic manifestations,Prednisone 15mg; Methotrexate 15mg;,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate,Prednisone|Methotrexate,H02AB07|L04AX03,L04AX03
IAL014,M,32.3,Moderna,3M6,392,175,NA,NA,NA,NA,17/mai/2022,Positif,152.3,5973,Négatif,1.2,IAL014 3M6,401.3,102.5,99.4,Other,Primary biliary cholangitis with extrahepatic manifestations,Prednisone 15mg; Methotrexate 15mg;,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate,Prednisone|Methotrexate,H02AB07|L04AX03,L04AX03
IAL015,M,88.1,Pfizer,3M3,369,76,NA,NA,NA,NA,21/fév/2022,Positif,23.4,149,Négatif,0.8,IAL015 3M3,22.2,11,8.5,Vasculitis,Micro-PAN,Rituximab 13.07.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL016,F,75.2,Pfizer,V3,31,NA,NA,NA,NA,NA,15/avr/2021,Positif,73.9,NA,NA,NA,IAL016V3b,87.6,13.5,10,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg; Methotrexate 15mg; Infliximab 5mg/Kg 23.12.2020; 19.01, 17.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL016,F,75.2,Pfizer,V4,92,NA,NA,NA,NA,NA,15/jun/2021,Positif,18,NA,Négatif,2.1,IAL016V4b,17.9,6.5,2.4,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg; Methotrexate 15mg; Infliximab 5mg/Kg 23.12.2020; 19.01, 17.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL016,F,75.2,Pfizer,V5,184,NA,NA,NA,NA,NA,15/sep/2021,Positif,6.3,NA,Négatif,3.3,IAL016V5b,1,1,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg; Methotrexate 15mg; Infliximab 5mg/Kg 23.12.2020; 19.01, 17.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL017,F,41.2,Pfizer,V3,33,NA,NA,V5-V6,NA,NA,08/avr/2021,Positif,93.9,NA,NA,NA,IAL017V3b,113,46.8,18.3,Uveitis,Refractory uveitis (Macular edema),Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL017,F,41.2,Pfizer,V4,95,NA,NA,V5-V6,NA,NA,09/jun/2021,Positif,41.3,NA,Négatif,0.3,IAL017V4b,54.9,25.3,12.5,Uveitis,Refractory uveitis (Macular edema),Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL017,F,41.2,Pfizer,V5,184,NA,NA,V5-V6,NA,NA,06/sep/2021,Positif,29.2,NA,Négatif,0.2,IAL017V5b,57.8,34.1,14.2,Uveitis,Refractory uveitis (Macular edema),Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL018,F,50.2,Moderna/Pfizer,V3,29,NA,NA,NA,NA,NA,29/mar/2021,Positif,96,NA,NA,NA,IAL018V3b,199.8,108.4,33.8,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL018,F,50.2,Moderna/Pfizer,V4,88,NA,NA,NA,NA,NA,27/mai/2021,Positif,78.9,NA,NA,NA,IAL018V4b,121,61.7,29.9,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL018,F,50.2,Moderna/Pfizer,V5,184,NA,NA,NA,NA,NA,31/aoû/2021,Positif,29.3,NA,Négatif,2.9,IAL018V5b,51.5,36.1,16.4,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL018,F,50.2,Moderna/Pfizer,3M3,375,87,NA,NA,NA,NA,10/mar/2022,Positif,80,1660,Négatif,2,IAL018 3M3,279,129.1,72.6,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL019,F,36.1,Moderna,V3,29,NA,NA,V5-V6,NA,NA,16/mar/2021,Positif,157.9,NA,NA,NA,IAL019V3b,693,231.5,21,Primary immunodeficiency,"Immune thrombocytopenia; primary immunodeficiency (Kabuki syndrome, Coffin-Siris ?)","Privigen 18.12.2020; 15.01, 12.02, 05.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL019,F,36.1,Moderna,V4,93,NA,NA,V5-V6,NA,NA,19/mai/2021,Positif,113.5,NA,NA,NA,IAL019V4b,242,72.7,9,Primary immunodeficiency,"Immune thrombocytopenia; primary immunodeficiency (Kabuki syndrome, Coffin-Siris ?)","Privigen 18.12.2020; 15.01, 12.02, 05.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL019,F,36.1,Moderna,V5,183,NA,NA,V5-V6,NA,NA,17/aoû/2021,Positif,41.7,NA,Indéterminé,5.8,IAL019V5b,98.3,39.4,11.3,Primary immunodeficiency,"Immune thrombocytopenia; primary immunodeficiency (Kabuki syndrome, Coffin-Siris ?)","Privigen 18.12.2020; 15.01, 12.02, 05.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL019,F,36.1,Moderna,V5+,318,NA,NA,V5-V6,117,NA,30/déc/2021,Positif,114.3,3372,Positif,16.5,IAL019V5+b,970.9,610.9,236.7,Primary immunodeficiency,"Immune thrombocytopenia; primary immunodeficiency (Kabuki syndrome, Coffin-Siris ?)","Privigen 18.12.2020; 15.01, 12.02, 05.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL019,F,36.1,Moderna,V6,375,NA,NA,V5-V6,174,NA,25/fév/2022,Positif,98.1,2488,Positif,14.1,IAL019V6,320.1,237.2,113.1,Primary immunodeficiency,"Immune thrombocytopenia; primary immunodeficiency (Kabuki syndrome, Coffin-Siris ?)","Privigen 18.12.2020; 15.01, 12.02, 05.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL020,F,56.2,Moderna,3M3,299,82,NA,NA,NA,NA,18/jan/2022,Positif,113.6,3331,Négatif,0.1,IAL020 3M3,167.2,56.8,28.9,SLE,SLE,"Hydroxychloroquine, Belimumab 10mg/Kg 21.12.2020; 18.01., 12.02, 16.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL020,F,56.2,Moderna,3M6,412,195,NA,NA,NA,NA,11/mai/2022,Positif,139.3,5000,Positif,7.2,IAL020 3M6,403.2258064516129,127.61613067891783,391.6960438699569,SLE,SLE,"Hydroxychloroquine, Belimumab 10mg/Kg 21.12.2020; 18.01., 12.02, 16.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL021,F,45.3,Moderna,3M3,370,85,NA,NA,NA,NA,12/avr/2022,Positif,94.4,2305,Négatif,1,IAL021 3M3,1740.9,841,259.5,Primary immunodeficiency,Primary immunodeficiency (not classified),Privigen 22.12.2020; 19.01. 16.02. 23.03.2021,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL023,F,61.2,Pfizer,V3,32,NA,NA,NA,NA,NA,19/avr/2021,Positif,56.8,NA,NA,NA,IAL023V3b,7.6,1,1,Uveitis,Refractory uveitis,"Abatacept 1000mg 18.12.2020, 12.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Abatacept,Abatacept,L04AA24,L04AA24
IAL023,F,61.2,Pfizer,V4,91,NA,NA,NA,NA,NA,17/jun/2021,Positif,21.6,NA,Négatif,0.1,IAL023V4b,14,7.9,4.8,Uveitis,Refractory uveitis,"Abatacept 1000mg 18.12.2020, 12.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Abatacept,Abatacept,L04AA24,L04AA24
IAL023,F,61.2,Pfizer,V5,182,NA,NA,NA,NA,NA,16/sep/2021,Positif,7.1,NA,Négatif,0.1,IAL023V5b,1,1,1,Uveitis,Refractory uveitis,"Abatacept 1000mg 18.12.2020, 12.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Abatacept,Abatacept,L04AA24,L04AA24
IAL023,F,61.2,Pfizer,3M3,321,121,NA,NA,NA,NA,02/fév/2022,Positif,120.5,3746,Négatif,0.1,IAL023 3M3,234.9,140,94,Uveitis,Refractory uveitis,"Abatacept 1000mg 18.12.2020, 12.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Abatacept,Abatacept,L04AA24,L04AA24
IAL023,F,61.2,Pfizer,3M6,384,184,NA,NA,NA,NA,06/avr/2022,Positif,87,1960,Négatif,0,IAL023 3M6,100.86746015735325,72.3589001447178,50.89058524173028,Uveitis,Refractory uveitis,"Abatacept 1000mg 18.12.2020, 12.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Abatacept,Abatacept,L04AA24,L04AA24
IAL025,F,50.2,Pfizer,V3,31,NA,NA,NA,NA,NA,15/avr/2021,Positif,91.2,NA,NA,NA,IAL025V3b,182.4,22.9,29,Sjoegren's syndrome,Sjoegren's syndrome - sarcoïdosis overlap,Rituximab 19.10.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL025,F,50.2,Pfizer,V4,91,NA,NA,NA,NA,NA,14/jun/2021,Positif,99.6,NA,Négatif,2,IAL025V4b,87.7,9.8,20.2,Sjoegren's syndrome,Sjoegren's syndrome - sarcoïdosis overlap,Rituximab 19.10.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL025,F,50.2,Pfizer,V5,176,NA,NA,NA,NA,NA,07/sep/2021,Positif,76,NA,Négatif,1.8,IAL025V5b,241.6,28.2,13,Sjoegren's syndrome,Sjoegren's syndrome - sarcoïdosis overlap,Rituximab 19.10.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL025,F,50.2,Pfizer,3M3,364,84,NA,NA,NA,NA,14/mar/2022,Positif,121,3777,Négatif,1.6,IAL025 3M3,165.2,25.5,17.8,Sjoegren's syndrome,Sjoegren's syndrome - sarcoïdosis overlap,Rituximab 19.10.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL026,F,62.1,Moderna,3M3,365,76,NA,NA,NA,NA,15/fév/2022,Positif,55.9,817,Négatif,0.3,IAL026 3M3,93.5,89.3,45.1,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg; Rituximab Foreseen 29.03.2020 (After 2nd Dose),"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL026,F,62.1,Moderna,3M6,463,174,NA,NA,NA,NA,24/mai/2022,Positif,64.4,1080,Négatif,0.2,IAL026 3M6,70.2,43.1,19.4,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 300mg; Rituximab Foreseen 29.03.2020 (After 2nd Dose),"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL027,F,67.2,Moderna,V3,35,NA,NA,NA,NA,NA,04/mai/2021,Positif,93.9,NA,NA,NA,IAL027V3b,378.9,1.2,3.1,SLE,SLE,"Prednisone 5mg; Mycophenolate Mofetil 1000mg; Hydroxychloroquine 200mg; Belimumab 10mg/Kg 11.12.2020; 14.01, 08.02, 08.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Belimumab,Prednisone|MycophenolateMofetil|Hydroxychloroquine|Belimumab,H02AB07|L04AA06|P01BA02|L04AA26,L04AA06|L04AA26
IAL027,F,67.2,Moderna,V4,91,NA,NA,NA,NA,NA,29/jun/2021,Positif,63.7,NA,Négatif,0.9,IAL027V4b,162,19,18,SLE,SLE,"Prednisone 5mg; Mycophenolate Mofetil 1000mg; Hydroxychloroquine 200mg; Belimumab 10mg/Kg 11.12.2020; 14.01, 08.02, 08.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Belimumab,Prednisone|MycophenolateMofetil|Hydroxychloroquine|Belimumab,H02AB07|L04AA06|P01BA02|L04AA26,L04AA06|L04AA26
IAL027,F,67.2,Moderna,V5,175,NA,NA,NA,NA,NA,21/sep/2021,Positif,38.6,NA,Négatif,1.1,IAL027V5b,86.4,15.3,10.1,SLE,SLE,"Prednisone 5mg; Mycophenolate Mofetil 1000mg; Hydroxychloroquine 200mg; Belimumab 10mg/Kg 11.12.2020; 14.01, 08.02, 08.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Belimumab,Prednisone|MycophenolateMofetil|Hydroxychloroquine|Belimumab,H02AB07|L04AA06|P01BA02|L04AA26,L04AA06|L04AA26
IAL027,F,67.2,Moderna,3M3,349,75,NA,NA,NA,NA,14/mar/2022,Positif,135.7,4746,Négatif,0.9,IAL027 3M3,311,116.1,68.7,SLE,SLE,"Prednisone 5mg; Mycophenolate Mofetil 1000mg; Hydroxychloroquine 200mg; Belimumab 10mg/Kg 11.12.2020; 14.01, 08.02, 08.03.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Belimumab,Prednisone|MycophenolateMofetil|Hydroxychloroquine|Belimumab,H02AB07|L04AA06|P01BA02|L04AA26,L04AA06|L04AA26
IAL028,M,56.2,Moderna,V3,31,NA,NA,V5-V6,NA,NA,22/avr/2021,Positif,154.9,NA,NA,NA,IAL028V3b,276.2,119,36.6,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 5mg; Infliximab 5mg/Kg 23.11.2020; 18.01, 15.03.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL028,M,56.2,Moderna,V4,92,NA,NA,V5-V6,NA,NA,22/jun/2021,Positif,25.3,NA,Négatif,0.1,IAL028V4b,57.6,21.3,16.8,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 5mg; Infliximab 5mg/Kg 23.11.2020; 18.01, 15.03.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL028,M,56.2,Moderna,V5,197,NA,NA,V5-V6,NA,NA,05/oct/2021,Positif,9.3,NA,Négatif,0.1,IAL028V5b,53,12.7,5.5,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 5mg; Infliximab 5mg/Kg 23.11.2020; 18.01, 15.03.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL028,M,56.2,Moderna,3M3,309,97,NA,V5-V6,51,NA,25/jan/2022,Positif,87.9,2001,Positif,8.9,IAL028 3M3,254.1,152.9,51.2,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 5mg; Infliximab 5mg/Kg 23.11.2020; 18.01, 15.03.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL028,M,56.2,Moderna,3M6,399,187,NA,V5-V6,141,NA,25/avr/2022,Positif,72.7,1373,Négatif,1.4,IAL028 3M6,145.4,90.8,28.6,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 5mg; Infliximab 5mg/Kg 23.11.2020; 18.01, 15.03.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL029,F,52.1,Pfizer,V3,30,NA,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,NA,NA,10/mar/2021,Négatif,0,NA,NA,NA,IAL029V3b,1,1,1,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL029,F,52.1,Pfizer,V4,93,NA,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,NA,NA,12/mai/2021,Négatif,0.3,NA,NA,NA,IAL029V4b,1,1,1,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL029,F,52.1,Pfizer,V5,184,NA,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,NA,NA,11/aoû/2021,Négatif,0.5,NA,Négatif,0.1,IAL029V5b,1,1,1,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL029,F,52.1,Pfizer,3M3,317,119,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,NA,NA,22/déc/2021,Négatif,0.2,0,Négatif,0.1,IAL029 3M3,5,10.3,7.3,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL029,F,52.1,Pfizer,3M6,380,182,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,3,NA,23/fév/2022,Négatif,0,0,Négatif,0,IAL029 3M6,1,1,1,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL029,F,52.1,Pfizer,3M9,478,280,rituximab: 02.03.2022 reactived COVID infection,3M3-3M6,101,NA,01/jun/2022,Positif,122.6,3877,Négatif,0.9,IAL029 3M9,289.35185185185185,225.68269013766644,131.5962626661403,Other,Autoimmune pancreatitis,Rituximab 1000mg 13.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL030,F,66.2,Moderna,V3,31,NA,NA,NA,NA,NA,26/avr/2021,Négatif,0.1,NA,NA,NA,IAL030V3b,1,1,1,Vasculitis,Granulomatosis with polyangeitis,"Rituximab 500mg 13.10.2020 (Next 13.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL030,F,66.2,Moderna,V4,94,NA,NA,NA,NA,NA,28/jun/2021,Négatif,0.2,NA,Négatif,0.1,IAL030V4b,1,1,1,Vasculitis,Granulomatosis with polyangeitis,"Rituximab 500mg 13.10.2020 (Next 13.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL030,F,66.2,Moderna,V5,181,NA,NA,NA,NA,NA,23/sep/2021,Négatif,0.2,NA,Négatif,0.2,IAL030V5b,1,1,1,Vasculitis,Granulomatosis with polyangeitis,"Rituximab 500mg 13.10.2020 (Next 13.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL030,F,66.2,Moderna,3M3,298,88,NA,NA,NA,NA,18/jan/2022,Négatif,0.1,0,Négatif,0.2,IAL030 3M3,1,1,1,Vasculitis,Granulomatosis with polyangeitis,"Rituximab 500mg 13.10.2020 (Next 13.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL030,F,66.2,Moderna,3M6,403,193,NA,NA,NA,NA,03/mai/2022,Négatif,0.3,0,Négatif,0.3,IAL030 3M6,1,1,1,Vasculitis,Granulomatosis with polyangeitis,"Rituximab 500mg 13.10.2020 (Next 13.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL031,F,73.1,Pfizer,V3,31,NA,NA,NA,NA,NA,22/mar/2021,Positif,128.1,NA,NA,NA,IAL031V3b,211.5,86.8,43.1,CVID,Common variable immunodeficiency,"Privigen 29.01,19.02, 12.03, 01.04",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL031,F,73.1,Pfizer,V4,89,NA,NA,NA,NA,NA,19/mai/2021,Positif,104,NA,NA,NA,IAL031V4b,156.2,69.4,45.6,CVID,Common variable immunodeficiency,"Privigen 29.01,19.02, 12.03, 01.04",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL031,F,73.1,Pfizer,V5,182,NA,NA,NA,NA,NA,20/aoû/2021,Positif,59.9,NA,Négatif,1.9,IAL031V5b,192,100.7,51.8,CVID,Common variable immunodeficiency,"Privigen 29.01,19.02, 12.03, 01.04",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL031,F,73.1,Pfizer,3M3,360,122,NA,NA,NA,NA,14/fév/2022,Positif,102,2689,Indéterminé,4.7,IAL031 3M3,186.5,103.9,58.5,CVID,Common variable immunodeficiency,"Privigen 29.01,19.02, 12.03, 01.04",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL031,F,73.1,Pfizer,3M6,417,179,NA,NA,NA,NA,12/avr/2022,Positif,92.1,2195,Négatif,2.7,IAL031 3M6,267.4,163.9,74.2,CVID,Common variable immunodeficiency,"Privigen 29.01,19.02, 12.03, 01.04",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL032,F,59.3,Moderna,V3,28,NA,NA,V5-V6,NA,NA,26/mai/2021,Positif,49.3,NA,NA,NA,IAL032V3b,325,40.3,21.6,Behcet's,Behcet's disease,REMICADE,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE,L04AB02,L04AB02
IAL032,F,59.3,Moderna,V4,86,NA,NA,V5-V6,NA,NA,23/jui/2021,Positif,18.5,NA,Négatif,0.2,IAL032V4b,46,14,7,Behcet's,Behcet's disease,REMICADE,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE,L04AB02,L04AB02
IAL032,F,59.3,Moderna,V5,190,NA,NA,V5-V6,NA,NA,04/nov/2021,Positif,24.7,NA,Négatif,0.2,IAL032V5b,1,1,1,Behcet's,Behcet's disease,REMICADE,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE,L04AB02,L04AB02
IAL032,F,59.3,Moderna,V6,358,NA,NA,V5-V6,93,NA,21/avr/2022,Positif,105,2848,Négatif,0.6,IAL032V6,406.8,271.3,186.4,Behcet's,Behcet's disease,REMICADE,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE,L04AB02,L04AB02
IAL035,F,43.2,Moderna,V3,31,NA,NA,NA,NA,NA,22/avr/2021,Positif,122.5,NA,NA,NA,IAL035V3b,381.8,139.8,52.6,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg; Belimumab 200mg Weekly,bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL035,F,43.2,Moderna,V4,92,NA,NA,NA,NA,NA,22/jun/2021,Positif,53.7,NA,Négatif,0.3,IAL035V4b,276.5,137.3,50.5,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg; Belimumab 200mg Weekly,bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL035,F,43.2,Moderna,V5,183,NA,NA,NA,NA,NA,21/sep/2021,Positif,37.4,NA,Négatif,0.4,IAL035V5b,77.6,38.3,23.3,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg; Belimumab 200mg Weekly,bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL035,F,43.2,Moderna,3M3,374,108,NA,NA,NA,NA,31/mar/2022,Positif,108.5,3040,Négatif,0.4,IAL035 3M3,1307.7,693,361.3,Sjoegren's syndrome,Sjoegren's syndrome,Hydroxychloroquine 400mg; Belimumab 200mg Weekly,bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL036,M,54.2,Moderna,V3,33,NA,NA,V5-3M3,NA,NA,26/avr/2021,Positif,87.7,NA,NA,NA,IAL036V3b,287,83.8,43.9,Sarcoidosis,Sarcoidosis,"Prednisone 2.5mg, Methotrexate 5mg, Infliximab 5mg/Kg 25.11.2020, 22.01, 16.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL036,M,54.2,Moderna,V4,92,NA,NA,V5-3M3,NA,NA,24/jun/2021,Positif,49.4,NA,Négatif,3.2,IAL036V4b,65.9,25.3,13.1,Sarcoidosis,Sarcoidosis,"Prednisone 2.5mg, Methotrexate 5mg, Infliximab 5mg/Kg 25.11.2020, 22.01, 16.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL036,M,54.2,Moderna,V5,187,NA,NA,V5-3M3,NA,NA,27/sep/2021,Positif,19,NA,Négatif,2.7,IAL036V5b,25.6,12.3,4.1,Sarcoidosis,Sarcoidosis,"Prednisone 2.5mg, Methotrexate 5mg, Infliximab 5mg/Kg 25.11.2020, 22.01, 16.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL036,M,54.2,Moderna,3M3,383,90,NA,V5-3M3,41,NA,11/avr/2022,Positif,98.5,2508,Positif,21,IAL036 3M3,2420.1,1923.1,554,Sarcoidosis,Sarcoidosis,"Prednisone 2.5mg, Methotrexate 5mg, Infliximab 5mg/Kg 25.11.2020, 22.01, 16.03.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Infliximab,Prednisone|Methotrexate|Infliximab,H02AB07|L04AX03|L04AB02,L04AX03|L04AB02
IAL037,F,56.3,Pfizer,V3,28,NA,NA,NA,NA,NA,12/mai/2021,Positif,145.9,NA,NA,NA,IAL037V3b,245.2,71,46.3,SLE,SLE,"Hydroxychloroquine 200mg, Belimumab 10mg/Kg 30.12.2020, 27.01., 24.02.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL037,F,56.3,Pfizer,V4,98,NA,NA,NA,NA,NA,21/jui/2021,Positif,54.6,NA,Négatif,0.3,IAL037V4b,141,40,19,SLE,SLE,"Hydroxychloroquine 200mg, Belimumab 10mg/Kg 30.12.2020, 27.01., 24.02.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL037,F,56.3,Pfizer,V5,180,NA,NA,NA,NA,NA,11/oct/2021,Positif,33.3,NA,Négatif,0.7,IAL037V5b,98.3,40.9,11.9,SLE,SLE,"Hydroxychloroquine 200mg, Belimumab 10mg/Kg 30.12.2020, 27.01., 24.02.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL037,F,56.3,Pfizer,3M3,357,105,NA,NA,NA,NA,06/avr/2022,Positif,107.5,2985,Négatif,0,IAL037 3M3,346.6,107,103.1,SLE,SLE,"Hydroxychloroquine 200mg, Belimumab 10mg/Kg 30.12.2020, 27.01., 24.02.2021",bDMARD + cs DMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Belimumab,Hydroxychloroquine|Belimumab,P01BA02|L04AA26,L04AA26
IAL038,F,47.2,Pfizer,3M3,365,103,NA,NA,NA,NA,31/mar/2022,Positif,100.7,2621,Négatif,3.3,IAL038 3M3,1875.1,660.1,540,Undifferentiated or mixed connective tissue disease,Undifferentiated connective tissue disease; celiac disease; S/p. treatement of Hodgkin lymphoma,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL040,F,52.2,Moderna,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Négatif,0.7,NA,NA,NA,IAL040V3b,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 23.12.2020 (Next Planned 14.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL040,F,52.2,Moderna,V4,95,NA,NA,NA,NA,NA,28/jun/2021,Négatif,0.5,NA,Positif,6.3,IAL040V4b,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 23.12.2020 (Next Planned 14.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL040,F,52.2,Moderna,V5,188,NA,NA,NA,NA,NA,29/sep/2021,Négatif,0.8,NA,Positif,6.5,IAL040V5b,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 23.12.2020 (Next Planned 14.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL040,F,52.2,Moderna,3M3,361,102,NA,NA,NA,NA,21/mar/2022,Négatif,0.3,0,Négatif,0.6,IAL040 3M3,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 23.12.2020 (Next Planned 14.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL040,F,52.2,Moderna,3M6,431,172,NA,NA,NA,NA,30/mai/2022,Négatif,0.3,0,Négatif,0.8,IAL040 3M6,7.5,18.7,12.1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 23.12.2020 (Next Planned 14.04.2021, After 2nd Dose)","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL041,F,67.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Négatif,0.9,NA,NA,NA,IAL041V3b,1,1,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg, Mycophenolate Mofetil 1500mg, Infliximab 5mg/Kg 11.12.2020, 05.02.2021",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Infliximab,Prednisone|MycophenolateMofetil|Infliximab,H02AB07|L04AA06|L04AB02,L04AA06|L04AB02
IAL041,F,67.2,Pfizer,V4,94,NA,NA,NA,NA,NA,28/jun/2021,Négatif,0.8,NA,Négatif,0,IAL041V4b,1,1,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg, Mycophenolate Mofetil 1500mg, Infliximab 5mg/Kg 11.12.2020, 05.02.2021",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Infliximab,Prednisone|MycophenolateMofetil|Infliximab,H02AB07|L04AA06|L04AB02,L04AA06|L04AB02
IAL041,F,67.2,Pfizer,V5,185,25,NA,NA,NA,NA,27/sep/2021,Positif,6.9,NA,Négatif,0,IAL041V5b,1,1,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg, Mycophenolate Mofetil 1500mg, Infliximab 5mg/Kg 11.12.2020, 05.02.2021",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Infliximab,Prednisone|MycophenolateMofetil|Infliximab,H02AB07|L04AA06|L04AB02,L04AA06|L04AB02
IAL041,F,67.2,Pfizer,3M6,334,174,NA,NA,NA,NA,23/fév/2022,Négatif,2.9,4,Négatif,0.1,IAL041 3M6,1,1,1,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg, Mycophenolate Mofetil 1500mg, Infliximab 5mg/Kg 11.12.2020, 05.02.2021",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Infliximab,Prednisone|MycophenolateMofetil|Infliximab,H02AB07|L04AA06|L04AB02,L04AA06|L04AB02
IAL041,F,67.2,Pfizer,3M9,431,271,NA,NA,NA,NA,31/mai/2022,Positif,124.6,4004,Négatif,1.4,IAL041 3M9,107.6,96.7,45.5,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy,"Prednisone 5mg, Mycophenolate Mofetil 1500mg, Infliximab 5mg/Kg 11.12.2020, 05.02.2021",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,MycophenolateMofetil|Infliximab,Prednisone|MycophenolateMofetil|Infliximab,H02AB07|L04AA06|L04AB02,L04AA06|L04AB02
IAL043,F,34.2,Moderna,V3,31,NA,NA,NA,NA,NA,22/avr/2021,Positif,117.6,NA,NA,NA,IAL043V3b,1924.9,782.5,73.7,Myasthenia gravis,Myasthenia gravis,Azathioprine 150mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine,L04AX01,L04AX01
IAL043,F,34.2,Moderna,V4,92,NA,NA,NA,NA,NA,22/jun/2021,Positif,57.9,NA,Négatif,2.2,IAL043V4b,96.4,41.8,23.1,Myasthenia gravis,Myasthenia gravis,Azathioprine 150mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine,L04AX01,L04AX01
IAL043,F,34.2,Moderna,V5,190,NA,NA,NA,NA,NA,28/sep/2021,Positif,81.3,NA,Négatif,2.5,IAL043V5b,477.8,222.6,114.4,Myasthenia gravis,Myasthenia gravis,Azathioprine 150mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine,L04AX01,L04AX01
IAL043,F,34.2,Moderna,3M3,331,91,NA,NA,NA,NA,16/fév/2022,Positif,120.8,3764,Négatif,1.2,IAL043 3M3,12871.7,4088.3,1404.1,Myasthenia gravis,Myasthenia gravis,Azathioprine 150mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine,L04AX01,L04AX01
IAL043,F,34.2,Moderna,3M6,422,182,NA,NA,NA,NA,18/mai/2022,Positif,99.3,2549,Négatif,0.8,IAL043 3M6,652.7,440.3,226.8,Myasthenia gravis,Myasthenia gravis,Azathioprine 150mg,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Azathioprine,L04AX01,L04AX01
IAL044,M,63.2,Moderna,V3,31,NA,NA,NA,NA,NA,22/avr/2021,Positif,139.6,NA,NA,NA,IAL044V3b,443.7,108.4,49,Other,Immune-mediated inflammatory myopathy,"Methotrexate 12.5mg; Privigen High-Dose 15-16.12.2020; 12-13.01. 8+10.02, 9-10.03.2021",csDMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Privigen,Methotrexate|Privigen,L04AX03|J06BA02,L04AX03|J06BA02
IAL044,M,63.2,Moderna,V4,92,NA,NA,NA,NA,NA,22/jun/2021,Positif,58.5,NA,Négatif,2.7,IAL044V4b,85.2,18.9,20.3,Other,Immune-mediated inflammatory myopathy,"Methotrexate 12.5mg; Privigen High-Dose 15-16.12.2020; 12-13.01. 8+10.02, 9-10.03.2021",csDMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Privigen,Methotrexate|Privigen,L04AX03|J06BA02,L04AX03|J06BA02
IAL044,M,63.2,Moderna,V5,183,NA,NA,NA,NA,NA,21/sep/2021,Positif,45.3,NA,Indéterminé,5.3,IAL044V5b,80.6,35.4,19.7,Other,Immune-mediated inflammatory myopathy,"Methotrexate 12.5mg; Privigen High-Dose 15-16.12.2020; 12-13.01. 8+10.02, 9-10.03.2021",csDMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Privigen,Methotrexate|Privigen,L04AX03|J06BA02,L04AX03|J06BA02
IAL044,M,63.2,Moderna,3M3,381,107,NA,NA,NA,NA,07/avr/2022,Positif,105.9,2897,Négatif,3.6,IAL044 3M3,280,148.1,81.8,Other,Immune-mediated inflammatory myopathy,"Methotrexate 12.5mg; Privigen High-Dose 15-16.12.2020; 12-13.01. 8+10.02, 9-10.03.2021",csDMARD and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate|Privigen,Methotrexate|Privigen,L04AX03|J06BA02,L04AX03|J06BA02
IAL046,M,63.2,Moderna,V3,26,NA,NA,3M3-3M6,NA,NA,24/mar/2021,Positif,129.9,NA,NA,NA,IAL046V3b,186.7,35.8,6.7,Sarcoidosis,Sarcoidosis,"Prednisone 5mg, Hydroxychloroquine 400mg, Infliximab 5mg/Kg 28.12.2020; 22.02.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Hydroxychloroquine|Infliximab,H02AB07|P01BA02|L04AB02,L04AB02
IAL046,M,63.2,Moderna,V4,89,NA,NA,3M3-3M6,NA,NA,26/mai/2021,Positif,62.4,NA,NA,NA,IAL046V4b,66.8,27.5,12.9,Sarcoidosis,Sarcoidosis,"Prednisone 5mg, Hydroxychloroquine 400mg, Infliximab 5mg/Kg 28.12.2020; 22.02.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Hydroxychloroquine|Infliximab,H02AB07|P01BA02|L04AB02,L04AB02
IAL046,M,63.2,Moderna,V5,181,NA,NA,3M3-3M6,NA,NA,26/aoû/2021,Positif,28.8,NA,Négatif,0.9,IAL046V5b,30,19.2,8.9,Sarcoidosis,Sarcoidosis,"Prednisone 5mg, Hydroxychloroquine 400mg, Infliximab 5mg/Kg 28.12.2020; 22.02.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Hydroxychloroquine|Infliximab,H02AB07|P01BA02|L04AB02,L04AB02
IAL046,M,63.2,Moderna,3M3,335,94,NA,3M3-3M6,NA,NA,27/jan/2022,Positif,109.4,3090,Négatif,0.7,IAL046 3M3,413.6,75.5,31.1,Sarcoidosis,Sarcoidosis,"Prednisone 5mg, Hydroxychloroquine 400mg, Infliximab 5mg/Kg 28.12.2020; 22.02.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Hydroxychloroquine|Infliximab,H02AB07|P01BA02|L04AB02,L04AB02
IAL046,M,63.2,Moderna,3M6,423,182,NA,3M3-3M6,17,NA,25/avr/2022,Positif,135.7,4746,Positif,10.1,IAL046 3M6,1246.6,423.7,214.3,Sarcoidosis,Sarcoidosis,"Prednisone 5mg, Hydroxychloroquine 400mg, Infliximab 5mg/Kg 28.12.2020; 22.02.2021",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Hydroxychloroquine|Infliximab,H02AB07|P01BA02|L04AB02,L04AB02
IAL047,F,78.1,Pfizer,V3,27,NA,NA,V5-V6,NA,NA,15/mar/2021,Négatif,1.5,NA,NA,NA,IAL047V3b,1,1,1,SLE,SLE with mononeuritis multiplex,Rituximab 500mg 12.01.2021,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL047,F,78.1,Pfizer,V4,90,NA,NA,V5-V6,NA,NA,17/mai/2021,Négatif,0.8,NA,NA,NA,IAL047V4b,1,1,1,SLE,SLE with mononeuritis multiplex,Rituximab 500mg 12.01.2021,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL047,F,78.1,Pfizer,V5,181,NA,NA,V5-V6,NA,NA,16/aoû/2021,Négatif,0.4,NA,Négatif,0.1,IAL047V5b,1,1,1,SLE,SLE with mononeuritis multiplex,Rituximab 500mg 12.01.2021,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL047,F,78.1,Pfizer,3M3,307,101,NA,V5-V6,70,NA,20/déc/2021,Positif,67.5,1186,Négatif,0.1,IAL047 3M3b,79.8,19.8,22.3,SLE,SLE with mononeuritis multiplex,Rituximab 500mg 12.01.2021,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL047,F,78.1,Pfizer,3M6,384,178,NA,V5-V6,147,NA,07/mar/2022,Positif,43.7,503,Négatif,0.1,IAL047 3M6,40.4,16.8,19.6,SLE,SLE with mononeuritis multiplex,Rituximab 500mg 12.01.2021,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL048,F,62.2,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,03/mai/2021,Positif,89.5,NA,NA,NA,IAL048V3b,133,26.2,22.1,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 250mg 11.11, 21.12.2020, 05.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL048,F,62.2,Pfizer,V4,91,NA,NA,V5-3M3,NA,NA,01/jui/2021,Positif,82.4,NA,Négatif,0.6,IAL048V4b,132,22,19,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 250mg 11.11, 21.12.2020, 05.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL048,F,62.2,Pfizer,V5,186,NA,NA,V5-3M3,NA,NA,04/oct/2021,Positif,56.5,NA,Négatif,0.5,IAL048V5b,75.8,23.1,13.2,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 250mg 11.11, 21.12.2020, 05.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL048,F,62.2,Pfizer,3M3,340,91,NA,V5-3M3,55,NA,07/mar/2022,Positif,108.3,3029,Négatif,1.2,IAL048 3M3,163.8,30.6,50.9,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 250mg 11.11, 21.12.2020, 05.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL048,F,62.2,Pfizer,3M6,424,175,NA,V5-3M3,139,NA,30/mai/2022,Positif,194.4,9722,Négatif,0.6,IAL048 3M6,72.4,17.8,38.8,Sjoegren's syndrome,Sjoegren's syndrome,"Rituximab 250mg 11.11, 21.12.2020, 05.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL049,F,53.2,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,22/avr/2021,Positif,29.6,NA,NA,NA,IAL049V3b,25.6,9.5,7.9,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 400mg, Rituximab 09 + 22.09.2020; 18.03.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL049,F,53.2,Pfizer,V4,96,NA,NA,V5-V6,NA,NA,28/jun/2021,Positif,10.8,NA,Négatif,0.4,IAL049V4b,11,7,4,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 400mg, Rituximab 09 + 22.09.2020; 18.03.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL049,F,53.2,Pfizer,V5,184,NA,NA,V5-V6,NA,NA,24/sep/2021,Indéterminé,4.9,NA,Négatif,0.4,IAL049V5b,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 400mg, Rituximab 09 + 22.09.2020; 18.03.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL050,M,71.3,Pfizer,V3,30,NA,NA,NA,NA,NA,06/mai/2021,Positif,98.8,NA,NA,NA,IAL050V3b,50.8,31.1,16.5,Inflammatory arthritis,"Pyoderma gangreanosum, ankylosing spondylitis","Prednisone 5mg; Infliximab 5mg/Kg 17.12.2020, 11.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL050,M,71.3,Pfizer,V4,100,NA,NA,NA,NA,NA,15/jui/2021,Positif,24.5,NA,Négatif,0.1,IAL050V4b,1,1,1,Inflammatory arthritis,"Pyoderma gangreanosum, ankylosing spondylitis","Prednisone 5mg; Infliximab 5mg/Kg 17.12.2020, 11.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL050,M,71.3,Pfizer,V5,196,NA,NA,NA,NA,NA,19/oct/2021,Positif,14,NA,Négatif,0.1,IAL050V5b,1,1,1,Inflammatory arthritis,"Pyoderma gangreanosum, ankylosing spondylitis","Prednisone 5mg; Infliximab 5mg/Kg 17.12.2020, 11.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL050,M,71.3,Pfizer,3M3,307,89,NA,NA,NA,NA,07/fév/2022,Positif,22.1,134,Négatif,0.1,IAL050 3M3,13,8.9,7.2,Inflammatory arthritis,"Pyoderma gangreanosum, ankylosing spondylitis","Prednisone 5mg; Infliximab 5mg/Kg 17.12.2020, 11.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL050,M,71.3,Pfizer,3M6,399,181,NA,NA,NA,NA,10/mai/2022,Positif,16,72,Négatif,0,IAL050 3M6,6.743088334457182,5.200208008320333,7.651109410864574,Inflammatory arthritis,"Pyoderma gangreanosum, ankylosing spondylitis","Prednisone 5mg; Infliximab 5mg/Kg 17.12.2020, 11.02.2021",bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Infliximab,Prednisone|Infliximab,H02AB07|L04AB02,L04AB02
IAL051,F,69.2,Pfizer,V3,34,NA,4th dose: 28.02.2022,NA,NA,NA,03/mai/2021,Positif,70.6,NA,NA,NA,IAL051V3b,90.2,39.5,14.2,Sarcoidosis,Sarcoidosis,"Prednisone 30mg (Started 26.02.2021), Azathioprine 70mg (? Started 26.02.2021)",IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Prednisone|Azathioprine,H02AB07|L04AX01,L04AX01
IAL051,F,69.2,Pfizer,V4,92,NA,4th dose: 28.02.2022,NA,NA,NA,30/jun/2021,Positif,14.5,NA,Négatif,0.4,IAL051V4b,16.3,11.8,1.9,Sarcoidosis,Sarcoidosis,"Prednisone 30mg (Started 26.02.2021), Azathioprine 70mg (? Started 26.02.2021)",IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Prednisone|Azathioprine,H02AB07|L04AX01,L04AX01
IAL051,F,69.2,Pfizer,V5,183,NA,4th dose: 28.02.2022,NA,NA,NA,29/sep/2021,Positif,8.9,NA,Négatif,0.6,IAL051V5b,1,1,1,Sarcoidosis,Sarcoidosis,"Prednisone 30mg (Started 26.02.2021), Azathioprine 70mg (? Started 26.02.2021)",IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Prednisone|Azathioprine,H02AB07|L04AX01,L04AX01
IAL051,F,69.2,Pfizer,3M3,307,90,4th dose: 28.02.2022,NA,NA,NA,31/jan/2022,Positif,54.2,769,Négatif,0.3,IAL051 3M3,88.4,51.9,11.8,Sarcoidosis,Sarcoidosis,"Prednisone 30mg (Started 26.02.2021), Azathioprine 70mg (? Started 26.02.2021)",IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Prednisone|Azathioprine,H02AB07|L04AX01,L04AX01
IAL051,F,69.2,Pfizer,3M6,398,181,4th dose: 28.02.2022,NA,NA,NA,02/mai/2022,Positif,148.9,5710,Négatif,0.2,IAL051 3M6,142.32849416453175,61.50061500615006,36.63003663003663,Sarcoidosis,Sarcoidosis,"Prednisone 30mg (Started 26.02.2021), Azathioprine 70mg (? Started 26.02.2021)",IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine,Prednisone|Azathioprine,H02AB07|L04AX01,L04AX01
IAL052,F,44.2,Moderna,V3,32,NA,NA,V5-V6,NA,NA,26/avr/2021,Positif,15.7,NA,NA,NA,IAL052V3b,2.7,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 300mg; Rituximab 250mg 19.11.2020, 04.01, 16.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL052,F,44.2,Moderna,V4,88,NA,NA,V5-V6,NA,NA,21/jun/2021,Positif,10.4,NA,Négatif,0,IAL052V4b,4.6,0.8,0.6,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 300mg; Rituximab 250mg 19.11.2020, 04.01, 16.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL052,F,44.2,Moderna,V5,187,NA,NA,V5-V6,NA,NA,28/sep/2021,Négatif,3.7,NA,Négatif,0,IAL052V5b,1,1,1,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 300mg; Rituximab 250mg 19.11.2020, 04.01, 16.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL052,F,44.2,Moderna,3M3,263,69,NA,V5-V6,15,NA,13/déc/2021,Positif,96.2,2393,Négatif,0,IAL052 3M3,2430,2430,4.7,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 300mg; Rituximab 250mg 19.11.2020, 04.01, 16.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL052,F,44.2,Moderna,3M6,364,170,NA,V5-V6,116,NA,24/mar/2022,Positif,113,3296,Négatif,0,IAL052 3M6,1758.1,1667.5,1.5,Sjoegren's syndrome,Sjoegren's syndrome,"Hydroxychloroquine 300mg; Rituximab 250mg 19.11.2020, 04.01, 16.02.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Hydroxychloroquine|Rituximab,P01BA02|L01FA01,L01FA01
IAL053,F,31.2,Pfizer,V3,34,NA,NA,3M3-3M6,NA,NA,03/mai/2021,Positif,83.9,NA,NA,NA,IAL053V3b,481,196.2,39,Undifferentiated or mixed connective tissue disease,Mixed connective tissue disease,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL053,F,31.2,Pfizer,V4,90,NA,NA,3M3-3M6,NA,NA,28/jun/2021,Positif,80.5,NA,Négatif,0.1,IAL053V4b,197.7,117.3,59.8,Undifferentiated or mixed connective tissue disease,Mixed connective tissue disease,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL053,F,31.2,Pfizer,V5,188,NA,NA,3M3-3M6,NA,NA,04/oct/2021,Positif,50.2,NA,Négatif,0.1,IAL053V5b,131.3,99.8,42.3,Undifferentiated or mixed connective tissue disease,Mixed connective tissue disease,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL053,F,31.2,Pfizer,3M3,370,84,NA,3M3-3M6,NA,NA,04/avr/2022,Positif,97.8,2473,Négatif,0.1,IAL053 3M3,672,320.1,205.5,Undifferentiated or mixed connective tissue disease,Mixed connective tissue disease,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL053,F,31.2,Pfizer,3M3+,405,119,NA,3M3-3M6,19,NA,09/mai/2022,Positif,131.9,4485,Positif,7.4,IAL053 3M3+,4520.795660036166,2921.4139643587496,2392.916965781287,Undifferentiated or mixed connective tissue disease,Mixed connective tissue disease,Hydroxychloroquine 300mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Hydroxychloroquine,P01BA02,"NA"
IAL054,F,59.2,Pfizer,V3,34,NA,NA,3M6-3M9,NA,NA,03/mai/2021,Négatif,0.3,NA,NA,NA,IAL054V3b,1,1,1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,V4,92,NA,NA,3M6-3M9,NA,NA,30/jun/2021,Négatif,0.1,NA,Négatif,0.6,IAL054V4b,1,1,1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,V5,184,35,NA,3M6-3M9,NA,NA,30/sep/2021,Positif,15.9,NA,Négatif,0.4,IAL054V5b,1,1,1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,3M3,265,116,NA,3M6-3M9,NA,NA,20/déc/2021,Positif,10.7,34,Négatif,0.2,IAL054 3M3b,10,12.9,4.1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,3M6,335,186,NA,3M6-3M9,NA,NA,28/fév/2022,Indéterminé,4.7,8,Négatif,0.4,IAL054 3M6,1,1,1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,3M6+,357,208,NA,3M6-3M9,21,NA,22/mar/2022,Positif,94.5,2310,Négatif,0,IAL054 3M6+,207.8,140.8,86.1,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL054,F,59.2,Pfizer,3M9,426,277,NA,3M6-3M9,90,NA,30/mai/2022,Positif,170.7,7499,Négatif,0.2,IAL054 3M9,148.2,124.8,91,Vasculitis,Granulomatosis with polyangiiis,"Rituximab 500mg 29.07.2020, Rituximab 500mg 27.01.2021","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL055,M,65.3,Pfizer,3M3,330,89,NA,NA,NA,NA,02/mar/2022,Positif,73.5,1403,Négatif,1,IAL055 3M3,1686.6,548.5,476.2,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 12.5mg, Methotrexate 15mg (Since 03.12.2020)",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate,Prednisone|Methotrexate,H02AB07|L04AX03,L04AX03
IAL055,M,65.3,Pfizer,3M6,419,178,NA,NA,NA,NA,30/mai/2022,Positif,201.1,10402,Négatif,0.5,IAL055 3M6,923.4,295.9,232.7,Inflammatory cardiomyopathy,Inflammatory cardiomyopathy (sarcoidosis),"Prednisone 12.5mg, Methotrexate 15mg (Since 03.12.2020)",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Methotrexate,Prednisone|Methotrexate,H02AB07|L04AX03,L04AX03
IAL056,F,55.3,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,06/mai/2021,Positif,104.5,NA,NA,NA,IAL056V3b,781.2,346.1,139.8,Behcet's,Behcet's,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL056,F,55.3,Pfizer,V4,91,NA,NA,V5-V6,NA,NA,07/jui/2021,Positif,106.8,NA,Négatif,0.2,IAL056V4b,178.3,93.5,41.6,Behcet's,Behcet's,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL056,F,55.3,Pfizer,V5,183,NA,NA,V5-V6,NA,NA,07/oct/2021,Positif,40,NA,Négatif,0.3,IAL056V5b,26.1,12.1,4.9,Behcet's,Behcet's,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL056,F,55.3,Pfizer,V6,365,NA,NA,V5-V6,68,NA,07/avr/2022,Positif,96.7,2418,Indéterminé,4.5,IAL056V6,1774.6,1286.3,877.2,Behcet's,Behcet's,Currently Untreated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL057,F,73.3,Pfizer,V3,28,NA,NA,NA,NA,NA,06/mai/2021,Positif,105.9,NA,NA,NA,IAL057V3b,133.6,64.5,26.3,Vasculitis,Large vessel vasculitis,Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL057,F,73.3,Pfizer,V4,84,NA,NA,NA,NA,NA,01/jui/2021,Positif,45.9,NA,Négatif,1.6,IAL057V4b,80,20,11,Vasculitis,Large vessel vasculitis,Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL057,F,73.3,Pfizer,V5,175,NA,NA,NA,NA,NA,30/sep/2021,Positif,21.6,NA,Négatif,1.3,IAL057V5b,51.4,11.2,6.3,Vasculitis,Large vessel vasculitis,Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL057,F,73.3,Pfizer,3M3,252,73,NA,NA,NA,NA,16/déc/2021,Positif,91.2,2153,Négatif,1.1,IAL057 3M3b,204.2,57.8,20.8,Vasculitis,Large vessel vasculitis,Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL057,F,73.3,Pfizer,3M6,364,185,NA,NA,NA,NA,07/avr/2022,Positif,108.3,3029,Positif,17.1,IAL057 3M6,277.9,159.7,118.4,Vasculitis,Large vessel vasculitis,Actemra 162mg Week,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL058,F,72.3,Moderna,V3,34,NA,NA,V5-3M3,NA,NA,01/jun/2021,Positif,66,NA,NA,NA,IAL058V3b,600.2,154,69.8,CVID,Common variable immunodeficiency,KIOVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,KIOVIG,KIOVIG,J06BA02,J06BA02
IAL058,F,72.3,Moderna,V4,90,NA,NA,V5-3M3,NA,NA,27/jui/2021,Positif,83.6,NA,Négatif,1.4,IAL058V4b,190.1,79.7,44.1,CVID,Common variable immunodeficiency,KIOVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,KIOVIG,KIOVIG,J06BA02,J06BA02
IAL058,F,72.3,Moderna,V5,195,NA,NA,V5-3M3,NA,NA,09/nov/2021,Positif,66.8,NA,Négatif,3.6,IAL058V5b,211.1,90.6,55,CVID,Common variable immunodeficiency,KIOVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,KIOVIG,KIOVIG,J06BA02,J06BA02
IAL058,F,72.3,Moderna,3M3,363,104,NA,V5-3M3,12,NA,26/avr/2022,Positif,146.6,5536,Indéterminé,5.4,IAL058 3M3,1008,431.2,325.5,CVID,Common variable immunodeficiency,KIOVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,KIOVIG,KIOVIG,J06BA02,J06BA02
IAL059,M,72.3,Pfizer,V3,42,NA,NA,3M3-3M6,NA,NA,19/mai/2021,Positif,9.5,NA,NA,NA,IAL059V3b,6.3,9.9,5.9,CVID,Common variable immunodeficiency,"Privigen 21.12.2020, 21.01, 18.02.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL059,M,72.3,Pfizer,V4,92,NA,NA,3M3-3M6,NA,NA,08/jui/2021,Positif,9.2,NA,Négatif,0.8,IAL059V4b,1,1,1,CVID,Common variable immunodeficiency,"Privigen 21.12.2020, 21.01, 18.02.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL059,M,72.3,Pfizer,V5,176,NA,NA,3M3-3M6,NA,NA,30/sep/2021,Positif,7.1,NA,Négatif,1.8,IAL059V5b,1,1,1,CVID,Common variable immunodeficiency,"Privigen 21.12.2020, 21.01, 18.02.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL059,M,72.3,Pfizer,3M3,278,96,NA,3M3-3M6,NA,NA,10/jan/2022,Positif,7.9,20,Négatif,0.5,IAL059 3M3,15.3,14.7,9.9,CVID,Common variable immunodeficiency,"Privigen 21.12.2020, 21.01, 18.02.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL059,M,72.3,Pfizer,3M6,371,189,NA,3M3-3M6,68,NA,13/avr/2022,Positif,98.2,2493,Positif,6.7,IAL059 3M6,141.4,67,323,CVID,Common variable immunodeficiency,"Privigen 21.12.2020, 21.01, 18.02.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL061,F,66.3,Pfizer,V3,30,NA,NA,NA,NA,NA,06/mai/2021,Positif,141.9,NA,NA,NA,IAL061V3b,460.4,88.5,53.1,Vasculitis,Large vessel vasculitis,Prednisone 12.5mg,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL061,F,66.3,Pfizer,V4,91,NA,NA,NA,NA,NA,06/jui/2021,Positif,81.8,NA,Négatif,0.5,IAL061V4b,68.8,13.4,5.5,Vasculitis,Large vessel vasculitis,Prednisone 12.5mg,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL061,F,66.3,Pfizer,V5,191,NA,NA,NA,NA,NA,14/oct/2021,Positif,31.6,NA,Négatif,0.9,IAL061V5b,44,4.2,3.8,Vasculitis,Large vessel vasculitis,Prednisone 12.5mg,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL061,F,66.3,Pfizer,3M3,329,81,NA,NA,NA,NA,01/mar/2022,Positif,100,2585,Négatif,0.4,IAL061 3M3,384.9,136.4,121.1,Vasculitis,Large vessel vasculitis,Prednisone 12.5mg,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL061,F,66.3,Pfizer,3M6,422,174,NA,NA,NA,NA,02/jun/2022,Positif,191.8,9464,Négatif,0.4,IAL061 3M6,270.05130974885225,102.70103728047653,67.88866259334691,Vasculitis,Large vessel vasculitis,Prednisone 12.5mg,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone,H02AB07,"NA"
IAL062,F,38.3,Pfizer,V3,35,NA,NA,V5-3M3,NA,NA,27/mai/2021,Positif,142.5,NA,NA,NA,IAL062V3b,710.7,297.4,47.3,SLE,SLE,"HCQ, CS, PROGRAF, Revious Anti-CD20>1y","CNI + cs or bDMARD + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,HCQ,P01BA02,"NA"
IAL062,F,38.3,Pfizer,V4,84,NA,NA,V5-3M3,NA,NA,15/jui/2021,Positif,67,NA,Négatif,0.3,IAL062V4b,222.6,88.4,29.4,SLE,SLE,"HCQ, CS, PROGRAF, Revious Anti-CD20>1y","CNI + cs or bDMARD + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,HCQ,P01BA02,"NA"
IAL062,F,38.3,Pfizer,V5,194,NA,NA,V5-3M3,NA,NA,02/nov/2021,Positif,73.4,NA,Négatif,0.2,IAL062V5b,118.2,56.9,17.8,SLE,SLE,"HCQ, CS, PROGRAF, Revious Anti-CD20>1y","CNI + cs or bDMARD + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,HCQ,P01BA02,"NA"
IAL062,F,38.3,Pfizer,3M3,372,95,NA,V5-3M3,48,NA,29/avr/2022,Positif,165.6,7059,Positif,7.8,IAL062 3M3,2430,2430,1942.5019425019423,SLE,SLE,"HCQ, CS, PROGRAF, Revious Anti-CD20>1y","CNI + cs or bDMARD + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,HCQ,P01BA02,"NA"
IAL063,F,23.3,Pfizer,V3,31,NA,NA,NA,NA,NA,10/mai/2021,Positif,110.3,NA,NA,NA,IAL063V3b,334.3,149.7,43.3,Primary immunodeficiency,Primary immunodeficiency (not classified),"Octagam 28.12.2020, 20.01, 10.02, 02.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Octagam,J06BA02,"NA"
IAL063,F,23.3,Pfizer,V4,94,NA,NA,NA,NA,NA,12/jui/2021,Positif,51.4,NA,Négatif,2.1,IAL063V4b,113,49,22,Primary immunodeficiency,Primary immunodeficiency (not classified),"Octagam 28.12.2020, 20.01, 10.02, 02.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Octagam,J06BA02,"NA"
IAL063,F,23.3,Pfizer,V5,185,NA,NA,NA,NA,NA,11/oct/2021,Positif,36.3,NA,Négatif,2.5,IAL063V5b,72.5,34.2,16.2,Primary immunodeficiency,Primary immunodeficiency (not classified),"Octagam 28.12.2020, 20.01, 10.02, 02.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Octagam,J06BA02,"NA"
IAL063,F,23.3,Pfizer,3M3,318,85,NA,NA,NA,NA,21/fév/2022,Positif,83.3,1798,Négatif,1.8,IAL063 3M3,369.8,102.2,85.3,Primary immunodeficiency,Primary immunodeficiency (not classified),"Octagam 28.12.2020, 20.01, 10.02, 02.03.2021",IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Octagam,J06BA02,"NA"
IAL065,F,43.3,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,10/mai/2021,Positif,109.6,NA,NA,NA,IAL065V3b,425,130.5,61.3,Vasculitis,polyarteritis nodosa PAN,"Colchicine 1mg, Prednisone Stop Mai 2019, Azarek 50mg",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine|Prednisone|Azarek,M04AC01|H02AB07|L04AX01,"NA"
IAL065,F,43.3,Pfizer,V4,84,NA,NA,V5-3M3,NA,NA,05/jui/2021,Positif,84.6,NA,Négatif,0.4,IAL065V4b,1038.1,282.2,198.1,Vasculitis,polyarteritis nodosa PAN,"Colchicine 1mg, Prednisone Stop Mai 2019, Azarek 50mg",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine|Prednisone|Azarek,M04AC01|H02AB07|L04AX01,"NA"
IAL065,F,43.3,Pfizer,V5,176,NA,NA,V5-3M3,NA,NA,05/oct/2021,Positif,50.2,NA,Négatif,0.2,IAL065V5b,166.5,73.8,37.4,Vasculitis,polyarteritis nodosa PAN,"Colchicine 1mg, Prednisone Stop Mai 2019, Azarek 50mg",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine|Prednisone|Azarek,M04AC01|H02AB07|L04AX01,"NA"
IAL065,F,43.3,Pfizer,3M3,346,94,NA,V5-3M3,13,NA,24/mar/2022,Positif,111.1,3187,Négatif,0.9,IAL065 3M3,1175.8,439.4,291.4,Vasculitis,polyarteritis nodosa PAN,"Colchicine 1mg, Prednisone Stop Mai 2019, Azarek 50mg",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine|Prednisone|Azarek,M04AC01|H02AB07|L04AX01,"NA"
IAL066,F,58.3,Pfizer,V3,34,NA,NA,NA,NA,NA,17/mai/2021,Négatif,0.3,NA,NA,NA,IAL066V3b,1,1,1,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL066,F,58.3,Pfizer,V4,91,NA,NA,NA,NA,NA,13/jui/2021,Négatif,0.3,NA,Négatif,0.2,IAL066V4b,1,1,1,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL066,F,58.3,Pfizer,V5,183,35,NA,NA,NA,NA,13/oct/2021,Négatif,0.3,NA,Négatif,0.1,IAL066V5b,1,1,1,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL066,F,58.3,Pfizer,3M3,246,98,NA,NA,NA,NA,15/déc/2021,Négatif,0.5,1,Négatif,0.2,IAL066 3M3b,0.8,3.6,2.2,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL066,F,58.3,Pfizer,3M6,337,189,NA,NA,NA,NA,16/mar/2022,Négatif,0.4,0,Négatif,0.1,IAL066 3M6,1,1,1,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL066,F,58.3,Pfizer,3M9,407,259,NA,NA,NA,NA,25/mai/2022,Négatif,0.4,0,Négatif,0.1,IAL069 3M6,1,1,1,SLE,SEL,"Benlysta 600 Mg, RTX 13.01.2020, RTX 27.04.21","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days + IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Benlysta|RTX,L04AA26|L01FA01,L04AA26
IAL067,F,51.3,Pfizer,V3,36,NA,NA,NA,NA,NA,27/mai/2021,Négatif,1.2,NA,NA,NA,IAL067V3b,1,1,1,Other,relapsing polychondritis,"REMICADE, CS, MTX",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE|MTX,L04AB02|L04AX03,L04AB02
IAL067,F,51.3,Pfizer,V4,90,NA,NA,NA,NA,NA,20/jui/2021,Négatif,0.3,NA,Négatif,0.4,IAL067V4b,1,1,1,Other,relapsing polychondritis,"REMICADE, CS, MTX",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,REMICADE,REMICADE|MTX,L04AB02|L04AX03,L04AB02
IAL068,F,39.3,Pfizer,V3,29,NA,NA,V5-3M3,NA,NA,12/mai/2021,Positif,50.5,NA,NA,NA,IAL068V3b,32.3,9.1,3.7,Inflammatory cardiomyopathy,Idiopathic recurrent pericarditis,"Actemra 162 Mg 1x/2semaine -> 1x/Semaine DÈS 20.05.2020, Prednisone 5 Mg 1x/Jour (à 5 Mg Depuis 1 Semaine),Colchicine 0.5mg 2x/Jour -> Plaquenil DÈS 20.05 2020",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra|Prednisone|Colchicine,L04AC07|H02AB07|M04AC01,"NA"
IAL068,F,39.3,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,14/jui/2021,Positif,22.8,NA,Négatif,0.1,IAL068V4b,43.3,19.8,12.7,Inflammatory cardiomyopathy,Idiopathic recurrent pericarditis,"Actemra 162 Mg 1x/2semaine -> 1x/Semaine DÈS 20.05.2020, Prednisone 5 Mg 1x/Jour (à 5 Mg Depuis 1 Semaine),Colchicine 0.5mg 2x/Jour -> Plaquenil DÈS 20.05 2020",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra|Prednisone|Colchicine,L04AC07|H02AB07|M04AC01,"NA"
IAL068,F,39.3,Pfizer,V5,183,NA,NA,V5-3M3,NA,NA,13/oct/2021,Positif,15.1,NA,Négatif,0.1,IAL068V5b,1,1,1,Inflammatory cardiomyopathy,Idiopathic recurrent pericarditis,"Actemra 162 Mg 1x/2semaine -> 1x/Semaine DÈS 20.05.2020, Prednisone 5 Mg 1x/Jour (à 5 Mg Depuis 1 Semaine),Colchicine 0.5mg 2x/Jour -> Plaquenil DÈS 20.05 2020",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra|Prednisone|Colchicine,L04AC07|H02AB07|M04AC01,"NA"
IAL068,F,39.3,Pfizer,3M3,290,107,NA,V5-3M3,17,NA,28/jan/2022,Positif,104.5,2821,Négatif,3.8,IAL068 3M3,481.5,251.6,145.4,Inflammatory cardiomyopathy,Idiopathic recurrent pericarditis,"Actemra 162 Mg 1x/2semaine -> 1x/Semaine DÈS 20.05.2020, Prednisone 5 Mg 1x/Jour (à 5 Mg Depuis 1 Semaine),Colchicine 0.5mg 2x/Jour -> Plaquenil DÈS 20.05 2020",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra|Prednisone|Colchicine,L04AC07|H02AB07|M04AC01,"NA"
IAL068,F,39.3,Pfizer,3M6,385,202,NA,V5-3M3,112,NA,03/mai/2022,Positif,179.5,8291,Négatif,1,IAL068 3M6,521.376433785193,233.1545814875262,149.1201908738443,Inflammatory cardiomyopathy,Idiopathic recurrent pericarditis,"Actemra 162 Mg 1x/2semaine -> 1x/Semaine DÈS 20.05.2020, Prednisone 5 Mg 1x/Jour (à 5 Mg Depuis 1 Semaine),Colchicine 0.5mg 2x/Jour -> Plaquenil DÈS 20.05 2020",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra|Prednisone|Colchicine,L04AC07|H02AB07|M04AC01,"NA"
IAL069,M,51.3,Pfizer/Moderna,V3,29,NA,NA,NA,NA,NA,12/mai/2021,Positif,118.8,NA,NA,NA,IAL069V3b,466.6,148.8,70.2,Sarcoidosis,Cardiac sarcoidosis,"Remicade 500 Mg IV, MTX",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade|MTX,L04AB02|L04AX03,L04AB02
IAL069,M,51.3,Pfizer/Moderna,V4,99,NA,NA,NA,NA,NA,21/jui/2021,Positif,64.6,NA,Négatif,2.5,IAL069V4b,104,56.1,16.7,Sarcoidosis,Cardiac sarcoidosis,"Remicade 500 Mg IV, MTX",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade|MTX,L04AB02|L04AX03,L04AB02
IAL069,M,51.3,Pfizer/Moderna,V5,184,NA,NA,NA,NA,NA,14/oct/2021,Positif,44.2,NA,Négatif,2.3,IAL069V5b,105.1,55.3,23.2,Sarcoidosis,Cardiac sarcoidosis,"Remicade 500 Mg IV, MTX",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade|MTX,L04AB02|L04AX03,L04AB02
IAL069,M,51.3,Pfizer/Moderna,3M3,336,91,NA,NA,NA,NA,15/mar/2022,Positif,93.2,2247,Négatif,2,IAL069 3M3,338,149.2,111.5,Sarcoidosis,Cardiac sarcoidosis,"Remicade 500 Mg IV, MTX",bDMARD + cs DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade|MTX,L04AB02|L04AX03,L04AB02
IAL070,F,27.3,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,12/mai/2021,Négatif,2.5,NA,NA,NA,IAL070V3b,1,1,1,CVID,CVID + Sp multiples syndromes autoimmuns,"RTX 2016, Privigen","anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g) and IVIG",NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,RTX|Privigen,L01FA01|J06BA02,J06BA02
IAL070,F,27.3,Pfizer,V4,98,NA,NA,V5-3M3,NA,NA,21/jui/2021,Négatif,1.7,NA,Négatif,0.8,IAL070V4b,1,1,1,CVID,CVID + Sp multiples syndromes autoimmuns,"RTX 2016, Privigen","anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g) and IVIG",NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,RTX|Privigen,L01FA01|J06BA02,J06BA02
IAL070,F,27.3,Pfizer,V5,188,NA,NA,V5-3M3,NA,NA,19/oct/2021,Positif,12,NA,Négatif,3.1,IAL070V5b,1,1,1,CVID,CVID + Sp multiples syndromes autoimmuns,"RTX 2016, Privigen","anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g) and IVIG",NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,RTX|Privigen,L01FA01|J06BA02,J06BA02
IAL070,F,27.3,Pfizer,3M3,362,96,NA,V5-3M3,24,NA,11/avr/2022,Positif,78.8,1611,Négatif,2.9,IAL070 3M3,216.8,119.2,51.7,CVID,CVID + Sp multiples syndromes autoimmuns,"RTX 2016, Privigen","anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g) and IVIG",NA,anti-CD20 therapy>365 days + other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,RTX|Privigen,L01FA01|J06BA02,J06BA02
IAL071,M,79.3,Pfizer,V3,32,NA,4th dose: 23.04.2022,NA,NA,NA,11/mai/2021,Positif,19.1,NA,NA,NA,IAL071V3b,13.8,12.4,4.7,GVHD,AML 2016 + alloHSC + GVHD 2020,"Prednisone, Jakavi 5 Mg 2cp/ 2x/J, Privigen",Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Jakavi|Privigen,Prednisone|Jakavi|Privigen,H02AB07|L01EJ01|J06BA02,L01EJ01|J06BA02
IAL071,M,79.3,Pfizer,V4,108,NA,4th dose: 23.04.2022,NA,NA,NA,26/jui/2021,Positif,7.1,NA,Négatif,0.4,IAL071V4b,1,1,1,GVHD,AML 2016 + alloHSC + GVHD 2020,"Prednisone, Jakavi 5 Mg 2cp/ 2x/J, Privigen",Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Jakavi|Privigen,Prednisone|Jakavi|Privigen,H02AB07|L01EJ01|J06BA02,L01EJ01|J06BA02
IAL071,M,79.3,Pfizer,V5,180,NA,4th dose: 23.04.2022,NA,NA,NA,06/oct/2021,Indéterminé,5.8,NA,Négatif,0.3,IAL071V5b,1,1,1,GVHD,AML 2016 + alloHSC + GVHD 2020,"Prednisone, Jakavi 5 Mg 2cp/ 2x/J, Privigen",Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Jakavi|Privigen,Prednisone|Jakavi|Privigen,H02AB07|L01EJ01|J06BA02,L01EJ01|J06BA02
IAL071,M,79.3,Pfizer,3M3,279,93,4th dose: 23.04.2022,NA,NA,NA,13/jan/2022,Positif,98.1,2488,Négatif,0.1,IAL071 3M3,820.3,223.4,138.4,GVHD,AML 2016 + alloHSC + GVHD 2020,"Prednisone, Jakavi 5 Mg 2cp/ 2x/J, Privigen",Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Jakavi|Privigen,Prednisone|Jakavi|Privigen,H02AB07|L01EJ01|J06BA02,L01EJ01|J06BA02
IAL071,M,79.3,Pfizer,3M6,367,181,4th dose: 23.04.2022,NA,NA,NA,11/avr/2022,Positif,98.8,2524,Négatif,0,IAL071 3M6,518.4,211.8,113.3,GVHD,AML 2016 + alloHSC + GVHD 2020,"Prednisone, Jakavi 5 Mg 2cp/ 2x/J, Privigen",Janus kinase inhibitors and IVIG,NA,IS + other treatment,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Jakavi|Privigen,Prednisone|Jakavi|Privigen,H02AB07|L01EJ01|J06BA02,L01EJ01|J06BA02
IAL073,F,32.2,Pfizer,V3,74,NA,NA,V1-V2,mars-mai 2021,NA,31/mai/2021,Positif,112.2,NA,NA,NA,IAL073V3b,198.5,68.4,14,SLE,SLE,"Cellcept, HCQ",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL073,F,32.2,Pfizer,V4,133,NA,NA,V1-V2,mars-mai 2021,NA,29/jui/2021,Positif,61.5,NA,Négatif,2.4,IAL073V4b,141.6,47.2,11.7,SLE,SLE,"Cellcept, HCQ",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL073,F,32.2,Pfizer,V5,189,NA,NA,V1-V2,mars-mai 2021,NA,23/sep/2021,Positif,45.1,NA,Négatif,1.2,IAL073V5b,60.1,28.3,7.9,SLE,SLE,"Cellcept, HCQ",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL073,F,32.2,Pfizer,V6,371,NA,NA,V1-V2,mars-mai 2021,NA,24/mar/2022,Positif,112.3,3256,Positif,27,IAL073V6,708.2,254.3,154,SLE,SLE,"Cellcept, HCQ",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL075,F,39.3,Pfizer,3M3,365,103,NA,NA,NA,NA,19/avr/2022,Positif,101.8,2678,Positif,12.1,IAL075 3M3,814.3,275.3,202.4,Other,Dysthyroid orbitopathy,Anti IL6R,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL076,F,61.3,Moderna,V3,29,NA,NA,NA,NA,NA,20/mai/2021,Positif,75.7,NA,NA,NA,IAL076V3b,1518.6,458.9,134.7,Vasculitis,Granulomatosis with polyangiitis (vasculitis),"CS, Previous Anti-CD20 > 1y","CS + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL076,F,61.3,Moderna,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,69.1,NA,Négatif,0.4,IAL076V4b,89.6,54.1,22.4,Vasculitis,Granulomatosis with polyangiitis (vasculitis),"CS, Previous Anti-CD20 > 1y","CS + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL076,F,61.3,Moderna,V5,190,NA,NA,NA,NA,NA,28/oct/2021,Positif,81.1,NA,Négatif,0.8,IAL076V5b,281.5,132.2,62,Vasculitis,Granulomatosis with polyangiitis (vasculitis),"CS, Previous Anti-CD20 > 1y","CS + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL076,F,61.3,Moderna,3M3,314,87,NA,NA,NA,NA,01/mar/2022,Positif,98.2,2493,Négatif,0.4,IAL076 3M3,2430,1282.7,264.1,Vasculitis,Granulomatosis with polyangiitis (vasculitis),"CS, Previous Anti-CD20 > 1y","CS + anti-CD20 therapy (> 1 year) (1g, 0.5g, 025g)",NA,anti-CD20 therapy>365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL077,M,36.3,Pfizer,V3,34,NA,NA,V5-V6,NA,NA,27/mai/2021,Positif,6.3,NA,NA,NA,IAL077V3b,2.2,4.9,3,CVID,Common variable immunodeficiency,NA,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,"NA","NA","NA","NA"
IAL077,M,36.3,Pfizer,V4,95,NA,NA,V5-V6,NA,NA,27/jui/2021,Indéterminé,4.2,NA,Négatif,0.3,IAL077V4b,1,1,1,CVID,Common variable immunodeficiency,NA,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,"NA","NA","NA","NA"
IAL077,M,36.3,Pfizer,V5,195,20,NA,V5-V6,NA,NA,04/nov/2021,Positif,8.6,NA,Négatif,1.5,IAL077V5b,1,1,1,CVID,Common variable immunodeficiency,NA,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,"NA","NA","NA","NA"
IAL077,M,36.3,Pfizer,V6,367,192,NA,V5-V6,95,NA,25/avr/2022,Positif,72.8,1377,Indéterminé,4.7,IAL077V6,112.9,95.7,69.4,CVID,Common variable immunodeficiency,NA,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,"NA","NA","NA","NA"
IAL078,F,28.3,Pfizer,V3,30,NA,NA,V5-V6,NA,NA,19/mai/2021,Positif,43.5,NA,NA,NA,IAL078V3b,15.1,2.5,1,Autoinflammatory diseases,PFAPA syndrome,"Tofacitinib 5mg 2x Depuis FÉVrier 2021, MTX 15 Mg 1x/Semaine, Colchicine 2mg 1x/J",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tofacitinib,Tofacitinib|MTX|Colchicine,L04AA29|L04AX03|M04AC01,L04AA29
IAL078,F,28.3,Pfizer,V4,87,NA,NA,V5-V6,NA,NA,15/jui/2021,Positif,21.1,NA,Négatif,1.9,IAL078V4b,10.6,2.8,0.4,Autoinflammatory diseases,PFAPA syndrome,"Tofacitinib 5mg 2x Depuis FÉVrier 2021, MTX 15 Mg 1x/Semaine, Colchicine 2mg 1x/J",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tofacitinib,Tofacitinib|MTX|Colchicine,L04AA29|L04AX03|M04AC01,L04AA29
IAL078,F,28.3,Pfizer,V5,183,NA,NA,V5-V6,NA,NA,19/oct/2021,Positif,18.6,NA,Négatif,2.3,IAL078V5b,1,1,1,Autoinflammatory diseases,PFAPA syndrome,"Tofacitinib 5mg 2x Depuis FÉVrier 2021, MTX 15 Mg 1x/Semaine, Colchicine 2mg 1x/J",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tofacitinib,Tofacitinib|MTX|Colchicine,L04AA29|L04AX03|M04AC01,L04AA29
IAL078,F,28.3,Pfizer,V6,365,NA,NA,V5-V6,NA,NA,19/avr/2022,Positif,97.1,2438,Négatif,3.6,IAL078V6,467.1,248.3,248.1,Autoinflammatory diseases,PFAPA syndrome,"Tofacitinib 5mg 2x Depuis FÉVrier 2021, MTX 15 Mg 1x/Semaine, Colchicine 2mg 1x/J",Janus kinase inhibitors,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tofacitinib,Tofacitinib|MTX|Colchicine,L04AA29|L04AX03|M04AC01,L04AA29
IAL080,M,40.4,Pfizer,V3,31,NA,NA,NA,NA,NA,11/jun/2021,Positif,82.8,NA,Négatif,2.4,IAL080V3b,149.1,62.2,29.5,Autoinflammatory diseases,Familial Mediterranean fever (Auto inflammatory disease),"Colchicine, Anti-IL1",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine,M04AC01,"NA"
IAL080,M,40.4,Pfizer,V4,85,NA,NA,NA,NA,NA,04/aoû/2021,Positif,40.6,NA,Négatif,2.3,IAL080V4b,77.7,6.5,19.8,Autoinflammatory diseases,Familial Mediterranean fever (Auto inflammatory disease),"Colchicine, Anti-IL1",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine,M04AC01,"NA"
IAL080,M,40.4,Pfizer,V5,192,NA,NA,NA,NA,NA,19/nov/2021,Positif,93.4,NA,Négatif,2,IAL080V5b,367.4,191,121.9,Autoinflammatory diseases,Familial Mediterranean fever (Auto inflammatory disease),"Colchicine, Anti-IL1",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Colchicine,M04AC01,"NA"
IAL081,F,66.2,Moderna,V3,29,NA,NA,NA,NA,NA,15/avr/2021,Positif,67,NA,NA,NA,IAL081V3b,64.1,13.1,4.4,Sjoegren's syndrome,Sjoegren's with ILD,MMF 1500,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,MMF,L04AA06,"NA"
IAL081,F,66.2,Moderna,V4,103,NA,NA,NA,NA,NA,28/jun/2021,Positif,66.8,NA,Négatif,0.3,IAL081V4b,95,34,18,Sjoegren's syndrome,Sjoegren's with ILD,MMF 1500,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,MMF,L04AA06,"NA"
IAL081,F,66.2,Moderna,V5,271,NA,NA,NA,NA,NA,13/déc/2021,Positif,65.6,1121,Négatif,0.2,IAL081V5b,121.4,48.8,31.7,Sjoegren's syndrome,Sjoegren's with ILD,MMF 1500,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,MMF,L04AA06,"NA"
IAL081,F,66.2,Moderna,3M3,356,78,NA,NA,NA,NA,08/mar/2022,Positif,85.5,1894,Négatif,0.3,IAL081 3M3,565.9,214.5,150.5,Sjoegren's syndrome,Sjoegren's with ILD,MMF 1500,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,MMF,L04AA06,"NA"
IAL082,F,70.4,Moderna,V3,31,NA,NA,NA,NA,NA,10/jun/2021,Positif,112,NA,Positif,7.7,IAL082V3b,1148,293.8,111.5,Systemic sclerosis,Systemic sclerosis,"OFEV, CS",Tyrosine kinase inhibitor TKI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,OFEV,OFEV,L01EX09,L01XE
IAL082,F,70.4,Moderna,V4,93,NA,NA,NA,NA,NA,11/aoû/2021,Positif,65.6,NA,Positif,10.7,IAL082V4b,168.1,54.9,42.8,Systemic sclerosis,Systemic sclerosis,"OFEV, CS",Tyrosine kinase inhibitor TKI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,OFEV,OFEV,L01EX09,L01XE
IAL082,F,70.4,Moderna,V5,182,NA,NA,NA,NA,NA,08/nov/2021,Positif,38.7,NA,Positif,8.7,IAL082V5b,181,63.8,30.7,Systemic sclerosis,Systemic sclerosis,"OFEV, CS",Tyrosine kinase inhibitor TKI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,OFEV,OFEV,L01EX09,L01XE
IAL082,F,70.4,Moderna,V6,372,NA,NA,NA,NA,NA,17/mai/2022,Positif,151.3,5895,Positif,7.3,IAL082V6,715.8,211.9,131.6,Systemic sclerosis,Systemic sclerosis,"OFEV, CS",Tyrosine kinase inhibitor TKI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,OFEV,OFEV,L01EX09,L01XE
IAL083,F,55.3,Pfizer,V3,31,NA,NA,NA,NA,NA,20/mai/2021,Positif,94.5,NA,NA,NA,IAL083V3b,299.8,152.8,55.9,CVID,CVID groupe smB+CD21lo,Privigen,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL083,F,55.3,Pfizer,V4,92,NA,NA,NA,NA,NA,20/jui/2021,Positif,63.6,NA,Négatif,0.8,IAL083V4b,182.7,111,52.2,CVID,CVID groupe smB+CD21lo,Privigen,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL083,F,55.3,Pfizer,V5,183,NA,NA,NA,NA,NA,19/oct/2021,Positif,37.7,NA,Négatif,1.2,IAL083V5b,72.3,46.4,24.6,CVID,CVID groupe smB+CD21lo,Privigen,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL083,F,55.3,Pfizer,3M3,323,83,NA,NA,NA,NA,08/mar/2022,Positif,84.7,1859,Négatif,1.8,IAL083 3M3,268.7,139.1,86.2,CVID,CVID groupe smB+CD21lo,Privigen,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL084,F,29.3,Pfizer,V3,29,NA,NA,NA,NA,NA,12/mai/2021,Positif,115,NA,NA,NA,IAL084V3b,1542.5,436.1,242.2,Behcet's,Behcet's avec atteinte multi-systémique,Remicade 5 Mg/Kg,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade,L04AB02,L04AB02
IAL084,F,29.3,Pfizer,V4,91,NA,NA,NA,NA,NA,13/jui/2021,Positif,80.5,NA,Indéterminé,5.1,IAL084V4b,441.1,224.4,72.9,Behcet's,Behcet's avec atteinte multi-systémique,Remicade 5 Mg/Kg,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade,L04AB02,L04AB02
IAL084,F,29.3,Pfizer,V5,185,NA,NA,NA,NA,NA,15/oct/2021,Positif,90.4,NA,Positif,6.4,IAL084V5b,310.6,139.7,81.7,Behcet's,Behcet's avec atteinte multi-systémique,Remicade 5 Mg/Kg,bDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Remicade,Remicade,L04AB02,L04AB02
IAL085,M,48.4,Moderna,V3,29,NA,NA,V4-V5,NA,NA,08/jun/2021,Positif,96.3,NA,NA,NA,IAL085V3b,783.7,305.5,94.9,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL085,M,48.4,Moderna,V4,99,NA,NA,V4-V5,NA,NA,17/aoû/2021,Positif,68,NA,Négatif,1.5,IAL085V4b,289.9,141.5,50.1,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL085,M,48.4,Moderna,V5,183,NA,NA,V4-V5,56,NA,09/nov/2021,Positif,87,NA,Positif,7.1,IAL085V5b,6978.4,2423.7,507.9,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL085,M,48.4,Moderna,V6,365,NA,NA,V4-V5,238,NA,10/mai/2022,Positif,146.5,5528,Négatif,3.3,IAL085  V6,1776.1989342806394,1028.7007509515481,202.79862096937742,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL086,M,36.3,Pfizer,V3,34,NA,NA,NA,NA,NA,31/mai/2021,Positif,100,NA,NA,NA,IAL086V3b,143.5,26.6,21.4,SLE,SLE,"Cellcept, HCQ, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL086,M,36.3,Pfizer,V4,92,NA,NA,NA,NA,NA,28/jui/2021,Positif,76.8,NA,Négatif,0.8,IAL086V4b,82.3,15.7,14.6,SLE,SLE,"Cellcept, HCQ, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL086,M,36.3,Pfizer,V5,184,NA,NA,NA,NA,NA,28/oct/2021,Positif,84.9,NA,Négatif,0.8,IAL086V5b,211.4,103.6,47.5,SLE,SLE,"Cellcept, HCQ, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept|HCQ,L04AA06|P01BA02,L04AA06
IAL087,F,24.3,Pfizer,V3,35,NA,NA,NA,NA,NA,27/mai/2021,Positif,116.2,NA,NA,NA,IAL087V3b,127.7,21.5,53.3,SLE,SLE,"Imurek 50 MG, CS, HCQ, Benlysta",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Imurek|HCQ|Benlysta,L04AX01|P01BA02|L04AA26,L04AA26
IAL087,F,24.3,Pfizer,V4,91,NA,NA,NA,NA,NA,22/jui/2021,Positif,50.5,NA,Négatif,0.2,IAL087V4b,84.2,24.9,15,SLE,SLE,"Imurek 50 MG, CS, HCQ, Benlysta",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Imurek|HCQ|Benlysta,L04AX01|P01BA02|L04AA26,L04AA26
IAL087,F,24.3,Pfizer,V5,189,NA,NA,NA,NA,NA,28/oct/2021,Positif,21.6,NA,Négatif,0.3,IAL087V5b,35.2,12.6,8.9,SLE,SLE,"Imurek 50 MG, CS, HCQ, Benlysta",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Imurek|HCQ|Benlysta,L04AX01|P01BA02|L04AA26,L04AA26
IAL087,F,24.3,Pfizer,V6,372,NA,NA,NA,NA,NA,29/avr/2022,Positif,164.8,6991,Négatif,0,IAL087V6,616.9,322.5,339.6,SLE,SLE,"Imurek 50 MG, CS, HCQ, Benlysta",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta,Imurek|HCQ|Benlysta,L04AX01|P01BA02|L04AA26,L04AA26
IAL088,F,22.3,Pfizer,V3,33,NA,NA,NA,NA,NA,31/mai/2021,Positif,68,NA,NA,NA,IAL088V3b,53.4,26.5,10.7,Behcet's,Behcet disease,"Imurek 150 Mg, Colchicine, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek|Colchicine,L04AX01|M04AC01,"NA"
IAL088,F,22.3,Pfizer,V4,91,NA,NA,NA,NA,NA,28/jui/2021,Positif,38.8,NA,Négatif,0.2,IAL088V4b,80.6,34.3,19.8,Behcet's,Behcet disease,"Imurek 150 Mg, Colchicine, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek|Colchicine,L04AX01|M04AC01,"NA"
IAL088,F,22.3,Pfizer,V5,194,NA,NA,NA,NA,NA,08/nov/2021,Positif,16.4,NA,Négatif,0.3,IAL088V5b,35.8,26.4,13,Behcet's,Behcet disease,"Imurek 150 Mg, Colchicine, CS",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek|Colchicine,L04AX01|M04AC01,"NA"
IAL089,F,39.3,Pfizer,V3,34,NA,NA,NA,NA,NA,31/mai/2021,Positif,96.7,NA,NA,NA,IAL089V3b,914.9,367.8,94.2,Sjoegren's syndrome,Sjoegren's syndrome,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL089,F,39.3,Pfizer,V4,93,NA,NA,NA,NA,NA,29/jui/2021,Positif,76.1,NA,Négatif,0.8,IAL089V4b,160.1,100.7,70.3,Sjoegren's syndrome,Sjoegren's syndrome,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL089,F,39.3,Pfizer,V5,195,NA,NA,NA,NA,NA,08/nov/2021,Positif,56.3,NA,Négatif,0.6,IAL089V5b,93,47,21,Sjoegren's syndrome,Sjoegren's syndrome,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL089,F,39.3,Pfizer,3M3,364,85,NA,NA,NA,NA,26/avr/2022,Positif,159.2,6525,Négatif,0.3,IAL089 3M3,1380.1,429,361.1,Sjoegren's syndrome,Sjoegren's syndrome,Not Treated,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL090,M,50.3,Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,31/mai/2021,Positif,107.5,NA,NA,NA,IAL090V3b,190.3,59.1,37.9,Sarcoidosis,Sarcoidosis,"CS 5 Mg, Humira 40 Mg, Mtx 20 Mg",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira|Mtx,L04AB04|L04AX03,L04AB04
IAL090,M,50.3,Pfizer,V4,96,NA,NA,V5-3M3,NA,NA,04/aoû/2021,Positif,47.8,NA,Négatif,0.1,IAL090V4b,103.2,31.5,19,Sarcoidosis,Sarcoidosis,"CS 5 Mg, Humira 40 Mg, Mtx 20 Mg",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira|Mtx,L04AB04|L04AX03,L04AB04
IAL090,M,50.3,Pfizer,V5,201,NA,NA,V5-3M3,NA,NA,17/nov/2021,Positif,49.2,NA,Négatif,0.2,IAL090V5b,64.9,32,16.1,Sarcoidosis,Sarcoidosis,"CS 5 Mg, Humira 40 Mg, Mtx 20 Mg",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira|Mtx,L04AB04|L04AX03,L04AB04
IAL090,M,50.3,Pfizer,3M3,300,89,NA,V5-3M3,28,NA,24/fév/2022,Positif,100.9,2631,Indéterminé,5.7,IAL090 3M3,1689.8,954.2,602.8,Sarcoidosis,Sarcoidosis,"CS 5 Mg, Humira 40 Mg, Mtx 20 Mg",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira|Mtx,L04AB04|L04AX03,L04AB04
IAL090,M,50.3,Pfizer,3M6,390,179,NA,V5-3M3,118,NA,25/mai/2022,Positif,151.5,5911,Négatif,0.8,IAL090 3M6,801.9,548.8,347.6,Sarcoidosis,Sarcoidosis,"CS 5 Mg, Humira 40 Mg, Mtx 20 Mg",bDMARD + cs DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Humira|Mtx,L04AB04|L04AX03,L04AB04
IAL091,M,31.3,Moderna,V3,33,NA,NA,NA,NA,NA,08/jun/2021,Positif,106.1,NA,NA,NA,IAL091V3b,251.7,124.1,37.5,Other,cogan syndrome,Actemra 162 Mg 1x/W,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL091,M,31.3,Moderna,V4,90,NA,NA,NA,NA,NA,04/aoû/2021,Positif,67.6,NA,Négatif,0.2,IAL091V4b,194.6,111.7,32.8,Other,cogan syndrome,Actemra 162 Mg 1x/W,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL091,M,31.3,Moderna,V5,195,NA,NA,NA,NA,NA,17/nov/2021,Positif,74.5,NA,Négatif,0.3,IAL091V5b,167.4,95.7,24.7,Other,cogan syndrome,Actemra 162 Mg 1x/W,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL091,M,31.3,Moderna,V6,369,NA,NA,NA,NA,NA,10/mai/2022,Positif,149,5718,Négatif,0.1,IAL091 V6,359.3244699964068,227.27272727272725,78.98894154818326,Other,cogan syndrome,Actemra 162 Mg 1x/W,bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL092,M,32.3,Pfizer,V3,34,NA,NA,NA,NA,NA,31/mai/2021,Négatif,0.8,NA,NA,NA,IAL092V3b,1,1,1,Vasculitis,Vasculitis and Multiple sclerosis,"Ongoing Anti-CD20 Therapy < 1y, CS","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL092,M,32.3,Pfizer,V4,91,NA,NA,NA,NA,NA,27/jui/2021,Négatif,0.9,NA,Négatif,0.2,IAL092V4b,1,1,1,Vasculitis,Vasculitis and Multiple sclerosis,"Ongoing Anti-CD20 Therapy < 1y, CS","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL092,M,32.3,Pfizer,V5,183,41,NA,NA,NA,NA,27/oct/2021,Négatif,0.4,NA,Négatif,0.4,IAL092V5b,1,1,1,Vasculitis,Vasculitis and Multiple sclerosis,"Ongoing Anti-CD20 Therapy < 1y, CS","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL092,M,32.3,Pfizer,3M3,237,95,NA,NA,NA,NA,20/déc/2021,Négatif,0.1,0,Négatif,0.2,IAL092 3M3,3.2,6.9,4.3,Vasculitis,Vasculitis and Multiple sclerosis,"Ongoing Anti-CD20 Therapy < 1y, CS","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL092,M,32.3,Pfizer,3M6,322,180,NA,NA,NA,NA,15/mar/2022,Négatif,0.1,0,Négatif,0.1,IAL092 3M6,1,1,1,Vasculitis,Vasculitis and Multiple sclerosis,"Ongoing Anti-CD20 Therapy < 1y, CS","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL093,F,62.3,Pfizer,V3,35,NA,NA,V5-3M3,NA,NA,08/jun/2021,Positif,58,NA,NA,NA,IAL093V3b,123.2,75,30.6,Vasculitis,Vasculits X,"Mtx 15 Mg 1x/S, CS 8 Mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL093,F,62.3,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,04/aoû/2021,Positif,37.9,NA,Négatif,0.4,IAL093V4b,70.7,34.9,18.2,Vasculitis,Vasculits X,"Mtx 15 Mg 1x/S, CS 8 Mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL093,F,62.3,Pfizer,V5,190,NA,NA,V5-3M3,NA,NA,10/nov/2021,Positif,25.5,NA,Négatif,0.2,IAL093V5b,49.5,25.9,12.3,Vasculitis,Vasculits X,"Mtx 15 Mg 1x/S, CS 8 Mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL093,F,62.3,Pfizer,3M3,293,90,NA,V5-3M3,16,NA,21/fév/2022,Positif,82.4,1760,Négatif,3,IAL093 3M3,659.2,379.7,307.8,Vasculitis,Vasculits X,"Mtx 15 Mg 1x/S, CS 8 Mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL093,F,62.3,Pfizer,3M6,384,181,NA,V5-3M3,107,NA,23/mai/2022,Positif,148.1,5649,Indéterminé,5.8,IAL093 3M6,1255.8,1227.9,769.8,Vasculitis,Vasculits X,"Mtx 15 Mg 1x/S, CS 8 Mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL094,F,50.4,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,23/jun/2021,Positif,28,NA,Négatif,0.4,IAL094V3b,38,12.4,5.6,Sarcoidosis,Cardiac sarcoidosis,"Cellcept 1000-0-1000 Mg 2x/J, Prednisone 5mg/J, Hydroxychloroquine 200 Mg 2x/J Stop, Infliximab Depuis Juillet 2016 -> Stop 11.2018",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept|Infliximab,Cellcept|Prednisone|Hydroxychloroquine|Infliximab,L04AA06|H02AB07|P01BA02|L04AB02,L04AA06|L04AB02
IAL094,F,50.4,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,20/aoû/2021,Positif,25,NA,Négatif,0.3,IAL094V4b,41,16,10,Sarcoidosis,Cardiac sarcoidosis,"Cellcept 1000-0-1000 Mg 2x/J, Prednisone 5mg/J, Hydroxychloroquine 200 Mg 2x/J Stop, Infliximab Depuis Juillet 2016 -> Stop 11.2018",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept|Infliximab,Cellcept|Prednisone|Hydroxychloroquine|Infliximab,L04AA06|H02AB07|P01BA02|L04AB02,L04AA06|L04AB02
IAL094,F,50.4,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,25/nov/2021,Positif,38.5,NA,Négatif,0.3,IAL094V5b,1,1,1,Sarcoidosis,Cardiac sarcoidosis,"Cellcept 1000-0-1000 Mg 2x/J, Prednisone 5mg/J, Hydroxychloroquine 200 Mg 2x/J Stop, Infliximab Depuis Juillet 2016 -> Stop 11.2018",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept|Infliximab,Cellcept|Prednisone|Hydroxychloroquine|Infliximab,L04AA06|H02AB07|P01BA02|L04AB02,L04AA06|L04AB02
IAL094,F,50.4,Pfizer,3M3,320,85,NA,V5-3M3,76,NA,05/avr/2022,Positif,123.1,3908,Positif,7.9,IAL094 3M3,2430,1653.2,733.7,Sarcoidosis,Cardiac sarcoidosis,"Cellcept 1000-0-1000 Mg 2x/J, Prednisone 5mg/J, Hydroxychloroquine 200 Mg 2x/J Stop, Infliximab Depuis Juillet 2016 -> Stop 11.2018",IMDHI + cs or b DMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept|Infliximab,Cellcept|Prednisone|Hydroxychloroquine|Infliximab,L04AA06|H02AB07|P01BA02|L04AB02,L04AA06|L04AB02
IAL095,M,47.4,Pfizer,V3,33,NA,NA,NA,NA,NA,16/jun/2021,Positif,119.1,NA,Négatif,0.8,IAL095V3b,591.7,276.8,85,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL095,M,47.4,Pfizer,V4,89,NA,NA,NA,NA,NA,11/aoû/2021,Positif,72.1,NA,Négatif,0.7,IAL095V4b,188.7,114.6,31.8,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL095,M,47.4,Pfizer,V5,180,NA,NA,NA,NA,NA,10/nov/2021,Positif,68.2,NA,Négatif,2.1,IAL095V5b,365.1,210.7,79.3,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL095,M,47.4,Pfizer,V6,357,130,NA,NA,NA,NA,06/mai/2022,Positif,135.3,4718,Négatif,2,IAL095 V6,293.08323563892145,151.9756838905775,66.75567423230974,CVID,Common variable immunodeficiency,IVIG,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,IVIG,J06BA02,"NA"
IAL096,F,34.6,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,26/aoû/2021,Positif,97,NA,Négatif,0.7,IAL096V3b,332.3,113.6,20.3,SLE,Systemic lupus erythematosus,"Prednisone 5mg, Myfortic Dx 360mg, HCQ 300",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Myfortic|HCQ,H02AB07|L04AA06|P01BA02,"NA"
IAL096,F,34.6,Pfizer,V4,94,NA,NA,V5-3M3,NA,NA,25/oct/2021,Positif,48.4,NA,Négatif,0.6,IAL096V4b,117,52,6,SLE,Systemic lupus erythematosus,"Prednisone 5mg, Myfortic Dx 360mg, HCQ 300",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Myfortic|HCQ,H02AB07|L04AA06|P01BA02,"NA"
IAL096,F,34.6,Pfizer,V5,185,NA,NA,V5-3M3,NA,NA,24/jan/2022,Positif,40.3,429,Négatif,0.3,IAL096V5,57.1,22.5,4.4,SLE,Systemic lupus erythematosus,"Prednisone 5mg, Myfortic Dx 360mg, HCQ 300",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Myfortic|HCQ,H02AB07|L04AA06|P01BA02,"NA"
IAL096,F,34.6,Pfizer,3M3,290,94,NA,V5-3M3,24,NA,09/mai/2022,Positif,171.9,7605,Indéterminé,4.9,IAL096 3M3,467.2897196261682,141.7836381681554,89.84725965858041,SLE,Systemic lupus erythematosus,"Prednisone 5mg, Myfortic Dx 360mg, HCQ 300",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Myfortic|HCQ,H02AB07|L04AA06|P01BA02,"NA"
IAL097,F,42.4,Pfizer,V3,31,NA,NA,NA,NA,NA,05/jui/2021,Positif,69,NA,Négatif,0.8,IAL097V3b,100,17.2,14.3,SLE,SLE,"Prednisone 4 G/J Benlysta 1x/Mois, Cellcept Dx 500 Mg/JourHCQ 200mg 1/2x/Jour",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta|Cellcept,Prednisone|Benlysta|Cellcept|HCQ,H02AB07|L04AA26|L04AA06|P01BA02,L04AA26|L04AA06
IAL097,F,42.4,Pfizer,V4,95,NA,NA,NA,NA,NA,07/sep/2021,Positif,42.5,NA,Négatif,0.5,IAL097V4b,58,16.7,10.8,SLE,SLE,"Prednisone 4 G/J Benlysta 1x/Mois, Cellcept Dx 500 Mg/JourHCQ 200mg 1/2x/Jour",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta|Cellcept,Prednisone|Benlysta|Cellcept|HCQ,H02AB07|L04AA26|L04AA06|P01BA02,L04AA26|L04AA06
IAL097,F,42.4,Pfizer,V5,189,NA,NA,NA,NA,NA,10/déc/2021,Positif,24.8,167,Négatif,0.7,IAL097V5b,28.3,11.4,5.8,SLE,SLE,"Prednisone 4 G/J Benlysta 1x/Mois, Cellcept Dx 500 Mg/JourHCQ 200mg 1/2x/Jour",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Benlysta|Cellcept,Prednisone|Benlysta|Cellcept|HCQ,H02AB07|L04AA26|L04AA06|P01BA02,L04AA26|L04AA06
IAL098,M,66.5,Moderna,V3,33,NA,NA,Avant V1,285,NA,16/aoû/2021,Positif,68.7,NA,Négatif,3.3,IAL098V3b,1289.3,415.1,291,Sjoegren's syndrome,Sjoegren's syndrome - COVID XI-2020,"Prednisone 5mg, Azathioprine 100mg, HCQ 400mg, Belimumab 10mg/Kg/Month I/V",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine|Belimumab,Prednisone|Azathioprine|HCQ|Belimumab,H02AB07|L04AX01|P01BA02|L04AA26,L04AX01|L04AA26
IAL098,M,66.5,Moderna,3M3,232,76,NA,Avant V1,484,NA,03/mar/2022,Positif,91.8,2181,Négatif,1.5,IAL098 3M3,696.8641114982578,230.9468822170901,165.28925619834712,Sjoegren's syndrome,Sjoegren's syndrome - COVID XI-2020,"Prednisone 5mg, Azathioprine 100mg, HCQ 400mg, Belimumab 10mg/Kg/Month I/V",IMDHI + cs or b DMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Azathioprine|Belimumab,Prednisone|Azathioprine|HCQ|Belimumab,H02AB07|L04AX01|P01BA02|L04AA26,L04AX01|L04AA26
IAL099,F,82.4,Pfizer,V3,31,NA,NA,NA,NA,NA,02/jui/2021,Positif,63.4,NA,Positif,16.5,IAL099V3b,6472.5,2334.3,1458.2,Vasculitis,VASCULITIS (Horton),"Actemra, CS 50 Mg",bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL099,F,82.4,Pfizer,V4,93,NA,NA,NA,NA,NA,02/sep/2021,Positif,80.3,NA,Positif,16.7,IAL099V4b,2430,1862.5,1296.8,Vasculitis,VASCULITIS (Horton),"Actemra, CS 50 Mg",bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL099,F,82.4,Pfizer,V5,185,NA,NA,NA,NA,NA,03/déc/2021,Positif,58.1,882,Positif,10.8,IAL099V5b,2430,1879,1217,Vasculitis,VASCULITIS (Horton),"Actemra, CS 50 Mg",bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL099,F,82.4,Pfizer,V6,357,NA,NA,NA,NA,NA,24/mai/2022,Positif,144.4,5371,Positif,12.2,IAL099V6,2430,1350.1,933.7,Vasculitis,VASCULITIS (Horton),"Actemra, CS 50 Mg",bDMARD,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Actemra,L04AC07,"NA"
IAL100,F,50.5,Pfizer,V3,32,NA,NA,NA,NA,NA,19/jui/2021,Positif,58.1,NA,Négatif,0.2,IAL100V3b,190.7,17.2,10.6,Sarcoidosis,Sarcoidosis,Mtx 20 Mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL100,F,50.5,Pfizer,V4,92,NA,NA,NA,NA,NA,17/sep/2021,Positif,61.1,NA,Négatif,0.5,IAL100V4b,29,1,1,Sarcoidosis,Sarcoidosis,Mtx 20 Mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL100,F,50.5,Pfizer,V5,179,NA,NA,NA,NA,NA,13/déc/2021,Positif,79.4,1635,Négatif,0.6,IAL100V5b,1,1,1,Sarcoidosis,Sarcoidosis,Mtx 20 Mg,csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Mtx,L04AX03,"NA"
IAL101,M,62.4,Pfizer,V3,41,NA,NA,NA,NA,NA,20/jui/2021,Positif,57.8,NA,Négatif,0,IAL101V3b,207.9,62.9,44.4,Uveitis,Uveales Effusions-Syndrom (other diseases),CS 50 MG,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL101,M,62.4,Pfizer,V4,96,NA,NA,NA,NA,NA,13/sep/2021,Positif,36.5,NA,Négatif,0.3,IAL101V4b,107.8,50.2,24,Uveitis,Uveales Effusions-Syndrom (other diseases),CS 50 MG,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL101,M,62.4,Pfizer,V5,188,NA,NA,NA,NA,NA,14/déc/2021,Positif,29.7,237,Négatif,0,IAL101V5b,60.1,28.6,15.2,Uveitis,Uveales Effusions-Syndrom (other diseases),CS 50 MG,CS,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,,"NA","NA"
IAL102,F,27.6,Moderna,V3,31,NA,NA,NA,NA,NA,06/sep/2021,Positif,72.5,NA,Négatif,1.2,IAL102V3b,625,207.7,78.4,Uveitis,Uveitis,"Metoject 10mg, Humira 40mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Metoject|Humira,L04AX03|L04AB04,L04AB04
IAL102,F,27.6,Moderna,V4,95,NA,NA,NA,NA,NA,09/nov/2021,Positif,88.1,NA,Négatif,1,IAL102V4b,339,143.7,88.9,Uveitis,Uveitis,"Metoject 10mg, Humira 40mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Metoject|Humira,L04AX03|L04AB04,L04AB04
IAL102,F,27.6,Moderna,V5,187,NA,NA,NA,NA,NA,09/fév/2022,Positif,72.8,1377,Négatif,0.2,IAL102V5,136.7,85.9,37.9,Uveitis,Uveitis,"Metoject 10mg, Humira 40mg",csDMARD,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Humira,Metoject|Humira,L04AX03|L04AB04,L04AB04
IAL103,F,23.4,Pfizer,V3,35,NA,IVIG perfusion 4 days after 3rd dose,3M3-3M6,NA,NA,24/jun/2021,Positif,16.6,NA,Négatif,0.1,IAL103V3b,19.8,8.2,5.2,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL103,F,23.4,Pfizer,V4,92,NA,IVIG perfusion 4 days after 3rd dose,3M3-3M6,NA,NA,20/aoû/2021,Négatif,3.5,NA,Négatif,0.1,IAL103V4b,1,1,1,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL103,F,23.4,Pfizer,V5,181,70,IVIG perfusion 4 days after 3rd dose,3M3-3M6,NA,NA,17/nov/2021,Négatif,2.8,NA,Négatif,0.1,IAL103V5b,1,1,1,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL103,F,23.4,Pfizer,3M3,216,105,IVIG perfusion 4 days after 3rd dose,3M3-3M6,NA,NA,22/déc/2021,Négatif,1.9,2,Négatif,0.1,IAL103 3M3,2.2,7.5,4.1,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL103,F,23.4,Pfizer,3M6,300,189,IVIG perfusion 4 days after 3rd dose,3M3-3M6,61,NA,16/mar/2022,Positif,75.2,1468,Négatif,1.6,IAL103 3M6,144.8,92.9,131.3,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL103,F,23.4,Pfizer,3M9,377,266,IVIG perfusion 4 days after 3rd dose,3M3-3M6,138,NA,01/jun/2022,Positif,46.7,573,Négatif,0.6,IAL103 3M9,72.41129616220131,17.787264318747777,38.80481179666278,Myasthenia gravis,Myasthenia gravis,"Ongoing Anti-CD20 Therapy < 1y, Imurek 150 Mg","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Imurek,L04AX01,"NA"
IAL104,F,51.6,Pfizer,V3,34,NA,NA,NA,NA,NA,24/aoû/2021,Négatif,0.8,NA,Négatif,0.3,IAL104V3b,1,1,1,Inflammatory arthritis,"Rhumatoid arthritis, secondary humoral deficiency","Prednisone 5mg, Actemra I/V 400mg Every Month, Privigen Every 6 Weeks",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Prednisone|Actemra|Privigen,H02AB07|L04AC07|J06BA02,J06BA02
IAL104,F,51.6,Pfizer,V4,90,49,NA,NA,NA,NA,19/oct/2021,Négatif,0.6,NA,Négatif,0.3,IAL104V4b,1,1,1,Inflammatory arthritis,"Rhumatoid arthritis, secondary humoral deficiency","Prednisone 5mg, Actemra I/V 400mg Every Month, Privigen Every 6 Weeks",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Prednisone|Actemra|Privigen,H02AB07|L04AC07|J06BA02,J06BA02
IAL104,F,51.6,Pfizer,V5,188,147,NA,NA,NA,NA,25/jan/2022,Négatif,0.4,0,Négatif,0.3,IAL104V5,1,1,1,Inflammatory arthritis,"Rhumatoid arthritis, secondary humoral deficiency","Prednisone 5mg, Actemra I/V 400mg Every Month, Privigen Every 6 Weeks",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Prednisone|Actemra|Privigen,H02AB07|L04AC07|J06BA02,J06BA02
IAL104,F,51.6,Pfizer,3M6,223,182,NA,NA,NA,NA,01/mar/2022,Négatif,0.5,1,Négatif,0.1,IAL104 3M6,1,1,1,Inflammatory arthritis,"Rhumatoid arthritis, secondary humoral deficiency","Prednisone 5mg, Actemra I/V 400mg Every Month, Privigen Every 6 Weeks",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Prednisone|Actemra|Privigen,H02AB07|L04AC07|J06BA02,J06BA02
IAL104,F,51.6,Pfizer,3M9,299,258,NA,NA,NA,NA,16/mai/2022,Indéterminé,4.1,6,Négatif,1.1,IAL104 3M9,1,1,1,Inflammatory arthritis,"Rhumatoid arthritis, secondary humoral deficiency","Prednisone 5mg, Actemra I/V 400mg Every Month, Privigen Every 6 Weeks",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Prednisone|Actemra|Privigen,H02AB07|L04AC07|J06BA02,J06BA02
IAL105,M,70.5,Moderna,V3,33,NA,NA,NA,NA,NA,03/aoû/2021,Négatif,1.6,NA,Négatif,0.6,IAL105V3b,1,1,1,CVID,Common variable immunodeficiency,Privigen 30mg Monthly,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL105,M,70.5,Moderna,V4,96,14,NA,NA,NA,NA,05/oct/2021,Négatif,3.6,NA,Négatif,1,IAL105V4b,1,1,1,CVID,Common variable immunodeficiency,Privigen 30mg Monthly,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL105,M,70.5,Moderna,3M3,188,106,NA,NA,NA,NA,05/jan/2022,Positif,11.7,40,Négatif,2,IAL105 3M3b,16.4,18.2,1021.9,CVID,Common variable immunodeficiency,Privigen 30mg Monthly,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL105,M,70.5,Moderna,3M6,271,189,NA,NA,NA,NA,29/mar/2022,Positif,54.1,766,Négatif,2.3,IAL105 3M6,61.5,34.6,2430,CVID,Common variable immunodeficiency,Privigen 30mg Monthly,IVIG,NA,Other treatment,Other treatment,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Privigen,Privigen,J06BA02,J06BA02
IAL106,F,38.5,Moderna,V3,31,NA,NA,NA,NA,NA,03/aoû/2021,Négatif,1.8,NA,Négatif,0.7,IAL106V3b,1,1,1,CVID,"Common variable immunodeficiency, polyathritis, diabetes","Octagam 30mg Monthly, Prednisone 15mg, Rituximab VII/2020,","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Octagam|Prednisone|Rituximab,J06BA02|H02AB07|L01FA01,L01FA01
IAL106,F,38.5,Moderna,V4,94,NA,NA,NA,NA,NA,05/oct/2021,Positif,8.7,NA,Négatif,2.3,IAL106V4b,1,1,1,CVID,"Common variable immunodeficiency, polyathritis, diabetes","Octagam 30mg Monthly, Prednisone 15mg, Rituximab VII/2020,","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Octagam|Prednisone|Rituximab,J06BA02|H02AB07|L01FA01,L01FA01
IAL106,F,38.5,Moderna,V5,186,NA,NA,NA,NA,NA,05/jan/2022,Positif,31.3,262,Négatif,3,IAL106V5,57,37.5,19.2,CVID,"Common variable immunodeficiency, polyathritis, diabetes","Octagam 30mg Monthly, Prednisone 15mg, Rituximab VII/2020,","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Octagam|Prednisone|Rituximab,J06BA02|H02AB07|L01FA01,L01FA01
IAL106,F,38.5,Moderna,3M3,278,92,NA,NA,NA,NA,07/avr/2022,Positif,62.1,1005,Négatif,1,IAL106 3M3,179.1,111.4,58.9,CVID,"Common variable immunodeficiency, polyathritis, diabetes","Octagam 30mg Monthly, Prednisone 15mg, Rituximab VII/2020,","anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Octagam|Prednisone|Rituximab,J06BA02|H02AB07|L01FA01,L01FA01
IAL107,M,61.5,Pfizer,V5,193,20,NA,NA,NA,NA,10/jan/2022,Positif,126.4,4120,Indéterminé,5,IAL107V5,1105,522.7,305.3,Inflammatory arthritis,Adult-onset Still's disease,"Prednisone 2.5mg/Day, Actemra 162mg Weekly",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Actemra,H02AB07|L04AC07,"NA"
IAL107,M,61.5,Pfizer,3M3,265,92,NA,NA,NA,NA,23/mar/2022,Positif,86.5,1938,Positif,21.8,IAL107 3M3,672.9,528.8,381.1,Inflammatory arthritis,Adult-onset Still's disease,"Prednisone 2.5mg/Day, Actemra 162mg Weekly",bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,,Prednisone|Actemra,H02AB07|L04AC07,"NA"
IAL108,M,49.5,Moderna,V3,30,NA,NA,NA,NA,NA,30/jui/2021,Négatif,0.8,NA,Négatif,0.4,IAL108V3b,1,1,1,Autoinflammatory diseases,Dermatomyositis (anti-MDA5),Rituximab 250mg 10.03.21; 13.01.2021; 18.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL108,M,49.5,Moderna,V4,86,NA,NA,NA,NA,NA,24/sep/2021,Négatif,0.7,NA,Négatif,0.5,IAL108V4b,1,1,1,Autoinflammatory diseases,Dermatomyositis (anti-MDA5),Rituximab 250mg 10.03.21; 13.01.2021; 18.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL108,M,49.5,Moderna,V5,211,NA,NA,NA,NA,NA,27/jan/2022,Négatif,0.9,1,Négatif,0.3,IAL108V5,1,1,1,Autoinflammatory diseases,Dermatomyositis (anti-MDA5),Rituximab 250mg 10.03.21; 13.01.2021; 18.11.2020,"anti-CD20 antibody therapy (<365 days) (1g, 0.5g, 025g)",NA,anti-CD20 therapy<365 days,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Rituximab,Rituximab,L01FA01,L01FA01
IAL109,F,66.5,Moderna,V3,33,NA,NA,NA,NA,NA,10/aoû/2021,Positif,62,NA,Positif,8.6,IAL109V3b,2478.3,829.9,395.9,Vasculitis,maladie d’horton (vasculitis),B DMARD Par Un Anti IL6R (Tocilizumab),bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tocilizumab,Tocilizumab,L04AC07,L04AC07
IAL109,F,66.5,Moderna,V4,91,NA,NA,NA,NA,NA,07/oct/2021,Positif,72.3,NA,Indéterminé,5.3,IAL109V4b,984.3,573.4,217.6,Vasculitis,maladie d’horton (vasculitis),B DMARD Par Un Anti IL6R (Tocilizumab),bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tocilizumab,Tocilizumab,L04AC07,L04AC07
IAL109,F,66.5,Moderna,V5,194,28,NA,NA,NA,NA,18/jan/2022,Positif,112.7,3279,Positif,6.4,IAL109V5,915.8,390.2,140.6,Vasculitis,maladie d’horton (vasculitis),B DMARD Par Un Anti IL6R (Tocilizumab),bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tocilizumab,Tocilizumab,L04AC07,L04AC07
IAL109,F,66.5,Moderna,3M3,258,92,NA,NA,NA,NA,23/mar/2022,Positif,87.5,1983,Négatif,3.4,IAL109 3M3,686.8,342.8,179.9,Vasculitis,maladie d’horton (vasculitis),B DMARD Par Un Anti IL6R (Tocilizumab),bDMARD and IVIG,NA,IS (b DMARD),IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Tocilizumab,Tocilizumab,L04AC07,L04AC07
IAL110,M,45.7,Pfizer,V3,29,NA,NA,V4-V5,NA,NA,24/sep/2021,Négatif,3.4,NA,Négatif,0.1,IAL110V3b,1,1,1,Sarcoidosis,sarcoidosis,Cellcept 500 Mg 3x/J + CS,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept,L04AA06,L04AA06
IAL110,M,45.7,Pfizer,V4,90,NA,NA,V4-V5,NA,NA,24/nov/2021,Positif,6.7,NA,Négatif,0.1,IAL110V4b,1,1,1,Sarcoidosis,sarcoidosis,Cellcept 500 Mg 3x/J + CS,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept,L04AA06,L04AA06
IAL110,M,45.7,Pfizer,V5,180,71,NA,V4-V5,50,NA,22/fév/2022,Positif,85.8,1907,Négatif,3.4,IAL110V5,204.3,101.1,110.3,Sarcoidosis,sarcoidosis,Cellcept 500 Mg 3x/J + CS,IMDHI,NA,IS,IS,NA,NA,NA,NA,NA,NA,NA,NA,IAL,Cellcept,Cellcept,L04AA06,L04AA06
IAL112,F,20.8,Pfizer,V5,175,NA,NA,V3-V5,70,NA,08/avr/2022,Positif,112.6,3273,Négatif,0.9,IAL112V5,1094.8,805.2,478.7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,IAL,"NA","NA","NA","NA"
ONM001,M,73.3,Moderna,V3,34,NA,NA,NA,NA,NA,20/mai/2021,Positif,96.5,NA,NA,NA,ONM001V3b,684.5,261.2,93.4,Skin,melanoma,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM001,M,73.3,Moderna,V4,90,NA,NA,NA,NA,NA,15/jui/2021,Positif,46.3,NA,Négatif,0.3,ONM001V4b,129.4,56.2,23.6,Skin,melanoma,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM001,M,73.3,Moderna,V5,181,NA,NA,NA,NA,NA,14/oct/2021,Positif,23.3,NA,Négatif,0.5,ONM001V5b,49.9,34.6,13.8,Skin,melanoma,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM001,M,73.3,Moderna,3M3,272,84,NA,NA,NA,NA,13/jan/2022,Positif,90.8,2134,Négatif,0.3,ONM001 3M3,706.7,322.3,204.2,Skin,melanoma,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM001,M,73.3,Moderna,3M6,370,182,NA,NA,NA,NA,21/avr/2022,Positif,104.5,2821,Négatif,0.2,ONM001 3M6,632.9,421.9,225.6,Skin,melanoma,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM002,M,75.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,22/mar/2021,Positif,96.6,NA,NA,NA,ONM002V3b,96.3,52.6,24.4,Skin,melanoma metsremission no treatmnet last dose IO:ipi 01.2016,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM002,M,75.1,Pfizer,V4,88,NA,NA,3M3-3M6,NA,NA,21/mai/2021,Positif,42.7,NA,NA,NA,ONM002V4b,45.9,29.9,7.1,Skin,melanoma metsremission no treatmnet last dose IO:ipi 01.2016,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM002,M,75.1,Pfizer,V5,182,NA,NA,3M3-3M6,NA,NA,23/aoû/2021,Positif,17.4,NA,Négatif,0.1,ONM002V5b,1,1,1,Skin,melanoma metsremission no treatmnet last dose IO:ipi 01.2016,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM002,M,75.1,Pfizer,3M3,365,104,NA,3M3-3M6,NA,NA,22/fév/2022,Positif,86.4,1934,Négatif,0.1,ONM002 3M3,634.5,302.1,128.6,Skin,melanoma metsremission no treatmnet last dose IO:ipi 01.2016,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM002,M,75.1,Pfizer,3M6,442,181,NA,3M3-3M6,61,NA,10/mai/2022,Positif,149.4,5749,Positif,11.5,ONM002 3M6,1594.896331738437,963.3911368015414,325.8390355164549,Skin,melanoma metsremission no treatmnet last dose IO:ipi 01.2016,NA,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM004,F,57.1,Pfizer,V3,28,NA,NA,NA,NA,NA,15/mar/2021,Positif,102.3,NA,NA,NA,ONM004V3b,112.3,24.1,6.3,Thoracic,SCLC limited,Remission.Last (IO-IO) IPI Nivo 06.2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM004,F,57.1,Pfizer,V4,88,NA,NA,NA,NA,NA,14/mai/2021,Positif,90.8,NA,NA,NA,ONM004V4b,21.7,4.8,2.5,Thoracic,SCLC limited,Remission.Last (IO-IO) IPI Nivo 06.2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM004,F,57.1,Pfizer,V5,182,NA,NA,NA,NA,NA,16/aoû/2021,Positif,32.2,NA,Négatif,0.2,ONM004V5b,1,1,1,Thoracic,SCLC limited,Remission.Last (IO-IO) IPI Nivo 06.2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM004,F,57.1,Pfizer,3M3,360,71,NA,NA,NA,NA,10/fév/2022,Positif,106.1,2908,Négatif,0.1,ONM004 3M3,362.7,154.1,105.1,Thoracic,SCLC limited,Remission.Last (IO-IO) IPI Nivo 06.2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM004,F,57.1,Pfizer,3M6,457,168,NA,NA,NA,NA,18/mai/2022,Positif,105.5,2875,Négatif,0.1,ONM004 3M6,140.5,66.1,62.7,Thoracic,SCLC limited,Remission.Last (IO-IO) IPI Nivo 06.2017,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM005,F,37.1,Pfizer,V3,28,NA,NA,NA,NA,NA,22/mar/2021,Positif,139.7,NA,NA,NA,ONM005V3b,194.3,71.6,36.9,Breast,breast cancer,Adjuvant IO Pembro Since 09.20,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM005,F,37.1,Pfizer,V4,92,NA,NA,NA,NA,NA,25/mai/2021,Positif,67.2,NA,NA,NA,ONM005V4b,76.6,26.8,15.5,Breast,breast cancer,Adjuvant IO Pembro Since 09.20,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM005,F,37.1,Pfizer,V5,182,NA,NA,NA,NA,NA,23/aoû/2021,Positif,28.3,NA,Négatif,0.1,ONM005V5b,58.4,30.9,14.9,Breast,breast cancer,Adjuvant IO Pembro Since 09.20,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM005,F,37.1,Pfizer,3M3,294,69,NA,NA,NA,NA,13/déc/2021,Positif,102.3,2704,Négatif,0.2,ONM005 3M3b,268.7,33.4,13.7,Breast,breast cancer,Adjuvant IO Pembro Since 09.20,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM005,F,37.1,Pfizer,3M6,422,197,NA,NA,NA,NA,20/avr/2022,Positif,108.3,3029,Négatif,2,ONM005 3M6,1702.7,521.6,420.7,Breast,breast cancer,Adjuvant IO Pembro Since 09.20,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM006,F,71.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,22/mar/2021,Positif,130.4,NA,NA,NA,ONM006V3b,226.2,100.3,51.3,Breast,breast cancer,Remission : No TTT Since 06.2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM006,F,71.1,Pfizer,V4,95,NA,NA,3M3-3M6,NA,NA,28/mai/2021,Positif,73,NA,NA,NA,ONM006V4b,140.2,56.8,23.1,Breast,breast cancer,Remission : No TTT Since 06.2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM006,F,71.1,Pfizer,V5,176,NA,NA,3M3-3M6,NA,NA,17/aoû/2021,Positif,34.4,NA,Négatif,0.1,ONM006V5b,73,44.6,22.6,Breast,breast cancer,Remission : No TTT Since 06.2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM006,F,71.1,Pfizer,3M3,357,92,NA,3M3-3M6,NA,NA,14/fév/2022,Positif,101.8,2678,Négatif,0.1,ONM006 3M3,389.7,177.8,119.9,Breast,breast cancer,Remission : No TTT Since 06.2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM006,F,71.1,Pfizer,3M6,441,176,NA,3M3-3M6,35,NA,09/mai/2022,Positif,169.4,7386,Positif,7,ONM006 3M6,2017.7562550443906,941.6195856873823,892.0606601248885,Breast,breast cancer,Remission : No TTT Since 06.2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM007,M,69.2,Pfizer,V3,29,NA,NA,NA,NA,NA,25/mar/2021,Positif,113.9,NA,NA,NA,ONM007V3b,606.4,275.3,77.1,Thoracic,lung ADK stage IIB,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM007,M,69.2,Pfizer,V4,85,NA,NA,NA,NA,NA,20/mai/2021,Positif,105.4,NA,NA,NA,ONM007V4b,483.1,213.7,30.9,Thoracic,lung ADK stage IIB,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM007,M,69.2,Pfizer,V5,181,NA,NA,NA,NA,NA,24/aoû/2021,Positif,74.3,NA,Négatif,0.5,ONM007V5b,219.6,125.1,61.7,Thoracic,lung ADK stage IIB,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM007,M,69.2,Pfizer,3M3,365,92,NA,NA,NA,NA,24/fév/2022,Positif,105.6,2881,Indéterminé,5.4,ONM007 3M3,1371.4,268.9,171.8,Thoracic,lung ADK stage IIB,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM007,M,69.2,Pfizer,3M6,454,181,NA,NA,NA,NA,24/mai/2022,Positif,162.1,6764,Négatif,2.8,ONM007 3M6,738.6,184.7,96.3,Thoracic,lung ADK stage IIB,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM008,F,58.2,Pfizer,V3,28,NA,NA,NA,NA,NA,26/mar/2021,Positif,110.1,NA,NA,NA,ONM008V3b,586.2,303.2,105.5,Breast,breast cancer early stage,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM008,F,58.2,Pfizer,V4,82,NA,NA,NA,NA,NA,19/mai/2021,Positif,101.7,NA,NA,NA,ONM008V4b,313.1,143.3,42.4,Breast,breast cancer early stage,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM008,F,58.2,Pfizer,V5,182,NA,NA,NA,NA,NA,27/aoû/2021,Positif,61.5,NA,Négatif,0.1,ONM008V5b,202.5,142,54.8,Breast,breast cancer early stage,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM008,F,58.2,Pfizer,3M3,361,75,NA,NA,NA,NA,22/fév/2022,Positif,86.1,1920,Négatif,0.1,ONM008 3M3,1765.8,688.7,383.6,Breast,breast cancer early stage,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM009,F,79.1,Pfizer,V3,29,NA,NA,NA,NA,NA,23/mar/2021,Positif,110.2,NA,NA,NA,ONM009V3b,224.1,59,24,Gastrointestinal,GIST,Targted TT. Imatinib 300mg/J,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM009,F,79.1,Pfizer,V4,92,NA,NA,NA,NA,NA,25/mai/2021,Positif,86.5,NA,NA,NA,ONM009V4b,189.1,55,23.8,Gastrointestinal,GIST,Targted TT. Imatinib 300mg/J,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM009,F,79.1,Pfizer,V5,189,NA,NA,NA,NA,NA,30/aoû/2021,Positif,60.9,NA,Positif,9.9,ONM009V5b,151.2,76.6,31,Gastrointestinal,GIST,Targted TT. Imatinib 300mg/J,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM009,F,79.1,Pfizer,3M3,364,97,NA,NA,NA,NA,21/fév/2022,Positif,85.5,1894,Positif,8.5,ONM009 3M3,2317,796.2,382,Gastrointestinal,GIST,Targted TT. Imatinib 300mg/J,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM009,F,79.1,Pfizer,3M6,451,184,NA,NA,NA,NA,19/mai/2022,Positif,132.2,4505,Positif,8.5,ONM009 3M6,1384.7,551.3,185.9,Gastrointestinal,GIST,Targted TT. Imatinib 300mg/J,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM010,F,76.2,Pfizer,V3,34,NA,NA,NA,NA,NA,06/avr/2021,Positif,115.9,NA,NA,NA,ONM010V3b,607.5,220.5,91.2,Thoracic,lung ADK,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM010,F,76.2,Pfizer,V4,91,NA,NA,NA,NA,NA,02/jun/2021,Positif,100.3,NA,NA,NA,ONM010V4b,512.3,125.9,52.7,Thoracic,lung ADK,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM010,F,76.2,Pfizer,V5,175,NA,NA,NA,NA,NA,25/aoû/2021,Positif,70.9,NA,Négatif,3.6,ONM010V5b,360.4,70.3,43.8,Thoracic,lung ADK,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM010,F,76.2,Pfizer,3M3,357,69,NA,NA,NA,NA,23/fév/2022,Positif,78.2,1587,Indéterminé,5.2,ONM010 3M3,1191.6,595.2,263.2,Thoracic,lung ADK,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM011,M,79.2,Pfizer,V3,33,NA,NA,V5-V6,NA,NA,19/avr/2021,Positif,121.7,NA,NA,NA,ONM011V3b,483.6,209.6,122.2,Thoracic,Lung ADK,IO,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM011,M,79.2,Pfizer,V4,98,NA,NA,V5-V6,NA,NA,23/jun/2021,Positif,85.9,NA,Négatif,0.6,ONM011V4b,184,67.5,29.2,Thoracic,Lung ADK,IO,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM011,M,79.2,Pfizer,V5,197,NA,NA,V5-V6,NA,NA,30/sep/2021,Positif,31.8,NA,Négatif,0.3,ONM011V5b,75.4,39.7,24.2,Thoracic,Lung ADK,IO,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM011,M,79.2,Pfizer,V6,363,131,NA,V5-V6,78,NA,15/mar/2022,Positif,92.8,2228,Négatif,3.3,ONM011V6,973.7,473.7,713.3,Thoracic,Lung ADK,IO,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM013,F,79.1,Pfizer,V3,29,NA,NA,3M3-3M6,NA,NA,23/mar/2021,Positif,113.3,NA,NA,NA,ONM013V3b,690.6,205,111.8,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 08.2018,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM013,F,79.1,Pfizer,V4,93,NA,NA,3M3-3M6,NA,NA,26/mai/2021,Positif,82,NA,NA,NA,ONM013V4b,331.1,120.4,56.7,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 08.2018,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM013,F,79.1,Pfizer,V5,177,NA,NA,3M3-3M6,NA,NA,18/aoû/2021,Positif,57.8,NA,Négatif,0.1,ONM013V5b,176.8,87.1,38.1,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 08.2018,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM013,F,79.1,Pfizer,3M3,351,71,NA,3M3-3M6,NA,NA,08/fév/2022,Positif,93.3,2252,Négatif,0.3,ONM013 3M3,3795.1,1061.2,574.1,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 08.2018,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM013,F,79.1,Pfizer,3M6,456,176,NA,3M3-3M6,11,NA,24/mai/2022,Positif,144.4,5371,Positif,22.6,ONM013 3M6,2430,2430,2015.3,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 08.2018,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM014,F,49.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,139.6,NA,NA,NA,ONM014V3b,520.6,224,60,Genitourinary,ovarien cancer,Adjuvant Chemo: Carboplatine Paclitaxel Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Paclitaxel,Carboplatin|Paclitaxel,L01XA02|L01CD01,L01CD01
ONM014,F,49.1,Pfizer,V4,91,NA,NA,NA,NA,NA,25/mai/2021,Positif,99.1,NA,NA,NA,ONM014V4b,463.8,160.7,58.7,Genitourinary,ovarien cancer,Adjuvant Chemo: Carboplatine Paclitaxel Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Paclitaxel,Carboplatin|Paclitaxel,L01XA02|L01CD01,L01CD01
ONM014,F,49.1,Pfizer,V5,181,NA,NA,NA,NA,NA,23/aoû/2021,Positif,75.1,NA,Négatif,0.7,ONM014V5b,567.5,201.7,100.2,Genitourinary,ovarien cancer,Adjuvant Chemo: Carboplatine Paclitaxel Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Paclitaxel,Carboplatin|Paclitaxel,L01XA02|L01CD01,L01CD01
ONM014,F,49.1,Pfizer,3M3,372,97,NA,NA,NA,NA,02/mar/2022,Positif,91.6,2171,Négatif,2.5,ONM014 3M3,1578,837.5,344.9,Genitourinary,ovarien cancer,Adjuvant Chemo: Carboplatine Paclitaxel Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Paclitaxel,Carboplatin|Paclitaxel,L01XA02|L01CD01,L01CD01
ONM014,F,49.1,Pfizer,3M6,464,189,NA,NA,NA,NA,02/jun/2022,Positif,204.8,10788,Négatif,2.1,ONM014 3M6,961.5384615384617,509.1649694501018,241.4875633904854,Genitourinary,ovarien cancer,Adjuvant Chemo: Carboplatine Paclitaxel Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Paclitaxel,Carboplatin|Paclitaxel,L01XA02|L01CD01,L01CD01
ONM016,M,77.1,Pfizer,V3,28,NA,NA,NA,NA,NA,22/mar/2021,Positif,111.4,NA,NA,NA,ONM016V3b,115.7,43.7,27.2,Gastrointestinal,rectal cancer,Remission,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM016,M,77.1,Pfizer,V4,92,NA,NA,NA,NA,NA,25/mai/2021,Positif,52,NA,NA,NA,ONM016V4b,45.5,24.5,10.3,Gastrointestinal,rectal cancer,Remission,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM016,M,77.1,Pfizer,V5,182,NA,NA,NA,NA,NA,23/aoû/2021,Positif,18.3,NA,Négatif,0.1,ONM016V5b,1,1,1,Gastrointestinal,rectal cancer,Remission,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM016,M,77.1,Pfizer,3M3,322,91,NA,NA,NA,NA,10/jan/2022,Positif,87.3,1974,Négatif,0.1,ONM016 3M3,285.4,129.1,60.7,Gastrointestinal,rectal cancer,Remission,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM016,M,77.1,Pfizer,3M6,410,179,NA,NA,NA,NA,08/avr/2022,Positif,101.1,2642,Négatif,0,ONM016 3M6,126.8,92.4,40.1,Gastrointestinal,rectal cancer,Remission,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM017,M,58.1,Pfizer,V3,30,NA,NA,NA,NA,NA,24/mar/2021,Positif,117.2,NA,NA,NA,ONM017V3b,595.6,102,50,Thoracic,lung ADK mets,Chimio+Beva : Carbo Taxol Avstin Since 18.01.2021. Previous: Ipi Nivo (High Dose Of Steroids (End In 12.20)For Cloitis Grade 3: Last Dose In August 2020),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Beva|Taxol,L01FG01|L01CD01,"NA"
ONM017,M,58.1,Pfizer,V4,88,NA,NA,NA,NA,NA,21/mai/2021,Positif,103.7,NA,NA,NA,ONM017V4b,242.4,37.6,21.8,Thoracic,lung ADK mets,Chimio+Beva : Carbo Taxol Avstin Since 18.01.2021. Previous: Ipi Nivo (High Dose Of Steroids (End In 12.20)For Cloitis Grade 3: Last Dose In August 2020),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Beva|Taxol,L01FG01|L01CD01,"NA"
ONM017,M,58.1,Pfizer,V5,182,NA,NA,NA,NA,NA,23/aoû/2021,Positif,26.3,NA,Négatif,0.1,ONM017V5b,99.4,51,20.3,Thoracic,lung ADK mets,Chimio+Beva : Carbo Taxol Avstin Since 18.01.2021. Previous: Ipi Nivo (High Dose Of Steroids (End In 12.20)For Cloitis Grade 3: Last Dose In August 2020),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Beva|Taxol,L01FG01|L01CD01,"NA"
ONM020,M,83.1,Pfizer,V3,28,NA,NA,NA,NA,NA,22/mar/2021,Positif,139,NA,NA,NA,ONM020V3b,473.5,252.4,101,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM020,M,83.1,Pfizer,V4,92,NA,NA,NA,NA,NA,25/mai/2021,Positif,110.5,NA,NA,NA,ONM020V4b,286.7,126.2,60.8,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM020,M,83.1,Pfizer,V5,183,NA,NA,NA,NA,NA,24/aoû/2021,Positif,52.7,NA,Négatif,0.2,ONM020V5b,199.4,104.1,44.7,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM020,M,83.1,Pfizer,3M3,365,81,NA,NA,NA,NA,22/fév/2022,Positif,93.1,2243,Négatif,0.2,ONM020 3M3,935.5,384.5,304.7,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM021,F,66.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,120.9,NA,NA,NA,ONM021V3b,1249.8,775.2,147,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 02.2019,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM021,F,66.1,Pfizer,V4,94,NA,NA,NA,NA,NA,28/mai/2021,Positif,127.3,NA,NA,NA,ONM021V4b,340,162.7,17.8,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 02.2019,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM021,F,66.1,Pfizer,V5,181,NA,NA,NA,NA,NA,23/aoû/2021,Positif,75.6,NA,Positif,10.2,ONM021V5b,198.5,137,38.4,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 02.2019,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM021,F,66.1,Pfizer,3M3,360,93,NA,NA,NA,NA,18/fév/2022,Positif,92.5,2214,Négatif,2.1,ONM021 3M3,1011.8,573.7,301.5,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 02.2019,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM021,F,66.1,Pfizer,3M6,449,182,NA,NA,NA,NA,18/mai/2022,Positif,88.8,2042,Négatif,3,ONM021 3M6,841.8,538.2,274.4,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 02.2019,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM022,M,54.2,Pfizer,V6,383,104,NA,NA,NA,NA,15/mar/2022,Positif,80.2,1668,Négatif,0.2,ONM022V6,616.1,163.9,206.5,Skin,melanome,"No TTT.Adjuvant IO Ipilimumab Stopped In 11.2017,Colitis Grade 3 In 2017",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ipilimumab,Ipilimumab,L01FX04,L01XC11
ONM023,M,58.2,Pfizer,V3,33,NA,NA,NA,NA,NA,19/avr/2021,Positif,119.6,NA,NA,NA,ONM023V3b,343.6,106.6,65.9,Genitourinary,"carcinome embryonnaire du testicule G, en remission depuis 2010",No TTT En Remission Depuis 2012,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM023,M,58.2,Pfizer,V4,89,NA,NA,NA,NA,NA,14/jun/2021,Positif,96.8,NA,Négatif,0.4,ONM023V4b,1143.9,577.7,43.1,Genitourinary,"carcinome embryonnaire du testicule G, en remission depuis 2010",No TTT En Remission Depuis 2012,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM023,M,58.2,Pfizer,V5,182,NA,NA,NA,NA,NA,15/sep/2021,Positif,51.2,NA,Négatif,0.2,ONM023V5b,114.2,54.8,24.2,Genitourinary,"carcinome embryonnaire du testicule G, en remission depuis 2010",No TTT En Remission Depuis 2012,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM023,M,58.2,Pfizer,V6,365,50,NA,NA,NA,NA,17/mar/2022,Positif,103.4,2763,Négatif,0,ONM023V6,277.5,84,69.9,Genitourinary,"carcinome embryonnaire du testicule G, en remission depuis 2010",No TTT En Remission Depuis 2012,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM024,M,74.2,Moderna,V3,29,NA,NA,NA,NA,NA,26/mar/2021,Positif,102.7,NA,NA,NA,ONM024V3b,147.3,71,37,Genitourinary,prostate cancer mets,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM024,M,74.2,Moderna,V4,92,NA,NA,NA,NA,NA,28/mai/2021,Positif,55.5,NA,NA,NA,ONM024V4b,98,27.4,9.5,Genitourinary,prostate cancer mets,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM024,M,74.2,Moderna,V5,179,NA,NA,NA,NA,NA,23/aoû/2021,Positif,27.8,NA,Négatif,0.2,ONM024V5b,57,36.4,12.4,Genitourinary,prostate cancer mets,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM024,M,74.2,Moderna,3M3,361,74,NA,NA,NA,NA,21/fév/2022,Positif,83.3,1798,Négatif,0.1,ONM024 3M3,198.1,103.6,41.2,Genitourinary,prostate cancer mets,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM025,F,69.2,Moderna,V3,31,NA,NA,NA,NA,NA,09/avr/2021,Positif,118,NA,NA,NA,ONM025V3b,846,323.4,98.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM025,F,69.2,Moderna,V4,92,NA,NA,NA,NA,NA,09/jun/2021,Positif,104.4,NA,Négatif,1.3,ONM025V4b,728.9,221.5,64.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM025,F,69.2,Moderna,V5,182,NA,NA,NA,NA,NA,07/sep/2021,Positif,84.4,NA,Négatif,0.8,ONM025V5b,391.2,108.8,64,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM025,F,69.2,Moderna,3M3,329,74,NA,NA,NA,NA,01/fév/2022,Positif,114.1,3360,Négatif,1,ONM025 3M3,634.5,229.8,113.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM025,F,69.2,Moderna,3M6,441,186,NA,NA,NA,NA,24/mai/2022,Positif,158.9,6501,Négatif,0.6,ONM025 3M6,319.4,115.8,55.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM026,F,78.1,Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,25/mar/2021,Positif,90.2,NA,NA,NA,ONM026V3b,282.1,81,38,Breast,breast cancer,Adjuvant Hormonotherapy Since 01.2013,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM026,F,78.1,Pfizer,V4,93,NA,NA,V5-3M3,NA,NA,27/mai/2021,Positif,76.9,NA,NA,NA,ONM026V4b,206.6,38.9,21.7,Breast,breast cancer,Adjuvant Hormonotherapy Since 01.2013,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM026,F,78.1,Pfizer,V5,183,NA,NA,V5-3M3,NA,NA,25/aoû/2021,Positif,41.7,NA,Négatif,0.3,ONM026V5b,112.6,56.4,27,Breast,breast cancer,Adjuvant Hormonotherapy Since 01.2013,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM026,F,78.1,Pfizer,3M3,408,85,NA,V5-3M3,79,NA,07/avr/2022,Positif,106.2,2913,Indéterminé,4.6,ONM026 3M3,1224.4,678,449.6,Breast,breast cancer,Adjuvant Hormonotherapy Since 01.2013,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM027,F,69.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,134.2,NA,NA,NA,ONM027V3b,247.6,127.6,58,Sarcoma,sarcoma (leiomyoscarome),No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM027,F,69.1,Pfizer,V4,94,NA,NA,NA,NA,NA,28/mai/2021,Positif,83.1,NA,NA,NA,ONM027V4b,78.7,18,6.2,Sarcoma,sarcoma (leiomyoscarome),No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM027,F,69.1,Pfizer,V5,181,NA,NA,NA,NA,NA,23/aoû/2021,Positif,43.2,NA,Négatif,0.3,ONM027V5b,92.7,64.4,31.9,Sarcoma,sarcoma (leiomyoscarome),No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM027,F,69.1,Pfizer,3M3,359,80,NA,NA,NA,NA,17/fév/2022,Positif,120.7,3758,Négatif,0.3,ONM027 3M3,1400.2,314.1,232,Sarcoma,sarcoma (leiomyoscarome),No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM028,F,63.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,124.2,NA,NA,NA,ONM028V3b,260.5,88,33,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM028,F,63.1,Pfizer,V4,92,NA,NA,NA,NA,NA,26/mai/2021,Positif,55.3,NA,NA,NA,ONM028V4b,140.8,54.6,34.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM028,F,63.1,Pfizer,V5,185,NA,NA,NA,NA,NA,27/aoû/2021,Positif,41.1,NA,Négatif,0.3,ONM028V5b,121,65.2,32.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM028,F,63.1,Pfizer,3M3,401,98,NA,NA,NA,NA,31/mar/2022,Positif,104.9,2843,Négatif,0.2,ONM028 3M3,336.2,137.2,65.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM029,F,71.2,Pfizer,V3,27,NA,NA,NA,NA,NA,24/mar/2021,Positif,101.4,NA,NA,NA,ONM029V3b,223,110,20,Thoracic,Lung ADK mets,IO(Ipi Nivo)+Since 08.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM031,F,74.2,Pfizer,V4,90,NA,NA,NA,NA,NA,14/jun/2021,Positif,38.2,NA,Négatif,0.4,ONM031V4b,31.5,8.3,6.5,Thoracic,lung ADK mets sous TKIS (gefitinib),TKIS: Gefitinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Gefitinib,Gefitinib,L01EB01,L01XE02
ONM031,F,74.2,Pfizer,V6,374,106,NA,NA,NA,NA,25/mar/2022,Positif,35.6,337,Négatif,0.1,ONM031V6,43,21.4,9,Thoracic,lung ADK mets sous TKIS (gefitinib),TKIS: Gefitinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Gefitinib,Gefitinib,L01EB01,L01XE02
ONM032,M,80.1,Pfizer,V3,28,NA,NA,NA,NA,NA,24/mar/2021,Positif,128.8,NA,NA,NA,ONM032V3b,365.8,208.9,55.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM032,M,80.1,Pfizer,V4,91,NA,NA,NA,NA,NA,26/mai/2021,Positif,77.8,NA,NA,NA,ONM032V4b,176.1,96.3,16.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM032,M,80.1,Pfizer,V5,175,NA,NA,NA,NA,NA,18/aoû/2021,Positif,36.2,NA,Négatif,0.1,ONM032V5b,101.3,76,18.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM032,M,80.1,Pfizer,3M3,301,68,NA,NA,NA,NA,22/déc/2021,Positif,148,5642,Négatif,0.1,ONM032 3M3b,2762.4,818.3,382,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM032,M,80.1,Pfizer,3M6,429,196,NA,NA,NA,NA,29/avr/2022,Positif,167,7178,Négatif,0.2,ONM032 3M6,888.1,223.8,126.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM034,M,70.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,126.8,NA,NA,NA,ONM034V3b,349.9,108.6,55.6,Thoracic,lung ADK mets,Tkis: Erlotinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Erlotinib,Erlotinib,L01EB02,L01EB02
ONM034,M,70.1,Pfizer,V4,84,NA,NA,NA,NA,NA,18/mai/2021,Positif,121.8,NA,NA,NA,ONM034V4b,283.8,45.2,27,Thoracic,lung ADK mets,Tkis: Erlotinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Erlotinib,Erlotinib,L01EB02,L01EB02
ONM034,M,70.1,Pfizer,V5,182,NA,NA,NA,NA,NA,24/aoû/2021,Positif,75.8,NA,Négatif,0.3,ONM034V5b,237.6,71.2,36.4,Thoracic,lung ADK mets,Tkis: Erlotinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Erlotinib,Erlotinib,L01EB02,L01EB02
ONM034,M,70.1,Pfizer,3M3,371,85,NA,NA,NA,NA,01/mar/2022,Positif,98.5,2508,Négatif,0.3,ONM034 3M3,684,264,165.7,Thoracic,lung ADK mets,Tkis: Erlotinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Erlotinib,Erlotinib,L01EB02,L01EB02
ONM035,F,57.1,Pfizer,V3,28,NA,NA,NA,NA,NA,23/mar/2021,Positif,129.3,NA,NA,NA,ONM035V3b,780.6,421,64,Brain,astrocytoma G2,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM035,F,57.1,Pfizer,V4,92,NA,NA,NA,NA,NA,26/mai/2021,Positif,66.7,NA,NA,NA,ONM035V4b,114.9,48.6,4.9,Brain,astrocytoma G2,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM035,F,57.1,Pfizer,V5,183,NA,NA,NA,NA,NA,25/aoû/2021,Positif,33.6,NA,Négatif,0.8,ONM035V5b,94.9,70,28.5,Brain,astrocytoma G2,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM035,F,57.1,Pfizer,3M3,365,78,NA,NA,NA,NA,23/fév/2022,Positif,75.7,1488,Négatif,0.8,ONM035 3M3,1330.1,729.9,490.2,Brain,astrocytoma G2,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM036,F,59.1,Pfizer,V3,36,NA,NA,V5-3M3,NA,NA,01/avr/2021,Positif,140.8,NA,NA,NA,ONM036V3b,481.9,187.1,71.3,Skin,melanoma mets,"IO IO: Ipi Nivo .Stop 12.20, Steroides High Doses Till 17.02.2021",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM036,F,59.1,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,27/mai/2021,Positif,94.8,NA,NA,NA,ONM036V4b,229.8,78.8,42.1,Skin,melanoma mets,"IO IO: Ipi Nivo .Stop 12.20, Steroides High Doses Till 17.02.2021",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM036,F,59.1,Pfizer,V5,175,NA,NA,V5-3M3,NA,NA,18/aoû/2021,Positif,52.3,NA,Négatif,1,ONM036V5b,152.2,81.8,45.4,Skin,melanoma mets,"IO IO: Ipi Nivo .Stop 12.20, Steroides High Doses Till 17.02.2021",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM036,F,59.1,Pfizer,3M3,407,106,NA,V5-3M3,30,NA,07/avr/2022,Positif,107,2957,Négatif,1.8,ONM036 3M3,1426.1,736.9,414.4,Skin,melanoma mets,"IO IO: Ipi Nivo .Stop 12.20, Steroides High Doses Till 17.02.2021",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM037,F,76.2,Pfizer,V3,31,NA,NA,V4-V5; V5-V6,NA,NA,29/mar/2021,Positif,99.4,NA,NA,NA,ONM037V3b,344.6,109.7,48.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM038,M,72.1,Pfizer,V3,28,NA,NA,NA,NA,NA,24/mar/2021,Positif,111.2,NA,NA,NA,ONM038V3b,672.9,327,120,Thoracic,lung ADK mets,IO: Pembro,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM038,M,72.1,Pfizer,V4,96,NA,NA,NA,NA,NA,31/mai/2021,Positif,71.8,NA,NA,NA,ONM038V4b,90.9,33.2,15.5,Thoracic,lung ADK mets,IO: Pembro,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM038,M,72.1,Pfizer,V5,187,NA,NA,NA,NA,NA,30/aoû/2021,Positif,25.2,NA,Négatif,0,ONM038V5b,44.4,33.8,15.7,Thoracic,lung ADK mets,IO: Pembro,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM038,M,72.1,Pfizer,3M3,329,113,NA,NA,NA,NA,19/jan/2022,Positif,106.2,2913,Négatif,0.1,ONM038 3M3,353.7,191.4,130.4,Thoracic,lung ADK mets,IO: Pembro,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM038,M,72.1,Pfizer,3M6,392,176,NA,NA,NA,NA,23/mar/2022,Positif,83.7,1816,Négatif,0,ONM038 3M6,145,81.1,62.9,Thoracic,lung ADK mets,IO: Pembro,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM039,M,78.2,Pfizer,V3,34,NA,NA,NA,NA,NA,20/avr/2021,Positif,126.8,NA,NA,NA,ONM039V3b,242.5,121.6,45.3,Renal,renal cancer stage IV,No TTT: IO IO Ipi Nivo En 2020 Stoped,NA,No,Not treated,Not treated,hepatitis grade 2 treated with high doses of steroides en march 2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM039,M,78.2,Pfizer,V4,97,NA,NA,NA,NA,NA,22/jun/2021,Positif,57.3,NA,Négatif,0,ONM039V4b,142.4,76.5,21.7,Renal,renal cancer stage IV,No TTT: IO IO Ipi Nivo En 2020 Stoped,NA,No,Not treated,Not treated,hepatitis grade 2 treated with high doses of steroides en march 2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM039,M,78.2,Pfizer,V5,184,NA,NA,NA,NA,NA,17/sep/2021,Positif,47,NA,Négatif,0,ONM039V5b,98.3,52.5,16.1,Renal,renal cancer stage IV,No TTT: IO IO Ipi Nivo En 2020 Stoped,NA,No,Not treated,Not treated,hepatitis grade 2 treated with high doses of steroides en march 2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM040,F,31.2,Pfizer,V3,32,NA,NA,NA,NA,NA,14/avr/2021,Positif,86.5,NA,NA,NA,ONM040V3b,1312.2,503,128.7,Thoracic,SCLC stage IV,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM040,F,31.2,Pfizer,V4,95,NA,NA,NA,NA,NA,16/jun/2021,Positif,109,NA,Négatif,0.2,ONM040V4b,711.7,241.5,68.8,Thoracic,SCLC stage IV,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM040,F,31.2,Pfizer,V5,192,NA,NA,NA,NA,NA,21/sep/2021,Positif,69.6,NA,Négatif,0.1,ONM040V5b,191.3,115.7,82.6,Thoracic,SCLC stage IV,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM040,F,31.2,Pfizer,V6,368,54,NA,NA,NA,NA,16/mar/2022,Positif,87.4,1978,Négatif,0,ONM040V6,1874.8,1066.6,516.3,Thoracic,SCLC stage IV,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM041,F,36.1,Pfizer,V3,29,NA,NA,NA,NA,NA,25/mar/2021,Positif,62.6,NA,NA,NA,ONM041V3b,111.1,25.3,15.5,Breast,breast cancer,"Adjuvant Chemo: Epirubicine Cyclophosphamide: Ongoing,Start Date18.12.2020",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Epirubicin|Cyclophosphamide,L01DB03|L01AA01,"NA"
ONM041,F,36.1,Pfizer,V4,90,NA,NA,NA,NA,NA,25/mai/2021,Positif,31.6,NA,NA,NA,ONM041V4b,59.5,21.2,10.3,Breast,breast cancer,"Adjuvant Chemo: Epirubicine Cyclophosphamide: Ongoing,Start Date18.12.2020",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Epirubicin|Cyclophosphamide,L01DB03|L01AA01,"NA"
ONM041,F,36.1,Pfizer,V5,181,NA,NA,NA,NA,NA,24/aoû/2021,Positif,35.5,NA,Négatif,0.4,ONM041V5b,65.5,24.6,12.6,Breast,breast cancer,"Adjuvant Chemo: Epirubicine Cyclophosphamide: Ongoing,Start Date18.12.2020",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Epirubicin|Cyclophosphamide,L01DB03|L01AA01,"NA"
ONM041,F,36.1,Pfizer,V6,359,107,NA,NA,NA,NA,18/fév/2022,Positif,90.6,2125,Négatif,0.2,ONM041V6,334.1,121.1,92.5,Breast,breast cancer,"Adjuvant Chemo: Epirubicine Cyclophosphamide: Ongoing,Start Date18.12.2020",Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Epirubicin|Cyclophosphamide,L01DB03|L01AA01,"NA"
ONM042,F,57.1,Pfizer,V3,29,NA,NA,NA,NA,NA,24/mar/2021,Positif,64.9,NA,NA,NA,ONM042V3b,51.3,26.2,8.2,Breast,breast cancer mets,Chemo: Metronomic Cyclophosphamide+MTX,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|MTX,L01AA01|L04AX03,"NA"
ONM042,F,57.1,Pfizer,V4,91,NA,NA,NA,NA,NA,25/mai/2021,Positif,45.4,NA,NA,NA,ONM042V4b,52.5,26,10.9,Breast,breast cancer mets,Chemo: Metronomic Cyclophosphamide+MTX,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|MTX,L01AA01|L04AX03,"NA"
ONM042,F,57.1,Pfizer,V5,182,NA,NA,NA,NA,NA,24/aoû/2021,Positif,17.6,NA,Négatif,1.3,ONM042V5b,31,27.8,13.2,Breast,breast cancer mets,Chemo: Metronomic Cyclophosphamide+MTX,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|MTX,L01AA01|L04AX03,"NA"
ONM042,F,57.1,Pfizer,3M3,322,98,NA,NA,NA,NA,11/jan/2022,Positif,155.5,6226,Négatif,1.2,ONM042 3M3,1516.1,885,439.9,Breast,breast cancer mets,Chemo: Metronomic Cyclophosphamide+MTX,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|MTX,L01AA01|L04AX03,"NA"
ONM042,F,57.1,Pfizer,3M6,413,189,NA,NA,NA,NA,12/avr/2022,Positif,95.1,2339,Négatif,1,ONM042 3M6,604.2,275,144.1,Breast,breast cancer mets,Chemo: Metronomic Cyclophosphamide+MTX,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|MTX,L01AA01|L04AX03,"NA"
ONM043,F,51.1,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,24/mar/2021,Positif,91.2,NA,NA,NA,ONM043V3b,2229.2,346.1,132,Breast,breast cancer mets,Ribociclib : TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ribociclib,Ribociclib,L01EF02,L01XE
ONM043,F,51.1,Pfizer,V4,93,NA,NA,V5-3M3,NA,NA,28/mai/2021,Positif,68,NA,NA,NA,ONM043V4b,1271,217.8,61.4,Breast,breast cancer mets,Ribociclib : TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ribociclib,Ribociclib,L01EF02,L01XE
ONM043,F,51.1,Pfizer,V5,177,NA,NA,V5-3M3,NA,NA,20/aoû/2021,Positif,73.6,NA,Négatif,0.2,ONM043V5b,1050.2,191.4,95.8,Breast,breast cancer mets,Ribociclib : TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ribociclib,Ribociclib,L01EF02,L01XE
ONM043,F,51.1,Pfizer,3M3,373,101,NA,V5-3M3,20,NA,04/mar/2022,Positif,89.9,2092,Positif,19,ONM043 3M3,2430,2087.7,1580.8,Breast,breast cancer mets,Ribociclib : TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ribociclib,Ribociclib,L01EF02,L01XE
ONM043,F,51.1,Pfizer,3M6,453,181,NA,V5-3M3,100,NA,23/mai/2022,Positif,91.6,2171,Positif,10.3,ONM043 3M6,2430,2430,2430,Breast,breast cancer mets,Ribociclib : TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Ribociclib,Ribociclib,L01EF02,L01XE
ONM044,M,68.2,Pfizer,V3,28,NA,NA,NA,NA,NA,14/avr/2021,Positif,103.1,NA,NA,NA,ONM044V3b,722,336.2,129.7,Skin,melanoma stage II,IO Adjuvant,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM044,M,68.2,Pfizer,V4,93,NA,NA,NA,NA,NA,18/jun/2021,Positif,109.4,NA,Négatif,0.3,ONM044V4b,322.2,142.4,42.9,Skin,melanoma stage II,IO Adjuvant,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM044,M,68.2,Pfizer,V5,183,NA,NA,NA,NA,NA,16/sep/2021,Positif,48,NA,Négatif,0.1,ONM044V5b,135.2,87.8,35.9,Skin,melanoma stage II,IO Adjuvant,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM044,M,68.2,Pfizer,V6,372,160,NA,NA,NA,NA,24/mar/2022,Positif,108.3,3029,Négatif,0,ONM044V6,284.9,128.9,78,Skin,melanoma stage II,IO Adjuvant,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM045,F,70.2,Pfizer,V3,28,NA,NA,NA,NA,NA,25/mar/2021,Positif,109.5,NA,NA,NA,ONM045V3b,628.5,285,121,Endocrine,adrenal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM045,F,70.2,Pfizer,V4,91,NA,NA,NA,NA,NA,27/mai/2021,Positif,111.7,NA,NA,NA,ONM045V4b,203.8,82,36.8,Endocrine,adrenal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM045,F,70.2,Pfizer,V5,186,NA,NA,NA,NA,NA,30/aoû/2021,Positif,54.5,NA,Négatif,0.2,ONM045V5b,123.7,77,39.3,Endocrine,adrenal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM045,F,70.2,Pfizer,3M3,362,78,NA,NA,NA,NA,22/fév/2022,Positif,87,1960,Négatif,0.2,ONM045 3M3,652.3,300.6,169.7,Endocrine,adrenal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM046,F,67.2,Pfizer,V3,31,NA,NA,NA,NA,NA,16/avr/2021,Positif,105.6,NA,NA,NA,ONM046V3b,177.2,53.2,27.2,Breast,breast cancer stage Ia,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM046,F,67.2,Pfizer,V4,97,NA,NA,NA,NA,NA,21/jun/2021,Positif,59,NA,Négatif,0.6,ONM046V4b,102,30.7,13.5,Breast,breast cancer stage Ia,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM046,F,67.2,Pfizer,V5,195,NA,NA,NA,NA,NA,27/sep/2021,Positif,31.5,NA,Négatif,0.3,ONM046V5b,73.8,22.3,12,Breast,breast cancer stage Ia,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM046,F,67.2,Pfizer,3M3,328,101,NA,NA,NA,NA,07/fév/2022,Positif,103.9,2789,Négatif,0.1,ONM046 3M3,288.7,103.6,55.9,Breast,breast cancer stage Ia,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM046,F,67.2,Pfizer,3M6,420,193,NA,NA,NA,NA,10/mai/2022,Positif,145.6,5461,Négatif,0,ONM046 3M6,215.42438604049977,68.44626967830253,42.680324370465215,Breast,breast cancer stage Ia,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM047,M,50.2,Pfizer,V3,28,NA,NA,NA,NA,NA,25/mar/2021,Positif,77.8,NA,NA,NA,ONM047V3b,87.8,32.7,18,Head and neck,SCC langue P16+,RCT: Cisplatine 3W. Start 28.12.20,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cisplatine,L01XA01,"NA"
ONM047,M,50.2,Pfizer,V4,91,NA,NA,NA,NA,NA,27/mai/2021,Positif,66.3,NA,NA,NA,ONM047V4b,81.3,31.7,18.3,Head and neck,SCC langue P16+,RCT: Cisplatine 3W. Start 28.12.20,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cisplatine,L01XA01,"NA"
ONM047,M,50.2,Pfizer,V5,175,NA,NA,NA,NA,NA,19/aoû/2021,Positif,30,NA,Négatif,0.1,ONM047V5b,43.1,28.3,12.3,Head and neck,SCC langue P16+,RCT: Cisplatine 3W. Start 28.12.20,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cisplatine,L01XA01,"NA"
ONM047,M,50.2,Pfizer,3M3,364,71,NA,NA,NA,NA,24/fév/2022,Positif,75.1,1464,Positif,7,ONM047 3M3,2699.8,1072.4,875.7,Head and neck,SCC langue P16+,RCT: Cisplatine 3W. Start 28.12.20,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cisplatine,L01XA01,"NA"
ONM048,F,54.2,Pfizer,V3,34,NA,NA,NA,NA,NA,21/avr/2021,Positif,116.9,NA,NA,NA,ONM048V3b,536.2,206.1,63.5,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM048,F,54.2,Pfizer,V4,97,NA,NA,NA,NA,NA,23/jun/2021,Positif,102,NA,Négatif,0.1,ONM048V4b,179.2,69.8,18.4,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM048,F,54.2,Pfizer,V5,189,NA,NA,NA,NA,NA,23/sep/2021,Positif,75.4,NA,Négatif,0,ONM048V5b,292.1,133.2,43.9,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM048,F,54.2,Pfizer,3M3,362,103,NA,NA,NA,NA,15/mar/2022,Positif,95.7,2369,Négatif,3.9,ONM048 3M3,1878.6,739.1,1317.2,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM048,F,54.2,Pfizer,3M6,439,180,NA,NA,NA,NA,31/mai/2022,Positif,128.6,4264,Négatif,1.7,ONM048 3M6,1296.8,515.2,769.8,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM050,M,74.2,Pfizer,V3,29,NA,NA,V5-3M3,NA,NA,26/mar/2021,Positif,111.2,NA,NA,NA,ONM050V3b,719.4,355.9,100.1,Genitourinary,prostate cancer,Hormonotherapy Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM050,M,74.2,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,28/mai/2021,Positif,101.2,NA,NA,NA,ONM050V4b,225,133.5,37.4,Genitourinary,prostate cancer,Hormonotherapy Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM050,M,74.2,Pfizer,V5,193,NA,NA,V5-3M3,NA,NA,06/sep/2021,Positif,54.9,NA,Négatif,2.2,ONM050V5b,121.8,88,27.5,Genitourinary,prostate cancer,Hormonotherapy Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM050,M,74.2,Pfizer,3M3,368,109,NA,V5-3M3,28,NA,28/fév/2022,Positif,95.8,2374,Positif,9.7,ONM050 3M3,2430,2050.4,1570.1,Genitourinary,prostate cancer,Hormonotherapy Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM050,M,74.2,Pfizer,3M6,439,180,NA,V5-3M3,99,NA,10/mai/2022,Positif,128.3,4244,Positif,7.7,ONM050 3M6,2862.0492272467086,1912.411550965768,1249.843769528809,Genitourinary,prostate cancer,Hormonotherapy Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM051,F,47.2,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,26/avr/2021,Positif,74.5,NA,NA,NA,ONM051V3b,2005.6,911.6,212.9,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM051,F,47.2,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,24/jun/2021,Positif,84.7,NA,Négatif,1.3,ONM051V4b,563.4,286.1,58.1,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM051,F,47.2,Pfizer,V5,187,NA,NA,V5-3M3,NA,NA,27/sep/2021,Positif,83.4,NA,Négatif,1.3,ONM051V5b,501.5,248.6,60.4,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM051,F,47.2,Pfizer,V5+,306,35,NA,V5-3M3,10,NA,24/jan/2022,Positif,93,2238,Négatif,2.3,ONM051V5+,3745.3,1563.7,584.5,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM051,F,47.2,Pfizer,3M3,355,84,NA,V5-3M3,59,NA,14/mar/2022,Positif,135.9,4760,Indéterminé,4.3,ONM051 3M3,2430,2430,1861.2,Breast,mets breast cancer,IO: Herceptine+Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM052,M,73.2,Pfizer,V3,29,NA,NA,NA,NA,NA,26/mar/2021,Positif,121.6,NA,NA,NA,ONM052V3b,275,120.3,56.3,Neuroendocrine,NET cancer,Somatostatine (Hormonotherapy),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Somatostatin,H01CB01,"NA"
ONM052,M,73.2,Pfizer,V4,95,NA,NA,NA,NA,NA,31/mai/2021,Positif,91.1,NA,NA,NA,ONM052V4b,127.3,60.1,29.4,Neuroendocrine,NET cancer,Somatostatine (Hormonotherapy),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Somatostatin,H01CB01,"NA"
ONM052,M,73.2,Pfizer,V5,186,NA,NA,NA,NA,NA,30/aoû/2021,Positif,38.5,NA,Négatif,0.3,ONM052V5b,69.1,47.3,23.8,Neuroendocrine,NET cancer,Somatostatine (Hormonotherapy),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Somatostatin,H01CB01,"NA"
ONM052,M,73.2,Pfizer,3M3,322,92,NA,NA,NA,NA,13/jan/2022,Positif,96,2384,Négatif,0.1,ONM052 3M3,471,156.1,96.1,Neuroendocrine,NET cancer,Somatostatine (Hormonotherapy),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Somatostatin,H01CB01,"NA"
ONM052,M,73.2,Pfizer,3M6,411,181,NA,NA,NA,NA,12/avr/2022,Positif,94.2,2296,Négatif,0,ONM052 3M6,198.5,100.1,56.6,Neuroendocrine,NET cancer,Somatostatine (Hormonotherapy),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Somatostatin,H01CB01,"NA"
ONM054,F,73.2,Pfizer,V3,29,NA,NA,NA,NA,NA,26/mar/2021,Positif,100.4,NA,NA,NA,ONM054V3b,137.3,84.7,27,Breast,breast cancer,No TTT (HIV+),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM054,F,73.2,Pfizer,V4,84,NA,NA,NA,NA,NA,20/mai/2021,Positif,45.6,NA,NA,NA,ONM054V4b,61.8,36,16.5,Breast,breast cancer,No TTT (HIV+),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM054,F,73.2,Pfizer,V5,181,NA,NA,NA,NA,NA,25/aoû/2021,Positif,21,NA,Négatif,0.4,ONM054V5b,39.9,26.4,10.5,Breast,breast cancer,No TTT (HIV+),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM054,F,73.2,Pfizer,V6,364,136,NA,NA,NA,NA,24/fév/2022,Positif,100.7,2621,Négatif,0.2,ONM054V6,225.8,99.7,60,Breast,breast cancer,No TTT (HIV+),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM055,M,82.3,Pfizer,V3,33,NA,NA,NA,NA,NA,12/mai/2021,Positif,119.3,NA,NA,NA,ONM055V3b,439.4,86.9,70.5,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM055,M,82.3,Pfizer,V4,97,NA,NA,NA,NA,NA,15/jui/2021,Positif,60.9,NA,Négatif,0.6,ONM055V4b,178.5,44.8,28.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM055,M,82.3,Pfizer,V5,180,NA,NA,NA,NA,NA,06/oct/2021,Positif,61.7,NA,Négatif,0.3,ONM055V5b,74.1,25.3,15.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM055,M,82.3,Pfizer,3M3,350,71,NA,NA,NA,NA,25/mar/2022,Positif,89.8,2088,Négatif,0.3,ONM055 3M3,597.4,282.1,141.7,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM056,F,43.2,Pfizer,V3,29,NA,NA,NA,NA,NA,30/mar/2021,Positif,136,NA,NA,NA,ONM056V3b,607.5,310,115,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 10.2017,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM056,F,43.2,Pfizer,V4,87,NA,NA,NA,NA,NA,27/mai/2021,Positif,113.3,NA,NA,NA,ONM056V4b,148.7,93.5,47.6,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 10.2017,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM056,F,43.2,Pfizer,V5,182,NA,NA,NA,NA,NA,30/aoû/2021,Positif,62.1,NA,Négatif,0.2,ONM056V5b,188.9,134.8,64,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 10.2017,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM056,F,43.2,Pfizer,3M3,366,76,NA,NA,NA,NA,02/mar/2022,Positif,80,1660,Positif,14,ONM056 3M3,2152.9,1108.9,1033.8,Breast,breast cancer,Adjuvant Hormonotherapy: Tamoxifene Since 10.2017,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM057,F,51.2,Pfizer,V3,32,NA,NA,NA,NA,NA,16/avr/2021,Positif,70.7,NA,NA,NA,ONM057V3b,1970.4,525.8,229.9,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM057,F,51.2,Pfizer,V4,94,NA,NA,NA,NA,NA,17/jun/2021,Positif,83.5,NA,Négatif,0.4,ONM057V4b,636.5,180.2,100,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM057,F,51.2,Pfizer,V5,182,NA,NA,NA,NA,NA,13/sep/2021,Positif,98.8,NA,Négatif,0.3,ONM057V5b,486.4,104.7,65.2,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM058,F,72.2,Pfizer,3M3,363,92,NA,NA,NA,NA,24/fév/2022,Positif,107.3,2974,Négatif,0.3,ONM058 3M3,366.8,153.1,84.1,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 03.2017,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM058,F,72.2,Pfizer,3M6,452,181,NA,NA,NA,NA,24/mai/2022,Positif,144.9,5408,Négatif,0.4,ONM058 3M6,227.7,81,47.4,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole Since 03.2017,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM059,F,83.2,Pfizer,V3,28,NA,NA,NA,NA,NA,26/mar/2021,Positif,69.3,NA,NA,NA,ONM059V3b,94,39.9,12.6,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM059,F,83.2,Pfizer,V4,84,NA,NA,NA,NA,NA,21/mai/2021,Positif,39.8,NA,NA,NA,ONM059V4b,27.8,19.1,8.7,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM059,F,83.2,Pfizer,V5,180,NA,NA,NA,NA,NA,25/aoû/2021,Positif,14,NA,Négatif,0.1,ONM059V5b,1,1,1,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM059,F,83.2,Pfizer,V6,363,86,NA,NA,NA,NA,24/fév/2022,Positif,105.7,2886,Négatif,0.1,ONM059V6,292,88.1,57.6,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM060,M,78.2,Pfizer,V3,31,NA,NA,NA,NA,NA,15/avr/2021,Positif,103.1,NA,NA,NA,ONM060V3b,332.4,77.3,10.2,Thoracic,sclc limited,RCT: End 11.02.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM060,M,78.2,Pfizer,V4,92,NA,NA,NA,NA,NA,15/jun/2021,Positif,78.6,NA,Négatif,1,ONM060V4b,95.9,41.3,14.1,Thoracic,sclc limited,RCT: End 11.02.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM060,M,78.2,Pfizer,V5,183,NA,NA,NA,NA,NA,14/sep/2021,Positif,36.5,NA,Négatif,0.4,ONM060V5b,88,35.8,14.5,Thoracic,sclc limited,RCT: End 11.02.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM060,M,78.2,Pfizer,3M3,308,82,NA,NA,NA,NA,17/jan/2022,Positif,112.1,3244,Négatif,0.1,ONM060 3M3,2430,1695.5,404.9,Thoracic,sclc limited,RCT: End 11.02.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM060,M,78.2,Pfizer,3M6,409,183,NA,NA,NA,NA,28/avr/2022,Positif,130,4357,Négatif,0.1,ONM060 3M6,1359.6,631.7,178.9,Thoracic,sclc limited,RCT: End 11.02.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM061,M,71.2,Pfizer,V3,28,NA,NA,NA,NA,NA,26/mar/2021,Positif,102.2,NA,NA,NA,ONM061V3b,539.7,252.3,130.4,Gastrointestinal,colon ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM061,M,71.2,Pfizer,V4,89,NA,NA,NA,NA,NA,26/mai/2021,Positif,87.8,NA,NA,NA,ONM061V4b,306.2,117.5,60.1,Gastrointestinal,colon ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM061,M,71.2,Pfizer,V5,180,NA,NA,NA,NA,NA,25/aoû/2021,Positif,64.2,NA,Négatif,0.3,ONM061V5b,147.3,85.5,42.1,Gastrointestinal,colon ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM061,M,71.2,Pfizer,3M3,361,105,NA,NA,NA,NA,22/fév/2022,Positif,87.9,2001,Négatif,0.3,ONM061 3M3,670.2,298.2,233.2,Gastrointestinal,colon ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM061,M,71.2,Pfizer,3M6,440,184,NA,NA,NA,NA,12/mai/2022,Positif,137.7,4886,Négatif,0.3,ONM061 3M6,317.8,140.6,117.5,Gastrointestinal,colon ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM062,F,39.2,Pfizer,V3,32,NA,NA,NA,NA,NA,29/mar/2021,Positif,91.8,NA,NA,NA,ONM062V3b,2430,334.8,134.3,Breast,breast cancer,Adjuvant IO: Pembro .,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM062,F,39.2,Pfizer,V4,90,NA,NA,NA,NA,NA,26/mai/2021,Positif,85.6,NA,NA,NA,ONM062V4b,570.5,123.3,46.9,Breast,breast cancer,Adjuvant IO: Pembro .,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM062,F,39.2,Pfizer,V5,172,NA,NA,NA,NA,NA,16/aoû/2021,Positif,49.1,NA,Négatif,1.4,ONM062V5b,125.2,66,17.8,Breast,breast cancer,Adjuvant IO: Pembro .,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM062,F,39.2,Pfizer,V6,365,142,NA,NA,NA,NA,25/fév/2022,Positif,99.2,2544,Négatif,0.8,ONM062V6,694.4,217.8,148,Breast,breast cancer,Adjuvant IO: Pembro .,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM063,M,66.2,Pfizer,V3,29,NA,NA,NA,NA,NA,13/avr/2021,Positif,117.3,NA,NA,NA,ONM063V3b,237.5,91.5,41.1,Gastrointestinal,GIST,TKIS: Imatinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM063,M,66.2,Pfizer,V4,93,NA,NA,NA,NA,NA,16/jun/2021,Positif,59.6,NA,Négatif,0.3,ONM063V4b,88,53.9,28.3,Gastrointestinal,GIST,TKIS: Imatinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM063,M,66.2,Pfizer,V5,183,NA,NA,NA,NA,NA,14/sep/2021,Positif,31,NA,Négatif,0.2,ONM063V5b,39.6,27.4,13.4,Gastrointestinal,GIST,TKIS: Imatinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM063,M,66.2,Pfizer,3M3,274,76,NA,NA,NA,NA,14/déc/2021,Positif,82.8,1777,Négatif,0.5,ONM063 3M3b,155.5,62.7,18.7,Gastrointestinal,GIST,TKIS: Imatinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM063,M,66.2,Pfizer,3M6,387,189,NA,NA,NA,NA,06/avr/2022,Positif,84.4,1846,Négatif,0.1,ONM063 3M6,272.2570106180234,83.47245409015025,51.07252298263534,Gastrointestinal,GIST,TKIS: Imatinib,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Imatinib,Imatinib,L01EA01,L01EA01
ONM064,M,71.2,Pfizer,V3,30,NA,NA,V5-V6,NA,NA,14/avr/2021,Négatif,0.1,NA,NA,NA,ONM064V3b,1,1,1,Thoracic,lung ADK stage IV,Chimio+Tacrolimus+Prednisone,Chemotherapy,NA,Cancer treatment + IS,Cancer treatment,transplantation pulmonaire,tacrolimus +prednisone,NA,NA,NA,NA,NA,NA,ONM,Tacrolimus,Prednisone,H02AB07,L04AD02
ONM064,M,71.2,Pfizer,V4,92,NA,NA,V5-V6,NA,NA,15/jun/2021,Négatif,0.2,NA,Négatif,0.1,ONM064V4b,1,1,1,Thoracic,lung ADK stage IV,Chimio+Tacrolimus+Prednisone,Chemotherapy,NA,Cancer treatment + IS,Cancer treatment,transplantation pulmonaire,tacrolimus +prednisone,NA,NA,NA,NA,NA,NA,ONM,Tacrolimus,Prednisone,H02AB07,L04AD02
ONM064,M,71.2,Pfizer,V5,182,33,NA,V5-V6,NA,NA,13/sep/2021,Négatif,0.3,NA,Négatif,0.1,ONM064V5b,1,1,1,Thoracic,lung ADK stage IV,Chimio+Tacrolimus+Prednisone,Chemotherapy,NA,Cancer treatment + IS,Cancer treatment,transplantation pulmonaire,tacrolimus +prednisone,NA,NA,NA,NA,NA,NA,ONM,Tacrolimus,Prednisone,H02AB07,L04AD02
ONM064,M,71.2,Pfizer,V6,373,224,NA,V5-V6,13,NA,23/mar/2022,Positif,51.6,698,Négatif,3.3,ONM064V6,108.9,62.3,43.7,Thoracic,lung ADK stage IV,Chimio+Tacrolimus+Prednisone,Chemotherapy,NA,Cancer treatment + IS,Cancer treatment,transplantation pulmonaire,tacrolimus +prednisone,NA,NA,NA,NA,NA,NA,ONM,Tacrolimus,Prednisone,H02AB07,L04AD02
ONM065,F,75.2,Moderna,V3,32,NA,NA,NA,NA,NA,16/avr/2021,Positif,130,NA,NA,NA,ONM065V3b,336.1,120.4,46.8,Gastrointestinal,mets rectal cancer,No TTT SIRT Performed On 14.12.2020,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM065,F,75.2,Moderna,V4,92,NA,NA,NA,NA,NA,15/jun/2021,Positif,85.7,NA,Négatif,0.2,ONM065V4b,149.4,61.8,20.5,Gastrointestinal,mets rectal cancer,No TTT SIRT Performed On 14.12.2020,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM065,F,75.2,Moderna,V5,183,NA,NA,NA,NA,NA,14/sep/2021,Positif,53.1,NA,Négatif,0.1,ONM065V5b,82,35.5,14.6,Gastrointestinal,mets rectal cancer,No TTT SIRT Performed On 14.12.2020,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM065,F,75.2,Moderna,3M3,366,113,NA,NA,NA,NA,16/mar/2022,Positif,88.6,2033,Négatif,0,ONM065 3M3,220.2,36,21.2,Gastrointestinal,mets rectal cancer,No TTT SIRT Performed On 14.12.2020,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM065,F,75.2,Moderna,3M6,442,189,NA,NA,NA,NA,31/mai/2022,Positif,124.6,4004,Négatif,0.3,ONM065 3M6,314.2,40.6,33.1,Gastrointestinal,mets rectal cancer,No TTT SIRT Performed On 14.12.2020,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM066,F,61.2,Pfizer,3M3,371,114,NA,NA,NA,NA,01/avr/2022,Positif,66.4,1148,Négatif,0,ONM066 3M3,97,53.1,17.3,Breast,mets breast cancer,Her 2 Inhibitor,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM067,M,63.2,Pfizer,V3,31,NA,NA,NA,NA,NA,15/avr/2021,Positif,104.3,NA,NA,NA,ONM067V3b,216.4,81.8,34.3,Thoracic,lung ADK stade II,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM067,M,63.2,Pfizer,V4,94,NA,NA,NA,NA,NA,17/jun/2021,Positif,82.7,NA,Négatif,0.7,ONM067V4b,106,53.2,23.6,Thoracic,lung ADK stade II,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM067,M,63.2,Pfizer,V5,175,NA,NA,NA,NA,NA,06/sep/2021,Positif,55.3,NA,Négatif,0.5,ONM067V5b,92.9,39.4,18.9,Thoracic,lung ADK stade II,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM067,M,63.2,Pfizer,3M3,365,122,NA,NA,NA,NA,15/mar/2022,Positif,70.2,1281,Négatif,0.1,ONM067 3M3,97.7,57.5,56.6,Thoracic,lung ADK stade II,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM067,M,63.2,Pfizer,3M6,421,178,NA,NA,NA,NA,10/mai/2022,Positif,74.6,1445,Négatif,0.2,ONM067 3M6,77.82101167315174,34.89183531053733,40.95004095004095,Thoracic,lung ADK stade II,No TTT Since 2019.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM068,F,52.2,Moderna,V3,30,NA,NA,NA,NA,NA,12/avr/2021,Positif,83.4,NA,NA,NA,ONM068V3b,1114.1,335.3,144.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM068,F,52.2,Moderna,V4,94,NA,NA,NA,NA,NA,15/jun/2021,Positif,123.4,NA,Positif,23.6,ONM068V4b,552.2,155.8,62.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM068,F,52.2,Moderna,V5,178,NA,NA,NA,NA,NA,07/sep/2021,Positif,94.3,NA,Positif,12.3,ONM068V5b,459.6,143.5,119.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM068,F,52.2,Moderna,3M3,366,86,NA,NA,NA,NA,14/mar/2022,Positif,138.8,4964,Indéterminé,4.7,ONM068 3M3,612,328.9,188.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM069,M,67.2,Moderna,V3,34,NA,NA,NA,NA,NA,21/avr/2021,Positif,94.4,NA,NA,NA,ONM069V3b,1214.5,470.6,231.6,Head and neck,oropharynx cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM069,M,67.2,Moderna,V4,98,NA,NA,NA,NA,NA,24/jun/2021,Positif,85,NA,Négatif,1,ONM069V4b,430.5,144.9,64.8,Head and neck,oropharynx cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM069,M,67.2,Moderna,V5,194,NA,NA,NA,NA,NA,28/sep/2021,Positif,76,NA,Négatif,0.8,ONM069V5b,166.6,70.3,43.3,Head and neck,oropharynx cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM069,M,67.2,Moderna,3M3,369,105,NA,NA,NA,NA,22/mar/2022,Positif,99.3,2549,Négatif,0.6,ONM069 3M3,562.1,294.4,108.4,Head and neck,oropharynx cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM070,M,74.2,Pfizer,V3,34,NA,NA,NA,NA,NA,20/avr/2021,Positif,122.4,NA,NA,NA,ONM070V3b,398.9,148.6,74.2,Thoracic,SCClung stage IV,IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM070,M,74.2,Pfizer,V4,97,NA,NA,NA,NA,NA,22/jun/2021,Positif,57.7,NA,Négatif,1.6,ONM070V4b,122,52.3,30.8,Thoracic,SCClung stage IV,IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM070,M,74.2,Pfizer,V5,198,NA,NA,NA,NA,NA,01/oct/2021,Positif,29.9,NA,Négatif,1.2,ONM070V5b,43.3,28,14.3,Thoracic,SCClung stage IV,IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM070,M,74.2,Pfizer,3M3,364,96,NA,NA,NA,NA,16/mar/2022,Positif,88.6,2033,Négatif,0.1,ONM070 3M3,1385.2,498.8,367.1,Thoracic,SCClung stage IV,IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM071,F,38.2,Pfizer,V3,31,NA,NA,NA,NA,NA,15/avr/2021,Positif,101.1,NA,NA,NA,ONM071V3b,223.9,87.2,46,Breast,breast cancer stage III,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM071,F,38.2,Pfizer,V4,91,NA,NA,NA,NA,NA,14/jun/2021,Positif,70.3,NA,Négatif,0.4,ONM071V4b,70.9,43.8,18,Breast,breast cancer stage III,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM071,F,38.2,Pfizer,V5,172,NA,NA,NA,NA,NA,03/sep/2021,Positif,42.5,NA,Négatif,0.5,ONM071V5b,65.4,39.7,21.2,Breast,breast cancer stage III,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM071,F,38.2,Pfizer,3M3,358,84,NA,NA,NA,NA,08/mar/2022,Positif,87.8,1996,Négatif,0.4,ONM071 3M3,553.4,212.1,113.1,Breast,breast cancer stage III,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM072,F,49.2,Moderna,V3,26,NA,NA,3M3-3M6,NA,NA,19/avr/2021,Positif,109.3,NA,NA,NA,ONM072V3,1,1,1,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM072,F,49.2,Moderna,V4,89,NA,NA,3M3-3M6,NA,NA,21/jun/2021,Positif,50.7,NA,Négatif,0.4,ONM072V4b,1,1,1,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM072,F,49.2,Moderna,V5,181,NA,NA,3M3-3M6,NA,NA,21/sep/2021,Positif,12.1,NA,Négatif,0.3,ONM072V5b,1,1,1,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM072,F,49.2,Moderna,3M3,313,84,NA,3M3-3M6,NA,NA,31/jan/2022,Positif,85.8,1907,Négatif,0.3,ONM072 3M3,141.4,70.5,39.2,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM072,F,49.2,Moderna,3M6,422,193,NA,3M3-3M6,67,NA,20/mai/2022,Positif,100.9,2631,Positif,17.6,ONM072 3M6,2430,1491.9,1041.7,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM073,F,47.2,Pfizer,V3,35,NA,NA,NA,NA,NA,21/avr/2021,Positif,92.9,NA,NA,NA,ONM073V3b,183.7,51.3,50.4,Breast,breast cancer,Neoadjuvant Chemo Untill 22.02.2021 .Currently Hormonotherapy+Herceptine +Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM073,F,47.2,Pfizer,V4,98,NA,NA,NA,NA,NA,23/jun/2021,Positif,50.1,NA,Négatif,0.8,ONM073V4b,51.5,19.3,20.5,Breast,breast cancer,Neoadjuvant Chemo Untill 22.02.2021 .Currently Hormonotherapy+Herceptine +Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM073,F,47.2,Pfizer,V5,196,NA,NA,NA,NA,NA,29/sep/2021,Positif,19.8,NA,Négatif,1,ONM073V5b,30.2,23.2,13.2,Breast,breast cancer,Neoadjuvant Chemo Untill 22.02.2021 .Currently Hormonotherapy+Herceptine +Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM073,F,47.2,Pfizer,3M3,308,96,NA,NA,NA,NA,19/jan/2022,Positif,74.4,1438,Positif,20,ONM073 3M3,2430,1832.2,1235.8,Breast,breast cancer,Neoadjuvant Chemo Untill 22.02.2021 .Currently Hormonotherapy+Herceptine +Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM073,F,47.2,Pfizer,3M6,408,196,NA,NA,NA,NA,29/avr/2022,Positif,155.2,6202,Positif,14.8,ONM073 3M6,1875.8,726.7,567.9,Breast,breast cancer,Neoadjuvant Chemo Untill 22.02.2021 .Currently Hormonotherapy+Herceptine +Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM074,M,68.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,106.8,NA,NA,NA,ONM074V3b,100.6,23.7,10.2,Gastrointestinal,colon cancer,No TTT Since 2013,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM074,M,68.2,Pfizer,V4,98,NA,NA,NA,NA,NA,02/jui/2021,Positif,86.2,NA,Négatif,1.4,ONM074V4b,86.2,18.2,8.2,Gastrointestinal,colon cancer,No TTT Since 2013,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM074,M,68.2,Pfizer,V5,192,NA,NA,NA,NA,NA,04/oct/2021,Positif,60.5,NA,Négatif,0.8,ONM074V5b,163.3,69.7,39.7,Gastrointestinal,colon cancer,No TTT Since 2013,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM074,M,68.2,Pfizer,3M3,335,94,NA,NA,NA,NA,24/fév/2022,Positif,105.1,2854,Négatif,0.7,ONM074 3M3,641.8,195.3,169,Gastrointestinal,colon cancer,No TTT Since 2013,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM074,M,68.2,Pfizer,3M6,423,182,NA,NA,NA,NA,23/mai/2022,Positif,147.3,5589,Négatif,0.6,ONM074 3M6,475.5,159.1,106.2,Gastrointestinal,colon cancer,No TTT Since 2013,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM075,M,64.2,Pfizer,V3,35,NA,NA,NA,NA,NA,20/avr/2021,Positif,116.8,NA,NA,NA,ONM075V3b,244.1,99.7,60.1,Thoracic,sclc extensive,Chemo+IO,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM075,M,64.2,Pfizer,V4,98,NA,NA,NA,NA,NA,22/jun/2021,Positif,41,NA,Négatif,0.1,ONM075V4b,96.8,25.5,21.6,Thoracic,sclc extensive,Chemo+IO,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM075,M,64.2,Pfizer,V5,189,NA,NA,NA,NA,NA,21/sep/2021,Positif,25.2,NA,Négatif,0.1,ONM075V5b,49.7,27.1,15.2,Thoracic,sclc extensive,Chemo+IO,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM075,M,64.2,Pfizer,3M3,273,76,NA,NA,NA,NA,14/déc/2021,Positif,77.8,1571,Négatif,0.1,ONM075 3M3b,576,228.5,186.6,Thoracic,sclc extensive,Chemo+IO,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM076,M,71.2,Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,16/avr/2021,Positif,103.3,NA,NA,NA,ONM076V3b,135.3,54.9,28.8,Gastrointestinal,pancreatic cancer,No TTT Since 2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM076,M,71.2,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,16/jun/2021,Positif,50.7,NA,Négatif,0.2,ONM076V4b,101.5,50.5,25.3,Gastrointestinal,pancreatic cancer,No TTT Since 2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM076,M,71.2,Pfizer,V5,184,NA,NA,V5-3M3,NA,NA,16/sep/2021,Positif,21.8,NA,Négatif,0.2,ONM076V5b,41.7,25.5,11.8,Gastrointestinal,pancreatic cancer,No TTT Since 2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM076,M,71.2,Pfizer,3M3,367,101,NA,V5-3M3,70,NA,18/mar/2022,Positif,101.5,2663,Positif,9.1,ONM076 3M3,3894.1,1531.6,1199.9,Gastrointestinal,pancreatic cancer,No TTT Since 2016,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM079,F,80.2,Pfizer,V3,31,NA,NA,NA,NA,NA,16/avr/2021,Positif,81.8,NA,NA,NA,ONM079V3b,1090.4,341.1,201.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM079,F,80.2,Pfizer,V4,91,NA,NA,NA,NA,NA,15/jun/2021,Positif,100.9,NA,Négatif,0.2,ONM079V4b,519.5,187.2,97.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM079,F,80.2,Pfizer,V5,185,NA,NA,NA,NA,NA,17/sep/2021,Positif,69.2,NA,Négatif,0.1,ONM079V5b,233.4,82.9,61.2,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM079,F,80.2,Pfizer,V6,367,112,NA,NA,NA,NA,18/mar/2022,Positif,94.6,2315,Négatif,0,ONM079V6,960.6,437.4,326.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM080,F,49.2,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,19/avr/2021,Positif,107.5,NA,NA,NA,ONM080V3b,197.4,95.5,46.6,Brain,Glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM080,F,49.2,Pfizer,V4,86,NA,NA,V5-3M3,NA,NA,10/jun/2021,Positif,64.5,NA,Négatif,0,ONM080V4b,77.6,56,31.8,Brain,Glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM080,F,49.2,Pfizer,V5,184,NA,NA,V5-3M3,NA,NA,16/sep/2021,Positif,33.9,NA,Négatif,0,ONM080V5b,69.9,49.9,22.2,Brain,Glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM080,F,49.2,Pfizer,3M3,387,118,NA,V5-3M3,14,NA,07/avr/2022,Positif,99.1,2539,Positif,9.2,ONM080 3M3,1665.3,587.2,301.7,Brain,Glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM081,F,50.2,Moderna,V4,99,NA,NA,NA,NA,NA,30/jun/2021,Positif,79.6,NA,Positif,9.9,ONM081V4b,391.5,186.3,84,Breast,breast cancer,No TTT Since 2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM081,F,50.2,Moderna,3M3,346,88,NA,NA,NA,NA,04/mar/2022,Positif,100,2585,Négatif,0.3,ONM081 3M3,416.5,179.5,62.9,Breast,breast cancer,No TTT Since 2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM081,F,50.2,Moderna,3M6,436,178,NA,NA,NA,NA,02/jun/2022,Positif,152.5,5989,Négatif,0.3,ONM081 3M6,286.8617326448652,135.68521031207598,55.035773252614206,Breast,breast cancer,No TTT Since 2018,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM082,F,78.2,Moderna,V3,31,NA,NA,NA,NA,NA,22/avr/2021,Positif,129.1,NA,NA,NA,ONM082V3b,1113,466.6,171.6,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM082,F,78.2,Moderna,V4,87,NA,NA,NA,NA,NA,17/jun/2021,Positif,97.3,NA,Négatif,0.5,ONM082V4b,289.9,115.1,65.4,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM082,F,78.2,Moderna,V5,184,NA,NA,NA,NA,NA,22/sep/2021,Positif,74.7,NA,Négatif,0.3,ONM082V5b,181.3,87.3,52.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM082,F,78.2,Moderna,3M3,371,112,NA,NA,NA,NA,28/mar/2022,Positif,88.7,2037,Négatif,0.2,ONM082 3M3,2430,1296.5,669.8,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM083,F,40.4,Pfizer,V6,364,130,NA,NA,NA,NA,20/mai/2022,Positif,140.9,5115,Indéterminé,4.2,ONM083V6,280.7,142.9,256.7,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM084,F,54.2,Pfizer,V3,30,NA,NA,NA,NA,NA,15/avr/2021,Positif,97.1,NA,NA,NA,ONM084V3b,524.1,240.8,104.9,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM084,F,54.2,Pfizer,V4,93,NA,NA,NA,NA,NA,17/jun/2021,Positif,94.7,NA,Négatif,0.1,ONM084V4b,212.6,99.9,59.3,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM084,F,54.2,Pfizer,V5,177,NA,NA,NA,NA,NA,09/sep/2021,Positif,64.2,NA,Négatif,0.1,ONM084V5b,141.1,96.4,62.2,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM084,F,54.2,Pfizer,3M3,366,92,NA,NA,NA,NA,17/mar/2022,Positif,105.2,2859,Négatif,0.2,ONM084 3M3,441.1,264,145.5,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM085,M,73.2,Moderna,V3,34,NA,NA,V5-V6,NA,NA,22/avr/2021,Positif,98.4,NA,NA,NA,ONM085V3b,686.8,207.6,99.8,Hepatic,CHC,IO Vs Placebo (Since 09.2020)Protocole,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM085,M,73.2,Moderna,V4,98,NA,NA,V5-V6,NA,NA,25/jun/2021,Positif,102.5,NA,Négatif,0.4,ONM085V4b,272.3,95,47.4,Hepatic,CHC,IO Vs Placebo (Since 09.2020)Protocole,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM085,M,73.2,Moderna,V5,179,NA,NA,V5-V6,NA,NA,14/sep/2021,Positif,59.5,NA,Négatif,0.2,ONM085V5b,138.2,72.4,40.8,Hepatic,CHC,IO Vs Placebo (Since 09.2020)Protocole,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM085,M,73.2,Moderna,V5+,278,NA,NA,V5-V6,23,NA,22/déc/2021,Positif,108.5,3040,Positif,18.7,ONM085V5+,2430,2430,2430,Hepatic,CHC,IO Vs Placebo (Since 09.2020)Protocole,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM085,M,73.2,Moderna,V6,378,NA,NA,V5-V6,123,NA,01/avr/2022,Positif,88.2,2014,Négatif,3.2,ONM085V6,2430,2430,1418.6,Hepatic,CHC,IO Vs Placebo (Since 09.2020)Protocole,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM086,F,61.2,Pfizer,V3,29,NA,NA,NA,NA,NA,13/avr/2021,Positif,111.9,NA,NA,NA,ONM086V3b,435,202.3,79.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM086,F,61.2,Pfizer,V4,93,NA,NA,NA,NA,NA,16/jun/2021,Positif,116.9,NA,Négatif,0.3,ONM086V4b,273.4,139.6,49.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM086,F,61.2,Pfizer,V5,191,NA,NA,NA,NA,NA,22/sep/2021,Positif,78.8,NA,Négatif,0.5,ONM086V5b,242.9,96.7,43.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM086,F,61.2,Pfizer,3M3,358,70,NA,NA,NA,NA,08/mar/2022,Positif,86.7,1947,Positif,10.4,ONM086 3M3,2430,2430,1936.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM087,F,78.2,Moderna,V3,31,NA,NA,NA,NA,NA,22/avr/2021,Positif,85.5,NA,NA,NA,ONM087V3b,1822.5,735.8,233.5,Thoracic,lung canecr (NOS) stage III,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM087,F,78.2,Moderna,V4,92,NA,NA,NA,NA,NA,22/jun/2021,Positif,57.4,NA,Négatif,0.3,ONM087V4b,628.5,258.3,92.1,Thoracic,lung canecr (NOS) stage III,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM087,F,78.2,Moderna,V5,183,NA,NA,NA,NA,NA,21/sep/2021,Positif,74.3,NA,Négatif,0.1,ONM087V5b,250.5,116.5,56.8,Thoracic,lung canecr (NOS) stage III,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM087,F,78.2,Moderna,3M3,324,91,NA,NA,NA,NA,09/fév/2022,Positif,100.7,2621,Négatif,0.2,ONM087 3M3,904.2,430.1,288.1,Thoracic,lung canecr (NOS) stage III,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM087,F,78.2,Moderna,3M6,416,183,NA,NA,NA,NA,12/mai/2022,Positif,141.5,5158,Négatif,0.1,ONM087 3M6,488,192.8,140.7,Thoracic,lung canecr (NOS) stage III,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM088,M,78.2,Moderna,V3,33,NA,NA,3M3-3M6,NA,NA,26/avr/2021,Positif,23.1,NA,NA,NA,ONM088V3b,72.2,21.8,15,Gastrointestinal,pancreatic cancer,Adj Chemo End 03.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM088,M,78.2,Moderna,V4,90,NA,NA,3M3-3M6,NA,NA,22/jun/2021,Positif,35.8,NA,Négatif,0.1,ONM088V4b,52.9,33.7,18.5,Gastrointestinal,pancreatic cancer,Adj Chemo End 03.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM088,M,78.2,Moderna,V5,188,NA,NA,3M3-3M6,NA,NA,28/sep/2021,Positif,31.3,NA,Négatif,0.1,ONM088V5b,49.3,37.1,19.1,Gastrointestinal,pancreatic cancer,Adj Chemo End 03.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM088,M,78.2,Moderna,3M3,307,91,NA,3M3-3M6,NA,NA,25/jan/2022,Positif,85.3,1885,Négatif,0.2,ONM088 3M3,190.4,83.5,64.6,Gastrointestinal,pancreatic cancer,Adj Chemo End 03.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM088,M,78.2,Moderna,3M6,398,182,NA,3M3-3M6,6,NA,26/avr/2022,Positif,148.1,5649,Négatif,0.3,ONM088 3M6,304.3,108.1,90.1,Gastrointestinal,pancreatic cancer,Adj Chemo End 03.2021,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,V3,37,NA,NA,3M3-3M6,NA,NA,29/avr/2021,Positif,109.9,NA,NA,NA,ONM089V3b,299.8,112.4,38.7,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,V4,93,NA,NA,3M3-3M6,NA,NA,24/jun/2021,Positif,70,NA,Négatif,0.2,ONM089V4b,130.6,99.1,53.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,V5,196,NA,NA,3M3-3M6,NA,NA,05/oct/2021,Positif,34.3,NA,Négatif,0.5,ONM089V5b,69.4,60,23,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,3M3,317,87,NA,3M3-3M6,NA,NA,03/fév/2022,Positif,107.5,2985,Négatif,0.2,ONM089 3M3,250.5,107.4,44.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,3M3+,356,126,NA,3M3-3M6,30,NA,14/mar/2022,Positif,139.8,5036,Positif,8.3,ONM089 3M3+,302,153.8,89.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM089,F,39.2,Moderna,3M6,412,182,NA,3M3-3M6,86,NA,09/mai/2022,Positif,167.7,7239,Indéterminé,5.3,ONM089 3M6,350.5082369435682,164.50074025333114,115.7273463719477,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM090,F,64.2,Pfizer,V3,33,NA,NA,NA,NA,NA,19/avr/2021,Positif,102.6,NA,NA,NA,ONM090V3b,1158.7,383.7,181.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM090,F,64.2,Pfizer,V4,96,NA,NA,NA,NA,NA,21/jun/2021,Positif,90.6,NA,Négatif,0.1,ONM090V4b,391.4,132.6,75.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM090,F,64.2,Pfizer,V5,194,NA,NA,NA,NA,NA,27/sep/2021,Positif,71.9,NA,Négatif,0.1,ONM090V5b,164.3,81.9,52,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM091,F,43.2,Pfizer,V3,34,NA,NA,NA,NA,NA,20/avr/2021,Positif,118.7,NA,NA,NA,ONM091V3b,538.2,216.3,119.3,Breast,mets breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM091,F,43.2,Pfizer,V4,98,NA,NA,NA,NA,NA,23/jun/2021,Positif,101.8,NA,Négatif,0.1,ONM091V4b,366,156.6,63,Breast,mets breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM091,F,43.2,Pfizer,V5,190,NA,NA,NA,NA,NA,23/sep/2021,Positif,80.9,NA,Négatif,0.1,ONM091V5b,207.7,102.7,55.1,Breast,mets breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM091,F,43.2,Pfizer,V6,364,87,NA,NA,NA,NA,16/mar/2022,Positif,91.8,2181,Négatif,0,ONM091V6,874.9,401.9,255.2,Breast,mets breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM092,F,72.2,Pfizer,V3,30,NA,NA,NA,NA,NA,16/avr/2021,Positif,136.8,NA,NA,NA,ONM092V3b,190.9,121.6,6.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM092,F,72.2,Pfizer,V4,92,NA,NA,NA,NA,NA,17/jun/2021,Positif,84.3,NA,Négatif,0.4,ONM092V4b,83.2,71.3,3.7,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM092,F,72.2,Pfizer,V5,184,NA,NA,NA,NA,NA,17/sep/2021,Positif,61.4,NA,Négatif,0.4,ONM092V5b,124.8,112.5,21.2,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM092,F,72.2,Pfizer,3M3,363,98,NA,NA,NA,NA,15/mar/2022,Positif,94.2,2296,Négatif,0.9,ONM092 3M3,376.9,210.7,88.7,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM093,M,63.2,Pfizer,3M3,328,100,NA,NA,NA,NA,09/fév/2022,Positif,99.2,2544,Négatif,0.3,ONM093 3M3,150.9,69.7,57.6,Gastrointestinal,mest colon cancer,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM093,M,63.2,Pfizer,3M6,413,185,NA,NA,NA,NA,05/mai/2022,Positif,83.2,1794,Négatif,0.2,ONM093 3M6,167.02856188408217,74.1839762611276,65.27415143603133,Gastrointestinal,mest colon cancer,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM094,F,62.2,Pfizer,3M3,370,97,NA,NA,NA,NA,23/mar/2022,Positif,85.6,1898,Positif,18.2,ONM094 3M3,434.4048653344918,229.3577981651376,179.75912277548085,Thoracic,lung neuroendocrine large cells cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM095,M,89.2,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,15/avr/2021,Positif,76.7,NA,NA,NA,ONM095V3b,116.8,55.5,22.5,Thoracic,lung ADK +prostate ADK,Hormonotherapy Fo Prostate Cancer,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM095,M,89.2,Pfizer,V4,95,NA,NA,V5-3M3,NA,NA,21/jun/2021,Positif,45.5,NA,Négatif,0.1,ONM095V4b,52.6,31.7,13.5,Thoracic,lung ADK +prostate ADK,Hormonotherapy Fo Prostate Cancer,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM095,M,89.2,Pfizer,V5,173,NA,NA,V5-3M3,NA,NA,07/sep/2021,Positif,26.6,NA,Négatif,0.1,ONM095V5b,39.4,33,14.7,Thoracic,lung ADK +prostate ADK,Hormonotherapy Fo Prostate Cancer,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM095,M,89.2,Pfizer,3M6,419,198,NA,V5-3M3,102,NA,11/mai/2022,Positif,141.7,5173,Positif,8.2,ONM095 3M6,2430,2430,1179.9410029498526,Thoracic,lung ADK +prostate ADK,Hormonotherapy Fo Prostate Cancer,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM097,F,49.2,Moderna,V3,32,NA,NA,NA,NA,NA,23/avr/2021,Positif,92,NA,NA,NA,ONM097V3b,509.7,114.2,38.6,Breast,breast cancer,Adjuvant Chemo Untill 12.03.2021 Then Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM097,F,49.2,Moderna,V4,95,NA,NA,NA,NA,NA,25/jun/2021,Positif,106.3,NA,Négatif,1.1,ONM097V4b,135.3,61.2,26.7,Breast,breast cancer,Adjuvant Chemo Untill 12.03.2021 Then Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM097,F,49.2,Moderna,V5,184,NA,NA,NA,NA,NA,22/sep/2021,Positif,88.7,NA,Négatif,1.3,ONM097V5b,161.9,100.7,60.4,Breast,breast cancer,Adjuvant Chemo Untill 12.03.2021 Then Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM097,F,49.2,Moderna,3M3,378,66,NA,NA,NA,NA,04/avr/2022,Positif,91.8,2181,Négatif,0.1,ONM097 3M3,1621.8,314.7,294.7,Breast,breast cancer,Adjuvant Chemo Untill 12.03.2021 Then Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM098,M,79.2,Moderna,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,87.5,NA,NA,NA,ONM098V3b,296.8,110.3,54,Genitourinary,mets prostate ADK,IO+Hormonotherapy,Immune checkpoint inhibitor ICI,NA,ICI + Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM098,M,79.2,Moderna,V4,101,NA,NA,NA,NA,NA,02/jui/2021,Positif,68.3,NA,Négatif,0.1,ONM098V4b,109.8,48.1,28.7,Genitourinary,mets prostate ADK,IO+Hormonotherapy,Immune checkpoint inhibitor ICI,NA,ICI + Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM098,M,79.2,Moderna,V5,185,NA,NA,NA,NA,NA,24/sep/2021,Positif,35.5,NA,Négatif,0.1,ONM098V5b,66.4,34.2,18.8,Genitourinary,mets prostate ADK,IO+Hormonotherapy,Immune checkpoint inhibitor ICI,NA,ICI + Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM098,M,79.2,Moderna,3M3,290,79,NA,NA,NA,NA,07/jan/2022,Positif,93.1,2243,Négatif,0,ONM098 3M3,370.5,154.2,97.5,Genitourinary,mets prostate ADK,IO+Hormonotherapy,Immune checkpoint inhibitor ICI,NA,ICI + Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM098,M,79.2,Moderna,3M6,395,184,NA,NA,NA,NA,22/avr/2022,Positif,65.8,1127,Négatif,0,ONM098 3M6,92.5,63.7,39.4,Genitourinary,mets prostate ADK,IO+Hormonotherapy,Immune checkpoint inhibitor ICI,NA,ICI + Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM099,F,59.2,Pfizer,V3,32,NA,NA,NA,NA,NA,20/avr/2021,Positif,101.1,NA,NA,NA,ONM099V3b,95.2,31.5,20.4,Thoracic,lung ADK,Chemo. Psoriasis Grade 3 IO Induit En Novembre 2020(A Recu Tociluzumab Et Infliximab 21.01.2021). HIV+,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM099,F,59.2,Pfizer,V4,96,NA,NA,NA,NA,NA,23/jun/2021,Positif,37,NA,Négatif,1.9,ONM099V4b,43.6,23.2,12.6,Thoracic,lung ADK,Chemo. Psoriasis Grade 3 IO Induit En Novembre 2020(A Recu Tociluzumab Et Infliximab 21.01.2021). HIV+,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM099,F,59.2,Pfizer,V5,195,28,NA,NA,NA,NA,30/sep/2021,Positif,44.8,NA,Négatif,1.3,ONM099V5b,1,1,1,Thoracic,lung ADK,Chemo. Psoriasis Grade 3 IO Induit En Novembre 2020(A Recu Tociluzumab Et Infliximab 21.01.2021). HIV+,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM099,F,59.2,Pfizer,3M6,356,189,NA,NA,NA,NA,10/mar/2022,Positif,80.4,1676,Négatif,1.4,ONM099 3M6,256.1,176.3,86.9,Thoracic,lung ADK,Chemo. Psoriasis Grade 3 IO Induit En Novembre 2020(A Recu Tociluzumab Et Infliximab 21.01.2021). HIV+,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM100,M,56.2,Pfizer,V3,28,NA,NA,NA,NA,NA,16/avr/2021,Positif,87.2,NA,NA,NA,ONM100V3b,1067.6,230.9,96.3,Genitourinary,car testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM100,M,56.2,Pfizer,V4,98,NA,NA,NA,NA,NA,25/jun/2021,Positif,106.7,NA,Négatif,0.3,ONM100V4b,327,99.5,67.8,Genitourinary,car testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM100,M,56.2,Pfizer,V5,172,NA,NA,NA,NA,NA,07/sep/2021,Positif,96.1,NA,Négatif,0.3,ONM100V5b,266.1,103.4,79.4,Genitourinary,car testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM100,M,56.2,Pfizer,3M3,371,93,NA,NA,NA,NA,25/mar/2022,Positif,89.9,2092,Négatif,0.2,ONM100 3M3,4073.3,1431,701.3,Genitourinary,car testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM102,F,66.2,Moderna,V3,32,NA,NA,NA,NA,NA,03/mai/2021,Positif,97.3,NA,NA,NA,ONM102V3b,1751.3,458.3,126,Breast,mets breast cancer,Chemo+Herceptine,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin,Herceptine,L01XC03,L01XC03
ONM103,F,63.2,Moderna,V3,31,NA,NA,NA,NA,NA,19/avr/2021,Positif,50.8,NA,NA,NA,ONM103V3b,36.8,18.7,4.5,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,maladie de gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM103,F,63.2,Moderna,V4,94,NA,NA,NA,NA,NA,21/jun/2021,Positif,51.5,NA,Négatif,2.9,ONM103V4b,77.3,30.7,17.5,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,maladie de gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM103,F,63.2,Moderna,V5,186,NA,NA,NA,NA,NA,21/sep/2021,Positif,24.2,NA,Négatif,2.9,ONM103V5b,44.9,30.6,14.1,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,maladie de gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM103,F,63.2,Moderna,3M3,311,91,NA,NA,NA,NA,24/jan/2022,Positif,104.5,2821,Négatif,2.5,ONM103 3M3,999,287.9,131.4,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,maladie de gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM103,F,63.2,Moderna,3M6,403,183,NA,NA,NA,NA,26/avr/2022,Positif,160.9,6665,Négatif,3,ONM103 3M6,683.1,207.2,186.2,Breast,mets breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,maladie de gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM104,F,63.2,Moderna,V4,91,NA,NA,NA,NA,NA,25/jun/2021,Positif,103.8,NA,Négatif,0.1,ONM104V4b,1,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM104,F,63.2,Moderna,3M3,378,115,NA,NA,NA,NA,08/avr/2022,Positif,110.6,3158,Négatif,0,ONM104 3M3,877.2,368.3,210.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM105,M,76.2,Moderna,V3,34,NA,NA,V4-V5,NA,NA,27/avr/2021,Positif,71.5,NA,NA,NA,ONM105V3b,114,33.7,10.1,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM105,M,76.2,Moderna,V4,104,NA,NA,V4-V5,NA,NA,06/jui/2021,Positif,33.6,NA,Négatif,0.1,ONM105V4b,40.7,16,4.8,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM105,M,76.2,Moderna,V5,197,NA,NA,V4-V5,17,NA,07/oct/2021,Positif,63.1,NA,Négatif,0.3,ONM105V5b,337.3,152.3,93.4,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM105,M,76.2,Moderna,3M3,307,91,NA,V4-V5,127,NA,25/jan/2022,Positif,89.3,2065,Négatif,0.3,ONM105 3M3,754.1,303.2,120.3,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM105,M,76.2,Moderna,3M6,408,192,NA,V4-V5,228,NA,06/mai/2022,Positif,127.7,4205,Négatif,0.1,ONM105 3M6,331.2355084465055,125.99218848431398,57.73672055427252,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM106,F,65.2,Moderna,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,115.7,NA,NA,NA,ONM106V3b,632.5,206.6,97.3,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM106,F,65.2,Moderna,V4,91,NA,NA,NA,NA,NA,25/jun/2021,Positif,102.2,NA,Négatif,0.5,ONM106V4b,167.9,82.9,32.8,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM106,F,65.2,Moderna,V5,196,NA,NA,NA,NA,NA,08/oct/2021,Positif,74.3,NA,Négatif,0.2,ONM106V5b,101,59.9,25.2,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM106,F,65.2,Moderna,3M3,357,105,NA,NA,NA,NA,18/mar/2022,Positif,100.3,2600,Positif,6.9,ONM106 3M3,2430,2134.9,1155.5,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,V3,31,NA,NA,3M3-3M6,NA,NA,22/avr/2021,Positif,147.6,NA,NA,NA,ONM107V3b,602,145.4,55,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,V4,94,NA,NA,3M3-3M6,NA,NA,24/jun/2021,Positif,82.5,NA,Négatif,0.1,ONM107V4b,383.6,75.5,26.2,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,V5,190,NA,NA,3M3-3M6,NA,NA,28/sep/2021,Positif,62.7,NA,Négatif,0.1,ONM107V5b,246.5,45.6,12.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,3M3,338,96,NA,3M3-3M6,NA,NA,23/fév/2022,Positif,79.5,1639,Négatif,0.1,ONM107 3M3,646,225.6,80.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,3M3+,364,122,NA,3M3-3M6,15,NA,21/mar/2022,Positif,91.7,2176,Indéterminé,5.7,ONM107 3M3+,928.5,471.5,179.2,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM107,F,79.2,Moderna,3M6,420,178,NA,3M3-3M6,71,NA,16/mai/2022,Positif,155.6,6234,Négatif,2.4,ONM107 3M6,1917.5,1214.3,242.8,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM109,F,72.2,Moderna,V3,34,NA,NA,V5-V6,NA,NA,27/avr/2021,Positif,106.4,NA,NA,NA,ONM109V3b,870.3,366.6,72.1,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM109,F,72.2,Moderna,V4,99,NA,NA,V5-V6,NA,NA,01/jui/2021,Positif,82.6,NA,Négatif,0.5,ONM109V4b,523.8,243,54.7,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM109,F,72.2,Moderna,V5,190,NA,NA,V5-V6,NA,NA,30/sep/2021,Positif,60.1,NA,Négatif,0.4,ONM109V5b,339.4,117,27.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM109,F,72.2,Moderna,3M3,306,64,NA,V5-V6,31,NA,24/jan/2022,Positif,94.6,2315,Positif,8.4,ONM109 3M3,2430,2430,2430,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM109,F,72.2,Moderna,3M6,426,184,NA,V5-V6,151,NA,24/mai/2022,Positif,158.5,6468,Indéterminé,4.1,ONM109 3M6,2430,2430,2429.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM110,F,45.2,Moderna,V3,34,NA,NA,3M3-3M6,NA,NA,26/avr/2021,Positif,96,NA,NA,NA,ONM110V3b,886.5,338.8,51.3,Breast,breast cancer,Adj TKIs: Anti CDK,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM110,F,45.2,Moderna,V4,99,NA,NA,3M3-3M6,NA,NA,30/jun/2021,Positif,77.3,NA,Négatif,0.3,ONM110V4b,251.1,130.6,40.8,Breast,breast cancer,Adj TKIs: Anti CDK,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM110,F,45.2,Moderna,V5,174,NA,NA,3M3-3M6,NA,NA,13/sep/2021,Positif,74.9,NA,Négatif,0.3,ONM110V5b,222.2,122.1,37.1,Breast,breast cancer,Adj TKIs: Anti CDK,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM110,F,45.2,Moderna,3M3,364,118,NA,3M3-3M6,NA,NA,22/mar/2022,Positif,97.5,2458,Négatif,0.1,ONM110 3M3,511.2,264.7,91.8,Breast,breast cancer,Adj TKIs: Anti CDK,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM110,F,45.2,Moderna,3M6,419,173,NA,3M3-3M6,10,NA,16/mai/2022,Positif,154,6107,Positif,7.8,ONM110 3M6,1837.9,1129.2,413.2,Breast,breast cancer,Adj TKIs: Anti CDK,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM111,M,65.2,Moderna,V3,30,NA,NA,NA,NA,NA,22/avr/2021,Positif,130,NA,NA,NA,ONM111V3b,694.9,296.6,109.2,Sarcoma,chondrosarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM111,M,65.2,Moderna,V4,97,NA,NA,NA,NA,NA,28/jun/2021,Positif,85,NA,Négatif,1,ONM111V4b,372.9,160.9,57.7,Sarcoma,chondrosarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM111,M,65.2,Moderna,V5,195,NA,NA,NA,NA,NA,04/oct/2021,Positif,68.2,NA,Négatif,0.5,ONM111V5b,137.8,72.9,37.2,Sarcoma,chondrosarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM111,M,65.2,Moderna,3M3,335,84,NA,NA,NA,NA,21/fév/2022,Positif,82.6,1769,Négatif,0.4,ONM111 3M3,4228.3,2241.6,614.3,Sarcoma,chondrosarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM111,M,65.2,Moderna,3M6,426,175,NA,NA,NA,NA,23/mai/2022,Positif,161.4,6706,Négatif,0.1,ONM111 3M6,1720,755.9,258.6,Sarcoma,chondrosarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM112,M,52.3,Pfizer,V3,32,NA,NA,NA,NA,NA,17/mai/2021,Positif,81,NA,NA,NA,ONM112V3b,117,45.9,31.8,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM112,M,52.3,Pfizer,V4,99,NA,NA,NA,NA,NA,23/jui/2021,Positif,48.7,NA,Négatif,0.2,ONM112V4b,99.8,47.6,26.8,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM112,M,52.3,Pfizer,V5,187,NA,NA,NA,NA,NA,19/oct/2021,Positif,41.1,NA,Négatif,0.2,ONM112V5b,49,30.5,14.9,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM112,M,52.3,Pfizer,3M3,277,90,NA,NA,NA,NA,17/jan/2022,Positif,126.8,4146,Négatif,0.1,ONM112 3M3,200.6,84.8,39.6,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM112,M,52.3,Pfizer,3M6,362,175,NA,NA,NA,NA,12/avr/2022,Positif,86.4,1934,Négatif,0,ONM112 3M6,153,84,46.2,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM113,F,54.2,Moderna,V3,30,NA,NA,NA,NA,NA,16/avr/2021,Positif,125.9,NA,NA,NA,ONM113V3b,349.8,129.1,53.9,Breast,ovarien+breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM113,F,54.2,Moderna,V4,93,NA,NA,NA,NA,NA,18/jun/2021,Positif,111.9,NA,Négatif,0.4,ONM113V4b,482.9,205.7,78.7,Breast,ovarien+breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM113,F,54.2,Moderna,V5,197,NA,NA,NA,NA,NA,30/sep/2021,Positif,60,NA,Négatif,0.2,ONM113V5b,219.3,103.6,50.5,Breast,ovarien+breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM113,F,54.2,Moderna,3M3,352,80,NA,NA,NA,NA,04/mar/2022,Positif,93.2,2247,Négatif,0.2,ONM113 3M3,772.2,319.5,208.3,Breast,ovarien+breast cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM114,M,68.2,Moderna,V3,34,NA,NA,NA,NA,NA,27/avr/2021,Positif,120.5,NA,NA,NA,ONM114V3b,2039.2,1260.1,54,Gastrointestinal,mets cholangiocarcinoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM114,M,68.2,Moderna,V4,99,NA,NA,NA,NA,NA,01/jui/2021,Positif,86.8,NA,Négatif,0.1,ONM114V4b,519.2,254.1,48.5,Gastrointestinal,mets cholangiocarcinoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM114,M,68.2,Moderna,V5,196,NA,NA,NA,NA,NA,06/oct/2021,Positif,89.4,NA,Négatif,0.2,ONM114V5b,149.1,86.7,29.9,Gastrointestinal,mets cholangiocarcinoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM115,F,44.2,Moderna,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,73.8,NA,NA,NA,ONM115V3b,1585.5,765.1,150.5,Breast,breast cancer,Adjuvant IO: Kadcyla,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Kadcyla,,"NA",L01XC14
ONM115,F,44.2,Moderna,V4,98,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.6,NA,Négatif,2.5,ONM115V4b,479.2,257.2,64.2,Breast,breast cancer,Adjuvant IO: Kadcyla,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Kadcyla,,"NA",L01XC14
ONM115,F,44.2,Moderna,V5,188,NA,NA,NA,NA,NA,27/sep/2021,Positif,72.9,NA,Négatif,3.5,ONM115V5b,244.4,132.3,31,Breast,breast cancer,Adjuvant IO: Kadcyla,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Kadcyla,,"NA",L01XC14
ONM115,F,44.2,Moderna,3M3,372,106,NA,NA,NA,NA,30/mar/2022,Positif,92.5,2214,Négatif,2,ONM115 3M3,2430,1100,273.7,Breast,breast cancer,Adjuvant IO: Kadcyla,Antibody-drug conjugate,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Kadcyla,,"NA",L01XC14
ONM116,M,73.2,Moderna,V3,30,NA,NA,3M3-3M6,NA,NA,21/avr/2021,Positif,108.5,NA,NA,NA,ONM116V3b,368.2,106.1,80,Genitourinary,prostate canecr,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM116,M,73.2,Moderna,V4,91,NA,NA,3M3-3M6,NA,NA,21/jun/2021,Positif,45.8,NA,Négatif,0,ONM116V4b,76.5,25,19.5,Genitourinary,prostate canecr,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM116,M,73.2,Moderna,V5,189,NA,NA,3M3-3M6,NA,NA,27/sep/2021,Positif,19.8,NA,Négatif,0.1,ONM116V5b,24,14.9,6.9,Genitourinary,prostate canecr,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM116,M,73.2,Moderna,3M3,297,90,NA,3M3-3M6,NA,NA,13/jan/2022,Positif,97.6,2463,Négatif,0.1,ONM116 3M3,237.4,53.2,36,Genitourinary,prostate canecr,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM116,M,73.2,Moderna,3M6,387,180,NA,3M3-3M6,64,NA,13/avr/2022,Positif,102.5,2715,Positif,12.8,ONM116 3M6,2430,2145.9,1567.2,Genitourinary,prostate canecr,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM117,M,72.2,Moderna,V3,34,NA,NA,V5-3M3,NA,NA,28/avr/2021,Positif,112,NA,NA,NA,ONM117V3b,832.6,97.9,9.3,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM117,M,72.2,Moderna,V4,98,NA,NA,V5-3M3,NA,NA,01/jui/2021,Positif,83.5,NA,Négatif,0.6,ONM117V4b,286.9,56.7,16.8,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM117,M,72.2,Moderna,V5,190,NA,NA,V5-3M3,NA,NA,01/oct/2021,Positif,86.9,NA,Négatif,0.3,ONM117V5b,101.3,34.9,25.8,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM117,M,72.2,Moderna,3M3,372,121,NA,V5-3M3,11,NA,01/avr/2022,Positif,71.7,1336,Positif,7.5,ONM117 3M3,2430,1432.9,1550.6,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM117,M,72.2,Moderna,3M6,428,177,NA,V5-3M3,67,NA,27/mai/2022,Positif,148.6,5687,Positif,7.6,ONM117 3M6,2430,2430,2430,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM118,F,70.2,Pfizer,V3,33,NA,NA,NA,NA,NA,12/avr/2021,Positif,89.8,NA,NA,NA,ONM118V3b,217.7,89,26,Breast,breast cancer,No TTT (Corticotehrapy Longue Date Stoppee En 2002),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM118,F,70.2,Pfizer,V4,90,NA,NA,NA,NA,NA,08/jun/2021,Positif,78.7,NA,NA,NA,ONM118V4b,119.5,63.4,22.2,Breast,breast cancer,No TTT (Corticotehrapy Longue Date Stoppee En 2002),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM118,F,70.2,Pfizer,V5,181,NA,NA,NA,NA,NA,07/sep/2021,Positif,44.9,NA,Négatif,0.3,ONM118V5b,78.7,46.1,18.9,Breast,breast cancer,No TTT (Corticotehrapy Longue Date Stoppee En 2002),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM118,F,70.2,Pfizer,3M3,363,110,NA,NA,NA,NA,08/mar/2022,Positif,85.8,1907,Négatif,0.3,ONM118 3M3,215.2,91.6,82.4,Breast,breast cancer,No TTT (Corticotehrapy Longue Date Stoppee En 2002),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM118,F,70.2,Pfizer,3M6,433,180,NA,NA,NA,NA,17/mai/2022,Positif,103.9,2789,Négatif,0.2,ONM118 3M6,97.1,40.8,39.1,Breast,breast cancer,No TTT (Corticotehrapy Longue Date Stoppee En 2002),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM119,F,64.2,Pfizer,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,101.2,NA,NA,NA,ONM119V3b,213.2,67.8,32.5,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM119,F,64.2,Pfizer,V4,98,NA,NA,NA,NA,NA,01/jui/2021,Positif,56.7,NA,Négatif,0.2,ONM119V4b,101.5,64.1,33.7,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM119,F,64.2,Pfizer,V5,197,NA,NA,NA,NA,NA,08/oct/2021,Positif,51.8,NA,Négatif,0.2,ONM119V5b,44.5,27.9,19.3,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM119,F,64.2,Pfizer,3M3,313,91,NA,NA,NA,NA,01/fév/2022,Positif,100,2585,Négatif,0.2,ONM119 3M3,1371.2,602.4,361.5,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM119,F,64.2,Pfizer,3M6,404,182,NA,NA,NA,NA,03/mai/2022,Positif,181.1,8439,Négatif,0.1,ONM119 3M6,799.3605115907275,362.71309394269133,266.8089647812167,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM120,F,50.2,Moderna,V3,32,NA,NA,3M3-3M6,NA,NA,23/avr/2021,Positif,92.6,NA,NA,NA,ONM120V3b,481.7,111.7,65.5,Breast,breast cancer,Adj IO: End 19.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM120,F,50.2,Moderna,V4,98,NA,NA,3M3-3M6,NA,NA,28/jun/2021,Positif,72.5,NA,Négatif,1.4,ONM120V4b,154,62.2,32.4,Breast,breast cancer,Adj IO: End 19.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM120,F,50.2,Moderna,V5,184,NA,NA,3M3-3M6,NA,NA,22/sep/2021,Positif,50.9,NA,Négatif,0.8,ONM120V5b,96.3,44.5,23.8,Breast,breast cancer,Adj IO: End 19.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM120,F,50.2,Moderna,3M3,294,81,NA,3M3-3M6,NA,NA,10/jan/2022,Positif,124.7,4010,Négatif,0.7,ONM120 3M3,916.6,267,141,Breast,breast cancer,Adj IO: End 19.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM120,F,50.2,Moderna,3M6,401,188,NA,3M3-3M6,16,NA,27/avr/2022,Positif,128.1,4231,Positif,11.7,ONM120 3M6,2430,818.3,487.8,Breast,breast cancer,Adj IO: End 19.03.2021,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM121,F,64.2,Moderna,V3,37,NA,NA,NA,NA,NA,29/avr/2021,Positif,89.4,NA,NA,NA,ONM121V3b,2430,1932.7,246,Breast,mets breast cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM121,F,64.2,Moderna,V4,93,NA,NA,NA,NA,NA,24/jun/2021,Positif,81.5,NA,Négatif,1.5,ONM121V4b,2296.2,1197,251.8,Breast,mets breast cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM121,F,64.2,Moderna,V5,177,NA,NA,NA,NA,NA,16/sep/2021,Positif,81.1,NA,Négatif,1.6,ONM121V5b,1218.5,776.4,228.4,Breast,mets breast cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM121,F,64.2,Moderna,3M3,373,84,NA,NA,NA,NA,31/mar/2022,Positif,104.2,2805,Négatif,1,ONM121 3M3,2430,2430,2430,Breast,mets breast cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM122,F,82.2,Moderna,V3,32,NA,NA,NA,NA,NA,23/avr/2021,Positif,88.2,NA,NA,NA,ONM122V3b,544.4,161.6,70.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM122,F,82.2,Moderna,V4,95,NA,NA,NA,NA,NA,25/jun/2021,Positif,101.1,NA,Négatif,1.4,ONM122V4b,275.2,106.9,48.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM122,F,82.2,Moderna,V5,191,NA,NA,NA,NA,NA,29/sep/2021,Positif,51,NA,Négatif,1,ONM122V5b,63.5,42.3,18.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM122,F,82.2,Moderna,3M3,337,104,NA,NA,NA,NA,22/fév/2022,Positif,92.5,2214,Négatif,0.5,ONM122 3M3,1942.9,482.9,212.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM122,F,82.2,Moderna,3M6,406,173,NA,NA,NA,NA,02/mai/2022,Positif,172.4,7649,Négatif,0.3,ONM122 3M6,889.6797153024911,234.02761525860052,123.74706100730108,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM123,M,75.2,Moderna,V3,34,NA,NA,NA,NA,NA,27/avr/2021,Positif,131.4,NA,NA,NA,ONM123V3b,2430,2079.9,1848.4,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM123,M,75.2,Moderna,V4,97,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.9,NA,Indéterminé,4.5,ONM123V4b,1790.2,1047.4,1464.3,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM123,M,75.2,Moderna,V5,195,NA,NA,NA,NA,NA,05/oct/2021,Positif,77.8,NA,Négatif,2.9,ONM123V5b,1091.6,905.8,1278.8,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM123,M,75.2,Moderna,3M3,378,79,NA,NA,NA,NA,06/avr/2022,Positif,107.9,3007,Négatif,1.3,ONM123 3M3,1583.3,664,712.8,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM124,M,81.2,Moderna,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,52.2,NA,NA,NA,ONM124V3b,67.1,29.5,19.2,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM124,M,81.2,Moderna,V4,99,NA,NA,NA,NA,NA,30/jun/2021,Positif,26.9,NA,Négatif,0.1,ONM124V4b,37,18.8,10,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM124,M,81.2,Moderna,V5,185,NA,NA,NA,NA,NA,24/sep/2021,Positif,16.8,NA,Négatif,0.1,ONM124V5b,1,1,1,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM124,M,81.2,Moderna,3M3,337,104,NA,NA,NA,NA,23/fév/2022,Positif,79,1619,Négatif,0.1,ONM124 3M3,105.2,53.8,24.1,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM124,M,81.2,Moderna,3M6,414,181,NA,NA,NA,NA,11/mai/2022,Positif,80.6,1685,Négatif,0.1,ONM124 3M6,38.19709702062644,18.96813353566009,15.415446277169725,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM126,F,55.2,Moderna,3M3,297,107,NA,NA,NA,NA,17/jan/2022,Positif,127.3,4178,Négatif,0.4,ONM126 3M3,1375.1,753,284.7,Gastrointestinal,pancreatic cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM127,F,71.2,Moderna,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Positif,81.4,NA,NA,NA,ONM127V3b,615.4,206.5,37.3,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM127,F,71.2,Moderna,V4,96,NA,NA,NA,NA,NA,29/jun/2021,Positif,83.7,NA,Négatif,0.3,ONM127V4b,252.5,136.9,45.8,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM127,F,71.2,Moderna,V5,183,NA,NA,NA,NA,NA,24/sep/2021,Positif,70.1,NA,Négatif,0.2,ONM127V5b,152,106.7,55.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM127,F,71.2,Moderna,3M3,329,97,NA,NA,NA,NA,17/fév/2022,Positif,117.4,3556,Négatif,0.2,ONM127 3M3,1873.7,614.6,372,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM127,F,71.2,Moderna,3M6,414,182,NA,NA,NA,NA,13/mai/2022,Positif,150.6,5841,Négatif,0.1,ONM127 3M6,510.5,202.7,157.6,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM128,F,65.2,Moderna,V3,35,NA,NA,NA,NA,NA,26/avr/2021,Positif,79,NA,NA,NA,ONM128V3b,446.4,101.9,10,Breast,mets breast  cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM128,F,65.2,Moderna,V4,98,NA,NA,NA,NA,NA,28/jun/2021,Positif,80.9,NA,Négatif,0.2,ONM128V4b,113.4,30.7,2.8,Breast,mets breast  cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM128,F,65.2,Moderna,V5,196,NA,NA,NA,NA,NA,04/oct/2021,Positif,60.3,NA,Négatif,0.2,ONM128V5b,194.7,103,39.8,Breast,mets breast  cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM128,F,65.2,Moderna,3M3,354,94,NA,NA,NA,NA,11/mar/2022,Positif,70,1274,Négatif,0,ONM1283M3,114.8,56.5,14.5,Breast,mets breast  cancer,Hormonotherapy+CDK 4inhib(TKI),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM129,F,71.2,Moderna,V3,34,NA,NA,NA,NA,NA,26/avr/2021,Positif,76.9,NA,NA,NA,ONM129V3b,2327.2,1423.3,157,Genitourinary,mets ovarien cancer,Tkis: Parp Inh,PARP inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM129,F,71.2,Moderna,V4,99,NA,NA,NA,NA,NA,30/jun/2021,Positif,76.8,NA,Négatif,0.8,ONM129V4b,1036.4,571.4,144.1,Genitourinary,mets ovarien cancer,Tkis: Parp Inh,PARP inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM129,F,71.2,Moderna,V5,197,NA,NA,NA,NA,NA,06/oct/2021,Positif,94.8,NA,Négatif,0.7,ONM129V5b,303.1,161.6,68.7,Genitourinary,mets ovarien cancer,Tkis: Parp Inh,PARP inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM129,F,71.2,Moderna,V6,379,112,NA,NA,NA,NA,06/avr/2022,Positif,103.2,2752,Négatif,0.8,ONM129V6,2430,2257.3,678,Genitourinary,mets ovarien cancer,Tkis: Parp Inh,PARP inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM130,M,55.2,Moderna,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,94,NA,NA,NA,ONM130V3b,1824.2,651.9,230.5,Thoracic,SCC lung,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM130,M,55.2,Moderna,V4,91,NA,NA,NA,NA,NA,30/jun/2021,Positif,77.3,NA,Négatif,0.1,ONM130V4b,511,210.7,76.9,Thoracic,SCC lung,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM130,M,55.2,Moderna,V5,196,NA,NA,NA,NA,NA,13/oct/2021,Positif,76.3,NA,Négatif,0.1,ONM130V5b,253.9,123.4,61.2,Thoracic,SCC lung,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM130,M,55.2,Moderna,3M3,385,119,NA,NA,NA,NA,20/avr/2022,Positif,107.8,3001,Positif,6.4,ONM130 3M3,1019.3,609.8,296.3,Thoracic,SCC lung,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM131,F,79.2,Moderna,V3,33,NA,NA,NA,NA,NA,27/avr/2021,Positif,80.4,NA,NA,NA,ONM131V3b,1250.5,510.2,169.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM131,F,79.2,Moderna,V4,102,NA,NA,NA,NA,NA,05/jui/2021,Positif,88.6,NA,Négatif,0.2,ONM131V4b,1341.7,583.4,139.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM131,F,79.2,Moderna,V5,203,NA,NA,NA,NA,NA,14/oct/2021,Positif,78.7,NA,Négatif,0.4,ONM131V5b,808.4,397.1,128.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM131,F,79.2,Moderna,V6,357,114,NA,NA,NA,NA,17/mar/2022,Positif,95.8,2374,Négatif,0.1,ONM131V6,1469.5,750.8,298.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM132,F,78.2,Moderna,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,104,NA,NA,NA,ONM132V3b,695.9,269.8,123.3,Skin,melanoma,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM132,F,78.2,Moderna,V6,365,109,NA,NA,NA,NA,25/mar/2022,Positif,90.3,2111,Négatif,0.1,ONM132 3M6,2430,1520.912547528517,1768.3465959328028,Skin,melanoma,IO IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,V3,33,NA,NA,V5-3M3,NA,NA,27/avr/2021,Positif,134,NA,NA,NA,ONM133V3b,332.4,162.1,45.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,V4,99,NA,NA,V5-3M3,NA,NA,02/jui/2021,Positif,54.6,NA,Négatif,0.1,ONM133V4b,87.1,51.9,14.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,V5,173,NA,NA,V5-3M3,NA,NA,14/sep/2021,Positif,29.7,NA,Négatif,0,ONM133V5b,63.9,37,7.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,V5+,315,77,NA,V5-3M3,34,NA,03/fév/2022,Positif,110,3124,Indéterminé,5,ONM133V5+,1787,1266.5,515.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,3M3,347,109,NA,V5-3M3,66,NA,07/mar/2022,Positif,113,3296,Négatif,3.9,ONM133 3M3,1373.8,867.3,517.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM133,F,83.2,Moderna,3M6,420,182,NA,V5-3M3,139,NA,19/mai/2022,Positif,130.5,4390,Négatif,1.8,ONM133 3M6,1164.6,870.3,327.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM134,F,47.2,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,29/avr/2021,Positif,76,NA,NA,NA,ONM134V3b,134.9,67.4,34.8,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM134,F,47.2,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,01/jui/2021,Positif,48.9,NA,Négatif,0.6,ONM134V4b,65.3,42,18,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM134,F,47.2,Pfizer,V5,188,NA,NA,V5-3M3,NA,NA,30/sep/2021,Positif,26.5,NA,Négatif,0.3,ONM134V5b,46.1,34.8,16.9,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM134,F,47.2,Pfizer,V5+,314,77,NA,V5-3M3,29,NA,03/fév/2022,Positif,109.5,3096,Positif,9.1,ONM134V5+,1022.6,413.4,216.8,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM134,F,47.2,Pfizer,3M3,363,126,NA,V5-3M3,78,NA,24/mar/2022,Positif,111.5,3210,Positif,7.9,ONM134 3M3,1187.4,585.5,322.1,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM134,F,47.2,Pfizer,3M6,419,182,NA,V5-3M3,134,NA,19/mai/2022,Positif,125.7,4074,Négatif,3.5,ONM134 3M6,749.1,360.6,213.9,Breast,breast cancer,Adjuvant IO: Herceptine Perjeta,Anti-HER2 antibody therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Herceptin|Perjeta,Herceptine|Perjeta,L01XC03|L01FD02,L01XC03|L01XC13
ONM135,F,28.3,Moderna,V4,96,NA,NA,NA,NA,NA,21/jui/2021,Positif,69.3,NA,Négatif,1.8,ONM135V4b,108.8,54.2,21.7,Gastrointestinal,canal anal cancer,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM135,F,28.3,Moderna,V5,180,NA,NA,NA,NA,NA,13/oct/2021,Positif,58.3,NA,Négatif,1.9,ONM135V5b,117.5,85,38.8,Gastrointestinal,canal anal cancer,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM135,F,28.3,Moderna,3M3,320,75,NA,NA,NA,NA,02/mar/2022,Positif,99.2,2544,Négatif,1,ONM135 3M3,531.3,254.7,158.7,Gastrointestinal,canal anal cancer,Double IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM136,M,51.2,Moderna,V3,35,NA,NA,NA,NA,NA,22/avr/2021,Positif,173.4,NA,NA,NA,ONM136V3b,797.4,445,130.8,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM136,M,51.2,Moderna,V4,91,NA,NA,NA,NA,NA,17/jun/2021,Positif,97.4,NA,Négatif,0.5,ONM136V4b,245.6,141.7,42.8,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM136,M,51.2,Moderna,V5,182,NA,NA,NA,NA,NA,16/sep/2021,Positif,72.5,NA,Négatif,0.4,ONM136V5b,184.6,103.1,43.5,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM136,M,51.2,Moderna,3M3,365,64,NA,NA,NA,NA,18/mar/2022,Positif,99,2534,Négatif,1.7,ONM136 3M3,2442.6,1209.3,477.1,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,V3,34,NA,NA,3M3-3M6,NA,NA,22/avr/2021,Positif,168.8,NA,NA,NA,ONM137V3b,438.4,205.8,79.4,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,V4,97,NA,NA,3M3-3M6,NA,NA,24/jun/2021,Positif,81.6,NA,Négatif,0.3,ONM137V4b,192.7,106.7,46.7,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,V5,188,NA,NA,3M3-3M6,NA,NA,23/sep/2021,Positif,53.2,NA,Négatif,0.2,ONM137V5b,133.6,87.4,29.8,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,3M3,311,68,NA,3M3-3M6,NA,NA,24/jan/2022,Positif,102.7,2725,Négatif,0.3,ONM137 3M3,577.4,317.3,105.5,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,3M3+,368,125,NA,3M3-3M6,14,NA,22/mar/2022,Positif,94.3,2300,Positif,9,ONM137 3M3+,2280.5,1025.4,819,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM137,F,52.2,Moderna,3M6,427,184,NA,3M3-3M6,73,NA,20/mai/2022,Positif,124.9,4023,Positif,6.8,ONM137 3M6,2430,975.6,647.2,Brain,oligoastrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM138,M,69.2,Moderna,V3,34,NA,NA,NA,NA,NA,27/avr/2021,Positif,135,NA,NA,NA,ONM138V3b,204,125,5.6,Sarcoma,sarcoma vocal corde,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM138,M,69.2,Moderna,V4,98,NA,NA,NA,NA,NA,30/jun/2021,Positif,69.5,NA,Négatif,0.7,ONM138V4b,174.3,100.2,18.9,Sarcoma,sarcoma vocal corde,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM138,M,69.2,Moderna,V5,197,NA,NA,NA,NA,NA,07/oct/2021,Positif,45.8,NA,Négatif,0.6,ONM138V5b,135.9,87.2,24,Sarcoma,sarcoma vocal corde,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM138,M,69.2,Moderna,3M3,316,77,NA,NA,NA,NA,03/fév/2022,Positif,108.7,3051,Négatif,0.2,ONM138 3M3,370.8,146,78.8,Sarcoma,sarcoma vocal corde,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM138,M,69.2,Moderna,3M6,421,182,NA,NA,NA,NA,19/mai/2022,Positif,124.2,3978,Négatif,0.2,ONM138 3M6,334.3,144.2,71,Sarcoma,sarcoma vocal corde,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM139,F,85.2,Moderna,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,116,NA,NA,NA,ONM139V3b,276.5,150.7,19.4,Genitourinary,ovarien cancer,Adj Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM139,F,85.2,Moderna,V4,98,NA,NA,NA,NA,NA,01/jui/2021,Positif,81.2,NA,Négatif,0.5,ONM139V4b,92.3,58.8,10.5,Genitourinary,ovarien cancer,Adj Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM139,F,85.2,Moderna,V5,183,NA,NA,NA,NA,NA,24/sep/2021,Positif,61.2,NA,Négatif,0.3,ONM139V5b,162.4,94.2,30.1,Genitourinary,ovarien cancer,Adj Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM139,F,85.2,Moderna,3M3,329,90,NA,NA,NA,NA,17/fév/2022,Positif,122.4,3864,Négatif,0.2,ONM139 3M3,6393.9,1956.9,473.5,Genitourinary,ovarien cancer,Adj Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM139,F,85.2,Moderna,3M6,432,193,NA,NA,NA,NA,31/mai/2022,Positif,135.7,4746,Négatif,0.4,ONM139 3M6,2110.1,545.9,190,Genitourinary,ovarien cancer,Adj Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM140,M,54.2,Moderna,V3,35,NA,NA,NA,NA,NA,30/avr/2021,Positif,118.2,NA,NA,NA,ONM140V3b,527.1,308.5,44.5,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM140,M,54.2,Moderna,V4,98,NA,NA,NA,NA,NA,02/jui/2021,Positif,87.1,NA,Négatif,0.7,ONM140V4b,372.3,210.2,42.1,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM140,M,54.2,Moderna,V5,196,NA,NA,NA,NA,NA,08/oct/2021,Positif,104.1,NA,Négatif,0.4,ONM140V5b,205,103.8,14.8,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM140,M,54.2,Moderna,3M3,378,102,NA,NA,NA,NA,08/avr/2022,Positif,118,3593,Positif,19,ONM140 3M3,2430,2118.6,730.5,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM141,M,77.2,Moderna,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,122.3,NA,NA,NA,ONM141V3b,435.4,149.7,46.8,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM141,M,77.2,Moderna,V4,91,NA,NA,NA,NA,NA,25/jun/2021,Positif,100.7,NA,Négatif,0.9,ONM141V4b,132.2,77.5,26.9,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM141,M,77.2,Moderna,V5,185,NA,NA,NA,NA,NA,27/sep/2021,Positif,52.1,NA,Négatif,0.5,ONM141V5b,112.5,61.3,18.6,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM141,M,77.2,Moderna,3M3,370,84,NA,NA,NA,NA,31/mar/2022,Positif,111.3,3198,Négatif,3.6,ONM141 3M3,864.3,281.3,89.8,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM142,M,55.2,Pfizer,V3,34,NA,NA,NA,NA,NA,26/avr/2021,Positif,96,NA,NA,NA,ONM142V3b,181.5,65.1,22.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM142,M,55.2,Pfizer,V4,105,NA,NA,NA,NA,NA,06/jui/2021,Positif,76.4,NA,Négatif,0.7,ONM142V4b,111.7,54.2,30.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM142,M,55.2,Pfizer,V5,191,NA,NA,NA,NA,NA,30/sep/2021,Positif,30.8,NA,Négatif,0.4,ONM142V5b,76.9,52.7,25.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM142,M,55.2,Pfizer,3M3,321,97,NA,NA,NA,NA,07/fév/2022,Positif,105.9,2897,Négatif,0.3,ONM142 3M3,260.9,152.8,109.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM142,M,55.2,Pfizer,3M6,419,195,NA,NA,NA,NA,16/mai/2022,Positif,105.6,2881,Négatif,0.2,ONM142 3M6,160.5,89.8,66.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM144,M,71.1,Pfizer,V3,30,NA,NA,NA,NA,NA,10/mar/2021,Positif,93.8,NA,NA,NA,ONM144V3b,2430,495.3,445,Gastrointestinal,gastric ADK mets,Chemo: 5FU,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM144,M,71.1,Pfizer,V4,86,NA,NA,NA,NA,NA,05/mai/2021,Positif,87.9,NA,NA,NA,ONM144V4b,1038.1,295.2,198.1,Gastrointestinal,gastric ADK mets,Chemo: 5FU,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM144,M,71.1,Pfizer,V5,184,NA,NA,NA,NA,NA,11/aoû/2021,Positif,72.3,NA,Positif,8.5,ONM144V5b,543.2,134.8,155.9,Gastrointestinal,gastric ADK mets,Chemo: 5FU,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM144,M,71.1,Pfizer,3M3,422,91,NA,NA,NA,NA,06/avr/2022,Positif,92.5,2214,Indéterminé,4.7,ONM144 3M3,3971.405877680699,791.7656373713381,655.7377049180327,Gastrointestinal,gastric ADK mets,Chemo: 5FU,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM145,F,49.1,Pfizer,V3,28,NA,NA,NA,NA,NA,08/mar/2021,Positif,135.4,NA,NA,NA,ONM145V3b,2120.9,566.6,211.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM145,F,49.1,Pfizer,V4,91,NA,NA,NA,NA,NA,10/mai/2021,Positif,108.1,NA,NA,NA,ONM145V4b,441.1,234.6,72.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM145,F,49.1,Pfizer,V5,182,NA,NA,NA,NA,NA,09/aoû/2021,Positif,70.5,NA,Négatif,0.1,ONM145V5b,283,137.2,58.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM145,F,49.1,Pfizer,3M3,364,63,NA,NA,NA,NA,07/fév/2022,Positif,81.8,1735,Négatif,0.1,ONM145 3M3,1747,576,264.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM146,F,50.2,Pfizer,V3,33,NA,NA,NA,NA,NA,20/avr/2021,Positif,113.5,NA,NA,NA,ONM146V3b,367.4,145.2,25,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM146,F,50.2,Pfizer,V4,99,NA,NA,NA,NA,NA,25/jun/2021,Positif,98.7,NA,Négatif,0.2,ONM146V4b,176.8,66,15.4,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM146,F,50.2,Pfizer,V5,181,NA,NA,NA,NA,NA,15/sep/2021,Positif,71.6,NA,Négatif,0.2,ONM146V5b,156.3,97.6,45.6,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM146,F,50.2,Pfizer,3M3,365,72,NA,NA,NA,NA,18/mar/2022,Positif,91.4,2162,Négatif,0.2,ONM146 3M3,766.3,398.4,289.2,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM147,F,71.1,Pfizer,3M6,388,183,NA,NA,NA,NA,03/mar/2022,Positif,96.5,2408,Négatif,0.1,ONM147 3M6,678.9,134.1,123.7,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM148,M,67.1,Pfizer,V3,28,NA,NA,NA,NA,NA,05/mar/2021,Positif,132.1,NA,NA,NA,ONM148V3b,251.2,80.3,22.5,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM148,M,67.1,Pfizer,3M3,367,59,NA,NA,NA,NA,07/fév/2022,Positif,101.8,2678,Négatif,2.1,ONM148 3M3,458.7,218.9,169.9,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM149,F,71.1,Pfizer,V3,29,NA,NA,NA,NA,NA,09/mar/2021,Positif,107.1,NA,NA,NA,ONM149V3b,274,124,17,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM149,F,71.1,Pfizer,V4,91,NA,NA,NA,NA,NA,10/mai/2021,Positif,82,NA,NA,NA,ONM149V4b,74.9,36.9,12.3,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM149,F,71.1,Pfizer,V5,182,NA,NA,NA,NA,NA,09/aoû/2021,Positif,25.1,NA,Négatif,0.2,ONM149V5b,13.6,5.4,2.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM149,F,71.1,Pfizer,3M3,365,85,NA,NA,NA,NA,08/fév/2022,Positif,100.5,2611,Négatif,0.3,ONM149 3M3,639,292.1,218.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM149,F,71.1,Pfizer,3M6,455,175,NA,NA,NA,NA,09/mai/2022,Positif,153.8,6091,Négatif,0.1,ONM149 3M6,336.2474781439139,167.11229946524065,114.91611123879568,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM151,M,67.2,Moderna,V3,34,NA,NA,NA,NA,NA,04/mai/2021,Positif,106.5,NA,NA,NA,ONM151V3b,686.3,232.4,86.4,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM151,M,67.2,Moderna,V4,96,NA,NA,NA,NA,NA,05/jui/2021,Positif,84.4,NA,Négatif,0.6,ONM151V4b,257.2,136,54.6,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM151,M,67.2,Moderna,V5,190,NA,NA,NA,NA,NA,07/oct/2021,Positif,43.9,NA,Négatif,0.9,ONM151V5b,71.4,38.3,27,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM151,M,67.2,Moderna,3M3,315,85,NA,NA,NA,NA,09/fév/2022,Positif,102.5,2715,Négatif,0.4,ONM151 3M3,695.9,270.5,131.7,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM151,M,67.2,Moderna,3M6,405,175,NA,NA,NA,NA,10/mai/2022,Positif,150,5795,Négatif,0.3,ONM151 3M6,647.2491909385113,226.29554197782304,116.63167716351761,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM152,F,75.2,Pfizer,V4,92,NA,NA,NA,NA,NA,24/jun/2021,Positif,76,NA,Négatif,1.2,ONM152V4b,160.8,57.7,37.8,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM152,F,75.2,Pfizer,V5,183,NA,NA,NA,NA,NA,23/sep/2021,Positif,52.7,NA,Négatif,1,ONM152V5b,95.3,56.7,26.6,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM152,F,75.2,Pfizer,V6,370,110,NA,NA,NA,NA,29/mar/2022,Positif,116,3472,Négatif,0.9,ONM152V6,1138.2,388.8,227.2,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM153,F,31.2,Moderna,V3,32,NA,NA,3M3-3M6,NA,NA,30/avr/2021,Positif,107.5,NA,NA,NA,ONM153V3b,1206.6,713.3,210.2,Breast,breast cancer,Adjuvant IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM153,F,31.2,Moderna,V4,92,NA,NA,3M3-3M6,NA,NA,29/jun/2021,Positif,83.9,NA,Négatif,0.3,ONM153V4b,533.6,238.7,87.6,Breast,breast cancer,Adjuvant IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM153,F,31.2,Moderna,V5,190,NA,NA,3M3-3M6,NA,NA,05/oct/2021,Positif,58.8,NA,Négatif,0.3,ONM153V5b,114,81.6,50.9,Breast,breast cancer,Adjuvant IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM153,F,31.2,Moderna,3M3,291,87,NA,3M3-3M6,NA,NA,14/jan/2022,Positif,88,2005,Négatif,0.4,ONM153 3M3,321.6,140.8,102.6,Breast,breast cancer,Adjuvant IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM153,F,31.2,Moderna,3M6,378,174,NA,3M3-3M6,67,NA,11/avr/2022,Positif,100.2,2595,Négatif,3.7,ONM153 3M6,664.5,456.2,365.2,Breast,breast cancer,Adjuvant IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM155,F,69.1,Pfizer,V3,30,NA,NA,NA,NA,NA,09/mar/2021,Positif,111,NA,NA,NA,ONM155V3b,462.7,106.1,44.4,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM155,F,69.1,Pfizer,V4,93,NA,NA,NA,NA,NA,11/mai/2021,Positif,91.7,NA,NA,NA,ONM155V4b,104.6,51.5,32.2,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM155,F,69.1,Pfizer,V5,170,NA,NA,NA,NA,NA,27/jui/2021,Positif,36.7,NA,Négatif,0,ONM155V5b,62.5,31.4,17.7,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM155,F,69.1,Pfizer,3M3,324,116,NA,NA,NA,NA,28/déc/2021,Positif,91,2143,Négatif,0,ONM155 3M3,548.2,172.8,94.6,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM155,F,69.1,Pfizer,3M6,387,179,NA,NA,NA,NA,01/mar/2022,Positif,95,2334,Négatif,0,ONM155 3M6,264.8,134.5,82,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM155,F,69.1,Pfizer,3M9,471,263,NA,NA,NA,NA,24/mai/2022,Positif,153.7,6083,Négatif,0,ONM155 3M9,230.1,97.8,59.1,Thoracic,lung ADK,Chemo Io: PEMTREXED PEMBROLIZUMAB,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,PEMBROLIZUMAB,PEMBROLIZUMAB,L01FF02,"L01XC18,L01FF02"
ONM156,F,64.2,Moderna,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,110.3,NA,NA,NA,ONM156V3b,383.4,134.9,69.6,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM156,F,64.2,Moderna,V4,91,NA,NA,NA,NA,NA,30/jun/2021,Positif,69,NA,Négatif,1.9,ONM156V4b,145.4,64.9,37.8,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM156,F,64.2,Moderna,V5,188,NA,NA,NA,NA,NA,05/oct/2021,Positif,39.4,NA,Négatif,0.9,ONM156V5b,64.2,35,25.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM156,F,64.2,Moderna,V6,366,115,NA,NA,NA,NA,01/avr/2022,Positif,89.9,2092,Positif,12.9,ONM156V6,2430,794.3,1035,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM157,F,41.2,Moderna,V3,32,NA,NA,3M3-3M6,NA,NA,19/avr/2021,Positif,96.2,NA,NA,NA,ONM157V3b,418.9,164.3,25,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM157,F,41.2,Moderna,V4,96,NA,NA,3M3-3M6,NA,NA,22/jun/2021,Positif,58.5,NA,Négatif,0.3,ONM157V4b,355.1,165.2,57.4,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM157,F,41.2,Moderna,V5,189,NA,NA,3M3-3M6,NA,NA,23/sep/2021,Positif,52.5,NA,Négatif,0.3,ONM157V5b,146.1,89.9,28.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM157,F,41.2,Moderna,3M3,306,111,NA,3M3-3M6,NA,NA,18/jan/2022,Positif,110.7,3164,Négatif,0.3,ONM157 3M3,250.3,160.9,71.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM157,F,41.2,Moderna,3M6,375,180,NA,3M3-3M6,31,NA,28/mar/2022,Positif,87.2,1969,Positif,10.5,ONM157 3M6,1382.7,956,556.5,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM158,M,53.1,Pfizer,V3,29,NA,4th dose: 13.11.2021,NA,NA,NA,09/mar/2021,Positif,104.4,NA,NA,NA,ONM158V3b,115.4,42,5,Other,Tm cellules geantes femur: benign,Denosumab Monthly,RANKL inhibitors,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Denosumab,Denosumab,M05BX04,M05BX04
ONM158,M,53.1,Pfizer,V4,91,NA,4th dose: 13.11.2021,NA,NA,NA,10/mai/2021,Positif,85.3,NA,NA,NA,ONM158V4b,58.8,17.8,4.2,Other,Tm cellules geantes femur: benign,Denosumab Monthly,RANKL inhibitors,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Denosumab,Denosumab,M05BX04,M05BX04
ONM158,M,53.1,Pfizer,V5,192,7,4th dose: 13.11.2021,NA,NA,NA,19/aoû/2021,Positif,99.2,NA,Négatif,0.7,ONM158V5b,443.1,196.7,184.2,Other,Tm cellules geantes femur: benign,Denosumab Monthly,RANKL inhibitors,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Denosumab,Denosumab,M05BX04,M05BX04
ONM158,M,53.1,Pfizer,3M6,364,179,4th dose: 13.11.2021,NA,NA,NA,07/fév/2022,Positif,96.5,2408,Négatif,0.5,ONM158 3M6,1041.2,484.7,248,Other,Tm cellules geantes femur: benign,Denosumab Monthly,RANKL inhibitors,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Denosumab,Denosumab,M05BX04,M05BX04
ONM158,M,53.1,Pfizer,3M9,444,259,4th dose: 13.11.2021,NA,NA,NA,28/avr/2022,Positif,121.2,3789,Positif,8.3,ONM158 3M9,2193.5,1224.4,657.5,Other,Tm cellules geantes femur: benign,Denosumab Monthly,RANKL inhibitors,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Denosumab,Denosumab,M05BX04,M05BX04
ONM159,F,63.2,Moderna,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,70.9,NA,NA,NA,ONM159V3b,1422.5,456.8,233,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM159,F,63.2,Moderna,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,92.3,NA,Négatif,0.3,ONM159V4b,816.3,241.1,114.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM159,F,63.2,Moderna,V5,196,NA,NA,NA,NA,NA,12/oct/2021,Positif,69.2,NA,Négatif,0.5,ONM159V5b,369.5,142.3,83.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM159,F,63.2,Moderna,3M3,379,117,NA,NA,NA,NA,13/avr/2022,Positif,91.7,2176,Négatif,0.2,ONM159 3M3,2430,481.7,490.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM160,F,79.1,Pfizer,V3,29,NA,NA,NA,NA,NA,09/mar/2021,Positif,129.4,NA,NA,NA,ONM160V3b,187,85.4,33.3,Breast,breast cancer,Adjuvant Hormonotherapy: Anastrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Anastrozole,L02BG03,"NA"
ONM160,F,79.1,Pfizer,V4,91,NA,NA,NA,NA,NA,10/mai/2021,Positif,39.7,NA,NA,NA,ONM160V4b,63.9,31.8,11.6,Breast,breast cancer,Adjuvant Hormonotherapy: Anastrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Anastrozole,L02BG03,"NA"
ONM160,F,79.1,Pfizer,V5,182,NA,NA,NA,NA,NA,09/aoû/2021,Positif,14.6,NA,Négatif,0.1,ONM160V5b,30.2,13.3,5.8,Breast,breast cancer,Adjuvant Hormonotherapy: Anastrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Anastrozole,L02BG03,"NA"
ONM160,F,79.1,Pfizer,3M3,364,68,NA,NA,NA,NA,07/fév/2022,Positif,102.9,2736,Négatif,0,ONM160 3M3,146.1,67.2,48.2,Breast,breast cancer,Adjuvant Hormonotherapy: Anastrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Anastrozole,L02BG03,"NA"
ONM161,F,48.2,Pfizer,V3,31,NA,NA,NA,NA,NA,19/avr/2021,Positif,102.6,NA,NA,NA,ONM161V3b,366.6,91.2,24.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM161,F,48.2,Pfizer,V4,97,NA,NA,NA,NA,NA,24/jun/2021,Positif,81.8,NA,Négatif,0.9,ONM161V4b,112.5,59.1,41.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM161,F,48.2,Pfizer,V5,181,NA,NA,NA,NA,NA,16/sep/2021,Positif,56,NA,Négatif,1.8,ONM161V5b,132.9,76.2,47.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM161,F,48.2,Pfizer,3M3,377,105,NA,NA,NA,NA,31/mar/2022,Positif,104.4,2816,Positif,20.5,ONM161 3M3,1338.5,585.8,428.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM162,M,75.1,Pfizer,V3,30,NA,NA,NA,NA,NA,11/mar/2021,Positif,126.2,NA,NA,NA,ONM162V3b,125.2,40.8,5.3,Sarcoma,sarcome kaposi,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM162,M,75.1,Pfizer,V4,97,NA,NA,NA,NA,NA,17/mai/2021,Positif,70.7,NA,NA,NA,ONM162V4b,87.4,59.5,24.3,Sarcoma,sarcome kaposi,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM162,M,75.1,Pfizer,V5,181,NA,NA,NA,NA,NA,09/aoû/2021,Positif,22.9,NA,Négatif,0.1,ONM162V5b,42.2,29.3,11.2,Sarcoma,sarcome kaposi,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM162,M,75.1,Pfizer,3M3,366,77,NA,NA,NA,NA,10/fév/2022,Positif,105,2848,Négatif,0.1,ONM162 3M3,362.84470246734395,168.54879487611663,97.5609756097561,Sarcoma,sarcome kaposi,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM162,M,75.1,Pfizer,3M6,457,168,NA,NA,NA,NA,12/mai/2022,Positif,131.6,4464,Négatif,0.1,ONM162 3M6,194.1,91.5,76.3,Sarcoma,sarcome kaposi,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM163,F,46.2,Moderna,V3,33,NA,NA,V5-V6,NA,NA,04/mai/2021,Positif,88.6,NA,NA,NA,ONM163V3b,680.7,386,72.2,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM163,F,46.2,Moderna,V4,90,NA,NA,V5-V6,NA,NA,30/jun/2021,Positif,79.1,NA,Négatif,0.3,ONM163V4b,680.3,411.4,118.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM163,F,46.2,Moderna,V5,189,NA,NA,V5-V6,NA,NA,07/oct/2021,Positif,67.8,NA,Négatif,0.1,ONM163V5b,243.2,143.3,68.5,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM163,F,46.2,Moderna,V5+,265,NA,NA,V5-V6,9,NA,22/déc/2021,Positif,139.1,4986,Positif,8,ONM163V5+b,1152.9,557.1,169.7,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM163,F,46.2,Moderna,V6,378,NA,NA,V5-V6,122,NA,14/avr/2022,Positif,96.8,2423,Positif,6.8,ONM163V6,1972,1029.2,301.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM164,F,60.2,Moderna,V3,33,NA,NA,NA,NA,NA,19/avr/2021,Négatif,1.4,NA,NA,NA,ONM164V3b,1,1,1,Gastrointestinal,canal anal cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,purpura thrombopenique immunologqiue(ITP) dans un contexte de CIVD,Immunoglobulines aux2 semaines,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM164,F,60.2,Moderna,V4,96,NA,NA,NA,NA,NA,21/jun/2021,Négatif,3.2,NA,Négatif,1.3,ONM164V4b,1,1,1,Gastrointestinal,canal anal cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,purpura thrombopenique immunologqiue(ITP) dans un contexte de CIVD,Immunoglobulines aux2 semaines,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM164,F,60.2,Moderna,V5,194,NA,NA,NA,NA,NA,27/sep/2021,Positif,11.7,NA,Indéterminé,5,ONM164V5b,1,1,1,Gastrointestinal,canal anal cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,purpura thrombopenique immunologqiue(ITP) dans un contexte de CIVD,Immunoglobulines aux2 semaines,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM164,F,60.2,Moderna,V6,369,135,NA,NA,NA,NA,21/mar/2022,Positif,86.4,1934,Négatif,3.4,ONM164V6,188.5,88.8,45.6,Gastrointestinal,canal anal cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,purpura thrombopenique immunologqiue(ITP) dans un contexte de CIVD,Immunoglobulines aux2 semaines,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM165,F,56.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,105.1,NA,NA,NA,ONM165V3b,434,161.2,74,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM165,F,56.2,Pfizer,V4,102,NA,NA,NA,NA,NA,06/jui/2021,Positif,90.4,NA,Négatif,1.5,ONM165V4b,148.8,70.3,42.1,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM165,F,56.2,Pfizer,V5,182,NA,NA,NA,NA,NA,24/sep/2021,Positif,52.9,NA,Négatif,0.6,ONM165V5b,100.9,42.1,23.8,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM165,F,56.2,Pfizer,V6,364,112,NA,NA,NA,NA,25/mar/2022,Positif,88.9,2046,Négatif,0.1,ONM165V6,1065.5,270.9,203.6,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM166,M,71.2,Pfizer,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,89.7,NA,NA,NA,ONM166V3b,183.6,82.4,40.6,Genitourinary,prostate ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM166,M,71.2,Pfizer,V4,94,NA,NA,NA,NA,NA,25/jun/2021,Positif,56.8,NA,Négatif,0.2,ONM166V4b,95,50.3,27.4,Genitourinary,prostate ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM166,M,71.2,Pfizer,V5,184,NA,NA,NA,NA,NA,23/sep/2021,Positif,25.6,NA,Négatif,0.1,ONM166V5b,33.4,23.3,13.9,Genitourinary,prostate ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM166,M,71.2,Pfizer,3M3,294,89,NA,NA,NA,NA,11/jan/2022,Positif,99.5,2559,Négatif,0.1,ONM166 3M3,153.3,53.7,40.1,Genitourinary,prostate ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM166,M,71.2,Pfizer,3M6,380,175,NA,NA,NA,NA,07/avr/2022,Positif,106.8,2946,Négatif,0.5,ONM166 3M6,664,290.6,186.7,Genitourinary,prostate ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM167,M,61.2,Moderna,V3,34,NA,NA,NA,NA,NA,04/mai/2021,Positif,92.3,NA,NA,NA,ONM167V3b,183.9,116.6,49.3,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM167,M,61.2,Moderna,V4,98,NA,NA,NA,NA,NA,07/jui/2021,Positif,109.6,NA,Négatif,0.1,ONM167V4b,829.2,432,201.9,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM167,M,61.2,Moderna,V5,194,NA,NA,NA,NA,NA,11/oct/2021,Positif,67.9,NA,Négatif,0.5,ONM167V5b,643.1,438.6,255,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM167,M,61.2,Moderna,3M3,342,98,NA,NA,NA,NA,08/mar/2022,Positif,84.7,1859,Indéterminé,5.4,ONM167 3M3,2062.3,1174.1,939,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM167,M,61.2,Moderna,3M6,425,181,NA,NA,NA,NA,30/mai/2022,Positif,201,10392,Négatif,1.3,ONM167 3M6,1709.4,1096.5,979.4,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM168,M,59.2,Moderna,V3,33,NA,NA,NA,NA,NA,04/mai/2021,Positif,81.7,NA,NA,NA,ONM168V3b,1451,659.6,283.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM168,M,59.2,Moderna,V4,99,NA,NA,NA,NA,NA,09/jui/2021,Positif,93.8,NA,Négatif,2.6,ONM168V4b,1302.1,607.9,291,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM168,M,59.2,Moderna,V5,196,NA,NA,NA,NA,NA,14/oct/2021,Positif,81.4,NA,Négatif,1.7,ONM168V5b,620.3,266.7,136.5,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM168,M,59.2,Moderna,3M3,334,88,NA,NA,NA,NA,01/mar/2022,Positif,97.3,2448,Négatif,0.8,ONM168 3M3,461,249.1,186.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM169,M,75.2,Pfizer,V3,34,NA,NA,NA,NA,NA,21/avr/2021,Positif,62,NA,NA,NA,ONM169V3b,82.2,66.5,24.3,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM169,M,75.2,Pfizer,V4,98,NA,NA,NA,NA,NA,24/jun/2021,Positif,26.5,NA,Négatif,0.5,ONM169V4b,53.6,42.7,15.2,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM169,M,75.2,Pfizer,V5,175,NA,NA,NA,NA,NA,09/sep/2021,Positif,16.1,NA,Négatif,0.2,ONM169V5b,41.5,34.3,14.1,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM169,M,75.2,Pfizer,3M3,365,119,NA,NA,NA,NA,18/mar/2022,Positif,55.4,803,Négatif,0,ONM169 3M3,78.3,68.7,39.9,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM169,M,75.2,Pfizer,3M6,425,179,NA,NA,NA,NA,17/mai/2022,Positif,51.2,687,Négatif,0,ONM169 3M6,54.4,40.3,29.2,Neuroendocrine,NET cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM170,M,70.2,Pfizer,V3,29,NA,NA,NA,NA,NA,16/avr/2021,Positif,126.9,NA,NA,NA,ONM170V3b,263.6,110.1,50.8,Genitourinary,prostate cancer,Hormonotherapy+Prednisone,Hormonal therapy,NA,Cancer treatment_Horm. + CS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM170,M,70.2,Pfizer,V4,96,NA,NA,NA,NA,NA,22/jun/2021,Positif,47.1,NA,Négatif,0.2,ONM170V4b,117.7,50.8,22.7,Genitourinary,prostate cancer,Hormonotherapy+Prednisone,Hormonal therapy,NA,Cancer treatment_Horm. + CS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM170,M,70.2,Pfizer,V5,175,NA,NA,NA,NA,NA,09/sep/2021,Positif,33.2,NA,Négatif,0.3,ONM170V5b,71.1,48.9,19.1,Genitourinary,prostate cancer,Hormonotherapy+Prednisone,Hormonal therapy,NA,Cancer treatment_Horm. + CS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM170,M,70.2,Pfizer,3M3,358,115,NA,NA,NA,NA,11/mar/2022,Positif,103.2,2752,Négatif,0.1,ONM170 3M3,193.53590090961873,95.78544061302682,61.012812690665044,Genitourinary,prostate cancer,Hormonotherapy+Prednisone,Hormonal therapy,NA,Cancer treatment_Horm. + CS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM170,M,70.2,Pfizer,3M6,413,170,NA,NA,NA,NA,05/mai/2022,Positif,116.5,3502,Négatif,0.1,ONM170 3M6,185.73551263001485,85.25149190110827,69.97900629811056,Genitourinary,prostate cancer,Hormonotherapy+Prednisone,Hormonal therapy,NA,Cancer treatment_Horm. + CS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM171,F,60.2,Pfizer,V3,27,NA,NA,NA,NA,NA,15/avr/2021,Positif,76.5,NA,NA,NA,ONM171V3b,1518.8,467.3,273.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM171,F,60.2,Pfizer,V4,96,NA,NA,NA,NA,NA,23/jun/2021,Positif,100,NA,Positif,7.2,ONM171V4b,477.8,200,95.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM171,F,60.2,Pfizer,V5,186,NA,NA,NA,NA,NA,21/sep/2021,Positif,72.6,NA,Négatif,3.6,ONM171V5b,252,139.2,74.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM171,F,60.2,Pfizer,3M3,367,109,NA,NA,NA,NA,21/mar/2022,Positif,87.2,1969,Négatif,1.2,ONM171 3M3,527.4,218.5,181.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM171,F,60.2,Pfizer,3M6,440,182,NA,NA,NA,NA,02/jun/2022,Positif,182.5,8570,Négatif,1.3,ONM171 3M6,605.3268765133172,267.5227394328518,195.19812609798947,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM172,M,63.2,Pfizer,V3,34,NA,NA,NA,NA,NA,22/avr/2021,Positif,145.3,NA,NA,NA,ONM172V3b,183.9,116.6,49.3,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM172,M,63.2,Pfizer,V4,97,NA,NA,NA,NA,NA,24/jun/2021,Positif,69.5,NA,Négatif,1.1,ONM172V4b,107.7,95.8,26.2,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM172,M,63.2,Pfizer,V5,193,NA,NA,NA,NA,NA,28/sep/2021,Positif,45.3,NA,Négatif,0.9,ONM172V5b,119.7,98.4,21.1,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM172,M,63.2,Pfizer,3M3,346,69,NA,NA,NA,NA,28/fév/2022,Positif,105,2848,Négatif,0.8,ONM172 3M3,351.4,217.5,134.4,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM173,M,72.1,Pfizer,V3,29,NA,NA,NA,NA,NA,11/mar/2021,Positif,90.9,NA,NA,NA,ONM173V3b,70.4,26.9,1.9,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM173,M,72.1,Pfizer,V4,90,NA,NA,NA,NA,NA,11/mai/2021,Positif,53.1,NA,NA,NA,ONM173V4b,49.1,34.6,8.1,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM173,M,72.1,Pfizer,V5,181,NA,NA,NA,NA,NA,10/aoû/2021,Positif,18.1,NA,Négatif,2.1,ONM173V5b,1,1,1,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM173,M,72.1,Pfizer,3M3,363,85,NA,NA,NA,NA,08/fév/2022,Positif,100.3,2600,Négatif,2.9,ONM173 3M3,294.9,145.2,85.3,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM173,M,72.1,Pfizer,3M6,453,175,NA,NA,NA,NA,09/mai/2022,Positif,165.4,7042,Négatif,2.8,ONM173 3M6,184.12815319462345,95.69377990430623,79.36507936507937,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM174,F,30.2,Pfizer,V3,33,NA,NA,NA,NA,NA,28/avr/2021,Positif,90.6,NA,NA,NA,ONM174V3b,2371.4,659.6,219.1,Breast,mets breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM174,F,30.2,Pfizer,V4,95,NA,NA,NA,NA,NA,29/jun/2021,Positif,73.5,NA,Négatif,0.8,ONM174V4b,648.1,240,106.8,Breast,mets breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM174,F,30.2,Pfizer,V5,186,NA,NA,NA,NA,NA,28/sep/2021,Positif,78.7,NA,Négatif,0.8,ONM174V5b,610.9,208,106.1,Breast,mets breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM174,F,30.2,Pfizer,V6,354,95,NA,NA,NA,NA,15/mar/2022,Positif,74.4,1438,Négatif,0.4,ONM174V6,2430,1425.3,703.2,Breast,mets breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM175,F,69.1,Pfizer,V3,29,NA,NA,NA,NA,NA,10/mar/2021,Positif,148.5,NA,NA,NA,ONM175V3b,236.1,54.2,14.4,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM175,F,69.1,Pfizer,V4,92,NA,NA,NA,NA,NA,12/mai/2021,Positif,115.5,NA,NA,NA,ONM175V4b,120.9,50,37.6,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM175,F,69.1,Pfizer,V5,192,NA,NA,NA,NA,NA,20/aoû/2021,Positif,54.6,NA,Négatif,0.5,ONM175V5b,176.4,85.2,61.2,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM175,F,69.1,Pfizer,3M3,364,71,NA,NA,NA,NA,08/fév/2022,Positif,92.5,2214,Négatif,0.5,ONM175 3M3,2430,672.0430107526882,348.91835310537334,Gastrointestinal,pancreatic ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM176,F,56.2,Pfizer,V3,33,NA,NA,NA,NA,NA,21/avr/2021,Positif,81.6,NA,NA,NA,ONM176V3b,1883.6,703.7,232.9,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM176,F,56.2,Pfizer,V4,95,NA,NA,NA,NA,NA,22/jun/2021,Positif,51.1,NA,Négatif,0.1,ONM176V4b,681.2,335.3,122.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM176,F,56.2,Pfizer,V5,174,NA,NA,NA,NA,NA,09/sep/2021,Positif,77.7,NA,Négatif,0.2,ONM176V5b,480.3,196.6,111,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM176,F,56.2,Pfizer,3M3,363,97,NA,NA,NA,NA,17/mar/2022,Positif,95.8,2374,Négatif,0.1,ONM176 3M3,2145.9,1117.2,784.3,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM177,F,74.2,Pfizer,V3,33,NA,NA,NA,NA,NA,21/avr/2021,Positif,108.5,NA,NA,NA,ONM177V3b,122.1,25.8,4.8,Thoracic,oesophagal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM177,F,74.2,Pfizer,V4,95,NA,NA,NA,NA,NA,22/jun/2021,Positif,58,NA,Négatif,1.4,ONM177V4b,119.6,61,23.8,Thoracic,oesophagal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM177,F,74.2,Pfizer,V5,172,NA,NA,NA,NA,NA,07/sep/2021,Positif,67.8,NA,Négatif,1.4,ONM177V5b,176.8,85,34.9,Thoracic,oesophagal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM177,F,74.2,Pfizer,3M3,368,104,NA,NA,NA,NA,22/mar/2022,Positif,99,2534,Négatif,0.2,ONM177 3M3,427.2,182.6,96.5,Thoracic,oesophagal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM178,F,79.2,Pfizer,V3,34,NA,NA,NA,NA,NA,22/avr/2021,Positif,135.8,NA,NA,NA,ONM178V3b,59.5,10.9,1.4,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM178,F,79.2,Pfizer,V4,95,NA,NA,NA,NA,NA,22/jun/2021,Positif,35.5,NA,Négatif,1.1,ONM178V4b,40.3,21.8,11.4,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM178,F,79.2,Pfizer,V5,182,NA,NA,NA,NA,NA,17/sep/2021,Positif,19.9,NA,Négatif,1.3,ONM178V5b,1,1,1,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM178,F,79.2,Pfizer,3M3,306,123,NA,NA,NA,NA,19/jan/2022,Positif,106.1,2908,Négatif,0.9,ONM178 3M3,491.4,208.2,106.9,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM178,F,79.2,Pfizer,3M6,364,181,NA,NA,NA,NA,18/mar/2022,Positif,99.7,2570,Négatif,0.6,ONM178 3M6,200.2,90.5,51.9,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM179,M,58.2,Pfizer,V3,31,NA,NA,NA,NA,NA,23/avr/2021,Positif,76.3,NA,NA,NA,ONM179V3b,303.6,56.5,10.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM179,M,58.2,Pfizer,V4,97,NA,NA,NA,NA,NA,28/jun/2021,Positif,82.3,NA,Négatif,0.2,ONM179V4b,183.2,79.6,50.4,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM179,M,58.2,Pfizer,V5,185,NA,NA,NA,NA,NA,24/sep/2021,Positif,42.1,NA,Négatif,0.3,ONM179V5b,79.2,45.9,24.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM179,M,58.2,Pfizer,3M3,366,68,NA,NA,NA,NA,24/mar/2022,Positif,108.5,3040,Négatif,1,ONM179 3M3,1421.3,414.8,327.9,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM181,F,39.2,Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,19/avr/2021,Positif,97.4,NA,NA,NA,ONM181V3b,579.4,189,126.5,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM181,F,39.2,Pfizer,V4,90,NA,NA,V5-3M3,NA,NA,17/jun/2021,Positif,95.9,NA,Négatif,0.3,ONM181V4b,208.5,88.4,61.1,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM181,F,39.2,Pfizer,V5,188,NA,NA,V5-3M3,NA,NA,23/sep/2021,Positif,70.8,NA,Négatif,0.2,ONM181V5b,104.3,51.1,33.6,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM181,F,39.2,Pfizer,3M3,361,103,NA,V5-3M3,46,NA,15/mar/2022,Positif,75.2,1468,Négatif,2.1,ONM181 3M3,682.1,274,118.2,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM182,F,44.2,Moderna,V3,32,NA,NA,V5-3M3,NA,NA,03/mai/2021,Positif,109.7,NA,NA,NA,ONM182V3b,375.8,122.4,63.3,Brain,gliome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM182,F,44.2,Moderna,V4,95,NA,NA,V5-3M3,NA,NA,05/jui/2021,Positif,86.6,NA,Négatif,0.4,ONM182V4b,123.2,56.6,24,Brain,gliome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM182,F,44.2,Moderna,V5,183,NA,NA,V5-3M3,NA,NA,01/oct/2021,Positif,55,NA,Négatif,0.2,ONM182V5b,84.5,27.9,16.2,Brain,gliome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM182,F,44.2,Moderna,V5+,292,46,NA,V5-3M3,5,NA,18/jan/2022,Positif,112.7,3279,Négatif,0.2,ONM182V5+,495.8,145.1,77.5,Brain,gliome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM182,F,44.2,Moderna,3M3,348,102,NA,V5-3M3,61,NA,15/mar/2022,Positif,99.8,2575,Positif,8.5,ONM182 3M3,2833.7,1170.3,1091.9,Brain,gliome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,V3,33,NA,NA,3M3-3M6,NA,NA,26/avr/2021,Positif,88.9,NA,NA,NA,ONM183V3b,433.1,220.8,56.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,V4,93,NA,NA,3M3-3M6,NA,NA,25/jun/2021,Positif,76.6,NA,Négatif,0.1,ONM183V4b,184.6,91.5,24.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,V5,188,NA,NA,3M3-3M6,NA,NA,28/sep/2021,Positif,36.7,NA,Négatif,0.1,ONM183V5b,68.5,38.3,14.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,3M3,299,91,NA,3M3-3M6,NA,NA,17/jan/2022,Positif,103,2741,Négatif,0.1,ONM183 3M3,135,72.1,45.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,3M3+,355,147,NA,3M3-3M6,47,NA,14/mar/2022,Positif,120.2,3727,Positif,8.3,ONM183 3M3+,1955.4,1510.6,1237.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM183,F,71.2,Pfizer,3M6,398,190,NA,3M3-3M6,90,NA,26/avr/2022,Positif,152.2,5965,Négatif,3.3,ONM183 3M6,1883.6,1216,817.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM184,F,64.2,Pfizer,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,27.8,NA,NA,NA,ONM184V3b,353.9,129.7,29.1,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM184,F,64.2,Pfizer,V4,98,NA,NA,NA,NA,NA,01/jui/2021,Positif,11.1,NA,Négatif,2.8,ONM184V4b,12,6.8,3.8,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM184,F,64.2,Pfizer,V5,183,NA,NA,NA,NA,NA,24/sep/2021,Négatif,3.4,NA,Négatif,1.9,ONM184V5b,1,1,1,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM184,F,64.2,Pfizer,3M3,299,116,NA,NA,NA,NA,18/jan/2022,Positif,14.9,63,Négatif,2.6,ONM184 3M3,16.3,9.7,5.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM184,F,64.2,Pfizer,3M6,364,181,NA,NA,NA,NA,24/mar/2022,Positif,7.5,18,Négatif,1.5,ONM184 3M6,19,15.8,7,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM185,F,86.1,Pfizer,V3,28,NA,NA,NA,NA,NA,11/mar/2021,Positif,89.1,NA,NA,NA,ONM185V3b,65.7,11.1,0.7,Breast,breast cancer+lymphoma + myelome,No TTT For The 3 : Remisiion,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM185,F,86.1,Pfizer,V4,89,NA,NA,NA,NA,NA,11/mai/2021,Positif,54.6,NA,NA,NA,ONM185V4b,27.9,15.4,4.6,Breast,breast cancer+lymphoma + myelome,No TTT For The 3 : Remisiion,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM185,F,86.1,Pfizer,V5,181,NA,NA,NA,NA,NA,11/aoû/2021,Positif,22.4,NA,Négatif,0.3,ONM185V5b,14.9,9,3.3,Breast,breast cancer+lymphoma + myelome,No TTT For The 3 : Remisiion,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM186,F,51.2,Pfizer,V3,32,NA,NA,3M3-3M6,NA,NA,03/mai/2021,Positif,30.8,NA,NA,NA,ONM186V3b,21.3,2.5,3.8,Breast,breast cancer,Neoajuvant IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,hypophsitis post IO treated with hydrocortisone,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM186,F,51.2,Pfizer,V4,98,NA,NA,3M3-3M6,NA,NA,08/jui/2021,Positif,26,NA,Négatif,1.2,ONM186V4b,1,1,1,Breast,breast cancer,Neoajuvant IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,hypophsitis post IO treated with hydrocortisone,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM186,F,51.2,Pfizer,V5,196,29,NA,3M3-3M6,NA,NA,14/oct/2021,Positif,26.2,NA,Négatif,1.4,ONM186V5b,1,1,1,Breast,breast cancer,Neoajuvant IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,hypophsitis post IO treated with hydrocortisone,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM186,F,51.2,Pfizer,3M3,265,98,NA,3M3-3M6,NA,NA,22/déc/2021,Positif,23.5,151,Négatif,1.2,ONM186 3M3b,12.5,4.2,3.9,Breast,breast cancer,Neoajuvant IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,hypophsitis post IO treated with hydrocortisone,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM186,F,51.2,Pfizer,3M6,362,195,NA,3M3-3M6,4,NA,29/mar/2022,Positif,23,144,Négatif,1,ONM186 3M6,19.3,6.2,3.1,Breast,breast cancer,Neoajuvant IO+Chemo,Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,hypophsitis post IO treated with hydrocortisone,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM187,F,68.2,Pfizer,3M3,365,104,NA,NA,NA,NA,23/mar/2022,Positif,88.5,2028,Négatif,0,ONM187 3M3,1358,505.3,278.3,Breast,breast cancer,Adjuvant Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM188,M,80.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,11/mar/2021,Positif,116.7,NA,NA,NA,ONM188V3b,150.7,41.4,6.5,Genitourinary,prostate ADK,Hormonotherapy: Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM188,M,80.1,Pfizer,V4,89,NA,NA,3M3-3M6,NA,NA,11/mai/2021,Positif,56.9,NA,NA,NA,ONM188V4b,105.9,53.2,25.9,Genitourinary,prostate ADK,Hormonotherapy: Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM188,M,80.1,Pfizer,V5,187,NA,NA,3M3-3M6,NA,NA,17/aoû/2021,Positif,22.6,NA,Négatif,0.3,ONM188V5b,58.4,30.2,12.3,Genitourinary,prostate ADK,Hormonotherapy: Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM188,M,80.1,Pfizer,3M3,327,98,NA,3M3-3M6,NA,NA,04/jan/2022,Positif,124.1,3972,Négatif,0.2,ONM188 3M3,590,177.3,111.2,Genitourinary,prostate ADK,Hormonotherapy: Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM188,M,80.1,Pfizer,3M6,407,178,NA,3M3-3M6,18,NA,25/mar/2022,Positif,90.7,2129,Indéterminé,5.5,ONM188 3M6,978.5,492.9,207.4,Genitourinary,prostate ADK,Hormonotherapy: Lucrin,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Lucrin,L02AE02,"NA"
ONM189,M,70.1,Pfizer,V3,29,NA,NA,NA,NA,NA,12/mar/2021,Positif,121.6,NA,NA,NA,ONM189V3b,292.5,169.1,55.8,Genitourinary,prostate ADK,Hormonotherapy: Zoladex,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Zoladex,L02AE03,"NA"
ONM189,M,70.1,Pfizer,V4,89,NA,NA,NA,NA,NA,11/mai/2021,Positif,86.6,NA,NA,NA,ONM189V4b,104,58.8,16.7,Genitourinary,prostate ADK,Hormonotherapy: Zoladex,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Zoladex,L02AE03,"NA"
ONM189,M,70.1,Pfizer,V5,180,NA,NA,NA,NA,NA,10/aoû/2021,Positif,32.5,NA,Négatif,1.2,ONM189V5b,33.3,19.1,5.3,Genitourinary,prostate ADK,Hormonotherapy: Zoladex,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Zoladex,L02AE03,"NA"
ONM190,F,58.2,Pfizer,V3,34,NA,NA,V5-V6,NA,NA,29/avr/2021,Positif,96.2,NA,NA,NA,ONM190V3b,554.3,235.1,95.5,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM190,F,58.2,Pfizer,V4,89,NA,NA,V5-V6,NA,NA,23/jun/2021,Positif,100.1,NA,Négatif,0.5,ONM190V4b,357.9,142.3,62.4,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM190,F,58.2,Pfizer,V5,188,NA,NA,V5-V6,NA,NA,30/sep/2021,Positif,55.1,NA,Négatif,0.3,ONM190V5b,173,77,41.6,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM190,F,58.2,Pfizer,V5+,264,NA,NA,V5-V6,18,NA,15/déc/2021,Positif,84.1,1833,Indéterminé,4.8,ONM190V5+b,1528.6,753.6,448.4,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM190,F,58.2,Pfizer,V6,377,NA,NA,V5-V6,131,NA,07/avr/2022,Positif,90.3,2111,Positif,16.2,ONM190V6,1549.7,805.2,490.2,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM191,F,73.2,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,27/avr/2021,Positif,131.5,NA,NA,NA,ONM191V3b,397,116.9,52.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM191,F,73.2,Pfizer,V4,98,NA,NA,V5-3M3,NA,NA,30/jun/2021,Positif,58,NA,Négatif,0.1,ONM191V4b,119.1,43.9,18,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM191,F,73.2,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,29/sep/2021,Positif,34.8,NA,Négatif,0.1,ONM191V5b,71.5,37,15.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM191,F,73.2,Pfizer,3M3,366,112,NA,V5-3M3,7,NA,25/mar/2022,Positif,92,2190,Négatif,0.9,ONM191 3M3,506.6,248.5,132.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM192,F,64.2,Pfizer,V3,33,NA,NA,NA,NA,NA,26/avr/2021,Positif,87.9,NA,NA,NA,ONM192V3b,224.8,83,19.7,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM192,F,64.2,Pfizer,V4,97,NA,NA,NA,NA,NA,29/jun/2021,Positif,73.2,NA,Négatif,0.1,ONM192V4b,186.7,87.2,40.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM192,F,64.2,Pfizer,V5,184,NA,NA,NA,NA,NA,24/sep/2021,Positif,46.2,NA,Négatif,0.1,ONM192V5b,234,103.9,42,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM192,F,64.2,Pfizer,3M3,364,116,NA,NA,NA,NA,23/mar/2022,Positif,89.3,2065,Négatif,0.1,ONM192 3M3,1089.1,227.6,163.4,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM192,F,64.2,Pfizer,3M6,429,181,NA,NA,NA,NA,27/mai/2022,Positif,152.9,6020,Négatif,0,ONM192 3M6,456.2,129.1,83.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM193,M,75.2,Pfizer,V3,34,NA,NA,V5-V6,NA,NA,27/avr/2021,Positif,121.5,NA,NA,NA,ONM193V3b,407.5,138.2,66.9,Sarcoma,sarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM193,M,75.2,Pfizer,V4,99,NA,NA,V5-V6,NA,NA,01/jui/2021,Positif,59.4,NA,Négatif,0.1,ONM193V4b,234.4,72.4,67.5,Sarcoma,sarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM193,M,75.2,Pfizer,V5,184,NA,NA,V5-V6,NA,NA,24/sep/2021,Positif,33.4,NA,Négatif,0.2,ONM193V5b,49.8,17.5,17.3,Sarcoma,sarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM193,M,75.2,Pfizer,V6,378,92,NA,V5-V6,20,NA,06/avr/2022,Positif,104,2794,Positif,6.8,ONM193V6,2430,1396.5,640.2,Sarcoma,sarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM194,F,73.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,82.3,NA,NA,NA,ONM194V3b,211.5,55.6,33.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM194,F,73.2,Pfizer,V4,87,NA,NA,NA,NA,NA,21/jun/2021,Positif,42.3,NA,Négatif,0.1,ONM194V4b,54,31.4,18.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM194,F,73.2,Pfizer,V5,185,NA,NA,NA,NA,NA,27/sep/2021,Positif,23.6,NA,Négatif,0,ONM194V5b,57.6,36.9,16.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM194,F,73.2,Pfizer,3M3,339,98,NA,NA,NA,NA,28/fév/2022,Positif,94,2286,Négatif,0.2,ONM194 3M3,199.4,110.5,92.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM194,F,73.2,Pfizer,3M6,423,182,NA,NA,NA,NA,23/mai/2022,Positif,99.2,2544,Négatif,0,ONM194 3M6,103,51.1,46,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM195,F,59.2,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,26/avr/2021,Positif,95.4,NA,NA,NA,ONM195V3b,167.7,56.7,9.5,Brain,anaplasic astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM195,F,59.2,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,30/jun/2021,Positif,70.5,NA,Négatif,0.1,ONM195V4b,40.2,13.3,3.6,Brain,anaplasic astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM195,F,59.2,Pfizer,V5,190,NA,NA,V5-3M3,NA,NA,01/oct/2021,Positif,83.3,NA,Négatif,0.1,ONM195V5b,1,1,1,Brain,anaplasic astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM195,F,59.2,Pfizer,3M3,369,113,NA,V5-3M3,7,NA,29/mar/2022,Positif,121.3,3795,Positif,20.6,ONM195 3M3,1901.1,1238.7,649.4,Brain,anaplasic astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM196,F,56.2,Pfizer,V3,33,NA,NA,NA,NA,NA,28/avr/2021,Positif,106,NA,NA,NA,ONM196V3b,809.7,357.3,107.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM196,F,56.2,Pfizer,V4,94,NA,NA,NA,NA,NA,28/jun/2021,Positif,82.4,NA,Négatif,0.2,ONM196V4b,329.2,144.7,72,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM196,F,56.2,Pfizer,V5,194,NA,NA,NA,NA,NA,06/oct/2021,Positif,88.2,NA,Négatif,0.1,ONM196V5b,216.4,108.3,61.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM196,F,56.2,Pfizer,3M3,383,84,NA,NA,NA,NA,13/avr/2022,Positif,97.2,2443,Indéterminé,4.8,ONM196 3M3,2430,1085.3,471.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM197,F,67.2,Pfizer,V3,33,NA,NA,NA,NA,NA,27/avr/2021,Positif,119.8,NA,NA,NA,ONM197V3b,261.1,137.5,47.8,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM197,F,67.2,Pfizer,V4,98,NA,NA,NA,NA,NA,01/jui/2021,Positif,53.6,NA,Positif,7,ONM197V4b,70.8,49.3,19.9,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM197,F,67.2,Pfizer,V5,193,NA,NA,NA,NA,NA,04/oct/2021,Positif,26.9,NA,Positif,10.1,ONM197V5b,42.6,32.1,16.2,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM197,F,67.2,Pfizer,3M3,322,92,NA,NA,NA,NA,10/fév/2022,Positif,106.1,2908,Positif,6.5,ONM197 3M3,205.4,123.6,77.6,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM197,F,67.2,Pfizer,3M6,410,180,NA,NA,NA,NA,09/mai/2022,Positif,168.3,7290,Positif,6,ONM197 3M6,1383.508577753182,814.9959250203749,306.37254901960785,Breast,breast cancer,Adj Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM198,F,59.2,Pfizer,V3,32,NA,NA,NA,NA,NA,26/avr/2021,Positif,92.1,NA,NA,NA,ONM198V3b,244.7,94.8,62.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM198,F,59.2,Pfizer,V4,97,NA,NA,NA,NA,NA,30/jun/2021,Positif,63.2,NA,Négatif,0.1,ONM198V4b,112.3,65.4,51.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM198,F,59.2,Pfizer,V5,174,NA,NA,NA,NA,NA,15/sep/2021,Positif,61.1,NA,Négatif,0.1,ONM198V5b,159.2,76.6,63.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM198,F,59.2,Pfizer,3M3,368,108,NA,NA,NA,NA,28/mar/2022,Positif,88.9,2046,Négatif,0,ONM198 3M3,1059.1,365.1,252.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM199,F,85.2,Pfizer,V3,34,NA,NA,NA,NA,NA,28/avr/2021,Positif,98.4,NA,NA,NA,ONM199V3b,388,219.5,52.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM199,F,85.2,Pfizer,V4,98,NA,NA,NA,NA,NA,01/jui/2021,Positif,49,NA,Négatif,0.5,ONM199V4b,123.9,84.5,14.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM199,F,85.2,Pfizer,V5,190,NA,NA,NA,NA,NA,01/oct/2021,Positif,26,NA,Négatif,0.4,ONM199V5b,88.9,61.5,14.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM199,F,85.2,Pfizer,3M3,369,98,NA,NA,NA,NA,29/mar/2022,Positif,124,3965,Négatif,0.3,ONM199 3M3,455.8,258.6,101.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM200,M,67.2,Pfizer,V3,34,NA,NA,V5-V6,NA,NA,29/avr/2021,Positif,108.2,NA,NA,NA,ONM200V3b,252.5,110.5,36.7,Skin,melanoma,No TTT: IO IO Ipi Nivo En March 2021,NA,No,Not treated,Not treated,hypophisitis post IO en march 2021,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM200,M,67.2,Pfizer,V4,103,NA,NA,V5-V6,NA,NA,07/jui/2021,Positif,76.4,NA,Négatif,0,ONM200V4b,163.4,100.9,34.8,Skin,melanoma,No TTT: IO IO Ipi Nivo En March 2021,NA,No,Not treated,Not treated,hypophisitis post IO en march 2021,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM200,M,67.2,Pfizer,V5,174,NA,NA,V5-V6,NA,NA,16/sep/2021,Positif,41.3,NA,Négatif,0.1,ONM200V5b,101.6,71,24.7,Skin,melanoma,No TTT: IO IO Ipi Nivo En March 2021,NA,No,Not treated,Not treated,hypophisitis post IO en march 2021,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM200,M,67.2,Pfizer,V6,378,183,NA,V5-V6,11,NA,08/avr/2022,Positif,114.2,3366,Positif,10.9,ONM200V6,896.9,682.6,463.2,Skin,melanoma,No TTT: IO IO Ipi Nivo En March 2021,NA,No,Not treated,Not treated,hypophisitis post IO en march 2021,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM201,F,63.2,Pfizer,V3,33,NA,NA,NA,NA,NA,26/avr/2021,Positif,76.6,NA,NA,NA,ONM201V3b,306.7,96.6,69.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM201,F,63.2,Pfizer,V4,96,NA,NA,NA,NA,NA,28/jun/2021,Positif,80.8,NA,Négatif,0.4,ONM201V4b,632.5,252.5,105.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM201,F,63.2,Pfizer,V5,187,NA,NA,NA,NA,NA,27/sep/2021,Positif,80.6,NA,Négatif,0.3,ONM201V5b,268.7,114,67.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM201,F,63.2,Pfizer,3M3,369,105,NA,NA,NA,NA,28/mar/2022,Positif,80,1660,Négatif,0,ONM201 3M3,717.4,319.8,263.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM202,F,44.2,Pfizer,V3,34,NA,NA,V5-3M3,NA,NA,29/avr/2021,Positif,124.1,NA,NA,NA,ONM202V3b,532.2,130.7,36.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM202,F,44.2,Pfizer,V4,89,NA,NA,V5-3M3,NA,NA,23/jun/2021,Positif,101.4,NA,Négatif,0.4,ONM202V4b,171.1,87.1,49,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM202,F,44.2,Pfizer,V5,187,NA,NA,V5-3M3,NA,NA,29/sep/2021,Positif,62.3,NA,Négatif,0.5,ONM202V5b,112.4,58.2,34.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM202,F,44.2,Pfizer,3M3,349,70,NA,V5-3M3,33,NA,10/mar/2022,Positif,81.8,1735,Négatif,2.5,ONM202 3M3,2430.1,680.7,1078.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM203,M,62.2,Pfizer,V3,32,NA,NA,NA,NA,NA,27/avr/2021,Positif,111.9,NA,NA,NA,ONM203V3b,283.8,151.1,69.8,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM203,M,62.2,Pfizer,V4,98,NA,NA,NA,NA,NA,02/jui/2021,Positif,44.8,NA,Négatif,0.3,ONM203V4b,79.9,44.2,18.2,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM203,M,62.2,Pfizer,V5,193,NA,NA,NA,NA,NA,05/oct/2021,Positif,22.9,NA,Négatif,0.4,ONM203V5b,25.3,18.8,8.1,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM203,M,62.2,Pfizer,3M3,291,76,NA,NA,NA,NA,11/jan/2022,Positif,99.2,2544,Négatif,0.1,ONM203 3M3,223.1,95.9,53.2,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM203,M,62.2,Pfizer,3M6,397,182,NA,NA,NA,NA,27/avr/2022,Positif,59.7,930,Négatif,0,ONM203 3M6,98.3,61.5,31.4,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM204,F,73.1,Pfizer,V3,28,NA,NA,NA,NA,NA,12/mar/2021,Positif,115.2,NA,NA,NA,ONM204V3b,950.6,408.2,141.8,Genitourinary,endometroide ADK,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM204,F,73.1,Pfizer,V4,89,NA,NA,NA,NA,NA,12/mai/2021,Positif,125.7,NA,NA,NA,ONM204V4b,214.7,106.3,48.2,Genitourinary,endometroide ADK,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM204,F,73.1,Pfizer,V5,178,NA,NA,NA,NA,NA,09/aoû/2021,Positif,37.5,NA,Négatif,0.1,ONM204V5b,117,74.2,29.3,Genitourinary,endometroide ADK,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM204,F,73.1,Pfizer,3M3,360,82,NA,NA,NA,NA,07/fév/2022,Positif,68.4,1217,Négatif,0.1,ONM204 3M3,3850.6,1798.2,626.6,Genitourinary,endometroide ADK,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM204,F,73.1,Pfizer,3M6,461,183,NA,NA,NA,NA,19/mai/2022,Positif,117.6,3568,Négatif,0.1,ONM204 3M6,942.5,488.8,288.9,Genitourinary,endometroide ADK,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM205,M,72.1,Pfizer,3M3,367,90,NA,NA,NA,NA,14/fév/2022,Positif,104.4,2816,Négatif,2.5,ONM205 3M3,186.1,122.9,55.7,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM205,M,72.1,Pfizer,3M6,473,196,NA,NA,NA,NA,31/mai/2022,Positif,124.2,3978,Positif,6.7,ONM205 3M6,410.5,246.7,173.4,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM206,M,58.2,Pfizer,V3,34,NA,NA,3M3-3M6,NA,NA,29/avr/2021,Positif,91.1,NA,NA,NA,ONM206V3b,103.5,14.7,7.1,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM206,M,58.2,Pfizer,V4,98,NA,NA,3M3-3M6,NA,NA,02/jui/2021,Positif,39.5,NA,Négatif,1.4,ONM206V4b,25.7,4.4,1.4,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM206,M,58.2,Pfizer,V5,174,NA,NA,3M3-3M6,NA,NA,16/sep/2021,Positif,21.3,NA,Négatif,1,ONM206V5b,1,1,1,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM206,M,58.2,Pfizer,3M3,308,100,NA,3M3-3M6,NA,NA,28/jan/2022,Positif,103.2,2752,Négatif,0.9,ONM206 3M3,418.2,93.9,65.1,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM206,M,58.2,Pfizer,3M6,381,173,NA,3M3-3M6,21,NA,11/avr/2022,Positif,100.2,2595,Positif,23.5,ONM206 3M6,2430,2430,1575.1,Hepatic,CHC,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM207,F,74.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,114.4,NA,NA,NA,ONM207V3b,394.5,113.9,63.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM207,F,74.2,Pfizer,V4,95,NA,NA,NA,NA,NA,02/jui/2021,Positif,60.1,NA,Négatif,1.7,ONM207V4b,116.4,47.9,21.3,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM207,F,74.2,Pfizer,V5,196,NA,NA,NA,NA,NA,11/oct/2021,Positif,25.5,NA,Négatif,0.9,ONM207V5b,40,26.7,8.7,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM207,F,74.2,Pfizer,3M3,301,89,NA,NA,NA,NA,24/jan/2022,Positif,104.2,2805,Négatif,0.2,ONM207 3M3,578.4,212,95.7,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM207,F,74.2,Pfizer,3M6,402,190,NA,NA,NA,NA,05/mai/2022,Positif,135.9,4760,Négatif,3.3,ONM207 3M6,1621.796951021732,683.0601092896175,691.5629322268327,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM208,F,73.2,Pfizer,V3,35,NA,NA,NA,NA,NA,23/avr/2021,Positif,82.7,NA,NA,NA,ONM208V3b,893.7,328.9,119,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM208,F,73.2,Pfizer,V4,96,NA,NA,NA,NA,NA,23/jun/2021,Positif,102.2,NA,Négatif,2.7,ONM208V4b,295.1,142.8,51.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM208,F,73.2,Pfizer,V5,181,NA,NA,NA,NA,NA,16/sep/2021,Positif,80.8,NA,Négatif,2.3,ONM208V5b,400,175.9,82,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM208,F,73.2,Pfizer,3M3,369,104,NA,NA,NA,NA,23/mar/2022,Positif,65,1100,Négatif,1.6,ONM208 3M3,1954.7,691.6,477.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM209,F,64.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,106.6,NA,NA,NA,ONM209V3b,1148.5,338.2,94.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM209,F,64.2,Pfizer,V4,94,NA,NA,NA,NA,NA,28/jun/2021,Positif,84.1,NA,Négatif,0.4,ONM209V4b,731,278.2,90.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM209,F,64.2,Pfizer,V5,185,NA,NA,NA,NA,NA,27/sep/2021,Positif,77.7,NA,Négatif,0.1,ONM209V5b,243.1,118.5,53.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM209,F,64.2,Pfizer,3M3,375,86,NA,NA,NA,NA,05/avr/2022,Positif,122.6,3877,Négatif,0.2,ONM209 3M3,2430,1070.4,457.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM210,F,51.2,Pfizer,V3,32,NA,NA,NA,NA,NA,27/avr/2021,Positif,119.3,NA,NA,NA,ONM210V3b,219.8,31.7,13.2,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM210,F,51.2,Pfizer,V4,96,NA,NA,NA,NA,NA,30/jun/2021,Positif,64.7,NA,Indéterminé,4.2,ONM210V4b,119.6,42,28.2,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM210,F,51.2,Pfizer,V5,186,NA,NA,NA,NA,NA,28/sep/2021,Positif,44.4,NA,Indéterminé,4.5,ONM210V5b,76.6,30.4,11.5,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM210,F,51.2,Pfizer,3M3,367,103,NA,NA,NA,NA,28/mar/2022,Positif,90.4,2115,Négatif,0.6,ONM210 3M3,923.4,200.7,145.6,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM211,F,58.2,Pfizer,V3,33,NA,NA,NA,NA,NA,28/avr/2021,Positif,103.2,NA,NA,NA,ONM211V3b,279.9,86.5,44.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM211,F,58.2,Pfizer,V4,97,NA,NA,NA,NA,NA,01/jui/2021,Positif,73.1,NA,Négatif,2.7,ONM211V4b,134,66,33.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM211,F,58.2,Pfizer,V5,192,NA,NA,NA,NA,NA,04/oct/2021,Positif,47.3,NA,Négatif,2.6,ONM211V5b,74.6,46.3,23.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM211,F,58.2,Pfizer,3M3,368,116,NA,NA,NA,NA,29/mar/2022,Positif,122.1,3845,Négatif,0.4,ONM211 3M3,386.5,180.5,113.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM211,F,58.2,Pfizer,3M6,427,175,NA,NA,NA,NA,27/mai/2022,Positif,150,5795,Négatif,0.6,ONM211 3M6,261.8,109.7,104.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM212,F,55.2,Pfizer,3M3,371,105,NA,NA,NA,NA,01/avr/2022,Positif,87.5,1983,Négatif,0.1,ONM212 3M3,238.4,114.8,81.7,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM213,F,72.2,Pfizer,V3,34,NA,NA,NA,NA,NA,29/avr/2021,Positif,15.5,NA,NA,NA,ONM213V3b,1.5,1,1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM213,F,72.2,Pfizer,V4,87,NA,NA,NA,NA,NA,21/jun/2021,Positif,17.3,NA,Négatif,0.7,ONM213V4b,1,1,1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM213,F,72.2,Pfizer,V5,185,NA,NA,NA,NA,NA,27/sep/2021,Positif,9.4,NA,Négatif,0.4,ONM213V5b,1,1,1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM213,F,72.2,Pfizer,V6,363,100,NA,NA,NA,NA,24/mar/2022,Positif,108.6,3046,Négatif,0.2,ONM213V6,163.2,40,36.2,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM214,F,40.1,Pfizer,V3,28,NA,NA,V5-V6,NA,NA,16/mar/2021,Positif,130.5,NA,NA,NA,ONM214V3b,258.8,118.2,14.3,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM214,F,40.1,Pfizer,V4,90,NA,NA,V5-V6,NA,NA,17/mai/2021,Positif,67.7,NA,NA,NA,ONM214V4b,102.7,77.5,36,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM214,F,40.1,Pfizer,V5,174,NA,NA,V5-V6,NA,NA,09/aoû/2021,Positif,32.4,NA,Négatif,2.6,ONM214V5b,73.7,58.4,19.7,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM214,F,40.1,Pfizer,V5+,316,65,NA,V5-V6,8,NA,29/déc/2021,Positif,84.9,1868,Positif,17.9,ONM214V5+b,2430,728.3,504,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM214,F,40.1,Pfizer,3M3,363,112,NA,V5-V6,55,NA,14/fév/2022,Positif,101.4,2657,Positif,15.9,ONM214 3M3,2122.7,548.8,297.4,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM214,F,40.1,Pfizer,3M6,419,168,NA,V5-V6,111,NA,11/avr/2022,Positif,100.3,2600,Positif,8.9,ONM214 3M6,1843,559.9,217.6,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM215,F,80.1,Pfizer,3M3,366,86,NA,NA,NA,NA,16/fév/2022,Positif,98,2483,Négatif,0.3,ONM215 3M3,3198,2586.7,1050,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM215,F,80.1,Pfizer,3M6,463,183,NA,NA,NA,NA,24/mai/2022,Positif,158.2,6444,Négatif,0.2,ONM215 3M6,526.9,403.7,199.4,Breast,breast cancer,Adjuvant Hormonotherapy: Exemestane,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Exemestane,L02BG06,"NA"
ONM216,F,51.1,Pfizer,3M3,361,95,NA,NA,NA,NA,11/fév/2022,Positif,74.1,1426,Négatif,0.2,ONM216 3M3,2430,1359.6,1009.1,Breast,breast cancer,No TTT : Adjuvant IO Pembro Last Dose11.12.20 Maladie D'Ehlers-Danlos.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM216,F,51.1,Pfizer,3M6,462,196,NA,NA,NA,NA,23/mai/2022,Positif,101,2637,Négatif,0.1,ONM216 3M6,2430,1448.4,758.2,Breast,breast cancer,No TTT : Adjuvant IO Pembro Last Dose11.12.20 Maladie D'Ehlers-Danlos.,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Pembro,L01FF02,"NA"
ONM217,M,66.1,Pfizer,V3,28,NA,NA,NA,NA,NA,17/mar/2021,Positif,90.8,NA,NA,NA,ONM217V3b,61.8,12.8,1.2,Skin,melanoma,No TTT: Infliximab In 12.2019 For Lupus AI,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM217,M,66.1,Pfizer,V4,90,NA,NA,NA,NA,NA,18/mai/2021,Positif,42.3,NA,NA,NA,ONM217V4b,41.5,25.2,12.4,Skin,melanoma,No TTT: Infliximab In 12.2019 For Lupus AI,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM217,M,66.1,Pfizer,V5,181,NA,NA,NA,NA,NA,17/aoû/2021,Positif,11.1,NA,Négatif,0.2,ONM217V5b,18,17.9,8.3,Skin,melanoma,No TTT: Infliximab In 12.2019 For Lupus AI,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM217,M,66.1,Pfizer,3M3,362,88,NA,NA,NA,NA,14/fév/2022,Positif,104.1,2800,Négatif,0.2,ONM217 3M3,225.3,130.9,48.4,Skin,melanoma,No TTT: Infliximab In 12.2019 For Lupus AI,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM217,M,66.1,Pfizer,3M6,456,182,NA,NA,NA,NA,19/mai/2022,Positif,91.9,2186,Négatif,0.1,ONM217 3M6,85.9,49.2,26.3,Skin,melanoma,No TTT: Infliximab In 12.2019 For Lupus AI,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Infliximab,Infliximab,L04AB02,L04AB02
ONM218,F,51.2,Moderna,V3,32,NA,NA,V5-3M3,NA,NA,23/avr/2021,Positif,68.1,NA,NA,NA,ONM218V3b,389.1,225,47.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM218,F,51.2,Moderna,V4,93,NA,NA,V5-3M3,NA,NA,23/jun/2021,Positif,98,NA,Négatif,0.6,ONM218V4b,384.9,172.1,117.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM218,F,51.2,Moderna,V5,184,NA,NA,V5-3M3,NA,NA,22/sep/2021,Positif,97.9,NA,Négatif,0.3,ONM218V5b,534.8,260.1,145.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM218,F,51.2,Moderna,3M3,385,119,NA,V5-3M3,14,NA,11/avr/2022,Positif,99,2534,Positif,18.4,ONM218 3M3,2430,1298,621.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM219,F,54.2,Moderna,V3,32,NA,NA,NA,NA,NA,23/avr/2021,Positif,74.1,NA,NA,NA,ONM219V3b,1257.1,524.9,151.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM219,F,54.2,Moderna,V4,95,NA,NA,NA,NA,NA,25/jun/2021,Positif,108,NA,Négatif,1.6,ONM219V4b,646,265.1,87.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM219,F,54.2,Moderna,V5,185,NA,NA,NA,NA,NA,23/sep/2021,Positif,86.9,NA,Négatif,1.1,ONM219V5b,219.8,105.3,50.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM219,F,54.2,Moderna,3M3,351,83,NA,NA,NA,NA,08/mar/2022,Positif,89.7,2083,Négatif,3.4,ONM219 3M3,565,281.5,99.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM221,F,75.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,16/mar/2021,Positif,122.4,NA,NA,NA,ONM221V3b,130.9,37.8,8.8,Breast,breast cancer,Hormonotherapy Tamoxifene,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM221,F,75.1,Pfizer,V4,91,NA,NA,3M3-3M6,NA,NA,18/mai/2021,Positif,89.1,NA,NA,NA,ONM221V4b,120.8,69,36.8,Breast,breast cancer,Hormonotherapy Tamoxifene,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM221,F,75.1,Pfizer,V5,181,NA,NA,3M3-3M6,NA,NA,16/aoû/2021,Positif,35.4,NA,Négatif,1,ONM221V5b,113.7,55.7,27.2,Breast,breast cancer,Hormonotherapy Tamoxifene,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM221,F,75.1,Pfizer,3M3,303,100,NA,3M3-3M6,NA,NA,16/déc/2021,Positif,92.5,2214,Négatif,0.6,ONM221 3M3b,226,88,47.5,Breast,breast cancer,Hormonotherapy Tamoxifene,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM221,F,75.1,Pfizer,3M6,388,185,NA,3M3-3M6,11,NA,11/mar/2022,Positif,105.6,2881,Négatif,1,ONM221 3M6,357.5,171.1,126.9,Breast,breast cancer,Hormonotherapy Tamoxifene,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Tamoxifen,L02BA01,"NA"
ONM223,F,72.1,Pfizer,V3,29,NA,NA,NA,NA,NA,16/mar/2021,Positif,126.5,NA,NA,NA,ONM223V3b,468.6,176.9,21.6,Breast,breast cancer,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM223,F,72.1,Pfizer,V4,92,NA,NA,NA,NA,NA,18/mai/2021,Positif,111.8,NA,NA,NA,ONM223V4b,266.4,118.9,76.2,Breast,breast cancer,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM223,F,72.1,Pfizer,V5,183,NA,NA,NA,NA,NA,17/aoû/2021,Positif,49.4,NA,Négatif,0.3,ONM223V5b,162.9,100.8,47.1,Breast,breast cancer,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM223,F,72.1,Pfizer,3M3,361,67,NA,NA,NA,NA,11/fév/2022,Positif,100.8,2626,Négatif,0.2,ONM223 3M3,862.1,416.5,297.1,Breast,breast cancer,Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM224,M,27.1,Pfizer,V3,29,NA,NA,NA,NA,NA,17/mar/2021,Positif,130.7,NA,NA,NA,ONM224V3b,129.3,48.4,4.3,Brain,astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM224,M,27.1,Pfizer,V4,90,NA,NA,NA,NA,NA,17/mai/2021,Positif,89.2,NA,NA,NA,ONM224V4b,148.4,81.4,45.3,Brain,astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM224,M,27.1,Pfizer,V5,181,NA,NA,NA,NA,NA,16/aoû/2021,Positif,27,NA,Négatif,1.1,ONM224V5b,76.3,52,20.4,Brain,astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM224,M,27.1,Pfizer,3M3,379,98,NA,NA,NA,NA,02/mar/2022,Positif,96.8,2423,Négatif,0.6,ONM224 3M3,742.9,414.4,234.7,Brain,astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM224,M,27.1,Pfizer,3M6,454,173,NA,NA,NA,NA,16/mai/2022,Positif,150.5,5833,Indéterminé,5.6,ONM224 3M6,1469.5,920.8,618.8,Brain,astrocytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM225,F,77.1,Pfizer,V3,29,NA,NA,NA,NA,NA,16/mar/2021,Positif,117.5,NA,NA,NA,ONM225V3b,1774.6,1010.4,214.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM225,F,77.1,Pfizer,V4,92,NA,NA,NA,NA,NA,18/mai/2021,Positif,107.6,NA,NA,NA,ONM225V4b,424.4,159.4,54.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM225,F,77.1,Pfizer,V5,183,NA,NA,NA,NA,NA,17/aoû/2021,Positif,66.5,NA,Indéterminé,4.7,ONM225V5b,473.7,189,95,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM225,F,77.1,Pfizer,3M3,413,104,NA,NA,NA,NA,04/avr/2022,Positif,74.8,1453,Positif,6.3,ONM225 3M3,2430,1117.9,744.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM226,F,76.2,Moderna,V6,377,158,NA,NA,NA,NA,04/avr/2022,Positif,96.6,2413,Positif,6.7,ONM226V6,622.3,355.6,169.4,Gastrointestinal,canal anal cancer,No TTT,NA,No,Not treated,Not treated,maladie Gilbert,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM227,F,53.1,Pfizer,V3,30,NA,NA,NA,NA,NA,19/mar/2021,Positif,120.3,NA,NA,NA,ONM227V3b,2240.6,823.7,124.3,Genitourinary,ovarian cancer,"Chemo: Cyclophosphamide Metronomic+ Beva Until 26.02.21, Then Carbo+Caelyx",VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|Beva,L01AA01|L01FG01,"NA"
ONM227,F,53.1,Pfizer,V4,93,NA,NA,NA,NA,NA,21/mai/2021,Positif,146.6,NA,NA,NA,ONM227V4b,68.8,34.1,27.6,Genitourinary,ovarian cancer,"Chemo: Cyclophosphamide Metronomic+ Beva Until 26.02.21, Then Carbo+Caelyx",VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|Beva,L01AA01|L01FG01,"NA"
ONM227,F,53.1,Pfizer,V5,170,NA,NA,NA,NA,NA,06/aoû/2021,Positif,81.5,NA,Négatif,0.3,ONM227V5b,146.3,89.7,39.2,Genitourinary,ovarian cancer,"Chemo: Cyclophosphamide Metronomic+ Beva Until 26.02.21, Then Carbo+Caelyx",VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|Beva,L01AA01|L01FG01,"NA"
ONM227,F,53.1,Pfizer,V6,357,NA,NA,NA,NA,NA,09/fév/2022,Positif,57.5,864,Négatif,0.2,ONM227V6,37.2,20.5,7.8,Genitourinary,ovarian cancer,"Chemo: Cyclophosphamide Metronomic+ Beva Until 26.02.21, Then Carbo+Caelyx",VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Cyclophosphamide|Beva,L01AA01|L01FG01,"NA"
ONM228,F,60.2,Moderna,V3,31,NA,NA,NA,NA,NA,26/avr/2021,Positif,92.6,NA,NA,NA,ONM228V3b,274.7,106.8,50,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM228,F,60.2,Moderna,V4,94,NA,NA,NA,NA,NA,28/jun/2021,Positif,55.2,NA,Négatif,0.8,ONM228V4b,73.2,43,17.8,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM228,F,60.2,Moderna,V5,186,NA,NA,NA,NA,NA,28/sep/2021,Positif,14.9,NA,Négatif,0.4,ONM228V5b,33,23.4,8.8,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM228,F,60.2,Moderna,3M3,297,90,NA,NA,NA,NA,17/jan/2022,Positif,112,3238,Négatif,0.4,ONM228 3M3,107.1,27.1,19.6,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM228,F,60.2,Moderna,3M6,384,177,NA,NA,NA,NA,14/avr/2022,Positif,63.8,1061,Négatif,0.2,ONM228 3M6,81.8,38.2,14.3,Breast,breast cancer,Neo Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM229,F,41.2,Moderna,V3,33,NA,NA,NA,NA,NA,27/avr/2021,Positif,127.4,NA,NA,NA,ONM229V3b,82.2,66.5,24.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM229,F,41.2,Moderna,V4,96,NA,NA,NA,NA,NA,29/jun/2021,Positif,80.4,NA,Négatif,0.3,ONM229V4b,138.6,83.3,44.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM229,F,41.2,Moderna,V5,188,NA,NA,NA,NA,NA,29/sep/2021,Positif,68.9,NA,Négatif,0.4,ONM229V5b,195.6,98.3,49.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM230,F,59.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,102,NA,NA,NA,ONM230V3b,899.3,218.1,112.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM230,F,59.3,Pfizer,V4,93,NA,NA,NA,NA,NA,08/jui/2021,Positif,106.9,NA,Négatif,3.3,ONM230V4b,305.3,99.4,57.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM230,F,59.3,Pfizer,V5,185,NA,NA,NA,NA,NA,08/oct/2021,Positif,86.9,NA,Négatif,2.5,ONM230V5b,146.9,57.4,37,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM230,F,59.3,Pfizer,3M3,356,101,NA,NA,NA,NA,28/mar/2022,Positif,87.8,1996,Négatif,1.9,ONM230 3M3,1279.9,406.7,230.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM231,M,76.1,Pfizer,V3,29,NA,NA,NA,NA,NA,19/mar/2021,Positif,117.5,NA,NA,NA,ONM231V3b,337.8,132.4,7.5,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM231,M,76.1,Pfizer,V4,91,NA,NA,NA,NA,NA,20/mai/2021,Positif,60.7,NA,NA,NA,ONM231V4b,99.5,69.4,30.4,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM231,M,76.1,Pfizer,V5,182,NA,NA,NA,NA,NA,19/aoû/2021,Positif,40.1,NA,Négatif,0.2,ONM231V5b,89,62.3,33.1,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM231,M,76.1,Pfizer,3M3,361,82,NA,NA,NA,NA,14/fév/2022,Positif,102.1,2694,Négatif,0.4,ONM231 3M3,276.8,153.2,72.8,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM231,M,76.1,Pfizer,3M6,460,181,NA,NA,NA,NA,24/mai/2022,Positif,104.1,2800,Négatif,0.4,ONM231 3M6,125,76.2,52,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM232,M,73.1,Pfizer,V3,28,NA,NA,NA,NA,NA,18/mar/2021,Positif,64,NA,NA,NA,ONM232V3b,42.5,15.5,1.8,Genitourinary,prostate cancer,Tkis: Abiraterone,AR-targeted therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone,L02BX03,L02BX03
ONM232,M,73.1,Pfizer,V4,89,NA,NA,NA,NA,NA,18/mai/2021,Positif,27.1,NA,NA,NA,ONM232V4b,1,1,1,Genitourinary,prostate cancer,Tkis: Abiraterone,AR-targeted therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone,L02BX03,L02BX03
ONM232,M,73.1,Pfizer,V5,186,NA,NA,NA,NA,NA,23/aoû/2021,Positif,7.8,NA,Négatif,0.2,ONM232V5b,1,1,1,Genitourinary,prostate cancer,Tkis: Abiraterone,AR-targeted therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone,L02BX03,L02BX03
ONM232,M,73.1,Pfizer,3M3,365,98,NA,NA,NA,NA,18/fév/2022,Positif,91.2,2153,Négatif,0.6,ONM232 3M3,195.9,109.7,76.3,Genitourinary,prostate cancer,Tkis: Abiraterone,AR-targeted therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone,L02BX03,L02BX03
ONM232,M,73.1,Pfizer,3M6,448,181,NA,NA,NA,NA,12/mai/2022,Positif,76.3,1511,Positif,6.8,ONM232 3M6,2430,2430,979.4,Genitourinary,prostate cancer,Tkis: Abiraterone,AR-targeted therapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone,L02BX03,L02BX03
ONM233,F,60.1,Pfizer,V3,28,NA,NA,3M3-3M6,NA,NA,18/mar/2021,Positif,124.4,NA,NA,NA,ONM233V3b,354.9,121.8,54.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM233,F,60.1,Pfizer,V4,91,NA,NA,3M3-3M6,NA,NA,20/mai/2021,Positif,62.4,NA,NA,NA,ONM233V4b,134.2,52.2,23.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM233,F,60.1,Pfizer,V5,182,NA,NA,3M3-3M6,NA,NA,19/aoû/2021,Positif,36.5,NA,Négatif,0.2,ONM233V5b,68.6,43.1,19.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM233,F,60.1,Pfizer,3M3,371,106,NA,3M3-3M6,NA,NA,24/fév/2022,Positif,106.7,2941,Négatif,0.2,ONM233 3M3,384,169.1,130,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM233,F,60.1,Pfizer,3M6,448,183,NA,3M3-3M6,45,NA,12/mai/2022,Positif,117.8,3581,Positif,10.7,ONM233 3M6,2430,1634.8,809.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM234,M,73.1,Pfizer,V3,28,NA,NA,NA,NA,NA,18/mar/2021,Positif,127,NA,NA,NA,ONM234V3b,517.1,160.5,17.4,Genitourinary,prostate cancer,Tkis (Abiraterone)+Prednisone,AR-targeted therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone|Prednisone,L02BX03|H02AB07,L02BX03
ONM234,M,73.1,Pfizer,V4,96,NA,NA,NA,NA,NA,25/mai/2021,Positif,95.9,NA,NA,NA,ONM234V4b,110.3,57.1,31.4,Genitourinary,prostate cancer,Tkis (Abiraterone)+Prednisone,AR-targeted therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone|Prednisone,L02BX03|H02AB07,L02BX03
ONM234,M,73.1,Pfizer,V5,180,NA,NA,NA,NA,NA,17/aoû/2021,Positif,35.5,NA,Négatif,0.2,ONM234V5b,74.6,36.6,20.5,Genitourinary,prostate cancer,Tkis (Abiraterone)+Prednisone,AR-targeted therapy,NA,Cancer treatment + IS,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Abiraterone,Abiraterone|Prednisone,L02BX03|H02AB07,L02BX03
ONM235,F,55.1,Pfizer,V3,28,NA,NA,NA,NA,NA,17/mar/2021,Positif,62.6,NA,NA,NA,ONM235V3b,89.3,16,9.1,Breast,breast cancer,Adjuvant Chemo: Taxol : Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Taxol,L01CD01,"NA"
ONM235,F,55.1,Pfizer,V4,90,NA,NA,NA,NA,NA,18/mai/2021,Positif,35.6,NA,NA,NA,ONM235V4b,48.4,23.3,14.8,Breast,breast cancer,Adjuvant Chemo: Taxol : Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Taxol,L01CD01,"NA"
ONM235,F,55.1,Pfizer,V5,183,NA,NA,NA,NA,NA,19/aoû/2021,Positif,17.8,NA,Négatif,0.5,ONM235V5b,44.3,25.1,12.6,Breast,breast cancer,Adjuvant Chemo: Taxol : Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Taxol,L01CD01,"NA"
ONM235,F,55.1,Pfizer,V6,373,140,NA,NA,NA,NA,25/fév/2022,Positif,97.6,2463,Négatif,0.7,ONM235V6,373.7,116.8,99.4,Breast,breast cancer,Adjuvant Chemo: Taxol : Ongoing,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Taxol,L01CD01,"NA"
ONM236,M,64.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,62.7,NA,NA,NA,ONM236V3b,258.7,41.7,21.2,Head and neck,SCC oral cavity,Surgery,NA,No,Not treated,Not treated,known for scc lung+ SCC oesophagal both treated with surgery,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM236,M,64.2,Pfizer,V4,94,NA,NA,NA,NA,NA,01/jui/2021,Positif,41.8,NA,Négatif,0.3,ONM236V4b,226.3,24.6,11.1,Head and neck,SCC oral cavity,Surgery,NA,No,Not treated,Not treated,known for scc lung+ SCC oesophagal both treated with surgery,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM236,M,64.2,Pfizer,V5,182,NA,NA,NA,NA,NA,27/sep/2021,Positif,35.9,NA,Négatif,0.2,ONM236V5b,358,42.6,20.2,Head and neck,SCC oral cavity,Surgery,NA,No,Not treated,Not treated,known for scc lung+ SCC oesophagal both treated with surgery,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM236,M,64.2,Pfizer,3M3,367,86,NA,NA,NA,NA,31/mar/2022,Positif,107.4,2979,Négatif,0.1,ONM236 3M3,568.8,156.3,95.1,Head and neck,SCC oral cavity,Surgery,NA,No,Not treated,Not treated,known for scc lung+ SCC oesophagal both treated with surgery,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM237,F,80.1,Pfizer,V3,28,NA,NA,NA,NA,NA,18/mar/2021,Positif,147.7,NA,NA,NA,ONM237V3b,756.4,132.5,29.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM237,F,80.1,Pfizer,V4,90,NA,NA,NA,NA,NA,19/mai/2021,Positif,117.2,NA,NA,NA,ONM237V4b,149.3,31.6,21.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM237,F,80.1,Pfizer,V5,181,NA,NA,NA,NA,NA,18/aoû/2021,Positif,61.3,NA,Négatif,0.2,ONM237V5b,94.6,22.9,11,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM237,F,80.1,Pfizer,3M3,343,106,NA,NA,NA,NA,27/jan/2022,Positif,108.5,3040,Négatif,0.5,ONM237 3M3,606.4,261.1,161.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM237,F,80.1,Pfizer,3M6,419,182,NA,NA,NA,NA,13/avr/2022,Positif,100.1,2590,Négatif,0.2,ONM237 3M6,280.8,125.5,81.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM238,M,80.1,Pfizer,V3,27,NA,NA,NA,NA,NA,18/mar/2021,Positif,27.8,NA,NA,NA,ONM238V3b,6,0.9,1,Thoracic,SCC lung,"Double IO: Ipi Nivo (Nivo Before) Last Dose 10.2020, Stopped Because Of Posisble Heart Failure, Treated With Surgery, No Steroides",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM238,M,80.1,Pfizer,V4,90,NA,NA,NA,NA,NA,20/mai/2021,Positif,12.4,NA,NA,NA,ONM238V4b,24.6,15.3,3.3,Thoracic,SCC lung,"Double IO: Ipi Nivo (Nivo Before) Last Dose 10.2020, Stopped Because Of Posisble Heart Failure, Treated With Surgery, No Steroides",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM238,M,80.1,Pfizer,V5,181,NA,NA,NA,NA,NA,19/aoû/2021,Positif,7.9,NA,Négatif,0.8,ONM238V5b,1,1,1,Thoracic,SCC lung,"Double IO: Ipi Nivo (Nivo Before) Last Dose 10.2020, Stopped Because Of Posisble Heart Failure, Treated With Surgery, No Steroides",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM238,M,80.1,Pfizer,3M3,346,125,NA,NA,NA,NA,31/jan/2022,Positif,88.7,2037,Négatif,0.7,ONM238 3M3,84.3,65.4,25.9,Thoracic,SCC lung,"Double IO: Ipi Nivo (Nivo Before) Last Dose 10.2020, Stopped Because Of Posisble Heart Failure, Treated With Surgery, No Steroides",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM238,M,80.1,Pfizer,3M6,405,184,NA,NA,NA,NA,31/mar/2022,Positif,56.7,840,Négatif,0.3,ONM238 3M6,57.6,42.5,10.2,Thoracic,SCC lung,"Double IO: Ipi Nivo (Nivo Before) Last Dose 10.2020, Stopped Because Of Posisble Heart Failure, Treated With Surgery, No Steroides",NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM239,F,68.1,Pfizer,V3,28,NA,NA,NA,NA,NA,19/mar/2021,Positif,42.2,NA,NA,NA,ONM239V3b,47.2,24.2,14,Gastrointestinal,colon ADK,Chemo+Beva: FOLFOX+Avastin,VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Avastin,Beva|Avastin,L01FG01,L01FG01
ONM239,F,68.1,Pfizer,V4,91,NA,NA,NA,NA,NA,21/mai/2021,Positif,66.9,NA,NA,NA,ONM239V4b,1,1,1,Gastrointestinal,colon ADK,Chemo+Beva: FOLFOX+Avastin,VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Avastin,Beva|Avastin,L01FG01,L01FG01
ONM239,F,68.1,Pfizer,V5,185,NA,NA,NA,NA,NA,23/aoû/2021,Positif,30.6,NA,Négatif,0.2,ONM239V5b,1,1,1,Gastrointestinal,colon ADK,Chemo+Beva: FOLFOX+Avastin,VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Avastin,Beva|Avastin,L01FG01,L01FG01
ONM239,F,68.1,Pfizer,3M3,311,110,NA,NA,NA,NA,27/déc/2021,Positif,118.7,3635,Négatif,0.1,ONM239 3M3,1970.1,691.6,379.9,Gastrointestinal,colon ADK,Chemo+Beva: FOLFOX+Avastin,VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Avastin,Beva|Avastin,L01FG01,L01FG01
ONM239,F,68.1,Pfizer,3M6,391,190,NA,NA,NA,NA,17/mar/2022,Positif,105.6,2881,Négatif,0,ONM239 3M6,955.1,471.3,294,Gastrointestinal,colon ADK,Chemo+Beva: FOLFOX+Avastin,VEGF inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Avastin,Beva|Avastin,L01FG01,L01FG01
ONM240,F,74.1,Pfizer,V6,362,70,NA,NA,NA,NA,16/fév/2022,Positif,104.6,2827,Négatif,0.3,ONM240V6,1267.3,173.8,156.9,Thoracic,SCC oesophagal,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM241,F,48.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,130.3,NA,NA,NA,ONM241V3b,582.8,177.3,48.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM241,F,48.2,Pfizer,V4,99,NA,NA,NA,NA,NA,06/jui/2021,Positif,95.7,NA,Négatif,0.8,ONM241V4b,282.7,144.8,71.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM241,F,48.2,Pfizer,V5,192,NA,NA,NA,NA,NA,07/oct/2021,Positif,59.5,NA,Négatif,0.7,ONM241V5b,140.5,75.8,44.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM241,F,48.2,Pfizer,3M3,365,109,NA,NA,NA,NA,29/mar/2022,Positif,126,4094,Négatif,0.4,ONM241 3M3,983.3,483.6,232.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM242,M,69.2,Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,29/avr/2021,Positif,107.5,NA,NA,NA,ONM242V3b,254,59.6,38.9,Gastrointestinal,rectal cancer +renal and prostate cancer,Hormonotherapy For Prostate,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM242,M,69.2,Pfizer,V4,99,NA,NA,V5-3M3,NA,NA,06/jui/2021,Positif,69.4,NA,Négatif,1.1,ONM242V4b,98.4,45.9,20.8,Gastrointestinal,rectal cancer +renal and prostate cancer,Hormonotherapy For Prostate,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM242,M,69.2,Pfizer,V5,196,NA,NA,V5-3M3,NA,NA,11/oct/2021,Positif,33.4,NA,Négatif,0.8,ONM242V5b,66.3,31.1,13.1,Gastrointestinal,rectal cancer +renal and prostate cancer,Hormonotherapy For Prostate,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM242,M,69.2,Pfizer,3M3,378,116,NA,V5-3M3,89,NA,11/avr/2022,Positif,100.2,2595,Positif,12,ONM242 3M3,2430,1515.6,803.2,Gastrointestinal,rectal cancer +renal and prostate cancer,Hormonotherapy For Prostate,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM243,F,67.2,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,30/avr/2021,Positif,108.1,NA,NA,NA,ONM243V3b,320.4,173.1,73.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM243,F,67.2,Pfizer,V4,87,NA,NA,V5-V6,NA,NA,25/jun/2021,Positif,50.5,NA,Négatif,0.6,ONM243V4b,96.2,28.5,17.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM243,F,67.2,Pfizer,V5,192,NA,NA,V5-V6,NA,NA,08/oct/2021,Positif,24,NA,Négatif,0.4,ONM243V5b,32.9,15.2,7.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM243,F,67.2,Pfizer,V6,374,165,NA,V5-V6,61,NA,08/avr/2022,Positif,113,3296,Positif,11.8,ONM243V6,2430,1221,899.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM245,M,70.3,Pfizer,V3,32,NA,NA,NA,NA,NA,07/mai/2021,Positif,56,NA,NA,NA,ONM245V3b,84.3,37.2,18,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM245,M,70.3,Pfizer,V4,92,NA,NA,NA,NA,NA,06/jui/2021,Positif,37.3,NA,Négatif,1.3,ONM245V4b,68.2,45.9,22.3,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM245,M,70.3,Pfizer,V5,190,NA,NA,NA,NA,NA,12/oct/2021,Positif,18.7,NA,Négatif,0.6,ONM245V5b,45.9,26.1,12.8,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM245,M,70.3,Pfizer,3M3,281,74,NA,NA,NA,NA,11/jan/2022,Positif,149.1,5726,Négatif,0.1,ONM245 3M3,819,404.4,249.1,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM245,M,70.3,Pfizer,3M6,379,172,NA,NA,NA,NA,19/avr/2022,Positif,94.7,2320,Négatif,0,ONM245 3M6,249.1,156.7,93.5,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM246,F,79.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,102.5,NA,NA,NA,ONM246V3b,242.1,78,45.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM246,F,79.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,78.5,NA,Négatif,0.3,ONM246V4b,97.9,63.9,32.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM246,F,79.2,Pfizer,V5,191,NA,NA,NA,NA,NA,07/oct/2021,Positif,41,NA,Négatif,0.2,ONM246V5b,69.4,41.5,23.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM246,F,79.2,Pfizer,3M3,325,95,NA,NA,NA,NA,18/fév/2022,Positif,92.7,2224,Négatif,0.1,ONM246 3M3,275.9,184.1,87.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM246,F,79.2,Pfizer,3M6,415,185,NA,NA,NA,NA,19/mai/2022,Positif,97.2,2443,Négatif,0,ONM246 3M6,246.5,129.9,75.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM247,F,66.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,126,NA,NA,NA,ONM247V3b,106.5,54,10.7,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM247,F,66.2,Pfizer,V4,94,NA,NA,NA,NA,NA,01/jui/2021,Positif,81,NA,Négatif,0.8,ONM247V4b,134.7,72.5,44.4,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM247,F,66.2,Pfizer,V5,189,NA,NA,NA,NA,NA,04/oct/2021,Positif,49.9,NA,Négatif,0.8,ONM247V5b,171.9,102.2,57,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM247,F,66.2,Pfizer,3M3,317,91,NA,NA,NA,NA,09/fév/2022,Positif,100.4,2605,Négatif,0.6,ONM247 3M3,347.5,192.5,116,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM247,F,66.2,Pfizer,3M6,414,188,NA,NA,NA,NA,17/mai/2022,Positif,84.6,1854,Négatif,0.2,ONM247 3M6,95.7,44.2,30.1,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM248,F,82.1,Pfizer,V3,28,NA,NA,V5-3M3,26.01.2022 (sérologie),NA,22/mar/2021,Positif,129.2,NA,NA,NA,ONM248V3b,512,256.9,138.4,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM248,F,82.1,Pfizer,V4,92,NA,NA,V5-3M3,26.01.2022 (sérologie),NA,25/mai/2021,Positif,88,NA,NA,NA,ONM248V4b,144.4,87.5,55.1,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM248,F,82.1,Pfizer,V5,183,NA,NA,V5-3M3,26.01.2022 (sérologie),NA,24/aoû/2021,Positif,46.4,NA,Négatif,0.1,ONM248V5b,87,63.3,36,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM248,F,82.1,Pfizer,3M3,338,105,NA,V5-3M3,26.01.2022 (sérologie),NA,26/jan/2022,Positif,83.8,1820,Positif,11.6,ONM248 3M3,2430,1749.5,1246.6,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM248,F,82.1,Pfizer,3M6,423,190,NA,V5-3M3,26.01.2022 (sérologie),NA,21/avr/2022,Positif,107.4,2979,Positif,7.6,ONM248 3M6,2430,1940.6,977.5,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM249,M,65.2,Pfizer,V3,28,NA,NA,NA,NA,NA,26/avr/2021,Positif,94.7,NA,NA,NA,ONM249V3b,344.1,162,70.6,Genitourinary,prostate cancer,RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM249,M,65.2,Pfizer,V4,92,NA,NA,NA,NA,NA,29/jun/2021,Positif,61,NA,Négatif,0.2,ONM249V4b,127,67.6,25.1,Genitourinary,prostate cancer,RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM249,M,65.2,Pfizer,V5,184,NA,NA,NA,NA,NA,29/sep/2021,Positif,36,NA,Négatif,0.2,ONM249V5b,45.5,34.6,12.6,Genitourinary,prostate cancer,RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM249,M,65.2,Pfizer,3M3,364,115,NA,NA,NA,NA,28/mar/2022,Positif,88.7,2037,Indéterminé,5.6,ONM249 3M3,2430,2430,2430,Genitourinary,prostate cancer,RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM249,M,65.2,Pfizer,3M6,430,181,NA,NA,NA,NA,02/jun/2022,Positif,217.9,12211,Indéterminé,4.5,ONM249 3M6,2430,1997.2039145196725,1575.795776867318,Genitourinary,prostate cancer,RT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM250,F,61.3,Pfizer,V3,30,NA,NA,NA,NA,NA,19/mai/2021,Positif,88.6,NA,NA,NA,ONM250V3b,324.8,134,28.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM250,F,61.3,Pfizer,V4,86,NA,NA,NA,NA,NA,14/jui/2021,Positif,72.4,NA,Négatif,0.8,ONM250V4b,353,170.3,89.2,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM250,F,61.3,Pfizer,V5,185,NA,NA,NA,NA,NA,21/oct/2021,Positif,58.2,NA,Négatif,1.3,ONM250V5b,146,107.1,62,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM250,F,61.3,Pfizer,3M3,324,91,NA,NA,NA,NA,09/mar/2022,Positif,89.8,2088,Négatif,0.4,ONM250 3M3,231.2,115.4,75,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM251,F,81.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,12.7,NA,NA,NA,ONM251V3b,21.9,12,11.2,Neuroendocrine,NET cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM251,F,81.2,Pfizer,V4,93,NA,NA,NA,NA,NA,30/jun/2021,Positif,6.3,NA,Négatif,0.1,ONM251V4b,1,1,1,Neuroendocrine,NET cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM251,F,81.2,Pfizer,V5,189,NA,NA,NA,NA,NA,04/oct/2021,Indéterminé,4.7,NA,Négatif,0,ONM251V5b,1,1,1,Neuroendocrine,NET cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM251,F,81.2,Pfizer,3M3,298,91,NA,NA,NA,NA,21/jan/2022,Positif,49.6,646,Négatif,0.1,ONM251 3M3,64.4,35.8,26.6,Neuroendocrine,NET cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM251,F,81.2,Pfizer,3M6,393,186,NA,NA,NA,NA,26/avr/2022,Positif,19.6,106,Négatif,0,ONM251 3M6,26,20.3,15.6,Neuroendocrine,NET cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM252,F,74.2,Pfizer,V3,31,NA,NA,NA,NA,NA,29/avr/2021,Positif,110.4,NA,NA,NA,ONM252V3b,230,51.5,10.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM252,F,74.2,Pfizer,V4,99,NA,NA,NA,NA,NA,06/jui/2021,Positif,67.2,NA,Négatif,0.1,ONM252V4b,131,77.5,43,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM252,F,74.2,Pfizer,V5,196,NA,NA,NA,NA,NA,11/oct/2021,Positif,34.6,NA,Négatif,0.1,ONM252V5b,84.5,62.1,32.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM252,F,74.2,Pfizer,3M3,318,108,NA,NA,NA,NA,10/fév/2022,Positif,107.4,2979,Négatif,0,ONM252 3M3,399.4,174.7,121.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM252,F,74.2,Pfizer,3M6,392,182,NA,NA,NA,NA,25/avr/2022,Positif,103.2,2752,Négatif,0,ONM252 3M6,159.5,85,67.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM253,M,55.2,Pfizer,V6,366,NA,NA,NA,NA,NA,30/mar/2022,Positif,94.2,2296,Négatif,0,ONM253V6,391.8,180.8,93.2,Thoracic,"Lung cancer cT4 cN0 cM0, stade IIIB",No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM254,F,67.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,94.5,NA,NA,NA,ONM254V3b,1384.5,341.4,172.2,Genitourinary,ovarian cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM254,F,67.2,Pfizer,V4,95,NA,NA,NA,NA,NA,02/jui/2021,Positif,82.2,NA,Négatif,0.4,ONM254V4b,485,147.7,76.8,Genitourinary,ovarian cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM254,F,67.2,Pfizer,V5,189,NA,NA,NA,NA,NA,04/oct/2021,Positif,56.9,NA,Négatif,0.2,ONM254V5b,175.7,56.1,34,Genitourinary,ovarian cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM254,F,67.2,Pfizer,3M3,296,78,NA,NA,NA,NA,19/jan/2022,Positif,81.3,1714,Négatif,0.3,ONM254 3M3,1139.6,419.8,166,Genitourinary,ovarian cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM254,F,67.2,Pfizer,3M6,399,181,NA,NA,NA,NA,02/mai/2022,Positif,129.9,4350,Positif,8,ONM254 3M6,1848.7705675725642,740.7407407407406,546.1496450027307,Genitourinary,ovarian cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM255,F,67.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,116.1,NA,NA,NA,ONM255V3b,768.6,373.4,105.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM255,F,67.2,Pfizer,V4,98,NA,NA,NA,NA,NA,05/jui/2021,Positif,93.6,NA,Négatif,0.3,ONM255V4b,370.4,158.2,65.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM255,F,67.2,Pfizer,V5,196,NA,NA,NA,NA,NA,11/oct/2021,Positif,50.1,NA,Négatif,0.2,ONM255V5b,135.9,69.9,34.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM255,F,67.2,Pfizer,3M3,378,116,NA,NA,NA,NA,11/avr/2022,Positif,90.8,2134,Négatif,0.4,ONM255 3M3,1418.8,750.8,372.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM256,M,47.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,124.2,NA,NA,NA,ONM256V3b,381.5,98.6,49.8,Other,hemangiopericytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM256,M,47.2,Pfizer,V4,94,NA,NA,NA,NA,NA,01/jui/2021,Positif,77.3,NA,Négatif,0.7,ONM256V4b,126,68.9,38.6,Other,hemangiopericytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM256,M,47.2,Pfizer,V5,190,NA,NA,NA,NA,NA,05/oct/2021,Positif,43.4,NA,Négatif,0.5,ONM256V5b,95.3,59.3,34.3,Other,hemangiopericytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM256,M,47.2,Pfizer,3M3,371,103,NA,NA,NA,NA,04/avr/2022,Positif,97.2,2443,Négatif,0,ONM256 3M3,1286,549.1,266,Other,hemangiopericytoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM257,F,66.2,Pfizer,V3,29,NA,NA,NA,NA,NA,27/avr/2021,Positif,107.6,NA,NA,NA,ONM257V3b,464.5,123.4,46.4,Brain,ganglioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM257,F,66.2,Pfizer,V4,93,NA,NA,NA,NA,NA,30/jun/2021,Positif,77.7,NA,Positif,6.5,ONM257V4b,307.2,130.1,79.1,Brain,ganglioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM257,F,66.2,Pfizer,V5,190,NA,NA,NA,NA,NA,05/oct/2021,Positif,67.8,NA,Indéterminé,5.3,ONM257V5b,241.1,103.6,62.3,Brain,ganglioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM257,F,66.2,Pfizer,3M3,343,94,NA,NA,NA,NA,07/mar/2022,Positif,109.3,3085,Indéterminé,5.3,ONM257 3M3,824.4,429.4,263.9,Brain,ganglioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM258,M,64.3,Moderna,V3,30,NA,NA,NA,NA,NA,28/mai/2021,Positif,96.9,NA,NA,NA,ONM258V3b,584.8,231.4,24.4,Brain,Glioblastoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM258,M,64.3,Moderna,V4,90,NA,NA,NA,NA,NA,27/jui/2021,Positif,80.3,NA,Négatif,2.3,ONM258V4b,228.3,103.2,39.1,Brain,Glioblastoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM258,M,64.3,Moderna,V5,188,NA,NA,NA,NA,NA,02/nov/2021,Positif,59.9,NA,Négatif,1.5,ONM258V5b,228.7,126.4,58.5,Brain,Glioblastoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM258,M,64.3,Moderna,3M3,316,77,NA,NA,NA,NA,10/mar/2022,Positif,83.9,1824,Négatif,1,ONM258 3M3,2285.7,854.7,558,Brain,Glioblastoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM259,F,67.2,Pfizer,V6,365,114,NA,V5-V6,30,NA,31/mar/2022,Positif,105.3,2864,Positif,18.8,ONM259V6,677.5,376.6,252.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM260,F,67.2,Pfizer,V3,30,NA,NA,NA,NA,NA,28/avr/2021,Positif,81,NA,NA,NA,ONM260V3b,215.7,49.5,31.3,Sarcoma,leiomyosarcoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM260,F,67.2,Pfizer,V4,85,NA,NA,NA,NA,NA,22/jun/2021,Positif,52.2,NA,Négatif,0.1,ONM260V4b,161.4,63.7,27.8,Sarcoma,leiomyosarcoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM260,F,67.2,Pfizer,V5,185,NA,NA,NA,NA,NA,30/sep/2021,Positif,33.3,NA,Négatif,0,ONM260V5b,75.8,38.6,14.3,Sarcoma,leiomyosarcoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM260,F,67.2,Pfizer,3M3,283,85,NA,NA,NA,NA,06/jan/2022,Positif,88.2,2014,Négatif,0.1,ONM260 3M3,2430,2430,901.7,Sarcoma,leiomyosarcoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM260,F,67.2,Pfizer,3M6,387,189,NA,NA,NA,NA,20/avr/2022,Positif,98.6,2513,Négatif,0,ONM260 3M6,2430,1415.6,375.5,Sarcoma,leiomyosarcoma,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM261,M,70.2,Pfizer,V3,31,NA,NA,NA,NA,NA,29/avr/2021,Positif,83.3,NA,NA,NA,ONM261V3b,261.2,86.7,27.5,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM261,M,70.2,Pfizer,V4,98,NA,NA,NA,NA,NA,05/jui/2021,Positif,49.3,NA,Négatif,0.2,ONM261V4b,96.8,50.6,19.9,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM261,M,70.2,Pfizer,V5,179,NA,NA,NA,NA,NA,24/sep/2021,Positif,33.3,NA,Négatif,0.4,ONM261V5b,75.7,39.8,15.2,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM261,M,70.2,Pfizer,V6,364,145,NA,NA,NA,NA,28/mar/2022,Positif,87,1960,Négatif,0,ONM261V6,236.4,82.7,38.7,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM262,F,56.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,111.1,NA,NA,NA,ONM262V3b,617.3,302.8,83.1,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM262,F,56.2,Pfizer,V4,98,NA,NA,NA,NA,NA,06/jui/2021,Positif,96.4,NA,Négatif,2.6,ONM262V4b,203.3,118.4,41.3,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM262,F,56.2,Pfizer,V5,196,NA,NA,NA,NA,NA,12/oct/2021,Positif,52.5,NA,Négatif,2,ONM262V5b,89.3,70.4,33.1,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM262,F,56.2,Pfizer,3M3,378,91,NA,NA,NA,NA,12/avr/2022,Positif,88.9,2046,Positif,11.4,ONM262 3M3,2430,2430,2187.2,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM263,F,56.2,Pfizer,3M3,366,111,NA,NA,NA,NA,30/mar/2022,Positif,90.9,2139,Négatif,0.1,ONM263 3M3,254.8,165.9,104.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM264,M,80.2,Pfizer,V3,32,NA,NA,NA,NA,NA,30/avr/2021,Positif,23.6,NA,NA,NA,ONM264V3b,27.7,2.2,1.5,Renal,renal cancer stage IV,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM264,M,80.2,Pfizer,V4,98,NA,NA,NA,NA,NA,05/jui/2021,Positif,28.8,NA,Négatif,0.2,ONM264V4b,1,1,1,Renal,renal cancer stage IV,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM264,M,80.2,Pfizer,V5,197,NA,NA,NA,NA,NA,12/oct/2021,Positif,19.6,NA,Négatif,0.2,ONM264V5b,1,1,1,Renal,renal cancer stage IV,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM264,M,80.2,Pfizer,V6,372,123,NA,NA,NA,NA,05/avr/2022,Positif,122.9,3896,Positif,13,ONM264V6,1299.2,350.1,310.4,Renal,renal cancer stage IV,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM265,M,74.3,Pfizer,V3,29,NA,NA,NA,NA,NA,11/mai/2021,Positif,115,NA,NA,NA,ONM265V3b,287.9,98.5,62.9,Thoracic,Lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM265,M,74.3,Pfizer,V4,91,NA,NA,NA,NA,NA,12/jui/2021,Positif,46.1,NA,Négatif,0.2,ONM265V4b,75.8,34.8,23.2,Thoracic,Lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM265,M,74.3,Pfizer,V5,189,NA,NA,NA,NA,NA,18/oct/2021,Positif,27,NA,Négatif,0.3,ONM265V5b,44.3,30.9,14.4,Thoracic,Lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM265,M,74.3,Pfizer,3M3,323,69,NA,NA,NA,NA,01/mar/2022,Positif,97.4,2453,Négatif,0.4,ONM265 3M3,332.4,170.3,115.8,Thoracic,Lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM266,F,74.2,Pfizer,V3,31,NA,NA,NA,NA,NA,29/avr/2021,Positif,112.5,NA,NA,NA,ONM266V3b,363.8,166.3,96.6,Genitourinary,ovarien cancer,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM266,F,74.2,Pfizer,V4,94,NA,NA,NA,NA,NA,01/jui/2021,Positif,66.7,NA,Négatif,0.3,ONM266V4b,118.2,69.5,32.5,Genitourinary,ovarien cancer,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM266,F,74.2,Pfizer,V5,189,NA,NA,NA,NA,NA,04/oct/2021,Positif,34.5,NA,Négatif,0.2,ONM266V5b,49.1,35.8,16.5,Genitourinary,ovarien cancer,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM267,F,78.2,Pfizer,V6,364,95,NA,NA,NA,NA,28/mar/2022,Positif,89.5,2074,Négatif,0,ONM267V6,841,421.2,276.7,Sarcoma,sarcoma,No TTT.IO Stoped On 2019,NA,No,Not treated,Not treated,colitis post IO on 10.2019 treated with high dose of steroides,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM268,M,84.2,Pfizer,V3,31,NA,NA,NA,NA,NA,29/avr/2021,Positif,103.5,NA,NA,NA,ONM268V3b,234.1,110.8,48,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM268,M,84.2,Pfizer,V4,99,NA,NA,NA,NA,NA,06/jui/2021,Positif,94,NA,Négatif,0.3,ONM268V4b,159.8,72.6,45.4,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM268,M,84.2,Pfizer,V5,177,NA,NA,NA,NA,NA,22/sep/2021,Positif,73.6,NA,Négatif,0.2,ONM268V5b,133.7,59.5,48.6,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM268,M,84.2,Pfizer,3M3,366,104,NA,NA,NA,NA,30/mar/2022,Positif,91.1,2148,Négatif,0.2,ONM268 3M3,1333.7,511.2,236.4,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM269,M,87.2,Pfizer,V3,35,NA,NA,NA,NA,NA,04/mai/2021,Positif,103.9,NA,NA,NA,ONM269V3b,323.8,81.9,77.9,Hepatic,hepatocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM269,M,87.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,73.7,NA,Négatif,0.3,ONM269V4b,147.2,57.2,35.5,Hepatic,hepatocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM269,M,87.2,Pfizer,V5,196,NA,NA,NA,NA,NA,12/oct/2021,Positif,29,NA,Négatif,0.2,ONM269V5b,35.6,23.5,19.3,Hepatic,hepatocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM269,M,87.2,Pfizer,3M3,378,95,NA,NA,NA,NA,12/avr/2022,Positif,91.8,2181,Négatif,0.1,ONM269 3M3,2430,2093.8,466.2,Hepatic,hepatocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM271,F,66.3,Pfizer,V3,30,NA,NA,V5-V6,NA,NA,05/mai/2021,Positif,83.9,NA,NA,NA,ONM271V3b,758.7,268.7,105.9,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM271,F,66.3,Pfizer,V4,98,NA,NA,V5-V6,NA,NA,12/jui/2021,Positif,81.3,NA,Négatif,0.9,ONM271V4b,608.6,212.6,107.3,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM271,F,66.3,Pfizer,V5,178,NA,NA,V5-V6,NA,NA,30/sep/2021,Positif,60.6,NA,Négatif,0.9,ONM271V5b,274.6,142.2,69.2,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM271,F,66.3,Pfizer,V6,381,150,NA,V5-V6,78,NA,21/avr/2022,Positif,105.2,2859,Positif,9.3,ONM271V6,473.3,263.8,179.1,Genitourinary,endometroide ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM272,M,54.2,Pfizer,V3,35,NA,NA,NA,NA,NA,04/mai/2021,Positif,18.9,NA,NA,NA,ONM272V3b,25.5,12.6,8.8,Gastrointestinal,pancreatic ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM272,M,54.2,Pfizer,V4,98,NA,NA,NA,NA,NA,06/jui/2021,Positif,14,NA,Négatif,1,ONM272V4b,1,1,1,Gastrointestinal,pancreatic ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM272,M,54.2,Pfizer,V5,191,NA,NA,NA,NA,NA,07/oct/2021,Indéterminé,5.9,NA,Négatif,0.7,ONM272V5b,1,1,1,Gastrointestinal,pancreatic ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM272,M,54.2,Pfizer,3M3,287,84,NA,NA,NA,NA,11/jan/2022,Positif,152.8,6012,Négatif,0.4,ONM272 3M3,729.4,523.6,356.5,Gastrointestinal,pancreatic ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM272,M,54.2,Pfizer,3M6,372,169,NA,NA,NA,NA,06/avr/2022,Positif,105.9,2897,Négatif,0.1,ONM272 3M6,711.7437722419929,331.2355084465055,181.88432157148054,Gastrointestinal,pancreatic ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM273,M,75.2,Pfizer,V3,28,NA,NA,NA,NA,NA,27/avr/2021,Positif,72.1,NA,NA,NA,ONM273V3b,127.9,54.2,28.9,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM273,M,75.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,36,NA,Négatif,0.6,ONM273V4b,46.1,33.9,13.4,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM273,M,75.2,Pfizer,V5,189,NA,NA,NA,NA,NA,05/oct/2021,Positif,14.7,NA,Négatif,0.3,ONM273V5b,1,1,1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM273,M,75.2,Pfizer,3M3,300,91,NA,NA,NA,NA,24/jan/2022,Positif,105.6,2881,Négatif,0.4,ONM273 3M3,358.8,122.5,70.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM273,M,75.2,Pfizer,3M6,387,178,NA,NA,NA,NA,21/avr/2022,Positif,92.2,2200,Négatif,0.2,ONM273 3M6,218.9,117.6,77.9,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM274,F,50.2,Pfizer,V3,31,NA,NA,NA,NA,NA,30/avr/2021,Positif,129.7,NA,NA,NA,ONM274V3b,287,72.2,15.2,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,thalasemia,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM274,F,50.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,86.5,NA,Négatif,0.2,ONM274V4b,163.6,60.5,34.9,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,thalasemia,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM274,F,50.2,Pfizer,V5,195,NA,NA,NA,NA,NA,11/oct/2021,Positif,42.3,NA,Négatif,0.4,ONM274V5b,125.8,73.5,37.2,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,thalasemia,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM274,F,50.2,Pfizer,V6,377,154,NA,NA,NA,NA,11/avr/2022,Positif,98.7,2519,Négatif,0.1,ONM274V6,460,216.6,133.1,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,thalasemia,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM275,M,74.2,Pfizer,V3,30,NA,NA,NA,NA,NA,28/avr/2021,Positif,133.2,NA,NA,NA,ONM275V3b,457.2,228.3,33.9,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM275,M,74.2,Pfizer,V4,98,NA,NA,NA,NA,NA,05/jui/2021,Positif,100.2,NA,Indéterminé,4,ONM275V4b,381.1,162.9,29.8,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM275,M,74.2,Pfizer,V5,191,NA,NA,NA,NA,NA,06/oct/2021,Positif,96.3,NA,Négatif,3.8,ONM275V5b,537.9,200.9,73.7,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM275,M,74.2,Pfizer,3M3,371,105,NA,NA,NA,NA,04/avr/2022,Positif,98.1,2488,Négatif,1.4,ONM275 3M3,1262.6,336.2,90.1,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM276,F,65.2,Pfizer,V3,31,NA,NA,NA,NA,NA,30/avr/2021,Positif,96,NA,NA,NA,ONM276V3b,148.8,90.1,32.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM276,F,65.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,52,NA,Négatif,0.3,ONM276V4b,85.5,51.3,20.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM276,F,65.2,Pfizer,V5,196,NA,NA,NA,NA,NA,12/oct/2021,Positif,25.2,NA,Négatif,0.2,ONM276V5b,52.8,39.2,16.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM276,F,65.2,Pfizer,V6,379,163,NA,NA,NA,NA,13/avr/2022,Positif,98.9,2529,Négatif,3,ONM276V6,1649.6,1638.3,1390.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM277,M,57.2,Pfizer,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,41.8,NA,NA,NA,ONM277V3b,23.7,7.7,4.9,Thoracic,lung ADK,IO (ATCD: Crohn+Verneuil),Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM277,M,57.2,Pfizer,V4,93,NA,NA,NA,NA,NA,02/jui/2021,Positif,26.8,NA,Négatif,0.3,ONM277V4b,1,1,1,Thoracic,lung ADK,IO (ATCD: Crohn+Verneuil),Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM277,M,57.2,Pfizer,V5,189,NA,NA,NA,NA,NA,06/oct/2021,Positif,12.1,NA,Négatif,0.1,ONM277V5b,1,1,1,Thoracic,lung ADK,IO (ATCD: Crohn+Verneuil),Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM278,F,86.1,Pfizer,V3,29,NA,NA,NA,NA,NA,24/mar/2021,Positif,128.2,NA,NA,NA,ONM278V3b,430.8,186.8,75.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM278,F,86.1,Pfizer,V4,91,NA,NA,NA,NA,NA,25/mai/2021,Positif,87.1,NA,NA,NA,ONM278V4b,161.2,86.8,34.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM278,F,86.1,Pfizer,V5,182,NA,NA,NA,NA,NA,24/aoû/2021,Positif,45.6,NA,Négatif,1.9,ONM278V5b,135.4,92.8,35.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM278,F,86.1,Pfizer,V6,365,77,NA,NA,NA,NA,23/fév/2022,Positif,76.2,1507,Négatif,1.2,ONM278V6,982.3,455.8,326.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM280,F,61.3,Moderna,V3,29,NA,NA,NA,NA,NA,02/jun/2021,Positif,83.4,NA,NA,NA,ONM280V3b,1119.8,452.5,215.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM280,F,61.3,Moderna,V4,93,NA,NA,NA,NA,NA,05/aoû/2021,Positif,66.1,NA,Négatif,3.5,ONM280V4b,1092.5,479.8,152.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM280,F,61.3,Moderna,V5,184,NA,NA,NA,NA,NA,04/nov/2021,Positif,73.1,NA,Indéterminé,4.1,ONM280V5b,882.6,471.9,224.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM280,F,61.3,Moderna,3M3,366,104,NA,NA,NA,NA,05/mai/2022,Positif,138.6,4950,Négatif,1.9,ONM280 3M3,625.3908692933084,310.8486167236556,213.31058020477815,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM281,F,55.3,Moderna,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,77.9,NA,NA,NA,ONM281V3b,1459.2,467.3,132.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM281,F,55.3,Moderna,V4,93,NA,NA,NA,NA,NA,08/jui/2021,Positif,106.8,NA,Négatif,1.2,ONM281V4b,619.6,222.5,77.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM281,F,55.3,Moderna,V5,191,NA,NA,NA,NA,NA,14/oct/2021,Positif,78.8,NA,Négatif,1.1,ONM281V5b,410.2,183.6,77.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM281,F,55.3,Moderna,3M3,373,99,NA,NA,NA,NA,14/avr/2022,Positif,95.5,2359,Négatif,0.2,ONM281 3M3,1079.3,390.5,131.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM282,F,44.2,Pfizer,V3,27,NA,NA,NA,NA,NA,27/avr/2021,Positif,104.2,NA,NA,NA,ONM282V3b,199.1,98.2,47,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM282,F,44.2,Pfizer,V4,93,NA,NA,NA,NA,NA,02/jui/2021,Positif,71.4,NA,Négatif,0.9,ONM282V4b,135.5,65.3,38.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM282,F,44.2,Pfizer,V5,189,NA,NA,NA,NA,NA,06/oct/2021,Positif,41.1,NA,Négatif,1,ONM282V5b,97.7,46.8,20.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM282,F,44.2,Pfizer,3M3,366,99,NA,NA,NA,NA,01/avr/2022,Positif,82.2,1752,Positif,10.4,ONM282 3M3,2430,949.7,746.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM283,F,48.3,Moderna,V3,33,NA,NA,NA,NA,NA,09/jun/2021,Positif,98.4,NA,Positif,7.2,ONM283V3b,2430,2430,635.7,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM283,F,48.3,Moderna,V4,94,NA,NA,NA,NA,NA,09/aoû/2021,Positif,72.5,NA,Positif,8.6,ONM283V4b,2430,1930.9,438.6,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM283,F,48.3,Moderna,V5,185,NA,NA,NA,NA,NA,08/nov/2021,Positif,87.9,NA,Indéterminé,4.9,ONM283V5b,2430,1669.2,574.4,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM283,F,48.3,Moderna,V6,374,122,NA,NA,NA,NA,16/mai/2022,Positif,137,4837,Positif,9.5,ONM283V6,2430,1264.5,805.2,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM284,M,78.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/jun/2021,Positif,120.6,NA,NA,NA,ONM284V3b,368.6,133.1,66.1,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM284,M,78.3,Pfizer,V4,91,NA,NA,NA,NA,NA,06/aoû/2021,Positif,80.4,NA,Négatif,0.2,ONM284V4b,260.5,117.2,44,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM284,M,78.3,Pfizer,V5,179,NA,NA,NA,NA,NA,02/nov/2021,Positif,61,NA,Négatif,0.3,ONM284V5b,136.7,75.2,35.4,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM284,M,78.3,Pfizer,3M3,280,72,NA,NA,NA,NA,11/fév/2022,Positif,111.2,3192,Négatif,0.2,ONM284 3M3,615,249.5,92.3,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM284,M,78.3,Pfizer,3M6,382,174,NA,NA,NA,NA,24/mai/2022,Positif,170.4,7473,Indéterminé,5.5,ONM284 3M6,2430,2430,2015.7,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM285,M,54.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,88.5,NA,NA,NA,ONM285V3b,156.6,68.8,45.3,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM285,M,54.2,Pfizer,V4,93,NA,NA,NA,NA,NA,01/jui/2021,Positif,63.1,NA,Négatif,0.6,ONM285V4b,122.1,68.8,38.9,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM285,M,54.2,Pfizer,V5,185,NA,NA,NA,NA,NA,01/oct/2021,Positif,54.2,NA,Négatif,0.2,ONM285V5b,98.5,62.3,35.1,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM285,M,54.2,Pfizer,3M3,280,83,NA,NA,NA,NA,04/jan/2022,Positif,123.8,3953,Négatif,1.1,ONM285 3M3,1431.6,374.8,252.5,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM285,M,54.2,Pfizer,3M6,379,182,NA,NA,NA,NA,13/avr/2022,Positif,102.6,2720,Négatif,1.8,ONM285 3M6,2430,1318.7,704.2,Genitourinary,urothelial cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM286,F,73.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,80.3,NA,NA,NA,ONM286V3b,1604.6,499,140.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM286,F,73.2,Pfizer,V4,90,NA,NA,NA,NA,NA,28/jun/2021,Positif,84.7,NA,Négatif,0.3,ONM286V4b,395.4,151.8,63.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM286,F,73.2,Pfizer,V5,177,NA,NA,NA,NA,NA,23/sep/2021,Positif,59,NA,Négatif,0.3,ONM286V5b,137.1,93.8,51.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM286,F,73.2,Pfizer,V6,365,113,NA,NA,NA,NA,30/mar/2022,Positif,91.7,2176,Négatif,0,ONM286V6,845.3,544.1,264.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM289,M,62.2,Pfizer,V3,30,NA,NA,NA,NA,NA,29/avr/2021,Positif,93.5,NA,NA,NA,ONM289V3b,157.9,62.3,7.6,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM289,M,62.2,Pfizer,V4,97,NA,NA,NA,NA,NA,05/jui/2021,Positif,68.8,NA,Négatif,0.4,ONM289V4b,104.8,83.1,37.1,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM289,M,62.2,Pfizer,V5,190,NA,NA,NA,NA,NA,06/oct/2021,Positif,50.4,NA,Négatif,0.4,ONM289V5b,135.2,107.1,48.5,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM289,M,62.2,Pfizer,3M3,330,92,NA,NA,NA,NA,23/fév/2022,Positif,78.1,1583,Négatif,0.4,ONM289 3M3,249.6,176.9,99.6,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM289,M,62.2,Pfizer,3M6,420,182,NA,NA,NA,NA,24/mai/2022,Positif,118,3593,Négatif,0.4,ONM289 3M6,211.7,130.1,62.5,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM290,M,73.2,Pfizer,V3,35,NA,NA,Before V1,178,NA,04/mai/2021,Positif,82.2,NA,NA,NA,ONM290V3b,2430,1705,409.8,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM290,M,73.2,Pfizer,V4,99,NA,NA,Before V1,242,NA,07/jui/2021,Positif,111.1,NA,Positif,9.6,ONM290V4b,1195.6,535.3,167.7,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM290,M,73.2,Pfizer,V5,192,NA,NA,Before V1,335,NA,08/oct/2021,Positif,106.8,NA,Positif,6.7,ONM290V5b,758.2,285.6,113.9,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM290,M,73.2,Pfizer,3M3,378,98,NA,Before V1,521,NA,12/avr/2022,Positif,69.4,1253,Positif,16.3,ONM290 3M3,2430,1672.8,1005.5,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM291,F,41.3,Pfizer,V3,31,NA,NA,3M3-3M6,NA,NA,07/mai/2021,Positif,101.6,NA,NA,NA,ONM291V3b,417.4,237.9,75.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM291,F,41.3,Pfizer,V4,97,NA,NA,3M3-3M6,NA,NA,12/jui/2021,Positif,58.8,NA,Négatif,0.5,ONM291V4b,118.2,76.2,31,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM291,F,41.3,Pfizer,V5,181,4,NA,3M3-3M6,NA,NA,04/oct/2021,Positif,39.4,NA,Négatif,0.3,ONM291V5b,74.6,50,19.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM291,F,41.3,Pfizer,3M6,363,186,NA,3M3-3M6,65,NA,04/avr/2022,Positif,98.7,2519,Négatif,2.7,ONM291 3M6,2163.6,1203.2,570.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM292,M,69.2,Pfizer,V3,33,NA,NA,NA,NA,NA,03/mai/2021,Positif,87.1,NA,NA,NA,ONM292V3b,171,69.5,22.2,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM292,M,69.2,Pfizer,V4,96,NA,NA,NA,NA,NA,05/jui/2021,Positif,50,NA,Négatif,0.7,ONM292V4b,61.7,21.2,7.5,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM292,M,69.2,Pfizer,V5,190,NA,NA,NA,NA,NA,07/oct/2021,Positif,31.5,NA,Négatif,0.9,ONM292V5b,44.8,21.3,6.6,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM292,M,69.2,Pfizer,3M3,310,91,NA,NA,NA,NA,04/fév/2022,Positif,104.2,2805,Négatif,0.7,ONM292 3M3,565.3,208.6,116.1,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM292,M,69.2,Pfizer,3M6,408,189,NA,NA,NA,NA,13/mai/2022,Positif,160.4,6624,Indéterminé,6,ONM292 3M6,1769.9,753.6,401,Genitourinary,prostate cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM293,F,36.2,Moderna,V3,28,NA,NA,NA,NA,NA,25/mar/2021,Positif,119.8,NA,NA,NA,ONM293V3b,2430,1330.1,214.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM293,F,36.2,Moderna,V4,91,NA,NA,NA,NA,NA,27/mai/2021,Positif,101.5,NA,NA,NA,ONM293V4b,1563,730.5,186.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM293,F,36.2,Moderna,V5,181,NA,NA,NA,NA,NA,25/aoû/2021,Positif,81.2,NA,Négatif,2.5,ONM293V5b,965.3,424.6,118.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM293,F,36.2,Moderna,3M3,392,85,NA,NA,NA,NA,24/mar/2022,Positif,108,3012,Négatif,0.8,ONM293 3M3,937.2,454.3,201.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM294,F,74.2,Pfizer,V3,34,NA,NA,NA,NA,NA,03/mai/2021,Positif,86.4,NA,NA,NA,ONM294V3b,761.6,310.9,100,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM294,F,74.2,Pfizer,V4,99,NA,NA,NA,NA,NA,07/jui/2021,Positif,107.7,NA,Négatif,0.9,ONM294V4b,410.7,157.2,61.7,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM294,F,74.2,Pfizer,V5,197,NA,NA,NA,NA,NA,13/oct/2021,Positif,56,NA,Négatif,0.6,ONM294V5b,206,97,42.4,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM294,F,74.2,Pfizer,3M3,379,114,NA,NA,NA,NA,13/avr/2022,Positif,101.6,2668,Positif,12.3,ONM294 3M3,2430,2430,1340.3,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM296,M,78.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,55.7,NA,NA,NA,ONM296V3b,102.1,43,26.3,Genitourinary,prostate cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM296,M,78.3,Pfizer,V4,99,NA,NA,NA,NA,NA,14/jui/2021,Positif,29.4,NA,Négatif,0.1,ONM296V4b,49.8,30.6,11.7,Genitourinary,prostate cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM296,M,78.3,Pfizer,V5,185,NA,NA,NA,NA,NA,08/oct/2021,Positif,26.2,NA,Négatif,0.1,ONM296V5b,1,1,1,Genitourinary,prostate cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM296,M,78.3,Pfizer,V6,386,113,NA,NA,NA,NA,27/avr/2022,Positif,129.6,4330,Négatif,0,ONM296V6,395.4,80.1,51.4,Genitourinary,prostate cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM297,F,61.3,Pfizer,V3,28,NA,NA,NA,NA,NA,12/mai/2021,Positif,132.2,NA,NA,NA,ONM297V3b,1248.6,498.3,233.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM297,F,61.3,Pfizer,V4,92,NA,NA,NA,NA,NA,15/jui/2021,Positif,59.9,NA,Indéterminé,5,ONM297V4b,949.7,439,186.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM297,F,61.3,Pfizer,V5,190,NA,NA,NA,NA,NA,21/oct/2021,Positif,79.1,NA,Négatif,3.4,ONM297V5b,683.1,305.1,170.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM297,F,61.3,Pfizer,3M3,378,112,NA,NA,NA,NA,27/avr/2022,Positif,122.2,3852,Négatif,1.4,ONM297 3M3,2430,863.6,598.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM300,F,56.2,Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,30/avr/2021,Positif,122.8,NA,NA,NA,ONM300V3b,413.6,202.1,28.6,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM300,F,56.2,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,06/jui/2021,Positif,97.9,NA,Négatif,0.3,ONM300V4b,427.7,216.5,75.2,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM300,F,56.2,Pfizer,V5,187,NA,NA,V5-3M3,NA,NA,04/oct/2021,Positif,71.5,NA,Négatif,0.2,ONM300V5b,281,189.4,54.6,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM300,F,56.2,Pfizer,3M3,363,105,NA,V5-3M3,47,NA,29/mar/2022,Positif,121.3,3795,Positif,8.2,ONM300 3M3,2430,2430,1962.7,Gastrointestinal,coecal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM301,F,57.3,Pfizer,V3,29,NA,NA,NA,NA,NA,07/mai/2021,Positif,93.4,NA,NA,NA,ONM301V3b,352.6,120,54.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM301,F,57.3,Pfizer,V4,88,NA,NA,NA,NA,NA,05/jui/2021,Positif,90,NA,Négatif,0.3,ONM301V4b,181.8,74,34.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM301,F,57.3,Pfizer,V5,183,NA,NA,NA,NA,NA,08/oct/2021,Positif,57.2,NA,Négatif,0.5,ONM301V5b,60.6,37.8,19.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM302,F,52.2,Pfizer,V3,34,NA,NA,NA,NA,NA,04/mai/2021,Positif,76.6,NA,NA,NA,ONM302V3b,57.9,25.9,3.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM302,F,52.2,Pfizer,V4,92,NA,NA,NA,NA,NA,01/jui/2021,Positif,38.1,NA,Négatif,1.8,ONM302V4b,71,38,13.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM302,F,52.2,Pfizer,V5,194,NA,NA,NA,NA,NA,11/oct/2021,Positif,17.8,NA,Négatif,1.2,ONM302V5b,38,32.4,12.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM302,F,52.2,Pfizer,3M3,289,85,NA,NA,NA,NA,14/jan/2022,Positif,88.2,2014,Négatif,1.6,ONM302 3M3,414.1,155.3,62.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM302,F,52.2,Pfizer,3M6,378,174,NA,NA,NA,NA,13/avr/2022,Positif,104,2794,Indéterminé,4.9,ONM302 3M6,2430,1176.5,504.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM303,F,59.2,Moderna,V3,28,NA,NA,NA,NA,NA,26/mar/2021,Positif,117.7,NA,NA,NA,ONM303V3b,1043.6,409,157.2,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM303,F,59.2,Moderna,V4,84,NA,NA,NA,NA,NA,21/mai/2021,Positif,143.7,NA,NA,NA,ONM303V4b,710.2,267.2,96.8,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM303,F,59.2,Moderna,V5,180,NA,NA,NA,NA,NA,25/aoû/2021,Positif,81.6,NA,Négatif,0.1,ONM303V5b,394.5,149.2,78.6,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM303,F,59.2,Moderna,3M3,411,99,NA,NA,NA,NA,13/avr/2022,Positif,100.6,2616,Négatif,0,ONM303 3M3,2430,1802.5,527.1,Breast,breast cancer,Adjuvant Hormonotherapy: Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM304,F,67.2,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,03/mai/2021,Positif,57.5,NA,NA,NA,ONM304V3b,94.4,53.9,7.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM304,F,67.2,Pfizer,V4,85,NA,NA,V5-3M3,NA,NA,24/jun/2021,Positif,32.3,NA,Négatif,0.3,ONM304V4b,45.2,32.6,5.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM304,F,67.2,Pfizer,V5,187,NA,NA,V5-3M3,NA,NA,04/oct/2021,Positif,18.1,NA,Négatif,0.2,ONM304V5b,1,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM304,F,67.2,Pfizer,3M3,370,105,NA,V5-3M3,7,NA,05/avr/2022,Positif,124.2,3978,Négatif,0.2,ONM304 3M3,397.8,288.4,147.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM305,F,74.2,Pfizer,V3,34,NA,NA,NA,NA,NA,04/mai/2021,Positif,104.9,NA,NA,NA,ONM305V3b,229.5,31.4,5.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM305,F,74.2,Pfizer,V4,93,NA,NA,NA,NA,NA,02/jui/2021,Positif,67.8,NA,Négatif,0.1,ONM305V4b,184.9,53.6,29.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM305,F,74.2,Pfizer,V5,191,NA,NA,NA,NA,NA,08/oct/2021,Positif,33.7,NA,Négatif,0.1,ONM305V5b,11.6,1,1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM306,M,63.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,72,NA,NA,NA,ONM306V3b,2430,1669.4,596.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM306,M,63.3,Pfizer,V4,91,NA,NA,NA,NA,NA,06/jui/2021,Positif,91.6,NA,Négatif,2,ONM306V4b,2312.7,1085.3,359.5,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM306,M,63.3,Pfizer,V5,188,NA,NA,NA,NA,NA,11/oct/2021,Positif,64.3,NA,Négatif,2.1,ONM306V5b,1085.4,587.5,248.6,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM306,M,63.3,Pfizer,3M3,370,75,NA,NA,NA,NA,11/avr/2022,Positif,98.7,2519,Positif,20.2,ONM306 3M3,1363.7,848.2,446.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM307,M,45.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,79.9,NA,NA,NA,ONM307V3b,306.5,77.5,9.6,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,hypothryoiditis post IO,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM307,M,45.3,Pfizer,V4,98,NA,NA,NA,NA,NA,13/jui/2021,Positif,82.4,NA,Négatif,0.6,ONM307V4b,71.1,21.9,3,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,hypothryoiditis post IO,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM307,M,45.3,Pfizer,V5,182,NA,NA,NA,NA,NA,05/oct/2021,Positif,49.1,NA,Négatif,0.4,ONM307V5b,123.4,85,34.1,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,hypothryoiditis post IO,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM307,M,45.3,Pfizer,3M3,275,79,NA,NA,NA,NA,06/jan/2022,Positif,109.4,3090,Négatif,0.5,ONM307 3M3,534.2,258.5,125.1,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,hypothryoiditis post IO,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM307,M,45.3,Pfizer,3M6,364,168,NA,NA,NA,NA,05/avr/2022,Positif,101.4,2657,Négatif,0.1,ONM307 3M6,171.5,140.3,58.9,Skin,melanoma,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,hypothryoiditis post IO,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM308,M,42.3,Pfizer,3M6,364,190,NA,NA,NA,NA,05/avr/2022,Positif,63.2,1041,Négatif,0,ONM308 3M6,95.1,77.3,30.2,Gastrointestinal,GIST,TKIs,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM309,M,52.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,79,NA,NA,NA,ONM309V3b,851.8,378.9,128,Genitourinary,tumeur germinale testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM309,M,52.3,Pfizer,V4,98,NA,NA,NA,NA,NA,13/jui/2021,Positif,84.5,NA,Négatif,0.6,ONM309V4b,310,128.3,60.1,Genitourinary,tumeur germinale testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM309,M,52.3,Pfizer,V5,196,NA,NA,NA,NA,NA,19/oct/2021,Positif,65.1,NA,Négatif,2.1,ONM309V5b,105.4,59,36.6,Genitourinary,tumeur germinale testiculaire,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM310,M,52.3,Pfizer,V4,94,NA,NA,NA,NA,NA,12/jui/2021,Positif,73.4,NA,Négatif,2.4,ONM310V4b,2209.9,1063.4,351.7,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM310,M,52.3,Pfizer,V5,189,NA,NA,NA,NA,NA,15/oct/2021,Positif,93.7,NA,Indéterminé,4.9,ONM310V5b,1714.7,809.1,358.2,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM310,M,52.3,Pfizer,V6,367,NA,NA,NA,NA,NA,11/avr/2022,Positif,96.9,2428,Négatif,2.1,ONM310V6,2430,1579,582.4,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM311,F,58.3,Pfizer,V3,32,NA,NA,NA,NA,NA,10/mai/2021,Positif,89.1,NA,NA,NA,ONM311V3b,494.3,126.6,49.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM311,F,58.3,Pfizer,V4,96,NA,NA,NA,NA,NA,13/jui/2021,Positif,86.7,NA,Négatif,0.1,ONM311V4b,478,124.5,48.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM311,F,58.3,Pfizer,V5,193,NA,NA,NA,NA,NA,18/oct/2021,Positif,68.2,NA,Négatif,0.1,ONM311V5b,200.1,89.2,33.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM311,F,58.3,Pfizer,V6,368,116,NA,NA,NA,NA,11/avr/2022,Positif,98.8,2524,Négatif,0.1,ONM311V6,2028.4,659.6,330.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM312,M,70.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,100.3,NA,NA,NA,ONM312V3b,570.8,272,86.5,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM312,M,70.3,Pfizer,V4,93,NA,NA,NA,NA,NA,08/jui/2021,Positif,101.3,NA,Négatif,0.3,ONM312V4b,219.6,139.1,38.6,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM312,M,70.3,Pfizer,V5,192,NA,NA,NA,NA,NA,15/oct/2021,Positif,60.3,NA,Négatif,0.4,ONM312V5b,138.6,92,33.7,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM312,M,70.3,Pfizer,3M3,372,113,NA,NA,NA,NA,13/avr/2022,Positif,102.5,2715,Négatif,0,ONM312 3M3,1176.5,517.6,173,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM313,M,79.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,77.2,NA,NA,NA,ONM313V3b,483.6,209.6,122.2,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM313,M,79.3,Pfizer,V4,92,NA,NA,NA,NA,NA,07/jui/2021,Positif,80.8,NA,Négatif,0,ONM313V4b,147.5,33.1,13.3,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM313,M,79.3,Pfizer,V5,181,NA,NA,NA,NA,NA,04/oct/2021,Positif,47.3,NA,Négatif,0,ONM313V5b,92.4,28.6,9.5,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM313,M,79.3,Pfizer,3M3,311,95,NA,NA,NA,NA,11/fév/2022,Positif,109.8,3113,Négatif,0.1,ONM313 3M3,417.4,204.3,107.2,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM313,M,79.3,Pfizer,3M6,398,182,NA,NA,NA,NA,09/mai/2022,Positif,166.3,7119,Négatif,1.8,ONM313 3M6,1457.9384749963551,1081.6657652785289,853.9709649871904,Sarcoma,liposarcoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM315,F,46.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,76.8,NA,NA,NA,ONM315V3b,635.7,163.6,84.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM315,F,46.3,Pfizer,V4,98,NA,NA,NA,NA,NA,13/jui/2021,Positif,80.7,NA,Négatif,2.8,ONM315V4b,226.6,78.9,39.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM315,F,46.3,Pfizer,V5,184,NA,NA,NA,NA,NA,07/oct/2021,Positif,55.7,NA,Négatif,3.6,ONM315V5b,184.3,93.6,44.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM315,F,46.3,Pfizer,3M3,365,112,NA,NA,NA,NA,06/avr/2022,Positif,106.9,2952,Négatif,1.4,ONM315 3M3,433.1,221.3,105.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM316,F,62.2,Moderna,V3,31,NA,NA,NA,NA,NA,01/avr/2021,Positif,142.6,NA,NA,NA,ONM316V3b,563.7,191.6,47,Breast,breast cancer,Hormonotherapy Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM316,F,62.2,Moderna,V4,98,NA,NA,NA,NA,NA,07/jun/2021,Positif,113.8,NA,NA,NA,ONM316V4b,185.7,90.5,33.4,Breast,breast cancer,Hormonotherapy Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM316,F,62.2,Moderna,V5,182,NA,NA,NA,NA,NA,30/aoû/2021,Positif,55.6,NA,Négatif,0.2,ONM316V5b,86.5,55.4,10.7,Breast,breast cancer,Hormonotherapy Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM316,F,62.2,Moderna,V6,373,69,NA,NA,NA,NA,09/mar/2022,Positif,99,2534,Positif,8.1,ONM316V6,2430,2430,2430,Breast,breast cancer,Hormonotherapy Letrozole,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Letrozole,L02BG04,"NA"
ONM318,M,75.2,Pfizer,V3,28,NA,NA,NA,NA,NA,26/mar/2021,Positif,113.6,NA,NA,NA,ONM318V3b,628.9,361.3,109.1,Genitourinary,prostate cancer,Hormonotherapy: Firmagon,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Firmagon,Firmagon,L02BX02,L02BX02
ONM318,M,75.2,Pfizer,V4,96,NA,NA,NA,NA,NA,02/jun/2021,Positif,100.4,NA,NA,NA,ONM318V4b,195.4,141.5,41.4,Genitourinary,prostate cancer,Hormonotherapy: Firmagon,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Firmagon,Firmagon,L02BX02,L02BX02
ONM318,M,75.2,Pfizer,V5,180,NA,NA,NA,NA,NA,25/aoû/2021,Positif,43.2,NA,Négatif,0,ONM318V5b,150,127.9,36.3,Genitourinary,prostate cancer,Hormonotherapy: Firmagon,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Firmagon,Firmagon,L02BX02,L02BX02
ONM318,M,75.2,Pfizer,3M3,364,92,NA,NA,NA,NA,25/fév/2022,Positif,99.7,2570,Négatif,3.1,ONM318 3M3,24943.9,7662.8,7501.9,Genitourinary,prostate cancer,Hormonotherapy: Firmagon,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Firmagon,Firmagon,L02BX02,L02BX02
ONM318,M,75.2,Pfizer,3M6,451,179,NA,NA,NA,NA,23/mai/2022,Positif,154.1,6115,Négatif,1.5,ONM318 3M6,2430,2430,2430,Genitourinary,prostate cancer,Hormonotherapy: Firmagon,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Firmagon,Firmagon,L02BX02,L02BX02
ONM319,F,65.3,Pfizer,V3,33,NA,NA,NA,NA,NA,10/mai/2021,Positif,104.8,NA,NA,NA,ONM319V3b,457.5,178.1,63.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM319,F,65.3,Pfizer,V4,91,NA,NA,NA,NA,NA,07/jui/2021,Positif,106.3,NA,Négatif,0,ONM319V4b,264.8,129,46.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM319,F,65.3,Pfizer,V5,197,NA,NA,NA,NA,NA,21/oct/2021,Positif,51.9,NA,Négatif,0.1,ONM319V5b,138.9,77,48,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM319,F,65.3,Pfizer,3M3,379,121,NA,NA,NA,NA,21/avr/2022,Positif,106.3,2919,Négatif,0,ONM319 3M3,540.5,254.6,175.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM320,F,71.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,97.6,NA,NA,NA,ONM320V3b,164.3,74.2,37.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM320,F,71.3,Pfizer,V4,93,NA,NA,NA,NA,NA,08/jui/2021,Positif,68.4,NA,Négatif,0.3,ONM320V4b,93,42.4,28.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM320,F,71.3,Pfizer,V5,190,NA,NA,NA,NA,NA,13/oct/2021,Positif,25.2,NA,Négatif,0.2,ONM320V5b,63.3,37.8,20.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM320,F,71.3,Pfizer,3M3,328,94,NA,NA,NA,NA,28/fév/2022,Positif,100.9,2631,Négatif,0.3,ONM320 3M3,375.5,174.4,85.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM320,F,71.3,Pfizer,3M6,420,186,NA,NA,NA,NA,31/mai/2022,Positif,121.3,3795,Négatif,0.3,ONM320 3M6,235.7,100.1,44.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM321,F,75.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,45.9,NA,NA,NA,ONM321V3b,63,23.4,14.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM321,F,75.3,Pfizer,V4,98,NA,NA,NA,NA,NA,13/jui/2021,Positif,43,NA,Négatif,0.2,ONM321V4b,69.2,29,20.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM321,F,75.3,Pfizer,V5,195,NA,NA,NA,NA,NA,18/oct/2021,Positif,29.6,NA,Négatif,0.2,ONM321V5b,45.3,27,16,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM321,F,75.3,Pfizer,3M3,378,117,NA,NA,NA,NA,19/avr/2022,Positif,97.2,2443,Négatif,0.1,ONM321 3M3,977.5,449,225.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM322,F,63.3,Pfizer,V3,33,NA,NA,NA,NA,NA,11/mai/2021,Positif,114.1,NA,NA,NA,ONM322V3b,676.1,254.6,116.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM322,F,63.3,Pfizer,V4,92,NA,NA,NA,NA,NA,09/jui/2021,Positif,98.6,NA,Négatif,0.5,ONM322V4b,263.6,135.7,42.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM322,F,63.3,Pfizer,V5,190,NA,NA,NA,NA,NA,15/oct/2021,Positif,80.1,NA,Négatif,0.8,ONM322V5b,185.6,92.3,60.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM322,F,63.3,Pfizer,3M3,337,97,NA,NA,NA,NA,11/mar/2022,Positif,104.9,2843,Négatif,0.3,ONM322 3M3,537.3,310.6,191.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM324,M,65.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,84.1,NA,NA,NA,ONM324V3b,424.8,198.2,47.5,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM324,M,65.3,Pfizer,V4,93,NA,NA,NA,NA,NA,08/jui/2021,Positif,99.8,NA,Négatif,0.1,ONM324V4b,210.7,120.7,32.1,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM324,M,65.3,Pfizer,V5,182,NA,NA,NA,NA,NA,05/oct/2021,Positif,45.6,NA,Négatif,0.1,ONM324V5b,123.9,75.5,26.3,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM324,M,65.3,Pfizer,V6,364,167,NA,NA,NA,NA,05/avr/2022,Positif,123,3902,Négatif,0,ONM324V6,407.8,155.5,78.6,Thoracic,SCC lung,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM325,F,52.3,Pfizer,V3,29,NA,NA,Before 3M3 after 3rd dose,NA,NA,11/mai/2021,Positif,134.2,NA,NA,NA,ONM325V3b,396.4,136.7,43.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM325,F,52.3,Pfizer,V5,183,NA,NA,Before 3M3 after 3rd dose,NA,NA,12/oct/2021,Positif,56.1,NA,Négatif,1.3,ONM325V5b,129.9,74.2,39.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM325,F,52.3,Pfizer,3M3,309,81,NA,Before 3M3 after 3rd dose,31,NA,15/fév/2022,Positif,99.5,2559,Négatif,3.1,ONM325 3M3,4750.6,1486.1,694,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM325,F,52.3,Pfizer,3M6,406,178,NA,Before 3M3 after 3rd dose,128,NA,23/mai/2022,Positif,148.1,5649,Négatif,2.8,ONM325 3M6,2430,1329.8,606.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM326,M,70.3,Pfizer,V3,31,NA,NA,NA,NA,NA,07/mai/2021,Positif,96.3,NA,NA,NA,ONM326V3b,360.2,132.3,28.3,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,TKIS: Imatinib stopped in 12.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM326,M,70.3,Pfizer,V4,92,NA,NA,NA,NA,NA,07/jui/2021,Positif,106,NA,Négatif,0.1,ONM326V4b,267,136,55.1,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,TKIS: Imatinib stopped in 12.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM326,M,70.3,Pfizer,V5,192,NA,NA,NA,NA,NA,15/oct/2021,Positif,76.2,NA,Négatif,0.2,ONM326V5b,147.4,95.3,43.3,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,TKIS: Imatinib stopped in 12.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM326,M,70.3,Pfizer,3M3,371,99,NA,NA,NA,NA,12/avr/2022,Positif,90.8,2134,Négatif,0.1,ONM326 3M3,1099.1,465.5,247.8,Gastrointestinal,GIST,No TTT,NA,No,Not treated,Not treated,TKIS: Imatinib stopped in 12.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM327,F,49.3,Pfizer,V3,32,NA,NA,NA,NA,NA,10/mai/2021,Positif,103.5,NA,NA,NA,ONM327V3b,435.2,158.6,63.1,Endocrine,desmoide tumor,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM327,F,49.3,Pfizer,V4,95,NA,NA,NA,NA,NA,12/jui/2021,Positif,57.8,NA,Négatif,0.1,ONM327V4b,67.6,21.8,4.5,Endocrine,desmoide tumor,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM327,F,49.3,Pfizer,V5,189,NA,NA,NA,NA,NA,14/oct/2021,Positif,37.4,NA,Négatif,0.2,ONM327V5b,75.8,49.6,28.6,Endocrine,desmoide tumor,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM327,F,49.3,Pfizer,3M3,309,100,NA,NA,NA,NA,11/fév/2022,Positif,105.8,2891,Négatif,0.1,ONM327 3M3,189.9,81.8,50,Endocrine,desmoide tumor,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM327,F,49.3,Pfizer,3M6,391,182,NA,NA,NA,NA,04/mai/2022,Positif,140.1,5057,Négatif,2.9,ONM327 3M6,853.2423208191126,316.9572107765452,402.4144869215292,Endocrine,desmoide tumor,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM328,F,45.5,Moderna,V3,30,NA,NA,NA,NA,NA,27/jui/2021,Positif,80.1,NA,Négatif,0.8,ONM328V3b,686.8,269.2,124,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM328,F,45.5,Moderna,V4,93,NA,NA,NA,NA,NA,28/sep/2021,Positif,81.7,NA,Négatif,0.7,ONM328V4,399.5,179.3,95.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM328,F,45.5,Moderna,V5,169,NA,NA,NA,NA,NA,13/déc/2021,Positif,91.9,2186,Négatif,0.7,ONM328V5b,104.2,43.8,17.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM328,F,45.5,Moderna,3M3,331,114,NA,NA,NA,NA,24/mai/2022,Positif,156.1,6274,Négatif,0.7,ONM328 3M3,2119.1,594.9,376.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM329,F,57.3,Pfizer,V3,29,NA,NA,NA,NA,NA,25/mai/2021,Positif,94.2,NA,NA,NA,ONM329V3b,752.4,330.9,190.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM329,F,57.3,Pfizer,V4,91,NA,NA,NA,NA,NA,26/jui/2021,Positif,85.8,NA,Indéterminé,4.1,ONM329V4b,577,248.1,151.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM329,F,57.3,Pfizer,V5,169,NA,NA,NA,NA,NA,12/oct/2021,Positif,68.5,NA,Négatif,2.7,ONM329V5b,970.9,514.9,335.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM329,F,57.3,Pfizer,3M3,365,78,NA,NA,NA,NA,26/avr/2022,Positif,156.8,6330,Négatif,0.8,ONM329 3M3,437.1,196.8,148.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM330,M,66.3,Pfizer,V3,29,NA,NA,NA,NA,NA,05/mai/2021,Positif,98.6,NA,NA,NA,ONM330V3b,125.8,41.3,5.3,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM330,M,66.3,Pfizer,V4,99,NA,NA,NA,NA,NA,14/jui/2021,Positif,35.5,NA,Négatif,0.2,ONM330V4b,76,37.1,15.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM330,M,66.3,Pfizer,V5,196,NA,NA,NA,NA,NA,19/oct/2021,Positif,20.9,NA,Négatif,0.2,ONM330V5b,48.8,40.3,17.7,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM330,M,66.3,Pfizer,3M3,287,77,NA,NA,NA,NA,18/jan/2022,Positif,112.1,3244,Négatif,0.3,ONM330 3M3,200.2,106.3,69.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM330,M,66.3,Pfizer,3M6,393,183,NA,NA,NA,NA,04/mai/2022,Positif,68.4,1217,Négatif,0,ONM330 3M6,96.99321047526674,44.208664898320066,32.88391976323578,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM331,F,72.3,Pfizer,V3,32,NA,NA,V5-V6,NA,NA,11/mai/2021,Positif,123.6,NA,NA,NA,ONM331V3b,787.4,328.6,116.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM331,F,72.3,Pfizer,V4,91,NA,NA,V5-V6,NA,NA,09/jui/2021,Positif,100.6,NA,Négatif,0.1,ONM331V4b,215.9,110,47.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM331,F,72.3,Pfizer,V5,189,NA,NA,V5-V6,NA,NA,15/oct/2021,Positif,54.9,NA,Négatif,0.1,ONM331V5b,99.1,69,35.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM331,F,72.3,Pfizer,V6,377,149,NA,V5-V6,98,NA,21/avr/2022,Positif,83.6,1811,Positif,18.4,ONM331V6,1786.7,1280.1,592.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM332,M,80.3,Pfizer,V3,30,NA,NA,NA,NA,NA,07/mai/2021,Positif,97.7,NA,NA,NA,ONM332V3b,258.4,118,49,Skin,SCC skin,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM332,M,80.3,Pfizer,V4,98,NA,NA,NA,NA,NA,14/jui/2021,Positif,49.1,NA,Négatif,1.8,ONM332V4b,90.1,47.4,18.2,Skin,SCC skin,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM332,M,80.3,Pfizer,V5,180,NA,NA,NA,NA,NA,04/oct/2021,Positif,35.6,NA,Négatif,1.6,ONM332V5b,63.6,37.5,12.9,Skin,SCC skin,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM332,M,80.3,Pfizer,3M3,322,90,NA,NA,NA,NA,23/fév/2022,Positif,79.3,1631,Négatif,3.4,ONM332 3M3,491.2,236.6,156.3,Skin,SCC skin,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM333,M,79.3,Pfizer,V3,30,NA,NA,NA,NA,NA,07/mai/2021,Positif,98.6,NA,NA,NA,ONM333V3b,254,102.1,52.9,Other,Chordoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM333,M,79.3,Pfizer,V4,92,NA,NA,NA,NA,NA,08/jui/2021,Positif,87.4,NA,Négatif,0.3,ONM333V4b,146.6,58.4,30.5,Other,Chordoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM333,M,79.3,Pfizer,V5,195,NA,NA,NA,NA,NA,19/oct/2021,Positif,37.2,NA,Négatif,0.3,ONM333V5b,60.6,34.5,16.7,Other,Chordoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM333,M,79.3,Pfizer,3M3,321,75,NA,NA,NA,NA,22/fév/2022,Positif,84.4,1846,Négatif,0.4,ONM333 3M3,379.2,123.8,117.6,Other,Chordoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM334,F,47.3,Pfizer,V3,30,NA,NA,NA,NA,NA,07/mai/2021,Positif,88.1,NA,NA,NA,ONM334V3b,569.2,186.6,93.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM334,F,47.3,Pfizer,V4,85,NA,NA,NA,NA,NA,01/jui/2021,Positif,81.6,NA,Négatif,0.3,ONM334V4b,231.3,93.2,35.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM334,F,47.3,Pfizer,V5,191,NA,NA,NA,NA,NA,15/oct/2021,Positif,50.4,NA,Négatif,0.3,ONM334V5b,99.7,55.1,26.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM334,F,47.3,Pfizer,3M3,372,108,NA,NA,NA,NA,14/avr/2022,Positif,94.4,2305,Négatif,0.4,ONM334 3M3,813.7,378.6,187.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM335,F,92.3,Pfizer,V3,33,NA,NA,NA,NA,NA,10/mai/2021,Positif,68.8,NA,NA,NA,ONM335V3b,79.7,49.2,20.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM335,F,92.3,Pfizer,V4,91,NA,NA,NA,NA,NA,07/jui/2021,Positif,48.8,NA,Négatif,0.4,ONM335V4b,50.3,36.4,19.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM335,F,92.3,Pfizer,V5,190,NA,NA,NA,NA,NA,14/oct/2021,Positif,25.4,NA,Négatif,0.5,ONM335V5b,48.3,36.4,16.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM335,F,92.3,Pfizer,V6,379,126,NA,NA,NA,NA,21/avr/2022,Positif,99.5,2559,Négatif,0.2,ONM335V6,213.7,123,79.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM336,M,73.3,Pfizer,V3,30,NA,NA,NA,NA,NA,12/mai/2021,Positif,149.5,NA,NA,NA,ONM336V3b,2430,1025.6,494.8,Gastrointestinal,cholangiocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM336,M,73.3,Pfizer,V4,86,NA,NA,NA,NA,NA,07/jui/2021,Positif,109.5,NA,Négatif,0.4,ONM336V4b,1097.7,417.7,199.8,Gastrointestinal,cholangiocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM336,M,73.3,Pfizer,V5,177,NA,NA,NA,NA,NA,06/oct/2021,Positif,95.6,NA,Négatif,0.6,ONM336V5b,695.9,264.2,176.3,Gastrointestinal,cholangiocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM336,M,73.3,Pfizer,V6,386,NA,NA,NA,NA,NA,03/mai/2022,Positif,178,8153,Négatif,0.3,ONM336 V6,828.5004142502072,279.09572983533354,148.52220406950838,Gastrointestinal,cholangiocarcinoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM337,F,54.3,Pfizer,V3,34,NA,NA,NA,NA,NA,11/mai/2021,Positif,114.3,NA,NA,NA,ONM337V3b,612.7,163,57,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM337,F,54.3,Pfizer,V4,90,NA,NA,NA,NA,NA,06/jui/2021,Positif,94.7,NA,Négatif,0.3,ONM337V4b,330,112.4,52.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM337,F,54.3,Pfizer,V5,188,NA,NA,NA,NA,NA,12/oct/2021,Positif,65.8,NA,Négatif,0.2,ONM337V5b,380.7,190.9,90.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM337,F,54.3,Pfizer,V6,377,129,NA,NA,NA,NA,19/avr/2022,Positif,77.3,1551,Négatif,0,ONM337V6,1751.3,974.7,652.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM338,F,75.3,Pfizer,V3,33,NA,NA,NA,NA,NA,12/mai/2021,Positif,117.2,NA,NA,NA,ONM338V3b,855.4,374.1,157.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM338,F,75.3,Pfizer,V4,97,NA,NA,NA,NA,NA,15/jui/2021,Positif,64.3,NA,Négatif,2.8,ONM338V4b,663.6,253.7,109.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM338,F,75.3,Pfizer,V5,194,NA,NA,NA,NA,NA,20/oct/2021,Positif,86.2,NA,Indéterminé,4.9,ONM338V5b,312,168,69.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM338,F,75.3,Pfizer,3M3,306,91,NA,NA,NA,NA,09/fév/2022,Positif,102,2689,Négatif,2.7,ONM338 3M3,570.8,278.9,192.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM338,F,75.3,Pfizer,3M6,397,182,NA,NA,NA,NA,11/mai/2022,Positif,142.3,5217,Négatif,1.7,ONM338 3M6,376.2227238525207,203.99836801305588,126.10340479192939,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM339,M,61.3,Pfizer,V3,33,NA,NA,NA,NA,NA,10/mai/2021,Positif,110.7,NA,NA,NA,ONM339V3b,276.5,97.9,46.5,Sarcoma,osteosarcoma,No TTT,NA,No,Not treated,Not treated,RT end date : 09.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM339,M,61.3,Pfizer,V4,92,NA,NA,NA,NA,NA,08/jui/2021,Positif,80.4,NA,Négatif,0.5,ONM339V4b,95.7,42.8,20.7,Sarcoma,osteosarcoma,No TTT,NA,No,Not treated,Not treated,RT end date : 09.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM339,M,61.3,Pfizer,V5,191,NA,NA,NA,NA,NA,15/oct/2021,Positif,46.2,NA,Négatif,0.4,ONM339V5b,58.1,36.6,16.8,Sarcoma,osteosarcoma,No TTT,NA,No,Not treated,Not treated,RT end date : 09.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM339,M,61.3,Pfizer,3M3,316,96,NA,NA,NA,NA,17/fév/2022,Positif,120,3715,Négatif,0.3,ONM339 3M3,298.5,144.2,108.4,Sarcoma,osteosarcoma,No TTT,NA,No,Not treated,Not treated,RT end date : 09.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM339,M,61.3,Pfizer,3M6,398,178,NA,NA,NA,NA,10/mai/2022,Positif,131.5,4458,Négatif,0.2,ONM339 3M6,251.7623363544814,103.35917312661499,96.43201542912246,Sarcoma,osteosarcoma,No TTT,NA,No,Not treated,Not treated,RT end date : 09.2020,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM340,F,75.3,Pfizer,V3,30,NA,NA,NA,NA,NA,12/mai/2021,Positif,158,NA,NA,NA,ONM340V3b,254.8,113.2,18.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM340,F,75.3,Pfizer,V4,84,NA,NA,NA,NA,NA,05/jui/2021,Positif,78.4,NA,Négatif,0.1,ONM340V4b,163.7,82.6,32.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM340,F,75.3,Pfizer,V5,172,NA,NA,NA,NA,NA,01/oct/2021,Positif,71.5,NA,Négatif,0.1,ONM340V5b,63.1,47.3,24.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM340,F,75.3,Pfizer,3M3,364,117,NA,NA,NA,NA,11/avr/2022,Positif,97.7,2468,Négatif,0.1,ONM340 3M3,136.7,87.9,46,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM341,M,46.3,Pfizer,V3,28,NA,NA,NA,NA,NA,12/mai/2021,Positif,126.5,NA,NA,NA,ONM341V3b,682.1,185.8,65.4,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM341,M,46.3,Pfizer,V4,91,NA,NA,NA,NA,NA,14/jui/2021,Positif,71.4,NA,Négatif,0.1,ONM341V4b,287.4,107.2,47,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM341,M,46.3,Pfizer,V5,190,NA,NA,NA,NA,NA,21/oct/2021,Positif,63,NA,Négatif,0.1,ONM341V5b,152.7,69.7,44.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM341,M,46.3,Pfizer,3M3,364,119,NA,NA,NA,NA,13/avr/2022,Positif,100.6,2616,Négatif,2.8,ONM341 3M3,2430,2430,713.8,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM343,F,48.8,Pfizer,V3,NA,NA,NA,V1-V2,59,NA,12/mai/2021,Positif,22.1,NA,NA,NA,ONM343V3b,62.4,25.5,10.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM343,F,48.8,Pfizer,V4,NA,NA,NA,V1-V2,124,NA,16/jui/2021,Positif,34.4,NA,Indéterminé,5.1,ONM343V4b,68.7,29.1,12.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM343,F,48.8,Pfizer,V5,NA,NA,NA,V1-V2,197,NA,27/sep/2021,Positif,30.4,NA,Négatif,2.5,ONM343V5b,56.4,30.7,11.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM343,F,48.8,Pfizer,3M3,183,59,NA,V1-V2,390,NA,08/avr/2022,Positif,111.3,3198,Négatif,0.7,ONM343 3M3,406,232.9,112.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM344,F,49.3,Pfizer,V3,33,NA,NA,V5-V6,sérologie 22.12.2021,NA,11/mai/2021,Positif,111.4,NA,NA,NA,ONM344V3b,597.7,278.6,84.8,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM344,F,49.3,Pfizer,V4,97,NA,NA,V5-V6,sérologie 22.12.2021,NA,14/jui/2021,Positif,72.1,NA,Négatif,0.1,ONM344V4b,337.3,144.2,46.8,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM344,F,49.3,Pfizer,V5,188,NA,NA,V5-V6,sérologie 22.12.2021,NA,13/oct/2021,Positif,70.1,NA,Négatif,0.2,ONM344V5b,166.7,88.3,46.9,Thoracic,lung cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM345,F,68.3,Pfizer,V3,33,NA,NA,NA,NA,NA,11/mai/2021,Positif,127,NA,NA,NA,ONM345V3b,189.1,103.4,47.6,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM345,F,68.3,Pfizer,V4,96,NA,NA,NA,NA,NA,13/jui/2021,Positif,65.4,NA,Négatif,0.1,ONM345V4b,141,70,28.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM345,F,68.3,Pfizer,V5,187,NA,NA,NA,NA,NA,12/oct/2021,Positif,38.6,NA,Négatif,0.1,ONM345V5b,105.2,72.6,26.6,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM345,F,68.3,Pfizer,V6,376,148,NA,NA,NA,NA,19/avr/2022,Positif,94.9,2330,Négatif,0.1,ONM345V6,596.3,229.9,129.3,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM346,M,70.3,Pfizer,V3,28,NA,NA,NA,NA,NA,05/mai/2021,Positif,104.1,NA,NA,NA,ONM346V3b,250.1,80.5,36.4,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM346,M,70.3,Pfizer,V4,93,NA,NA,NA,NA,NA,09/jui/2021,Positif,80.8,NA,Négatif,0.1,ONM346V4b,109.7,48.3,17.2,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM346,M,70.3,Pfizer,V5,196,NA,NA,NA,NA,NA,20/oct/2021,Positif,42.9,NA,Négatif,0.1,ONM346V5b,83.1,27,8.9,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM346,M,70.3,Pfizer,3M3,329,100,NA,NA,NA,NA,02/mar/2022,Positif,89.2,2060,Négatif,0,ONM346 3M3,161.7,64.9,34.1,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM346,M,70.3,Pfizer,3M6,406,177,NA,NA,NA,NA,18/mai/2022,Positif,78.8,1611,Négatif,0,ONM346 3M6,98.7,31.2,18.5,Thoracic,oesophagal ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM347,F,51.3,Pfizer,V3,33,NA,NA,NA,NA,NA,12/mai/2021,Positif,121.2,NA,NA,NA,ONM347V3,443.1,114.1,23.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM347,F,51.3,Pfizer,V4,96,NA,NA,NA,NA,NA,14/jui/2021,Positif,67.3,NA,Négatif,0.2,ONM347V4b,178,77.5,44.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM347,F,51.3,Pfizer,V5,194,NA,NA,NA,NA,NA,20/oct/2021,Positif,68.2,NA,Négatif,0.2,ONM347V5b,205.8,128.4,84.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM347,F,51.3,Pfizer,3M3,360,115,NA,NA,NA,NA,04/avr/2022,Positif,95.4,2354,Négatif,0.2,ONM347 3M3,1042.6,544.7,306.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM348,F,72.3,Pfizer,V3,31,NA,NA,NA,NA,NA,03/jun/2021,Positif,118.2,NA,NA,NA,ONM348V3b,618.8,251.4,140.4,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM348,F,72.3,Pfizer,V4,94,NA,NA,NA,NA,NA,05/aoû/2021,Positif,58.3,NA,Négatif,0.6,ONM348V4b,227.9,101.6,44.9,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM348,F,72.3,Pfizer,V5,185,NA,NA,NA,NA,NA,04/nov/2021,Positif,44.3,NA,Négatif,0.8,ONM348V5b,82.4,53.8,29.1,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM348,F,72.3,Pfizer,V6,365,152,NA,NA,NA,NA,03/mai/2022,Positif,130,4357,Négatif,0.1,ONM348 V6,331.6749585406302,172.08742040956807,130.70186903672723,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM349,F,56.3,Pfizer,V3,35,NA,NA,NA,NA,NA,14/mai/2021,Positif,105.3,NA,NA,NA,ONM349V3b,413.6,202.1,28.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM349,F,56.3,Pfizer,V4,98,NA,NA,NA,NA,NA,16/jui/2021,Positif,84,NA,Négatif,0.2,ONM349V4b,278.6,120.3,52.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM349,F,56.3,Pfizer,V5,185,NA,NA,NA,NA,NA,11/oct/2021,Positif,51.9,NA,Négatif,0.8,ONM349V5b,122.7,75.1,34,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM349,F,56.3,Pfizer,3M3,343,91,NA,NA,NA,NA,18/mar/2022,Positif,79.4,1635,Négatif,0,ONM349 3M3,2063.1,849.6,613.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,12/mai/2021,Positif,125.3,NA,NA,NA,ONM350V3b,75.2,19.3,1.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,15/jui/2021,Positif,47.2,NA,Négatif,0.6,ONM350V4b,38.8,9.3,1.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,V5,175,NA,NA,V5-3M3,NA,NA,01/oct/2021,Positif,42.1,NA,Négatif,0.5,ONM350V5b,1,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,V5+,297,69,NA,V5-3M3,25,NA,31/jan/2022,Positif,104.7,2832,Positif,9.3,ONM350V5+,933.7,271.1,138.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,3M3,320,92,NA,V5-3M3,48,NA,23/fév/2022,Positif,81.2,1710,Positif,7,ONM350 3M3,1005.6,369.8,255.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM350,F,65.3,Pfizer,3M6,409,181,NA,V5-3M3,137,NA,23/mai/2022,Positif,159.8,6574,Indéterminé,4.9,ONM350 3M6,573.1,141.3,67.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM351,F,74.3,Pfizer,V3,33,NA,NA,NA,NA,NA,11/mai/2021,Positif,123,NA,NA,NA,ONM351V3b,167.2,75.5,36,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM351,F,74.3,Pfizer,V4,91,NA,NA,NA,NA,NA,08/jui/2021,Positif,76.5,NA,Négatif,1.2,ONM351V4b,88,53.5,21.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM351,F,74.3,Pfizer,V5,173,NA,NA,NA,NA,NA,28/sep/2021,Positif,36.1,NA,Négatif,1.2,ONM351V5b,55.4,33.6,8.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM351,F,74.3,Pfizer,3M3,365,92,NA,NA,NA,NA,08/avr/2022,Positif,114.8,3401,Négatif,0.8,ONM351 3M3,460.6,231.1,114.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM352,M,73.3,Pfizer,V3,31,NA,NA,V5-V6,?. 11.2021,NA,25/mai/2021,Positif,97.3,NA,NA,NA,ONM352V3b,766.9,395.7,162.8,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM352,M,73.3,Pfizer,V4,96,NA,NA,V5-V6,?. 11.2021,NA,29/jui/2021,Positif,79.1,NA,Négatif,0.3,ONM352V4b,329.3,145.5,56.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM352,M,73.3,Pfizer,V5,193,NA,NA,V5-V6,?. 11.2021,NA,03/nov/2021,Positif,59.1,NA,Négatif,0.4,ONM352V5b,112.1,68.2,40.4,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM352,M,73.3,Pfizer,V6,381,NA,NA,V5-V6,?. 11.2021,NA,10/mai/2022,Positif,150.1,5802,Négatif,2.5,ONM352 V6,2552.3226135783566,2271.6946842344387,494.07114624505925,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM353,F,43.3,Pfizer,V3,33,NA,NA,NA,NA,NA,12/mai/2021,Positif,137.8,NA,NA,NA,ONM353V3b,78.6,22.1,7.4,Breast,breast cancer,Hormonotherapy (ATCD Lupus),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM353,F,43.3,Pfizer,V4,97,NA,NA,NA,NA,NA,15/jui/2021,Positif,38.5,NA,Négatif,0.4,ONM353V4b,18.7,4.4,0.4,Breast,breast cancer,Hormonotherapy (ATCD Lupus),Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM355,F,39.3,Pfizer,V3,33,NA,NA,V5-3M3,NA,NA,12/mai/2021,Positif,110.4,NA,NA,NA,ONM355V3b,292.6,81.3,40.1,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM355,F,39.3,Pfizer,V4,97,NA,NA,V5-3M3,NA,NA,15/jui/2021,Positif,45.7,NA,Négatif,0.8,ONM355V4b,89,36.1,13.7,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM355,F,39.3,Pfizer,V5,195,NA,NA,V5-3M3,NA,NA,21/oct/2021,Positif,22,NA,Négatif,0.9,ONM355V5b,38.4,28.6,13.8,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM355,F,39.3,Pfizer,3M3,381,112,NA,V5-3M3,4,NA,25/avr/2022,Positif,131.9,4485,Négatif,0.1,ONM355 3M3,221.3,72.5,64,Genitourinary,cervical cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM356,F,64.3,Pfizer,V3,33,NA,NA,V5-V6,NA,NA,12/mai/2021,Positif,121.5,NA,NA,NA,ONM356V3b,82.8,27.6,3,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM356,F,64.3,Pfizer,V4,91,NA,NA,V5-V6,NA,NA,09/jui/2021,Positif,60.6,NA,Négatif,0.9,ONM356V4b,24.2,7.9,2.1,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM356,F,64.3,Pfizer,V5,180,NA,NA,V5-V6,NA,NA,06/oct/2021,Positif,31.9,NA,Négatif,2.2,ONM356V5b,1,1,1,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM356,F,64.3,Pfizer,V6,378,127,NA,V5-V6,62,NA,22/avr/2022,Positif,87.7,1992,Négatif,3.1,ONM356V6,1807,1017.3,510.5,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM357,F,59.2,Moderna,3M3,371,96,NA,NA,NA,NA,07/mar/2022,Positif,111.3,3198,Négatif,0,ONM357 3M3,741.3,269.9,228.9,Thoracic,lung ADK stage IV,Chemo+Double IO (Start Date: 12.03.2021),Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM357,F,59.2,Moderna,3M6,456,181,NA,NA,NA,NA,31/mai/2022,Positif,122.4,3864,Négatif,0.3,ONM357 3M6,727.8,277.2,199.8,Thoracic,lung ADK stage IV,Chemo+Double IO (Start Date: 12.03.2021),Chemotherapy + Immune checkpoint inhibitor,NA,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM358,F,54.3,Pfizer,V6,378,124,NA,NA,NA,NA,25/avr/2022,Positif,130.3,4377,Négatif,0.1,ONM358V6,789.9,501.5,239.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM359,F,74.3,Pfizer,V3,32,NA,NA,NA,NA,NA,14/mai/2021,Positif,97.4,NA,NA,NA,ONM359V3b,235.8,118.7,45.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM359,F,74.3,Pfizer,V4,94,NA,NA,NA,NA,NA,15/jui/2021,Positif,34.3,NA,Négatif,0.4,ONM359V4b,69.4,33.9,10.5,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM359,F,74.3,Pfizer,V5,191,NA,NA,NA,NA,NA,20/oct/2021,Positif,27.2,NA,Négatif,0.1,ONM359V5b,26.3,20.5,7.2,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM359,F,74.3,Pfizer,V6,379,131,NA,NA,NA,NA,26/avr/2022,Positif,160.6,6640,Positif,12.4,ONM359V6,1791.2,1087.5,989.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM360,F,68.3,Pfizer,V3,30,NA,NA,NA,NA,NA,12/mai/2021,Positif,128.2,NA,NA,NA,ONM360V3b,822.4,389.7,117.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM360,F,68.3,Pfizer,V4,94,NA,NA,NA,NA,NA,15/jui/2021,Positif,65.3,NA,Négatif,0.1,ONM360V4b,353.4,140.9,51,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM360,F,68.3,Pfizer,V5,171,NA,NA,NA,NA,NA,30/sep/2021,Positif,53.3,NA,Négatif,0.1,ONM360V5b,116.9,75.2,30.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM360,F,68.3,Pfizer,3M3,282,96,NA,NA,NA,NA,19/jan/2022,Positif,102.6,2720,Négatif,0.1,ONM360 3M3,914.9,526.9,265.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM360,F,68.3,Pfizer,3M6,372,186,NA,NA,NA,NA,19/avr/2022,Positif,97.1,2438,Négatif,0,ONM360 3M6,492.9,325.3,164,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM361,M,46.3,Pfizer,V3,30,NA,NA,3M3-3M6,NA,NA,12/mai/2021,Positif,98.7,NA,NA,NA,ONM361V3b,189,60.6,35.1,Gastrointestinal,GIST,TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM361,M,46.3,Pfizer,V4,92,NA,NA,3M3-3M6,NA,NA,13/jui/2021,Positif,59,NA,Négatif,0.1,ONM361V4b,93,37,17.2,Gastrointestinal,GIST,TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM361,M,46.3,Pfizer,V5,190,NA,NA,3M3-3M6,NA,NA,19/oct/2021,Positif,40.7,NA,Négatif,0.3,ONM361V5b,63.9,38,16.9,Gastrointestinal,GIST,TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM361,M,46.3,Pfizer,3M3,281,61,NA,3M3-3M6,NA,NA,18/jan/2022,Positif,110.4,3147,Négatif,0.1,ONM361 3M3,174.2,61.7,39.4,Gastrointestinal,GIST,TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM361,M,46.3,Pfizer,3M6,393,173,NA,3M3-3M6,21,NA,10/mai/2022,Positif,147.2,5581,Négatif,3.7,ONM361 3M6,299.4011976047904,178.826895565093,130.63357282821684,Gastrointestinal,GIST,TKIS,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM362,F,48.3,Pfizer,V3,31,NA,NA,V5-V6,NA,NA,12/mai/2021,Positif,108.1,NA,NA,NA,ONM362V3b,353.9,129.7,29.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM362,F,48.3,Pfizer,V4,86,NA,NA,V5-V6,NA,NA,06/jui/2021,Positif,94.8,NA,Négatif,0.3,ONM362V4b,236.6,102.9,54.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM362,F,48.3,Pfizer,V5,180,NA,NA,V5-V6,NA,NA,08/oct/2021,Positif,77.9,NA,Négatif,0.2,ONM362V5b,49.7,18.5,4.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM362,F,48.3,Pfizer,V5+,261,NA,NA,V5-V6,13,NA,28/déc/2021,Positif,48.6,620,Négatif,0.1,ONM362V5+b,67.7,35,18.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM362,F,48.3,Pfizer,V6,366,NA,NA,V5-V6,118,NA,12/avr/2022,Positif,36.3,350,Négatif,0.1,ONM362V6,23.2,3.6,0.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM363,F,53.3,Pfizer,V3,31,NA,NA,NA,NA,NA,21/mai/2021,Positif,135.5,NA,NA,NA,ONM363V3b,555.6,125.2,32.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM363,F,53.3,Pfizer,V4,87,NA,NA,NA,NA,NA,16/jui/2021,Positif,72.8,NA,Négatif,0.6,ONM363V4b,256.5,98,36.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM363,F,53.3,Pfizer,V5,188,NA,NA,NA,NA,NA,25/oct/2021,Positif,56.5,NA,Négatif,1.3,ONM363V5b,135.8,53.9,18.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM363,F,53.3,Pfizer,3M3,272,62,NA,NA,NA,NA,17/jan/2022,Positif,129.3,4310,Négatif,0.3,ONM363 3M3,510.5,146.2,101.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM363,F,53.3,Pfizer,3M6,385,175,NA,NA,NA,NA,10/mai/2022,Positif,129.1,4297,Négatif,0.2,ONM363 3M6,311.91515907673113,110.98779134295226,81.63265306122449,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM364,F,66.3,Pfizer,V3,30,NA,NA,V5-3M3,NA,NA,14/mai/2021,Positif,119.6,NA,NA,NA,ONM364V3b,91.4,23.8,10.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM364,F,66.3,Pfizer,V4,99,NA,NA,V5-3M3,NA,NA,22/jui/2021,Positif,63,NA,Négatif,0.2,ONM364V4b,95.7,46.2,28.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM364,F,66.3,Pfizer,V5,194,NA,NA,V5-3M3,NA,NA,25/oct/2021,Positif,49.6,NA,Négatif,0.2,ONM364V5b,33.3,12.8,5.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM364,F,66.3,Pfizer,3M3,342,91,NA,V5-3M3,25,NA,22/mar/2022,Positif,98.1,2488,Indéterminé,4.1,ONM364 3M3,1028.6,493.3,442.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM365,F,70.3,Pfizer,V3,29,NA,NA,NA,NA,NA,12/mai/2021,Positif,49.9,NA,NA,NA,ONM365V3b,57.6,21.8,12.5,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM365,F,70.3,Pfizer,V4,91,NA,NA,NA,NA,NA,13/jui/2021,Positif,20.8,NA,Négatif,0.6,ONM365V4b,28.2,14.1,5.3,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM365,F,70.3,Pfizer,V5,188,NA,NA,NA,NA,NA,18/oct/2021,Positif,14.7,NA,Négatif,0.8,ONM365V5b,1,1,1,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM365,F,70.3,Pfizer,V6,393,159,NA,NA,NA,NA,11/mai/2022,Positif,114.8,3401,Positif,11.1,ONM365 V6,1639.0755613833796,760.4562737642585,584.1121495327103,Genitourinary,ovarien cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM367,F,58.3,Pfizer,V6,379,110,NA,V5-V6,4,NA,27/avr/2022,Positif,132.1,4498,Négatif,0.4,ONM367V6,1084,438.2,315.6,Breast,breast+cortico surrenalien cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM368,F,47.3,Pfizer,V3,31,NA,NA,V5-3M3,NA,NA,14/mai/2021,Positif,129.2,NA,NA,NA,ONM368V3b,374,106,49.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM368,F,47.3,Pfizer,V4,91,NA,NA,V5-3M3,NA,NA,13/jui/2021,Positif,81.8,NA,Négatif,0.1,ONM368V4b,161.3,61.4,36,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM368,F,47.3,Pfizer,V5,189,NA,NA,V5-3M3,NA,NA,19/oct/2021,Positif,61.5,NA,Négatif,0.1,ONM368V5b,107.7,65.3,31.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM368,F,47.3,Pfizer,3M3,378,106,NA,V5-3M3,49,NA,26/avr/2022,Positif,114.7,3395,Positif,18,ONM368 3M3,2430,2160.8,1323.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM369,F,81.3,Pfizer,V3,31,NA,NA,NA,NA,NA,21/mai/2021,Positif,146.5,NA,NA,NA,ONM369V3b,424.6,173.5,18,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM369,F,81.3,Pfizer,V4,84,NA,NA,NA,NA,NA,13/jui/2021,Positif,82.5,NA,Négatif,0.4,ONM369V4b,338.8,150.3,53.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM369,F,81.3,Pfizer,V5,195,NA,NA,NA,NA,NA,01/nov/2021,Positif,54.3,NA,Négatif,0.4,ONM369V5b,166.2,89,34.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM369,F,81.3,Pfizer,3M3,398,89,NA,NA,NA,NA,23/mai/2022,Positif,130.4,4384,Négatif,0.2,ONM369 3M3,800.6,400,308.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM370,F,49.3,Pfizer,V3,31,NA,NA,3M3-3M6,NA,NA,10/mai/2021,Positif,99.3,NA,NA,NA,ONM370V3b,164.9,39.9,19.1,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM370,F,49.3,Pfizer,V4,96,NA,NA,3M3-3M6,NA,NA,14/jui/2021,Positif,66.7,NA,Négatif,0.6,ONM370V4b,148.9,62.4,29.1,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM370,F,49.3,Pfizer,V5,178,NA,NA,3M3-3M6,NA,NA,04/oct/2021,Positif,53.9,NA,Négatif,0.7,ONM370V5b,101.9,98.4,43.2,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM370,F,49.3,Pfizer,3M3,283,93,NA,3M3-3M6,NA,NA,17/jan/2022,Positif,123.9,3959,Négatif,0.4,ONM370 3M3,828.5,371.9,139.4,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM370,F,49.3,Pfizer,3M6,367,177,NA,3M3-3M6,25,NA,11/avr/2022,Positif,74.6,1445,Positif,19.6,ONM370 3M6,2430,2430,1810,Breast,breast cancer,Adjuvant Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM371,F,66.3,Pfizer,V3,30,NA,NA,NA,NA,NA,14/mai/2021,Positif,122.4,NA,NA,NA,ONM371V3b,1143.5,454.5,121.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM371,F,66.3,Pfizer,V4,93,NA,NA,NA,NA,NA,16/jui/2021,Positif,83.6,NA,Négatif,0.8,ONM371V4b,445.2,166.2,64.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM371,F,66.3,Pfizer,V5,191,NA,NA,NA,NA,NA,22/oct/2021,Positif,52,NA,Négatif,0.8,ONM371V5b,135.9,63.7,33,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM371,F,66.3,Pfizer,3M3,302,92,NA,NA,NA,NA,10/fév/2022,Positif,105,2848,Négatif,0.4,ONM371 3M3,314.8,182.8,120,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM371,F,66.3,Pfizer,3M6,390,180,NA,NA,NA,NA,09/mai/2022,Positif,125.4,4055,Négatif,0.1,ONM371 3M6,181.55410312273057,93.1098696461825,63.69426751592357,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM372,F,47.3,Moderna,3M3,356,115,NA,NA,NA,NA,14/avr/2022,Positif,94,2286,Négatif,0.1,ONM372 3M3,430.3,162,106.1,Thoracic,lung ADK,IO,Immune checkpoint inhibitor ICI,NA,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM373,F,56.3,Pfizer,V3,34,NA,NA,NA,NA,NA,18/mai/2021,Positif,112.3,NA,NA,NA,ONM373V3b,284.1,109.9,59.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM373,F,56.3,Pfizer,V4,91,NA,NA,NA,NA,NA,14/jui/2021,Positif,65.9,NA,Négatif,0.4,ONM373V4b,254.9,156.1,61.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM373,F,56.3,Pfizer,V5,188,NA,NA,NA,NA,NA,19/oct/2021,Positif,49.5,NA,Négatif,0.4,ONM373V5b,100,67.5,26.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM373,F,56.3,Pfizer,3M3,321,91,NA,NA,NA,NA,01/mar/2022,Positif,97.6,2463,Négatif,0.7,ONM373 3M3,523,207.8,152.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM373,F,56.3,Pfizer,3M6,411,181,NA,NA,NA,NA,30/mai/2022,Positif,117.9,3587,Indéterminé,5,ONM373 3M6,2430,1055.3,721.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM374,F,55.3,Pfizer,V3,30,NA,NA,NA,NA,NA,14/mai/2021,Positif,129.5,NA,NA,NA,ONM374V3b,394,137.8,55.4,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM374,F,55.3,Pfizer,V4,100,NA,NA,NA,NA,NA,23/jui/2021,Positif,67.7,NA,Négatif,0.4,ONM374V4b,226.5,99.1,38.7,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM374,F,55.3,Pfizer,V5,187,NA,NA,NA,NA,NA,18/oct/2021,Positif,52.2,NA,Négatif,0.3,ONM374V5b,133.7,66.4,33.6,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM374,F,55.3,Pfizer,3M3,352,99,NA,NA,NA,NA,01/avr/2022,Positif,92.1,2195,Négatif,0.2,ONM374 3M3,244.8,165.2,105.5,Gastrointestinal,colon cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM375,M,80.1,Pfizer,V3,29,NA,NA,3M3-3M6,NA,NA,23/mar/2021,Positif,62.4,NA,NA,NA,ONM375V3b,78.1,21.4,13.6,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM375,M,80.1,Pfizer,V4,99,NA,NA,3M3-3M6,NA,NA,01/jun/2021,Positif,28.2,NA,NA,NA,ONM375V4b,26.6,11.8,6.9,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM375,M,80.1,Pfizer,V5,184,NA,NA,3M3-3M6,NA,NA,25/aoû/2021,Positif,7.9,NA,Négatif,0.1,ONM375V5b,1,1,1,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM375,M,80.1,Pfizer,3M3,303,103,NA,3M3-3M6,NA,NA,22/déc/2021,Positif,80.7,1689,Négatif,0.1,ONM375 3M3b,80.5,8.5,5.1,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM375,M,80.1,Pfizer,3M6,382,182,NA,3M3-3M6,68,NA,11/mar/2022,Positif,107,2957,Indéterminé,6,ONM375 3M6,2001.6,201.6,167.1,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM376,M,62.3,Pfizer,V3,31,NA,NA,NA,NA,NA,20/mai/2021,Positif,90.5,NA,NA,NA,ONM376V3b,412.5,167.2,90.6,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM376,M,62.3,Pfizer,V4,98,NA,NA,NA,NA,NA,26/jui/2021,Positif,59.6,NA,Négatif,0.2,ONM376V4b,123.8,58.7,28.7,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM376,M,62.3,Pfizer,V5,190,NA,NA,NA,NA,NA,26/oct/2021,Positif,27,NA,Négatif,1,ONM376V5b,58.1,41.9,17.5,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM376,M,62.3,Pfizer,3M3,344,112,NA,NA,NA,NA,29/mar/2022,Positif,123.2,3915,Négatif,0.1,ONM376 3M3,924.2,422.5,232.5,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM377,F,46.3,Pfizer,V3,29,NA,NA,NA,NA,NA,18/mai/2021,Positif,102,NA,NA,NA,ONM377V3b,1011.5,198.5,121.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM377,F,46.3,Pfizer,V4,95,NA,NA,NA,NA,NA,23/jui/2021,Positif,66.1,NA,Négatif,1.7,ONM377V4b,318.5,60,41.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM377,F,46.3,Pfizer,V5,197,NA,NA,NA,NA,NA,02/nov/2021,Positif,45.3,NA,Négatif,0.8,ONM377V5b,165,43.7,23.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM377,F,46.3,Pfizer,3M3,344,105,NA,NA,NA,NA,29/mar/2022,Positif,120.7,3758,Positif,8.2,ONM377 3M3,597,224.1,251.2,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM378,F,71.3,Pfizer,V3,29,NA,NA,NA,NA,NA,18/mai/2021,Positif,84.6,NA,NA,NA,ONM378V3b,91.3,41.7,4.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM378,F,71.3,Pfizer,V4,98,NA,NA,NA,NA,NA,26/jui/2021,Positif,82.4,NA,Négatif,0.5,ONM378V4b,66,31.7,3.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM378,F,71.3,Pfizer,V5,190,NA,NA,NA,NA,NA,26/oct/2021,Positif,45.4,NA,Négatif,0.4,ONM378V5b,30.2,13.2,3.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM378,F,71.3,Pfizer,3M3,338,90,NA,NA,NA,NA,23/mar/2022,Positif,69.6,1260,Négatif,0.3,ONM378 3M3,603.9,304.2,149.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM379,F,59.3,Pfizer,V3,33,NA,NA,NA,NA,NA,17/mai/2021,Positif,97.1,NA,NA,NA,ONM379V3b,416.5,159.5,61.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM379,F,59.3,Pfizer,V4,96,NA,NA,NA,NA,NA,19/jui/2021,Positif,68.2,NA,Négatif,0.2,ONM379V4b,171.3,74.2,30.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM379,F,59.3,Pfizer,V5,180,NA,NA,NA,NA,NA,11/oct/2021,Positif,51,NA,Négatif,0.2,ONM379V5b,96.7,55.3,27,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM379,F,59.3,Pfizer,3M3,327,91,NA,NA,NA,NA,07/mar/2022,Positif,111.3,3198,Négatif,0.1,ONM379 3M3,1251.3,409.8,212.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM380,F,62.3,Pfizer,V3,33,NA,NA,NA,NA,NA,19/mai/2021,Positif,97.5,NA,NA,NA,ONM380V3b,540.2,206.6,44.8,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM380,F,62.3,Pfizer,V4,89,NA,NA,NA,NA,NA,14/jui/2021,Positif,64.3,NA,Négatif,0.7,ONM380V4b,204.3,98.4,33.2,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM380,F,62.3,Pfizer,V5,187,NA,NA,NA,NA,NA,20/oct/2021,Positif,63.4,NA,Négatif,0.8,ONM380V5b,121.9,84.2,36.8,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM380,F,62.3,Pfizer,3M3,355,112,NA,NA,NA,NA,06/avr/2022,Positif,105.2,2859,Négatif,0.5,ONM380 3M3,2430,1643.1,591.7,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM381,F,55.4,Moderna,V3,30,NA,NA,V5-V6,NA,NA,24/jun/2021,Positif,80.9,NA,Négatif,3.2,ONM381V3b,817.7,251.1,64.1,Genitourinary,endometre ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM381,F,55.4,Moderna,V4,94,NA,NA,V5-V6,NA,NA,27/aoû/2021,Positif,76.8,NA,Négatif,2.9,ONM381V4b,262.4,120.8,47.4,Genitourinary,endometre ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM381,F,55.4,Moderna,V5,185,NA,NA,V5-V6,NA,NA,26/nov/2021,Positif,73.9,NA,Indéterminé,4.3,ONM381V5b,132.3,67.9,32.6,Genitourinary,endometre ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM381,F,55.4,Moderna,V6,373,NA,NA,V5-V6,149,NA,02/jun/2022,Positif,208.8,11213,Positif,9.9,ONM381 V6,971.8172983479107,564.3340857787811,469.2632566870014,Genitourinary,endometre ADK,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM382,F,68.3,Pfizer,V3,31,NA,NA,NA,NA,NA,20/mai/2021,Positif,99.6,NA,NA,NA,ONM382V3b,415.1,220.8,42.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM382,F,68.3,Pfizer,V4,95,NA,NA,NA,NA,NA,23/jui/2021,Positif,44.4,NA,Négatif,0.1,ONM382V4b,91.3,58.9,16.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM382,F,68.3,Pfizer,V5,182,NA,NA,NA,NA,NA,18/oct/2021,Positif,23.6,NA,Négatif,0.1,ONM382V5b,42.3,42.3,11.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM382,F,68.3,Pfizer,3M3,324,77,NA,NA,NA,NA,09/mar/2022,Positif,84.5,1850,Indéterminé,4,ONM382 3M3,1702.1,1166.5,641,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM383,F,71.3,Pfizer,3M3,372,120,NA,NA,NA,NA,26/avr/2022,Positif,160.2,6607,Négatif,0.1,ONM383 3M3,513.6,156.2,91.7,Gastrointestinal,GIST,Tkis,Tyrosine kinase inhibitor TKI,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM384,F,59.3,Pfizer,3M3,346,104,NA,NA,NA,NA,01/avr/2022,Positif,72.3,1358,Négatif,0.1,ONM384 3M3,1586.3,569.2,357.8,Gastrointestinal,colon cancer,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,V3,30,NA,NA,V5-3M3/3M3-3M6,NA,NA,20/mai/2021,Positif,91.7,NA,NA,NA,ONM385V3b,530.5,195.2,134.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,V4,92,NA,NA,V5-3M3/3M3-3M6,NA,NA,21/jui/2021,Positif,66.9,NA,Négatif,0.1,ONM385V4b,182.3,78.2,39.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,V5,190,NA,NA,V5-3M3/3M3-3M6,NA,NA,27/oct/2021,Positif,32.1,NA,Négatif,0.2,ONM385V5b,39.4,24.5,12.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,V5+,276,24,NA,V5-3M3/3M3-3M6,11,NA,21/jan/2022,Positif,125.8,4081,Négatif,0.1,ONM385V5+,1196.2,365.5,168.4,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,3M3,350,98,NA,V5-3M3/3M3-3M6,85,NA,05/avr/2022,Positif,118,3593,Négatif,0,ONM385 3M3,257.4,123.1,82.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM385,F,70.3,Pfizer,3M3+,373,121,NA,V5-3M3/3M3-3M6,108,13,28/avr/2022,Positif,132.2,4505,Négatif,3.9,ONM385 3M3+,941.6,423.4,253.9,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM386,F,61.3,Pfizer,V3,36,NA,NA,NA,NA,NA,25/mai/2021,Positif,98.3,NA,NA,NA,ONM386V3b,284.1,109.9,59.7,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM386,F,61.3,Pfizer,V4,93,NA,NA,NA,NA,NA,21/jui/2021,Positif,66.6,NA,Négatif,0.4,ONM386V4b,169.9,77.8,37.5,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM386,F,61.3,Pfizer,V5,189,NA,NA,NA,NA,NA,25/oct/2021,Positif,50.8,NA,Négatif,0.4,ONM386V5b,65.5,45.2,19.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM386,F,61.3,Pfizer,3M3,378,101,NA,NA,NA,NA,02/mai/2022,Positif,151.9,5942,Négatif,0.2,ONM386 3M3,1113.7097672346588,343.4065934065934,267.8810608090008,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM387,F,60.3,Pfizer,V3,28,NA,NA,NA,NA,NA,17/mai/2021,Positif,102.5,NA,NA,NA,ONM387V3b,636.5,233.6,103,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM387,F,60.3,Pfizer,V4,95,NA,NA,NA,NA,NA,23/jui/2021,Positif,78.9,NA,Négatif,2.1,ONM387V4b,279.4,123.5,52.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM387,F,60.3,Pfizer,V5,196,NA,NA,NA,NA,NA,01/nov/2021,Positif,44.2,NA,Négatif,1.6,ONM387V5b,161.7,78.7,42,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM387,F,60.3,Pfizer,V6,358,126,NA,NA,NA,NA,12/avr/2022,Positif,94.3,2300,Négatif,0.7,ONM387V6,406.2,168.7,118,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM388,F,47.3,Pfizer,V3,29,NA,NA,V5-V6,NA,NA,18/mai/2021,Positif,90.2,NA,NA,NA,ONM388V3b,687.8,251,101.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM388,F,47.3,Pfizer,V4,93,NA,NA,V5-V6,NA,NA,21/jui/2021,Positif,71.6,NA,Positif,7.6,ONM388V4b,406.3,163.3,71.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM388,F,47.3,Pfizer,V5,182,NA,NA,V5-V6,NA,NA,18/oct/2021,Positif,70.1,NA,Positif,9.3,ONM388V5b,182.9,87.9,53.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM388,F,47.3,Pfizer,V5+,330,67,NA,V5-V6,64,NA,15/mar/2022,Positif,76.9,1535,Positif,10,ONM388 V5+,2430,642.2607578676943,706.7137809187279,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM388,F,47.3,Pfizer,V6,379,116,NA,V5-V6,113,NA,03/mai/2022,Positif,177.5,8107,Positif,9.5,ONM388 V6,1661.1295681063123,458.9261128958238,422.8329809725159,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM389,F,67.3,Pfizer,3M3,398,115,NA,NA,NA,NA,23/mai/2022,Positif,138.1,4914,Négatif,0.6,ONM389 3M3,260.6,153.9,66.3,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM390,F,58.3,Pfizer,V3,32,NA,NA,NA,NA,NA,21/mai/2021,Positif,143.3,NA,NA,NA,ONM390V3b,574.4,211.6,65.6,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM390,F,58.3,Pfizer,V4,95,NA,NA,NA,NA,NA,23/jui/2021,Positif,80.8,NA,Négatif,0.1,ONM390V4b,274.7,130.4,55.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM390,F,58.3,Pfizer,V5,190,NA,NA,NA,NA,NA,26/oct/2021,Positif,64.3,NA,Négatif,0.1,ONM390V5b,137.1,68.4,38,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM390,F,58.3,Pfizer,3M3,379,112,NA,NA,NA,NA,03/mai/2022,Positif,137.2,4851,Négatif,1.4,ONM390 3M3,2093.364036005861,1118.4431271669835,825.0825082508251,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM391,F,72.3,Pfizer,V3,25,NA,NA,NA,NA,NA,14/mai/2021,Positif,104.7,NA,NA,NA,ONM391V3b,2430,2430,635.7,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM391,F,72.3,Pfizer,V4,86,NA,NA,NA,NA,NA,14/jui/2021,Positif,69.6,NA,Négatif,0.4,ONM391V4b,230.7,102.7,47.8,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM391,F,72.3,Pfizer,V5,190,NA,NA,NA,NA,NA,26/oct/2021,Positif,33.3,NA,Négatif,0.4,ONM391V5b,54.1,33.2,16.1,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM391,F,72.3,Pfizer,3M3,326,119,NA,NA,NA,NA,11/mar/2022,Positif,106.8,2946,Négatif,0.2,ONM391 3M3,607.2,332.8,164,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM391,F,72.3,Pfizer,3M6,400,193,NA,NA,NA,NA,24/mai/2022,Positif,160.7,6648,Négatif,0.3,ONM391 3M6,549.5,242.9,125.6,Genitourinary,endometre ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM392,M,71.3,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,28/mai/2021,Négatif,0.4,NA,NA,NA,ONM392V3b,1,1,1,Thoracic,lung ADK +Lymphoma,IO (ATCD: Rituximab En 07. 2020),anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Rituximab,Rituximab,L01FA01,L01FA01
ONM392,M,71.3,Pfizer,V4,92,NA,NA,V5-3M3,NA,NA,27/jui/2021,Négatif,0.2,NA,Négatif,0,ONM392V4b,1,6.9,1.5,Thoracic,lung ADK +Lymphoma,IO (ATCD: Rituximab En 07. 2020),anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Rituximab,Rituximab,L01FA01,L01FA01
ONM392,M,71.3,Pfizer,V5,190,7,NA,V5-3M3,NA,NA,02/nov/2021,Négatif,0.1,NA,Négatif,0,ONM392V5b,1,1,1,Thoracic,lung ADK +Lymphoma,IO (ATCD: Rituximab En 07. 2020),anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Rituximab,Rituximab,L01FA01,L01FA01
ONM392,M,71.3,Pfizer,3M3,281,98,NA,V5-3M3,8,NA,01/fév/2022,Positif,28.5,219,Négatif,0.1,ONM392 3M3,34.9,28.4,19.4,Thoracic,lung ADK +Lymphoma,IO (ATCD: Rituximab En 07. 2020),anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Rituximab,Rituximab,L01FA01,L01FA01
ONM392,M,71.3,Pfizer,3M6,372,189,NA,V5-3M3,99,NA,03/mai/2022,Positif,16.4,76,Négatif,0.5,ONM392 3M6,17.146776406035666,13.480722566729577,23.741690408357076,Thoracic,lung ADK +Lymphoma,IO (ATCD: Rituximab En 07. 2020),anti-CD20 antibody therapy (<365 days) (375 mg/m2),NA,anti-CD20 therapy<365 days,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,Rituximab,Rituximab,L01FA01,L01FA01
ONM393,F,46.3,Pfizer,V3,35,NA,NA,NA,NA,NA,27/mai/2021,Positif,116.1,NA,NA,NA,ONM393V3b,377.4,178,81.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM393,F,46.3,Pfizer,V4,82,NA,NA,NA,NA,NA,13/jui/2021,Positif,74.1,NA,Négatif,0.1,ONM393V4b,148.3,88.8,32.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM393,F,46.3,Pfizer,V5,186,NA,NA,NA,NA,NA,25/oct/2021,Positif,40.2,NA,Négatif,0.1,ONM393V5b,88,56.1,18.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM393,F,46.3,Pfizer,3M3,319,83,NA,NA,NA,NA,07/mar/2022,Positif,113.1,3302,Négatif,0.1,ONM393 3M3,681.2,314.3,127.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM394,M,48.3,Pfizer,V3,30,NA,NA,NA,NA,NA,20/mai/2021,Positif,83.3,NA,NA,NA,ONM394V3b,371.7,113.7,104.5,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM394,M,48.3,Pfizer,V4,87,NA,NA,NA,NA,NA,16/jui/2021,Positif,83.4,NA,Négatif,0.1,ONM394V4b,286.8,76.6,61.6,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM394,M,48.3,Pfizer,V5,188,NA,NA,NA,NA,NA,25/oct/2021,Positif,60.1,NA,Négatif,0.1,ONM394V5b,76.7,15.2,16.6,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM394,M,48.3,Pfizer,3M3,335,95,NA,NA,NA,NA,21/mar/2022,Positif,87.3,1974,Négatif,0,ONM394 3M3,796.8,210,123.1,Gastrointestinal,pancreatic cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM395,M,74.3,Moderna,3M3,291,60,NA,NA,NA,NA,14/fév/2022,Positif,105.2,2859,Négatif,0.4,ONM395 3M3,313.7,76.9,37.2,Thoracic,œsophage cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM396,F,56.3,Pfizer,V3,30,NA,NA,NA,NA,NA,21/mai/2021,Positif,146.2,NA,NA,NA,ONM396V3b,433.8,177.9,32.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM396,F,56.3,Pfizer,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,70.9,NA,Négatif,0.6,ONM396V4b,239.5,100.2,33.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM396,F,56.3,Pfizer,V5,183,NA,NA,NA,NA,NA,21/oct/2021,Positif,72.8,NA,Négatif,0.8,ONM396V5b,190.8,126.9,53.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM396,F,56.3,Pfizer,3M3,327,82,NA,NA,NA,NA,14/mar/2022,Positif,141.9,5188,Négatif,0.6,ONM396 3M3,402.9,171.8,113.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM397,F,57.3,Pfizer,V3,34,NA,NA,NA,NA,NA,25/mai/2021,Positif,97.5,NA,NA,NA,ONM397V3b,883.4,334,129,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM397,F,57.3,Pfizer,V4,99,NA,NA,NA,NA,NA,29/jui/2021,Positif,73.6,NA,Négatif,0.2,ONM397V4b,246.1,115.7,52.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM397,F,57.3,Pfizer,V5,188,NA,NA,NA,NA,NA,26/oct/2021,Positif,47.3,NA,Négatif,0.2,ONM397V5b,84,36.8,21.8,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM397,F,57.3,Pfizer,3M3,309,83,NA,NA,NA,NA,24/fév/2022,Positif,101.8,2678,Négatif,0.2,ONM397 3M3,697.4,270.3,218,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM397,F,57.3,Pfizer,3M6,407,181,NA,NA,NA,NA,02/jun/2022,Positif,207.9,11117,Positif,12.4,ONM397 3M6,2430,2430,2430,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM398,F,72.3,Pfizer,V3,30,NA,NA,NA,NA,NA,21/mai/2021,Positif,109.5,NA,NA,NA,ONM398V3b,140.4,50.8,13.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM398,F,72.3,Pfizer,V4,91,NA,NA,NA,NA,NA,21/jui/2021,Positif,64.7,NA,Négatif,0.1,ONM398V4b,133.7,65.4,42.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM398,F,72.3,Pfizer,V5,183,NA,NA,NA,NA,NA,21/oct/2021,Positif,53.8,NA,Négatif,0.1,ONM398V5b,101.1,89.7,35.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM398,F,72.3,Pfizer,3M3,308,92,NA,NA,NA,NA,23/fév/2022,Positif,79.5,1639,Négatif,0.1,ONM398 3M3,343.9,181.1,122.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM398,F,72.3,Pfizer,3M6,397,181,NA,NA,NA,NA,23/mai/2022,Positif,130.7,4404,Négatif,0,ONM398 3M6,183.7,96.4,56.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM399,F,69.2,Moderna,V3,32,NA,NA,NA,NA,NA,23/avr/2021,Positif,18.7,NA,NA,NA,ONM399V3b,2.2,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM399,F,69.2,Moderna,V4,93,NA,NA,NA,NA,NA,23/jun/2021,Positif,10.7,NA,Négatif,0.1,ONM399V4b,1,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM399,F,69.2,Moderna,V5,190,NA,NA,NA,NA,NA,28/sep/2021,Positif,6,NA,Négatif,0.1,ONM399V5b,1,1,1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM399,F,69.2,Moderna,3M3,323,121,NA,NA,NA,NA,08/fév/2022,Positif,80.4,1676,Négatif,0.1,ONM399 3M3,78.3,21,16.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM399,F,69.2,Moderna,3M6,396,194,NA,NA,NA,NA,22/avr/2022,Positif,52.3,717,Négatif,0.1,ONM399 3M6,54.1,13.3,8.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM400,M,46.3,Pfizer,V3,32,NA,NA,NA,NA,NA,25/mai/2021,Positif,102.6,NA,NA,NA,ONM400V3b,363.8,145.8,79.3,Genitourinary,seminome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM400,M,46.3,Pfizer,V4,95,NA,NA,NA,NA,NA,27/jui/2021,Positif,65.7,NA,Négatif,0.8,ONM400V4b,195.5,83.5,42.7,Genitourinary,seminome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM400,M,46.3,Pfizer,V5,186,NA,NA,NA,NA,NA,26/oct/2021,Positif,47,NA,Négatif,0.8,ONM400V5b,126.1,61.1,28.1,Genitourinary,seminome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM400,M,46.3,Pfizer,V6,388,154,NA,NA,NA,NA,16/mai/2022,Positif,155.6,6234,Positif,9.5,ONM400V6,2430,1490.5,949.7,Genitourinary,seminome,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM401,F,59.2,Moderna,V3,32,NA,NA,NA,NA,NA,23/avr/2021,Positif,82.7,NA,NA,NA,ONM401V3b,442.9,217.4,59.9,Neuroendocrine,carcinoide Tm,Interferon,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Interferon,L03AB,"NA"
ONM401,F,59.2,Moderna,V4,93,NA,NA,NA,NA,NA,23/jun/2021,Positif,102.4,NA,Négatif,0.3,ONM401V4b,229.3,135.9,50,Neuroendocrine,carcinoide Tm,Interferon,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Interferon,L03AB,"NA"
ONM401,F,59.2,Moderna,V5,184,NA,NA,NA,NA,NA,22/sep/2021,Positif,61,NA,Négatif,0.2,ONM401V5b,125.9,70.8,41.5,Neuroendocrine,carcinoide Tm,Interferon,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Interferon,L03AB,"NA"
ONM401,F,59.2,Moderna,V6,373,118,NA,NA,NA,NA,30/mar/2022,Positif,90.6,2125,Négatif,0.3,ONM401V6,2430,977.5,473.7,Neuroendocrine,carcinoide Tm,Interferon,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Interferon,L03AB,"NA"
ONM402,F,64.2,Moderna,3M3,365,63,NA,NA,NA,NA,22/mar/2022,Positif,97.1,2438,Négatif,0.5,ONM402 3M3,1084.6,256,179.4,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM403,F,59.4,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,15/jun/2021,Indéterminé,5.9,NA,Négatif,0.3,ONM403V3b,1,1,1,Breast,breast cancer,No TTT (ATCD: SEP),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM403,F,59.4,Pfizer,V4,88,NA,NA,V5-3M3,NA,NA,10/aoû/2021,Indéterminé,4.1,NA,Négatif,0.2,ONM403V4b,10.2,13.8,5.6,Breast,breast cancer,No TTT (ATCD: SEP),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM403,F,59.4,Pfizer,V5,179,NA,NA,V5-3M3,NA,NA,09/nov/2021,Négatif,3,NA,Négatif,0.3,ONM403V5b,1,1,1,Breast,breast cancer,No TTT (ATCD: SEP),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM403,F,59.4,Pfizer,3M3,314,94,NA,V5-3M3,16,NA,24/mar/2022,Positif,110,3124,Négatif,0.1,ONM403 3M3,109.8,102.5,40.4,Breast,breast cancer,No TTT (ATCD: SEP),NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM404,M,68.4,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,15/jun/2021,Positif,121.5,NA,Négatif,0.1,ONM404V3b,695.4,303.1,115.3,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM404,M,68.4,Pfizer,V4,95,NA,NA,V5-3M3,NA,NA,17/aoû/2021,Positif,65.5,NA,Négatif,0.1,ONM404V4b,203.5,94,47.2,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM404,M,68.4,Pfizer,V5,195,NA,NA,V5-3M3,NA,NA,25/nov/2021,Positif,65.2,NA,Négatif,0.1,ONM404V5b,106.4,61.2,29.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM404,M,68.4,Pfizer,3M3,360,123,NA,V5-3M3,33,NA,09/mai/2022,Positif,169.7,7412,Positif,17.2,ONM404 3M3,2430,2430,2430,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM405,F,74.4,Moderna,V3,31,NA,NA,NA,NA,NA,21/jun/2021,Positif,85,NA,Négatif,0.1,ONM405V3b,1260.2,618.8,112.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM405,F,74.4,Moderna,V4,98,NA,NA,NA,NA,NA,27/aoû/2021,Positif,89.4,NA,Négatif,0.2,ONM405V4b,796.8,343.4,86.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM405,F,74.4,Moderna,V5,189,NA,NA,NA,NA,NA,26/nov/2021,Positif,100.7,NA,Négatif,0.2,ONM405V5b,220.6,162.3,62.7,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM405,F,74.4,Moderna,3M3,321,83,NA,NA,NA,NA,07/avr/2022,Positif,104.7,2832,Négatif,0.1,ONM405 3M3,1181.5,636.5,346.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM406,M,75.3,Pfizer,V3,32,NA,NA,V5-3M3,NA,NA,17/mai/2021,Positif,51.8,NA,NA,NA,ONM406V3b,127.2,22.5,18.2,Genitourinary,prostate ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM406,M,75.3,Pfizer,V4,99,NA,NA,V5-3M3,NA,NA,23/jui/2021,Positif,23.2,NA,Négatif,0.4,ONM406V4b,1.9,1,0.1,Genitourinary,prostate ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM406,M,75.3,Pfizer,V5,193,NA,NA,V5-3M3,NA,NA,25/oct/2021,Positif,12.5,NA,Négatif,0.2,ONM406V5b,1,1,1,Genitourinary,prostate ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM406,M,75.3,Pfizer,3M3,375,119,NA,V5-3M3,NA,NA,25/avr/2022,Positif,129.2,4304,Négatif,1.4,ONM406 3M3,289.5,93.7,123.5,Genitourinary,prostate ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM407,M,80.4,Pfizer,V3,33,NA,NA,NA,NA,NA,22/jun/2021,Positif,59.5,NA,Négatif,0.6,ONM407V3b,222.8,128.9,37,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM407,M,80.4,Pfizer,V4,92,NA,NA,NA,NA,NA,20/aoû/2021,Positif,52.8,NA,Négatif,0.5,ONM407V4b,177.6,99.3,24.2,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM407,M,80.4,Pfizer,V5,189,NA,NA,NA,NA,NA,25/nov/2021,Positif,48.8,NA,Négatif,0.6,ONM407V5b,95.1,68.3,20.6,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM407,M,80.4,Pfizer,3M3,267,67,NA,NA,NA,NA,11/fév/2022,Positif,111,3181,Négatif,0.4,ONM407 3M3,300.5,182.6,88.7,Renal,renal cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM408,F,58.4,Moderna,V3,31,NA,NA,NA,NA,NA,30/jun/2021,Positif,78.3,NA,Négatif,0.7,ONM408V3b,535,180.9,48.1,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM408,F,58.4,Moderna,V4,92,NA,NA,NA,NA,NA,30/aoû/2021,Positif,79.4,NA,Négatif,1,ONM408V4b,182.3,97.6,40,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM408,F,58.4,Moderna,V5,177,NA,NA,NA,NA,NA,23/nov/2021,Positif,58.4,NA,Négatif,0.1,ONM408V5b,125.5,57,20.2,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM408,F,58.4,Moderna,3M3,333,120,NA,NA,NA,NA,28/avr/2022,Positif,129.6,4330,Négatif,1.2,ONM408 3M3,2079.9,1006.5,655.7,Skin,melanoma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM409,F,59.4,Pfizer,V3,31,NA,NA,NA,NA,NA,21/jun/2021,Positif,89.2,NA,Négatif,0.2,ONM409V3b,222.8,128.9,37,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM409,F,59.4,Pfizer,V4,96,NA,NA,NA,NA,NA,25/aoû/2021,Positif,78.2,NA,Négatif,0.2,ONM409V4b,271.3,154.1,64.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM409,F,59.4,Pfizer,V5,186,NA,NA,NA,NA,NA,23/nov/2021,Positif,67.7,NA,Négatif,0.1,ONM409V5b,152.4,86.9,43.1,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM409,F,59.4,Pfizer,V6,364,154,NA,NA,NA,NA,20/mai/2022,Positif,118.2,3605,Négatif,0.1,ONM409V6,1395.9,568.2,439.2,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM410,M,42.2,Pfizer,V3,31,NA,NA,NA,NA,NA,26/avr/2021,Positif,92.2,NA,NA,NA,ONM410V3b,695.4,303.1,115.3,Brain,glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM410,M,42.2,Pfizer,V4,96,NA,NA,NA,NA,NA,30/jun/2021,Positif,53.9,NA,Négatif,0.3,ONM410V4b,98.4,51.8,26.9,Brain,glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM410,M,42.2,Pfizer,V5,189,NA,NA,NA,NA,NA,01/oct/2021,Positif,38.9,NA,Négatif,0.2,ONM410V5b,68.9,46.4,23.5,Brain,glioma,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM411,F,51.4,Pfizer,V3,28,NA,NA,V5-3M3,NA,NA,25/jun/2021,Positif,105.2,NA,Négatif,0.3,ONM411V3b,306.7,96.6,69.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM411,F,51.4,Pfizer,V4,91,NA,NA,V5-3M3,NA,NA,27/aoû/2021,Positif,88.1,NA,Négatif,0.3,ONM411V4b,385.7,89.8,93,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM411,F,51.4,Pfizer,V5,182,NA,NA,V5-3M3,NA,NA,26/nov/2021,Positif,106.2,NA,Négatif,0.2,ONM411V5b,95.2,53.4,54.8,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM411,F,51.4,Pfizer,3M3,343,98,NA,V5-3M3,11,NA,06/mai/2022,Positif,151.7,5926,Positif,17.9,ONM411 3M3,874.1258741258741,250.56376847907794,197.66752322593396,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM412,F,63.3,Pfizer,V3,28,NA,NA,NA,NA,NA,02/jun/2021,Positif,55.4,NA,NA,NA,ONM412V3b,82.6,32.4,13.5,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM412,F,63.3,Pfizer,V4,92,NA,NA,NA,NA,NA,05/aoû/2021,Positif,16.4,NA,Négatif,1.9,ONM412V4b,23.8,13.7,6.2,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM412,F,63.3,Pfizer,V5,183,NA,NA,NA,NA,NA,04/nov/2021,Positif,9.6,NA,Négatif,2.7,ONM412V5b,1,1,1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM412,F,63.3,Pfizer,3M3,294,83,NA,NA,NA,NA,23/fév/2022,Positif,78.9,1615,Négatif,2.2,ONM412 3M3,348.1,148,102.5,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM412,F,63.3,Pfizer,3M6,393,182,NA,NA,NA,NA,02/jun/2022,Positif,134.7,4676,Négatif,0.6,ONM412 3M6,224.4165170556553,128.96569512509674,86.4304235090752,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM413,F,65.4,Pfizer,V3,33,NA,NA,NA,NA,NA,06/jui/2021,Positif,95.8,NA,Négatif,0.5,ONM413V3b,253,130.1,28.4,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM413,F,65.4,Pfizer,V4,90,NA,NA,NA,NA,NA,01/sep/2021,Positif,53.5,NA,Négatif,0.8,ONM413V4b,151.1,110.5,27.5,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM413,F,65.4,Pfizer,V5,179,49,NA,NA,NA,NA,29/nov/2021,Positif,86,1916,Négatif,0.1,ONM413V5b,618.4,326.8,104.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM413,F,65.4,Pfizer,3M3,232,102,NA,NA,NA,NA,21/jan/2022,Positif,126.7,4139,Négatif,0.6,ONM413 3M3,400,244.5,50.9,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM413,F,65.4,Pfizer,3M6,309,179,NA,NA,NA,NA,08/avr/2022,Positif,92.5,2214,Négatif,0.2,ONM413 3M6,250.2,182.7,43,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM415,F,68.4,Pfizer,V3,31,NA,NA,NA,NA,NA,21/jun/2021,Positif,79.3,NA,Positif,17.6,ONM415V3b,1251.1,481.9,319.1,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM415,F,68.4,Pfizer,V4,90,NA,NA,NA,NA,NA,19/aoû/2021,Positif,97.4,NA,Positif,11.6,ONM415V4b,834,343.9,183.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM415,F,68.4,Pfizer,V5,188,NA,NA,NA,NA,NA,25/nov/2021,Positif,100,NA,Positif,11.6,ONM415V5b,595.2,308.2,166.9,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM415,F,68.4,Pfizer,V6,355,NA,NA,NA,NA,NA,11/mai/2022,Positif,123.6,3940,Indéterminé,5.4,ONM415 V6,277.0850651149903,175.59262510974537,115.64704521799467,Thoracic,lung ADK,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM416,F,57.4,Pfizer,V3,34,NA,NA,NA,NA,NA,21/jun/2021,Positif,89.3,NA,Indéterminé,4.9,ONM416V3b,1153.8,503,194.3,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM416,F,57.4,Pfizer,V4,92,NA,NA,NA,NA,NA,18/aoû/2021,Positif,80.7,NA,Négatif,3.2,ONM416V4b,532.8,205.1,110.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM416,F,57.4,Pfizer,V5,176,NA,NA,NA,NA,NA,10/nov/2021,Positif,68.4,NA,Négatif,2.1,ONM416V5b,417,211.1,117.6,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM416,F,57.4,Pfizer,3M3,351,143,NA,NA,NA,NA,04/mai/2022,Positif,141,5122,Négatif,0.9,ONM416 3M3,559.5970900951315,319.38677738741615,192.60400616332822,Breast,breast cancer,Hormonotherapy,Hormonal therapy,NA,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM417,M,54.5,Moderna,V3,30,NA,NA,NA,NA,NA,29/jui/2021,Positif,74.2,NA,Négatif,0.2,ONM417V3b,199.1,98.2,47,Gastrointestinal,rectal ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM417,M,54.5,Moderna,V4,86,NA,NA,NA,NA,NA,23/sep/2021,Positif,86.8,NA,Négatif,0.1,ONM417V4b,410.8,174.3,90.2,Gastrointestinal,rectal ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM417,M,54.5,Moderna,V5,169,NA,NA,NA,NA,NA,15/déc/2021,Positif,93,2238,Négatif,0.1,ONM417V5b,310.8,143.2,76.2,Gastrointestinal,rectal ADK,Chemo,Chemotherapy,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM418,F,63.4,Moderna,V3,35,NA,NA,NA,NA,NA,29/jun/2021,Positif,64.6,NA,Négatif,0.3,ONM418V3b,1054,207.8,70,Genitourinary,ovarien cancer,Tkis (PARP Inhibitor),PARP inhibitor,NA,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM419,F,63.5,Pfizer,V3,29,NA,NA,NA,NA,NA,05/aoû/2021,Positif,68.4,NA,Négatif,3.2,ONM419V3b,320.4,173.1,73.1,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM419,F,63.5,Pfizer,V4,86,NA,NA,NA,NA,NA,01/oct/2021,Positif,95.3,NA,Indéterminé,4.9,ONM419V4b,196.7,95.9,40.7,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM419,F,63.5,Pfizer,V5,184,NA,NA,NA,NA,NA,07/jan/2022,Positif,55.8,814,Négatif,2.9,ONM419V5,103.6,57.8,39.8,Breast,breast cancer,No TTT,NA,No,Not treated,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM420,F,37.4,Moderna,3M3,238,77,NA,3M3-3M6,NA,NA,14/jan/2022,Positif,66.1,1138,Négatif,2.3,ONM420 3M3,1220.7,406,293.5,Breast,neoadj chemo IO breast cancer,NA,Chemotherapy + Immune checkpoint inhibitor,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM420,F,37.4,Moderna,3M6,343,182,NA,3M3-3M6,36,NA,29/avr/2022,Positif,154.3,6131,Positif,16.2,ONM420 3M6,1093.6,505.1,444.8,Breast,neoadj chemo IO breast cancer,NA,Chemotherapy + Immune checkpoint inhibitor,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM421,M,89.3,Pfizer,3M3,328,120,NA,NA,NA,NA,01/mar/2022,Positif,98.5,2508,Négatif,0.1,ONM421 3M3,386.8,119.5,66.3,Genitourinary,metastatic  prostat ADK,Yes (Dexa 1mg/J),Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Dexa,H02AB02,"NA"
ONM421,M,89.3,Pfizer,3M6,387,179,NA,NA,NA,NA,29/avr/2022,Positif,162.3,6781,Négatif,0,ONM421 3M6,452.1,146.8,40,Genitourinary,metastatic  prostat ADK,Yes (Dexa 1mg/J),Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Dexa,H02AB02,"NA"
ONM422,F,61.3,Pfizer,3M3,273,98,NA,NA,NA,NA,04/jan/2022,Positif,122.6,3877,Négatif,0.3,ONM422 3M3,706.7,274.3,241.3,Breast,breast cancer stage IIA,NA,Anti-HER2 antibody therapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM422,F,61.3,Pfizer,3M6,358,183,NA,NA,NA,NA,30/mar/2022,Positif,94.8,2325,Négatif,0.2,ONM422 3M6,324.6,172.8,139.1,Breast,breast cancer stage IIA,NA,Anti-HER2 antibody therapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM424,F,68.3,Pfizer,3M3,288,86,NA,3M3-3M6,NA,NA,17/jan/2022,Positif,105.3,2864,Négatif,0.1,ONM424 3M3,142.8,76.7,37.3,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM424,F,68.3,Pfizer,3M6,381,179,NA,3M3-3M6,51,NA,20/avr/2022,Positif,108.8,3057,Négatif,3.6,ONM424 3M6,1613.9,705.2,393.1,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM425,M,73.3,Pfizer,3M3,272,85,NA,NA,NA,NA,04/jan/2022,Positif,103.8,2784,Négatif,0,ONM425 3M3,264.8,51.2,53.5,Renal,stage IV renal cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM425,M,73.3,Pfizer,3M6,366,179,NA,NA,NA,NA,08/avr/2022,Positif,95.9,2379,Positif,11.9,ONM425 3M6,2430,1399.4,1546.1,Renal,stage IV renal cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM426,F,44.2,Pfizer,3M3,259,66,NA,3M3-3M6,NA,NA,13/déc/2021,Positif,101.4,2657,Négatif,0.3,ONM426 3M3b,186.2,70.2,22.2,Breast,stage IIA breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM426,F,44.2,Pfizer,3M6,379,186,NA,3M3-3M6,80,NA,12/avr/2022,Positif,92.1,2195,Positif,7.5,ONM426 3M6,1784.1,682.6,406,Breast,stage IIA breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM427,F,43.1,Pfizer,3M3,301,84,NA,NA,NA,NA,14/déc/2021,Positif,70.2,1281,Négatif,0.1,ONM427 3M3b,2040,780,328.4,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM427,F,43.1,Pfizer,3M6,385,168,NA,NA,NA,NA,08/mar/2022,Positif,88.1,2010,Négatif,0.1,ONM427 3M6,1084.4,490.7,205.8,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM428,F,47.1,Pfizer,3M3,327,76,NA,NA,NA,NA,12/jan/2022,Positif,105.7,2886,Négatif,0.5,ONM428 3M3,2209,868.1,519.8,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM428,F,47.1,Pfizer,3M6,430,179,NA,NA,NA,NA,25/avr/2022,Positif,160.8,6657,Négatif,0.4,ONM428 3M6,565.9,276.3,192.3,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM429,F,36.1,Moderna,3M3,323,93,NA,3M3-3M6,NA,NA,12/jan/2022,Positif,110.3,3141,Négatif,0.3,ONM429 3M3,659.6,306.7,173.3,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM429,F,36.1,Moderna,3M6,414,184,NA,3M3-3M6,72,NA,13/avr/2022,Positif,101,2637,Indéterminé,5,ONM429 3M6,1020.3,672,547.3,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM430,M,53.1,Pfizer,3M3,327,107,NA,NA,NA,NA,13/jan/2022,Positif,87.3,1974,Négatif,0.5,ONM430 3M3,280,124.2,72.7,Gastrointestinal,adjuvant GIST,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM430,M,53.1,Pfizer,3M6,402,182,NA,NA,NA,NA,29/mar/2022,Positif,77.3,1551,Négatif,0.3,ONM430 3M6,253.4,127.3,56.1,Gastrointestinal,adjuvant GIST,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM431,M,68.2,Pfizer,3M3,280,91,NA,NA,NA,NA,05/jan/2022,Positif,102.2,2699,Négatif,0,ONM431 3M3b,183.3,51.4,43.4,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM431,M,68.2,Pfizer,3M6,385,196,NA,NA,NA,NA,20/avr/2022,Positif,51.9,706,Négatif,0.1,ONM431 3M6,68.4,34.3,19.1,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM432,M,66.2,Moderna,3M3,283,93,NA,NA,NA,NA,03/jan/2022,Positif,144.3,5364,Négatif,0.2,ONM432 3M3,935.5,303,185.6,Gastrointestinal,stage IV colon cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM432,M,66.2,Moderna,3M6,376,186,NA,NA,NA,NA,06/avr/2022,Positif,101.2,2647,Négatif,0.1,ONM432 3M6,324,156.4,83.4,Gastrointestinal,stage IV colon cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM434,M,65.4,Moderna,3M3,224,71,NA,3M3-3M6,NA,NA,21/déc/2021,Positif,120,3715,Négatif,0,ONM434 3M3b,809.7,370.5,234.6,Genitourinary,stage IV prostate cancer,Oui (Prednisone 5 Mg/J),Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM434,M,65.4,Moderna,3M3+,308,155,NA,3M3-3M6,67,NA,15/mar/2022,Positif,98.8,2524,Négatif,1.2,ONM434 3M3+,831.3,518.1,599.2,Genitourinary,stage IV prostate cancer,Oui (Prednisone 5 Mg/J),Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM434,M,65.4,Moderna,3M6,336,183,NA,3M3-3M6,95,NA,12/avr/2022,Positif,93.8,2276,Négatif,1,ONM434 3M6,1050.2,565.3,485.7,Genitourinary,stage IV prostate cancer,Oui (Prednisone 5 Mg/J),Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM435,F,77.2,Moderna,3M3,259,67,NA,NA,NA,NA,13/déc/2021,Positif,70.8,1303,Négatif,0.2,ONM435 3M3b,65,24.5,12.2,Breast,stage IV breast cancer,Oui Dexa 0.5mg/J,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Dexa,H02AB02,"NA"
ONM435,F,77.2,Moderna,3M6,392,200,NA,NA,NA,NA,25/avr/2022,Positif,41,444,Négatif,0.1,ONM435 3M6,59.2,44.9,30.6,Breast,stage IV breast cancer,Oui Dexa 0.5mg/J,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Dexa,H02AB02,"NA"
ONM436,M,79.1,Pfizer,3M3,351,112,NA,NA,NA,NA,21/jan/2022,Positif,115.5,3443,Négatif,0.1,ONM436 3M3,206.7,61.3,41.3,Genitourinary,stage IV prostate cancer,Oui Prednisone 10mg/J,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM436,M,79.1,Pfizer,3M6,434,195,NA,NA,NA,NA,14/avr/2022,Positif,61.5,986,Négatif,0,ONM436 3M6,90.3,43,33.6,Genitourinary,stage IV prostate cancer,Oui Prednisone 10mg/J,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM437,F,73.2,Moderna,3M3,285,81,NA,NA,NA,NA,14/déc/2021,Positif,84.6,1854,Indéterminé,5.5,ONM437 3M3b,538.2,205.4,74,Thoracic,stage I lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM437,F,73.2,Moderna,3M6,399,195,NA,NA,NA,NA,07/avr/2022,Positif,108.5,3040,Négatif,0.2,ONM437 3M6,142.2,77.8,30.5,Thoracic,stage I lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM438,M,80.2,Pfizer,3M3,300,91,NA,NA,NA,NA,24/jan/2022,Positif,103.4,2763,Négatif,0.5,ONM438 3M3,2573.3,630.1,473,Thoracic,stage IV lung ADK,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM438,M,80.2,Pfizer,3M6,399,190,NA,NA,NA,NA,03/mai/2022,Positif,180.2,8355,Négatif,0.2,ONM438 3M6,1248.1278082875688,315.05986137366097,285.46959748786753,Thoracic,stage IV lung ADK,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM440,F,59.3,Pfizer,3M3,260,86,NA,3M3-3M6,NA,NA,05/jan/2022,Positif,94,2286,Négatif,0.1,ONM440 3M3,254.5,89.8,44.6,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM440,F,59.3,Pfizer,3M6,370,196,NA,3M3-3M6,11,NA,25/avr/2022,Positif,133.1,4566,Positif,15.8,ONM440 3M6,788,570.5,184,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM441,F,64.3,Moderna,3M3,289,76,NA,NA,NA,NA,17/fév/2022,Positif,107.6,2990,Négatif,0.2,ONM441 3M3,3628.4,781.9,446,Breast,stage III breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM441,F,64.3,Moderna,3M6,394,181,NA,NA,NA,NA,02/jun/2022,Positif,134.7,4676,Négatif,0.1,ONM441 3M6,539.6654074473826,186.98578908002992,180.6684733514002,Breast,stage III breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM442,F,58.4,Pfizer,3M3,220,79,NA,NA,NA,NA,17/déc/2021,Positif,66.2,1141,Négatif,0,ONM442 3M3b,36.5,8.1,1.5,Thoracic,stage IV lung ADK,NA,Chemotherapy + Immune checkpoint inhibitor,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM442,F,58.4,Pfizer,3M6,315,174,NA,NA,NA,NA,22/mar/2022,Positif,39.6,415,Négatif,0,ONM442 3M6,27.4,16.9,8.7,Thoracic,stage IV lung ADK,NA,Chemotherapy + Immune checkpoint inhibitor,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM443,F,39.2,Pfizer,3M3,319,97,NA,NA,NA,NA,14/fév/2022,Positif,36.2,348,Négatif,0.1,ONM443 3M3,33.9,22,14.4,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM444,F,40.1,Pfizer,Baseline1,84,NA,NA,Before 3M3 after 3rd dose,NA,NA,14/mai/2021,Positif,146.7,NA,NA,NA,ONM444 BL1,253,153.6,50.3,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM444,F,40.1,Pfizer,Baseline2,168,NA,NA,Before 3M3 after 3rd dose,NA,NA,06/aoû/2021,Positif,54.0,NA,Négatif,0.3,ONM444 BL2,117.9,86.9,25.1,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM444,F,40.1,Pfizer,3M3,335,79,NA,Before 3M3 after 3rd dose,20,NA,20/jan/2022,Positif,103.5,2768,Positif,7.1,ONM444 3M3,2237.1,1123.6,694.9,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM444,F,40.1,Pfizer,3M6,440,184,NA,Before 3M3 after 3rd dose,125,NA,05/mai/2022,Positif,142.8,5253,Indéterminé,5.2,ONM444 3M6,765.1109410864575,325.30904359141186,321.02728731942216,Breast,stage IV breast cancer,NA,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM445,M,78.2,Pfizer,3M3,267,63,NA,NA,NA,NA,22/déc/2021,Positif,131.4,4451,Négatif,0.3,ONM445 3M3,800.6,113.7,79.1,Skin,adjuvant melanoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM445,M,78.2,Pfizer,3M6,386,182,NA,NA,NA,NA,20/avr/2022,Positif,106.5,2930,Négatif,0.3,ONM445 3M6,683.5,147.1,80,Skin,adjuvant melanoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM446,M,48.6,Moderna,3M3,134,63,NA,3M3-3M6,NA,NA,08/déc/2021,Positif,108.6,3046,Négatif,0.1,ONM446 3M3b,312.4,144,54.1,Brain,oligodendroglioma,NA,VEGF inhibitor,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM446,M,48.6,Moderna,3M6,260,189,NA,3M3-3M6,75,NA,13/avr/2022,Positif,103.1,2747,Négatif,2.3,ONM446 3M6,1318.6,847.5,657.9,Brain,oligodendroglioma,NA,VEGF inhibitor,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM447,F,43.2,Pfizer,3M3,312,91,NA,NA,NA,NA,21/jan/2022,Positif,124.9,4023,Négatif,0.1,ONM447 3M3,528,206.4,95.6,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM447,F,43.2,Pfizer,3M6,395,174,NA,NA,NA,NA,14/avr/2022,Positif,95.3,2349,Négatif,0.1,ONM447 3M6,239.1,127.2,52.7,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM448,F,75.4,Pfizer,3M3,196,60,NA,NA,NA,NA,20/déc/2021,Positif,119.2,3666,Négatif,0.7,ONM448 3M3b,440.3,159,81,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM448,F,75.4,Pfizer,3M6,308,172,NA,NA,NA,NA,11/avr/2022,Positif,81.9,1739,Négatif,0.6,ONM448 3M6,311,143.3,54.9,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM449,F,61.3,Pfizer,3M3,244,84,NA,NA,NA,NA,16/déc/2021,Positif,100.9,2631,Négatif,0,ONM449 3M3b,339.6,132.9,88.3,Breast,stage IV breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM449,F,61.3,Pfizer,3M6,346,186,NA,NA,NA,NA,28/mar/2022,Positif,87.6,1987,Négatif,0,ONM449 3M6,276.9,149.9,89.2,Breast,stage IV breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM450,F,76.3,Pfizer,3M3,269,79,NA,NA,NA,NA,07/jan/2022,Positif,89.2,2060,Négatif,0,ONM450 3M3,764.5,301.8,204.3,Breast,stage II breast cancer,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM450,F,76.3,Pfizer,3M6,372,182,NA,NA,NA,NA,20/avr/2022,Positif,102.1,2694,Négatif,0,ONM450 3M6,241.7,137.6,77,Breast,stage II breast cancer,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM451,F,34.3,Pfizer,3M3,258,77,NA,3M3-3M6,NA,NA,10/jan/2022,Positif,55.6,808,Négatif,0.2,ONM451 3M3,93.5,22.7,20.8,Breast,stge I breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM451,F,34.3,Pfizer,3M6,363,182,NA,3M3-3M6,71,NA,25/avr/2022,Positif,128.6,4264,Indéterminé,5,ONM451 3M6,780,486.1,368.7,Breast,stge I breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM452,M,77.1,Pfizer,3M3,331,114,NA,NA,NA,NA,20/jan/2022,Positif,88.8,2042,Négatif,0.1,ONM452 3M3,4207,1009.6,559,Renal,stage IV renal cancer,NA,Immune checkpoint inhibitor ICI,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM452,M,77.1,Pfizer,3M6,406,189,NA,NA,NA,NA,05/avr/2022,Positif,117.3,3550,Négatif,0,ONM452 3M6,2430,642.3,432.5,Renal,stage IV renal cancer,NA,Immune checkpoint inhibitor ICI,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM453,F,40.4,Moderna,Baseline1,91,NA,NA,Before 3M3 after 3rd dose,NA,NA,30/aoû/2021,Positif,91.6,NA,Négatif,0.4,ONM453 BL1,253.1,77.6,32.4,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM453,F,40.4,Moderna,Baseline2,155,NA,NA,Before 3M3 after 3rd dose,NA,NA,02/nov/2021,Positif,59.5,NA,Négatif,0.3,ONM453 BL2,125.6,46.9,16.6,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM453,F,40.4,Moderna,V5+,266,83,NA,Before 3M3 after 3rd dose,14,NA,21/fév/2022,Positif,85.5,1894,Négatif,3.3,ONM453 V5+,588.9,259.7,157.6,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM453,F,40.4,Moderna,3M3,280,97,NA,Before 3M3 after 3rd dose,28,NA,07/mar/2022,Positif,112.8,3284,Indéterminé,5.9,ONM453 3M3,695.4,235.9,124,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM453,F,40.4,Moderna,3M6,350,167,NA,Before 3M3 after 3rd dose,98,NA,16/mai/2022,Positif,151.6,5919,Négatif,2.8,ONM453 3M6,395.6,164.7,91.8,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM454,F,53.1,Pfizer,3M3,372,91,NA,Before 3M3 after 3rd dose,49,NA,18/fév/2022,Positif,91.3,2157,Négatif,2,ONM454 3M3,1757.8,946.1,709.7,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM454,F,53.1,Pfizer,3M6,462,181,NA,Before 3M3 after 3rd dose,139,NA,19/mai/2022,Positif,106.9,2952,Négatif,0.8,ONM454 3M6,1196.3,718.9,596.3,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM455,F,75.1,Pfizer,3M3,338,72,NA,NA,NA,NA,12/jan/2022,Positif,109.7,3107,Indéterminé,4.3,ONM455 3M3,1096.6,547.3,281.2,Breast,stage I breast cancer,NA,Chemotherapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM455,F,75.1,Pfizer,3M6,450,184,NA,NA,NA,NA,04/mai/2022,Positif,134.5,4662,Négatif,1.2,ONM455 3M6,2207.5055187637968,1642.845408247084,552.4861878453039,Breast,stage I breast cancer,NA,Chemotherapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM456,F,77.2,Pfizer,3M3,288,72,NA,NA,NA,NA,17/déc/2021,Positif,100.4,2605,Négatif,0.1,ONM456 3M3b,1533,701.8,137.7,Gastrointestinal,stage IV colon cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,Greffe de la cornée de l'oeil gauche,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM457,F,36.3,Pfizer,3M3,271,81,NA,3M3-3M6,NA,NA,24/jan/2022,Positif,102.2,2699,Indéterminé,4.8,ONM457 3M3,272.3,84.5,69,Breast,stagee IIIC breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM457,F,36.3,Pfizer,3M6,376,186,NA,3M3-3M6,64,NA,09/mai/2022,Positif,171.8,7596,Indéterminé,5.6,ONM457 3M6,1048.6577181208054,469.4835680751174,254.97195308516064,Breast,stagee IIIC breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM458,M,75.3,Pfizer,3M3,287,93,NA,NA,NA,NA,09/fév/2022,Positif,99.4,2554,Négatif,0.3,ONM458 3M3,171.1,88.8,39.6,Gastrointestinal,GIST,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM459,M,72.3,Pfizer,3M3,255,72,NA,NA,NA,NA,17/déc/2021,Positif,103.4,2763,Négatif,0.2,ONM459 3M3b,190.7,23.7,25.9,Genitourinary,stage IV renal cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM461,F,79.1,Pfizer,3M3,331,86,NA,NA,NA,NA,05/jan/2022,Positif,107.1,2963,Négatif,0.4,ONM461 3M3,666.7,233.8,121.5,Skin,stage IV melanoma,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM461,F,79.1,Pfizer,3M6,443,198,NA,NA,NA,NA,27/avr/2022,Positif,131.1,4431,Indéterminé,5.6,ONM461 3M6,2430,1904.8,752.4,Skin,stage IV melanoma,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM462,F,54.3,Pfizer,3M3,304,92,NA,NA,NA,NA,11/fév/2022,Positif,111.9,3233,Négatif,0.1,ONM462 3M3,584.5,246.9,144.1,Breast,stage IIB breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM462,F,54.3,Pfizer,3M6,394,182,NA,NA,NA,NA,12/mai/2022,Positif,139,4978,Négatif,0,ONM462 3M6,526.3,215.2,104.3,Breast,stage IIB breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM463,F,86.1,Pfizer,3M3,365,126,NA,NA,NA,NA,23/fév/2022,Positif,82.2,1752,Négatif,0.1,ONM463 3M3,446.4,156.6,87.7,Breast,stage II breast cancer,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM464,F,63.2,Pfizer,3M3,287,78,NA,NA,NA,NA,09/déc/2021,Positif,111,3181,Négatif,0.8,ONM464 3M3b,3003,316.9,114.1,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM464,F,63.2,Pfizer,3M6,392,183,NA,NA,NA,NA,24/mar/2022,Positif,110.9,3175,Négatif,0.3,ONM464 3M6,361,177,96.1,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM465,M,77.2,Moderna,3M3,270,79,NA,3M3-3M6,NA,NA,17/déc/2021,Positif,104.9,2843,Négatif,0.1,ONM465 3M3b,1212.9,361.5,118.8,Genitourinary,stage IV urothelial carcinoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM465,M,77.2,Moderna,3M6,374,183,NA,3M3-3M6,10,NA,31/mar/2022,Positif,106.3,2919,Négatif,0.1,ONM465 3M6,498.8,118.3,49.5,Genitourinary,stage IV urothelial carcinoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM466,F,50.2,Moderna,3M3,263,65,NA,3M3-3M6,NA,NA,03/déc/2021,Positif,77.5,1559,Négatif,1,ONM466 3M3b,949.7,408.3,120.2,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM467,F,53.3,Pfizer,3M3,317,94,NA,NA,NA,NA,17/fév/2022,Positif,119.5,3684,Négatif,0,ONM467 3M3,247.2,151.4,89.6,Breast,stage I breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM467,F,53.3,Pfizer,3M6,400,177,NA,NA,NA,NA,11/mai/2022,Positif,88.3,2019,Négatif,0,ONM467 3M6,138.1788033715628,64.97725795971411,53.59056806002144,Breast,stage I breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM469,F,42.3,Pfizer,3M3,270,92,NA,NA,NA,NA,25/jan/2022,Positif,88.4,2023,Négatif,0.2,ONM469 3M3,307.9,168.5,122,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM470,M,31.3,Pfizer,3M3,306,103,NA,NA,NA,NA,02/mar/2022,Positif,93.4,2257,Négatif,0.5,ONM470 3M3,292,118.8,55.1,Sarcoma,stage IV rhabdomysarcoma,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM470,M,31.3,Pfizer,3M6,384,181,NA,NA,NA,NA,19/mai/2022,Positif,106.3,2919,Négatif,1.2,ONM470 3M6,157.1,67,39.9,Sarcoma,stage IV rhabdomysarcoma,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM471,F,53.3,Pfizer,3M3,281,92,NA,NA,NA,NA,26/jan/2022,Positif,87.2,1969,Négatif,1.2,ONM471 3M3,415.1,253.8,130.7,Thoracic,stage IA lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM471,F,53.3,Pfizer,3M6,385,196,NA,NA,NA,NA,10/mai/2022,Positif,138.9,4971,Négatif,0.5,ONM471 3M6,304.04378230465187,195.92476489028212,125.42330364981815,Thoracic,stage IA lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM473,F,48.4,Moderna,3M3,228,83,NA,Before 3M3 after 3rd dose,14,NA,17/jan/2022,Positif,128.9,4284,Positif,11.9,ONM473 3M3,307.7,127.2,110.7,Breast,stage II breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM473,F,48.4,Moderna,3M6,333,188,NA,Before 3M3 after 3rd dose,119,NA,02/mai/2022,Positif,164.3,6949,Négatif,3.4,ONM473 3M6,486.3813229571984,251.25628140703517,183.01610541727672,Breast,stage II breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM474,F,67.1,Pfizer,3M3,326,100,NA,NA,NA,NA,07/jan/2022,Positif,76.7,1527,Négatif,0,ONM474 3M3,1866,897.7,213.9,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM474,F,67.1,Pfizer,3M6,399,173,NA,NA,NA,NA,21/mar/2022,Positif,84.3,1841,Négatif,0,ONM474 3M6,1489,568.5,196.9,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM475,F,49.3,Pfizer,3M3,327,90,NA,Before 3M3 after 3rd dose,17,NA,01/mar/2022,Positif,94.7,2320,Positif,7.8,ONM475 3M3,710.7,354.7,278.5,Breast,stage II breast cancer,NA,Anti-HER2 antibody therapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM475,F,49.3,Pfizer,3M6,418,181,NA,Before 3M3 after 3rd dose,108,NA,31/mai/2022,Positif,123.7,3946,Négatif,3.5,ONM475 3M6,825.8,383,276.5,Breast,stage II breast cancer,NA,Anti-HER2 antibody therapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM476,F,81.2,Moderna,3M3,321,91,NA,NA,NA,NA,11/jan/2022,Positif,164.5,6966,Négatif,0.1,ONM476 3M3,2312.7,556.2,200.3,Thoracic,stage IIIA lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM476,F,81.2,Moderna,3M6,404,174,NA,NA,NA,NA,04/avr/2022,Positif,99.4,2554,Négatif,0,ONM476 3M6,847.5,232.9,99.3,Thoracic,stage IIIA lung ADK,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM477,F,78.1,Pfizer,3M3,356,92,NA,NA,NA,NA,10/fév/2022,Positif,105.3,2864,Négatif,0.1,ONM477 3M3,670.2,252.7,193.7,Breast,stage II breast cancer,Plaquenil,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,Polyarthrite seropositive,plaquenil,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM477,F,78.1,Pfizer,3M6,447,183,NA,NA,NA,NA,12/mai/2022,Positif,126.5,4126,Négatif,0.1,ONM477 3M6,538.2,196,100.2,Breast,stage II breast cancer,Plaquenil,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,Polyarthrite seropositive,plaquenil,NA,NA,NA,NA,NA,NA,ONM,,,"NA","NA"
ONM478,F,58.2,Pfizer,3M3,337,91,NA,NA,NA,NA,01/mar/2022,Positif,96.6,2413,Positif,12.8,ONM478 3M3,2430,1246.3,1045.5,Genitourinary,stage IV ovarien cancer,NA,VEGF inhibitor,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM479,F,69.3,Pfizer,3M3,277,92,NA,NA,NA,NA,21/jan/2022,Positif,93.9,2281,Négatif,3,ONM479 3M3,76.7,23.7,11.6,Breast,stage II breast cancer,NA,Chemotherapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM479,F,69.3,Pfizer,3M6,373,188,NA,NA,NA,NA,27/avr/2022,Positif,133.5,4594,Positif,23.5,ONM479 3M6,2430,677.5,433.1,Breast,stage II breast cancer,NA,Chemotherapy,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM480,M,84.2,Moderna,3M3,319,101,NA,NA,NA,NA,11/fév/2022,Positif,113.1,3302,Négatif,0.2,ONM480 3M3,997,195.6,94.8,Renal,stage IV renal cancer,Hydrocortisone 10-5,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,"pneumonite auto immune in june 2020, traite par sterpidies haute dose",hydroortisone pour surrenale insff,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM480,M,84.2,Moderna,3M6,399,181,NA,NA,NA,NA,02/mai/2022,Positif,167.6,7230,Négatif,0.1,ONM480 3M6,541.1255411255411,117.99410029498526,85.6898029134533,Renal,stage IV renal cancer,Hydrocortisone 10-5,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,"pneumonite auto immune in june 2020, traite par sterpidies haute dose",hydroortisone pour surrenale insff,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM481,F,77.2,Moderna,3M3,285,96,NA,NA,NA,NA,10/jan/2022,Positif,131.9,4485,Négatif,0.2,ONM481 3M3,1866,833.3,361.9,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM481,F,77.2,Moderna,3M6,369,180,NA,NA,NA,NA,04/avr/2022,Positif,99.3,2549,Négatif,0.1,ONM481 3M6,779.4,445.6,249.8,Breast,stage IIA breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM482,F,47.5,Pfizer,3M3,181,64,NA,NA,NA,NA,16/déc/2021,Positif,58.5,894,Négatif,0.4,ONM482 3M3b,47.3,19,2.8,Breast,stage IIIA breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM482,F,47.5,Pfizer,3M6,297,180,NA,NA,NA,NA,11/avr/2022,Positif,29.4,232,Négatif,0,ONM482 3M6,58.2,53.9,11.1,Breast,stage IIIA breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM483,F,53.3,Pfizer,3M3,315,76,NA,NA,NA,NA,16/fév/2022,Positif,119.1,3660,Négatif,0.9,ONM483 3M3,2008.8,463.4,305.5,Skin,stage IV melanoma,Prednisone 30 Mg+Actemera +Vedolizumab,Immune checkpoint inhibitor ICI,Yes,Cancer treatment,Cancer treatment,colitis autoimmune,prednisone +actemera+vedolizumab,NA,NA,NA,NA,NA,NA,ONM,Vedolizumab,Prednisone|Vedolizumab,H02AB07|L04AA33,L04AA
ONM483,F,53.3,Pfizer,3M6,419,180,NA,NA,NA,NA,31/mai/2022,Positif,129.3,4310,Indéterminé,4.5,ONM483 3M6,478,212.2,126.6,Skin,stage IV melanoma,Prednisone 30 Mg+Actemera +Vedolizumab,Immune checkpoint inhibitor ICI,Yes,Cancer treatment,Cancer treatment,colitis autoimmune,prednisone +actemera+vedolizumab,NA,NA,NA,NA,NA,NA,ONM,Vedolizumab,Prednisone|Vedolizumab,H02AB07|L04AA33,L04AA
ONM484,F,66.1,Pfizer,3M3,336,112,NA,NA,NA,NA,13/jan/2022,Positif,64,1067,Négatif,0,ONM484 3M3,127,75.6,44.2,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM484,F,66.1,Pfizer,3M6,417,193,NA,NA,NA,NA,04/avr/2022,Positif,97.2,2443,Indéterminé,5.5,ONM484 3M6,270.1,180.9,159,Breast,stage IV breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM485,M,57.4,Moderna,3M3,248,94,NA,3M3-3M6,NA,NA,07/fév/2022,Positif,85.3,1885,Négatif,0.3,ONM485 3M3,677.5,261,183.6,Genitourinary,stage II urothelial carcinoma,NA,Chemotherapy,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM485,M,57.4,Moderna,3M6,335,181,NA,3M3-3M6,42,NA,05/mai/2022,Positif,85.9,1911,Positif,8.7,ONM485 3M6,2430,2310.00231000231,2419.5499637067505,Genitourinary,stage II urothelial carcinoma,NA,Chemotherapy,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM487,F,58.2,Pfizer,3M3,281,70,NA,NA,NA,NA,04/jan/2022,Positif,122.5,3871,Négatif,0.1,ONM487 3M3b,298.7,154.1,108.3,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM487,F,58.2,Pfizer,3M6,393,182,NA,NA,NA,NA,26/avr/2022,Positif,150.1,5802,Négatif,0.1,ONM487 3M6,443.7,137.1,90.1,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM488,F,43.3,Pfizer,3M3,279,94,NA,NA,NA,NA,03/fév/2022,Positif,110.2,3136,Négatif,0.2,ONM488 3M3,582.8,122.5,51.1,Breast,stage IA breast cancer,NA,Anti-HER2 antibody therapy,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM488,F,43.3,Pfizer,3M6,367,182,NA,NA,NA,NA,02/mai/2022,Positif,163.8,6907,Négatif,0.1,ONM488 3M6,382.55547054322875,81.9000819000819,49.01960784313725,Breast,stage IA breast cancer,NA,Anti-HER2 antibody therapy,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM489,M,46.4,Pfizer,3M3,235,92,NA,3M3-3M6,NA,NA,27/jan/2022,Positif,45.6,547,Négatif,0.2,ONM489 3M3,120.5,1120.4,19.4,Gastrointestinal,stage IV pancreatic cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM489,M,46.4,Pfizer,3M6,339,196,NA,3M3-3M6,10,NA,11/mai/2022,Positif,141.3,5144,Positif,19.3,ONM489 3M6,2430,2313.208420078649,1343.7248051599033,Gastrointestinal,stage IV pancreatic cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM490,F,34.1,Pfizer,3M3,325,94,NA,NA,NA,NA,03/jan/2022,Positif,123.1,3908,Négatif,0.5,ONM490 3M3,1341.4,429.6,363.6,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM490,F,34.1,Pfizer,3M6,423,192,NA,NA,NA,NA,11/avr/2022,Positif,94.6,2315,Négatif,1.1,ONM490 3M6,888.9,404.5,330,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM491,M,86.1,Pfizer,3M3,343,109,NA,3M3-3M6,NA,NA,18/jan/2022,Positif,92.6,2219,Négatif,0.8,ONM491 3M3,145,77.3,52.5,Thoracic,stage I lung ADK,Prednisone 10mg,NA,No,Not treated,NA,arterite de Horton,prednisone 10 mg,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM491,M,86.1,Pfizer,3M6,429,195,NA,3M3-3M6,8,NA,14/avr/2022,Positif,95.5,2359,Négatif,1,ONM491 3M6,423.2,171.8,99.4,Thoracic,stage I lung ADK,Prednisone 10mg,NA,No,Not treated,NA,arterite de Horton,prednisone 10 mg,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM493,M,61.2,Pfizer,3M3,318,101,NA,Before 3M3 after 3rd dose,42,NA,07/fév/2022,Positif,99,2534,Négatif,2.7,ONM493 3M3,168.9,90.7,52.8,Neuroendocrine,NET grele,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM493,M,61.2,Pfizer,3M6,412,195,NA,Before 3M3 after 3rd dose,136,NA,12/mai/2022,Positif,139.7,5029,Positif,11.4,ONM493 3M6,654.5,358.8,175.8,Neuroendocrine,NET grele,NA,NA,No,Not treated,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM495,F,52.1,Pfizer,Baseline1,NA,NA,NA,Before 3M3 after 3rd dose,NA,NA,11/jan/2021,Négatif,0.1,NA,NA,NA,ONM495 BL1,2.1,6.5,3.1,Breast,stage III breast cancer,Prednisone 4mg,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,pericardite (secondaire a une connectivite),prednisone 4 mg/j,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM495,F,52.1,Pfizer,Baseline2,121,NA,NA,Before 3M3 after 3rd dose,NA,NA,17/jun/2021,Positif,6.2,NA,Négatif,0.2,ONM495 BL2,10.4,8.6,2.9,Breast,stage III breast cancer,Prednisone 4mg,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,pericardite (secondaire a une connectivite),prednisone 4 mg/j,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM495,F,52.1,Pfizer,Baseline3,219,NA,NA,Before 3M3 after 3rd dose,NA,NA,23/sep/2021,Négatif,2.0,NA,Négatif,0.1,ONM495 BL3,11.2,11.9,6.9,Breast,stage III breast cancer,Prednisone 4mg,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,pericardite (secondaire a une connectivite),prednisone 4 mg/j,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM495,F,52.1,Pfizer,3M3,338,106,NA,Before 3M3 after 3rd dose,8,NA,20/jan/2022,Positif,74.6,1445,Négatif,1.3,ONM495 3M3,195,82,60.9,Breast,stage III breast cancer,Prednisone 4mg,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,pericardite (secondaire a une connectivite),prednisone 4 mg/j,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM495,F,52.1,Pfizer,3M6,422,190,NA,Before 3M3 after 3rd dose,92,NA,14/avr/2022,Positif,96.8,2423,Positif,13.3,ONM495 3M6,355.1,204.6,143.1,Breast,stage III breast cancer,Prednisone 4mg,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,pericardite (secondaire a une connectivite),prednisone 4 mg/j,NA,NA,NA,NA,NA,NA,ONM,,Prednisone,H02AB07,"NA"
ONM496,M,69.2,Pfizer,3M3,314,84,NA,NA,NA,NA,04/jan/2022,Positif,50.7,674,Négatif,0.7,ONM496 3M3b,68.4,26.9,22.6,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM496,M,69.2,Pfizer,3M6,419,189,NA,NA,NA,NA,19/avr/2022,Positif,28.3,216,Négatif,0.7,ONM496 3M6,37.8,29,17,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM497,F,83.1,Pfizer,3M3,337,94,NA,NA,NA,NA,21/jan/2022,Positif,101.2,2647,Négatif,0.1,ONM497 3M3,145.6,61.7,44.9,Breast,stage IV breast cancer,Metotrexate,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,Polyarthrite seronegative,metotrexate,NA,NA,NA,NA,NA,NA,ONM,,Metotrexate,L04AX03,"NA"
ONM497,F,83.1,Pfizer,3M6,420,177,NA,NA,NA,NA,14/avr/2022,Positif,48,605,Négatif,0.1,ONM497 3M6,72.2,28.3,15.9,Breast,stage IV breast cancer,Metotrexate,Anti-HER2 antibody therapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,Polyarthrite seronegative,metotrexate,NA,NA,NA,NA,NA,NA,ONM,,Metotrexate,L04AX03,"NA"
ONM498,M,45.3,Pfizer,3M3,249,73,NA,NA,NA,NA,13/déc/2021,Positif,83.6,1811,Négatif,3.3,ONM498 3M3b,425.2,192.9,127,Skin,stage IV melanoma,Hydrocortisone 10-5,Immune checkpoint inhibitor ICI,Yes,Cancer treatment + ICI,Cancer treatment,insuf cortico surrenalienne,hydrocortisone,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM498,M,45.3,Pfizer,3M6,361,185,NA,NA,NA,NA,04/avr/2022,Positif,96.5,2408,Négatif,1.9,ONM498 3M6,351.5,182.5,144.2,Skin,stage IV melanoma,Hydrocortisone 10-5,Immune checkpoint inhibitor ICI,Yes,Cancer treatment + ICI,Cancer treatment,insuf cortico surrenalienne,hydrocortisone,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM499,F,76.1,Pfizer,3M3,295,71,NA,3M3-3M6,NA,NA,10/déc/2021,Positif,94.4,2305,Négatif,0.3,ONM499 3M3b,606.1,329.1,62.7,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM499,F,76.1,Pfizer,3M6,397,173,NA,3M3-3M6,73,NA,22/mar/2022,Positif,102.6,2720,Positif,6.7,ONM499 3M6,4492.4,3172.6,1656.5,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM500,F,63.2,Pfizer,3M3,252,69,NA,3M3-3M6,NA,NA,08/déc/2021,Positif,106.3,2919,Négatif,0.2,ONM500 3M3b,429.2,128.6,103.6,Gastrointestinal,stage IV pancreatic cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM500,F,63.2,Pfizer,3M6,357,174,NA,3M3-3M6,54,NA,23/mar/2022,Positif,59.3,918,Positif,17.2,ONM500 3M6,27063.6,16262.8,15537.6,Gastrointestinal,stage IV pancreatic cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM501,M,49.1,Pfizer,3M3,304,89,NA,3M3-3M6,NA,NA,13/déc/2021,Positif,101.7,2673,Négatif,0.4,ONM501 3M3b,181.2,66.8,48.3,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM501,M,49.1,Pfizer,3M6,395,180,NA,3M3-3M6,38,NA,14/mar/2022,Positif,136.8,4823,Négatif,2.6,ONM501 3M6,2326.7,888.9,1218,Thoracic,stage IV lung ADK,NA,Immune checkpoint inhibitor ICI,Yes,Cancer treatment + ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM502,F,66.2,Moderna,3M3,309,89,NA,NA,NA,NA,26/jan/2022,Positif,85.6,1898,Négatif,0.5,ONM502 3M3,1465.8,451.7,161.9,Genitourinary,stage IV cervical cancer,NA,VEGF inhibitor,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM502,F,66.2,Moderna,3M6,402,182,NA,NA,NA,NA,29/avr/2022,Positif,135.7,4746,Indéterminé,4.2,ONM502 3M6,2430,1306,847.5,Genitourinary,stage IV cervical cancer,NA,VEGF inhibitor,No,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM503,M,62.3,Moderna,3M3,252,77,NA,3M3-3M6,NA,NA,07/jan/2022,Positif,98.7,2519,Négatif,0,ONM503 3M3,679.8,225.5,128.4,Genitourinary,stage IV urothelial carcinoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM503,M,62.3,Moderna,3M6,357,182,NA,3M3-3M6,24,NA,22/avr/2022,Positif,91.8,2181,Négatif,1.9,ONM503 3M6,443.3,232.3,130,Genitourinary,stage IV urothelial carcinoma,NA,Immune checkpoint inhibitor ICI,Yes,ICI,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM504,F,64.4,Moderna,3M3,202,63,NA,NA,NA,NA,15/déc/2021,Positif,70.7,1299,Négatif,0.1,ONM504 3M3b,106.8,42,18.9,Thoracic,stage IV lung ADK,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM504,F,64.4,Moderna,3M6,333,194,NA,NA,NA,NA,25/avr/2022,Positif,35.9,343,Négatif,0.1,ONM504 3M6,48.5,30.4,12.2,Thoracic,stage IV lung ADK,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM505,F,64.4,Moderna,Baseline1,150,NA,NA,Before 3M3 after 3rd dose,NA,NA,07/oct/2021,Positif,70.3,NA,Négatif,0.7,ONM505 3M6,1276.6500702157539,939.8496240601503,903.342366757001,Breast,in situ breast carcinoma,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM505,F,64.4,Moderna,3M3,262,93,NA,Before 3M3 after 3rd dose,18,NA,27/jan/2022,Positif,92.8,2228,Positif,10.7,ONM505 3M3,1362.2,755.9,499.3,Breast,in situ breast carcinoma,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM506,F,57.2,Pfizer,3M3,328,98,NA,Before 3M3 after 3rd dose,13,NA,20/jan/2022,Positif,106.4,2924,Positif,8.9,ONM506 3M3,1011.1,587.5,557.4,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM506,F,57.2,Pfizer,3M6,418,188,NA,Before 3M3 after 3rd dose,103,NA,20/avr/2022,Positif,108.8,3057,Négatif,2,ONM506 3M6,1676.7,1107.5,851.8,Breast,stage II breast cancer,NA,Hormonal therapy,Yes,Cancer treatment_Horm.,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM508,F,56.3,Pfizer,3M3,274,113,NA,NA,NA,NA,25/jan/2022,Positif,78.1,1583,Négatif,0.2,ONM508 3M3,407.8,174.4,120.5,Breast,stage IV breast cancer,Hydrocortisone 20-10,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,insuf cortico surrenalienne,hydrocortisone,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM508,F,56.3,Pfizer,3M6,344,183,NA,NA,NA,NA,05/avr/2022,Positif,117.9,3587,Négatif,0,ONM508 3M6,253.2,160.6,87.6,Breast,stage IV breast cancer,Hydrocortisone 20-10,Antibody-drug conjugate,Yes,Cancer treatment,Cancer treatment,insuf cortico surrenalienne,hydrocortisone,NA,NA,NA,NA,NA,NA,ONM,Hydrocortisone,,"NA",H02AB09
ONM509,F,41.1,Pfizer,3M3,331,71,NA,NA,NA,NA,06/jan/2022,Positif,91,2143,Positif,9,ONM509 3M3,100.9,47.4,34.4,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM509,F,41.1,Pfizer,3M6,436,176,NA,NA,NA,NA,21/avr/2022,Positif,44.3,517,Négatif,0.7,ONM509 3M6,77,55.7,39,Breast,stage IV breast cancer,NA,Anti-HER2 antibody therapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM510,F,47.4,Moderna,3M3,257,63,NA,NA,NA,NA,24/jan/2022,Positif,104.6,2827,Négatif,0.4,ONM510 3M3,247.8,72.7,56.2,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM510,F,47.4,Moderna,3M6,369,175,NA,NA,NA,NA,16/mai/2022,Positif,138.2,4921,Négatif,0.2,ONM510 3M6,172.1,47.4,45.2,Breast,stage IV breast cancer,NA,Tyrosine kinase inhibitor TKI,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,denosumab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM511,F,48.5,Moderna,3M3,266,115,NA,Before 3M3 after 3rd dose,67,NA,07/avr/2022,Positif,108.2,3023,Indéterminé,5.3,ONM511 3M3,2430,1014.7,869.6,Breast,stage II breast cancer,NA,Chemotherapy,Yes,Cancer treatment_Horm. + other treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM512,M,74.2,Pfizer,3M3,280,96,NA,NA,NA,NA,03/jan/2022,Négatif,2,2,Négatif,0.4,ONM512 3M3,1,1.4,1,Gastrointestinal,satge III colon cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,LLC traitee en 2010: Ribomustin,chemo+cetuximab,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM513,F,32.5,Pfizer,3M3,226,90,NA,3M3-3M6,NA,NA,24/fév/2022,Positif,96.6,2413,Négatif,0.1,ONM513 3M3,190.6,100.6,65.1,Breast,stage II breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
ONM513,F,32.5,Pfizer,3M6,322,186,NA,3M3-3M6,88,NA,31/mai/2022,Positif,98.8,2524,Négatif,2.4,ONM513 3M6,1296.848657761639,515.1983513652756,769.8229407236336,Breast,stage II breast cancer,NA,Chemotherapy,Yes,Cancer treatment,Cancer treatment,NA,NA,NA,NA,NA,NA,NA,NA,ONM,"NA","NA","NA","NA"
